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Abstract 
This thesis describes investigations into the ability of isothioureas to act as 
organocatalysts in formal [4+2] cycloadditions between carboxylic acids and various 
Michael acceptors via C1-ammonium enolate intermediates. 
Initial research focused upon establishing optimal reaction conditions to affect the 
asymmetric intermolecular formal [4+2] cycloaddition between a range of arylacetic 
acids and -keto-,-unsaturated esters, giving anti-dihydropyranones in high yield (49-
87%) and with excellent diastereo- and enantioselectivity (up to 98:2 dr, up to 99% ee). 
This represented the first time that carboxylic acid derived ammonium enolates have 
been successfully applied towards an intermolecular reaction process. 
Subsequent studies utilised trifluoromethyl enones as Michael acceptors, forming a 
range of C(6)-trifluoromethyl anti-dihydropyranones with good diastereoselectivity (up 
to 95:5 dr) and enantioselectivity (up to >99% ee). Detailed mechanistic studies were 
carried out, revealing that the process was stereospecific, with the diastereoisomer of 
product formed dependent upon the configuration of trifluoromethyl enone used. A 
variety of product derivatisations were demonstrated including those which introduce 
additional trifluoromethyl-bearing stereogenic centres with high diastereoselectivity. 
Kinetic studies indicated that this Michael addition-lactonisation process is first order 
with respect to both in situ formed anhydride and catalyst concentration, with a primary 
kinetic isotope effect observed using ,-di-deuterio 4-fluorophenylacetic acid. DFT 
computational studies support a rate-determining formation of a reactive ammonium 
enolate prior to a stereochemistry-determining enone conjugate-addition step. 
The isothiourea-catalysed -amination of carboxylic acids with low catalyst loadings (as 
low as 0.25 mol%) using N-aryl-N-aroyl Michael acceptors was demonstrated, forming a 
range of 1,3,4-oxadiazin-6(5H)-ones or hydrazide products with excellent enantiocontrol 
(typically >99% ee). Notably, the scope of this methodology was expanded to allow the 
direct functionalisation of carboxylic acids bearing -heteroatom and alkyl substitution 
for the first time. The synthetic utility of the hydrazide products was demonstrated 
through their derivatisation into a range of bespoke functionalised N-aryl--arylglycine 
derivatives in high enantiopurity (up to 99% ee). 
Isothiourea-mediated functionalisation of 3-alkenoic acids was shown to occur 
regioselectively, giving products derived from -functionalisation of an intermediate 
C1-ammonium dienolate in a range of formal [2+2] and [4+2] cycloadditions. Formal 
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[4+2] cycloadditions with either trifluoromethyl enones of N-aryl-N-aroyl diazenes 
allow access to products in high diastereo- and enantiocontrol (up to 95:5 dr, up to 99% 
ee). The simple, two-step elaboration of stereodefined hydrazides into aza-sugar 
analogues without erosion of enantiopurity has also been demonstrated. 
2-Arylacetic anhydrides were also demonstrated as useful precursors for the formation 
of C1-ammonium enolates in isothiourea-mediated Michael addition-lactonisation 
processes. Trifluoromethylenones,-keto-,-unsaturated esters and N-aryl-N-
aroyldiazenes are reactive Michael accceptors in this process, with HBTM-2.1 (5 mol%) 
readily promoting heterocycle formation with high diastereo- and enantiocontrol (up to 
95:5 dr, up to >99% ee). This protocol offered a useful and practical alternative to the in 
situ carboxylic acid activation method, in which by-product formation and the amount of 
sacrificial base used is minimised. 
DHPB was shown to promote the one-pot synthesis of 2,4,6-subsituted pyridines bearing 
a readily derivatised 2-sulfonate functionality from (phenylthio)acetic acid and a range 
of ,-unsaturated ketimines in moderate yields (40-66%). Functionalisation of the 2-
sulfonate group via various methodologies allowed the rapid assembly of both novel and 
biologically relevant pyridines. 
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Chapter 1: Introduction 
1.1 Asymmetric Catalysis 
In many biological systems it is known that the two enantiomers of a chiral compound 
are recognised as different substances and often produce biological responses distinct 
from one another. There are documented cases, such as the sedative thalidomide which 
was withdrawn from the market in 1961 due to being identified as the cause of birth 
defects, in which one enantiomer of a drug when administered has the desired 
therapeutic effect while the other enantiomer causes adverse biological effects.
1
 It is 
therefore important to be able to prepare pharmaceutical compounds in exclusively one 
enantiomeric form (100% enantiomeric excess) or the U.S. Food and Drug 
Administration agency – who treat the presence of the undesired enantiomer as an 
impurity – will withhold drug approval. A variety of ways exist to access one 
enantiomeric form of a chiral compound including traditional methods such as chemical 
resolution and the use of chiral auxiliaries. 
Despite the merits of these approaches a particularly appealing, yet challenging field is 
asymmetric catalysis that aims to use chiral catalysts in sub-stoichiometric quantities to 
create enantiomerically pure products. The potential economic advantages of this 
approach over stoichiometric methods are clear, and this is reflected by the explosion of 
interest in developing new catalytic asymmetric processes suitable for application on 
industrial scale. There are currently a number of such processes operating in industry, 
many of which use transition metals. A leading example is the industrial synthesis of 
Metachlor (S)-1, a popular herbicide, which includes within its synthesis the 
hydrogenation of an imine using iridium and a chiral ferrocene-derived phosphine ligand 
2. The process yields over 10,000 tonnes of product a year from only 34 kg of iridium 
(Scheme 1).
2
 
 
Scheme 1: Industrial asymmetric synthesis of Metachlor (S)-1. 
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1.1.1 Organocatalysis 
Although the field of enantioselective metal-catalysed processes had been well 
established, until around the year 2000, relatively few processes had been communicated 
which make use of organic molecules to catalyse asymmetric reactions. Organocatalysis 
is an attractive alternative to metal-catalysed processes due to the inherent benefits of 
using organic molecules as catalysts such as their typically low sensitivity to moisture 
and air, low cost and toxicity along with being easily handled and readily accessed from 
the chiral pool.  
Organocatalysis is typically defined as the acceleration of a chemical reaction by 
addition of a substoichiometric amount of an organic molecule which does not contain a 
metal atom,
3,4
  and can be divided into four main types of activation modes: Brønsted 
acid, Brønsted base, Lewis acid and Lewis base. 
 
1.1.1.1 Brønsted Acid Catalysis 
In Brønsted acid activation the catalyst initially donates a proton to the substrate 
(Brønsted base) and subsequently imparts asymmetry via hydrogen bonding or tight ion-
pairing.
5
 Typical catalysts that operate by this organocatalytic reaction mode are ureas, 
thioureas, BINOL derivatives, phosphoric acids and more recently phosphoramides. 
Jacobsen is one of the pioneers in this field and in 1998, illustrated how chiral ureas 
could be used as Brønsted acid catalysts for an asymmetric Strecker reaction by 
lowering the LUMO of the imine via hydrogen bonding to the substrate.
6
 Reaction of 
imine 3 with TBSCN in the presence of TFAA and a chiral urea derivative gave 
cyanated amide (R)-4 in 78% yield and 91% ee via Si-face attack of cyanide on the 
LUMO activated imine 5 (Scheme 2). 
 
Scheme 2: Brønsted acid-catalysed Strecker reaction. 
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1.1.1.2 Brønsted Base Catalysis 
Brønsted base catalysis involves the initial deprotonation of the substrate (Brønsted acid) 
by the catalyst and asymmetry results from a tight ion-pair between the protonated chiral 
catalyst and the deprotonated substrate.
7
 Many catalyst architectures have found 
application as Brønsted bases including Cinchona alkaloids, thioureas, amidines and 
guanidines. A recent example from the Lambert group utilises the highly basic chiral 
cyclopropenimine organocatalyst 6 to impart high levels of asymmetry in the Michael 
addition of glycine imine substrate 7 to acrylate 8, giving amino acid derivative (S)-9 in 
99% yield and 98% ee (Scheme 3) via pre-TS assembly 10.
8 
 
Scheme 3: Brønsted base-catalysed Michael addition. 
 
1.1.1.3 Lewis Acid Catalysis 
In Lewis acid activation the organocatalyst has the ability to accept a lone pair of 
electrons from the substrate and asymmetry can be induced via tight ion pairing.
9
 Many 
organic Lewis acid catalysts operate via phase transfer catalysis and an example from 
the Maruoka group utilised axially chiral phosphonium salt 11 as catalyst for the 
asymmetric -amination of -keto ester 12 using diazodicarboxylate 13, giving (S)-14 in 
99% yield and 91% ee (Scheme 4).
10 
 
Scheme 4: Lewis Acid-catalysed asymmetric -amination. 
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1.1.1.4 Lewis Base Catalysis 
Lewis base activation represents the largest area of organocatalysis and can be broadly 
described by the ability of a catalyst to activate a substrate molecule through the 
donation of a lone pair of electrons.
11
 The term Lewis base catalysis encompasses a 
range of activation modes including enamine, iminium, SOMO, ylide, acyl ammonium, 
ammonium enolate and carbene catalysis. Representative examples of selected reaction 
modes are described here with ammonium/azolium enolates described later in more 
detail. 
 
1.1.1.4.1 Enamine Catalysis 
Enamine catalysis involves the condensation of a secondary amine with a carbonyl 
group, followed by tautomerisation of the iminium cation formed in situ to generate an 
enamine intermediate.
12
 This HOMO activated, nucleophilic species can then undergo 
reaction with various electrophiles or can partake in pericylic reactions. The Hajos-
Parrish-Eder-Sauer-Wiechert cyclisation, published in 1971, is one of the earliest and 
perhaps most celebrated examples of enamine catalysis and involves a proline-catalysed 
asymmetric intramolecular aldol reaction.
13
 This reaction allows the conversion of 
triketone 15 to the enantiomerically enriched bicyclic diketone (3aS,7aS)-16 in the 
presence of (S)-17, the amino acid proline, through proposed pre-TS assembly 18 in 
quantitative yield and 93% ee (Scheme 5).
 
 
Scheme 5: Hajos-Parrish-Eder-Sauer-Wiechert cyclisation. 
 
In 2000, List and co-workers further explored the utility of (S)-proline in enamine 
organocatalysis.
14
 Their work showed that the enamine intermediate could be applied to 
the asymmetric intermolecular aldol reaction. For example, an intermolecular aldol 
reaction between acetone 19 and isobutyraldehyde 20 in the presence of (S)-17 generates 
the aldol product (R)-21, through proposed pre-TS assembly 22 in 97% yield and 96% 
ee (Scheme 6). 
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Scheme 6: (S)-proline-catalysed asymmetric aldol reaction. 
 
This powerful illustration of the utility of (S)-proline in the asymmetric aldol reaction 
spurred on research into its ability to catalyse related asymmetric reactions such as the 
Mannich and Michael addition reactions.
15
 
 
1.1.1.4.2 Iminium Catalysis 
Iminium catalysis involves the generation of a reactive iminium ion via the condensation 
of an amine catalyst with a carbonyl substrate.
16
 In 2000, Macmillan and co-workers 
showed how this principle could be used to catalyse a highly enantioselective 
organocatalytic Diels-Alder reaction.
17
 Treatment of (E)-cinnamaldehyde 23 with 
cyclopentadiene 24 and imidazolidinone (S)-25 affords the Diels-Alder adducts 
(1S,2S,3S,4R)-26 and (1R,2S,3S,4S)-27 as a 1.3:1 exo/endo ratio in 99% combined yield 
and with both isomers formed in 93% ee via the LUMO activated iminium ion 28 
(Scheme 7).  
 
Scheme 7: Asymmetric Diels-Alder reaction. 
 
1.1.1.4.3 SOMO Catalysis 
Singly occupied molecular orbital (SOMO) catalysis involves the generation of a 
reactive radical cation via the one electron oxidation of an electron rich enamine. The 
resulting electrophilic species can react with carbon-based nucleophiles to produce a 
variety of -functionalised products. In 2007, Macmillan and co-workers illustrated how 
this new mode of activation could be used to catalyse the highly enantioselective 
organocatalytic -allylation of aldehydes.18 Reaction of hexanal 29 and allyl silane 30 
Chapter 1: Introduction 
 
 
 6 
with imidazolidinone (2S,5S)-31 and 2 eq of oxidant ceric ammonium nitrate gives -
allylated aldehyde (R)-32 in 81% yield and 91% ee via the SOMO activated radical 
cation 33 (Scheme 8).  
 
Scheme 8: Asymmetric -allylation reaction. 
 
1.1.1.4.4 N-Heterocyclic Carbene Catalysis 
Carbene catalysis involves the utilisation of a nucleophilic carbene species, often an N-
heterocyclic carbene (NHC).
19
 The formally electron deficient carbene centre is 
stabilised by two separate effects. Mesomeric stabilisation arises from -electron 
donation from the adjacent nitrogen lone pairs into the vacant p orbital. There is also a 
-withdrawing effect due to the adjacent electronegative nitrogen substitutents (Figure 
1). Introducing bulky N-substituents also increases the stability of NHCs by shielding 
the orthogonal lone pair. 
 
Figure 1: Stabilisation of NHCs. 
 
In organocatalysis, NHCs are considered as versatile reactive species and have found 
application in a variety of different reaction types.
20
 For example, in 2002 Nolan and co-
workers illustrated the use of various N-heterocylic carbenes to mediate a 
transesterification reaction.
21,22
 Treatment of methyl acetate 34 and benzyl alcohol 35 
with catalytic quantities of NHC 36 furnishes ester 37 in quantitative yield (Scheme 9). 
 
Scheme 9: NHC-catalysed transesterification reaction. 
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The Benzoin condensation reaction involves an acyl anion equivalent reacting with an 
aldehyde. In 2002, Enders and co-workers illustrated the use of a triazolium-derived 
triazolinylidene NHC to catalyse an asymmetric benzoin reaction.
23
 Treatment of 
benzaldehyde 38 with catalytic amounts of NHC, formed from salt (S)-39, affords 
benzoin product (S)-40 in 83% yield and 90% ee via Breslow intermediate 41 (Scheme 
10).
24 
 
Scheme 10: NHC-catalysed asymmetric benzoin reaction. 
 
1.1.1.4.5 Ammonium Enolate Catalysis 
Ammonium enolates can be considered as nucleophilic species that are generated by the 
action of a chiral tertiary amine catalyst.
25
 Ammonium enolates can be generated by 
several different methods involving nucleophilic attack of the amine catalyst (NR3) with 
various electrophiles (Scheme 11). For example, reaction of an amine catalyst with 
ketenes 42, -halocarbonyl compounds 43 and ,-unsaturated carbonyl compounds 44 
generates C1-, C2- and C3-ammonium enolates respectively. The ammonium enolates 
formed can react with various electrophiles. C1-azolium enolates are formed via similar 
methods using NHC catalysts and these will be discussed in Section 1.2.2. 
 
Scheme 11: C1-, C2- and C3-ammonium enolates. 
 
In 1982, Wynberg and co-workers illustrated the use of a C1-ammonium enolate to 
catalyse enantioselective -lactone formation.26 Treatment of ketene 45 with chloral 46 
and catalytic amounts of cinchona alkaloid 47 furnishes -lactone (S)-48 in 95% yield 
and 98% ee via C1-ammonium enolate 49 (Scheme 12). 
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Scheme 12: Wynberg's -lactone synthesis. 
 
Ammonium enolates are considered as exceptionally versatile reactive intermediates and 
have been exploited for a range of asymmetric transformations. C1-ammonium enolates, 
commonly formed from the interaction of a nucleophilic tertiary amine such as 50 or 51 
with either a preformed or in situ generated ketene, have found utility in many reactions, 
including -lactone27 and -lactam28 formation, ketene dimerisation,29 -halogenation30 
and formal [4+2] cycloadditions
31
 (Figure 2). Alternatively, C1-ammonium enolates can 
be generated by the acylation of a tertiary amine followed by deprotonation by a base.
25 
 
Figure 2: Selection of reactions utilising C1-ammonium enolates. 
 
In 2003, Gaunt and co-workers illustrated the ability of C2-ammonium enolates, also 
known as ammonium ylides, to function as asymmetric cyclopropanating agents.
32
 The 
catalysed reaction between -bromo ester 52 and enone 53 by cinchona alkaloid 
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derivative 54 in the presence of caesium carbonate gave cyclopropane (1R,2R)-55 in 
96% yield and 86% ee via C2-ammonium enolate 56 (Scheme 13). 
 
Scheme 13: Gaunt's cyclopropane synthesis. 
 
C3-ammonium enolates have found utility in their ability to catalyse the Morita-Baylis-
Hillman reaction with high enantioselectivity. In 1999, Hatakeyama and co-workers 
discovered that -isocupreidine 57 catalysed the asymmetric reaction between 
benzaldehyde 38 and ,-unsaturated ester 58 to furnish the coupled product (R)-59 in 
57% yield and 95% ee via C3-ammonium enolate 60 (Scheme 14).
33 
 
Scheme 14: Application of C3-ammonium enolates. 
 
1.2 C1-Ammonium/Azolium Enolates in Formal [4+2] Cycloadditions 
Both C1-ammonium and azolium enolates are reactive nucleophilic intermediates that 
participate in a various formal [4+2] cycloaddition reactions, many of which have been 
discovered over the past few years.
34
 A selection of these processes will be discussed in 
the following sections. 
 
1.2.1 C1-Ammonium Enolates in Formal [4+2] Cycloadditions 
As described previously, C1-ammonium enolates are commonly formed from the 
interaction of a nucleophilic tertiary amine with either a preformed or in situ generated 
ketene and these nucleophilic species have been utilised in formal [4+2] 
cycloadditions.
25
 In 2006 Lectka and co-workers showed that cinchona alkaloid-derived 
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ketene enolates undergo a variety of enantioselective [4+2] cycloadditions with o-
quinones,
35
 o-quinone diimides
36
 and quinone imides.
37
 For example, reaction of acid 
chloride 61 with o-quinone 62 in the presence of catalytic cinchona alkaloid 63 gave 
cycloadduct (R)-64 in 90% yield and 90% ee via C1-ammonium enolate 65 (Scheme 
15). 
 
Scheme 15: Formal [4+2] cycloaddition of C1-ammonium enolate. 
 
1.2.2 C1-Azolium Enolates in Formal [4+2] Cycloadditions 
C1-azolium enolates also partake in a vast array of formal [4+2] cycloadditions. The 
enolates are formed using NHCs, with ketenes, -functionalised aldehydes and enals the 
commonly employed enolate precursors.
38
 For example, Ye and co-workers have shown 
that NHCs catalyse the [4+2] cycloaddition of isolable disubstituted ketenes with 
enones.
39
 The catalysed reaction of ketene 66 and enone 67 by NHC precatalyst 68 in the 
presence of caesium carbonate gave anti-dihydropyranone (3R,4R)-69 in 79% yield, 
>20:1 dr and 91% ee via azolium enolate 70 (Scheme 16). 
 
Scheme 16: NHC-catalysed formal [4+2] cycloaddition using isolable, disubstituted ketenes. 
 
In 2006, Bode and co-workers employed NHCs to catalyse asymmetric [4+2] 
cycloadditions, using azolium enolates generated from -chloroaldehydes to give syn-
dihydropyranones with excellent enantio- and diastereocontrol.
40
 Reaction of -
chloroaldehyde 71 with enone 72 in the presence of NHC precatalyst 73 and base gave 
syn-dihydropyranone (3S,4S)-74 in 88% yield, >20:1 dr and 99% ee via azolium enolate 
75 (Scheme 17). 
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Scheme 17: Formal [4+2] cycloaddition of NHC derived azolium enolate. 
 
The same group has also demonstrated the utility of enals as C1-azolium enolate 
precursors and their subsequent application towards asymmetric formal [4+2] 
cycloadditions.
41
 In a representative example, NHC precatalyst 73 in the presence of i-
Pr2NEt promotes the annulation of enal 76 with ketimine 77, giving syn-dihydropyridone 
(3S,4S)-78 in 90% yield, >50:1 dr and 99% ee via azolium enolate 79 (Scheme 18). 
 
Scheme 18: Enals as C1-azolium enolate precursors. 
 
In 2012 the Chi group showed the ability to generate C1-azolium enolates from activated 
carboxylate ester starting materials and demonstrated their subsequent utility in formal 
[4+2] cycloadditions.
42
 For example, triazolium-based NHC precatalyst 80 promoted the 
reaction between ester 81 and ketimine 82 in the presence of Me4NCl and excess i-
Pr2NEt, giving anti-dihydropyridone (3S,4S)-83 in 87% yield, 20:1 dr and 88% ee via 
azolium enolate 84 (Scheme 19). 
 
Scheme 19: Activated esters as C1-azolium enolate precursors. 
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Recently, Rovis and co-workers demonstrated the use of simple aliphatic aldehydes as 
C1-azolium enolate precursors when a stoichiometric amount of an oxidant is used.
43
 In 
a representative case, NHC precatalyst 85 efficiently catalyses the formal [4+2] 
cycloaddition between propionaldehyde 86 and chalcone 87 in the presence of K2CO3 as 
base and 88 as oxidant, giving syn-dihydropyranone (3R,4R)-89 in 89% yield, 20:1 dr 
and 99% ee via azolium enolate 90 (Scheme 20). 
 
Scheme 20: Aliphatic aldehydes as C1-azolium enolate precursors. 
 
1.3 Organocatalytic Generation of Enolates from Carboxylic Acids 
Many of the organocatalytic methods known to date act upon substrates at the 
aldehyde/ketone oxidation level. An alternative and synthetically appealing strategy for 
the organocatalytic generation of enolates is directly from cheap, readily available and 
easily handled carboxylic acids. Surprisingly, this area has received little attention to 
date, however Romo and co-workers have demonstrated the intramolecular cyclisation 
of aldehyde- and keto-acids to give -lactones with good yields and stereoselectivities, 
making use of cinchona alkaloids
44
 or PPY
45
 as organocatalysts. For example aldehyde-
acid 91 undergoes a nucleophile-catalysed aldol lactonisation (NCAL) reaction when 
treated with pyridinium salt 92 and cinchona alkaloid 93 in the presence of base to give 
bicyclic -lactone (1S,5R)-94 in 54% yield, >19:1 dr and 92% ee via C1-ammonium 
enolate 95 (Scheme 21).   
 
Scheme 21: Organocatalytic -lactone formation from aldehyde-acids. 
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At the onset of these PhD studies no catalytic variant of this reaction had been disclosed. 
Subsequently Romo extended this protocol towards highly enantioselective 
intramolecular desymmetrising aldol-lactonisation reactions, initially using 
stoichiometric isothiourea tetramisole (TM)
46
 and recently to substoichiometric 
homobenzotetramisole (HBTM),
47
 first introduced by Birman who demonstrated its 
ability to catalyse the kinetic resolution of secondary alcohols.
48
 For example, initial 
activation of keto-acid 96 with p-TsCl and i-Pr2NEt, followed by reaction with catalytic 
homobenzotetramisole (S)-97 and LiCl as a co-catalyst, gave tricyclic -lactone 
(2aS,4aS,8aS)-98 in 93% yield and 90% ee via C1-ammonium enolate 99 (Scheme 22). 
The organocatalytic reaction using homobenzotetramisole was published during the 1
st
 
year of this PhD. 
 
Scheme 22: Organocatalytic activation of carboxylic acids using isothioureas. 
 
1.4 Development of Isothioureas as Organocatalysts 
Birman was the first to demonstrate the use of isothioureas in catalysis. The isothiourea 
catalyst architecture evolved over time beginning from the initial discovery of amidine 
catalyst (R)-100. The Lewis base organocatalyst could act as an acyl transfer agent and 
was efficient in catalysing the kinetic resolution of secondary alcohols.
49
 The kinetic 
resolution of alcohol 101 with amidine (R)-100 and propionic anhydride gave ester (R)-
102 and alcohol (S)-103 with 39% conversion and a selectivity factor of 36 (Scheme 23). 
The reaction is believed to proceed through pre-TS assembly 104 in which the steric 
interactions between the alcohol and acyl transfer agent are minimised. 
 
Scheme 23: Amidine-catalysed kinetic resolution of secondary alcohols. 
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The catalyst substructure was optimised, firstly to amidine (R)-105 which was designed 
to provide enhanced -stacking with benzylic and cinnamyl alcohol substrates in kinetic 
resolution of secondary alcohols.
50
 This catalyst considerably increased reaction rates 
and selectivities compared with the first generation catalyst (R)-100 (Figure 3). Birman 
then highlighted the ability of isothioureas tetramisole (S)-106 and its derivative 
benzotetramisole (R)-107 to act as acyl transfer agents.
51
 These catalysts were found to 
be more selective than amidines (R)-100 and (R)-105 in the kinetic resolution of 
secondary alcohols.   
 
Figure 3: Amidine catalyst substructure optimisation. 
 
The groups of Birman and Okamoto independently discovered the ability of achiral 
isothiourea DHPB 108 to act as a highly efficient acyl transfer catalyst.
52,53
 Birman 
subsequently reported the higher catalytic activity of homobenzotetramisole (S)-109 
compared to benzotetramisole (R)-107 and highlighted its ability to achieve high 
enantioselectivities in the kinetic resolution of secondary benzylic alcohols and in 
particular 2-aryl substituted cycloalkanols.
54
 Independent studies by Birman
55
 and 
Smith
56
 showed that the incorporation of an alkyl substituent at the C(3) position of the 
homobenzotetramisole catalyst scaffold, giving isothioureas 110, resulted in a further 
improvement in catalytic activity (Figure 4).  
 
Figure 4: Further isothiourea catalyst substructure optimisation. 
 
These isothioureas have been utilised within the Smith group as Lewis bases to catalyse 
numerous different reaction processes in which variation of the substituents at C(2) and 
C(3) have been investigated.  
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1.5 Previous Research in the Smith Group Using Isothioureas 
1.5.1 Asymmetric Steglich rearrangement 
In 2009, Smith and co-workers reported the ability of chiral isothioureas to catalyse the 
asymmetric Steglich rearrangement.
56
 This process utilises the ability of the isothiourea 
to operate as a carboxyl transfer agent. Treatment of oxazolyl carbonate 111 with 
HBTM-2.1 112 undergoes rearrangement to give C-carboxyazlactone (R)-113 in 96% 
yield and 93% ee via proposed N-carboxy intermediate 114 (Scheme 24). 
 
Scheme 24: Isothiourea-catalysed Steglich rearrangement. 
 
The proposed catalytic cycle for this reaction involves the initial nucleophilic attack of 
HBTM-2.1 112 on oxazolyl carbonate 115 to generate N-carboxy intermediate 116 and 
enolate 117. Subsequent nucleophilic attack of the enolate through C(4) to the carboxyl 
carbonyl group gives C-carboxyazlactone (R)-118 and regenerates the catalyst (Scheme 
25). 
 
Scheme 25: Proposed catalytic cycle for the Steglich rearrangement. 
 
It was proposed that upon formation of an N-carboxy derivative 119, the stereodirecting 
C(2) substituent adopts a pseudo-axial conformation that blocks one face of the 
isothiourea. The enolate 120 then approaches the N-carboxy derivative anti to the 
stereodirecting C(2) substituent in an electrostatically complimentary orientation, 
assisted by C-H···O interactions, and minimising the steric interactions with the axial 
C(3)-H (Figure 5). These factors give rise to a highly enantioselective reaction. 
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Figure 5: Proposed pre-TS assembly in Steglich rearrangement. 
 
In this process it was found that when the phenyl stereodirecting group at C(2) was 
changed to an i-Pr substituent there was an observable decrease in catalytic activity 
although the product was still formed in high enantioselectivity. 
 
1.5.2 C-acylation of Silyl Ketene Acetals 
In 2010, Smith and co-workers reported the isothiourea catalysed diastereoselective C-
acylation of silyl ketene acetals.
57
 In this process, the isothiourea operates as an acyl 
transfer agent. Treatment of silyl ketene acetal 121 with DHPB 108 in the presence of 
acetic anhydride gives C-acylated lactone (±)-122 in 78% yield and 98:2 dr via proposed 
N-acyl intermediate 123 (Scheme 26). 
 
Scheme 26: Isothiourea-catalysed diastereoselective C-acylation of silyl ketene acetals. 
 
An asymmetric variant of this methodology has been developed within the Smith 
group.
58
 For example, treatment of silyl ketene acetal 124 with chiral isothiourea 125 in 
the presence of propionic anhydride gives C-acylated lactone (S)-126 in 86% yield and 
80% ee via proposed N-acyl intermediate 127 (Scheme 27). 
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Scheme 27: Isothiourea-catalysed asymmetric C-acylation of silyl ketene acetals. 
 
The proposed catalytic cycle for this reaction involves the initial nucleophilic attack of 
125 on propionic anhydride to generate an activated acyl-isothiouronium ion 128, with 
desilyation of the silyl ketene acetal promoted by the carboxylate counterion generating 
enolate 129. Subsequent nucleophilic attack of the enolate with 127 generates lactone 
(S)-126 and regenerates the isothiourea (Scheme 28). 
 
Scheme 28: Proposed catalytic cycle for the C-acylation of silyl ketene acetals. 
 
The sense of asymmetric induction in these systems can be rationalised by direct 
comparison to the related C-carboxylation of oxazolyl carbonates discussed previously. 
 
1.5.3 Intramolecular Michael Addition-Lactonisations 
At the onset of these PhD studies no isothiourea-catalysed Michael addition-
lactonisation methodologies had been reported. However, based upon the interest within 
the Smith group in the use of Lewis bases as organocatalysts
59
 and specifically 
isothioureas
60
 and building upon the precedents outlined by Romo and co-workers, in 
2011 the Smith group reported the ability of chiral isothioureas to promote the highly 
enantioselective intramolecular Michael addition-lactonisation process of a range of 
enone acid substrates.
61
 For example, commercially available chiral isothiourea 
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tetramisole hydrochloride (S)-106 was a highly efficient precatalyst for the conversion of 
enone acid 130, preactivated in situ to the mixed anhydride with pivaloyl chloride and i-
Pr2NEt, into tricycle (4aR,9aR)-131 in 81% yield, 99:1 dr and 95% ee (Scheme 29). 
 
Scheme 29: Isothiourea-catalysed intramolecular Michael addition-lactonisation. 
 
A mechanistic pathway has been proposed which firstly involves the in situ generation 
of a transient mixed anhydride 132 formed by the reaction of enone-acid and pivaloyl 
chloride in the presence of i-Pr2NEt. Nucleophilic attack of the isothiourea catalyst on 
this activated species generates an acyl ammonium species 133 that, upon deprotonation, 
can form the key (Z)-ammonium enolate intermediate 134. Intramolecular Michael 
addition via proposed pre-TS assembly 135 gives a second acyl ammonium species 136 
that undergoes lactonisation to give the desired product 137 in high dr and ee, 
regenerating the isothiourea catalyst (Scheme 30). 
 
Scheme 30: Proposed catalytic pathway and pre-TS assembly. 
 
This approach was recently applied to the synthesis of disubstituted pyrrolidines.
62
 In a 
representative case enone-acid 138 was transformed into 3,4-syn-disubstituted 
pyrrolidine (3S,4R)-139 under similar catalytic conditions in 67% yield, 99:1 dr and 99% 
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ee after in situ ring-opening with MeOH (Scheme 31). 
 
Scheme 31: Telescoped synthesis of stereodefined pyrrolidines. 
 
At the time of commencing this PhD, no intermolecular variant of this Michael addition-
lactonisation reaction or the aldol-lactonisation reaction shown by Romo and co-workers 
had been described. Furthermore, in Gaunt’s review on ammonium enolate catalysis,25 
with reference to Romo’s work on the intramolecular NCAL reaction he specifically 
comments on the difficulties of extending this methodology towards an intermolecular 
process: “The moderate reactivity of the zwitterionic ammonium enolates is bypassed in 
the intramolecular reaction because of the proximity of the aldehyde, but it cannot be 
avoided in the intermolecular process.” 
 
1.6 Aims and Objectives 
As a consequence of the findings of both Romo and Smith regarding the ability of chiral 
isothioureas to organocataytically functionalise carboxylic acids towards both 
intramolecular aldol-lactonisation
47
 and Michael addition-lactonisation reactions,
61,62
 in 
addition to various communications concerning the ability of ammonium and azolium 
enolates to undergo intermolecular formal [4+2] cycloadditions,
35-43
 the aim of this 
project was to investigate the ability of chiral isothiourea catalysts to catalyse the 
intermolecular formal [4+2] cycloadditions of carboxylic acids and various Michael 
acceptors (Figure 6). The aim was to create a robust and efficient methodology for the 
highly stereoselective formation of heterocyclic products from cheap and readily 
available carboxylic acids. It was proposed that structural variation upon both the acid 
and Michael acceptor components would be used to evaluate any effects on the ability of 
the chiral isothiourea to promote the Michael addition-cyclisation reaction. The 
derivatisation of stereodefined heterocycles into valuable building blocks in addition to 
mechanistic investigations through both computational and kinetic analysis were also 
significant aims of this PhD. 
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Figure 6: Proposed catalytic strategy for intermolecular Michael addition-cyclisations. 
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Chapter 2: Formal [4+2] Cycloadditions of -Keto-,-Unsaturated Esters 
This chapter describes the discovery of reaction conditions to effect the HBTM-2.1 112 
catalysed Michael addition-lactonisation reaction between arylacetic acids 140 and α-
keto-β,γ-unsaturated esters 141, affording a variety of anti-dihydropyranones 142 in high 
yield and with excellent levels of diastereo- and enantioselectivity (Scheme 32).
61
 This 
represents the first time that carboxylic acid derived ammonium enolates have been 
successfully applied towards an intermolecular reaction process. 
 
Scheme 32: Formal [4+2] cycloaddition of -keto-,-unsaturated esters. 
 
2.1 Synthesis and Formal [4+2] Cycloaddition of 143 
In order to evaluate the ability of isothioureas to catalyse the intermolecular Michael 
addition-lactonisation reaction between arylacetic acids and α-keto-β,γ-unsaturated 
esters a model system was selected. This Michael acceptor was chosen based upon its 
widespread use as an electron-deficient 4 component in various methodologies.63 Using 
modified procedures to those outlined by Srivastava
64
 and Zhang,
65
 ketoester 143 was 
obtained via a simple two-step procedure. An aldol reaction of benzaldehyde 38 with 
pyruvic acid 144 and potassium hydroxide in MeOH furnished the corresponding 
potassium salt 145 in 83% yield. Subsequent alkylation via addition of 145 to a solution 
of methanol and acetyl chloride gave ketoester 143 in 43% yield (Scheme 33).  
 
Scheme 33: Synthetic route towards ketoester 143. 
 
With ketoester 143 in hand, its subsequent use in the model intermolecular Michael 
addition-lactonisation reaction with phenylacetic acid 140 could be investigated. The 
reaction conditions for the intermolecular reaction were chosen based upon those 
already optimised for the corresponding intramolecular reaction within the Smith group. 
Using pivaloyl chloride as activating agent, i-Pr2NEt as base and achiral isothiourea 
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DHPB 108 as catalyst the reaction proceeded efficiently to give anti-dihydropyranone 
(±)-147 with high diastereoselectivity (95:5 dr) in 64% yield (Scheme 34). Racemic 
samples needed for chiral HPLC analysis for all dihydropyranones in this chapter were 
made using achiral DHPB 108 as catalyst. 
 
a
 Isolated yield of major diastereoisomer of 147 (96:4 dr). 
b
 Determined by 
1
H NMR spectroscopic 
analysis of the crude reaction mixture. 
Scheme 34: Reaction using model system. 
 
Based upon this promising result giving good conversion and diastereoselectivity using 
an achiral isothiourea catalyst, subsequent studies focused upon the development of an 
asymmetric protocol. Due to the work previously carried out in the group investigating 
the various applications of isothioureas in organocatalysis, several different isothioureas 
were readily available. In the asymmetric series, commercially available tetramisole 
hydrochloride (S)-106 proved a competent enantioselective precatalyst for this 
transformation, giving (3S,4S)-147 in promising diastereo- and enantioselectivity (94:6 
dr, 86% ee). Variation of the isothiourea showed that HBTM-2.1 112 offered the highest 
levels of enantiocontrol at 23 °C (96:4 dr, 91% ee). For optimal enantioselectivity 
lowering the temperature was necessary. Carrying out the reaction at 30 °C gave 
(3R,4R)-147 with excellent enantiocontrol (97% ee). Subsequent variation of the catalyst 
loading showed that the reaction proceeds with 2 mol% of HBTM-2.1 112 at 30 °C 
over 72 h without significantly compromising selectivity or yield (Table 1). 
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Entry Isothiourea (mol%) T (°C) Time (h) Yield (%)
a 
dr
b 
ee (%)
c 
1 108 (20) 23 1 64 95:5 - 
2 106 (20) 23 3 60 94:6 86 (ent) 
3 148 (20) 23 3 55 96:4 83 
4 112 (20) 23 3 52 96:4 91 
5 112 (20) 10 3 55 95:5 93 
6 112 (20) 30 3 60 94:6 97 
7 112 (20) 50 3 55 96:4 95 
8 112 (20) 78 3 60 98:2 96 
9 112 (10) 30 16 68 95:5 97 
10 112 (5) 30 24 68 95:5 96 
11 112 (2) 30 72 55 94:6 96 
a
 Isolated yield of major diastereoisomer of 147 (98:2 dr). b Determined by 1H NMR spectroscopic 
analysis of the crude reaction mixture. 
c
 Determined by chiral HPLC analysis. 
Table 1: Optimisation studies for Michael addition-lactonisation protocol. 
 
Entry 9 in Table 1 represents the optimal reaction conditions for the model system as it 
gives the best enantioselectivity (97% ee) at an acceptable catalyst loading (10 mol%) 
whilst maintaining good conversion and isolated yield (>95% conversion, 68% isolated 
yield). The relative and absolute configuration of (3R,4R)-147 was assigned by analogy 
to a X-ray crystal structure obtained for a related compound (see Section 2.4). Chiral 
HPLC
66
 was used to determine the enantiopurity of (3R,4R)-147. Comparison of the 
HPLC trace of the (3R,4R)-147 with that of a racemic sample of (±)-147 allowed for the 
unambiguous determination of the ee. The analysis revealed that anti-dihydropyranone 
(3R,4R)-147 had been prepared with an enantiopurity of 97% ee (Figure 7). 
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Figure 7: Chiral HPLC traces for (±)-147 and (3R,4R)-147. 
  
Before these optimised reaction conditions could be used to assess the scope of the 
Michael addition-lactonisation process, isothiourea catalysts DHPB 108 and HBTM-2.1 
112 needed to be synthesised on a larger scale – DHPB 108 in order to obtain racemic 
products and HBTM-2.1 112 due to its identification as the optimal chiral catalyst. 
 
2.2 Synthesis of DHPB 108 
Following the methods described by Birman,
52
 DHPB 108 was obtained via a simple 
two-step procedure. Reaction of 3-aminopropan-1-ol 149 with 2-chlorobenzothiazole 
150 and i-Pr2NEt in a sealed tube furnished alcohol 151 in 80% yield. Subsequent 
reaction with Et3N and methanesulfonyl chloride in CH2Cl2 furnished DHPB 108 in 91% 
yield (4.41 g) (Scheme 35). 
 
Scheme 35: Synthetic route towards DHPB 108 
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2.3 Synthesis of HBTM-2.1 112 
Boc-protected amino aldehyde (1S,2S)-152 was easily prepared from readily available 
starting materials following synthetic procedures outlined by List.
67
 Initially, 
benzaldehyde 38 was converted into sulfone 153 via reaction with sodium benzene 
sulfinate and t-butylcarbamate in the presence of formic acid. This reaction proceeded in 
97% yield to give sulfone 153 as a white solid. Formation of Boc-imine 154 was 
achieved by heating sulfone 153 in the presence of potassium carbonate and sodium 
sulphate. Reaction of Boc-imine 154 and isovaleraldehyde 155 in a (S)-proline-catalysed 
asymmetric Mannich reaction furnished Boc-amino aldehyde (1S,2S)-152 in 70% yield. 
This reaction is robust and can be performed on a multi-gram (5 g) scale in addition to 
being both highly enantio- and diastereoselective – which is central to obtaining 
enantiomerically pure HBTM-2.1 112 (>99% ee and >99:1 dr). The relative and absolute 
configuration within (1S,2S)-152 was assigned by comparison to the literature. 
Subsequent reduction of Boc-amino aldehyde (1S,2S)-152 with sodium borohydride in 
methanol proceeded in quantitative yield to afford Boc-amino alcohol (1S,2S)-156. 
Finally, removal of the Boc-protecting group with HCl in dioxane gave amino alcohol 
(1S,2S)-157 in 99% yield (Scheme 36). 
 
a
 Isolated yield of major diastereoisomer of 152 (>99:1 dr). 
b
 Determined by 
1
H NMR spectroscopic 
analysis of the crude reaction mixture. 
Scheme 36: Synthetic route to -amino alcohol (1S,2S)-157. 
 
A model explaining the enantio- and diastereoselectivity of the (S)-proline-catalysed 
Mannich reaction has been proposed by Córdova (Figure 8).
68
 The model depicts the 
enamine – formed upon reaction of (S)-proline with isovaleraldehyde 155 – adopting a 
favourable conformation to attack Boc-imine 154. A hydrogen bond between the 
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carboxylic acid of (S)-proline and the nitrogen atom of the imine stabilises the 
arrangment - this directs the facial selectivity of the enamine. The energy of the pre-TS 
assembly is minimised by orienting the N-Boc substitutent away from the pyrrolidine, 
which results in a highly diastereoselective reaction. 
 
Figure 8: Proposed pre-TS assembly for the (S)-proline-catalysed Mannich reaction. 
 
Conversion of amino alcohol (1S,2S)-157 to HTBM-2.1 112 was carried out using 
modified procedures described by Birman
52
 and Okamoto.
53 
Firstly, amino alcohol 
(1S,2S)-157 was heated in a sealed tube with 2-chlorobenzothiazole 150 and i-Pr2NEt to 
give alcohol (1S,2S)-158 in 97% yield. Alcohol (1S,2S)-158 was next heated with 
thionyl chloride in toluene to give HBTM-2.1 112 in 34% yield (Scheme 37). This 
procedure yielded approximately 1.5 g of catalyst as a single diastereoisomer in >99% ee 
which allowed the scope of the intermolecular Michael addition-lactonisation reaction to 
be assessed. 
 
Scheme 37: Synthetic route to isothiourea catalyst HBTM-2.1 112. 
 
In conclusion, a robust and straightforward synthesis towards HBTM-2.1 112 was 
carried out. The catalyst was accessed in good yield and excellent enantioselectivity 
starting from cheap, commercially available starting materials. The synthesis of HBTM-
2.1 112 was subsequently improved with the help of a colleague to remove the 
requirement for sealed tubes and chromatographic purification, allowing for the 
preparation of approximately 40 g of HBTM-2.1 (2S,3R)-112 in enantiomerically pure 
form.
69
 A large quantity of racemic HBTM-2.1 (±)-112 was also obtained using this 
improved route, using (±)-proline for the key Mannich reaction step.
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2.4 Substrate Scope – Variation of the Acid Component 
With optimised reaction conditions and gram-quantities of reagents and catalysts in 
hand, the generality of this intermolecular Michael addition-lactonisation process 
catalysed by HBTM-2.1 112 was first exemplified through variation of the arylacetic 
acid component (Table 2). An array of arylacetic acids are tolerated in this system, 
allowing the incorporation of both electron-donating and electron-withdrawing 
substitutents as well as 2-, 3- and 4-substitution of the aryl unit. Naphthyl and heteroaryl 
substituents are also accommodated within the arylacetic acid, giving the corresponding 
anti-dihydropyranones in good yield and excellent stereoselectivities (up to 96:4 dr, up 
to 99% ee). 
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a
 Isolated yield of major diastereoisomer (98:2 dr) unless otherwise stated. b Determined by 1H NMR 
spectroscopic analysis of the crude reaction mixture. 
c
 Determined by chiral HPLC analysis. 
d
 Required a 
reaction time of 72 h to give approximately 80% conversion of Michael acceptor. 
e
 Isolated yield of 
product (97:3 dr). 
f
 Isolated yield of product (95:5 dr).  
Table 2: Substrate scope - variation of arylacetic acid component. 
 
The relative and absolute configuration of dihydropyranone (3R,4R)-161 was 
unambiguously confirmed by X-ray crystal structure analysis. The crystal structure 
shown (Figure 9) highlights the two aromatic substituents at C(3) and C(4) positions to 
have an anti relationship and confirmed the absolute configuration as (3R,4R). All other 
dihydropyranone derivatives were assigned by analogy. For a detailed rationale 
regarding the observed enantio- and diastereoselectivity of these reactions, see Section 
3.7. 
 
Figure 9: Crystal structure of (3R,4R)-161 showing relative and absolute configuration. 
 
Within this series the stereoselectivity (80:20 dr, 83% ee) for the formation of 
dihydropyranone (3R,4R)-167 was significantly lower than for other examples. It was 
also found that dihydropyranone (±)-167 underwent an isomerisation process to form 
(±)-169 upon extended exposure to DHPB 108 which was isolated in 90% yield 
(Scheme 38). Control studies showed that reaction of the isolated dihydropyranone (±)-
167 with DHPB 108 in CD2Cl2 in an NMR tube proceeds to give the isomerised product 
(±)-169.   
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Scheme 38: Observed isomerisation process of dihydropyranone (±)-167. 
 
This allowed a possible mechanism to be proposed which involved the catalyst in a 
Lewis base-mediated isomerisation process (Figure 10). Although isomerisation was 
only observed in very few cases, generally it was found that the isomerisation pathway 
could be disfavoured by lowering the temperature. 
 
Figure 10: Possible Lewis base-mediated mechanism for observed isomerisation process. 
 
The potential for a racemic background reaction was tested by reacting 2-(thiophen-2-
yl)acetic acid with ketoester 143 under standard reaction conditions in the absence of an 
isothiourea catalyst. Surprisingly, this reaction proceeded to give 60% conversion of 143 
to the desired dihydropyranone (±)-167 in 80:20 dr with no observable isomerisation by-
product (±)-169 (Scheme 39). This result allowed us to draw two important conclusions: 
i) it is possible to carry out a racemic background reaction in the absence of the 
isothiourea catalyst; ii) isomerisation between (±)-167 and (±)-169 must be mediated by 
the isothiourea. 
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Scheme 39: Discovery of a background reaction. 
 
A plausible mechanism for the racemic background reaction proceeds via initial in situ 
formation of mixed anhydride 170, followed by deprotonation to form an enolate 171, 
which can undergo intermolecular Michael addition to form a second enolate 172 
followed by lactonisation to furnish racemic dihydropyranone (Scheme 40).   
 
Scheme 40: Proposed mechanism for non-catalysed intermolecular Michael addition-lactonisation 
process. 
 
In order to achieve a highly enantioselective protocol, the racemic background reaction 
must be minimised. Theoretically, this can be achieved by minimising the contact time 
of the mixed anhydride 170 and Michael acceptor in the absence of the chiral isothiourea 
catalyst. Practically, this can be realised by addition of the Michael acceptor last into the 
reaction mixture. Initially, the experimental procedure involved having all reaction 
components present in solution with addition of the catalyst last. This procedure allowed 
access to dihydropyranone (3S,4R)-167 in 65% yield, 80:20 dr and 83% ee (Scheme 41). 
Utilising the new order of addition – Michael acceptor added last – dihydropyranone 
(3S,4R)-167 could now be obtained in 88% yield, 80:20 dr and 91% ee indicating both a 
cleaner reaction profile and that the racemic background reaction has been minimised. 
This improved protocol is now standard for all intermolecular Michael addition-
lactonisation reactions. 
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a
 Isolated yield of major diastereoisomer of 167 (95:5 dr). 
b
 Determined by 
1
H NMR spectroscopic 
analysis of the crude reaction mixture. 
c
 Determined by chiral HPLC analysis. 
Scheme 41: Improved reaction protocol - minimising racemic background reaction. 
 
The yield (49%) and stereoselectivity (85:15 dr, 71% ee) for the formation of 
dihydropyranone (3R,4R)-160 is also significantly lower than for other examples in 
Table 2. A possible explanation for this result is that the ammonium enolate derived 
from 4-(trifluoromethyl)phenylacetic acid is poorly nucleophilic and as a result the 
catalyst turnover is slow. This explains the extended reaction time required and lower 
conversion observed (80%). The slow catalyst turnover in this example could allow the 
racemic background reaction to become more important which would explain the 
decrease in stereoselectivity. 
 
2.5 Substrate Scope – Variation of the Michael Acceptor 
To further probe the generality of this protocol, the Michael-addition lactonisation 
procedure using phenylacetic acid and a range of synthesised -aryl- and -alkyl-
substituted -keto-,-unsaturated esters was studied. 
 
2.5.1 Synthesis of γ-Aryl-β,γ-Unsaturated α-Ketoesters 
Using the same synthetic route as described previously for ketoester 143, a variety of 
other -aryl-β,γ-unsaturated α-ketoesters were obtained through variation of the starting 
aryl aldehyde including 3- and 4-substituted examples and those bearing electron-
donating (OMe) and electron withdrawing (NO2) groups. -Heteroaryl-β,γ-unsaturated 
α-ketoesters were also synthesised from furfural and pyridine-3-carboxaldehyde. 
Additionally, the ester group could also be easily varied by selecting a different alcohol 
in the alkylation step (Scheme 42). 
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Scheme 42: Synthetic route towards ketoesters. 
 
Ketoester 173, substituted by a methyl group in the -position was synthesised from 
benzaldehyde 38 and 2-ketobutyric acid 174 using the same procedure in 25% yield over 
2 steps (Scheme 43). 
 
Scheme 43: Synthetic route towards ketoester 173. 
 
In some cases the yield for the alkylation reaction was poor and this was attributed to the 
limited solubility of the potassium salts in alcoholic solvents. In order to synthesise 
ketoester 174 an alternative alkylation procedure was required. Following the procedure 
outlined by Srivastava,
64
 potassium salt 175 was reacted with methyl iodide in DMF to 
furnish 174 in 27% yield (Scheme 44). 
 
Scheme 44: Alternative alkylation towards ketoester 174. 
 
In order to obtain a 2-OMe substituted aromatic ring at the -position a modified 
procedure was required. It has been reported in the literature that when 2-
methoxybenzaldehyde and pyruvic acid are left to react with base overnight, any aldol 
product formed decomposes back to the starting materials.
70
 Following the procedure 
outlined by Reimer
70
 reaction of 2-methoxybenzaldehyde 176 with pyruvic acid 144 and 
potassium hydroxide in MeOH at 40 °C for 1 h, followed by addition of concentrated 
hydrochloric acid gave ,-unsaturated carboxylic acid 177 which was treated with 
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acetyl chloride in methanol to furnish ketoester 178 in 46% yield over 2 steps (Scheme 
45). 
 
Scheme 45: Modified synthetic route towards 2-substituted aromatic ketoester 178. 
 
2.5.2 Synthesis of γ-Alkyl-β,γ-Unsaturated α-Ketoesters 
Following modified procedures to those outlined by Baltas
71
 and Yoshida,
72
 ketoester 
179 was obtained via a two-step procedure. Initially, reaction of methylpyruvate 144 
with DMAP, TMSCl and Et3N in toluene gave silylated enol ester 180 which was taken 
on crude without purification. Subsequent addition of trifluoroboron etherate to a 
solution of 180 and 1,1-dimethoxy-2-methylpropane 181 in CH2Cl2 gave ketoester 179 
in a poor 2% yield over two steps (Scheme 46). 
 
Scheme 46: Synthetic route towards ketoester 179. 
 
The yield of this procedure was most unsatisfactory and can be partly attributed to the 
large amounts of triethylamine hydrochloride salt formed in the first step, resulting in 
difficult filtration and poor recovery of silylated enol ester 180. 
 
2.5.3 Synthesis of Cyclic-β,γ-Unsaturated α-Ketoesters 
Following the procedure outline by Fell,
73
 cyclic ketoester 182 was obtained via a two-
step procedure. Initially, deprotonation of dimethyoxyacetate 183 with LDA in THF 
followed by addition of cyclohexanone 184 gave hydroxy acetal 185 in 92% yield. 
Subsequent treatment of 185 with thionyl chloride and pyridine in CH2Cl2 followed by 
stirring in 4M HCl in dioxane carried out both elimination and acetal deprotection steps 
to afford cyclic ketoester 182 in 9% yield over 2 steps (Scheme 47). 
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Scheme 47: Synthetic route towards cyclic ketoester 182. 
 
Following the procedure outline by Stetter,
74
 heterocyclic ketoester 186 was obtained in 
22% yield by reacting dihydropyran 187 with ethyl chlorooxoacetate 188 in the presence 
of Et3N in diethyl ether (Scheme 48). 
 
Scheme 48: Synthetic route towards heterocyclic ketoester 186. 
 
2.5.4 Intermolecular Michael Addition-Lactonisations 
With a variety of -aryl-, -heteroaryl- and -alkyl- substituted -keto-,-unsaturated 
esters in hand, their subsequent use in the intermolecular Michael addition-lactonisation 
protocol was evaluated (Table 3). Variation of the ester group is well tolerated in this 
reaction to include methyl, ethyl and i-propyl alkyl esters. A variety of substituted -aryl 
substituents including 2-, 3- and 4-substitution, electron-withdrawing and electron-
donating substituents as well as -heteroaryl and naphthyl substituents are all readily 
accommodated, furnishing anti-dihydropyranones 189-198 with high dr (up to 98:2 dr) 
and ee (up to 99% ee). Pleasingly, -alkyl substituted -keto-,-unsaturated esters are 
also accommodated, albeit with reduced diastereoselectivity, generating anti-
dihydropyranones (3R,4R)-199 and (3R,4R)-200 with excellent enantioselectivity. 
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a
 Isolated yield of major diastereoisomer (98:2 dr) unless otherwise stated. b Determined by 1H NMR 
spectroscopic analysis of the crude reaction mixture. 
c
 Determined by chiral HPLC analysis. 
d
 Isolated 
yield of product (97:3 dr). 
e
 Isolated yield of product (92:8 dr). 
f
 Reaction time of 40 h. 
g
 Isolated yield of 
product (91:9 dr). 
h
 Reaction temperature of 78 °C. i Isolated yield of product (90:10 dr). 
Table 3 - Substrate scope - variation of -keto-,-unsaturated ester component. 
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The comparison of the reactions to form dihydropyranones (3R,4R)-194 and (3R,4R)-
195 provides a useful overview of the general reactivity in these systems. The use of an 
electron-rich Michael acceptor to form dihydropyranone (3R,4R)-194 requires an 
extended reaction time of 40 h to achieve total consumption of the Michael acceptor 
whereas the use of an electron-deficient Michael acceptor to form dihydropyranone 
(3R,4R)-195 is rapid and is carried out at 78 °C overnight in order to minimise the 
formation of isomerised by-products as discussed previously for the formation of 
dihydropyranone (3S,4R)-167. The overall reactivity in this system correlates well with 
that observed for an inverse electron demand Diels-Alder reaction in which an electron 
deficient diene and an electron rich dienophile result in the fastest reaction rate (Figure 
11).
75
 A detailed investigation into the mechanism of this Michael addition-lactonisation 
process will be discussed in Chapter 3. 
 
Figure 11: Similar reactivity patterns observed to inverse electron demand Diels-Alder reactions. 
 
2.6 Scale Up and Derivatisation 
Although the intermolecular Michael addition-lactonisation reactions were routinely 
carried out on an analytical scale (0.2 mmol), to illustrate the applicability of this 
protocol towards larger-scale synthesis, the reaction between phenylacetic acid and 
ketoester 143 was carried out on a 2 mmol scale, giving anti-dihydropyranone (3R,4R)-
147 in 66% yield (0.4 g), 90:10 dr and 99% ee (Scheme 49). This reaction can also be 
carried out in an open flask using bench-grade solvents without degradation towards the 
reactivity or stereoselectivity, highlighting it as a robust and easily-reproduced protocol.  
 
a
 Isolated yield of major diastereoisomer of 147 (91:9 dr). 
b
 Determined by 
1
H NMR spectroscopic 
analysis of the crude reaction mixture. 
c
 Determined by chiral HPLC analysis. 
Scheme 49: Reproducible, scalable Michael addition-lactonisation protocol. 
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To exemplify the synthetic utility of this intermolecular reaction protocol, a domino 
Michael addition-lactonisation followed by in situ ring opening with methanol was 
demonstrated. Preparation of anti-dihydropyranone (3R,4R)-147 using HBTM-2.1 112 
under standard reaction conditions, followed by direct addition of methanol to the crude 
reaction mixture gave the ring-opened product (2R,3R)-201 in 92% isolated yield, 95:5 
dr and 96% ee (Scheme 50). 
 
a
 Isolated yield of major diastereoisomer of 201 (97:3 dr). 
b
 Determined by 
1
H NMR spectroscopic 
analysis of the crude reaction mixture. 
c
 Determined by chiral HPLC analysis. 
Scheme 50: Tandem Michael addition-lactonisation and ring opening. 
 
2.7 Limitations of the System 
2.7.1 Acid Component 
Despite the success of this Michael addition-lactonisation procedure using arylacetic 
acids, attempts to extend the scope of the methodology towards other carboxylic acids 
have been unsuccessful (Figure 12). When mono-alkyl, di-alkyl, aryl/alkyl acetic and di-
arylacetic acids are used in this protocol minimal consumption of the Michael acceptor 
is observed. Even replacing one of the -hydrogen atoms with fluorine has a 
catastrophic effect upon reactivity. 
 
Figure 12: Various carboxylic acids tested in Michael addition-lactonisation procedure. 
 
Analysis of the 
1
H NMR of the crude reaction mixture (after acidic work-up) when using 
acid 202 revealed a complex mixture involving the presence of remaining Michael 
acceptor 143 and several acid-derived species. These are likely to include, among others, 
the parent acid 202, mixed anhydride 203 and homoanhydride 204 although these 
products could not be isolated from the reaction mixture (Scheme 51). 
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Scheme 51: Failed reaction using acid 202. 
 
The total amount of the acid-derived products in the crude 
1
H NMR spectrum would 
appear to be significantly less than the amount of remaining unreacted Michael acceptor. 
A possible explanation for this observation is that the ammonium enolate derived from 
acid 202 may undergo competing Claisen-type self-condensation with either the mixed 
anhydride 203 or acyl ammonium 205 under the reaction conditions as an alternative to 
the desired reaction with Michael acceptor 143 (Figure 13). 
 
Figure 13: Possible undesired Claisen-type condensation. 
 
Amongst others, four possible explanations for the observed drop in reactivity using 
alternative carboxylic acids can be suggested: i) the acyl ammonium species formed 
from the corresponding mixed anhydride cannot adopt a suitable conformation to 
deprotonate and form the ammonium enolate; ii) the acyl ammonium species formed 
cannot be deprotonated because the pKa of the -hydrogen atom is too high and requires 
the use of a base other than i-Pr2NEt; iii) the ammonium enolate is formed, however it is 
present in very low concentration; iv) the ammonium enolate is not nucleophilic enough 
to react with the Michael acceptor (Figure 14). These questions are addressed in greater 
detail in Section 4.4 where selected acids out with arylacetic acids are successfully 
employed in a related system. 
 
Figure 14: Possible explanations for low conversions with other carboxylic acids. 
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2.7.2 -Keto-,-Unsaturated Ester Component 
Despite the ability of this procedure to tolerate a wide range of -substituted -keto-,-
unsaturated esters, several Michael acceptors within this class did not lead to any 
observed products (Figure 15). Using the standard reaction conditions, Michael 
acceptors bearing -branched -substituents along with cyclic and heterocyclic -keto-
,-unsaturated esters were not consumed and the desired dihydropyranones were not 
formed. The subtle change of placing a methyl substituent on the -position also results 
in <5% conversion to the desired product. As discussed in Section 2.7.1, in all cases 
analysis of the crude reaction mixtures by 
1
H NMR showed remaining Michael acceptor 
and several acid-derived products. 
 
Figure 15: Various -substituted -keto-,-unsaturated esters tested in Michael addition-
lactonisation procedure. 
 
Several interesting comparisons can be made from these results: i) the difference in 
reactivity between having a -methyl substituent compared to a -isopropyl substituent 
as a result of increased steric hindrance; ii) the reduction in reactivity going from a -
methyl substituent to having a 6-membered carbocycle linking - and - positions; iii) 
the massive effect of placing a methyl substituent at the -position compared to the 
parent -aryl substituted -keto-,-unsaturated esters. 
 
The conclusions that can be drawn are that neither -branched -substituents nor -
substitution are tolerated within the -keto-,-unsaturated esters. The reasons behind 
these observations remain unclear, however it would seem safe to assume that there is a 
very subtle relationship between the diene and dienophile within the transition state in 
which certain substitutions are not tolerated. 
 
 
Chapter 2: Formal [4+2] Cycloadditions of -Keto-,-Unsaturated Esters 
 
 43 
2.8 Conclusions 
In conclusion, it has been shown that chiral isothiourea HBTM-2.1 112 promotes the 
highly diastereo- and enantioselective intermolecular Michael addition-lactonisation of a 
range of arylacetic acids and -keto-,-unsaturated esters, generating anti-
dihydropyranones with good diastereoselectivity (up to 98:2 dr) and enantioselectivity 
(up to 99% ee).
61
 A detailed investigation of the scope and limitations of this protocol 
has been demonstrated. The broader applicability of this chemistry has been 
demonstrated via an efficient scale up procedure using open flasks and bench-grade 
solvents along with a simple derivatisation to illustrate the use of anti-dihydropyranones 
as useful synthetic building blocks. 
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Chapter 3: Formal [4+2] Cycloadditions of Trifluoromethyl Enones 
This chapter describes the discovery of trifluoromethyl enones 206 as highly useful 
Michael acceptors in HBTM-2.1 112 catalysed Michael addition-lactonisation reactions 
with arylacetic acids 140, forming trifluoromethyl bearing anti-dihydropyranones 270 in 
high yield and with excellent levels of diastereo- and enantioselectivity (Scheme 52).
69
 
Products were readily derivatised to diverse synthetic building blocks containing 
trifluoromethyl stereogenicity. Detailed kinetic and computational analyses were carried 
out, shedding light on the mechanism of these reactions.  
 
Scheme 52: Trifluoromethyl enones as Michael acceptors in formal [4+2] cycloadditions. 
  
3.1 Synthesis and Formal [4+2] Cycloadditions 
3.1.1 -Keto-,-Unsaturated Amides 
Upon development of a highly diastereo- and enantioselective protocol for the Michael 
addition-lactonisation reaction between arylacetic acids and -keto-,-unsaturated 
esters (Chapter 2), interest moved towards assessing the reactivity of other Michael 
acceptors in this process. Several-keto-,-unsaturated amides were readily available 
from within the research group
76
 and were tested using the standard reaction conditions. 
Reaction of phenylacetic acid with keto amide 208 catalysed by HBTM-2.1 112 gave 
anti-dihydropyranone (3R,4R)-209 in 61% yield, 68:32 dr and 95% ee. Interestingly, 
keto amide 210 was poorly reactive in this system, giving minimal conversion to the 
corresponding dihydropyranone after 16 h at 23 °C using highly reactive DHPB 108 as 
catalyst (Scheme 53). The limited reactivity of Michael acceptor 210 is another 
illustration of the subtle relationship between the ammonium enolate and the acceptor in 
which certain structural motifs appear to be poorly tolerated. 
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a
 Isolated yield of major diastereoisomer of 209 (97:3 dr). 
b
 Determined by 
1
H NMR spectroscopic 
analysis of the crude reaction mixture. 
c
 Determined by chiral HPLC analysis. 
Scheme 53: Intermolecular Michael addition-lactonisation using -keto-,-unsaturated amides. 
 
3.1.2 -Keto-,-Unsaturated Ketones 
Following the procedures outlined by Muxfeldt,
77
 -keto-,-unsaturated ketone 211 
was synthesised in two simple steps. An aldol reaction of benzaldehyde 38 and 3,3-
dimethoxybutan-2-one 212 with NaOH in MeOH gave acetal 213 in 80% yield. 
Subsequent deprotection using p-TSA in acetone gave -keto-,-unsaturated ketone 
211 in 53% yield (Scheme 54). 
 
Scheme 54: Synthetic route towards -keto-,-unsaturated ketone 211. 
 
The subsequent isothiourea-catalysed Michael addition-lactonisation reaction between 
phenylacetic acid and -keto-,-unsaturated ketone 211 with DHPB 108 did not give 
full consumption of 211 after 16 h at 23 °C suggesting that the ketone appendage is not 
sufficiently electron withdrawing to activate the Michael acceptor (Scheme 55). 
Analysis of the crude reaction mixture by 
1
H NMR showed a complex mixture including 
several products – likely to include the desired dihydropyranone and other isomerised 
products – which could not be separated and together amounted to ~40% conversion of 
211.  
 
Scheme 55: Intermolecular Michael addition-lactonisation using -keto-,-unsaturated ketone 211. 
 
3.1.3 Enones 
Enones 214 and 215 were prepared via the procedures described by Das and George.
78
 
Aldol reaction between benzaldehyde 38 and the requisite substituted acetophenone 216 
or 217 with NaOH in EtOH gave enones 214 and 215 in 41% and 59% yield respectively 
(Scheme 56). 
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Scheme 56 - Synthetic route towards enones 214 and 215. 
 
In addition to the commercially available (E)-4-phenylbut-3-en-2-one 218 and chalcone 
87, enones 214 and 215 were subjected to the standard conditions for the isothiourea-
catalysed Michael addition-lactonisation reaction with DHPB 108 and phenylacetic acid 
for 16 h at 23 °C. Both (E)-4-phenylbut-3-en-2-one 218 and chalcone 87 were not 
consumed (<5%), whereas the more electron deficient enones 214 and 215 gave slightly 
improved reactivity with the crude 
1
H NMR containing some peaks characteristic of the 
dihydropyranone products (Scheme 57). However, due to the poor conversion under 
these reaction conditions (~30% and ~25% conversion respectively) these products were 
not pursued. 
 
Scheme 57 - Intermolecular Michael addition-lactonisation using various enones. 
 
Upon establishing that only very electron deficient Michael acceptors give complete 
conversion within the reaction protocol, enones 219 and 220 were next considered. 
Enone 219 was prepared following the procedure outlined by Bryce.
79
 Cinnamoyl 
chloride 221 was reacted with n-Bu4NBr and NaCN in a biphasic mixture of CH2Cl2 and 
H2O to give enone 219 in 35% yield (Scheme 58). 
 
Scheme 58 - Synthetic route to enone 219. 
 
 Chapter 3: Formal [4+2] Cycloadditions of Trifluoromethyl Enones 
 
 48 
Initially, enone 220 was prepared according to the procedure described by Liu.
80
 The 
piperidine acid-catalysed aldol reaction between benzaldehyde 38 and trifluoroacetone 
222 in THF gave enone 220 in 21% yield (Scheme 59). 
 
Scheme 59 - Initial synthetic route towards enone 220. 
 
The isothiourea-catalysed intermolecular Michael addition-lactonisation reactions using 
the electron deficient enones 219 and 220 were much more successful. Using the 
standard asymmetric reaction conditions with HBTM-2.1 112, reaction of phenylacetic 
acid with enone 219 gave anti-dihydropyranone (3R,4R)-223 in 67% yield, 79:21 dr and 
96% ee. The same reaction using enone 222 gave anti-dihydropyranone (3R,4R)-224 in 
73% yield, 85:15 dr and 95% ee (Scheme 60). Both reactions had reached completion 
after 15 minutes at 23 °C by TLC analysis. 
 
a
 Isolated yield of major diastereoisomer (>98:2 dr). 
b
 Determined by 
1
H NMR spectroscopic analysis of 
the crude reaction mixture. 
c
 Determined by chiral HPLC analysis. 
Scheme 60 - Intermolecular Michael addition-lactonisation using enones 219 and 220. 
 
The trifluoromethyl unit holds a privileged position in organic chemistry. It is widely 
employed within both the pharmaceutical and agrochemical industries, with the 
incorporation of this motif strategically used to enhance binding selectivity and 
metabolic stability, as well as increasing lipophilicity.
81
 In this context, the generation of 
practical and efficient methodologies capable of the selective introduction of this unit 
into organic molecules has developed widely, with a series of elegant strategies utilised 
towards these aims.
82
 Bearing this in mind, along with the promising initial result using 
trifluoromethyl enone 220 in this reaction protocol, future work focused upon exploring 
the intermolecular Michael addition-lactonisation reaction of CF3-bearing Michael 
acceptors. 
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3.2 Formal [4+2] Cycloaddition of 220 
With trifluoromethyl enone 220 in hand, its subsequent use in the intermolecular 
Michael addition-lactonisation reaction with phenylacetic acid 146 could be 
investigated. The reaction conditions for the isothiourea-catalysed intermolecular 
Michael addition-lactonisation protocol were optimised for trifluoromethyl enone 
acceptor 220 in a similar manner to the -keto-,-unsaturated esters studied previously 
using phenylacetic acid 146 and enone 220 as the model system (Table 4). The catalysis 
could routinely be carried out at a lower catalyst loading and temperature presumably 
due to the greater reactivity of trifluoromethyl enone Michael acceptors compared to -
keto-,-unsaturated esters. All reactions were carried out using bench grade solvents 
under air as standard. 
 
Entry Isothiourea (mol%) T (°C) Time (h) Yield (%)
a 
dr
b 
ee (%)
c 
1 108 (20) 23 0.5 66 86:14 - 
2 106 (10) 23 0.25 61 87:13 89 (ent) 
3 107 (10) 23 0.25 76 82:18 77 (ent) 
4 112 (10) 23 0.25 73 85:15 95 
5 112 (10) 30 3 79 86:14 96 
6 112 (10) 78 4 83 90:10 99 
7 112 (5) 78 16 80 90:10 99 
8 112 (2) 78 16 79 90:10 99 
9 112 (1) 78 16 79 90:10 99 
a
 Isolated yield of major diastereoisomer of 224 (98:2 dr). b Determined by 1H NMR spectroscopic 
analysis of the crude reaction mixture. 
c
 Determined by chiral HPLC analysis. 
Table 4: Optimisation studies for Michael addition-lactonisation protocol. 
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Entry 7 in Table 4 was chosen as the optimal reaction conditions for the model system as 
it gives the best diastereo- and enantioselectivity (90:10 dr, 99% ee) at a low catalyst 
loading (5 mol%) whilst maintaining good conversion and isolated yield (>95% 
conversion, 80% isolated yield). Notably, in this system the catalysis remains efficient 
down to 1 mol% catalyst loading without any observable detriment towards 
stereoselectivity or yield. The optimal reactions conditions were then used to assess the 
scope of the Michael addition-lactonisation process. Racemic samples needed for chiral 
HPLC analysis for all dihydropyranones in this chapter were made using achiral DHPB 
108 as catalyst.  
 
3.3 Substrate Scope – Variation of the Acid Component 
With optimised reaction conditions in hand, the generality of this intermolecular Michael 
addition-lactonisation process catalysed by HBTM-2.1 112 was first exemplified 
through variation of the arylacetic acid component (Table 5). A vast array of arylacetic 
acids are tolerated in this system including 3- and 4-substituted aryl rings in addition to 
electron-donating and electron-withdrawing substituents on the aryl unit. Naphthyl and 
heteroaryl substituents are also accommodated within the arylacetic acid, giving the 
corresponding anti-dihydropyranones 224-238 in good yield and excellent 
stereoselectivities (up to 95:5 dr, up to >99% ee) 
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a
 Isolated yield of major diastereoisomer (98:2 dr) unless otherwise stated. b Determined by 1H NMR 
spectroscopic analysis of the crude reaction mixture. 
c
 Determined by chiral HPLC analysis. 
d
 Isolated 
yield of product (92:8 dr). 
e
 Isolated yield of product (95:5 dr). 
f
 Isolated yield of product (71:29 dr). 
g
 
Reaction carried out at 30 °C. h Isolated yield of product (96:4 dr). 
Table 5: Substrate scope - variation of arylacetic acid component. 
 
The relative and absolute configuration of dihydropyranone (3R,4R)-227 was 
unambiguously confirmed by X-ray crystal structure analysis. The crystal structure 
shown (Figure 16) highlights the two aromatic substituents at C(3) and C(4) positions to 
have an anti relationship and confirmed the absolute configuration as (3R,4R) – 
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analogous to the -keto-,-unsaturated ester series. All other anti-dihydropyranone 
derivatives were assigned by analogy. For a detailed rationale regarding the observed 
enantio- and diastereoselectivity of these reactions, see Section 3.7 
 
Figure 16: Crystal structure of (3R,4R)-227 showing relative and absolute configuration. 
 
Generally, the results mirrored those found using -keto-,-unsaturated esters as 
Michael acceptors. However, the formation of dihydropyranones (3R,4R)-234 and 
(3R,4R)-237 occurred with reduced diastereoselectivity (67:33 anti:syn and 74:26 
anti:syn respectively). The low diastereocontrol in the formation of (3R,4R)-237 allowed 
isolation and characterisation of the minor (syn) diastereoisomer. It was found that the 
syn diastereoisomer is formed with low enantiocontrol (28% ee). The absolute 
configuration of the syn diastereoisomer is tentatively assigned as (3S,4R). Detailed 
investigations regarding the absolute configuration of the syn diastereoisomer formed in 
these reaction processes is discussed later in Section 3.6.3. 
 
Within this series, and in contrast to the work in Chapter 2, no isomerisation products 
were observed. There are two reasonable explanations for this: i) the lower temperature 
used in these reactions (78 °C compared to 30 °C when using -keto-,-unsaturated 
esters as Michael acceptors) retards product isomerisation; ii) conjugation into the ester 
functionality of dihydropyranones 239 is important in facilitating deprotonation, 
allowing the isothiourea catalyst to mediate the isomerisation process. As this 
deprotonation is not possible in dihydropyranones 240 derived from trifluoromethyl 
enone Michael acceptors, isomerisation products are not formed (Figure 17). 
 
Figure 17: Possible explanation for absence of isomerisation products. 
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An interesting result was obtained upon employing (phenylthio)acetic acid 241 in this 
protocol. Under standard reaction conditions, using DHPB 108 as catalyst, full 
consumption of trifluoromethyl enone 220 was observed however the product obtained 
was pyrone 242 in 48% yield, resulting from initial Michael addition-lactonisation and 
subsequent elimination of PhSH (Scheme 61). This unexpected discovery was later 
applied to the synthesis of highly functionalised pyridines (see Chapter 7). 
 
Scheme 61: Unexpected pyrone product 242 formed from functionalisation of acid 241. 
 
3.4 Substrate Scope – Variation of the Michael Acceptor 
To further probe the generality of this protocol, the Michael-addition lactonisation 
procedure using phenylacetic acid and a range of trifluoromethyl enones was studied. 
 
3.4.1 Synthesis of Trifluoromethyl Enones 
For the preparation of a range of trifluoromethyl enones, a robust and cost-effective 
method was required. The generally low yielding piperidine-catalysed aldol reaction 
between aldehydes and the expensive and difficult to handle trifluoroacetone described 
by Liu was not a suitable option.
80
 An alternative route towards trifluoromethyl enones 
was found using a two-step procedure following the methods described by Uneyama
83
 
and Yuan.
84
 Reaction of TFA 243 with aniline 244, PPh3 and Et3N in CCl4 as solvent 
gave imine 245 in 68% yield. Subsequent reaction of imine 245 with LDA, diethyl 
methylphosphonate 246 and benzaldehyde 38 followed by acidic hydrolysis gave 
trifluoromethyl enone 220 in 91% yield (Scheme 62). The intermediate imine 245 is 
commercially available and was commonly purchased in preference to being 
synthesised.
85
 This robust and high-yielding procedure allowed access to a variety of -
aryl substituted trifluoromethyl enones through variation of the aldehyde including those 
bearing 2-, 3- and 4- substituents, electron-donating (4-OMe) and withdrawing groups 
(4-NO2), in addition to naphthyl and heteroaryl substituents (2-furyl and 2-thiophenyl).  
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Scheme 62: Synthetic route towards trifluoromethyl enone 220. 
 
A -alkyl substituted trifluoromethyl enone 247 was also synthesised via this route 
employing hexanal 248 as the starting aldehyde in 76% yield (Scheme 63). 
 
Scheme 63: Synthetic route towards -alkyl substituted trifluoromethyl enone 247. 
 
3.4.2 Intermolecular Michael Addition-Lactonisations 
With a variety of trifluoromethyl enones in hand, their subsequent use in the 
intermolecular Michael addition-lactonisation protocol was evaluated (Table 6). A wide 
range of substituted -aryl substituents are tolerated including 2-, 3- and 4-substitution, 
electron-withdrawing and electron-donating substituents as well as -heteroaryl and 
naphthyl substituents, furnishing in all cases anti-dihydropyranones 249-260 with high 
dr (up to 95:5 dr) and ee (up to >99% ee). Anti-dihydropyranone 261 bearing an alkyl 
substituent at C(4) was also obtained in excellent ee (98%), albeit with slightly 
attenuated diastereoselectivity (78:22 dr). 
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a
 Isolated yield of major diastereoisomer (98:2 dr) unless otherwise stated. b Determined by 1H NMR 
spectroscopic analysis of the crude reaction mixture. 
c
 Determined by chiral HPLC analysis. 
d
 Isolated 
yield of product (95:5 dr). 
e
 Isolated yield of product (96:4 dr). 
Table 6: Substrate scope - variation of trifluoromethyl enone component. 
 
Although in general the system is very robust and tolerates considerable substrate 
variation, the stereoselectivity for the formation of dihydropyranone (3R,4R)-256 is 
poorer than for other examples (73:27 dr, 86% ee). A possible explanation for the 
reduction in stereoselectivity is that because the Michael acceptor is very electron 
deficient, the non-catalysed background reaction is accelerated relative to the Lewis 
base-catalysed process, leading to the formation of racemic product with lower 
diastereocontrol (see Section 2.4 for a discussion of the background reaction in these 
processes). 
 
3.5 Scale Up and Derivatisation 
The synthetic versatility of these trifluoromethyl-substituted products was next 
demonstrated through a series of derivatisation processes. Firstly, this reaction sequence 
is readily applicable to scale up with reaction of m-tolylacetic acid 262 and 
trifluoromethyl enone 220 carried out on a multi-gram scale (7.5 mmol), generating anti-
dihydropyranone (3R,4R)-226 in 85% yield (2.12 g), 94:6 dr and 98% ee (Scheme 64). 
Notably, this reaction was carried out using 1 mol% of HBTM-2.1 112 with no 
observable detriment towards the isolated yield or stereoselectivity. This reaction was 
performed in an open flask using bench-grade solvents, highlighting it as a robust and 
easily-reproduced protocol. Dihydropyranone (3R,4R)-226 readily undergoes ring-
opening with MeOH in situ, allowing a tandem Michael-lactonisation/ring-opening 
sequence to be developed, giving trifluoromethyl ketone (2R,3R)-263 in 72% isolated 
yield, 92:8 dr and 97% ee directly from m-tolylacetic acid.  
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a
 Isolated yield of major diastereoisomer of 226 (96:4 dr). 
b
 Determined by 
1
H NMR spectroscopic 
analysis of the crude reaction mixture. 
c
 Determined by chiral HPLC analysis. 
d 
Isolated yield of major 
diastereoisomer of 263 (92:8 dr). 
Scheme 64: Scale-up of Michael addition-lactonisation process and tandem ring-opening protocol. 
 
One of the main goals for this project was to introduce a stereogenic centre bearing a 
trifluoromethyl substituent. This was achieved through the simple hydrogenation of anti-
dihydropyranone (3R,4R)-226 (Table 7). The use of 10 mol% Pd/C as catalyst gave low 
diastereoselectivity (53:47 dr) but allowed the isolation and characterisation of both 
diastereoisomers (3R,4R,6R)-264 and (3R,4R,6S)-265. Using Wilkinson’s catalyst – 
(PPh3)3RhCl – gave the best diastereoselectivity (96:4 dr) using a hydrogen gas pressure 
of 50 bar and 80 °C reaction temperature, giving lactone (3R,4R,6R)-264 in 96% yield 
and 98% ee in which the trifluoromethyl substituent is placed pseudo equatorial. Efforts 
to selectively access the other diastereoisomer (3R,4R,6S)-265 through screening a small 
number of catalyst and ligand combinations were not successful. 
 
Entry 
Catalyst (mol%) / 
Ligand (mol%) 
T 
(°C) 
P 
(atm) 
Conversion 
(%) 
dr
a 
Yield 
(264:265) 
(%)
b 
ee  
(264:265) 
(%)
c 
1 Pd/C (10) 23 1 >99 53:47 51:45 98:97 
2 Rh/C (10) 23 1 >99 92:8 - - 
3 Pd(OH)2/C (10) 23 1 >99 56:44 - - 
4 
[Ir(COD)pyPCy3]
+
PF6
-
 
(5) 
23 1 <5 - - - 
5 [Ir(COD)pyPCy3]
+
PF6
-
 80 50 ~10 95:5 - - 
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(5) 
6 
[Rh(COD)Cl]2 (5) / 
BINAP (15) 
23 1 <5 - - - 
7 
[Rh(COD)Cl]2 (5) / 
BINAP (15) 
80 50 ~40 90:10 - - 
8 Rh(PPh3)3Cl (5) 23 1 <5 - - - 
9 Rh(PPh3)3Cl (5) 80 50 >99 96:4 96:- 98:- 
a
 Isolated yields of 264 and 265 (>98:2 dr). 
b
 Determined by 
1
H NMR spectroscopic analysis of the crude 
reaction mixture. 
c
 Determined by chiral HPLC analysis. 
Table 7: Screening for optimal hydrogenation conditions. 
 
The relative configuration of lactones (3R,4R,6R)-264 and (3R,4R,6S)-265 were 
determined by NOE analysis. Irradiation of the hydrogen atom attached to C(6) in 
lactone (3R,4R,6R)-264 gave a positive NOE with the hydrogen atom attached to C(4) 
whereas the same NOE was not present in lactone (3R,4R,6S)-265 (Figures 18 and 19).  
 
Figure 18 – NOE analysis of diastereomeric lactones 264 and 265. 
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a) 
1
H NMR (300 MHz, CDCl ) of (3R,4R,6R)-264. b) 1D gs-NOESY spectra of (3R,4R,6R)-264. c)
 1
H 
NMR (300 MHz, CDCl ) of (3R,4R,6S)-265. d) 1D gs-NOESY spectra of (3R,4R,6S)-265. 
Figure 19: 1D gs-NOESY spectra for determining relative configurations. 
 
In the case of lactone (3R,4R,6S)-265, a surprisingly strong NOE between the hydrogen 
atoms attached to C(3) and C(6) was observed. This can be explained by the presence of 
a boat conformation 266, which according to DFT calculations at the B3LYP/6-31G** 
level of theory, is only 6.4 kJmol
-1
 higher in energy than the more stable chair 
conformation 267 and hence will be present in solution to a small extent (Figure 20). 
This brings the two protons at C(3) and C(6) in close enough proximity (2.319 Å) to 
observe an NOE. 
 
Figure 20: Geometries of both chair and boat conformations of (3R,4R,6S)-265. 
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Alternatively, the two diastereoisomers could also be distinguished by a coupling 
constant analysis for the C(6)H atom that has ddq multiplicity (Figure 21). In lactone 
(3R,4R,6R)-264 there is an axial-axial 
3
JHH coupling constant of 12.2 Hz and an axial-
equatorial 
3
JHH coupling constant of 3.2 Hz; whereas in lactone (3R,4R,6S)-265 there is 
an equatorial-axial 
3
JHH coupling constant of 5.6 Hz and an equatorial-equatorial 
3
JHH 
coupling constant of 4.6 Hz.  
 
Figure 21 – Coupling constant analysis of diastereomeric lactones 264 and 265. 
 
The observed coupling constants for C(6)H in (3R,4R,6R)-264 are in agreement with a 
simulation of the ddq coupling pattern by Bruker Topspin DAISY module. The 
simulated spectrum shows a 
3
JHH coupling constant of 12.2 Hz which is in accordance 
with an axial position of C(6)H in the minimum energy chair conformation of 
(3R,4R,6R)-264. The structure of (3R,4R,6R)-264, obtained by MM conformational 
search and geometry optimisation at B3LYP/6-31G** level of theory is shown in Figure 
22. The C(5)Ha-C-C-C(6)H dihedral angle of 170.8 corresponds to coupling constant of 
11.7 Hz, calculated by the Altona equation, which is in good agreement with the 
experimental data.  
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a) Experimental ddq coupling pattern of C(6)H in (3R,4R,6R)-264. b) Simulated ddq coupling pattern of 
C(6)H in (3R,4R,6R)-264. c)
 
Structure of minimum energy conformation of (3R,4R,6R)-264. 
Figure 22: Coupling constant analysis of (3R,4R,6R)-264. 
 
Two illustrative examples for the further elaboration of these substrates have been 
explored. Firstly, ring opening of lactone (3R,4R,6R)-264 with MeOH and catalytic 
amounts of DMAP gave alcohol (2R,3R,5R)-268 in 90% yield, >99:1 dr and 98% ee 
(Scheme 65). Alternatively, treatment of lactones (3R,4R,6R)-264 and (3R,4R,6S)-265 
with LiAlH4 gave diastereomerically pure diols (2R,3R,5R)-269 and (2R,3R,5S)-270  in 
high yields and ee.  
 
a
 Isolated yield of major diastereoisomer (>98:2 dr). 
b
 Determined by 
1
H NMR spectroscopic analysis of 
the crude reaction mixture. 
c
 Determined by chiral HPLC analysis. 
Scheme 65: Lactone ring-opening procedures. 
 
Another method for the introduction of a stereogenic centre bearing a trifluoromethyl 
substituent was discovered upon the treatment of dihydropyranone 226 with LiAlH4, 
giving CF3-lactol 271 as a single diastereoisomer in 80% yield and 97% ee after 
purification. This simple procedure is general and highly diastereoselective, tolerates 
c) 
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various substitution patterns at C(3)- and C(4)- in the dihydropyranone, and delivers 
CF3-lactols 271-277 as single diastereoisomers in >80% yields and high ee’s (Table 8). 
 
   
   
 
 
 
a
 Isolated yield of major diastereoisomer (>98:2 dr). 
b
 Determined by chiral HPLC analysis. 
c
 
Enantioselectivity could not be determined. 
Table 8: Substrate scope for the pyran formation from dihydropyranones. 
 
It is likely that this reaction proceeds by firstly reducing the dihydropyranone 278 to 
intermediate alcohol 279 which then undergoes cyclisation upon basic work-up to give 
the pyran 280, placing the trifluoromethyl substituent in an equatorial position (Figure 
23). 
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Figure 23: Possible mechanism for dihydropyranone conversion to pyran 280. 
 
The relative configuration of pyran (2R,4R,5R)-271 was determined via heteronuclear 
NOE analysis (Figures 24 and 25). Reciprocal NOE interactions were observed between 
the hydroxyl group and the hydrogen atoms on C(4) and C(6). These NOE interactions 
would only be possible for pyran (2R,4R,5R)-271 in which the OH group is axial, not for 
pyran (2S,4R,5R)-281 in which the hydroxyl group is placed equatorially as the through-
space distance between the hydrogen atoms is too great (>4 Å).  
 
Figure 24 - NOE analysis of diastereomeric pyrans 271 and 281. 
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a) 
1
H NMR (500 MHz, CDCl ) of (2R,4R,5R)-271. b) 1D gs-NOESY spectra of (2R,4R,5R)-271 upon 
selective irradiation of C(4)H. c)
 
1D gs-NOESY spectra of (2R,4R,5R)-271 upon selective of OH. 
Figure 25: 1D gs-NOESY spectra for determining relative configurations. 
   
The anti relationship of the C(4) and C(5) substituents on pyran (2R,4R,5R)-271 was 
also confirmed by analysis of the coupling constants for the hydrogen atoms on C(4) and 
C(5) (Figure 26). In the 
1
H NMR, the signal for C(4)H appears an apparent triplet of 
doublets with an axial-axial 
3
JHH coupling constant of 12.2 Hz and an axial-equatorial 
3
JHH coupling constant of 3.8 Hz. The signal for C(5)H also appears as an apparent 
triplet of doublets with an axial-axial 
3
JHH coupling constant of 11.7 Hz and an axial-
equatorial 
3
JHH coupling constant of 4.6 Hz. If the two aryl substituents on C(4) and C(5) 
had a syn relationship, one of the axial-axial 
3
JHH coupling constants for either C(4)H or 
C(5)H would not be present. 
 
Figure 26 – Coupling constant analysis of pyran 271. 
 
The relative configuration of pyran (2R,4R,5R)-271 was unambiguously confirmed by 
X-ray crystal structure analysis, with the absolute configuration derived from the known 
anti-dihydropyranone (3R,4R)-226 (Figure 27). All other pyran derivatives were 
assigned by analogy. 
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Figure 27: Crystal structure of (2R,4R,5R)-271 showing relative and absolute configuration.  
 
3.6 Mechanistic and Kinetic Studies 
3.6.1 Kinetic Analysis 
To complement these synthetic studies, kinetic investigations aimed at establishing the 
catalytic cycle of the Michael addition-lactonisation process were performed. 4-
Fluorophenylacetic acid (preactivated in situ with pivaloyl chloride and i-Pr2NEt to 
prepare the mixed anhydride 282) and trifluoromethylenone 220 were used as model 
substrates in order to measure reaction kinetics by in situ 
19
F NMR spectroscopic 
analysis. The reactions were performed in CD2Cl2 at 78 °C using HBTM-2.1 112 as 
catalyst and 1-fluoro-4-nitrophenol 283 as an internal standard (Scheme 66).  
 
Scheme 66: Model system used for in situ 
19
F NMR spectroscopic analysis. 
 
Experimentally, stock solutions of known concentration of 4-fluorophenylacetic acid, 1-
fluoro-4-nitrobenzene 283, trifluoromethylenone 220 and HBTM-2.1 112 were made 
using CD2Cl2 as solvent. Reactions were carried out by adding the required amount of 4-
fluorophenylacetic acid, 1-fluoro-4-nitrobenzene 283, i-Pr2NEt, pivaloyl chloride and 
CD2Cl2 to an NMR tube. At 78 °C the required amount of HBTM-2.1 112, 
trifluoromethylenone 220 and i-Pr2NEt were added, with the total volume always 
constant at 0.7 mL. The reaction was subsequently followed dynamically by 
19
F NMR at 
78 °C. The NMR sample was analysed using 8 scans with a relaxation delay (d1) of 25 
seconds giving a total experiment time of 3 minutes 25 seconds and the sample was 
analysed approximately every 15 minutes. A typical 
19
F NMR spectrum is shown below 
(Figure 28) in which the key species are clearly visible and highlighted, including both 
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diastereoisomers of the forming dihydropyranone 229 and 284, 4-fluoronitrobenzene 
(internal standard) 283, trifluoromethylenone 220 and mixed anhydride 282. 
 
Figure 28: Typical 
19
F NMR obtained during kinetic experiments (470 MHz, CDCl ). 
 
The initial kinetic experiment was run over approximately 6 h using the following 
reactant concentrations: 100 mM 4-fluorophenylacetic anhydride 282, 100 mM 
trifluoromethylenone 220, 20 mM 4-fluoro-1-nitrophenol 283, 0.5 mM HBTM-2.1 112 
(Scheme 67).  
 
Scheme 67: Initial kinetic experiment. 
 
Data points were collected at approximately 15 minute intervals and the data were 
plotted using Excel (Figure 29). It is clearly visible that both the major and minor 
diastereoisomers of dihydropyranone anti-229 and syn-284 increase in concentration 
over time while the concentration of both the mixed anhydride 282 and trifluoromethyl 
enone 220 decrease over time. It can also be seen that the reaction was approximately 
20% complete by the time of the first obtained data point and this is typically the case in 
most of the kinetic experiments. 
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Figure 29: Excel plot of reaction course over time. 
 
The concentration data for this experiment for both the mixed anhydride and 
trifluoromethyl enone over time is displayed below (Table 9). 
Time (minutes) [Mixed anhydride 282] / mM [Trifluoromethyl enone 220] / mM 
14.40 75.9 72.3 
24.02 71.3 68.7 
40.52 64.6 61.7 
57.03 58.5 55.3 
73.55 53.2 49.7 
90.07 48.2 45.7 
106.58 43.9 40.3 
123.00 40.0 36.7 
139.60 35.7 32.9 
156.10 32.9 29.8 
172.65 29.9 27.1 
189.17 27.1 24.5 
205.67 24.9 20.7 
222.20 22.6 18.5 
238.70 20.4 16.6 
255.22 18.7 14.9 
271.73 17.1 13.5 
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288.23 15.8 12.5 
304.75 14.3 11.2 
321.27 13.1 10.0 
337.80 12.1 8.9 
354.32 11.1 7.9 
Table 9: Data for mixed anhydride and trifluoromethyl enone concentration over time. 
 
Plots of the natural log of either mixed anhydride 282 or trifluoromethyl enone 220 vs. 
time were then constructed from this data using MATLAB
®
 R2011a (Figure 30). Using 
one equivalent of enone with respect to anhydride the reaction progress could be fitted to 
a first-order rate expression for the concentration of the mixed anhydride 282 or the 
trifluoromethyl enone 220. Plots of the natural log of the concentration of the mixed 
anhydride 282 vs. time are linear in all cases and these were used to obtain reaction 
rates. The gradient of the best fit line through the data points represents the first order 
rate constant kobs for the reaction and is equal to 5.64±0.03 x 10
-3
. 
  
Figure 30: MATLAB plots to determine first order rate constants. 
 
Kinetic runs for eight combinations of initial concentrations of mixed anhydride 282, 
trifluoromethyl enone 220 and HBTM-2.1 112 were performed (Table 10). Only data 
where either the concentration of 282 or 220 had not fallen to zero is presented and 
fitted. The fitted (t=0) intercept concentrations of the anhydride and observed rate 
constants kobs are shown in the table.  
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Run [Trifluoromethyl 
enone 220] / 
mM 
[Mixed 
Anhydride 
282]   / mM 
[HBTM-
2.1 112] / 
mM 
[Mixed 
Anhydride 
282]0 / mM 
kobs × 10
3
 / 
s
-1 
1 100 100 0.5 80.2±1 5.64±0.03 
2 50 100 0.5 74.4±1 4.5±0.1 
3 75 100 0.5 74.5±1 4.09±0.02 
4 200 100 0.5 69.8±1 4.57±0.03 
5 300 100 0.5 69.3±1 4.71±0.03 
6 100 100 0.25 66.7±1 3.11±0.01 
7 100 100 1.0 65.5±1 12.17±0.07 
8 100 100
a
 (d2) 0.5 72.0±1 1.47±0.01 
a
 2-d
2
-(4-fluorophenyl)acetic acid used. 
Table 10: Kinetic data for various initial reagent concentrations. 
 
Varying the initial concentration of trifluoromethyl enone 220 (50 mM, 75 mM, 100 
mM, 200 mM and 300 mM) showed that while the reaction rate remained first order 
with respect to anhydride the rate was essentially independent of the concentration of the 
trifluoromethyl enone 220. This result can be visualised using a plot of the natural log of 
the observed rate constant (kobs) against the natural log of the initial concentration of the 
enone acceptor. The gradient of the best-fit line (roughly zero) is indicative of the order 
of the rate with respect to the concentration of the enone (Figure 31). Repeating the 
analysis, varying the initial concentration of catalyst (0.25 mM, 0.5 mM and 1.0 mM) 
showed a near linear first order dependence of rate on catalyst concentration (Figure 32).
 
 
Figure 31: Plot of ln(kobs) vs. ln([trifluoromethyl enone 220]). 
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Figure 32: Plot of ln(kobs) vs. ln(initial [HBTM-2.1 112]). 
 
Further kinetic studies revealed that increasing the total equivalents of i-Pr2NEt from 4 
to 8 led to a minimal change in reaction rate. Notably for the acetylation of alcohols 
using DMAP, Zipse demonstrated kinetically that alcohol deprotonation is performed in 
a rate determining step by acetate instead of a trialkylamine auxiliary base in CH2Cl2.
86
 
Extrapolation of these studies to this system implicates potential deprotonation of an 
acyl ammonium intermediate by pivalate and the use of i-Pr2NEt as a shuttle base. 
Shiina has reported a related process using isothioureas where pivalate has been 
postulated to act as a base.
87 
 
Overall these results suggest that the reaction is most likely to be first order with respect 
to mixed anhydride 282 and HBTM-2.1 112 and zero order with respect to 
trifluoromethyl enone 220. In order to test for kinetic isotope effects, ,-di-deuterio 4-
fluorophenylacetic acid 285 was synthesised by heating a mixture of 4-
fluorophenylacetic acid 286 and K2CO3 in D2O at reflux for 16 h, giving 285 in 56% 
yield which was >99% ,-di-deuterated by 1H NMR analysis (Scheme 68). 
 
Scheme 68: Synthesis of ,-di-deuterated acid 285. 
 
When the Michael addition-lactonisation reaction was performed using ,-di-deuterio 
4-fluorophenylacetic acid 285 (>99% d2) the observed rate (kobs) was approximately a 
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quarter of that for the equivalent reaction using 4-fluorophenylacetic acid (kobsH/kobsD = 
3.8) (Scheme 69).  
 
Scheme 69: Michael addition-lactonisation using ,-di-deuterated acid 285. 
 
Lectka and co-workers reported a kinetic isotope effect (kobsH/kobsD = 3.12) when using 
,-dideuteriophenylacetylchloride 287 in a related process involving the catalytic, 
enantioselective -fluorination of acid chlorides (Scheme 70). They use this as evidence 
for dehydrohalogenation being the rate-determining step in this process.
88
  
 
Scheme 70: Kinetic isotope effect observed in a related system. 
 
Based on these kinetic studies, the catalytic cycle for this reaction likely proceeds via 
initial formation of the mixed anhydride 288, followed by generation of the 
corresponding acyl ammonium ion 289. Deprotonation will generate the (Z)-enolate 290, 
which undergoes stereoselective Michael addition to the trifluoromethylenone 206, 
followed by intramolecular cyclisation, to generate the dihydropyranone 207 and 
regenerate HBTM-2.1 112 (Figure 33).  
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Figure 33: Proposed catalytic cycle for asymmetric Michael-lactonisation process. 
 
An alternative reaction process, involving the in situ generation of a ketene 291 from the 
mixed anhydride 288 followed by nucleophilic addition of HBTM-2.1 112 to generate 
the (Z)-enolate 289 can also be envisaged (Scheme 69).  
 
Scheme 69: Alternative ketene pathway. 
 
The kinetic studies indicate that the rate-determining transition structure is constructed 
from the catalyst and the anhydride. While either the N-acylation or deprotonation steps 
are consistent with this requirement the deuterium kinetic isotope effect described above 
is consistent with deprotonation being rate determining. Such knowledge suggests that, 
within certain boundaries, the reaction rate will not be limited by the choice of enone 
acceptor. 
 
3.6.2 Reaction Intermediates 
The formation of an acyl ammonium ion such as 289 is supported by the treatment of 4-
fluorophenylacetyl chloride 292 with HBTM-2.1 112 to give N-acyl isothiouronium 
chloride 293 in 92% isolated yield (Scheme 70).  
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Scheme 70: Acyl ammonium formation. 
  
The validity of 293 as a plausible reaction intermediate was probed by its use as a 
precatalyst (Scheme 71). Treatment of 4-fluorophenylacetic acid 286 with pivaloyl 
chloride and i-Pr2NEt, followed by addition of trifluoromethylenone 220 and acyl 
ammonium salt 293 (5 mol%) as the precatalyst gave dihydropyranone (3R,4R)-229 in 
88% isolated yield and identical diastereo- and enantioselectivity (90:10 dr and >99% 
ee) to that employing HBTM-2.1 112 directly in this protocol.  
 
a
 Isolated yield of major diastereoisomer of 229 (>98:2 dr). 
b
 Determined by 
1
H NMR spectroscopic 
analysis of the crude reaction mixture. 
c
 Determined by chiral HPLC analysis. 
Scheme 71: Acyl ammonium used as a precatalyst. 
 
Treatment of HBTM-2.1 112 with the mixed anhydride derived from 4-
fluorophenylacetic acid 286 without trifluoromethyl enone 220 does not produce a single 
acyl ammonium product, as happens with the acid chloride, but rather a complex 
mixture which seemingly included a significant proportion of catalyst. This result 
suggests that, while the reaction with the acid chloride proceeds to completion and then 
stops because chloride is not particularly basic, pivalate, generated in the anhydride 
reaction, may be basic enough to produce the enolate and further reaction such as 
Claisen-type condensation can occur (Scheme 72). 
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Scheme 72: Proposed Claisen-type condensation process. 
 
Notably, for all cases in this kinetic analysis monitoring the product distribution with 
reaction progress indicated that the product diastereoselectivity increased with time, with 
typically an 83:17 anti:syn ratio observed after 5 minutes, and a 90:10 anti:syn ratio 
observed at the end of the kinetic experiments (typically 4-6 hours). Furthermore, 
dihydropyanone 294 derived from ,-di-deuterio 4-fluorophenylacetic acid 285 (>99% 
d2) contained around 30% proton incorporation at C(3) (Scheme 73).  
 
a
 Isolated yield of major diastereoisomer of 294 (>98:2 dr). 
b
 Determined by 
1
H NMR spectroscopic 
analysis of the crude reaction mixture. 
Scheme 73: Reaction using ,-di-deuterio 4-fluorophenylacetic acid 285. 
 
3.6.3 Stereospecificity 
These observations imply in situ equilibration and epimerisation at C(3) during the 
reaction and prompted an investigation regarding the stereospecificity of this process 
through the employment of the (Z)-enone 295 as the Michael acceptor. (Z)-enone 295 
was accessed following the procedure outline by Sasaki via treatment of phenylacetylene 
296 with n-BuLi followed by quenching the resulting anion with ethyl trifluoroacetate 
297, giving alkyne 298 in quantitative yield (Scheme 74).
89
 Selective reduction of 298 
using Lindlar’s catalyst affords the desired trifluoromethyl enone (Z)-295 in 40% yield 
which must be used immediately to avoid isomerisation to (E)-enone 220. 
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Scheme 74: Synthesis of trifluormethyl enone (Z)-95. 
 
Initial studies with DHPB 108 as the isothiourea catalyst and (Z)-enone 295 using 
standard reaction conditions at 23 °C gave an 87:13 anti:syn mixture of 
dihydropyranones after 16 hours, essentially identical to the observed 86:14 anti:syn 
product ratio observed using DHPB from the (E)-enone (Scheme 75). At lower 
temperature (78 ˚C) a 47:53 anti:syn mixture of dihydropyranones was generated, 
suggesting epimerisation of the initially formed syn-isomer to the thermodynamically 
preferred anti-isomer.  
 
a
 Determined by 
1
H NMR spectroscopic analysis of the crude reaction mixture. 
Scheme 75: Reaction of trifluormethyl enone (Z)-295 using DHPB 108. 
 
In the asymmetric series, the use of HBTM-2.1 112 at 78 ˚C with (Z)-enone 295 gave 
preferentially the syn-dihydropyranone (3R,4S)-299 with good diastereoselectivity 
(85:15 dr), with purification giving a 91:9 mixture of (3R,4S)-299 (99% ee):(3R,4R)-224 
(54% ee) in 74% yield (Scheme 76). 
 
a
 Isolated yield of major diastereoisomer of 299 (91:9 dr). 
b
 Determined by 
1
H NMR spectroscopic 
analysis of the crude reaction mixture. 
c
 Determined by chiral HPLC analysis. 
Scheme 76: Reaction of trifluoromethyl enone (Z)-295 using HBTM-2.1 112. 
 
To experimentally test the hypothesis of epimerisation at C(3), treatment of the 91:9 
mixture of (3R,4S)-299 (99% ee):(3R,4R)-224 (54% ee) with DHPB 108 (10 mol%) at 
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23 °C for 16 h gave a 12:88 mixture of (3R,4S)-299 (86% ee):(3S,4S)-224 (85% ee), 
consistent with epimerisation at C(3) of the syn-dihydropyranone (3R,4S)-299 to the 
anti-dihydropyanone (3S,4S)-224 (Scheme 78). This observation is in agreement with 
both proton/deuterium exchange at C(3) (Scheme 73) and the observed increase in 
product diastereoselectivity over time in the kinetic experiments. This experiment also 
allowed the absolute configuration of the syn diastereoisomer formed using (Z)-enone 
295 assigned as (3R,4S)-299 via HPLC analysis. 
 
a
 Determined by 
1
H NMR spectroscopic analysis of the crude reaction mixture. 
b
 Determined by chiral 
HPLC analysis. 
Scheme 78: Epimerisation study using DHPB 108. 
 
The epimerisation experiment detailed above allowed for the assignment of all four 
stereoisomers using chiral HPLC analysis. With knowledge of the absolute configuration 
of syn diastereoisomer (3R,4S)-299 formed using (Z)-enone 295, the reaction using (E)-
enone 220 could be re-examined to determine the absolute configuration of the minor 
syn-diastereoisomer formed (Scheme 79). Upon chiral HPLC analysis, it was found that 
the minor diastereoisomer 229 was formed in 34% ee and was determined to have 
(3S,4R) absolute configuration. 
 
a
 Isolated yield of major diastereoisomer of 224 (98:2 dr). 
b
 Determined by 
1
H NMR spectroscopic 
analysis of the crude reaction mixture. 
c
 Determined by chiral HPLC analysis. 
Scheme 79: Re-examination of reaction using (E)-enone 220. 
 
With syn-dihydropyranone (3R,4S)-299 (dr 91:9) in hand, treatment with LiAlH4 
generates the CF3-lactol (2S,4S,5R)-300 (dr 91:9) in 76% isolated yield and 99% ee after 
purification (Scheme 80). This protocol thus allows access to stereoisomeric product 
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trifluoromethyl lactols by judicious choice of enone geometry. The relative 
configuration within (2S,4S,5R)-300 was confirmed by X-ray crystal structure analysis. 
The known absolute configuration of the starting dihydropyranone (3R,4S)-299 allowed 
the absolute configuration of (2S,4S,5R)-300 to be assigned. 
 
a
 Isolated yield of major diastereoisomer of 299 (94:6 dr). 
b
 Determined by 
1
H NMR spectroscopic 
analysis of the crude reaction mixture. 
c
 Determined by chiral HPLC analysis. 
Scheme 80: Syn-diastereoisomer derivatisation to lactol and crystal structure. 
 
3.7 Computational Studies 
In collaboration with Dr David Fox at Warwick University, computational investigation 
of the proposed catalytic cycle was also undertaken. DFT calculations were performed 
using PC-GAMESS at the B3LYP/6-31G(d) level.
90-92 
Objectives of the computational 
analysis included: 1) differentiating between possible Michael addition and Diels-Alder 
reaction mechanisms; 2) determining the lowest energy transition state for the key 
carbon-carbon bond forming step and use this to rationalise the observed stereochemical 
outcome; 3) providing further evidence to support the mechanistic findings of the kinetic 
analysis such as the rate-determining step of the reaction. The relative energies (in kJ 
mol
-1
) for each stage of the catalytic cycle were found (Figure 34)
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Figure 34: Catalytic cycle studied by computational modelling. 
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The electronic energy, ZPE and total energy of each species as well as “total energies” 
for each stage of the catalytic cycle (Figure 34, ground states and transition states) are 
given below (Table 11).
 
Compound E / Hartrees 
ZPE / 
Hartrees 
Total Energy/ 
Hartrees 
Relative Energy 
/ kJ mol
-1
 
     
GS A (catalyst) -1243.769254 0.350804 -1243.41845  
GS B (anhydride) -730.7190804 0.266361 -730.4527194  
GS F (enone) -760.0088765 0.148957 -759.8599195  
Me3N -174.4744039 0.121105 -174.3532989  
Total -2908.971615 0.887227 -2908.084388 0 
     
TS A (acylation) -1974.472874 0.618616 -1973.854258  
GS F (enone) -760.0088765 0.148957 -759.8599195  
Me3N -174.4744039 0.121105 -174.3532989  
Total -2908.956155 0.888678 -2908.067477 44.3921625 
     
GS C (acylation prod.) -1974.477571 0.619483 -1973.858088  
GS F (enone) -760.0088765 0.148957 -759.8599195  
Me3N -174.4744039 0.121105 -174.3532989  
Total -2908.960851 0.889545 -2908.071306 34.3399875 
     
TS B (enolisation) -1974.466 0.614399 -1973.851601  
GS F (enone) -760.0088765 0.148957 -759.8599195  
Me3N -174.4744039 0.121105 -174.3532989  
Total -2908.94928 0.884461 -2908.064819 51.3683625 
     
GS D (enolate) -1627.435438 0.469951 -1626.965487  
GS E (ammonium salt) -521.5195892 0.270399 -521.2491902  
GS F (enone) -760.0088765 0.148957 -759.8599195  
Total -2908.963904 0.889307 -2908.074597 25.7021625 
     
TS C1 (addition) -2387.441492 0.621901 -2386.819591  
 Chapter 3: Formal [4+2] cycloadditions of trifluoromethyl enones 
 
 80 
GS E (ammonium salt) -521.5195892 0.270399 -521.2491902  
Total -2908.961081 0.8923 -2908.068781 40.9681125 
     
GS G (addition prod.) -2387.445938 0.6236 -2386.822338  
GS E (ammonium salt) -521.5195892 0.270399 -521.2491902  
Total -2908.965527 0.893999 -2908.071528 33.75645 
     
TS D (bond rotation) -2387.440664 0.623242 -2386.817422  
GS E (ammonium salt) -521.5195892 0.270399 -521.2491902  
Total -2908.960254 0.893641 -2908.066613 46.66044653 
     
GS H (ring closed) -2387.460795 0.623199 -2386.837596  
GS E (ammonium salt) -521.5195892 0.270399 -521.2491902  
Total -2908.980384 0.893598 -2908.086786 -6.295274999 
     
TS E (cat. loss) -2387.460427 0.622643 -2386.837784  
GS E (ammonium salt) -521.5195892 0.270399 -521.2491902  
Total -2908.980016 0.893042 -2908.086974 -6.787725 
     
GS I (lactone prod.) -1143.706165 0.270281 -1143.435884  
GS E (ammonium salt) -521.5195892 0.270399 -521.2491902  
GS A (catalyst) -1243.769254 0.350804 -1243.41845  
Total -2908.995009 0.891484 -2908.103525 -50.2338375 
Table 11: Relative energies for all GS and TS in catalytic cycle. 
 
Transition states for the N-acylation TS A and deprotonation TS B steps were located as 
well as their associated intermediate ground state structures. (Figures 34 and 35).
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Figure 35: Calculated transition structures for the N-acylation (TS A) and deprotonation (TS B) 
steps. 
 
The acylation of the catalyst (GS A) with the mixed anhydride (GS B) occurs in a single 
step to give an isothiouronium ion as its pivalate salt (GS C) via TS A (Figure 35). It is 
well known that acyl substitution reactions involving weak bases (pKaH(H2O) less than 
14) as nucleophiles and leaving groups can occur via concerted mechanisms, meaning 
there is no stable tetrahedral intermediate.
93
 Examples include the reaction of aryl 
acetates with aryloxides
94
 and the reactions of acylpyridinium ions with pyridine.
95
 In 
these cases the strong leaving group ability of both nucleophile and leaving group 
renders the tetrahedral intermediate-like structure unstable with respect to instantaneous 
decomposition.
96
 Theoretical calculations, such as for the displacement of phenolate by 
an amine,
97
 also support a concerted displacement mechanism. Of particular note are the 
calculations by Zipse concerning the reaction of dimethylaminopyridine (DMAP) with 
acetic anhydride that indicate a concerted displacement mechanism.
86
 The similar 
reacting atoms and basicities of DMAP (sp
2
 nitrogen, pKaH(H2O) = 9.87
98
) and 
isothiourea catalyst (GS A) (sp
2
 nitrogen, pKaH(H2O) = 9.8 for a related isothiourea
99
) 
suggest that the acylation mechanism of HBTM-2.1 112 may be very similar to that of 
DMAP. Our calculations suggest that after acylation of HBTM-2.1 112, the carboxylate 
deprotonates the cationic intermediate to give the ammonium enolate (GS D) (Figure 
34). Zipse has also demonstrated kinetically that deprotonation, in their case of an 
alcohol, is performed in a rate determining step by acetate instead of a trialkylamine 
auxiliary base in dichloromethane, which was supported with DFT calculations.
86 
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Transition states for the conjugate addition TS C (a number of diastereoisomers) were 
located as well as the associated intermediate ground state structures (Figures 34 and 
36).
 
 
Figure 36: Calculated transition structures for the conjugate addition (TS C1) step. 
 
The structure of the enolate GS D highlights the preference for the isothiouronium 
heterocycle to adopt a half-chair type conformation with the C(2)-phenyl unit 
pseudoaxial to minimise 1,2 steric interactions and the C(3)-i-Pr unit pseudoequatorial.
 
Previous modelling studies within the group showed that upon N-carboxylation of 
HBTM-2.1 112, the C(2)-phenyl substituent preferentially adopts a pseudoaxial 
orientation to minimise 1,2 steric interactions.
56
 A similar conformational preference in 
the key (Z)-ammonium enolate intermediate is expected due to sp
2
 hybridisation at the 
adjacent centre. The groups of Birman and Houk have recently disclosed two reports 
including DFT calculations to investigate the origin of enantioselectivity in 
benzotetramisole (BTM)-catalysed dynamic kinetic resolutions. The computational 
analysis carried out also highlights the preference of the C(2)-phenyl substituent in BTM 
to adopt a pseudoaxial orientation upon N-carboxylation.
100
 The enolate oxygen 
preferentially lies approximately coplanar and syn to the S atom within the 
isothiouronium ion, allowing a potentially stabilising no to *C-S interaction.
101
 Notably, 
the 1,5-S---O distance calculated within the enolate (2.40 Å) is the shortest of all TS or 
products within this proposed catalytic cycle, with a general trend indicating the 1,5-S---
O distance is inversely proportional to charge on the oxygen atom (Figure 37). 
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Structure S-O distance / Å Lowdin charge on enolate oxygen 
GS C 2.478 -0.224856 
TS B 2.43 -0.284809 
GS D 2.401 -0.37678 
TS C1 2.42 -0.282726 
GS G 2.447 -0.238161 
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Figure 37: Computational analysis of 1,5-S---O bond distance. 
 
This interaction is stabilising as can be clearly seen by comparison of the energy 
corresponding to the “anti”-enolate rotamer ground-state structure (Figure 38). This 
structure is roughly 17 kJ/mol higher in energy (including ZPE) than the “syn”-enolate 
structure GS D.  
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Figure 38: Calculated ground-state structures for GS D and the “anti-enolate”. 
 
A number of diastereoisomeric transition states were found for the reaction of the 
enolate GS D with the (E)-enone 220 giving both the observed and different 
stereoisomers of the product (Table 12). See Section 9.3.3 for all calculated structures 
(TS C1-9).   
TS 
Product 
stereochemistry 
Energy / 
Hartrees 
ZPE / 
Hartrees 
Total Energy / 
Hartrees 
Relative energy  
/ kJ/mol 
TS C1 (3R,4R) -2387.441492 0.621901 -2386.819591 0 
TS C2 (3R,4R) -2387.435291 0.621401 -2386.81389 14.9659125 
TS C3 (3R,4R) -2387.428468 0.621535 -2386.806933 33.227775 
TS C4 (3R,4R) -2387.431979 0.621095 -2386.810884 22.85535 
TS C5 (3R,4S) -2387.434845 0.621491 -2386.813354 16.372125 
TS C6 (3R,4S) -2387.434845 0.621491 -2386.813354 16.372125 
TS C7 (3S,4S) -2387.436265 0.621812 -2386.814453 13.48725 
TS C8 (3S,4R) -2387.431979 0.621395 -2386.810584 23.6431125 
TS C9 (3S,4R) -2387.43197 0.621252 -2386.810718 23.2918875 
Table 12: Relative energies for various TS C structures. 
 
Transition state TS C1 is significantly lower in energy than others (more stable by over 
13 kJmol
-1
). This energy difference corresponds to a selectivity of over 1000-to-1 in 
favour of the major product stereoisomer compared to others and these calculations are 
consistent with the high level of enantiomeric excess observed for the major 
diastereoisomer. We postulate that the structure of TS C1 is stabilised by the relatively 
short distances between the forming oxy-anion of the acceptor and three C-H hydrogens 
of the positively charged isothiouronium catalyst (NCH-O 2.09 Å, PhH-O 2.27 Å and i-
PrH-O 2.16 Å). While not particularly strong individually these stabilising contacts may 
be enough to impart the high selectivity for the observed stereoisomer of product 
(3R,4R)-224. The transition state TS C1 and the associated stereochemical rational 
detailed here can be applied to all HBTM-2.1 112 catalysed reactions detailed in this 
thesis.  
 
The enolate product GS G of this major reaction pathway was established as a ground-
state structure. Transition states for the bond rotation (TS D) and ring closure steps (TS 
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E) were located as well as the associated intermediate ground state structures (Figures 
34 and 39).
 
 
Figure 39: Calculated transition structures for the bond rotation (TS D) and ring closure (TS E) 
steps. 
  
The GS G intermediate must rearrange via a transition state structure such as eclipsed 
structure TS D (Figure 39) in order to allow the formation of the C-O bond and the six-
membered ring “tetrahedral-intermediate” GS H. GS H then decomposes to free catalyst 
(GS A) and lactone product (GS I) via TS E. Despite exhaustive searching a true ground 
state structure for the product of this rotation could not be found as all such structures 
minimise to the ring-closed structure GS H. These studies imply that once the carbon-
carbon bond formation is complete to give GS G, only bond rotation around this new 
bond is a barrier to formation of the six-membered ring. Interestingly, while the 
electronic energy of the tetrahedral intermediate GS H is lower in energy than the 
subsequent transition state TS E involving regeneration of the free catalyst, if zero-point 
energies are included in overall energies then the relative order of stability is reversed 
i.e. GS H is higher in energy than the subsequent transition state TS E and would seem 
to decompose to give free catalyst and lactone product in a barrier-less exergonic 
process. Intrinsic reaction coordinate calculations support GS H to be the ground state 
starting material for TS E, but it would seem that GS H is not a true ground state on the 
reaction path. Instead, it is possible that after bond rotation, the six-membered ring is 
formed with concerted, but highly asynchronous expulsion of the catalyst. 
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Another addition transition state (TS C4) leading to product (3R,4R)-224 is roughly 23 
kJ/mol higher in energy (inc. ZPE) than TS C1 (Figures 40 and 41). Intrinsic reaction 
coordinate calculations on TS C4 indicate that this higher energy transition state is much 
closer to that of a concerted Diels-Alder type reaction. This type of mechanism has been 
suggested by Bode for the reaction of acrolein and a carbene-catalyst-derived enolate.
102
  
 
Figure 40: Comparison of calculated transition structures for the conjugate addition (TS C1) and 
Diels-Alder-like (TS C4) steps. 
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Figure 41: Calculated transition structures for the Diels-Alder type-like transition state (TS C4). 
 
The reaction coordinate shows that the reaction is highly asynchronous with two phases: 
i) C-C bond formation giving a non-ground state enolate structure, and ii) C-O bond 
formation giving a “tetrahedral-intermediate” structure similar to GS H. As discussed 
above it is unlikely that this GS H-like structure is a true ground-state and so a third 
phase, that of catalyst expulsion, is probably part of this concerted addition process. 
Despite involving concerted C-C and C-O bond formations this reaction pathway is so 
asynchronous that the expected transition-state stabilisation for a normal pericyclic 
processes is not seen, and the seemingly more unusual stepwise reaction path via TS C1 
and the zwitterionic intermediate GS G is lower in energy and therefore a more 
significant conduit of reaction flux. 
 
The energies in Figures 34 and 40 are relative to the sum of the energies of the free 
catalyst (GS A), the mixed anhydride (GS B), Et3N (a surrogate for i-Pr2NEt) and the 
enone (GS F), and are electronic energies including zero point energy (ZPE). We were 
particularly interested in supporting the proposal that the rate-determining step of the 
reaction is the enolisation step and considered the relative energies from these 
calculations to predict the highest energy transition state in the reaction sequence. The 
deprotonation step TS B has a higher energy than the isomeric acylation transition step 
TS A. The reactions are performed in the presence of an excess of amine base so it is 
assumed that the pivalic acid forms a hydrogen-bond complex with an amine after 
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enolisation. The full proton transfer between pivalic acid and Et3N is not seen on the gas 
phase, but rather an arrangement consistent with a strong hydrogen bond. As the reaction 
solvent is relatively non-polar compared to water it is not certain as to the degree of salt 
formation seen in the reaction. It is however probable that a strong association of the 
pivalic acid and excess amine occurs. The subsequent conjugate addition and cyclisation 
steps have a lower energy, suggesting that the deprotonation step may be rate 
determining. The kinetic analysis suggests a first order dependence of the reaction rate 
on the concentration of the anhydride, and the computational modelling suggests that the 
initial acylation is endergonic. Together these results suggest that the resting state of the 
reaction is the free catalyst, and that the initial acylation of the catalyst is reversible, i.e. 
the isothiouronium pivalate (GS C) reverts to catalyst (GS A) and mixed anhydride (GS 
B) faster than the enolisation. It must be noted that the computational analysis does not 
include effects due to the changing concentration of the enone 220. Overall, the 
computational analysis suggests that the acylation is reversible, the rate determining step 
is the enolisation and, given the highly exergonic nature of the cyclisation step, that the 
reaction rate should be first order in catalyst and mixed anhydride, and zero order in 
enone, in agreement with the kinetic analysis. 
 
The transition state structure for this Michael addition reaction using (Z)-enone 295 that 
leads to the observed product configuration (3R,4S)-299 (calculated using the method as 
described earlier) is shown in Figure 42 in which the important stabilising CH-O 
interactions are highlighted (NCH-O 2.17 Å, PhH-O 2.38 Å and i-PrH-O 2.17 Å).  
 
Figure 42: Calculated transition structures for the conjugate addition to (Z)-enone 295. 
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3.8 Rational Catalyst Design 
Upon identification of stabilising CH-O interactions between the catalyst backbone and 
incoming Michael acceptor (Figures 41 and 42), the development of novel isothioureas 
capable of enhancing these interactions and potentially giving higher reaction 
efficiencies and stereoselectivities was investigated. It was proposed that an elaborated 
isothiourea, incorporating a 3,5-(CF3)2C6H3 aryl ring at C(2) would increase the acidity 
of neighboring protons and enhance the attractive PhH-O interaction with the developing 
negative charge on the enone oxygen atom (Figure 43). Isothiourea 301 was selected as 
a suitable catalyst to test this hypothesis. 
 
Figure 43: Proposed catalyst modification to increase indentified stabilising interactions. 
 
Isothiourea 301 was synthesised via the route described for HBTM-2.1 112 in Section 
2.3. Boc-imine 302 was prepared in 2 simple steps from the corresponding aldehyde 
303, via sulfone 304. However, the subsequent (S)-proline-catalysed Mannich reaction 
using 302 is not as clean as when using the benzaldehyde derived imine (as for the 
synthesis of HBTM-2.1) and the product is taken on crude at this stage. Reduction of the 
resulting aldehyde (1S,2S)-305 with NaBH4 allowed isolation of the product alcohol 
(1S,2S)-306 in 16% yield over 2 steps. Removal of the Boc-protecting group with HCl in 
dioxane gave amino alcohol (1S,2S)-307 in 91% yield (Scheme 81). 
 
Scheme 81: Synthetic route to -amino alcohol (1S,2S)-307. 
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Amino alcohol (1S,2S)-307 was converted into the isothiourea catalyst (2S,3R)-301 in 
20% yield over 2 steps using the same procedures as described for the synthesis of 
HBTM-2.1 112 (Scheme 82). One exception was that the final isothiourea catalyst was 
treated with 4M HCl in dioxane in order to isolate the HCl salt of 301 which could be 
purified by recrystallisation. The unoptimised synthesis afforded (2S,3R)-301 in 2% 
yield over 7 steps, as one diastereoisomer in 97% ee. 
 
a
 Determined by 
1
H NMR spectroscopic analysis. 
b
 Determined by chiral HPLC analysis. 
Scheme 82: Synthetic route to isothiourea catalyst 301. 
 
Isothiourea 301 was then tested as a catalyst for the model reaction between 
phenylacetic acid 146 and trifluoromethyl enone 220 in the presence of pivaloyl chloride 
and i-PrNEt2 (Scheme 83). Unfortunately, the reaction towards dihydropyranone 224 
only proceeded to approximately 20% conversion of 220 to 224 after 6 h at 23 °C and 
hence the yield and ee of this transformation were not determined. Comparatively, 
HBTM-2.1 112 gives full conversion to 220 after only 15 minutes at 23 °C. This 
decrease in catalytic efficiency could be attributed towards a reduction in the 
nucleophilicity of isothiourea 301 due to the electron-withdrawing groups added to the 
C(2)-aryl ring. 
 
Scheme 83: Isothiourea 301 as catalyst for Michael addition-lactonisation reaction. 
 
3.9 Conclusions 
In conclusion, after testing several electron deficient Michael acceptors, it was found 
that trifluoromethyl enones are highly compatible in the HBTM-2.1 catalysed Michael 
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addition-lactonisation protocol, forming a range of C(6)-trifluoromethyl anti-
dihydropyranones with good diastereoselectivity (up to 95:5 dr) and enantioselectivity 
(up to >99% ee).
69
 Furthermore, this process is stereospecific, with the diastereoisomer 
of product formed dependent upon the configuration of trifluoromethyl enone used. A 
variety of product derivatisations were demonstrated including those that introduce an 
additional trifluoromethyl-bearing stereogenic centre with high diastereoselectivity. 
Kinetic studies indicate this process is first order with respect to both in situ formed 
anhydride and catalyst concentration, with a primary kinetic isotope effect observed 
using ,-di-deuterio 4-fluorophenylacetic acid. DFT computational studies support a 
rate-determining formation of a reactive ammonium enolate prior to a stereochemistry-
determining enone conjugate-addition step. Attempts to make use of attractive CH-O 
interactions identified during the computational studies to design more efficient and 
selective isothiourea catalysts have not proved successful. 
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Chapter 4: Formal [4+2] Cycloadditions of N-Aryl-N-Aroyldiazenes 
This chapter describes the ability of HBTM-2.1 112 to catalyse the -amination of 
carboxylic acids 309 through the use of N-aryl-N-aroyldiazene Michael acceptors 310. 
Either 1,3,4-oxadiazin-6-ones 311 or N-protected -substituted amino acid derivatives 
312 (upon ring opening) are formed in high yields and excellent enantioselectivity 
(Scheme 84).
103
 For the first time, carboxylic acids other than arylacetic acids have been 
successfully applied to this protocol. 
 
Scheme 84: Formal [4+2] cycloaddition of N-aryl-N-aroyldiazenes. 
 
4.1 Introduction 
The development of new methodologies which allow access to amino acid derivatives is 
an area of great importance in organic chemistry.
104
 In particular, catalytic, asymmetric 
methodologies which allow amino acid derivatives to be accessed in high enantiomeric 
excess are extremely valuable.
105
 Within the arena of formal [4+2] cycloadditions the 
group of Ye have shown that NHCs catalyse the asymmetric -amination of ketene-
derived enolates using N-aryl-N-aroyl diazenes as Michael acceptors.
106
 For example, 
reaction of ketene 66 and diazene 313 in the presence of NHC precatalyst 314 and 
caesium carbonate afforded 1,3,4-oxadiazin-6-one (5R)-316 in 93% yield and 94% ee 
via azolium enolate 316 (Scheme 85). 
 
Scheme 85: -amination of ketene-derived enolates using diazenes. 
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The utility of 1,3,4-oxadiazin-6-one (5R)-315 was then demonstrated via the simple 
ring-opening with sodium methoxide, giving ,-disubstituted amino acid derivative 
(2R)-316 in 99% yield and 97% ee (Scheme 86). 
 
Scheme 86: Derivatisation to ,-disubstituted amino acid derivative 316. 
 
Based upon this precedent, it was proposed that N-aryl-N-aroyl diazenes could be useful 
Michael acceptors for the isothiourea-catalysed -amination of acetic acids. 
Interestingly, this methodology would allow access to mono -substituted amino acid 
derivatives and care would be needed to avoid epimerisation of the acid labile -
stereocentre in these enantioenriched products. 
  
4.2 Synthesis and Formal [4+2] Cycloaddition of 313 
In order to evaluate the ability of isothioureas to catalyse the -amination of carboxylic 
acids, N-aryl-N-aroyldiazene 313 was synthesised via a two-step procedure outlined by 
Bowman.
107
 Acylation of phenyl hydrazine 317 with benzoyl chloride 318 in the 
presence of Et3N in Et2O gave hydrazide 319 in 45% yield. Subsequent oxidation using 
NBS and pyridine afforded diazene 313 in 79% yield after chromatographic purification 
(Scheme 87). 
 
Scheme 87: Synthetic route towards diazene 313. 
 
With diazene 313 in hand, its subsequent use in the model intermolecular Michael 
addition-lactonisation reaction with phenylacetic acid 146 could be investigated. 
Initially, using DHPB 108 as catalyst and 1 eq of acid 146, the diazene acceptor was 
78% consumed after 1 h at 23 °C but consumption did not increase beyond this time. 
Diazene 313 was fully consumed if 1.5 eq of carboxylic acid was used and the amounts 
of activating agent and i-Pr2NEt were scaled up accordingly to 2.25 eq. However, it 
proved difficult to purify the highly non-polar 1,3,4-oxadiazin-6-one 320 via 
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chromatography due to the presence of pivalic anhydride – a by-product from the 
carboxylic acid activation step – which co-elutes with the product. To overcome this 
problem, p-methoxybenzoyl chloride was employed as the activating agent; the more 
polar p-methoxybenzoic anhydride contaminant is easily separated from the 1,3,4-
oxadiazin-6-one 320. Further studies showed that the amount of base used in the second 
(Michael addition) step could be reduced from 2.5 to 1.5 eq with no detriment towards 
product conversion. Using these modified conditions, (±)-320 could be isolated pure in 
63% yield (Scheme 88). Racemic samples needed for chiral HPLC analysis for all 
products in this chapter were made using achiral DHPB 108 as catalyst. 
 
Scheme 88: Modified reaction conditions towards 1,3,4-oxadiazin-6-one 320. 
 
Focus next shifted towards identifying an asymmetric protocol. Using the optimised 
reaction conditions for DHPB, tetramisole hydrochloride (2S)-106 (10 mol%) and 
benzotetramisole (2R)-107 (10 mol%) gave approximately 65% and 20% conversion 
respectively towards the product while HBTM-2.1 (2S,3R)-112 (10 mol%) again proved 
the most efficient catalyst, giving full conversion of diazene 313 after 1 h at 23 °C, 
affording (5R)-320 in 66% yield and 95% ee. Lowering the temperature to 78 °C 
allowed the product to be obtained in >99% ee and the catalyst loading could be lowered 
to 1 mol% without detriment towards product yield (Table 13). All reactions were 
carried out using bench grade solvents under air as standard. 
 
Entry Isothiourea (mol%) T (°C) Time (h) Conversion (%) Yield (%)
 
ee (%)
a 
1 106 (10) 23 1 65 - - 
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2 107 (10) 23 1 20 - - 
3 112 (10) 23 1 100 66 95 
4 112 (10) 0 2 100 65 98 
5 112 (10) 30 16 100 61 99 
6 112 (10) 78 16 100 81 99 
7 112 (5) 78 16 100 83 >99 
8 112 (1) 78 16 100 89 >99 
a
 Determined by chiral HPLC analysis. 
Table 13: Optimisation studies for Michael addition-lactonisation protocol. 
 
Entry 8 in Table 13 represents the optimal reaction conditions for the model system and 
these conditions were used for testing the scope of this reaction (see Section 4.3.1).  
 
It should be noted that heterocyclic products such as 320 are susceptible towards 
decomposition (presumably due to ring-opening) during chromatographic purification on 
silica meaning that these products had to be routinely purified via a rapid and short 
“silica plug”. With this limitation in mind, a one-pot Michael addition ring-opening 
protocol was also optimised, allowing access to hydrazide products that show much 
improved stability towards chromatographic purification (Table 14). In this system 
benzoyl chloride was used as activating agent, again to allow for easy chromatographic 
purification of the more polar hydrazide product from the less polar benzoic anhydride 
by-product derived from the activation step. Using the previously optimised reaction 
conditions, the 1,3,4-oxadiazin-6-one 320 intermediate could be directly ring opened by 
treatment with MeOH in situ, giving hydrazide (2R)-321 in 94% yield and 99% ee. In 
this process the catalyst loading could be lowered further to 0.25 mol%, giving (2R)-321 
in 83% yield and >99% ee. The enantioselectivity is maintained upon lowering to 0.1 
mol% catalyst loading (40 h reaction time) although the isolated yield drops to 60%. 
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Entry HBTM-2.1 112 (mol%) Time (h) Conversion (%) Yield (%)
 
ee (%)
a 
1 1 16 100 94 99 
2 0.5 16 100 85 >99 
3 0.25 16 100 83 >99 
4 0.1 40 65 60 99 
a
 Determined by chiral HPLC analysis. 
Table 14: Optimisation studies for Michael addition-lactonisation/ring-opening protocol. 
 
The conditions outlined in Entry 1 were used to assess the scope of this reaction (see 
Section 4.3.2). 
 
All hydrazides such as 321 exist as a mixture of rotamers (typically a 90:10 mixture) by 
1
H NMR. The rotameric nature of these compounds was proven through 1D gs-
NOSEY/EXSY NMR analysis in which exchange between the two rotamers was 
observed (Figure 44). In the figure below a) is the expansion of 
1
H NMR spectrum of 
compound (2R)-321 and b) is the 1D gs-NOESY/EXSY spectrum acquired upon 
selective irradiation of aliphatic C(2)H resonance at 5.89 ppm. The positive phased peak 
at 5.58 ppm indicates that hydrazide (2R)-321 exists in solution in the form of two fast 
exchanging species, likely rotamers. The negative phased doublets at 7.03 and 7.48 ppm 
appear in the spectrum due to NOE between the aliphatic C(2)H resonance and adjacent 
C(2)-Ar(2,6)H for both major and minor rotamer. 
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a) Expansion of 
1
H NMR (300 MHz, CDCl ) spectrum of compound (2R)-321. b) 1D gs-NOESY/EXSY 
spectrum acquired upon selective irradiation of aliphatic C(2)H resonance at 5.89 ppm. 
Figure 44: NMR evidence for rotameric hydrazides. 
 
4.3 Synthesis of N-Aryl-N-Aroyl Diazenes 
Using the same synthetic route as described previously for diazene 313, a variety of N-
aryl-N-aroyl diazenes were obtained via variation of the starting aryl hydrazine and aroyl 
chloride components (Scheme 89). The aryl hydrazine was varied to include aryl 
substitutents bearing electron-donating (4-OMe), electron-withdrawing (4-F, 4-CF3, 4-
CN) and 2,4,6-substitution (mesityl). The aroyl chloride was varied to include 2-, 3- and 
4-aryl substitution including electron-donating (4-OMe) and electron-withdrawing 
groups (4-NO2 and 4-CF3). Heteroaryl (2-furyl) and naphthyl aroyl chlorides were also 
used in the synthesis of diazene Michael acceptors. 
 
Scheme 89: Synthetic route towards diazene Michael acceptors. 
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A diazene in which the N-aroyl substituent was replaced by an N-acetyl group 322 was 
also synthesised by oxidation of commercially available 1-acetyl-2-phenyl hydrazine 
323 in a poor 17% yield (Scheme 90). 
 
Scheme 90: Synthetic route towards diazene 322. 
 
As can be seen from Scheme 89, the initial acylation of hydrazines with aroyl chlorides 
to form hydrazides often proceeded in modest isolated yields (30-50%). Despite this, in 
most cases this was acceptable to provide sufficient quantities of the final diazene 
Michael acceptors to study their use in the Michael addition lactamisation protocol. 
However, for the more expensive hydrazine starting materials this low yield was 
undesirable and an alternative synthetic route was designed for diazene 324 as an 
illustration of a more scalable and practical synthesis of this Michael acceptor class. 
Following the procedure outlined by Buchwald,
108
 the copper-catalysed cross coupling 
between 4-iodoanisole 325 and benzyl carbazate 326 in DMF gave 327 in 96% yield 
(Scheme 91). Subsequent acylation with 4-trifluoromethylbenzoyl chloride 328 
following the procedure outlined by Bowman
107
 gave Cbz-protected hydrazide 329 that 
was taken on crude and deprotected using Pd/C (10 mol%) under at atmosphere of H2 
(g), giving hydrazide 330 in 63% yield over 2 steps. Subsequent oxidation as outlined 
previously proceeded in 74% yield allowing access to multigram quantities of diazene 
324. 
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Scheme 91: Practical and scalable route to diazene 324. 
 
4.3.1 Substrate Scope – 1,3,4-Oxadiazin-6(5H)-ones  
Subsequent studies probed the generality of this process through variation of the 
arylacetic acid and diazene components to form a variety of 1,3,4-oxadiazin-6(5H)-ones 
(Table 15). Using 1 mol% of HBTM-2.1 112, this protocol readily tolerates a wide range 
of 4- and 3- substituted arylacetic acids, containing electron withdrawing and donating 
groups in addition to extended aromatic systems (products 320 and 331-337). Diazenes 
containing electron withdrawing N-aryl substitution (product 338), and extensive N-
aroyl substituent variation (products 339-344) are also accommodated, in all cases 
giving the corresponding 1,3,4-oxadiazin-6(5H)-ones in high yield and enantioselectivity 
(typically ≥99% ee).  
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a
 Determined by chiral HPLC analysis. 
 Table 15: Substrate scope - 1,3,4-oxadiazin-6(5H)-ones.  
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The absolute configuration of 1,3,4-oxadiazin-6(5H)-one (5R)-332 was unambiguously 
confirmed by X-ray crystal structure analysis (Figure 45). All other 1,3,4-oxadiazin-
6(5H)-one derivatives were assigned by analogy. For a detailed rationale regarding the 
observed enantioselectivity of these reactions, see Section 3.7. 
 
Figure 45: Crystal structure of (5R)-332 showing absolute configuration. 
 
Michael acceptors 345-348 were not fully consumed after 16 h reaction time at 23 °C 
using the highly reactive DHPB 108 as catalyst (Scheme 92). Analysis of the crude 
reaction mixtures by 
1
H NMR showed the presence unreacted diazene along with signals 
characteristic of product formation from which approximate conversions could be 
calculated. The poorer reactivity in these cases is attributed towards the Michael 
acceptors being too electron rich (345-347) or too sterically encumbered (348) for 
efficient reaction. 
 
Scheme 92: Poorly reactive diazenes 345-348. 
 
4.3.2 Substrate Scope – Hydrazides 
The generality of this procedure was further demonstrated through utilising the one-pot 
Michael-lactonisation/ring-opening sequence to access a range of hydrazides (Tables 16 
and 17). In addition to in situ ring opening with methanol, alternative nucleophiles such 
as allyl alcohol, isopropylamine and pyrrolidine can also be used, leading to a variety of 
hydrazides in high yield and ee (products 321 and 349-351). Heteroaryl and electron rich 
arylacetic acids are readily accommodated (products 352 and 353). Within a series of 
diazene acceptors differing in N-aroyl substitution, the electron withdrawing N-4-
nitrobenzoyl group results in increased reaction rate, with the electron rich N-4-
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methylbenzoyl substituent giving reduced rate (products 354-356). For example, in the 
case of forming hydrazide 354, 3 eq of phenylacetic acid are required for complete 
diazene consumption, while N-heteroaroyl and N-4-nitrobenzoyl substitution are well 
tolerated (products 355 and 356). The use of this highly electron-deficient N-4-
nitrobenzoyl diazene allowed the incorporation of more challenging arylacetic acids 
bearing strongly electron-withdrawing substituents (less nucleophilic ammonium 
enolates) or 2-arylsubstitution (sterically encumbered ammonium enolates) which 
typically perform poorly in isothiourea-catalysed Michael addition lactonisation 
processes (products 357-359).  
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a
 Determined by chiral HPLC analysis. 
b
 3 eq of phenylacetic acid used. 
c
 Methanolysis carried out at 78 
°C. 
Table 16 - Substrate scope – hydrazides. 
 
The generality of this protocol was also demonstrated through the incorporation of 
diazenes with electron deficient N-aryl groups (products 360 and 361) and further 
variation of both the diazene and arylacetic acid component (products 362-364) (Table 
17). In all cases, the hydrazide is obtained in good yield (66-95%) and excellent 
enantioselectivity (up to >99% ee). Additionally, this reaction is readily suited to scale 
up, with hydrazide 362 prepared on a 6.5 mmol scale using HBTM-2.1 112 (1 mol%) 
generating >2.5 g of product (95% yield, 99% ee). 
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a
 Determined by chiral HPLC analysis. 
b
 Methanolysis carried out at 78 °C. 
Table 17 - Substrate scope – hydrazides (continued). 
 
In practice, methanolysis to give hydrazides 360 and 361 at room temperature resulted in 
lower than expected ee (92% and 91% respectively). For these substrates, methanolysis 
at 78 °C led to optimal enantioselectivity, consistent with in situ racemisation of these 
particularly sensitive hydrazides at room temperature rather than decreased 
enantioselectivity in the key C-N bond forming step. This hypothesis was confirmed 
when an enantioenriched sample of (2R)-360 (98% ee) was re-treated with i-Pr2NEt in 
CH2Cl2 for 1 h at 23 °C, giving product in 91% ee, indicating that the product (2R)-360 
can racemise in the presence of base at 23 °C (Scheme 93). 
 
a
 Determined by chiral HPLC analysis. 
Scheme 93 – Control experiment testing base-mediated epimerisation of 360. 
 
The reactivity of 2-thiopheneacetic acid 365 in isothiourea-catalysed Michael addition 
lactonisation reactions is particularly interesting. Using the optimised conditions 
outlined above, reaction with diazene 313 gives hydrazide (2S)-366 in 82% yield but in 
only 54% ee which represents a significant deviation from the usual high enantiomeric 
excess observed (Scheme 94).  
 
a
 Determined by chiral HPLC analysis. 
Scheme 94: Unusual reactivity using 2-thiopheneacetic acid 365. 
 
A similar reduction in enantioselectivity was observed when this acid was used in the 
formal [4+2] cycloaddition with -keto-,-unsaturated ester 146 (83% ee, see Section 
2.4). In the stereochemical rationale for these processes, it is postulated that the observed 
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stereoselectivity can be explained via a transition state in which the enolate oxygen is 
orientated syn to the sulfur atom of the catalyst, allowing for a stablising no to *c-s 
interaction (Figure 46).
101
 This gives rise to a well defined ammonium enolate which can 
impart high levels of facial selectivity. A possible explanation for the unusually poor 
enantioselectivity when using 2-thiopheneacetic acid is that it may disrupt this important 
stabilising interaction as the enolate oxygen of the ammonium enolate can donate 
electron density into two different *c-s, one in the thiophene ring and the other in the 
isothiourea. This may allow some rotation around the C-N bond of the ammonium 
enolate, resulting in a less well defined transition state and lower facial selectivity. 
 
Figure 46: Possible explanation regarding poor enantioselectivity using 2-thiopheneacetic acid 365. 
 
4.4 Expansion of Acid Scope 
To this point, the scope of the intermolecular isothiourea-catalysed Michael addition 
lactonisation protocol has been limited to the use of monosubstituted arylacetic acids 
that represents a significant limitation of this methodology. Pleasingly, through the use 
of the highly reactive N-4-nitrobenzoyl diazene 367, the scope of this carboxylic acid 
functionalisation methodology has been expanded. For example, (phenylthio)acetic acid 
241 is readily tolerated using the standard optimised reaction conditions, giving 
hydrazide 368 in 83% yield and 98% ee (Scheme 95). Interestingly, under these reaction 
conditions acid 241 shows no reactivity with parent diazene 313 indicating that although 
the ammonium enolate clearly forms, the Michael acceptor must be highly electron 
deficient to lead to the observed products. 
 
a
 Determined by chiral HPLC analysis. 
Scheme 95: Functionalisation of (phenylthio)acetic acid 241. 
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Under these standard reaction conditions both methoxyacetic acid 369 and 3-
phenylpropionic acid 202 show minimal reactivity. However, these acids can be 
functionalised using 10 mol% of HBTM-2.1 112 and PS-BEMP as base at room 
temperature giving hydrazides 370 and 371 (Scheme 96). The lower enantioselectivity of 
370 (83% ee) may be due to partial racemisation under the reaction conditions due to the 
two -heteroatoms and the -ester group increasing the acidity at the stereocentre.  
 
Scheme 96: Functionalisation of methoxyacetic acid 369 and phenylpropionic acid 202. 
 
The need for a phosphazene base in these processes presumably reflects the expected 
increased pKa of the -protons in the assumed intermediate acyl ammonium species 
derived from both methoxyacetic acid and 3-phenylpropionic acid. For comparison, the 
pKas in DMSO of 1,2-diphenylethanone 372, 1-phenyl-2-(phenylthio)ethanone 373, 2-
methoxy-1-phenylethanone 374 and propiophenone 375 are 17.7,
109
 17.1,
110
 22.9
111
 and 
24.4
109
 respectively (Figure 47). However, an alternative reaction pathway involving 
ketene formation from an in situ formed mixed anhydride under these conditions cannot 
be ruled out (see Section 3.6 for mechanistic discussions). 
 
Figure 47: Comparison of relevant pKa’s in DMSO. 
 
Despite these advances in reaction scope, several carboxylic acids tested including 
cyanoacetic acid, propionic acid and 2-phenylpropionic acid remain incompatible with 
this methodology.  
 
4.5 Derivatisations 
The synthesis of N-aryl amino acid derivatives is of great importance due to their 
presence in various synthetically challenging and medicinally important molecules such 
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as protein kinase C activators indolactam-V 376
112
 and benzolactam-V8 377,
113
 ACE 
inhibitors
114
 and NMDA receptor antagonist L689560 378
115
 (Figure 48). 
 
Figure 48: N-aryl amino acid containing biologically active molecules. 
 
Direct N-arylation using Cu or Pd-mediated couplings is well established in organic 
chemistry.
116
 However, direct N-arylation of -arylglycines using these methods is 
limited, presumably due to facile racemisation,
117
 although nucleophilic aromatic 
substitution of arylglycines can be used.
118
 Catalytic asymmetric routes to N-aryl--
arylglycines typically focus upon reduction of -imino esters. For example, Akiyama 
has demonstrated that -aryl imino ester 379 undergoes enantioselective transfer 
hydrogenation in the presense of chiral phosphoric acid 380 as catalyst and 
benzothiazoline 381 as reductant, giving -aryl amino acid derivative 382 in 95% yield 
and 98% ee (Scheme 97).
119
  
 
Scheme 97: Transfer hydrogenation of imino ester 379. 
 
It was proposed that the catalytic asymmetric -amination of carboxylic acids described 
could offer an alternative route to tailor-made N-aryl--arylglycines via selective 
deprotection of the hydrazide products. This was realised through treatment of hydrazide 
(2R)-362 with SmI2, giving N-phenyl--phenylglycine derivative (2R)-383 in 77% yield 
and 99% ee. Notably, this transformation has to be carried out in THF:MeOH (3:1) at 
78 °C to avoid partial racemisation of these sensitive compounds. For example, when 
SmI2 mediated cleavage of (2R)-361 to give N-aryl--aryglycine (2R)-387 was carried 
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out at 23 °C the enantiomeric excess obtained was 91%. This simple SmI2 mediated N-N 
cleavage procedure is general and tolerates various aryl substitution patterns in the 
hydrazide, delivering bespoke N-aryl--arylglycine derivatives 383-387 with minimal 
racemisation (98% ee) and in good yield >75% (Table 18). Representative examples of 
this approach indicate that N-aryl--arylglycine derivatives bearing Ph, 4-FC6H4 or 2-
napththyl -substitution can be readily accessed, in addition to electron rich (4-
OMeC6H4) or electron deficient (4-CF3C6H4) N-aryl substitution. 
 
   
 
 
a
 Determined by chiral HPLC analysis. 
Table 18 – Synthesis of bespoke N-aryl--aryl glycine derivatives. 
 
The p-methoxyphenyl group was often incorporated into the hydrazide products and 
subsequently N-aryl--aryl glycine derivatives with the intention of removing this 
protecting group in order to access a range of bespoke -aryl glycine derivatives. 
However, the PMP-deprotection of (2R)-383 proved problematic, with minimal 
observed conversion to the desired free amine using CAN despite several related 
procedures being described in the literature.
120
 An alternative deprotection reaction using 
trichloroisocyanuric acid also gave minimal conversion to the desired amine. Other 
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deprotection strategies including a) formylation of the amine with acetic anhydride and 
formic acid followed by PMP deprotection with CAN, b) reduction of the ester to the 
corresponding alcohol using LiAlH4 followed by PMP deprotection with periodic acid 
and c) PMP deprotection with periodic acid directly on hydrazide (2R)-362 all gave 
minimal conversions to the desired products (Scheme 98). In all cases the starting 
material was consumed, however the desired products could not be identified through 
analysis of the crude reaction mixtures by 
1
H NMR or isolated after work-
up/purification. 
 
Scheme 98: Attempted PMP deprotections. 
 
The best deprotection methodology found used periodic acid, giving phenylglycine 
methyl ester (2R)-388 in 47% yield and 90% ee from (2R)-383 (Scheme 99). The 
erosion of enantiopurity is likely due to the strongly acidic conditions causing partial 
racemisation of the sensitive stereocentre. The enantioselectivity of the product was 
determined via acylation with acetic anhydride in the presence of Et3N, giving (2R)-389 
in 90% yield that could be analysed by chiral HPLC. The absolute configuration of (2R)-
388 was confirmed by comparison of the experimental optical rotation – 

 
D
20
-192 (c 
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0.025, CH2Cl2) – to a literature value – 

 
D
20
+202.3 (c 0.49 in CH2Cl2) for a 91% ee 
sample (2S)-configuration.
121 
 
a
 Determined by derivatisation. 
b
 Determined by chiral HPLC analysis. 
Scheme 99: Best deprotection conditions using periodic acid and subsequent derivatisation. 
 
Finally, the synthetic utility of the 1,3,4-oxadiazin-6(5H)-one products was also 
demonstrated. The simple reductive ring-opening reaction of 1,3,4-oxadiazin-6(5H)-one 
(5R)-331 with LiAlH4 gave alcohol (2R)-390 in 97% yield and 99% ee (Scheme 100). 
 
a
 Determined by chiral HPLC analysis. 
Scheme 100: Reductive ring-opening of 1,3,4-oxadiazin-6(5H)-one (5R)-331. 
   
4.6 Conclusions 
In conclusion, isothiourea HBTM-2.1 112 catalyses the practical and scalable direct -
amination of carboxylic acids using low catalyst loadings (as low as 0.25 mol%), 
forming a range of 1,3,4-oxadiazin-6(5H)-ones or hydrazide products with excellent 
enantiocontrol (typically >99% ee).
103
 Notably, the scope of this methodology has been 
expanded to allow the direct functionalisation of carboxylic acids bearing -heteroatom 
and alkyl substitution for the first time in addition to aryl substitution. The synthetic 
utility of the hydrazide products was demonstrated through their derivatisation into a 
range of bespoke functionalised N-aryl--arylglycine derivatives in high enantiopurity. 
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Chapter 5: Functionalisation of 3-Alkenoic Acids 
This chapter describes the use of 3-alkenoic acids 391 as suitable precursors to 
isothiourea-derived C1-ammonium dienolates that react to give exclusively -
functionalised products. The ability of HBTM-2.1 112 to catalyse the -
functionalisation of 3-alkenoic acids 391 through formal [4+2] cycloadditions with both 
trifluoromethyl enones 206 and N-aryl-N-aroyl diazenes 310 in good yield and with 
excellent enantiocontrol is disclosed, providing access to useful synthetic building 
blocks amenable to further elaboration (Scheme 101). 
 
Scheme 101: Functionalisation of 3-alkenoic acids via formal [4+2] cycloadditions. 
 
5.1 Introduction 
The organocatalytic generation of dienolates or their dienamine equivalents is an 
increasingly popular area of research.
123
 These intermediates have powerful synthetic 
potential due to their ability to react regio- and enantioselectively through either - or -
positions, allowing rapid access to diverse molecular scaffolds. In particular, recent 
research has demonstrated the ability of ammonium and azolium dienolates to 
participate in asymmetric transformations. Peters and co-workers
 
have shown that 
cinchona alkaloid-derived C1-ammonium dienolates, prepared from ,-unsaturated 
acid chloride starting materials, partake in formal [4+2] cycloadditions.
124
 For example, 
TMS-quinidine 392 catalyses the reaction of ,-unsaturated acid chloride 393 and 
chloral 46 in the presence of i-Pr2NEt and Sn(OTf)2 giving -lactone (S)-394 in 78% 
yield and 82% ee via C1-ammonium dienolate 395 (Scheme 102). 
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Scheme 102: Formal [4+2] cycloaddition of C1-ammonium dienolate with chloral 46. 
 
Ye and co-workers
 
have demonstrated the -amination of cinchona alkaloid-derived C1-
ammonium dienolates.
125
 For example, TMS-quinidine 392 catalyses the reaction of 
,-unsaturated acid chloride 396 and diazodicarboxylate 397 in the presence of Et3N, 
giving (S)-398 in 92% yield and 99% ee via a closely related C1-ammonium dienolate 
(Scheme 103). 
 
Scheme 103: -amination of C1-ammonium dienolate with diazodicarboxylate 397. 
 
In both of the above examples, the C1-ammonium dienolate 399 may form either via 
initial dehydrohalogenation of ,-unsaturated acid chloride 400 to form the vinyl 
ketene 401 that is intercepted by the Lewis base (pathway 1, Scheme 104), or from 
initial attack of the Lewis base to form ,-acyl ammonium 402 followed by -
deprotonation (pathway 2, Scheme 104). All catalytically generated ,-disubstituted 
C1-ammonium dienolates documented in the literature react to give-functionalized 
products. 
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Scheme 104: Two possible routes towards C1-ammonium dienolate 399. 
 
C1-azolium dienolates have also received considerable attention within the past two 
years. For example, Ye demonstrated that NHCs can activate ,-unsaturated acid 
chlorides towards formal [4+2] cycloadditions via C1-azolium dienolates.
126
 In a 
representative example, the reaction between ,-unsaturated acid chloride 403 and 
trifluoromethyl ketone 404 catalysed by chiral NHC, generated from precatalyst 405 in 
the presence of Cs2CO3, gave (R)-406 in 90% yield and 81% ee via C1-azolium 
dienolate 407 (Scheme 105). 
 
Scheme 105: Formal [4+2] involving C1-azolium dienolate 407. 
 
In addition to the ,-unsaturated acid chlorides 408, several different starting materials 
have been used to access the key C1-azolium dienolate that react via the -centre in 
asymmetric formal [4+2] cycloadditions with 2 electrophiles (Scheme 106). Chi 
disclosed the ability to access the same dienolate via both enals 409 (in the presence of a 
stoichiometric oxidant)
127,128
 and ,-unsaturated esters 410.129 Alternatively, enals 
bearing an -bromo leaving group such as 411 have also been demonstrated as suitable 
azolium dienolate precursors.
130
 In examples a-d, each process is postulated to involve -
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deprotonation of the corresponding ,-disubstituted-,-acyl azolium intermediate to 
generate the corresponding dienolate, often depicted in both (E)- and (Z)-configurations, 
followed by -functionalization of the resulting azolium dienolate.  
 
Scheme 106: Established methods to access C1-azolium dienolates. 
 
Alternatively, aldehydes that contain a -leaving group such as 412 have been used to 
access C1-azolium dienolates 413 (Scheme 107). Interestingly, these dienolates give -
functionalization via fluorination with NFSI, and -functionalization in the formal [4+2] 
cycloaddition with diazodicarboxylates, affording esters 414
131
 and lactams 415
132
 
respectively. 
 
Scheme 107: - and -functionalisation of C1-azolium dienolates 413. 
 
 Chapter 5: Functionalisation of 3-Alkenoic Acids 
 
 119 
Despite the advances made in the isothiourea-catalysed intermolecular Michael addition-
lactonisation methodology outlined thus far, the difficulties in employing acids other 
than simple arylacetic acids constitutes a limitation of this organocatalytic strategy. To 
broaden the substrate scope of such processes, the use of 3-alkenoic acids would allow 
access to extended dienolates that could give rise to either - or -functionalized 
products in a stereodefined manner (Scheme 108). In this chapter, the generation of 
isothiourea-derived C1-ammonium dienolates formed from 3-alkenoic acids and their 
subsequent reactivity is investigated.
 
 
Scheme 108: Generation of C1-ammonium dienolates using isothioureas. 
  
5.2 Reaction of C1-Ammonium Dienolates with 2 Electrophiles 
Initial studies probed the ability of isothioureas to generate an ammonium dienolate from 
a 3-alkenoic acid, with subsequent reaction with a reactive 2 component used to test if 
- or -selectivity is observed. 
 
5.2.1 Synthesis of Carboxylic Acid Starting Materials 
To test the ability of isothioureas to generate C1-ammonium dienolates, suitable 
carboxylic acid starting materials were identified and synthesised. Acid 416 was formed 
via a 3-step route beginning with a Horner-Wadsworth-Emmons (HWE) reaction 
between cyclopentanone 417 and phosphonate 418, giving alkene 419 in 91% yield 
(Scheme 109). Subsequent isomerisation with LDA followed by ester hydrolysis gave 
carboxylic acid 416 in 57% yield over 2 steps. Closely related carboxylic acids 420 and 
421 were made using the same HWE and ester hydrolysis steps from the corresponding 
ketone starting materials. 
 Chapter 5: Functionalisation of 3-Alkenoic Acids 
 
 120 
 
Scheme 109: Synthetic route towards carboxylic acids 416, 420 and 421. 
 
Carboxylic acid 422 was also obtained via Jones’ oxidation of commercially available 3-
methylbut-3-en-1-ol in 76% yield (Scheme 110). 
 
Scheme 110: Jones’ oxidation towards carboxylic acid 422. 
 
5.2.2 Functionalisation with 2 Electrophiles 
With carboxylic acids 416 and 420-422 in hand, these were tested along with 
commercially available (E)-4-phenylbut-3-enoic acid 423 for their ability to act as C1-
ammonium dienolate precursors. Encouraged by Ye’s report demonstrating 
diazadicarboxylates as suitable reaction partners with C1-ammonium dienolates,
125
 
along with both Ye and Chi who showed that trifluoromethyl ketones are suitable 
partners in [4+2] cycloadditions with C1-azolium dienolates,
126,127
 these 2 components 
were initially evaluated. Using carboxylic acids 416 and 420-422 with pivaloyl chloride 
as activating agent, achiral DHPB 108 as catalyst and trifluoromethyl ketone 404 as the 
2 electrophile, no distinguishable cycloaddition products were observed (Table 19). 
However, under the same reaction conditions, 423 reacted with trifluoromethyl ketone 
404, giving solely the [2+2] cycloaddition product -lactone 424 (60:40 dr anti:syn) 
derived from -functionalisation in 71% combined yield. Unfortunately, 
diazodicarboxylate 425 proved incompatible with this system giving no distinguishable 
product despite full consumption of 425.  
 Chapter 5: Functionalisation of 3-Alkenoic Acids 
 
 121 
 
Entry 
Carboxylic 
Acid 
2Electrophile Product (major) 
Yield 
(% anti, syn)
a 
Dr 
(anti:syn)
b 
1 
  
None - - 
2 
 
 
None - - 
3 
  
None - - 
4 
  
None - - 
5 
 
 
 
43,29 60:40 
6 
 
 
None - - 
a
 Isolated yield (98:2 dr). b Determined by 1H NMR spectroscopic analysis of the crude reaction mixture.  
Table 19: Evaluation of carboxylic acids 416 and 420-423 as C1-ammonium dienolate precursors. 
 
The relative configurations of -lactones (anti 424 and syn 426) were unambiguously 
confirmed by X-ray crystal structure analysis (Figure 49). 
 
Figure 49: Crystal structures of 424 and 426 showing relative configuration. 
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When carboxylic acids 416 and 420-422 were used in this protocol, analysis of the crude 
reaction mixtures by 
1
H NMR revealed that in all cases the corresponding mixed 
anhydride had formed and that trifluoromethyl ketone 404 remained. Possible reasons 
for the lack of reactivity include: 1) the acyl ammonium does not form from the mixed 
anhydride; 2) the -deprotonation of the acyl ammonium to form the C1-ammonium 
dienolate does not take place; 3) the C1-ammonium dienolate is poorly nucleophilic and 
does not react with the electrophile. In order to gain some insight into this problem, the 
corresponding acyl ammonium was synthesised by reaction of acid chloride 403 with 
DHPB 108 to give N-acyl isothiouronium chloride 427 in 73% yield (Scheme 111). 
 
Scheme 111: Acyl ammonium formation. 
 
The reaction with trifluoromethyl ketone 404 was carried out using 1 equivalent of 427 
and no consumption of the electrophile was observed (Scheme 112). This result suggests 
that either -deprotonation does not take place or that the C1-ammonium dienolate is 
poorly nucleophilic. Employing a stronger base – PS-Bemp – also resulted in no 
consumption of the electrophile. 
 
Scheme 112: Acyl ammonium 427 used directly in reaction. 
 
Due to the discovery that DHPB 108 catalyses the formal [2+2] cycloaddition between 
carboxylic acid 423 and trifluoromethyl ketone 404, attention focused upon the 
development on suitable conditions to affect an asymmetric variant of this 
transformation. Preliminary studies showed that carrying out this reaction using HBTM-
2.1 112 at 78 °C allowed formation of -lactone in 65:35 dr with the anti-
diastereoisomer (3S,4S)-424 formed in 79% ee and the syn-diastereoisomer (3S,4R)-426 
formed in 77% ee (Scheme 113). The absolute configurations are tentatively assigned by 
analogy to that typically observed using HBTM-2.1 112 in these processes.
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a
 Isolated yield (98:2 dr). b Determined by 1H NMR spectroscopic analysis of the crude reaction mixture. 
c
 Determined by chiral HPLC analysis.  
Scheme 113: Preliminary studies into asymmetric formal [2+2] cycloadditions. 
 
The area of formal [2+2] cycloadditions of isothiourea-derived C1-ammonium 
dienolates was continued by an undergraduate project student.
133
 It was found that 
HBTM-2.1 112 efficiently catalysed the formal [2+2] cycloadditions between a range of 
3-alkenoic acids 391 and N-tosyl aldimines 428, affording a variety of anti--lactams 
429 in high yield and with high levels of diastereo- and enantioselectivity (Scheme 114). 
 
Scheme 114: Formal [2+2] cycloaddition of N-tosyl aldimines. 
 
5.3 Functionalisation with 4 electrophiles 
5.3.1 Formal [4+2] cycloadditions with trifluoromethyl enones 
Having established the propensity of these ammonium dienolates to react at the -
position with 2 electrophiles, their ability to partake in formal [4+2] cycloadditions 
with electron deficient 4 Michael acceptors was investigated. It was found that HBTM-
2.1 112 efficiently catalyses the reaction between commercially available (E)-pent-3-
enoic acid 430 and previously utilised trifluoromethyl enone 220 (see Chapter 3) in only 
5 minutes at rt, giving anti-dihydropyranone (3S,4R)-431 in 80% yield with good 
diastereoselectivity (88:12 dr) and excellent enantioselectivity (96% ee) (Scheme 115). 
The minor diastereoisomer was formed in only 15% ee. This reaction does not give full 
consumption of enone 220 at 78 °C even with extended reaction times. 
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a
 Isolated yield (88:12 dr). 
b
 Determined by 
1
H NMR spectroscopic analysis of the crude reaction mixture. 
c
 Determined by chiral HPLC analysis.  
Scheme 112: Formal [4+2] cycloaddition of carboxylic acid 430. 
 
The relative and absolute configuration of (3S,4R)-431 was assigned by comparison with 
the products formed in Chapter 3 and all other products in Table 20 were assigned by 
analogy. Racemic samples needed for chiral HPLC analysis for all dihydropyranones in 
this Section were made using HBTM-2.1 (±)-112 as catalyst due to the higher 
diastereoselectivities obtained in comparison to DHPB 108.  
 
A brief examination of the scope revealed that the reaction proceeds efficiently using 
(E)-3-hexenoic acid, giving anti-dihydropyranone 432, although when using the more 
reactive (E)-styrylacetic acid, the reaction has to be carried out at −78 °C to prevent 
product decomposition and gives the major diastereoisomer of 433 in reduced 
enantioselectivity (60% ee). Heteroaryl and 4-bromophenyl substituted trifluoromethyl 
enones are also tolerated giving 434 and 435 in good yields and high diastereo- and 
enantioselectivity (Table 20). 
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a
 Isolated yield of major diastereoisomer (88:12 dr). 
b
 Determined by 
1
H NMR spectroscopic analysis of 
the crude reaction mixture. 
c
 Determined by chiral HPLC analysis. 
d
 Isolated yield of major 
diastereoisomer (93:7 dr). 
e
 Isolated yield of major diastereoisomer (98:2 dr). f Isolated yield of major 
diastereoisomer (95:5 dr). 
g
 Isolated yield of major diastereoisomer (84:16 dr).  
Table 20: Substrate scope using trifluoromethyl enones. 
 
5.3.2 Synthesis of Carboxylic Acid Starting Materials 
In order to further assess the scope of this methodology a range of additional 3-alkenoic 
acids were synthesised. 4-i-Pr substituted and 4-Bn substituted acids 436 and 437 were 
made according to the one-step method described by Tan.
134
 Piperidine-acetic acid 
catalysed Doebner-modified Knoevenagel reaction between malonic acid 438 and the 
requisite aldehyde gave 436 and 437 in 57% and 59% yield respectively (Scheme 116).  
 
Scheme 116: Synthetic route towards carboxylic acids 436 and 437. 
 
A carboxylic acid with a (Z)-double bond 438 was also synthesised via the two step 
procedure outlined by Breit.
135
 Commercially available alkyne 439 was partially 
hydrogenated to (Z)-alcohol 440 using Lindlar’s catalyst followed by oxidation to give 
(Z)-acid 438 in 23% yield over 2 steps (Scheme 117). 
 
Scheme 117: Synthetic route towards (Z)-carboxylic acid 438. 
 
5.3.3 Formal [4+2] cycloadditions with N-aryl-N-aroyl diazenes 
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With these additional carboxylic acid starting materials in hand, the generality of this 
asymmetric Michael addition-lactonisation process was next investigated using the 
previously utilised N-aryl-N-aroyldiazenes as Michael acceptors (see Chapter 4), 
followed by in situ ring opening with MeOH. This catalytic methodology tolerates a 
range of 3-alkenoic acids bearing 4-alkyl (Me, Et, i-Pr), 4-benzyl and 4-phenyl 
substituents, in addition to (E)- and (Z)-alkene configurations, giving, after in situ ring-
opening with methanol, a range of hydrazides 441-446 in high yields (71-85 %) and 
excellent enantioselectivity (91-99 % ee) (Table 21). Diazenes bearing electron deficient 
(4-FC6H4) and heteroaryl (2-furyl) N-aroyl substituents are also tolerated giving products 
447 and 448 in excellent ee. The absolute configuration of hydrazide (2R)-441 was 
assigned by comparison to the products formed in Chapter 4 and all other products in 
Table 21 were assigned by analogy. Racemic samples needed for chiral HPLC analysis 
for all hydrazides in this section were made using DHPB 108 as catalyst. 
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a
 Determined by chiral HPLC analysis.  
Table 21: Substrate scope using N-aryl-N-aroyl diazenes. 
 
Unfortunately both but-3-enoic acid 449 and but-3-ynoic acid 450 gave no conversion to 
the desired hydrazide product when reacted with diazene Michael acceptor 313 using the 
optimised reaction conditions. 
1
H NMR analysis of the crude reaction mixture revealed 
the presence of both the corresponding mixed anhydrides and remaining diazene 313 
(Scheme 118). 
 
Scheme 118: Unreactive carboxylic acid starting materials 449 and 450. 
 
5.4 Derivatisations 
Having developed a highly enantioselective route to hydrazides 441-448, their potential 
for further elaboration through functionalisation of the olefin was probed. Treatment of 
hydrazide 441 under Upjohn dihydroxylation conditions, followed by acid catalysed 
cyclisation using p-TSA, gave a 70:30 mixture of separable diastereomeric 5-membered 
lactones 451 and 452 in 85% combined yield, both in 99% ee (Scheme 119). These 
interesting aza-sugar derivatives structurally resemble the cyclized form of (+)-
polyoxamic acid 453, indicating their potential biological significance. 
 Chapter 5: Functionalisation of 3-Alkenoic Acids 
 
 128 
 
a
 Isolated yield of major diastereoisomer (98:2 dr). b Determined by 1H NMR spectroscopic analysis of 
the crude reaction mixture. 
c
 Determined by chiral HPLC analysis. 
Scheme 119: Derivatisation towards aza-sugar analogues. 
 
It proved difficult to determine the relative configurations of lactones 451 and 452 at this 
stage by NOE or coupling constant analysis due to poorly resolved signals in the 
1
H 
NMR. In order to simplify the 
1
H NMR spectra the N-N bond in both lactones 451 and 
452 was cleaved using SmI2 giving 453 and 454 in 70% and 76% yield respectively 
(Scheme 120). The enantioselectivity of these products was not determined. 
 
Scheme 120: Further derivatisation to allow for determination of relative configurations. 
 
Diastereoisomers (3R,4R,5R)-453 and (3R,4S,5S)-454 were assigned based upon the J 
coupling constant between C(3)H and C(4)H which is 7.3 Hz for (3R,4R,5R)-453 due to 
the anti relationship and 2.9 Hz for (3R,4S,5S)-454 due to the syn relationship (Figure 
50). Additional evidence was found using NOE experiments. Upon irradiation of C(5)H 
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in (3R,4R,5R)-453 there is a NOE with both C(4)H and CH . However, irradiation of 
C(5)H in (3R,4S,5S)-454 gives NOE with C(4)H, CH  and importantly C(3)H, indicating 
that C(3)H, C(4)H and C(5)H are all on the same face of the 5-membered lactone. This 
analysis allowed the relative configuration of the lactone products to be assigned with 
the absolute configuration defined by the starting hydrazide (2R)-441. 
 
Figure 50: Determination of relative configurations of 453 and 454. 
 
5.5 Reaction Mechanism 
A plausible catalytic cycle for these transformations proceeds via initial N-acylation of 
HBTM-2.1 112 with the pre-formed mixed anhydride to form the corresponding acyl 
ammonium ion. -Deprotonation generates the (Z,E)-enolate (from the (E)-alkenoic 
acid), which undergoes stereoselective Michael addition via -functionalization with 
electron deficient 4 Michael acceptors, followed by intramolecular cyclisation, to 
generate the corresponding heterocyclic species (Figure 51). The sense of 
stereoinduction in these transformations is consistent with the rationale outlined in 
Chapter 3. The origin of the observed -functionalization in these processes can be 
tentatively assigned to preferential reaction via the assumed s-trans (Z,E)-dienolate 
conformation 455, in preference to the s-cis (Z,E)-dienolate conformation 456 that is 
presumably necessary to participate in -functionalization. 
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Figure 51: Proposed mechanism for heterocycle formation. 
   
5.6 Conclusions 
In conclusion, isothiourea-mediated functionalisation of 3-alkenoic acids occurs 
regioselectively, giving products derived from -functionalisation of an intermediate 
C1-ammonium dienolate in a range of formal [2+2] and [4+2] cycloadditions. This 
contrasts with all other C1-ammonium dienolates reported in the literature that react at 
the -position. Formal [4+2] cycloadditions with either trifluoromethyl enones of N-aryl-
N-aroyl diazenes are catalysed by HBTM-2.1, with products obtained in high diastereo- 
and enantiocontrol (up to 95:5 dr, up to 99% ee). The simple, two-step elaboration of 
stereodefined hydrazides into aza-sugar analogues without erosion of enantiopurity has 
also been demonstrated. 
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Chapter 6: 2-Arylacetic Anhydrides as Ammonium Enolate Precursors 
This chapter describes the use of 2-arylacetic anhydrides 457 as precursors to 
isothiourea-derived C1-ammonium enolates. HBTM-2.1 112 efficiently catalyses the 
formal [4+2] cycloadditions between 457 and a range of electron deficient Michael 
acceptors, namely -keto-,-unsaturated esters 141, trifluoromethyl enones 206 and N-
aryl-N-aroyl diazene 313, giving stereodefined products in good yield and with exquisite 
enantiocontrol (Scheme 121).
136
 
 
Scheme 121: Functionalisation of 2-arylacetic anhydrides via formal [4+2] cycloadditions. 
 
6.1 Introduction 
The in situ activation and subsequent isothiourea-mediated functionalisation of 
carboxylic acids has been shown to be a highly powerful strategy, allowing access to a 
range of stereodefined product in high enantioselectivity. However, noteworthy 
drawbacks of this method include the use of excess sacrificial base (up to 4 eq of i-
Pr2NEt) and the generation of unwanted by-products derived from the acid activating 
agent (such as pivalic anhydride derived from pivaloyl chloride) that can be difficult to 
separate from the desired products as discussed in Section 4.2 (Scheme 122). These 
drawbacks led to the desire to identify alternative bench stable precursors to ammonium 
enolates at the carboxylic acid oxidation level.  
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Scheme 122: Previous access to C1-ammonium enolates from carboxylic acids. 
 
The group of Connon recently demonstrated the functionalisation of enolisable 
anhydrides using bifunctional squaramides.
137
 For example, 458 catalyses the reaction of 
anhydride 459 and 4-chlorobenzaldehyde 460 giving, after in situ methyl ester 
formation, bicyclic ester (3R,4R)-461 in 93% yield, 95:5 dr and 95% ee (Scheme 123). 
 
Scheme 123: Functionalisation of enolisable anhydride 459. 
 
Inspired by this report, in addition to the work of Chi using p-nitrophenyl esters as 
azolium enolate precursors (see Section 1.2.2),
42
 it was proposed that readily available 2-
arylacetic anhydrides could act as C1-ammonium enolate precursors (Scheme 124). 
Using this strategy, the only by-product from such a process would be an equivalent of 
the parent acid that would be easily removed via basic aqueous work-up. While one 
equivalent of the (generally cheap and commercially available) parent arylacetic acid 
would be discarded in this process, this may be offset by the use of less sacrificial base 
and easier product purifications. 
 
Scheme 124: Access to C1-ammonium enolates from 2-arylacetic anhydrides. 
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6.2 Formal [4+2] Cycloadditions of 2-Arylacetic Anhydrides 
6.2.1 Synthesis of 2-Arylacetic Anhydrides 
A variety of 2-arylacetic anhydrides 462-464 were synthesised in good yields via 
treatment of the parent arylacetic acid with DCC in toluene at rt for 15 minutes. These 
products are bench stable for approximately one week (Scheme 125). Several other 
anhydrides were synthesised and made available by colleagues.
138 
 
Scheme 125: Synthetic route towards 2-arylacetic anhydrides 462, 463 and 464. 
 
6.2.2 Formal [4+2] Cycloadditions with Trifluoromethyl Enones 
With 2-arylacetic anhydrides 462-464 in hand, these were tested in the isothiourea-
catalysed formal [4+2] cycloaddition reaction with the previously utilised 
trifluoromethyl enones Michael acceptors (see Chapters 3 and 5). HBTM-2.1 112 
efficiently catalyses the reaction between 2-arylacetic anhydride 462 and trifluoromethyl 
enone 220 after 16 h at 78 °C, giving anti-dihydropyranone (3R,4R)-224 in 81% yield 
with good diastereoselectivity (94:6 dr) and excellent enantioselectivity (98% ee) 
(Scheme 126). Notably, a slight excess of both anhydride 462 (1.25 eq) and i-Pr2NEt 
(1.25 eq) was necessary for complete consumption of 220, presumably due to competing 
Claisen-type self condensation of the anhydride. Approximately 80% conversion of 
enone 220 to (3R,4R)-224 is achieved using 1 eq of anhydride 462. As anticipated, 
highly pure material could be obtained after a simple acid/base work-up, with 
chromatographic purification used to obtain an analytical sample. 
 
a
 Isolated yield of major diastereoisomer of 224 (98:2 dr). b Determined by 1H NMR spectroscopic 
analysis of the crude reaction mixture. 
c
 Determined by chiral HPLC analysis.  
Scheme 126: Formal [4+2] cycloaddition of 2-arylacetic anhydride 462. 
 
 Chapter 6: 2-Arylacetic Anhydrides as Ammonium Enolate Precursors 
 
 135 
The relative and absolute configuration of (3R,4R)-224 was the same as that formed 
using the in situ carboxylic acid activation method used previously (see Chapter 3). All 
other products in Table 22 were assigned by analogy.
139
 
 
A brief examination of the reaction scope revealed that the protocol tolerates 4-FC6H4 
and 4-MeC6H4 substitution within the anhydride and 4-ClC6H4 and 2-naphthyl 
substitution within the enone, in each case giving the corresponding anti-
dihydropyranones in good yields and high diastereo- and enantioselectivity (Table 22). 
Several other examples of this methodology was demonstrated by colleagues.
138 
 
   
  
a
 Isolated yield of major diastereoisomer (98:2 dr). b Determined by 1H NMR spectroscopic analysis of 
the crude reaction mixture. 
c
 Determined by chiral HPLC analysis.  
Table 22: Substrate scope using trifluoromethyl enones. 
 
6.2.3 Formal [4+2] Cycloadditions with Other Michael Acceptors 
Having developed an efficient protocol for the isothiourea catalysed Michael addition-
lactonisation of anhydrides and trifluoromethylenones, this process was extended to 
other classes of suitably electron deficient Michael acceptors. -Keto-,-unsaturated 
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esters proved suitable partners within this process (Table 23). Once more, electron-
donating and electron-withdrawing substituents, as well as heteroaryl substitution within 
both anhydride and -keto-,-unsaturated ester reaction components was tolerated, 
affording a range of anti-dihydropyranones in high yields (78-86%) and with high 
diastereo- and enantioselectivity (up to 98:2 dr, exclusively >99% ee). 
 
   
   
a
 Isolated yield of major diastereoisomer (98:2 dr). b Determined by 1H NMR spectroscopic analysis of 
the crude reaction mixture. 
c
 Determined by chiral HPLC analysis. 
d
 Isolated yield of major 
diastereoisomer (93:7 dr). 
Table 23: Substrate scope using -keto-,-unsaturated esters. 
 
As a final demonstration of this methodology, HBTM-2.1 112 catalysed 
functionalisation of 2-arylacetic anhydride 462 with diazene 313 using a tandem 
Michael addition-lactonisation ring-opening protocol with MeOH was achieved, 
afforded hydrazide 321 in 61% yield and 98% ee (Scheme 127). Several other examples 
of this methodology was demonstrated by a colleague.
140 
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a
 Determined by chiral HPLC analysis.  
Scheme 127: Formal [4+2] cycloaddition of using diazene 313. 
 
6.3 Reaction Mechanism 
A plausible catalytic cycle for these transformations proceeds via initial N-acylation of 
HBTM-2.1 112 with the arylacetic anhydride to form the corresponding acyl ammonium 
ion. Deprotonation generates the (Z)-enolate, which undergoes stereoselective Michael 
addition, followed by intramolecular cyclisation, to generate the corresponding 
heterocyclic species (Figure 52). The sense of stereoinduction in these transformations is 
consistent with the rationale outlined in Section 3.7. 
 
Figure 52: Proposed mechanism for functionalisation of 2-arylacetic acids. 
 
6.4 Conclusions 
In conclusion, it has been shown that 2-arylacetic anhydrides are convenient and readily 
prepared precursors for the formation of C1-ammonium enolates in isothiourea-mediated 
Michael addition-lactonisation processes. Trifluoromethylenones,-keto-,-
unsaturated esters and N-aryl-N-aroyldiazenes are reactive Michael accceptors in this 
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process, with HBTM-2.1 (5 mol%) readily promoting heterocycle formation with high 
diastereo- and enantiocontrol (up to 95:5 dr, up to >99% ee).
136
 This protocol offers a 
useful and practical alternative to the in situ carboxylic acid activation method, in which 
by-product formation and the amount of sacrificial base used is minimised. 
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Chapter 7: One-Pot Synthesis of Functionalised Pyridines 
This chapter describes the discovery of reaction conditions to affect the DHPB 108 
catalysed Michael addition-lactamisation reaction between (phenylthio)acetic acid 242 
and ,-unsaturated ketimines 467, giving initially anti-dihydropyridone products which 
undergo subsequent elimination and N- to O-sulfonyl migration affording a variety of 
2,4,6-substituted pyridines 468 in moderate to high yield (Scheme 128).
141
 This 
represents a one-pot organocatalytic route towards highly functionalised pyridines 
bearing a 2-sulfonate group that is shown to be a highly versatile functional handle. An 
application of this methodology was demonstrated through the synthesis of a known 
COX-2 inhibitor. 
 
Scheme 128: One-pot synthesis of functionalised pyridines. 
 
7.1 Introduction 
Pyridines are an extremely privileged heterocyclic class commonly found in natural 
products and functional materials, as well as being important building blocks in both the 
agrochemical and pharmaceutical industries.
142
 Consequently, a vast array of synthetic 
methods have been successfully developed to access these useful molecules.
143
 A recent 
example from the group of Yoshikai demonstrated the modular synthesis of pyridines 
from oximes and enals using synergistic copper/iminium catalysis.
144
 For example, 
condensation of oxime 469 with cinnamaldehyde 470, catalysed by CuI and 
pyrrolidinium perchlorate 471 gave pyridine 472 in 75% yield via dually activated 
couple 473 (Scheme 129). 
 
Scheme 129: Pyridine formation via synergistic copper/iminium catalysis. 
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Another recent report from the Rovis group highlights the use of rhodium(III) catalysis 
to access pyridines from alkenes and ,-unsaturated oximes.145 In a representative 
example, formal [4+2] cycloaddition between O-pivaloyl ketoxime 474 and ethyl 
acrylate 475, catalysed by [RhCp*Cl2]2 (Cp* = pentamethylcyclopentadienyl) with 
AgOAc as oxidant, gave pyridine 476 in 92% yield with 477 a proposed reaction 
intermediate (Scheme 130). 
 
Scheme 130: Rh(III)-catalysed pyridine synthesis. 
 
7.2 Previous Work in the Smith Group 
In addition to the isothiourea-catalysed intermolecular Michael addition-lactonisation 
methodology outlined in this thesis, in 2012 the Smith group has also demonstrated an 
intermolecular Michael addition-lactamisation process using ,-unsaturated ketimines 
as Michael acceptors.
146
 For example, benzotetramisole (2R)-107 is a highly efficient 
catalyst for the functionalisation of phenylacetic acid 146, preactivated to the mixed 
anhydride with pivaloyl chloride and i-Pr2NEt, with ketimine 82 giving anti-
dihydropyridone (3R,4R)-478 in 79% yield, 88:12 dr and 99% ee (Scheme 131). 
 
Scheme 131: Isothiourea-catalysed intramolecular Michael addition-lactamisation. 
 
In Section 3.3 it was shown that (phenylthio)acetic acid 241 could be successfully 
functionalised using the isothiourea-catalysed Michael addition-lactonisation 
methodology developed to access pyrone 242 after elimination of thiophenol. Within the 
Smith group it was found that when ,-unsaturated ketimine 479 was used as the 
Michael acceptor in this system it was fully consumed and that a mixture of the expected 
pyridone 480 and unexpected pyridine 481 (80:20 480:481) were present in the crude 
reaction mixture by 
1
H NMR analysis (Scheme 132).
147
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Scheme 132: Initial discovery. 
 
After some optimisation, the Smith group discovered suitable conditions to selectively 
obtain pyridine products.
148
 It was found that, after the initial activation step, heating the 
reaction mixture at 80 °C in THF for 16 h allowed access to pyridine 481 in 67% yield 
(Scheme 133). It was noted that increased temperatures were necessary to promote 
effective N- to O-sulfonyl migration in this process, with lower temperatures leading to 
mixtures of intermediate pyridone and desired pyridine. The use of alternative Lewis 
basic catalysts such as DBU, TBD and DMAP had a negative effect upon the isolated 
product yield in this process. Additionally, bromo- and chloroacetic acid were tested in 
this protocol although neither resulted in any conversion towards pyridine 481. 
 
Scheme 133: Optimised reaction conditions for one-pot pyridine synthesis. 
 
It is proposed that this reaction proceeds via initial Michael addition-lactamisation 
followed by elimination of thiophenol to form pyridone 480. Subsequent N- to O-
sulfonyl migration allows pyridine 481 to be accessed directly in one-pot (Scheme 134). 
Importantly, in this process the activating sulfonyl group on the ketimine is transformed 
into a synthetically useful functional handle (the 2-sulfonate group) in the resulting 
pyridine, allowing subsequent derivatisation into a variety of products. 
 Chapter 7: One-Pot Synthesis of Functionalised Pyridines 
 
 142 
 
Scheme 134: One-pot formation of pyridine from 479 and 242. 
 
Several reports regarding the final N- to O-sulfonyl migration step to form pyridines 
from pyridones can be found in the literature,
149
 with this rearrangement often 
considered to be an undesired, non productive pathway.
150
 For example, the group of 
Fujita found that the Diels-Alder reaction between pyridone 482 and diene 483 to form 
bicycle 484 proceeded in 46% yield with significant amounts of the undesired pyridine 
485 (arising from N- to O-sulfonyl migration) also formed (Scheme 135).
151 
 
Scheme 135: Literature precedent for N- to O-sulfonyl migration. 
 
In the context of the organocatalytic functionalisation of (phenylthio)acetic acid, N- to 
O-sulfonyl migration of intermediate pyridones would represent a highly desirable 
transformation, allowing direct access to valuable pyridine products in one-pot.  
 
7.3 Synthesis and Reactivity of ,-Unsaturated Ketimines 486 and 487 
In order to expand the scope of the methodology described above a novel class of ,-
unsaturated ketimines was proposed and synthesised (Scheme 136). Following the 
procedures outlined by Yamazaki
152,153
 trifluoromethyl enones 488 and 489 was 
obtained via a simple two-step procedure. Treatment of alkene 490 with LDA and 
subsequent reaction with benzaldehyde 38 affords an intermediate alkynyl alcohol that 
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isomerises to a mixture of (E)- and (Z)-enones 488 and 489 (80:20 488:489 ratio) after 
treatment with Et3N, which were isolated in 72% and 17% yield respectively over 2 
steps. Treatment of (E)-488 or (Z)-489 with 4-toluenesulfonamide 490 in the presence of 
TiCl4 and Et3N gives ,-unsaturated ketimines 486 and 487 in 80% and 21% yield 
respectively after recrystallisation. 
 
Scheme 136: Synthetic route towards ,-unsaturated ketimines 486 and 487. 
 
With ,-unsaturated ketimine 486 in hand, its subsequent use in the isothiourea-
catalysed one-pot formation of pyridines was investigated. Using the optimised reaction 
conditions already developed in the group, DHPB 108 efficiently catalysed the reaction 
between (phenylthio)acetic acid 242 and ,-unsaturated ketimine 486 giving pyridine 
491 in 58% yield (Scheme 137). It was found that this reaction is scalable, giving >5 g 
of pyridine 491 when carried out on 25.9 mmol scale. 
 
Scheme 137: Reaction using novel ,-unsaturated ketimine 486. 
 
The reaction could also be performed using (Z)-487, forming pyridine 491 in 54% yield 
indicating the geometry of ketimine starting material is not important for product yield 
(Scheme 138). 
 
Scheme 138: Reaction using (Z)-487. 
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7.4 Substrate Scope – Variation of the Michael Acceptor 
To further probe the generality of this protocol, the isothiourea-mediated one-pot 
pyridine synthesis procedure was studied using a range of synthesised -unsaturated 
ketimines and aldimines. The objective being to synthesise and test a range of Michael 
acceptors which have different substitution patterns including -substituted, ,-
disubstituted examples in order to access a vast array of pyridine architectures.  
 
7.4.1 Synthesis and reactivity of CF3-substituted ,-unsaturated ketimines 
Using the same synthetic route as described previously for -unsaturated ketimine 
486, a variety of others were obtained through variation of the starting aldehyde 
including p-bromobenzaldehyde, p-methanesulfonylbenzaldehyde and furfural. 
Additionally, the N-sulfonyl group could also be easily varied by selecting a different 
sulfonamide (p-toluenesulfonamide and benzenesulfonamide) in the second 
condensation step (Scheme 139).  
 
Scheme 139: Synthetic route towards ,-unsaturated--CF3-ketimines. 
 
-Unsaturated ketimine 492 was also made via the same condensation procedure as 
described previously for 486 (Scheme 140). Trifluoromethyl enone 220 was used as 
starting material, giving 492 in a poor 19% yield, largely due to product instability. 
 
Scheme 140: Synthetic route towards ,-unsaturated ketimine 492. 
 
With a selection of CF3-substituted-,-unsaturated ketimines in hand, their subsequent 
use in the isothiourea-mediated one-pot pyridine synthesis was evaluated (Table 24). 
Variation of the aryl group within the -CF3-,-unsaturated ketimines is tolerated in 
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this reaction to include phenyl, 4-BrC6H4, 4-SO2MeC6H4 and 2-furyl substitution, all 
affording the corresponding pyridines 491 and 493-495 in moderate to good yields (47-
66%). The nature of the N-sulfonyl group can also be altered (from tosyl to 
benzenesulfonyl) allowing access to pyridines 496 and 497 in good yields. Isomeric 
pyridine 498 could also be accessed in 40% yield when 492 is used as starting material 
although extended heating (48 h) is required to ensure full conversion to 498. Several 
other examples of this methodology was demonstrated by a colleague.
148 
 
   
   
 
a
 Reaction time of 48 h. 
Table 24 - Substrate scope - variation of ,-unsaturated--CF3-ketimine component. 
 
7.4.2 Synthesis and reactivity of other ketimines and aldimines
-Unsaturated ketimine 499 bearing a -CCl3 group was synthesised via a two step 
procedure (Scheme 141). Following the protocol described by Tsuboia,
154
 diketone 500 
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was reacted with chloral 46 in the presence of K2CO3 afforded enone 501 in 67% yield. 
Subsequent condensation with 4-toluenesulfonamide 490 in the presence of TiCl4 and 
Et3N gave -unsaturated ketimine 499 in 75% yield. 
 
Scheme 141: Synthetic route towards -CCl3-,-unsaturated ketimine. 
 
Michael acceptor 499 did not undergo any observable reaction with (phenylthio)acetic 
aicd, preactivated to the mixed anhydride, after 16 h at 80 °C using DHPB as catalyst. 
The poorer reactivity may be attributed towards the Michael acceptor not being 
sufficiently electron-deficient for reaction. Analysis of the crude reaction mixture by 
1
H 
NMR revealed the presence of mixed anhydride derived from (phenylthio)acetic acid 
and remaining Michael acceptor 499. 
 
-Unsaturated ketimines 82 and 502 were made via the same condensation procedure 
as described above for 499 (Scheme 142). Commercially available chalcone 503 and -
keto-,-unsaturated ester 143 (synthesised previously) were used as starting materials. 
 
Scheme 142: Synthetic route towards ,-unsaturated ketimines 82 and 502. 
  
Chalcone-derived imine 82 was unreactive under the optimised one-pot pyridine 
synthesis conditions, presumably due to being insufficiently electron-deficient, similar to 
499. Interestingly, reaction using -unsaturated ketimine 502 under the standard 
reaction conditions furnished pyridone 504 in 45% yield which had undergone 
thiophenol elimination but not the subsequent N- to O-sulfonyl migration step (Scheme 
143). This result suggests that a strongly electron withdrawing substituent at C(6) 
significantly disfavours the ability of the pyridone to undergo N- to O-sulfonyl migration 
to the corresponding pyridine, presumably due to decreased nucleophilicity of the 
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nitrogen atom. The observation that the formation of pyridine 498 required heating for 
an extended time (48 h) is in accordance with this result. 
 
Scheme 143: Isolation of pyridone 504. 
 
-Unsaturated ketimines 505 and 506 substituted at the -position were made via 
closely related routes (Scheme 144). Following the procedure outlined by Shi,
155
 
reaction of N-tosyl aldimine 507 with dimethyl acetylenedicarboxylate 508 in the 
presence of DMAP gave ketimine 505 in 34% yield. Alternatively, following the 
protocol described by Tong,
156
 reaction of the same N-tosyl aldimine 507 with methyl 
propiolate 509 and PPh3 affords ketimine 506 in 27% yield. 
 
Scheme 144: Synthetic route towards ,-unsaturated ketimines 505 and 506. 
 
,-Disubstituted Michael acceptor 505 did not undergo any observable reaction with 
(phenylthio)acetic acid, preactivated to the mixed anhydride, after 16 h at 80 °C using 
DHPB as catalyst. The poor reactivity may be attributed towards the Michael acceptor 
being too sterically encumbered for efficient reaction. However, reaction using -
unsubstituted ketimine 506 under the standard reaction conditions furnished lactam (±)-
510 in 53% yield which had not undergone the thiophenol elimination and N- to O-
sulfonyl migration steps (Scheme 145). This result suggests that a substituent at C(4) is 
necessary to acidify the C(4) proton allowing elimination of thiophenol to occur under 
the reaction conditions. 
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Scheme 145: Isolation of lactam (±)-510. 

This observation can be related to an observation made by Donohoe and co-workers who 
identified the need for an acidifying group at C(6) to facilitate the elimination of benzyl 
alcohol from dihydropyridone 511 to form pyridone 512 (Scheme 146).
157
 If the 
electron-withdrawing 2-pyridyl substituent is replaced by a phenyl substituent the 
elimination does not proceed. 
 
Scheme 146: Elimination of benzyl alcohol in a related system. 

Finally -unsaturated aldimine 513 was synthesised according to the two step 
procedure outlined by Bode.
158
 Reaction of cinnamaldehyde 23 with p-TSA in MeOH 
afforded acetal 514 which was heated with 4-methoxybenzenesulfonamide 515 to give 
aldimine 513 in 45% yield over 2 steps (Scheme 147). 
 
Scheme 147: Synthetic route towards ,-unsaturated aldimine 513. 
 
Unfortunately, -unsaturated aldimine 513 was not a suitable Michael acceptor for this 
process, giving no observable conversion to the desired pyridine product after 16 h at 80 
°C using DHPB as catalyst. Analysis of the crude reaction mixture by 
1
H NMR revealed 
the presence of the mixed anhydride derived from (phenylthio)acetic acid and remaining 
513. 
 
7.5 Derivatisations 
7.5.1 Elaboration of Pyridine 491 
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The synthetic utility of the newly installed 2-sulfonate functional handle within pyridine 
491 was next demonstrated through a series of product derivatisations. Firstly, following 
the procedure described by Yamamoto,
159
 pyridine 491 can be reduced using Pd(OAc)2, 
dppp and HCO2H as proton source to give 2,4-disubstituted pyridine 516 in 89% yield 
(Scheme 148). Pyridine 491 can also be hydrolysed using n-Bu NOH to give pyridone 
517 in 89% yield as described by Grierson.  Alternatively, SNAr with either morpholine 
518 or cyclohexylamine 519 gives pyridines 520 and 521 in 85% and 79% yield 
respectively. 
 
Scheme 148: Reduction, hydrolysis and SNAr derivatisations. 
 
Pyridine 491 was shown to be compatible with traditional cross-coupling methodologies, 
leading to diverse 2,4,6-substituted pyridines (Scheme 149). For example, following the 
procedure described by Skrydstrup,
161
 491 undergoes Mizoroki-Heck reaction with N-
vinylacetamide using Pd(dba)2 and dppf as ligand, affording pyridine 522 in 76% yield. 
In accordance with the procedure described by Buchwald,
162
 pyridine 491 also 
undergoes Suzuki coupling with either 3-furanylboronic acid 523 or indole-derived 
boronic acid 524, giving pyridines 525 and 526 in 70% and 81% respectively using 
Pd(OAc)  and BrettPhos as ligand. 
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Scheme 149: Mizoroki-Heck and Suzuki couplings. 
 
Following the procedure described by Ackermann,
163
 Kumada cross-coupling of 
pyridine 491 with 4-methoxyphenylmagensium bromide 527 using Pd(dba)2 and 
PinP(O)H as ligand, afforded pyridine 528 in 66% yield (Scheme 150). In addition to 
sp
2
-sp
2
 coupling reactions, Fe-catalysed sp
2
-sp
3
 coupling of pyridine 491 with n-
hexylmagnesium bromide, as described by the group of Skrydstrup,
164
 gave 529 in 74% 
yield. 
 
Scheme 159: Kumada and Fe-catalysed cross-couplings. 
 
7.5.2 Regiodivergence 
To further demonstrate the potential of these scaffolds the sequential functionalisation of 
pyridine 493 was explored. Selective arylation of the aryl-bromide through Suzuki 
coupling with 4-ethoxyphenylboronic acid 530 was readily achieved using the 
conditions outlined by Buchwald,
165
 affording pyridine 531 in 87% yield, leaving the 2-
sulfonate functional group untouched for further derivatisation through SNAr with 
morpholine giving 532 in 82% yield (Scheme 151). This illustrates how this 
methodology can be used to build up bespoke pyridines in rapid fashion. 
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Scheme 151: Selective sequential pyridine derivatisations. 
 
7.5.3 Synthesis of COX-2 Inhibitor 
The utility of this approach for the synthesis of a medicinally relevant pyridine 
containing molecule was illustrated (Scheme 152). For example, pyridine 533, which 
possesses activity as a COX-2 inhibitor (<0.5 mM activity, >100 fold selectivity for 
COX-2 vs. COX-1) for the treatment of depressive disorders,
166
 can be made in 49% 
yield over two synthetic steps from ,-unsaturated ketimine 534 (14% overall yield 
from commercially available starting materials). 
 
Scheme 152: Synthesis of biologically activity pyridine 533. 
 
7.6 Reaction Mechanism 
The proposed reaction mechanism proceeds via initial formation of mixed anhydride 535 
from (phenylthio)acetic acid 242 and pivaloyl chloride, followed by N-acylation of 
DHPB 108 to generate the corresponding acyl ammonium ion 536. Deprotonation 
generates (Z)-enolate 537, which undergoes Michael addition with the ,-unsaturated 
ketimine 467, followed by intramolecular lactamisation, to generate the corresponding 
dihydropyridone 538 and regenerate DHPB 108 (Figure 53). Subsequent elimination of 
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thiophenol gives pyridone 539, which undergoes thermally promoted N- to O-sulfonyl 
migration to afford pyridine 540.  
 
Figure 53: Proposed mechanism for one-pot pyridine formation. 
 
Within the literature, sporadic examples of the key N- to O-sulfonyl rearrangement 
utilised in this process have been observed, usually as an undesired non-productive 
pathway in thermally promoted Diels-Alder reactions of sulfonyl pyridones.
150
 To 
understand this process further, a crossover experiment was performed to determine if 
the N- to O-sulfonyl migration process involves an intra- or intermolecular transfer. 
Reaction of (phenylthio)acetic acid 242 (1 eq) with a 50:50 mixture of ketimines 541 
and 542 under optimised conditions led exclusively to a 50:50 mixture of pyridines 493 
and 496, consistent with intramolecular N- to O-sulfonyl transfer from an intermediate 
pyridone being involved within this process (Scheme 153).
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Scheme 153: Crossover experiment indicating intramolecular N- to O-sulfonyl migration. 
 
7.7 Conclusions 
In conclusion, it has been shown that DHPB 108 promotes the one-pot synthesis of 
2,4,6-subsituted pyridines bearing a readily derivatised 2-sulfonate functionality from 
(phenylthio)acetic acid and a range of ,-unsaturated ketimines.141 This process 
proceeds via intermolecular Michael addition-lactamisation, thiophenyl elimination and 
N- to O-intramolecular sulfonyl migration, with the N-sulfonyl activating group within 
the ,-unsaturated ketimine transformed into a valuable 2-sulfonate functional handle 
in the resulting pyridine. Functionalisation of this group via various methodologies 
allows the rapid assembly of both novel and biologically relevant pyridines. 
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Chapter 8: Conclusions and Outlook 
This thesis has documented investigations into the ability of isothioureas to act as 
organocatalysts in the functionalisation of carboxylic acid and anhydride starting 
materials via C1-ammonium enolates. A variety of methodologies have been developed 
which add to the current literature on formal [4+2] cycloadditions catalysed by tertiary 
amines. 
 
Firstly the isothiourea-catalysed formal [4+2] cycloaddition between arylacetic acids and 
α-keto-β,γ-unsaturated esters has been reported. This methodology represents the first 
time that carboxylic acid derived ammonium enolates have been successfully applied 
towards an intermolecular reaction process. The protocol is scalable and can be carried 
out using open flasks and bench-grade solvents. A variety of anti-dihydropyranones 
were accessed in high yield (49-87%) and with good diastereo- and enantioselectivity 
(up to 98:2 dr, up to 99% ee).  
 
 
Subsequent studies focused on the use of trifluoromethyl enones as Michael acceptors in 
the isothiourea-catalysed formal [4+2] cycloaddition protocol with arylacetic acids. A 
range of C(6)-trifluoromethyl anti-dihydropyranones were accessed in high yield (60-
93%) with good diastereo- and enantioselectivity (up to 95:5 dr, up to >99% ee).  
 
 
Detailed mechanistic studies were carried out, revealing that the process was 
stereospecific, with the diastereoisomer of product formed dependent upon the 
configuration of trifluoromethyl enone used. A variety of product derivatisations were 
demonstrated including those which introduce additional trifluoromethyl-bearing 
stereogenic centres with high diastereoselectivity. Kinetic studies indicated that this 
Michael addition-lactonisation process is first order with respect to both in situ formed 
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anhydride and catalyst concentration, with a primary kinetic isotope effect observed 
using ,-di-deuterio 4-fluorophenylacetic acid. DFT computational studies support a 
rate-determining formation of a reactive ammonium enolate prior to a stereochemistry-
determining enone conjugate-addition step. 
 
 
In addition to C-C bond-forming processes, it was shown that isothioureas efficiently 
catalyse the -amination of carboxylic acids via a formal [4+2] cycloaddition process 
with N-aryl-N-aroyldiazene Michael acceptors using low catalyst loadings (as low as 
0.25%). Either 1,3,4-oxadiazin-6-ones or N-protected -substituted amino acid 
derivatives (upon ring opening) were accessed in high yields and excellent 
enantioselectivity (up to >99% ee). Importantly, the scope of this methodology was 
expanded to allow the direct functionalisation of carboxylic acids bearing -heteroatom 
and alkyl substitution for the first time in addition to aryl substitution. The synthetic 
utility of the hydrazide products was demonstrated through their derivatisation into a 
range of bespoke functionalised N-aryl--arylglycine derivatives in high enantiopurity 
(up to 99% ee). 
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Efforts to further expand the acid scope of this methodology led to the discovery that  3-
alkenoic acids are suitable precursors to isothiourea-derived C1-ammonium dienolates 
that react to give exclusively -functionalised products in a range of formal [2+2] and 
[4+2] cycloadditions. This contrasts with all other C1-ammonium dienolates reported in 
the literature that react at the -position. It was shown that HBTM-2.1 efficiently 
catalysed the -functionalisation of 3-alkenoic acids through formal [4+2] 
cycloadditions with both trifluoromethyl enones and N-aryl-N-aroyl diazenes in good 
yield and with high diastereo- and enantiocontrol (up to 90:10 dr, up to 99% ee). The 
simple, two-step elaboration of stereodefined hydrazides into aza-sugar analogues 
without erosion of enantiopurity was also demonstrated. 
 
 
2-Arylacetic anhydrides were found to be convenient and readily prepared precursors to 
isothiourea-derived C1-ammonium enolates. HBTM-2.1 efficiently catalysed the formal 
[4+2] cycloadditions between 2-arylacetic anhydrides and a range of electron deficient 
Michael acceptors, giving stereodefined products in good yield and with high diastereo- 
and enantiocontrol (up to 95:5 dr, up to >99% ee). This protocol offers a useful and 
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practical alternative to the in situ carboxylic acid activation method, in which by-product 
formation and the amount of sacrificial base used is minimised. 
 
 
Finally it was found that the isothiourea-catalysed formal [4+2] cycloaddition 
methodology developed could also be utilised to access important aromatic heterocycles. 
DHPB was shown to promote the one-pot synthesis of 2,4,6-subsituted pyridines bearing 
a readily derivatised 2-sulfonate functionality from (phenylthio)acetic acid and a range 
of ,-unsaturated ketimines in moderate yields (40-66%). This proceeds via 
intermolecular Michael addition-lactamisation, thiophenyl elimination and N- to O-
intramolecular sulfonyl migration, with the N-sulfonyl activating group within the ,-
unsaturated ketimine transformed into a valuable 2-sulfonate functional handle in the 
resulting pyridine. This represents a novel one-pot organocatalytic route towards highly 
functionalised pyridines. Functionalisation of 2-sulfonate group via various 
methodologies allows the rapid assembly of both novel and biologically relevant 
pyridines. An application of this methodology was demonstrated through the synthesis 
of a known COX-2 inhibitor. 
 
 
At the outset of this thesis in late 2010, carboxylic acid starting materials had been 
sparsely utilised as ammonium enolate precursors with Romo and co-workers the only 
contributor, demonstrating a variety of elegant intramolecular nucleophile-catalysed 
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aldol-lactonisation (NCAL) procedures. Additionally, at the outset of these studies, 
isothioureas had not been demonstrated in any catalytic generation of ammonium 
enolates. This thesis details investigations that significantly add to the existing research 
within the ammonium enolate literature. For the first time, carboxylic acid-derived 
ammonium enolates have been applied towards intermolecular reactions. Additionally, 
isothioureas have been shown to be highly useful nucleophilic Lewis base 
organocatalysts for the generation of highly defined C1-ammonium enolates that are 
capable of imparting exceptionally high levels of stereocontrol upon reactions. 
 
It appears likely that building upon this established precedent further, undocumented 
reactions employing isothiourea-derived C1-ammonium enolates will be investigated. 
One can envisage many other suitable electrophilic species which may act as suitable 
partners in other formal [4+2], [2+2] and perhaps the less common formal [3+2] 
cycloadditions. Research is currently underway to investigate the potential for these 
enolates to participate in formal [3+2] cycloaddition processes. Additionally, it would be 
of widespread interest to the scientific community if isothioureas could be demonstrated 
in a wider range of organocatalytic methodologies. For instance, are isothioureas 
suitable Lewis bases to access the C2- or C3-ammonium enolate reaction modes that 
have previously been accessed mainly through the use of cinchona alkaloids? These are 
the types of questions that are likely to be addressed by researchers in the field over the 
coming years. 
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Chapter 9: Experimental 
9.1 General Information 
Reactions involving moisture sensitive reagents were carried out under an argon 
atmosphere using standard vacuum line techniques in addition to dry solvents. All 
glassware used was flame dried and cooled under vacuum. 
For moisture sensitive reactions, solvents (THF, CH2Cl2, toluene, hexane and Et2O) 
were obtained anhydrous and purified by an alumina column (Mbraun SPS-800). Petrol 
is defined as petroleum ether 40-60 °C. All other solvents and commercial reagents were 
used as supplied without further purification unless stated otherwise. 
Room temperature (rt) refers to 20-25 °C. Temperatures of 0 °C and 78 °C were 
obtained using ice/water and CO2(s)/acetone baths respectively. Temperatures of 0 °C to 
50 °C for overnight reactions were obtained using an immersion cooler (HAAKE EK 
90). Reflux conditions were obtained using an oil bath equipped with a contact 
thermometer. In vacuo refers to the use of a Büchi Rotavapor R-2000 rotary evaporator 
with a Vacubrand CVC2 vacuum controller or a Heidolph Laborota 4001 rotary 
evaporator with a vacuum controller.  
Analytical thin layer chromatography was performed on pre-coated aluminium plates 
(Kieselgel 60 F254 silica). TLC visualisation was carried out with ultraviolet light (254 
nm), followed by staining with a 1% aqueous KMnO4 solution. Flash column 
chromatography was performed on Kieselgel 60 silica in the solvent system stated. 
1
H, 
13
C and 
19
F nuclear magnetic resonance (NMR) spectra were acquired on either a 
Bruker Avance 300 (300 MHz, 
1
H, 75 MHz 
13
C{1H}, 282 MHz 
19
F{1H}), Bruker 
Avance II 400 (400 MHz, 
1
H, 100 MHz 
13
C{1H}, 376 MHz 
19
F{1H}) or a Bruker 
Avance II 400 (500 MHz, 
1
H, 125 MHz 
13
C{1H}, 470 MHz 
19
F{1H}) spectrometer at 
ambient temperature in the deuterated solvent stated. All chemical shifts are quoted in 
parts per million (ppm) relative to the residual solvent as the internal standard. All 
coupling constants, J, are quoted in Hz. Multiplicities are indicated by: s (singlet), d 
(doublet), t (triplet), q (quartet), sept (septet), ABq (AB quartet), oct (octet), m 
(multiplet), dd (doublet of doublets), ddd (doublet of doublet of doublets, dt (doublet of 
triplets), dq (doublet of quartets) and td (triplet of doublets). The abbreviation Ar is used 
to denote aromatic, Ph to denote phenyl, Bn to denote benzyl, br to denote broad and 
app to denote apparent. NMR peak assignments were confirmed using 2D 1H correlated 
spectroscopy (COSY), 2D 1H nuclear Overhauser effect spectroscopy (NOESY), 2D 
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1H−13C heteronuclear multiple-bond correlation spectroscopy (HMBC), and 2D 
1H−13C heteronuclear single quantum coherence (HSQC) where necessary. 
Infrared spectra (max/cm
-1
) were recorded on either a Perkin-Elmer Spectrum GX FT-IR 
spectrometer using either thin films on NaCl plates or KBr discs or a Shimadzu 
IRAffinity-1 using a Pike attenuated total reflectance (ATR) accessory. Only the 
characteristic peaks are quoted.  
Melting points were recorded on an Electrothermal 9100 melting point apparatus and are 
uncorrected. Dec refers to decomposition. 
HPLC analyses were obtained on two separate machines; a Gilson HPLC consisting of a 
Gilson 305 pump, Gilson 306 pump, Gilson 811C dynamic mixer, Gilson 805 
manometric module, Gilson 401C dilutor, Gilson 213XL sample injector and sample 
detection was performed with a Gilson 118 UV/vis detector while the temperature was 
assumed to be 23 °C; a Shimadzu HPLC consisting of a DGU-20A5 degasser, LC-20AT 
liquid chromatograph, SIL-20AHT autosampler, CMB-20A communications bus 
module, SPD-M20A diode array detector and a CTO-20A column oven which allowed 
the temperature to be set from 25-40 °C. Separation was achieved using DAICEL 
CHIRALCEL OD-H and OJ-H columns or DAICEL CHIRALPAK AD-H, AS-H, IA, 
IB, IC and ID columns. All chiral HPLC traces were compared to the authentic racemic 
trace prepared in analogous fashion. 
Mass spectrometry (m/z) data were acquired by electrospray ionisation (ESI), chemical 
ionisation (CI), electron impact (EI), atmospheric solids analysis probe (ASAP), 
atmospheric pressure chemical ionization (APCI) or nanospray ionisation (NSI) either at 
the University of St Andrews or the EPSRC National Mass Spectrometry Service 
Centre, Swansea. At the University of St Andrews, low and high resolution ESI MS 
were carried out on a Micromass LCT spectrometer. At the EPSRC National Mass 
Spectrometry Service Centre, low resolution NSI MS was carried out on a Micromass 
Quattro II spectrometer and high resolution NSI MS on a Thermofisher LTQ Orbitrap 
XL spectrometer. 
Optical rotations were measured on a Perkin Elmer Precisely/Model-341 polarimeter 
operating at the sodium D line with a 100 mm path cell at rt. 
 
9.2 Experimental for Chapter 2  
9.2.1 Experimental Procedures and Characterisation Data  
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Isothiourea Catalysts 
 
Tetramisole hydrochloride (2S)-106 was used as supplied. Benzotetramisole (2R)-107 
and (2S)-148 were readily available in the group. DHPB 108 and HBTM-2.1 (2S,3R)-
112 were synthesised as outlined below. 
 
3-(benzo[d]thiazol-2-ylamino)propan-1-ol 
 
To a sealed pressure tube was charged 2-chlorobenzothiazole (1.02 mL, 8.00 mmol), i-
Pr2NEt (2.11 mL, 12.0 mmol) and 3-amino-1-propanol (0.61 mL, 8.00 mmol). The tubes 
were purged with argon and then sealed and heated at 110 °C for 24 h. The reaction 
mixture was allowed to cool to rt. Chromatographic purification (eluent i-PrOH:CH2Cl2 
10:90) gave alcohol 151 as a white solid (1.24 g, 80%); mp 120-122 °C; {lit.
52
 mp 123-
123.5 °C}; H (400 MHz, CDCl3) 1.82-1.88 (2H, m, CH2CH2CH2), 3.69 (2H, t, J 6.0, 
CH2), 3.74 (2H, t, J 5.6, CH2), 7.09 (1H, ddd, J 7.9, 7.4, 1.2, Ar(6)H), 7.29 (1H, ddd, J 
8.1, 7.4, 1.3, Ar(5)H), 7.50-7.56 (2H, m, Ar(4)H and Ar(7)H). Spectroscopic data are in 
accordance with the literature.
52
 
 
3,4-dihydro-2H-benzo[4,5]thiazolo[3,2-a]pyrimidine 
 
To a solution of alcohol 151 (4.97 g, 25.6 mmol) in dry CH2Cl2 (250 mL) at 0 °C under 
argon was added Et3N (10.7 mL, 76.8 mmol) and methanesulfonyl chloride (2.99 mL, 
38.4 mmol). The reaction mixture was allowed to stir at 0 °C for 1 h. The solution was 
then warmed to rt and MeOH (6 mL) was added to quench any remaining 
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methanesulfonyl chloride. A further portion of Et3N (42.0 mL, 0.30 mol) was added to 
the solution and it was stirred at reflux for 16 h. The cooled reaction mixture was 
washed with H2O, dried (MgSO4), filtered and concentrated in vacuo. Chromatographic 
purification (eluent Et3N:i-PrOH:CH2Cl2 1:9:89) gave DHPB 108 as a white solid (4.41 
g, 91%); mp 120-121 °C; {lit.
52
 mp 122-123 °C}; H (400 MHz, CDCl3) 1.95 (2H, 
quintet, J 5.7, CH2CH2CH2), 3.50 (2H, t, J 5.6, =NCH2), 3.70 (2H, t, J 6.1 NCH2), 6.66 
(1H, dd, J 8.0, 0.7, Ar(9)H), 6.91 (1H, td, J 7.6, 1.1, Ar(7)H), 7.11 (1H, td, J 7.6, 1.1, 
Ar(8)H), 7.19-7.22 (1H, m, Ar(6)H). Spectroscopic data are in accordance with the 
literature.
52
 
 
tert-butyl (phenyl(phenylsulfonyl)methyl)carbamate 
 
To a stirred solution of t-butyl carbamate (2.68 g, 22.9 mmol) in THF (10 mL) under 
argon was added H2O (20 mL), sodium benzenesulfinate (3.76 g, 22.9 mmol) and 
benzaldehyde (2.37 mL, 23.3 mmol) sequentially followed by formic acid (5.00 mL, 133 
mmol). The reaction mixture was stirred under nitrogen for 16 h at rt. The resulting 
precipitate was filtered and washed with H2O. Trituration with hexane/CH2Cl2 (91/9) 
gave sulfone 153 as a white solid (6.49 g, 82%); mp 158-160 °C (hexane/CH2Cl2); {lit.
67
 
mp 153-154 °C (hexane/CH2Cl2)}; H (400 MHz, (CD3)2CO) 1.26 (9H, s, C(CH3)3), 
5.75-5.94 (2H, m, CH and NH), 7.39-7.46 (5H, m, ArH), 7.52-7.56 (2H, m, 
SO2Ar(3,5)H), 7.62-7.66 (1H m, SO2Ar(4)H), 7.90-7.92 (2H, m, SO2Ar(2,6)H). 
Spectroscopic data are in accordance with the literature.
67
 
 
tert-butyl benzylidenecarbamate 
 
To a stirred solution of K2CO3 (23.9 g, 0.17 mol) and Na2SO4 (30.0 g, 0.21 mol) in THF 
(250 mL) under argon was added sulfone 153 (10.0 g, 28.8 mmol). The reaction mixture 
was heated at reflux under argon for 16 h. Once cooled to rt the solids were removed by 
filtration. The filtrate was concentrated in vacuo to give imine 154 as a colourless oil 
(5.04 g, 85%); H (300 MHz, (CD3)2CO) 1.54 (9H, s, C(CH3)3), 7.52-7.66 (3H, m, 
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Ar(3,5)H and Ar(4)H), 7.92-7.97 (2H, m, Ar(2,6)H), 8.80 (1H, s, =CH). Spectroscopic 
data are in accordance with the literature.
67
 
 
tert-butyl ((1S,2S)-2-formyl-3-methyl-1-phenylbutyl)carbamate 
 
To a stirred solution of imine 154 (5.00 g, 24.4 mmol) in anhydrous CH3CN (240 mL) 
under argon was added isovaleraldehyde (5.23 mL, 48.8 mmol). The resulting solution 
was cooled to 0 °C. (S)-proline (561 mg, 4.87 mmol) was added and the reaction mixture 
was stirred for 18 h at 0 °C. Distilled H2O (80 mL) was added and the reaction mixture 
was allowed to warm to rt whilst maintaining vigorous stirring. Et2O (100 mL) was 
added and the organic layer was separated. The aqueous layer was extracted with Et2O 
(x 3). The organic extracts were combined, washed with brine, dried (MgSO4), filtered 
and concentrated in vacuo. Trituration of the resulting solid with hexane gave aldehyde 
(1S,2S)-152 as a white solid (4.97 g, 70%); mp 135-136 °C (hexane); {lit.
56
 mp 146-148 
°C (hexane)}; 

 
D
20
–70.0 (c 1.0 in CHCl3); {lit.
56 

 
D
20
–71.2 (c 0.5 in CHCl3)}; H (300 
MHz, CDCl3) 0.95 (3H, d, J 6.9, CH3), 1.07 (3H, d, J 6.9, CH3), 1.34 (9H, s, C(CH3)3), 
2.02-2.11 (1H, m, C(3)H), 2.40-2.43 (1H, m, C(2)H), 5.02-5.03 (2H, m, C(1)H and NH), 
7.15-7.29 (5H, m, ArH), 9.43 (1H, d, J 4.2, C(O)H). Spectroscopic data are in 
accordance with the literature.
167
 
 
tert-butyl ((1S,2S)-2-(hydroxymethyl)-3-methyl-1-phenylbutyl)carbamate 
 
To a stirred solution of aldehyde (1S,2S)-152 (4.45 g, 15.3 mmol) in MeOH (125 mL) 
under argon was added NaBH4 (0.87 g, 23.0 mmol) and the reaction mixture was left to 
stir for 2 h at rt. Saturated aqueous NaHCO3 was added and the MeOH was removed in 
vacuo. The aqueous layer was extracted with CH2Cl2 (x 3). The organic extracts were 
combined, dried (MgSO4), filtered and concentrated in vacuo to give alcohol (1S,2S)-
156 as a white solid (4.45 g, 99%); mp 78-79 °C; {lit.
56
 mp 106-108 °C}; 

 
D
20
–25.4 (c 
0.5 in CHCl3); {lit.
56
 

 
D
20
–26.7 (c 0.7 in CHCl3)}; H (400 MHz, CDCl3) 0.78 (3H, d, J 
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6.9, CH3), 0.93 (3H, d, J 6.9, CH3), 1.35 (9H, s, C(CH3)3), 1.63-1.80 (2H, m, C(2)H and 
C(3)H), 2.00-2.10 (1H, br s, OH), 3.40-3.46 (1H, m, CHH), 3.60-3.63 (1H, m, CHH), 
4.96 (1H, br s, C(1)H), 5.43-5.45 (1H, m, NH), 7.17-7.30 (5H, m, ArH). Spectroscopic 
data are in accordance with the literature.
56
 
 
(S)-2-((S)-amino(phenyl)methyl)-3-methylbutan-1-ol hydrochloride 
 
To a flask containing alcohol (1S,2S)-156 (4.45 g, 15.2 mmol) under argon was added 
HCl (4 M in dioxane, 47.8 mL, 0.19 mol) and the reaction mixture was left to stir for 4 h 
at rt. The reaction mixture was concentrated in vacuo to give amino alcohol (1S,2S)-157 
as a white solid (3.48 g, 99%); mp 163-165 °C; {lit.
56
 mp 168-170 °C}; 

 
D
20
–23.0 (c 
1.0 in CH3OH); {lit.
56
 

 
D
20
–22.9 (c 0.98 in CH3OH)}; H (400 MHz, CD3OD) 0.84 
(3H, d, J 6.8, CH3), 1.15 (3H, d, J 6.8, CH3), 1.53 (1H, app dq, J 13.7, 6.8, C(3)H), 1.99-
2.05 (1H, m, C(2)H), 3.49 (1H, app t, J 10.2, C(1)HH), 3.76 (1H, dd, J 10.5, 4.3, 
C(1)HH), 4.58 (1H, d, J 4.3, CHN), 7.42-7.54 (5H, m, ArH). Spectroscopic data are in 
accordance with the literature.
56
 
 
(S)-2-((S)-(benzo[d]thiazol-2-ylamino)(phenyl)methyl)-3-methylbutan-1-ol 
 
To a sealed pressure tube containing amino alcohol (1S,2S)-157 (3.31 g, 14.4 mmol) and 
i-Pr2NEt (9.76 mL, 56.0 mmol) under argon at 135 °C was added 2-chlorobenzothiazole 
(1.92 mL, 15.2 mmol) and the reaction mixture was left to stir for 2 days at 135 °C. The 
reaction mixture was allowed to cool to rt. Chromatographic purification (eluent 
EtOH:CH2Cl2 2:98) gave alcohol (1S,2S)-158 as a white solid (4.55 g, 97%); mp 131-
133 °C; {lit.
56
 mp 137-139 °C}; 

 
D
20
–54.8 (c 1.0 in CHCl3); {lit.
56
 

 
D
20
–54.8 (c 0.5 in 
CHCl3)}; H (300 MHz, CDCl3) 0.75 (3H, d, J 6.8, CH3), 1.04 (3H, d, J 6.8, CH3), 1.56-
1.68 (1H, m, C(3)H), 2.01-2.09 (1H, m, C(2)H), 3.57 (1H, app t, J 10.4, C(1)HH), 3.80 
(1H, dd, J 11.2, 3.6, C(1)HH), 4.17 (1H, br s, NH), 4.91 (1H, dd, J 7.0, 4.2 CHN), 6.91-
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6.98 (1H, m, Benzothiazole Ar(6)H), 7.12-7.29 (3H, m, ArH), 7.31-7.48 (5H, m, ArH). 
Spectroscopic data are in accordance with the literature.
56
 
 
(2S,3R)-3-isopropyl-2-phenyl-3,4-dihydro-2H-benzo[4,5]thiazolo[3,2-a]pyrimidine 
 
To a stirred solution of alcohol (1S,2S)-158 (4.40 g, 13.5 mmol) in toluene (70 mL) 
under argon was added thionyl chloride (2.16 mL, 29.7 mmol) and the reaction mixture 
was heated at reflux for 3 h with no condenser fitted. The reaction mixture was allowed 
to cool to rt. The reaction mixture was quenched by addition of a few drops of MeOH 
and was concentrated in vacuo. 10% aqueous NaOH solution (110 mL) was added and 
the aqueous layer was extracted with CH2Cl2 (x 3). The combined extracts were washed 
with brine, dried (MgSO4), filtered and concentrated in vacuo. Chromatographic 
purification (eluent MeOH:petrol 5:95) gave HBTM-2.1 (2S,3R)-112 as a light brown 
solid (1.42 g, 34%); mp 140-142 °C; {lit.
56
 mp 136-138 °C}; 

 
D
20
+280.0 (c 0.5 in 
CHCl3); {lit.
56
 

 
D
20
+288.4 (c 0.5 in CHCl3)}; Chiral HPLC Chiralpak AD-H (20% 
IPA:hexane, flow rate 1 mL min
-1
, 254 nm, 20 °C) tR(2S,3R): 17.6 min, tR(2R,3S): 30.7 
min, >99% ee; H (300 MHz, CDCl3) 0.88 (3H, d, J 6.6, CH3), 1.17 (3H, d, J 6.6, CH3), 
1.26-1.40 (1H, m, CH(CH3)2), 1.94-2.04 (1H, m, C(2)H), 3.38 (1H, app. t, J 11.6, 
C(4)HH), 3.91 (1H, ddd, J 11.6, 5.2, 1.7, C(4)HH), 4.96 (1H, dd, J 4.4, 1.6, C(3)H), 6.84 
(1H, d, J 7.5, Ar(9)H), 7.07 (1H, td, J 7.6, 1.1, Ar(7)H), 7.22-7.38 (7H, m, ArH). 
Spectroscopic data are in accordance with the literature.
56
 Note: Racemic sample for 
HPLC analysis already available in group. 
 
General procedure A: Preparation of potassium salts. 
To a solution of pyruvic acid (1 eq) and arylaldehyde (1 eq) in MeOH at 0 °C was added 
a solution of KOH (1.5 eq) in MeOH. The first 1 eq of the KOH solution was added 
dropwise over 30 minutes. The last third was added as one portion and the reaction 
mixture was stirred at 40 °C for 1 h followed by 0 °C for 16 h. The precipitate was 
collected by filtration, washed twice with cold MeOH, once with ether and dried under 
vacuum to furnish the potassium salt which was used as an intermediate, without further 
purification. Note: These compounds, if novel, were characterised only via 
1
H NMR and 
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mp due to poor solubility in deuterated solvents (for 
13
C NMR) and difficulties in 
observing molecular ions during mass spec analysis. 
 
potassium (E)-2-oxo-4-phenylbut-3-enoate 
 
Following general procedure A, benzaldehyde (5.09 mL, 50.0 mmol) in MeOH (4 mL), 
pyruvic acid (3.52 mL, 50.0 mmol) and KOH (4.21 g, 75.0 mmol) in MeOH (15 mL) 
gave potassium salt 145 as a yellow solid (8.85 g, 83%); mp 246-248 °C; {lit.
168
 mp 248 
°C}; H (400 MHz, D2O) 6.80 (1H, d, J 16.5, C(3)H), 7.37-7.46 (3H, m, Ar(3,5)H and 
Ar(4)H), 7.59-7.65 (3H, m, C(4)H and Ar(2,6)H). Spectroscopic data are in accordance 
with the literature.
168
 
 
potassium (E)-4-(furan-2-yl)-2-oxobut-3-enoate 
 
Following general procedure A, furfuraldehyde (4.14 mL, 50.0 mmol) in MeOH (15 
mL), pyruvic acid (3.52 mL, 50.0 mmol) and KOH (4.21 g, 75.0 mmol) in MeOH (15 
mL) gave potassium salt 175 as a yellow solid (7.25 g, 71%); mp 178-180 °C (Decomp); 
H (400 MHz, D2O) 6.53 (1H, dd, J 3.5, 1.6, Ar(4)H), 6.58 (1H, d, J 16.1, C(3)H), 6.88 
(1H, d, J 3.5, Ar(3)H), 7.39 (1H, d, J 16.1, C(4)H), 7.61 (1H, d, J 1.6, Ar(5)H). 
Spectroscopic data are in accordance with the literature.
168
 
 
potassium (E)-3-methyl-2-oxo-4-phenylbut-3-enoate 
 
Following a general procedure A, benzaldehyde (2.55 mL, 25.0 mmol) in MeOH (4 
mL), 2-ketobutyric acid (2.55 g, 25.0 mmol) and KOH (2.10 g, 37.5 mmol) in MeOH 
(15 mL) gave potassium salt 543 as a yellow solid (4.53 g, 79%); mp 310 °C (Decomp); 
{lit.
169
 mp 319 °C (Decomp)}; H (300 MHz, D2O) 1.93 (3H, d, J 1.3, CH3), 7.32-7.48 
(6H, m, C(4)H and ArH). Spectroscopic data are in accordance with the literature.
169
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potassium (E)-4-(2-naphthyl)-2-oxobut-3-enoate
 
 
Following general procedure A, 2-naphthaldehyde (5.33 g, 34.2 mmol) in MeOH (15 
mL), pyruvic acid (2.37 mL, 34.2 mmol) and KOH (2.87 g, 51.2 mmol) in MeOH (15 
mL) gave potassium salt 544 as a yellow solid (6.90 g, 77%); mp 270-272 °C (Decomp); 
H (400 MHz, D2O) 6.86 (1H, d, J 16.4, C(3)H), 7.44-7.54 (2H, m, ArH), 7.67-7.74 (2H, 
m, C(4)H and ArH), 7.81-7.88 (3H, m, ArH), 8.01 (1H, s, Ar(1)H). 
 
potassium (E)-2-oxo-4-(pyridin-3-yl)but-3-enoate 
 
Following general procedure A, nicotinaldehyde (4.69 mL, 0.05 mol) in MeOH (15 mL), 
pyruvic acid (3.52 mL, 0.05 mol) and KOH (4.21 g, 0.075 mol) in MeOH (15 mL) gave 
potassium salt 545 as a yellow solid (6.53 g, 61%); mp 218-220 °C (Decomp); H (300 
MHz, D2O) 6.88 (1H, d, J 16.6, C(3)H), 7.36-7.42 (1H, m, Ar(5)H), 7.58 (1H, d, J 16.6, 
C(4)H), 8.00-8.06 (1H, m, Ar(4)H), 8.43 (1H, dd, J 5.0, 1.6, Ar(6)H), 8.62 (1H, d, J 1.6, 
Ar(2)H). All spectroscopic data are in accordance with the literature.
168
 
 
General Procedure B: Preparation of γ-aryl-β,γ-unsaturated α-ketoesters. 
Acetyl chloride (11.5 eq) was added to the desired alcohol at 0 °C to generate HCl. 
Potassium salt (1 eq) was added and the mixture stirred at 0 °C for thirty minutes then 
warmed to rt for 2 h before heating at reflux for 16 h. Concentration in vacuo gave a 
solid which was dissolved in H2O and extracted with CH2Cl2 (x 3). The combined 
organics were washed with sat. aq. NaHCO3, H2O and brine before being dried 
(MgSO4), filtered and concentrated in vacuo to give the crude reaction mixture. 
 
(E)-methyl 2-oxo-4-phenylbut-3-enoate 
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Following general procedure B, acetyl chloride (28.6 mL, 0.40 mol) in MeOH (200 mL) 
and potassium salt 145 (7.48 g, 35.0 mmol) gave, after chromatographic purification 
(eluent EtOAc:petrol 10:90), ketoester 143 as a yellow solid (2.85 g, 43%); mp 67-69 °C 
(CH3OH); {lit.
170
 mp 69-70 °C (CH3OH)}; max (KBr)/cm
-1
 3075, 2957 (C-H), 1736 
(C=O ketone), 1691 (C=O ester), 1607, 1572; H (400 MHz, CDCl3) 3.88 (3H, s, CH3), 
7.32 (1H, d, J 16.1, C(3)H), 7.34-7.43 (3H, m, Ar(3,5)H and Ar(4)H), 7.56-7.60 (2H, m, 
Ar(2,6)H), 7.82 (1H, d, J 16.1, C(4)H); δ (75 MHz, CDCl ) 53.1 (CH ), 120.5 (C(3)), 
129.1 (ArC), 129.1 (ArC), 131.8 (ArC(4)), 134.0 (ArC(1)), 148.7 (C(4)), 162.6 (C(1)), 
182.4 (C(2)); m/z (NSI
+
) 191 ([M+H]
+
, 100%); HRMS (NSI
+
) C11H11O3
+
 ([M+H]
+
) 
requires 191.0703; found 191.0701 (-0.9 ppm). 
 
(E)-methyl 3-methyl-2-oxo-4-phenylbut-3-enoate 
 
Following general procedure B, acetyl chloride (16.1 mL, 0.23 mol) in MeOH (125 mL) 
and potassium salt 543 (4.50 g, 19.7 mmol) gave, after chromatographic purification 
(eluent EtOAc:petrol 7.5:92.5), ketoester 173 as a light yellow oil (1.27 g, 32%); max 
(ATR)/cm
-1
 2955 (C-H), 1732 (C=O ketone), 1665 (C=O ester), 1614; H (500 MHz, 
CDCl3) 2.16 (3H, s, =CH3), 3.97 (3H, s, OCH3), 7.40-7.50 (6H, m, C(4)H and ArH); δ
(100 MHz, CDCl ) 12.2 (C(3)CH ), 52.7 (OCH ), 128.7 (ArC), 129.9 (ArC(4)), 130.3 
(ArC), 133.4 (C(3)), 134.8 (ArC(1)), 147.1 (C(4)), 165.5 (C(1)), 189.8 (C(2)); m/z (NSI
+
) 
205 ([M+H]
+
, 53%); HRMS (NSI
+
) C12H13O3
+
 ([M+H]
+
) requires 205.0859; found 
205.0859 (-0.1 ppm). 
 
(E)-isopropyl 2-oxo-4-phenylbut-3-enoate 
 
Following general procedure B, acetyl chloride (28.6 mL, 0.40 mol) in i-PrOH (200 mL) 
and potassium salt 145 (7.48 g, 35.0 mmol) gave, after chromatographic purification 
(eluent EtOAc:petrol 5:95), ketoester 546 as a yellow oil (1.88 g, 25%); max (thin 
film)/cm
-1
 3063, 3029, 2984 (C-H), 2938, 1723 (C=O ketone), 1695 (C=O ester), 1604, 
1576; H (400 MHz, CDCl3) 1.41 (6H, d, J 6.3, CH(CH3)2), 5.24 (1H, sept, J 6.3, 
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CH(CH3)2), 7.35 (1H, d, J 16.1, C(3)H), 7.40-7.49 (3H, m, Ar(3,5)H and Ar(4)H), 7.61-
7.66 (2H, m, Ar(2,6)H), 7.85 (1H, d, J 16.1, C(4)H); δ (75 MHz, CDCl ) 22.1 
(CH(CH ) ), 71.1 (CH(CH ) ), 121.1 (C(3)), 129.4 (ArC), 129.5 (ArC), 132.0 (ArC(4)), 
134.5 (ArC(1)), 148.7 (C(4)), 162.3 (C(1)), 183.7 (C(2)); m/z (NSI
+
) 219 ([M+H]
+
, 
100%); HRMS (NSI
+
) C13H15O3
+
 ([M+H]
+
) requires 219.1016; found 219.1018 (+1.0 
ppm). 
 
(E)-methyl 4-(4-bromophenyl)-2-oxobut-3-enoate
 
 
Following general procedure B, acetyl chloride (8.37 mL, 0.12 mol) in MeOH (70 mL) 
and potassium (E)-4-(4-bromophenyl)-2-oxobut-3-enoate
5
 (3.00 g, 10.2 mmol) gave, 
after chromatographic purification (eluent EtOAc:petrol 10:90), ketoester 547 as a 
yellow solid (0.65 g, 24%); mp 116-118 °C (CH3OH); {lit.
170
 mp 120 °C (CH3OH)}; 
max (KBr)/cm
-1
 3073, 3030, 2961 (C-H), 1728 (C=O ketone), 1691 (C=O ester), 1607, 
1586, 1561; H (400 MHz, CDCl3) 3.96 (3H, s, CH3), 7.40 (1H, d, J 16.1, C(3)H), 7.50-
7.55 (2H, m, ArH), 7.57-7.62 (2H, m, ArH), 7.83 (1H, d, J 16.1, C(4)H); δ (100 MHz, 
CDCl ) 53.2 (CH ), 120.9 (C(3)), 126.3 (ArC(4)), 130.4 (ArC), 132.5 (ArC), 132.9 
(ArC(1)), 147.1 (C(4)), 162.4 (C(1)), 182.1 (C(2)); m/z (ES
+
) 293 ([M+Na]
+
, 100%); 
HRMS (ES
+
) C11H9
81
BrNaO3
+
 ([M+Na]
+
) requires 292.9612; found 292.9611 (-0.4 
ppm). 

(E)-methyl 4-(3-bromophenyl)-2-oxobut-3-enoate
 
 
Following general procedure B, acetyl chloride (8.37 mL, 0.12 mol) in MeOH (70 mL) 
and potassium (E)-4-(3-bromophenyl)-2-oxobut-3-enoate
171
 (3.00 g, 10.2 mmol) gave, 
after chromatographic purification (eluent EtOAc:petrol 10:90), ketoester 548 as a 
yellow solid (850 mg, 31%); mp 96-98 °C (CH3OH); {lit.
172
 mp 127-128 °C (CH3OH)}; 
max (KBr)/cm
-1
 3025, 2968 (C-H), 1733 (C=O ketone), 1698 (C=O ester), 1611, 1560; 
H (400 MHz, CDCl3) 3.87 (3H, s, CH3), 7.24 (1H, t, J 7.9, Ar(5)H), 7.30 (1H, d, J 16.1, 
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C(3)H), 7.46-7.53 (2H, m, ArH), 7.69-7.74 (2H, m, C(4)H and ArH); δ (100 MHz, 
CDCl ) 53.2 (CH ), 121.6 (C(3)), 123.3 (ArC(3)), 127.7 (ArC), 130.6 (ArC), 131.5 
(ArC), 134.4 (ArC), 136.0 (ArC(1)), 146.6 (C(4)), 162.2 (C(1)), 182.0 (C(2)); m/z (ES
+
) 
291 ([M+Na]
+
, 100%); HRMS (ES
+
) C11H9
79
BrNaO3
+
 ([M+Na]
+
) requires 290.9633; 
found 290.9637 (+1.5 ppm). 

(E)-methyl 4-(4-methoxyphenyl)-2-oxobut-3-enoate
 
 
Following general procedure B, acetyl chloride (6.70 mL, 94.3 mmol) in MeOH (70 mL) 
and potassium (E)-4-(4-methoxyphenyl)-2-oxobut-3-enoate
171
 (2.00 g, 8.20 mmol) gave, 
after chromatographic purification (eluent EtOAc:petrol 10:90), ketoester 549 as a 
yellow solid (652 mg, 24%); mp 86-88 °C (CH3OH); {lit.
173
 mp 99-100 °C (CH3OH)}; 
max (KBr)/cm
-1
 3071, 3028, 2961 (C-H), 1729 (C=O ketone), 1696 (C=O ester), 1608, 
1583, 1561; H (400 MHz, CDCl3) 3.88 (3H, s, OCH3), 3.95 (3H, s, CO CH ), 6.93-6.98 
(2H, m, Ar(3,5)H), 7.28 (1H, d, J 16.0, C(3)H), 7.60-7.65 (2H, m, Ar(2,6)H), 7.87 (1H, 
d, J 16.0, C(4)H); δ (100 MHz, CDCl ) 53.0 (CO CH ), 55.5 (OCH ), 114.6 (ArC(3,5)), 
118.1 (C(3)), 126.8 (ArC(1)), 131.2 (ArC(2,6)), 148.6 (C(4)), 162.7 (C(1) or ArC(4), 
162.9 (C(1) or ArC(4)), 182.2 (C(2)); m/z (ES
+
) 243 ([M+Na]
+
, 100%); HRMS (ES
+
) 
C12H12NaO4
+
 ([M+Na]
+
) requires 243.0633; found 243.0625 (-3.2 ppm). 
 
(E)-methyl 4-(naphthalen-2-yl)-2-oxobut-3-enoate 
 
Following general procedure B, acetyl chloride (12.4 mL, 0.17 mol) in MeOH (100 mL) 
and potassium salt 544 (4.00 g, 15.2 mmol) gave, after chromatographic purification 
(eluent EtOAc:petrol 10:90), ketoester 550 as a yellow solid (1.32 g, 36%); mp 70-72 °C 
(CH3OH); max (KBr)/cm
-1
 3051, 2965 (C-H), 1736 (C=O ketone), 1691 (C=O ester), 
1608; H (400 MHz, CDCl3) 3.99 (3H, s, CH3), 7.52 (1H, d, J 16.1, C(3)H), 7.54-7.62 
(2H, m, ArH), 7.77-7.82 (1H, m, ArH), 7.86-7.94 (3H, m, ArH), 8.05-8.11 (2H, m, 
C(4)H and Ar(1)H); δ (100 MHz, CDCl ) 53.1 (CH ), 120.5 (C(3)), 123.6 (ArC), 127.0 
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(ArC), 127.9 (ArC), 128.1 (ArC), 128.9 (ArC), 129.0 (ArC), 131.6 (ArC), 132.1 (ArC), 
133.2 (ArC), 134.9 (ArC), 148.8 (C(4)), 162.7 (C(1)), 182.3 (C(2)); m/z (ES
+
) 263 
([M+Na]
+
, 100%); HRMS (ES
+
) C15H12NaO3
+
 ([M+Na]
+
) requires 263.0684; found 
263.0688 (+1.4 ppm). 
 
(E)-methyl 2-oxo-4-(pyridin-3-yl)but-3-enoate 
 
Following general procedure B, acetyl chloride (11.4 mL, 0.16 mol) in MeOH (100 mL) 
and potassium salt 545 (3.00 g, 14.0 mmol) gave, after chromatographic purification 
(eluent EtOAc:petrol 80:20), ketoester 551 as a yellow solid (0.20 g, 8%); mp 56-58 °C 
(CH3OH); max (KBr)/cm
-1
 3075, 3023, 2960 (C-H), 1731 (C=O ketone), 1687 (C=O 
ester), 1607, 1585; H (400 MHz, CDCl3) 3.89 (3H, s, CH3), 7.32 (1H, dd, J 8.0, 4.8, 
Ar(5)H), 7.39 (1H, d, J 16.2, C(3)H), 7.81 (1H, d, J 16.2, C(4)H), 7.87-7.92 (1H, m, 
Ar(6)H), 8.61 (1H, dd, J 4.8, 1.6, Ar(4)H), 8.77 (1H, d, J 1.6, Ar(2)H); δ (100 MHz, 
CDCl ) 53.3 (CH ), 122.2 (C(3)), 123.9 (ArC(5)), 129.8 (ArC(3)), 134.8 (ArC(6)), 144.7 
(C(4)), 150.7 (ArC(2)), 152.2 (ArC(4)), 162.1 (C(1)), 181.8 (C(2)); m/z (ES
+
) 192 
([M+H]
+
, 100%); HRMS (ES
+
) C10H10NO3
+
 ([M+H]
+
) requires 192.0661; found 
192.0655 (-2.8 ppm). 
 
(E)-methyl 4-(furan-2-yl)-2-oxobut-3-enoate 
 
To a solution of potassium salt 175 (3.00 g, 14.7 mmol) in DMF (40 mL) was added 
methyl iodide (1.01 mL, 16.2 mmol) and the reaction mixture was heated at 75 °C for 4 
h. Once cool the reaction mixture was poured into H2O and extracted with CH2Cl2 (x 3). 
The combined organic extracts were washed with H2O and brine, dried (MgSO4), 
filtered and concentrated in vacuo. Chromatographic purification (eluent EtOAc:petrol 
15:85) gave ketoester 174 as a yellow solid (0.73 g, 27%); mp 56-58 °C (CH3OH); 
{lit.
174
 mp 58-60 °C (petroleum ether)}; max (KBr)/cm
-1
 3138, 3091, 3035, 2959 (C-H), 
1736 (C=O ketone), 1680 (C=O ester), 1595, 1545; H (400 MHz, CDCl3) 3.85 (3H, s, 
CH3), 6.48 (1H, dd, J 3.5, 1.8, Ar(4)H), 6.77 (1H, d, J 3.5, Ar(3)H), 7.16 (1H, d, J 15.7, 
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C(3)H), 7.50-7.52 (1H, m, Ar(5)H), 7.56 (1H, d, J 15.7, C(4)H); δ (100 MHz, CDCl ) 
53.0 (CH ), 113.2 (ArC(4)), 118.0 (C(3)), 118.7 (ArC(3)), 133.7 (C(4)), 146.4 (ArC(5)), 
151.0 (ArC(2)), 162.4 (C(1)), 182.0 (C(2)); m/z (ES
+
) 203 ([M+Na]
+
, 100%); HRMS 
(ES
+
) C9H8NaO4
+
 ([M+Na]
+
) requires 203.0320; found 203.0318 (-1.4 ppm). 
 
(E)-methyl 4-(2-methoxyphenyl)-2-oxobut-3-enoate 
 
To a solution of 2-methoxybenzaldehyde (3.02 mL, 25.0 mmol) in MeOH (4 mL) was 
added pyruvic acid (1.76 mL, 25.0 mmol). To this was added a solution of KOH (2.10 g, 
37.5 mmol) in MeOH (15 mL) at 0 °C. The solution was stirred for 1 h at 40 °C 
followed by addition of concentrated HCl at 0 °C. The reaction mixture was extracted 
with Et2O (x 3), dried (MgSO4), filtered and concentrated in vacuo to give the 
intermediate acid 177 as an orange solid which was used without purification.  
Acetyl chloride (20.4 mL, 0.29 mol) was added to MeOH (150 mL) at 0 °C to generate 
HCl. The previously synthesised acid (5.15 g, 25.0 mmol assuming 100% conversion) 
was added and the mixture was stirred at 0 °C for thirty minutes then warmed to rt for 
two hours before heating at reflux overnight. Concentration in vacuo gave a solid which 
was dissolved in H2O and extracted with CH2Cl2 (x 3). The combined organics were 
washed with sat. aq. NaHCO3, H2O and brine before being dried (MgSO4), filtered and 
concentrated in vacuo to give keto ester 178 as a yellow solid (2.55 g, 46% over 2 steps); 
mp 49-51 °C; {lit.
70
 mp 48 °C}; max (ATR)/cm
-1
 3011, 2949 (C-H), 2839, 1726 (C=O 
ketone), 1686 (C=O ester), 1591; H (400 MHz, CDCl3) 3.94 (3H, s, OCH3), 3.96 (3H, s, 
CO CH ), 6.68 (1H, d, J 8.4, Ar(3)H), 7.02 (1H, t, J 7.5, Ar(5)H), 7.43-7.48 (2H, m, 
C(3)H and Ar(4)H), 7.66 (1H, dd, J 7.7, 1.6, Ar(6)H), 8.24 (1H, d, J 16.3, C(4)H); δ
(100 MHz, CDCl ) 52.9 (CO CH ), 55.6 (OCH ), 111.3 (ArC(3)), 120.8 (C(3)), 120.8 
(ArC(4)), 122.9 (ArC(1)), 129.5 (ArC(6)), 133.2 (ArC(4)), 144.1 (C(4)), 159.2 (ArC(2)), 
162.9 (C(1)), 183.0 (C(2)); m/z (NSI
+
) 221 ([M+H]
+
, 100%); HRMS (NSI
+
) C12H13O4
+
 
([M+H]
+
) requires 221.0808; found 221.0806 (-1.1 ppm). 
 
(E)-ethyl 5-methyl-2-oxohex-3-enoate 
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To a solution of ethyl pyruvate (11.1 mL, 0.10 mol) in toluene (70 mL) at rt was added 
DMAP (24.4 mg, 0.20 mmol), trimethylsilyl chloride (19.0 mL, 0.15 mol) and Et3N 
(20.9 mL, 0.15 mol) and the reaction mixture was heated at reflux for 2 h. Once cool the 
reaction mixture was filtered under a flow of argon gas and the toluene was removed 
under reduced pressure to give crude silylated enol ester. This was subsequently added 
via cannula to a solution of 1,1-dimethoxy-2-methylpropane (9.83 g, 83.3 mmol) in 
CH2Cl2 (350 mL). Trifluoroboron etherate (11.5 mL, 91.6 mmol) was added dropwise at 
78 °C and the reaction mixture was allowed to stir at 0 °C for 3 h. The reaction mixture 
was poured into sat. aq. NaHCO3 and extracted with CH2Cl2 (x 3). The combined 
organics were dried (MgSO4), filtered and concentrated in vacuo to afford the crude 
reaction mixture. Kugelrohr distillation and chromatographic purification (eluent 
EtOAc:petrol 4:96) gave ketoester 179 as a yellow oil (268 mg, 2%); max (thin film)/cm
-
1
 2966 (C-H), 2936, 2872, 1734 (C=O ketone), 1702 (C=O ester), 1678, 1624; H (400 
MHz, CDCl3) 1.14 (6H, d, J 6.8, CH(CH3)2), 1.41 (3H, t, J 6.8, CH2CH3), 2.54-2.64 
(1H, m, CH(CH3)2), 4.38 (2H, q, J 7.1, CH CH ), 6.64 (1H, dd, J 16.0, 1.4, C(3)H), 7.18 
(1H, dd, J 16.0, 6.6, C(4)H); δ (100 MHz, CDCl ) 14.1 (CH CH ), 21.0 (CH(CH ) ), 31.8 
(CH(CH ) ), 62.3 (CH CH ), 122.4 (C(3)), 160.8 (C(4)), 162.5 (C(1)), 183.8 (C(2)); m/z 
(ES
+
) 193 ([M+Na]
+
, 100%); HRMS (ES
+
) C9H14NaO3
+
 ([M+Na]
+
) requires 193.0841; 
found 193.00841 (+0.1 ppm). 
 
methyl 2-(1-hydroxycyclohexyl)-2,2-dimethoxyacetate 
 
To a solution of i-Pr2NH (3.95 mL, 28.0 mmol) in THF (30 mL) at 78 °C under argon 
was added n-BuLi (2.5M in hexanes, 12.0 mL, 30.0 mmol) and the solution was stirred 
at 78 °C for 30 minutes. A solution of methyl dimethoxyacetate (3.66 mL, 30.0 mmol) 
in THF (25 mL) was then added dropwise over 15 minutes at 78 °C and the reaction 
mixture was stirred for a further 15 minutes. A solution of cyclohexanone (2.07 mL, 
20.0 mmol) in THF (25 mL) was then added over 15 minutes at 78 °C and the solution 
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was stirred at 78 °C for a further 30 minutes. The reaction mixture was poured into 
H2O and extracted with Et2O (x 3). The organic fraction was washed with H2O, brine, 
dried (MgSO4), filtered and concentrated in vacuo. Chromatographic purification (eluent 
EtOAc:petrol 10:90) gave acetal 185 as a colourless oil (4.29 g, 92%); δ (500 MHz, 
CDCl ) 1.07-1.75 (10H, m, 5 CH ), 2.27 (1H, s, OH), 3.48 (6H, s, 2 OCH ), 3.82 (3H, s, 
CO CH ). Spectroscopic data are in accordance with the literature.
73
 
 
methyl 2-(cyclohex-1-en-1-yl)-2-oxoacetate 
 
To a solution of acetal 185 (2.00 g, 8.62 mmol) in CH2Cl2 (80 mL) was added pyridine 
(6.95 mL, 86.2 mmol) and thionyl chloride (2.51 mL, 34.5 mmol) slowly at 0 °C. The 
reaction mixture was allowed to stir for 1 h before being concentrated in vacuo. The 
residue was dissolved in dioxane (50 mL) and treated with HCl (4 M in dioxane, 30.0 
mL, 0.12 mol) for 15 minutes at rt. The reaction mixture was placed in a separating 
funnel and the organic fraction was washed with H2O, brine, dried (MgSO4), filtered and 
concentrated in vacuo. Chromatographic purification (eluent EtOAc:petrol 7.5:92.5) 
gave cyclic keto ester 182 as a colourless oil (125 mg, 9%); δ (400 MHz, CDCl ) 1.58-
1.64 (4H, m, 2 CH ), 2.19-2.29 (4H, m, 2 CH ), 3.81 (3H, s, CH ), 6.92-6.94 (1H, m, 
CH=C). Spectroscopic data are in accordance with the literature.
175
 
 
ethyl 2-(3,4-dihydro-2H-pyran-5-yl)-2-oxoacetate 
 
To a solution of 3,4-dihydro-2H-pyran (1.37 mL, 15.0 mmol) in Et2O (10 mL) at 0 °C 
was added a solution of ethyl chlorooxoacetate (1.12 mL, 10.0 mmol) in Et2O (10 mL) 
over 1 h. The reaction mixture was stirred at rt for 16 h. Et3N (1.54 mL, 11.0 mmol) was 
added and the reaction mixture was stirred for a further 4 h. Et2O was added a precipitate 
formed which was removed by filtration. Concentration of the filtrate in vacuo gave 
cyclic keto ester 186 as a colourless oil (0.40 g, 22 %); max (KBr)/cm
-1
 2984 (C-H), 
2943, 1732 (C=O ketone), 1690 (C=O ester) 1652, 1607; δ (400 MHz, CDCl ) 1.39 (3H, 
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t, J 7.2, CH CH ), 1.92-1.98 (2H, m, CH CH CH ), 2.34 (2H, t, J 6.3, =CH ), 4.19 (2H, t, 
J 5.3, OCH ), 4.35 (2H, q, J 7.2, CH CH ), 7.85 (1H, s, C(4)H); δ (100 MHz, CDCl ) 
14.1 (CH CH ), 17.5 (CH ), 20.6 (CH ), 62.0 (CH CH ), 67.9 (OCH ), 114.2 (C(3)), 
163.3 (C(4)), 163.9 (C(1)), 185.0 (C(2)); m/z (NSI
+
) 185 ([M+H]
+
, 100%); HRMS 
(NSI
+
) C9H13O4
+
 ([M+H]
+
) requires 185.0808; found 185.0807 (-0.7 ppm). 
 
General procedure C: Intermolecular Michael addition-lactonisation. 
To a solution of acid (1 eq) in CH2Cl2 (~1 mL per 0.2 mmol of acid) were added i-
Pr2NEt (1.5 eq based on acid) and pivaloyl chloride (1.5 eq based on acid) at rt. The 
reaction mixture was allowed to stir at rt for 10 minutes. The requisite Lewis base (1-20 
mol%), Michael acceptor (1 eq) and i-Pr2NEt (2.5 eq) were then added at the required 
temperature in that order. The reaction mixture was stirred at the required temperature 
until complete by TLC and was subsequently quenched by addition of HCl (1 M in 
H2O). The reaction mixture was poured into H2O and extracted with CH2Cl2 (x 3). The 
combined organics were dried (MgSO4), filtered and concentrated in vacuo to give the 
crude reaction mixture. Note: All racemic samples were obtained via this general 
procedure using DHPB 108 as catalyst. 
 
Optimisation studies on compound 147 
methyl 2-oxo-3,4-diphenyl-3,4-dihydro-2H-pyran-6-carboxylate 
 
Following general procedure C, phenylacetic acid (27.2 mg, 0.20 mmol), ketoester 143 
(38.0 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in CH2Cl2 (1 mL), pivaloyl 
chloride (37.0 L, 0.30 mmol), DHPB 108 (7.60 mg, 0.04 mmol) and i-Pr2NEt (87.0 L, 
0.50 mmol) for 1 h at rt gave crude lactone (±)-147 (95:5 dr). Chromatographic 
purification (eluent EtOAc:petrol 15:85) gave lactone (±)-147 (96:4 dr) as a white solid 
(39.0 mg, 64%); mp 118-120 °C; Chiral HPLC Chiralpak AD-H (40% IPA:hexane, flow 
rate 1 mL min
-1
, 211 nm, 20 °C) tR(3R,4R): 15.0 min, tR(3S,4S): 28.2 min; max 
(KBr)/cm
-1
 3085, 3031, 3007, 2955 (C-H), 1764 (C=O lactone), 1733 (C=O ester), 1660, 
1496; Data for major diastereoisomer: δ (400 MHz, CDCl ) 3.92 (3H, s, CH ), 3.96 (1H, 
d, J 8.7, C(3)H), 4.08 (1H, dd, J 8.7, 4.0, C(4)H), 6.71 (1H, d, J 4.0, C(5)H), 7.06-7.08 
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(2H, m, ArH), 7.12-7.14 (2H, m, ArH), 7.24-7.36 (6H, m, ArH); δ (100 MHz, CDCl ) 
45.4 (C(4)), 52.5 (C(3)), 52.8 (CH ), 117.8 (C(5)), 127.5 (ArC), 127.9 (ArC), 128.0 
(ArC), 128.3 (ArC), 128.8 (ArC), 129.1 (ArC), 135.4 (ArC), 139.1 (ArC), 142.0 (C(6)), 
160.7 (CO CH ), 166.8 (C(2)); m/z (NSI
+
) 326 ([M+NH4]
+
, 100%); HRMS (NSI
+
) 
C19H20NO4
+
 ([M+NH4]
+
) requires 326.1387; found 326.1389 (+0.7 ppm). 

Asymmetric Catalyst Screen:  
All reactions at rt for 3 h. 
 
Tetramisole hydrochloride (2S)-106 (9.63 mg, 0.04 mmol, 20 mol%) gave crude lactone 
(3S,4S)-147 (94:6 dr). Chromatographic purification (eluent EtOAc:petrol 15:85) gave 
lactone (3S,4S)-147 (98:2 dr) as a white solid (37.0 mg, 60%); 

 
D
20
+196.0 (c 0.05, 
CH2Cl2); 86% ee. 
 
i-Pr isothiourea catalyst (2S)-148 (9.28 mg, 0.04 mmol, 20 mol%) gave crude lactone 
(3S,4S)-147 (96:4 dr). Chromatographic purification (eluent EtOAc:petrol 15:85) gave 
lactone (3S,4S)-147 (98:2 dr) as a white solid (34.0 mg, 55%); 

 
D
20
+183.2 (c 0.2, 
CH2Cl2); 83% ee. 
 
HBTM-2.1 (2S,3R)-112 (12.3 mg, 0.04 mmol, 20 mol%) gave crude lactone (3R,4R)-
147 (96:4 dr). Chromatographic purification (eluent EtOAc:petrol 15:85) gave lactone 
(3R,4R)-147 (98:2 dr) as a white solid (32.0 mg, 52%); 

 
D
20
-179.0 (c 0.5, CH2Cl2); 
91% ee. 
 
Temperature Screen:  
All reactions with HBTM-2.1 (2S,3R)-112 (12.3 mg, 0.04 mmol, 20 mol%) 
 
Reaction for 3 h at 10 °C gave crude lactone (3R,4R)-147 (95:5 dr). Chromatographic 
purification (eluent EtOAc:petrol 15:85) gave lactone (3R,4R)-147 (98:2 dr) as a white 
solid (34.0 mg, 55%); 93% ee. 
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Reaction for 3 h at 30 °C gave crude lactone (3R,4R)-147 (94:6 dr). Chromatographic 
purification (eluent EtOAc:petrol 15:85) gave lactone (3R,4R)-147 (98:2 dr) as a white 
solid (37.0 mg, 60%); 97% ee. 
 
Reaction for 3 h at 50 °C gave crude lactone (3R,4R)-147 (96:4 dr). Chromatographic 
purification (eluent EtOAc:petrol 15:85) gave lactone (3R,4R)-147 (98:2 dr) as a white 
solid (34.0 mg, 55%); 95% ee. 
 
Reaction for 3 h at 78 °C gave crude lactone (3R,4R)-147 (98:2 dr). Chromatographic 
purification (eluent EtOAc:petrol 15:85) gave lactone (3R,4R)-147 (98:2 dr) as a white 
solid (37.0 mg, 60%); 96% ee. 
 
Catalyst Loading Screen:  
HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 10 mol%) for 16 h at 30 °C gave crude 
lactone (3R,4R)-147 (95:5 dr). Chromatographic purification (eluent EtOAc:petrol 
15:85) gave lactone (3R,4R)-147 (98:2 dr) as a white solid (42.0 mg, 68%); 97% ee. 
 
HBTM-2.1 (2S,3R)-112 (3.08 mg, 0.01 mmol, 5 mol%) for 24 h at 30 °C gave crude 
lactone (3R,4R)-147 (95:5 dr). Chromatographic purification (eluent EtOAc:petrol 
15:85) gave lactone (3R,4R)-147 (98:2 dr) as a white solid (42.0 mg, 68%); 96% ee. 
 
HBTM-2.1 (2S,3R)-112 (1.23 mg, 0.004 mmol, 2 mol%) for 72 h at 30 °C gave crude 
lactone (3R,4R)-147 (94:6 dr). Chromatographic purification (eluent EtOAc:petrol 
15:85) gave lactone (3R,4R)-147 (98:2 dr) as a white solid (34.0 mg, 55%); 96% ee. 
 
Scale-up: 
Following general procedure C, phenylacetic acid (0.27 g, 2.00 mmol), ketoester 143 
(0.38 g, 2.00 mmol) and i-Pr2NEt (0.52 mL, 3.00 mmol) in CH2Cl2 (10 mL), pivaloyl 
chloride (0.37 mL, 3.00 mmol), HBTM-2.1 (2S,3R)-112 (61.7 mg, 0.2 mmol, 10 mol%) 
and i-Pr2NEt (0.87 mL, 5.00 mmol) for 16 h at 30 °C gave crude lactone (3R,4R)-147 
(90:10 dr). Chromatographic purification (eluent EtOAc:petrol 15:85) gave lactone 
(3R,4R)-147 (91:9 dr) as a white solid (0.40 g, 66%); 99% ee. 
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(3R,4R)-methyl 3-(4-methoxyphenyl)-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-
carboxylate 
 
Following general procedure C, 4-methoxyphenylacetic acid (33.2 mg, 0.20 mmol), 
ketoester 143 (38.0 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in CH2Cl2 (1 
mL), pivaloyl chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 
mmol) and i-Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 30 °C gave crude lactone 
(3R,4R)-159 (92:8 dr). Chromatographic purification (eluent EtOAc:petrol 20:80) gave 
lactone (3R,4R)-159 (98:2 dr) as a white solid (51.1 mg, 76%); mp 118-120 °C; 

 
D
20
-
212.0 (c 0.25, CH2Cl2); Chiral HPLC Chiralpak AD-H (30% IPA:hexane, flow rate 1 
mL min
-1
, 211 nm, 20 °C) tR(3R,4R): 24.9 min, tR(3S,4S): 43.7 min, 98% ee; max 
(KBr)/cm
-1
 3080, 3029, 2958 (C-H), 2839, 1778 (C=O lactone), 1745 (C=O ester), 1656, 
1616, 1587, 1519; Data for major diastereoisomer: δ (400 MHz, CDCl ) 3.69 (3H, s, 
OCH ), 3.79-3.81 (4H, m, C(3)H and CO CH ), 3.95 (1H, dd, J 8.8, 3.9 C(4)H), 6.61 
(1H, d, J 3.9, C(5)H), 6.72-6.76 (2H, m, C(3)Ar(3,5)H), 6.92-6.98 (4H, m, ArH), 7.16-
7.22 (3H, m, ArH); δ (100 MHz, CDCl ) 45.4 (C(4)), 51.7 (C(3) or CO CH ), 52.8 (C(3) 
or CO CH ), 55.3 (OCH ), 114.3 (C(3)ArC(3,5)), 117.9 (C(5)), 127.3 (C(3)ArC(1)), 
127.5 (ArC), 127.8 (C(4)ArC(4)), 129.1 (ArC), 129.4 (ArC), 139.3 (C(4)ArC(1)), 142.0 
(C(6)), 159.2 (C(3)ArC(4)), 160.8 (CO CH ), 167.1 (C(2)); m/z (NSI
+
) 356 ([M+NH4]
+
, 
100%); HRMS (NSI
+
) C20H22NO5
+
 ([M+NH4]
+
) requires 356.1492; found 356.1494 
(+0.4 ppm). 
 
(3R,4R)-methyl 2-oxo-4-phenyl-3-(4-(trifluoromethyl)phenyl)-3,4-dihydro-2H-
pyran-6-carboxylate 
 
Following general procedure C, 2-(4-(trifluoromethyl)phenyl)acetic acid (40.8 mg, 0.20 
mmol), ketoester 143 (38.0 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in 
CH2Cl2 (1 mL), pivaloyl chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 
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mg, 0.02 mmol) and i-Pr2NEt (87.0 L, 0.50 mmol) for 72 h at 30 °C gave crude 
lactone (3R,4R)-160 (85:15 dr). Chromatographic purification (eluent EtOAc:petrol 
15:85) gave lactone (3R,4R)-160 (98:2 dr) as a white solid (36.5 mg, 49%); mp 130-132 
°C; 

 
D
20
-100.0 (c 0.2, CH2Cl2); Chiral HPLC Chiralpak AD-H (30% IPA:hexane, flow 
rate 1 mL min
-1
, 211 nm, 20 °C) tR(3R,4R): 14.8 min, tR(3S,4S): 18.4 min, 71% ee; max 
(KBr)/cm
-1
 3097, 3045, 2961 (C-H), 1765 (C=O lactone), 1737 (C=O ester), 1667, 1619; 
Data for major diastereoisomer: δ (400 MHz, CDCl ) 3.83 (3H, s, CH ), 3.89 (1H, d, J 
10.3, C(3)H), 3.98 (1H, dd, J 10.3, 3.4 C(4)H), 6.62 (1H, d, J 3.4, C(5)H), 6.90-6.95 
(2H, m, ArH), 7.11 (2H, d, J 8.1, C(3)Ar(2,6)H), 7.16-7.22 (3H, m, ArH), 7.46 (2H, d, J 
8.2, C(3)Ar(3,5)H); δ (125 MHz, CDCl ) 45.4 (C(4)), 52.4 (C(3) or CH ), 52.9 (C(3) or 
CH ), 118.1 (C(5)), 123.9 (q, J 271, CF ), 125.7 (q, J 3.4, C(3)ArC(3,5)), 127.5 (ArC), 
128.2 (C(4)ArC(4)), 129.1 (ArC), 129.2 (ArC), 130.2 (q, J 32.6, C(3)ArC(4)), 138.5 
(C(3)ArC(1)), 139.2 (C(4)ArC(1)), 142.1 (C(6)), 160.5 (CO CH ), 166.3 (C(2)); m/z 
(NSI
+
) 394 ([M+NH4]
+
, 100%); HRMS (NSI
+
) C20H19FNO4
+
 ([M+NH4]
+
) requires 
394.1261; found 394.1262 (+0.3 ppm). 
 
(3R,4R)-methyl 3-(4-bromophenyl)-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-
carboxylate 
 
Following general procedure C, 4-bromophenylacetic acid (43.0 mg, 0.20 mmol), 
ketoester 143 (38.0 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in CH2Cl2 (1 
mL), pivaloyl chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 
mmol) and i-Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 30 °C gave crude lactone 
(3R,4R)-161 (90:10 dr). Chromatographic purification (eluent EtOAc:petrol 15:85) gave 
lactone (3R,4R)-161 (98:2 dr) as a white solid (48.1 mg, 62%); mp 110-112 °C; 

 
D
20
-
156.0 (c 0.2, CH2Cl2); Chiral HPLC Chiralpak AD-H (30% IPA:hexane, flow rate 1 mL 
min
-1
, 211 nm, 20 °C) tR(3R,4R): 22.0 min, tR(3S,4S): 31.5 min, 93% ee; max (KBr)/cm
-1
 
3089, 3029, 2954 (C-H), 1782 (C=O lactone), 1747 (C=O ester), 1660; Data for major 
diastereoisomer: δ (400 MHz, CDCl ) 3.79 (1H, d, J 10.1, C(3)H), 3.82 (3H, s, CH ), 
3.94 (1H, dd, J 10.1, 3.5 C(4)H), 6.60 (1H, d, J 3.5, C(5)H), 6.86-6.88 (2H, m, 
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C(3)Ar(2,6)H), 6.92-6.94 (2H, m, C(4)Ar(2,6)H), 7.17-7.22 (3H, m, C(4)Ar(3,5)H and 
C(4)Ar(4)H), 7.31-7.34 (2H, m, C(3)Ar(3,5)H); δ (100 MHz, CDCl ) 45.3 (C(4)), 52.0 
(C(3)), 52.9 (CH ), 118.1 (C(5)), 122.1 (C(3)ArC(4)), 127.5 (ArC), 128.0 (C(4)ArC(4)), 
129.2 (ArC), 130.2 (ArC), 131.9 (ArC), 134.2 (C(3)ArC(1)), 138.7 (C(4)ArC(1)), 142.0 
(C(6)), 160.6 (CO CH ), 166.5 (C(2)); m/z (NSI
+
) 404 ([M+NH4]
+
, 100%); HRMS 
(NSI
+
) C19H19
79
BrNO4
+
 ([M+NH4]
+
) requires 404.0492; found 404.0494 (+0.5 ppm). 
 
(3R,4R)-methyl 2-oxo-4-phenyl-3-(p-tolyl)-3,4-dihydro-2H-pyran-6-carboxylate 
 
Following general procedure C, p-tolyl acetic acid (30.0 mg, 0.20 mmol), ketoester 143 
(38.0 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in CH2Cl2 (1 mL), pivaloyl 
chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 10 mol%) 
and i-Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 30 °C gave crude lactone (3R,4R)-162 
(95:5 dr). Chromatographic purification (eluent EtOAc:petrol 15:85) gave lactone 
(3R,4R)-162 (97:3 dr) as a white solid (52.1 mg, 81%); mp 144-146 °C; 

 
D
20
-223.2 (c 
0.25, CH2Cl2); Chiral HPLC Chiralpak AD-H (30% IPA:hexane, flow rate 1 mL min
-1
, 
211 nm, 20 °C) tR(3R,4R): 16.3 min, tR(3S,4S): 23.4 min, 99% ee; max (KBr)/cm
-1
 3056, 
3028, 2956 (C-H), 2924, 2854, 1784 (C=O lactone), 1744 (C=O ester), 1519; Data for 
major diastereoisomer: δ (400 MHz, CDCl ) 2.23 (3H, s, 4-CH C H ), 3.81 (3H, s, CH ), 
3.84 (1H, d, J 8.5, C(3)H), 3.97 (1H, dd, J 8.5, 4.0, C(4)H), 6.60 (1H, d, J 4.0, C(5)H), 
6.92-6.94 (2H, m, C(3)Ar(3,5)H), 6.97-7.03 (4H, m, ArH), 7.17-7.23 (3H, m, ArH); δ
(100 MHz, CDCl ) 21.1 (4-CH C H ), 45.3 (C(4)), 52.0(C(3)), 52.8 (CO CH ), 117.8 
(C(5)), 127.5 (ArC), 127.9 (C(4)ArC(4)), 128.1 (ArC), 129.1 (ArC), 129.5 (ArC), 132.4 
(C(3)ArC(1)), 137.7 (C(3)ArC(4)), 139.3 (C(4)ArC(1)), 142.0 (C(6)), 160.8 (CO CH ), 
167.0 (C(2)); m/z (NSI
+
) 340 ([M+NH4]
+
, 100%); HRMS (NSI
+
) C20H22NO4
+
 
([M+NH4]
+
) requires 340.1543; found 340.1548 (+1.4 ppm). 
 
(3R,4R)-methyl 2-oxo-4-phenyl-3-(m-tolyl)-3,4-dihydro-2H-pyran-6-carboxylate 
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Following general procedure C, m-tolyl acetic acid (30.0 mg, 0.20 mmol), ketoester 143 
(38.0 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in CH2Cl2 (1 mL), pivaloyl 
chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 10 mol%) 
and i-Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 30 °C gave crude lactone (3R,4R)-163 
(95:5 dr). Chromatographic purification (eluent EtOAc:petrol 15:85) gave lactone 
(3R,4R)-163 (98:2 dr) as a white solid (43.3 mg, 67%); mp 118-120 °C; 

 
D
20
-184.8 (c 
0.25, CH2Cl2); Chiral HPLC Chiralpak AD-H (30% IPA:hexane, flow rate 1 mL min
-1
, 
211 nm, 20 °C) tR(3R,4R): 12.5 min, tR(3S,4S): 16.9 min, 97% ee; max (KBr)/cm
-1
 3084, 
3029, 2962 (C-H), 2923, 2871, 1780 (C=O lactone), 1745 (C=O ester), 1664, 1606; Data 
for major diastereoisomer: δ (400 MHz, CDCl ) 2.22 (3H, s, 3-CH C H ), 3.81 (3H, s, 
CH ), 3.84 (1H, d, J 8.2, C(3)H), 3.98 (1H, dd, J 8.2, 4.2 C(4)H), 6.60 (1H, d, J 4.2, 
C(5)H), 6.83-6.85 (2H, m, ArH), 6.97-7.00 (3H, m, ArH), 7.09 (1H, t, J 7.6, 
C(3)Ar(5)H), 7.16-7.22 (3H, m, ArH); δ (100 MHz, CDCl ) 21.4 (3-CH C H ), 45.3 
(C(4)), 52.3 (C(3) or CO CH ), 52.8 (C(3) or CO CH ), 117.7 (C(5)), 125.2 (ArC), 127.5 
(ArC), 127.9 (ArC), 128.7 (ArC), 128.8 (ArC), 129.0 (ArC), 129.1 (ArC), 135.4 
(C(3)ArC(1)), 138.6 (C(3)ArC(3)), 139.2 (C(4)ArC(1)), 142.0 (C(6)), 160.8 (CO CH ), 
166.9 (C(2)); m/z (NSI
+
) 340 ([M+NH4]
+
, 100%); HRMS (NSI
+
) C20H22NO4
+
 
([M+NH4]
+
) requires 340.1543; found 340.1545 (+0.5 ppm). 
 
(3R,4R)-methyl 2-oxo-4-phenyl-3-(o-tolyl)-3,4-dihydro-2H-pyran-6-carboxylate 
 
Following general procedure C, o-tolyl acetic acid (30.0 mg, 0.20 mmol), ketoester 143 
(38.0 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in CH2Cl2 (1 mL), pivaloyl 
chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 10 mol%) 
and i-Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 30 °C gave crude lactone (3R,4R)-164 
(95:5 dr). Chromatographic purification (eluent EtOAc:petrol 15:85) gave lactone 
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(3R,4R)-164 (98:2 dr) as a white solid (42.3 mg, 66%); mp 152-154 °C; 

 
D
20
-116.0 (c 
0.15, CH2Cl2); Chiral HPLC Chiralpak AS-H (10% IPA:hexane, flow rate 1 mL min
-1
, 
211 nm, 20 °C) tR(3R,4R): 29.9 min, tR(3S,4S): 33.3 min, 87% ee; max (KBr)/cm
-1
 3086, 
3032, 2956 (C-H), 2925, 1764 (C=O lactone), 1732 (C=O ester), 1659; Data for major 
diastereoisomer: δ (400 MHz, CDCl ) 2.04 (3H, s, 2-CH C H ), 3.94 (3H, s, CH ), 4.05 
(1H, dd, J 9.8, 3.5 C(4)H) 4.14 (1H, d, J 9.8, C(3)H), 6.71 (1H, d, J 3.5, C(5)H), 
7.02-7.04 (2H, m, ArH), 7.08-7.10 (1H, m, ArH), 7.14-7.28 (6H, m, ArH); δ (100 MHz, 
CDCl ) 19.6 (2-CH C H ), 45.3 (C(4)), 48.7 (C(3)), 52.8 (CO CH ), 118.1 (C(5)), 126.6 
(ArC), 127.6 (ArC), 127.9 (ArC), 127.9 (ArC), 127.9 (ArC), 128.9 (ArC), 130.7 (ArC), 
134.2 (C(3)ArC(1)), 136.5 (C(3)ArC(2)), 139.3 (C(4)ArC(1)), 142.0 (C(6)), 160.8 
(CO CH ), 166.9 (C(2)); m/z (NSI
+
) 340 ([M+NH4]
+
, 100%); HRMS (NSI
+
) C20H22NO4
+
 
([M+NH4]
+
) requires 340.1543; found 340.1546 (+0.8 ppm). 
 
(3R,4R)-methyl 3-(naphthalen-2-yl)-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-
carboxylate 
 
Following general procedure C, 1-naphthyl acetic acid (37.2 mg, 0.20 mmol), ketoester 
143 (38.0 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in CH2Cl2 (1 mL), 
pivaloyl chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 
10 mol%) and i-Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 30 °C gave crude lactone 
(3R,4R)-165 (93:7 dr). Chromatographic purification (eluent EtOAc:petrol 15:85) gave 
lactone (3R,4R)-165 (98:2 dr) as a white solid (52.4 mg, 73%); mp 170-172 °C;
 

 
D
20
-
212.4 (c 0.25, CH2Cl2); Chiral HPLC Chiralpak AD-H (30% IPA:hexane, flow rate 1 
mL min
-1
, 211 nm, 20 °C) tR(3R,4R): 18.2 min, tR(3S,4S): 25.8 min, 97% ee; max 
(KBr)/cm
-1
 3059, 3027, 2955 (C-H), 1774 (C=O lactone), 1745 (C=O ester), 1655, 1603; 
Data for major diastereoisomer: δ (400 MHz, CDCl ) 3.82 (3H, s, CH ), 4.03 (1H, d, J 
8.8, C(3)H), 4.12 (1H, dd, J 8.8, 3.9, C(4)H), 6.64 (1H, d, J 3.9, C(5)H), 6.98-7.00 (2H, 
m, ArH), 7.13-7.19 (3H, m, ArH), 7.21 (1H, dd, J 8.6, 1.9, ArH), 7.35-7.42 (3H, m, 
ArH) 7.63-7.65 (1H, m, ArH), 7.71-7.74 (2H, m, ArH); δ (100 MHz, CDCl ) 45.2 
(C(4)), 52.6 (C(3) or CH ), 52.8 (C(3) or CH ), 117.9 (C(5)), 125.7 (ArC), 126.4 (ArC), 
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126.4 (ArC), 127.5 (ArC), 127.7 (ArC), 127.7 (ArC), 127.9 (ArC), 127.9 (ArC), 128.8 
(ArC), 129.1 (ArC), 132.7 (ArC), 132.8 (ArC), 133.2 (ArC), 139.1 (C(4)ArC(1), 142.0 
(C(6)), 160.7 (CO CH ), 166.8 (C(2)); m/z (NSI
+
) 376 ([M+NH4]
+
, 100%); HRMS 
(NSI
+
) C23H22NO4
+
 ([M+NH4]
+
) requires 376.1543; found 376.1546 (+0.7 ppm). 
 
(3R,4R)-methyl 3-(naphthalen-1-yl)-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-
carboxylate 
 
Following general procedure C, 1-naphthyl acetic acid (37.2 mg, 0.20 mmol), ketoester 
143 (38.0 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in CH2Cl2 (1 mL), 
pivaloyl chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 
10 mol%) and i-Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 30 °C gave crude lactone 
(3R,4R)-166 (96:4 dr). Chromatographic purification (eluent EtOAc:petrol 15:85) gave 
lactone (3R,4R)-166 (97:3 dr) as a white solid (51.6 mg, 72%); mp 152-154 °C; 

 
D
20
-
129.6 (c 0.25, CH2Cl2); Chiral HPLC Chiralpak AD-H (30% IPA:hexane, flow rate 1 
mL min
-1
, 211 nm, 20 °C) tR(3R,4R): 14.1 min, tR(3S,4S): 15.5 min, 86% ee; max 
(KBr)/cm
-1
 3084, 2956 (C-H), 1770 (C=O lactone), 1739 (C=O ester), 1664, 1599; Data 
for major diastereoisomer: δ (400 MHz, CDCl ) 3.85 (3H, s, CH ), 4.15 (1H, dd, J 6.7, 
4.7, C(4)H), 4.61 (1H, d, J 6.7, C(3)H), 6.59 (1H, d, J 4.7, C(5)H), 7.00-7.02 (2H, m, 
ArH), 7.13 (1H, d, J 7.0, ArH), 7.17-7.22 (3H, m, ArH), 7.29 (1H, t, J 7.7, ArH), 7.41-
7.48 (2H, m, ArH), 7.71-7.82 (3H, m, ArH); δ (100 MHz, CDCl ) 45.2 (C(4)), 49.3 
(C(3)), 52.9 (CH ), 117.5 (C(5)), 123.0 (ArC), 125.3 (ArC), 125.9 (ArC), 125.9 (ArC), 
126.7 (ArC), 127.3 (ArC), 128.0 (ArC), 129.0 (ArC), 129.3 (ArC), 129.5 (ArC), 130.6 
(ArC), 131.9 (ArC), 134.2 (ArC), 139.6 (C(4)ArC(1)), 141.8 (C(6)), 160.8 (CO CH ), 
166.6 (C(2)); m/z (NSI
+
) 376 ([M+NH4]
+
, 100%); HRMS (NSI
+
) C23H22NO4
+
 
([M+NH4]
+
) requires 376.1543; found 376.1547 (+1.0 ppm). 
 
(3S,4R)-methyl 2-oxo-4-phenyl-3-(thiophen-2-yl)-3,4-dihydro-2H-pyran-6-
carboxylate 
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Following general procedure C, 2-(thiophen-2-yl)acetic acid (28.4 mg, 0.20 mmol), 
ketoester 143 (38.0 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in CH2Cl2 (1 
mL), pivaloyl chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 
mmol) and i-Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 30 °C gave crude lactone 
(3S,4R)-167 (80:20 dr). Chromatographic purification (eluent EtOAc:petrol 15:85) gave 
lactone (3S,4R)-167 (95:5 dr) as a white solid (55.4 mg, 88%); mp 118-120 °C; 

 
D
20
-
200.4 (c 0.25, CH2Cl2); Chiral HPLC Chiralpak AD-H (30% IPA:hexane, flow rate 1 
mL min
-1
, 211 nm, 20 °C) tR(3S,4R): 13.3 min, tR(3R,4S): 30.1 min, 91% ee; max 
(KBr)/cm
-1
 3110, 2953 (C-H), 2919, 1769 (C=O lactone), 1736 (C=O ester), 1656; Data 
for major diastereoisomer: δ (400 MHz, CDCl ) 3.91 (3H, s, CO CH ), 4.13 (1H, dd, J 
6.7, 4.7 C(4)H), 4.30 (1H, d, J 6.7, C(3)H), 6.73 (1H, d, J 4.7, C(5)H), 6.88 (1H, dt, J 
3.5, 0.9, C(3)Ar(3)H), 6.94 (1H, dd, J 5.1, 3.5, C(3)Ar(4)H), 7.14-7.17 (2H, m, ArH), 
7.27 (1H, dd, J 5.1, 1.2, C(3)Ar(5)H), 7.31-7.37 (3H, m, ArH); δ (100 MHz, CDCl ) 
45.9 (C(4)), 47.8 (C(3)), 52.9 (CO CH ), 116.9 (C(5)), 125.7 (C(3)ArC(5)), 127.0 (ArC), 
127.0 (ArC), 127.3 (ArC), 128.2 (ArC), 129.3 (ArC), 137.0 (C(3)ArC(2)), 138.6 
(C(4)ArC(1)), 142.2 (C(6)), 160.6 (CO CH ), 165.5 (C(2)); m/z (CI
+
) 332 ([M+NH4]
+
, 
100%); HRMS (CI
+
) C17H18NO4S
+
 ([M+NH4]
+
) requires 332.0951; found 332.0945 (-
1.8 ppm). 
 
(3R,4R)-methyl 3-(1-methyl-1H-indol-3-yl)-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-
6-carboxylate 
 
Following general procedure C, 2-(1-methyl-1H-indol-3-yl)acetic acid (37.8 mg, 0.20 
mmol), ketoester 143 (38.0 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in 
CH2Cl2 (1 mL), pivaloyl chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 
mg, 0.02 mmol) and i-Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 30 °C gave crude 
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lactone (3R,4R)-168 (91:9 dr). Chromatographic purification (eluent EtOAc:petrol 
25:75) gave lactone (3R,4R)-168 (98:2 dr) as a yellow solid (48.0 mg, 66%); mp 48-50 
°C; 

 
D
20
-286.0 (c 0.1, CH2Cl2); Chiral HPLC Chiralpak AD-H (40% IPA:hexane, flow 
rate 1 mL min
-1
, 211 nm, 20 °C) tR(3R,4R): 13.1 min, tR(3S,4S): 26.6 min, 97% ee; max 
(KBr)/cm
-1
 3060, 3028, 2953 (C-H), 1774 (C=O lactone), 1736 (C=O ester), 1663; Data 
for major diastereoisomer: δ (400 MHz, CDCl ) 3.75 (3H, s, NCH ), 3.92 (3H, s, 
CO CH ), 4.23 (1H, app t, J 5.1, C(4)H), 4.34 (1H, d, J 4.8, C(3)H), 6.73 (1H, dd, J 5.3, 
0.8, C(5)H), 6.90 (1H, s, C(3)Ar(2)H), 7.16-7.20 (3H, m, ArH), 7.27-7.38 (5H, m, ArH), 
7.64 (1H, dt, J 8.0, 0.9, C(3)Ar(4)H); δ (100 MHz, CDCl ) 32.9 (NCH ), 44.4 (C(3) or 
C(4)), 44.6 (C(3) or C(4)), 52.8 (CO CH ), 108.8 (C(3)ArC(3)), 109.7 (C(3)ArC(7)), 
116.8 (C(5)), 118.9 (ArC), 119.8 (ArC), 122.3 (ArC), 126.3 (C(3)ArC(3a)), 126.7 (ArC), 
127.2 (ArC), 128.0 (ArC), 129.3 (ArC), 137.0 (ArC), 139.5 (ArC), 142.1 (C(6)), 161.0 
(CO CH ), 166.3 (C(2)); m/z (NSI
+
) 362 ([M+H]
+
, 100%); HRMS (NSI
+
) C22H20NO4
+
 
([M+H]
+
) requires 362.1398; found 362.1391 (-1.9 ppm). 
 
(3R,4R)-ethyl 2-oxo-3,4-diphenyl-3,4-dihydro-2H-pyran-6-carboxylate 
 
Following general procedure C, phenylacetic acid (27.2 mg, 0.20 mmol), (E)-ethyl 2-
oxo-4-phenylbut-3-enoate  (40.8 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in 
CH2Cl2 (1 mL), pivaloyl chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 
mg, 0.02 mmol, 10 mol%) and i-Pr2NEt (87 L, 0.50 mmol) for 16 h at 30 °C gave 
crude lactone (3R,4R)-189 (85:15 dr). Chromatographic purification (eluent 
EtOAc:petrol 15:85) gave lactone (3R,4R)-189 (98:2 dr) as a white solid (47.7 mg, 
74%); mp 146-148 °C; 

 
D
20
-199.6 (c 0.25, CH2Cl2); Chiral HPLC Chiralpak AD-H 
(30% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(3R,4R): 20.0 min, tR(3S,4S): 
48.1 min, 98% ee; max (KBr)/cm
-1
 3084, 3067, 2988, 2941 (C-H), 1773 (C=O lactone), 
1732 (C=O ester), 1660, 1606; Data for major diastereoisomer: δ (400 MHz, CDCl ) 
1.29 (3H, t, J 7.1, CH CH ), 3.85 (1H, d, J 8.8, C(3)H), 3.98 (1H, dd, J 8.8, 3.9, C(4)H), 
4.24-4.32 (2H, m, CH CH ), 6.60 (1H, d, J 3.9, C(5)H), 6.95-6.98 (2H, m, ArH), 7.01-
7.04 (2H, m, ArH), 7.16-7.23 (6H, m, ArH); δ (100 MHz, CDCl ) 14.2 (CH CH ), 45.5 
(C(4)), 52.5 (C(3)), 62.1 (CH CH ), 117.6 (C(5)), 127.5 (ArC), 127.9 (ArC), 128.0 
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(ArC), 128.4 (ArC), 128.8 (ArC), 129.1 (ArC), 135.5 (C(3)ArC(1)), 139.2 (C(4)ArC(1)), 
142.3 (C(6)), 160.3 (CO CH ), 166.9 (C(2)); m/z (NSI
+
) 340 ([M+NH4]
+
, 100%); HRMS 
(NSI
+
) C20H22NO4
+
 ([M+NH4]
+
) requires 340.1543; found 340.1546 (+0.8 ppm). 
 
(3R,4R)-isopropyl 2-oxo-3,4-diphenyl-3,4-dihydro-2H-pyran-6-carboxylate 
 
Following general procedure C, phenylacetic acid (27.2 mg, 0.20 mmol), ketoester 546 
(43.6 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in CH2Cl2 (1 mL), pivaloyl 
chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 10 mol%) 
and i-Pr2NEt (87 L, 0.50 mmol) for 16 h at 30 °C gave crude lactone (3R,4R)-190 
(87:13 dr). Chromatographic purification (eluent EtOAc:petrol 10:90) gave lactone 
(3R,4R)-190 (97:3 dr) as a white solid (51.7 mg, 77%); mp 128-130 °C; 

 
D
20
-185.6 (c 
0.25, CH2Cl2); Chiral HPLC Chiralpak AD-H (40% IPA:hexane, flow rate 1 mL min
-1
, 
211 nm, 20 °C) tR(3R,4R): 16.6 min, tR(3S,4S): 46.6 min, 99% ee; max (KBr)/cm
-1 
3066, 
3030, 2992, 2937 (C-H), 1773 (C=O lactone), 1728 (C=O ester), 1660, 1607; Data for 
major diastereoisomer: δ (400 MHz, CDCl ) 1.37 (6H, dd, J 6.3, 1.2, CH(CH3)CH3 and 
CH(CH3)CH3), 3.94 (1H, d, J 9.1, C(3)H), 4.06 (1H, dd, J 9.1, 3.8, C(4)H), 5.23 (1H, 
sept, J 6.3, CH(CH3)2), 6.67 (1H, d, J 3.8, C(5)H), 7.05-7.08 (2H, m, ArH), 7.10-7.13 
(2H, m, ArH), 7.26-7.33 (6H, m, ArH); δ (100 MHz, CDCl ) 21.8 (CH(CH3)CH3), 21.8 
(CH(CH3)CH3), 45.5 (C(4)), 52.5 (C(3)), 70.0 (CH(CH3)2), 117.4 (C(5)), 127.6 (ArC), 
127.8 (ArC), 127.9 (ArC), 128.4 (ArC), 128.8 (ArC), 129.0 (ArC), 135.5 (C(3)ArC(1)), 
139.3 (C(4)ArC(1)), 142.5 (C(6)), 159.8 (CO CH ), 167.1 (C(2)); m/z (ES
+
) 359 
([M+Na]
+
, 100%); HRMS (ES
+
) C21H20NaO4
+
 ([M+Na]
+
) requires 359.1259; found 
359.1254 (-1.4 ppm). 
 
(3R,4R)-methyl 4-(2-methoxyphenyl)-2-oxo-3-phenyl-3,4-dihydro-2H-pyran-6-
carboxylate 
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Following general procedure C, phenylacetic acid (27.2 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH2Cl2 (1 mL), HBTM-
2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 10 mol%), keto ester 178 (44.0 mg, 0.20 mmol) 
and i-Pr2NEt (87 L, 0.50 mmol) for 16 h at 30 °C gave crude lactone (3R,4R)-191 
(89:11 dr). Chromatographic purification (eluent EtOAc:petrol 15:85) gave lactone 
(3R,4R)-191 (96:4 dr) as a white solid (58.9 mg, 87%); mp 78-80 °C; 

 
D
20
-188.8 (c 
0.25, CH2Cl2); Chiral HPLC Chiralpak AD-H (30% IPA:hexane, flow rate 1 mL min
-1
, 
211 nm, 20 °C) tR(3R,4R): 15.0 min, tR(3S,4S): 22.3 min, 99% ee; max (KBr)/cm
-1
 3095, 
3029, 2957 (C-H), 1778 (C=O lactone), 1740 (C=O ester), 1660, 1617, 1588; Data for 
major diastereoisomer: δ (400 MHz, CDCl ) 3.71 (3H, s, OCH ), 3.80 (3H, s, CO CH ), 
4.05 (1H, d, J 4.6, C(3)H), 4.19 (1H, t, J 4.9, C(4)H), 6.47 (1H, dd, J 5.3, 0.7, C(5)H), 
6.79-6.83 (2H, m, C(4)Ar(3)H and C(4)Ar(5)H), 6.97 (1H, dd, J 7.5, 1.7, C(4)Ar(6)H), 
7.15-7.26 (6H, m, ArH); δ (100 MHz, CDCl ) 41.5 (C(4)), 50.3 (C(3)), 52.9 (CO CH ), 
55.0 (OCH ), 111.0 (C(4)ArC(3)), 116.3 (C(5)), 121.0 (C(4)ArC(5)), 127.1 
(C(4)ArC(1)), 127.6 (ArC), 127.8 (ArC), 128.5 (ArC), 128.9 (ArC), 129.3 (ArC), 137.1 
(C(3)ArC(1)), 141.8 (C(6)), 156.9 (C(4)ArC(2)), 161.0 (CO CH ), 167.0 (C(2));m/z 
(NSI
+
) 356 ([M+NH4]
+
, 100%); HRMS (NSI
+
) C20H22O5N
+
 ([M+NH4]
+
) requires 
356.1492; found 356.1493 (+0.1 ppm). 
 
(3R,4R)-methyl 4-(3-bromophenyl)-2-oxo-3-phenyl-3,4-dihydro-2H-pyran-6-
carboxylate 
 
Following general procedure C, phenylacetic acid (27.2 mg, 0.20 mmol), ketoester 548 
(53.8 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in CH2Cl2 (1 mL), pivaloyl 
chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 10 mol%) 
and i-Pr2NEt (87 L, 0.50 mmol) for 16 h at 30 °C gave crude lactone (3R,4R)-192 
(97:3 dr). Chromatographic purification (eluent EtOAc:petrol 15:85) gave lactone 
(3R,4R)-192 (98:2 dr) as a white solid (49.7 mg, 64%); mp 110-112 °C; 

 
D
20
-176.8 (c 
0.25, CH2Cl2); Chiral HPLC Chiralcel OD-H (50% IPA:hexane, flow rate 1 mL min
-1
, 
211 nm, 20 °C) tR(3R,4R): 22.1 min, tR(3S,4S): 30.2 min, 97% ee; max (KBr)/cm
-1
 3086, 
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3061, 3028, 2960 (C-H), 1779 (C=O lactone), 1741 (C=O ester), 1660, 1570; Data for 
major diastereoisomer: δ (400 MHz, CDCl ) 3.80-3.83 (4H, m, C(3)H and CH ), 3.96 
(1H, dd, J 9.0, 3.8, C(4)H), 6.57 (1H, d, J 3.8, C(5)H), 6.85 (1H, d, J 7.7, C(4)Ar(6)H), 
7.00-7.07 (3H, m, C(4)Ar(5)H and ArH), 7.13 (1H, t, J 1.7, C(4)Ar(2)H), 7.19-7.25 (3H, 
m, ArH), 7.29-7.31 (1H, m, C(4)Ar(4)H); δ (100 MHz, CDCl ) 45.1 (C(4)), 52.3 (C(3) 
or CH ), 52.9 (C(3) or CH ), 116.9 (C(5)), 123.0 (C(4)ArC(3)), 126.3 (ArC), 128.2 
(ArC), 128.3 (ArC), 129.0 (ArC), 130.6 (ArC), 130.6 (ArC), 131.1 (ArC), 134.9 
(C(3)ArC(1)), 141.3 (C(4)ArC(1)), 142.4 (C(6)), 160.6 (CO CH ), 166.4 (C(2)); m/z 
(ES
+
) 409 ([M+Na]
+
, 100%); HRMS (ES
+
) C19H15
79
BrNaO4
+
 ([M+Na]
+
) requires 
409.0051; found 409.0040 (-2.8 ppm).
 
(3R,4R)-methyl 4-(4-bromophenyl)-2-oxo-3-phenyl-3,4-dihydro-2H-pyran-6-
carboxylate 
 
Following general procedure C, phenylacetic acid (27.2 mg, 0.20 mmol), ketoester 547 
(53.8 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in CH2Cl2 (1 mL), pivaloyl 
chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 10 mol%) 
and i-Pr2NEt (87 L, 0.50 mmol) for 16 h at 30 °C gave crude lactone (3R,4R)-193 
(94:6 dr). Chromatographic purification (eluent EtOAc:petrol 15:85) gave lactone 
(3R,4R)-193 (98:2 dr) as a white solid (55.1 mg, 71%); mp 68-70 °C; 

 
D
20
-189.2 (c 
0.25, CH2Cl2); Chiral HPLC Chiralcel OD-H (50% IPA:hexane, flow rate 1 mL min
-1
, 
211 nm, 20 °C) tR(3R,4R): 21.2 min, tR(3S,4S): 26.4 min, 98% ee; max (KBr)/cm
-1
 3088, 
3031, 2955 (C-H), 1782 (C=O lactone), 1745 (C=O ester), 1660; Data for major 
diastereoisomer: δ (300 MHz, CDCl ) 3.89 (1H, d, J 9.4, C(3)H), 3.93 (3H, s, CH ), 4.07 
(1H, dd, J 9.4, 3.7, C(4)H), 6.67 (1H, d, J 3.7, C(5)H), 6.92-6.95 (2H, m, C(4)Ar(2,6)H), 
7.09-7.12 (2H, m, ArH), 7.30-7.34 (3H, m, ArH) 7.40-7.43 (2H, m, C(4)Ar(3,5)H); δ
(75 MHz, CDCl ) 45.3 (C(4)), 52.8 (C(3) or CH ), 53.3 (C(3) or CH ), 117.7 (C(5)), 
122.3 (C(4)ArC(4)), 128.5 (C(3)ArC(4)), 128.8 (ArC), 129.3 (ArC), 129.7 (ArC), 132.6 
(C(4)ArC(3,5)), 135.5 (C(3)ArC(1)), 138.6 (C(4)ArC(1)), 142.7 (C(6)), 161.0 (CO CH ), 
166.9 (C(2)); m/z (ES
+
) 409 ([M+Na]
+
, 100%); HRMS (ES
+
) C19H15
79
BrNaO4
+
 
([M+Na]
+
) requires 409.0051; found 409.0059 (+1.8 ppm). 
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(3R,4R)-methyl 4-(4-methoxyphenyl)-2-oxo-3-phenyl-3,4-dihydro-2H-pyran-6-
carboxylate 
 
Following general procedure C, phenylacetic acid (27.2 mg, 0.20 mmol), ketoester 549 
(44.0 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in CH2Cl2 (1 mL), pivaloyl 
chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 10 mol%) 
and i-Pr2NEt (87 L, 0.50 mmol) for 40 h at 30 °C gave crude lactone (3R,4R)-194 
(92:8 dr). Chromatographic purification (eluent EtOAc:petrol 15:85) gave lactone 
(3R,4R)-194 (92:8 dr) as a white solid (50.0 mg, 74%); mp 98-100 °C; 

 
D
20
-191.6 (c 
0.25, CH2Cl2); Chiral HPLC Chiralcel OD-H (50% IPA:hexane, flow rate 1 mL min
-1
, 
211 nm, 20 °C) tR(3R,4R): 22.7 min, tR(3S,4S): 29.0 min, 99% ee; max (KBr)/cm
-1
 3095, 
3031, 2954 (C-H), 1778 (C=O lactone), 1736 (C=O ester), 1660, 1614, 1586, 1513; Data 
for major diastereoisomer: δ (400 MHz, CDCl ) 3.69 (3H, s, OCH ), 3.81-3.83 (4H, m, 
C(3)H and CO CH ), 3.94 (1H, dd, J 8.6, 4.0, C(4)H), 6.60 (1H, d, J 4.0, C(5)H), 
6.70-6.73 (2H, m, C(4)Ar(3,5)H), 6.86-6.90 (2H, m, C(4)Ar(2,6)H), 7.02-7.04 (2H, m, 
ArH) 7.19-7.24 (3H, m, ArH); δ (100 MHz, CDCl ) 44.7 (C(4)), 52.7 (C(3) or CO CH ), 
52.8 (C(3) or CO CH ), 55.3 (OCH ), 114.4 (C(4)ArC(3,5)), 118.2 (C(5)), 127.9 
(C(3)ArC(4)), 128.3 (ArC), 128.6 (ArC), 128.8 (ArC), 131.1 (C(4)ArC(1)), 135.5 
(C(3)ArC(1)), 141.8 (C(6)), 159.1 (C(4)ArC(4)), 160.8 (CO CH ), 166.9 (C(2)); m/z 
(ES
+
) 361 ([M+Na]
+
, 100%); HRMS (ES
+
) C20H18NaO5
+
 ([M+Na]
+
) requires 361.1052; 
found 361.1045 (-1.9 ppm). 
 
(3R,4R)-ethyl 4-(4-nitrophenyl)-2-oxo-3-phenyl-3,4-dihydro-2H-pyran-6-
carboxylate 
 
Following general procedure C, phenylacetic acid (27.2 mg, 0.20 mmol), (E)-methyl 4-
(4-nitrophenyl)-2-oxobut-3-enoate  (49.8 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 
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mmol) in CH2Cl2 (1 mL), pivaloyl chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-
112 (6.17 mg, 0.02 mmol, 10 mol%) and i-Pr2NEt (87 L, 0.50 mmol) for 16 h at 78 
°C gave crude lactone (3R,4R)-195 (91:9 dr). Chromatographic purification (eluent 
EtOAc:petrol 20:80) gave lactone (3R,4R)-195 (91:9 dr) as a light yellow solid (46.4 mg, 
63%); mp 116-118 °C; 

 
D
20
-143.5 (c 0.2, CH2Cl2); Chiral HPLC Chiralcel OD-H (50% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(3R,4R): 34.2 min, tR(3S,4S): 41.7 
min, 90% ee; max (KBr)/cm
-1
 3083, 3032, 2997 (C-H), 1775 (C=O lactone), 1727 (C=O 
ester), 1668, 1597, 1518 (N=O), 1353 (N=O); Data for major diastereoisomer: δ (400 
MHz, CDCl ) 1.31 (3H, t, J 7.1, CH CH ), 3.79 (1H, d, J 10.4, C(3)H), 4.12 (1H, dd, J 
10.4, 3.4, C(4)H), 4.27-4.33 (2H, m, CH CH ), 6.56 (1H, d, J 3.4, C(5)H), 6.96-6.99 
(2H, m, ArH), 7.11-7.13 (2H, m, C(4)Ar(2,6)H), 7.19-7.24 (3H, m, ArH), 8.03-8.05 (2H, 
m, C(4)Ar(3,5)H); δ (100 MHz, CDCl ) 14.2 (CH CH ), 45.3 (C(4)), 52.2 (C(3)), 62.4 
(CH CH ), 115.9 (C(5)), 124.2 (C(4)ArC(3,5)), 128.4 (C(3)ArC(4)), 128.5 (ArC), 128.7 
(ArC), 129.1 (ArC), 134.4 (C(3)ArC(1)), 143.1 (C(6)), 146.5 (ArC), 147.5 (ArC), 159.9 
(CO CH CH ), 166.2 (C(2)); m/z (ES
+
) 390 ([M+Na]
+
, 100%); HRMS (ES
+
) 
C20H17NNaO6
+
 ([M+Na]
+
) requires 390.0954; found 390.0942 (-2.9 ppm). 
 
(3R,4R)-methyl 4-(furan-2-yl)-2-oxo-3-phenyl-3,4-dihydro-2H-pyran-6-carboxylate 
 
Following general procedure C, phenylacetic acid (27.2 mg, 0.20 mmol), ketoester 174 
(36.0 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in CH2Cl2 (1 mL), pivaloyl 
chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 10 mol%) 
and i-Pr2NEt (87 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone (3R,4R)-196 
(98:2 dr). Chromatographic purification (eluent EtOAc:petrol 15:85) gave lactone 
(3R,4R)-196 (99:1 dr) as a white solid (43.0 mg, 72%); mp 80-82 °C; 

 
D
20
-190.0 (c 0.2, 
CH2Cl2); Chiral HPLC Chiralcel OJ-H (20% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 
20 °C) tR(3S,4S): 49.5 min, tR(3R,4R): 56.2 min, 98% ee; max (KBr)/cm
-1
 3092, 2954 
(C-H), 1770 (C=O lactone), 1732 (C=O ester), 1662, 1508; Data for major 
diastereoisomer: δ (400 MHz, CDCl ) 3.90 (3H, s, CH ), 4.18-4.23 (2H, m, C(3)H and 
C(4)H), 6.05 (1H, d, J 3.3, C(5)H), 6.28 (1H, dd, J 3.3, 1.9, C(4)Ar(3)H), 6.66 (1H, dd, J 
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3.8, 1.4, C(4)Ar(4)H), 7.21-7.23 (2H, m, C(3)Ar(2,6)H), 7.32-7.38 (4H, m, 
C(3)Ar(3,5)H, C(3)Ar(4)H and C(4)Ar(5)H); δ (100 MHz, CDCl ) 38.7 (C(4)), 49.2 
(C(3), 52.8 (CO CH ), 107.4 (C(5)), 110.5 (C(4)ArC(3)), 114.7 (C(4)ArC(4)), 127.9 
(ArC), 128.2 (C(3)ArC(4)), 129.0 (ArC), 135.0 (C(3)ArC(1)), 142.3 (C(6)), 142.8 
(C(4)ArC(5)), 150.7 (C(4)ArC(2)), 160.6 (CO CH ), 166.4 (C(2)); m/z (ES
+
) 321 
([M+Na]
+
, 95%); HRMS (ES
+
) C17H14NaO5
+
 ([M+Na]
+
) requires 321.0739; found 
321.0741 (+0.6 ppm). 
 
(3R,4R)-methyl 2-oxo-3-phenyl-4-(pyridin-3-yl)-3,4-dihydro-2H-pyran-6-
carboxylate 
 
Following general procedure C, phenylacetic acid (27.2 mg, 0.20 mmol), ketoester 551 
(38.2 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in CH2Cl2 (1 mL), pivaloyl 
chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 10 mol%) 
and i-Pr2NEt (87 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone (3R,4R)-197 
(94:6 dr). Chromatographic purification (eluent EtOAc:petrol 65:35) gave lactone 
(3R,4R)-197 (93:7 dr) as a white solid (53.8 mg, 87%); mp 104-106 °C; 

 
D
20
-119.5 (c 
0.2, CH2Cl2); Chiral HPLC Chiralpak AD-H (20% IPA:hexane, flow rate 1 mL min
-1
, 
211 nm, 20 °C) tR(3R,4R): 39.2 min, tR(3S,4S): 53.1 min, 97% ee; max (KBr)/cm
-1
 3086, 
2992, 2955 (C-H), 1775 (C=O lactone), 1731 (C=O ester), 1662; Data for major 
diastereoisomer: δ (400 MHz, CDCl ) 3.80 (1H, d, J 9.9, C(3)H), 3.83 (3H, s, CH ), 4.04 
(1H, dd, J 9.9, 3.6, C(4)H), 6.59 (1H, d, J 3.6, C(5)H), 6.99-7.01 (2H, m, C(3)Ar(2,6)H), 
7.12-7.15 (1H, m, C(4)Ar(5)H), 7.19-7.25 (3H, m, C(3)Ar(3,5)H and C(3)Ar(4)H), 7.29 
(1H, dt, J 7.9, 2.1, C(4)Ar(4)H), 8.22 (1H, d, J 2.1, C(4)Ar(2)H), 8.42 (1H, dd, J 4.8, 
1.5, C(4)Ar(6)H); δ (100 MHz, CDCl ) 43.1 (C(4)), 52.3 (C(3) or CO CH ), 52.9 (C(3) 
or CO CH ), 116.7 (C(5)), 123.8 (C(4)ArC(5)), 128.3 (C(3)ArC(4)), 128.5 (ArC), 129.0 
(ArC), 134.5 (C(3)ArC(1)), 134.9 (C(4)ArC(3)), 134.9 (C(4)ArC(4)), 142.8 (C(6)), 149.2 
(C(4)ArC(2)), 149.4 (C(4)ArC(6)), 160.5 (CO CH ), 166.3 (C(2)); m/z (ES
+
) 310 
([M+H]
+
, 32%); HRMS (ES
+
) C18H16NO4
+
 ([M+H]
+
) requires 310.1079; found 310.1087 
(+2.4 ppm). 
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(3R,4R)-methyl 4-(naphthalen-2-yl)-2-oxo-3-phenyl-3,4-dihydro-2H-pyran-6-
carboxylate 
 
Following general procedure C, phenylacetic acid (27.2 mg, 0.20 mmol), ketoester 550 
(48.0 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in CH2Cl2 (1 mL), pivaloyl 
chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 10 mol%) 
and i-Pr2NEt (87 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone (3R,4R)-198 
(95:5 dr). Chromatographic purification (eluent EtOAc:petrol 15:85) gave lactone 
(3R,4R)-198 (99:1 dr) as a white solid (59.0 mg, 82%); mp 146-148 °C; 

 
D
20
-259.5 (c 
0.2, CH2Cl2); Chiral HPLC Chiralcel OD-H (50% IPA:hexane, flow rate 1 mL min
-1
, 
211 nm, 20 °C) tR(3R,4R): 25.0 min, tR(3S,4S): 29.2 min, 99% ee; max (KBr)/cm
-1
 3054, 
3025, 2955 (C-H), 1788 (C=O lactone), 1736 (C=O ester), 1663, 1600; Data for major 
diastereoisomer: δ (300 MHz, CDCl ) 3.95 (3H, s, CH ), 4.10 (1H, d, J 8.6, C(3)H), 4.27 
(1H, dd, J 8.6, 4.0, C(4)H), 6.80 (1H, d, J 4.0, C(5)H), 7.16-7.21 (3H, m, ArH), 7.27-
7.34 (3H, m, ArH), 7.50-7.54 (3H, m, ArH), 7.76-7.85 (3H, m, ArH); δ (75 MHz, 
CDCl ) 45.5 (C(4)), 52.4 (C(3) or CO CH ), 52.9 (C(3) or CO CH ), 117.7 (C(5)), 125.2 
(ArC), 126.3 (ArC), 126.5 (ArC), 126.6 (ArC), 127.7 (ArC), 127.8 (ArC), 128.0 (ArC), 
128.3 (ArC), 128.9 (ArC), 129.1 (ArC), 132.8 (ArC), 133.4 (ArC), 135.4 (ArC), 136.4 
(ArC), 142.1 (C(6)), 160.8 (CO CH ), 166.8 (C(2)); m/z (ES
+
) 381 ([M+Na]
+
, 100%); 
HRMS (ES
+
) C23H18NaO4
+
 ([M+Na]
+
) requires 381.1103; found 381.1089 (-3.7 ppm). 
  
(3R,4R)-methyl 4-methyl-2-oxo-3-phenyl-3,4-dihydro-2H-pyran-6-carboxylate 
 
Following general procedure C, phenylacetic acid (27.2 mg, 0.20 mmol), (E)-methyl 2-
oxopent-3-enoate  (25.6 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in CH2Cl2 
(1 mL), pivaloyl chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 
mmol, 10 mol%) and i-Pr2NEt (87 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone 
(3R,4R)-199 (88:12 dr). Chromatographic purification (eluent EtOAc:petrol 15:85) gave 
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lactone (3R,4R)-199 (93:7 dr) as a white solid (39.6 mg, 80%); mp 94-96 °C; 

 
D
20
-46.7 
(c 0.15, CH2Cl2); Chiral HPLC Chiralpak AD-H (20% IPA:hexane, flow rate 1 mL 
min
-1
, 211 nm, 20 °C) tR(3R,4R): 12.7 min, tR(3S,4S): 17.4 min, 96% ee; max (KBr)/cm
-1 
3089, 2976 (C-H), 2952, 1768 (C=O lactone), 1729 (C=O ester), 1661, 1499; Data for 
major diastereoisomer: δ (400 MHz, CDCl ) 1.04 (3H, d, J 7.1, C(4)HCH ), 2.86-2.95 
(1H, m, C(4)H), 3.39 (1H, d, J 10.4, C(3)H), 3.79 (3H, s, CO CH ), 6.44 (1H, d, J 3.3, 
C(5)H), 7.11-7.13 (2H, m, Ar(2,6)H), 7.23-7.32 (3H, m, Ar(3,5)H and Ar(4)H)); δ (100 
MHz, CDCl ) 19.0 (C(4)CH ), 33.3 (C(4)), 52.0 (C(3) or CO CH ), 52.7 (C(3) or 
CO CH ), 120.7 (C(5)), 128.0 (ArC(4)), 128.5 (ArC), 129.0 (ArC), 135.4 (ArC(1)), 141.1 
(C(6)), 160.8 (CO CH ), 167.8 (C(2)); m/z (ES
+
) 269 ([M+Na]
+
, 100%); HRMS (ES
+
) 
C14H14NaO4
+
 ([M+Na]
+
) requires 269.0790; found 269.0789 (-0.5 ppm). 
 
(3R,4R)-methyl 2-oxo-4-pentyl-3-phenyl-3,4-dihydro-2H-pyran-6-carboxylate 
 
Following general procedure C, phenylacetic acid (27.2 mg, 0.20 mmol), (E)-methyl 2-
oxonon-3-enoate  (36.8 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in CH2Cl2 
(1 mL), pivaloyl chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 
mmol, 10 mol%) and i-Pr2NEt (87 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone 
(3R,4R)-200 (80:20 dr). Chromatographic purification (eluent EtOAc:petrol 10:90) gave 
lactone (3R,4R)-200 (90:10 dr) as a white solid (46.1 mg, 76%); mp 48-50 °C; 

 
D
20
-
87.0 (c 0.1, CH2Cl2); Chiral HPLC Chiralpak AD-H (20% IPA:hexane, flow rate 1 mL 
min
-1
, 211 nm, 20 °C) tR(3R,4R): 9.7 min, tR(3S,4S): 13.2 min, 95% ee; max (KBr)/cm
-1
 
2929, 2860 (C-H), 1777 (C=O lactone), 1741 (C=O ester), 1661; Data for major 
diastereoisomer: δ (400 MHz, CDCl ) 0.79 (3H, t, J 7.0, (CH ) CH ), 1.12-1.41 (8H, m, 
4CH ), 2.76-2.83 (1H, m, C(4)H), 3.58 (1H, d, J 8.6, C(3)H), 3.79 (3H, s, CO CH ), 6.51 
(1H, d, J 4.1, C(5)H), 7.11-7.13 (2H, m, Ar(2,6)H), 7.23-7.32 (3H, m, Ar(3,5)H and 
Ar(4)H); δ (100 MHz, CDCl ) 14.0 ((CH ) CH ), 22.5 (CH ), 25.8 (CH ), 31.5 (CH ), 
32.7 (CH ), 38.2 (C(4)), 49.9 (C(3)), 52.7 (CO CH ), 118.8 (C(5)), 128.0 (ArC(4)), 128.2 
(ArC), 129.0 (ArC), 135.6 (ArC(1)), 141.4 (C(6)), 160.8 (CO CH ), 167.8 (C(2)); m/z 
(ES
+
) 325 ([M+Na]
+
, 100%); HRMS (ES
+
) C18H22NaO4
+
 ([M+Na]
+
) requires 325.1416; 
found 325.1419 (+0.9 ppm). 
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Isomerisation studies 
The Michael addition-lactonisation to form lactone (±)-167 was carried out for 30 
minutes at 78 °C with DHPB 108 as catalyst. At higher reaction temperatures, such as 
rt, lactone (±)-167 showed a marked propensity to isomerise to lactone (±)-169. Carrying 
out the reaction at 78 °C, followed by addition of HCl (1 M in H2O) to quench the 
reaction at 78 °C prevents the formation of lactone (±)-169. 
 
A simple NMR experiment showed that addition of DHPB to (±)-167 in CDCl3 rapidly 
promoted complete isomerisation to (±)-169. 
 
Characterisation data for compound (±)-169: 
Lactone (±)-169 was obtained as a light yellow oil; max (thin film)/cm
-1
 3064, 2955 (C-
H), 2921, 2852, 1752 (C=O lactone), 1725 (C=O ester), 1625, 1587; δ (400 MHz, 
CDCl ) 3.18 (2H, d, J 5.3, C(5)H), 3.78 (3H, s, CO CH ), 5.11 (1H, t, J 5.3, C(6)H), 
6.73-6.75 (2H, m, C(3)Ar(3)H), 7.08-7.10 (2H, m, ArH), 7.15-7.17 (1H, m, ArH), 7.21-
7.24 (3H, m, ArH); δ (100 MHz, CDCl ) 33.9 (C(5)), 53.2 (CO CH ), 73.6 (C(6)), 122.6 
(C(3)), 126.3 (ArC), 127.3 (ArC), 128.2 (ArC), 128.7 (ArC), 129.2 (ArC), 130.1 (ArC), 
134.2 (C(3)ArC(2)), 137.9 (C(4)ArC(1)), 149.8 (C(4)), 162.9 (C(2)), 169.7 (CO CH ); 
m/z (ES
+
) 337 ([M+Na]
+
, 100%); HRMS (ES
+
) C17H14NaO4S
+
 ([M+Na]
+
) requires 
337.0511; found 337.0513 (+0.8 ppm). 
 
(2R,3R)-dimethyl 5-oxo-2,3-diphenylhexanedioate 
 
Following general procedure C, phenylacetic acid (27.2 mg, 0.20 mmol), ketoester 143 
(38.0 mg, 0.20 mmol) and i-Pr2NEt (51.9 L, 0.30 mmol) in CH2Cl2 (1 mL), pivaloyl 
chloride (37.0 L, 0.30 mmol), HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 10 mol%) 
and i-Pr2NEt (87 L, 0.50 mmol) for 16 h at 30 °C followed by addition of MeOH (2 
mL) and stirring at rt for 1 h gave crude diester (2R,3R)-201 (95:5 dr). Chromatographic 
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purification (eluent EtOAc:petrol 15:85) gave diester (2R,3R)-201 (97:3 dr) as a 
colourless oil (62.3 mg, 92%); 

 
D
20
-108.8 (c 0.25, CH2Cl2); Chiral HPLC Chiralcel 
OD-H (5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(3R,4R): 19.3 min, 
tR(3S,4S): 23.4 min, 96% ee; max (thin film)/cm
-1
 3064, 3031, 2954 (C-H), 2849, 1732 
(C=O), 1603; Data for major diastereoisomer: δ (300 MHz, CDCl ) 3.14 (1H, dd, J 17.4, 
4.3, C(4)H), 3.44 (1H, dd, J 17.4, 9.3, C(4)H), 3.60 (3H, s, CO CH ), 3.70 (3H, s, 
C(O)CO CH ), 3.79 (1H, d, J 10.9, C(2)H), 3.84-3.96 (1H, m, C(3)H), 6.92-7.06 (10H, 
m, ArH); δ (75 MHz, CDCl ) 44.0 (C(4)), 44.2 (C(3)), 52.3 (CH ), 53.0 (CH ), 57.3 
(C(2), 126.8 (ArC), 127.4 (ArC), 128.2 (ArC), 128.3 (ArC), 128.4 (ArC), 128.5 (ArC), 
136.4 (C(2)ArC(1)), 140.1 (C(3)ArC(1)), 161.0 (C(O)CO CH ), 173.4 (C(1)), 191.7 
(C(5)); m/z (ES
+
) 363 ([M+Na]
+
, 90%); HRMS (ES
+
) C20H20NaO5
+
 ([M+Na]
+
) requires 
363.1208; found 363.1210 (+0.4 ppm). 
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9.3 Experimental for Chapter 3 
9.3.1 Experimental Procedures and Characterisation Data  
General procedure D: Intermolecular Michael addition-lactonisation. 
To a solution of acid (1 eq) in CH2Cl2 (~1 mL per 0.2 mmol of acid) were added i-
Pr2NEt (1.5 eq based on acid) and pivaloyl chloride (1.5 eq based on acid) at rt. The 
reaction mixture was allowed to stir at rt for 10 minutes. The requisite Lewis base (1-20 
mol%), Michael acceptor (1 eq) and i-Pr2NEt (2.5 eq) were then added at the required 
temperature in that order. The reaction mixture was stirred at the required temperature 
until complete by TLC and was subsequently quenched by addition of HCl (1 M in 
H2O). The reaction mixture was poured into H2O and extracted with CH2Cl2 (x 3). The 
combined organics were dried (MgSO4), filtered and concentrated in vacuo to give the 
crude reaction mixture. Note: All racemic samples were obtained via this general 
procedure using DHPB 108 as catalyst. 
 
(3R,4R)-N-benzyl-2-oxo-3,4-diphenyl-3,4-dihydro-2H-pyran-6-carboxamide
 
 
Following general procedure D, phenylacetic acid (27.2 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH2Cl2 (1 mL), HBTM-
2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 10 mol%), (E)-N-benzyl-2-oxo-4-phenylbut-3-
enamide
171
 (53.0 mg, 0.20 mmol) and i-Pr2NEt (87 L, 0.50 mmol) for 16 h at 30 °C 
gave crude lactone (3R,4R)-209 (68:32 dr). Chromatographic purification (eluent 
EtOAc:petrol 25:75) gave lactone (3R,4R)-209 (97:3 dr) as a white solid (47.1 mg, 
61%); mp 50-52 °C; 

 
D
20
-158.0 (c 0.15, CH2Cl2); Chiral HPLC Chiralpak AD-H (30% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(3S,4S): 10.5 min, tR(3R,4R): 13.3 
min, 95% ee; max (KBr)/cm
-1
 3063, 3031, 2959, 2932 (C-H), 1774 (C=O lactone), 1731 
(C=O amide), 1660, 1527; Data for major diastereoisomer: δ (300 MHz, CDCl ) 3.82 
(1H, d, J 9.3, C(3)H), 3.99 (1H, dd, J 9.3, 3.7, C(4)H), 4.49 (2H, qd, J 13.3, 5.9, CH2Ph), 
 Chapter 9: Experimental 
 
 198 
6.65 (1H, d, J 3.7, C(5)H), 6.91-6.95 (2H, m, ArH), 6.97-7.02 (2H, m, ArH), 7.13-7.32 
(11H, m, ArH); δ (125 MHz, CDCl ) 43.7 (CH2Ph), 45.1 (C(4)), 52.8 (C(3)), 114.0 
(C(5)), 127.6 (ArC), 127.8 (ArC), 127.9 (ArC), 128.1 (ArC), 128.2 (ArC), 128.4 (ArC), 
128.8 (ArC) 128.9 (ArC), 129.0 (ArC), 135.4 (ArC), 137.2 (ArC), 139.4 (ArC), 144.0 
(C(6)), 159.1 (CONH), 167.2 (C(2)); m/z (NSI
+
) 384 ([M+H]
+
, 78%); HRMS (NSI
+
) 
C25H22NO3
+
 ([M+H]
+
) requires 384.1594; found 384.1597 (+0.7 ppm). 
 
(E)-4,4-dimethoxy-1-phenylpent-1-en-3-one 
 
To a solution of benzaldehyde (1.02 mL, 10.0 mmol) and 3,3-dimethoxybutan-2-one 
(1.22 mL, 9.1 mmol) in MeOH (10 mL) was added a solution of NaOH (1.6 g, 40 mmol) 
in H2O (8 mL). The reaction mixture was stirred at rt for 16 h. The MeOH was removed 
under reduced pressure and the reaction mixture was extracted with Et2O (x 3). The 
combined organics were dried (MgSO4), filtered and concentrated in vacuo. The product 
was purified by heating at 100 °C under reduced pressure to remove volatile impurities 
giving 212 as a yellow oil (1.59 g, 80 %); H (400 MHz, CDCl3) 1.40 (3H, s, CH3), 3.24 
(6H, s, 2 OCH3), 7.20 (1H, d, J 16.0, C(2)H), 7.32-7.35 (3H, m, Ar(3,5)H and Ar(4)H), 
7.54-7.57 (2H, m, Ar(2,6)H), 7.73 (1H, d, J 16.0, C(1)H). Spectroscopic data are in 
accordance with the literature.
77
 
 
(E)-5-phenylpent-4-ene-2,3-dione 
 
To a solution of p-toluene sulfonic acid mono hydrate (173 mg, 0.91 mmol) in acetone 
(50 mL) was added 212 (1.00 g, 4.55 mmol) and the reaction was allowed to stir at rt for 
16 h. The acetone was removed under reduced pressure and the residue was dissolved in 
Et2O. The organic fraction was washed several times with H2O, dried (MgSO4), filtered 
and concentrated in vacuo. Chromatographic purification (eluent EtOAc:petrol 5:95) 
gave keto enone 210 as a yellow solid (0.42 g, 53%); mp 50-52 °C; {lit.
176
 mp 48-50 
°C}; H (400 MHz, CDCl3) 2.48 (3H, s, CH3), 7.43-7.49 (4H, m, Ar(3,5)H, Ar(4)H and 
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C(4)H), 7.66-7.68 (2H, m, Ar(2,6)H), 7.87 (1H, d, J 16.2, C(5)H). Spectroscopic data 
are in accordance with the literature.
77
 
 
4-cinnamoylbenzonitrile 
 
To a solution of NaOH (3.00 g, 75.0 mmol) in ethanol (40 mL), at 0 °C was added 4-
acetylbenzonitrile (1.45 g, 10.0 mmol). The solution was warmed to rt and benzaldehyde 
(1.02 mL, 10.0 mmol) was added. The reaction mixture was allowed to stir for 16 h at 0 
°C. The solid was then filtered, washed with H2O, dried and recrystallised from ethanol 
to give enone 214 as a yellow solid (0.95 g, 41 %); mp 122-124 °C (EtOH); {lit.
176
 mp 
110-112 °C (EtOH)}; H (500 MHz, CDCl3) 7.45-7.50 (4H, m, ArH and C(2)H), 7.66-
7.68 (2H, m, ArH), 7.82-7.87 (3H, m, ArH and C(3)H), 8.10 (2H, d, J 8.4, ArH). 
Spectroscopic data are in accordance with the literature.
176
 
 
(E)-1-(4-nitrophenyl)-3-phenylprop-2-en-1-one 
 
To a solution of NaOH (3.00 g, 75.0 mmol) in ethanol (40 mL), at 0 °C was added 1-(4-
nitrophenyl)ethanone (1.65 g, 10.0 mmol). The solution was warmed to rt and 
benzaldehyde (1.02 mL, 10.0 mmol) was added. The reaction mixture was allowed to 
stir for 16 h at 0 °C. The solid was then filtered, washed with H2O, dried and 
recrystallised from ethanol to give enone 215 as an orange solid (1.49 g, 59 %); mp 148-
150 °C (EtOH); {lit.
177
 mp 151-152 °C (EtOH)}; H (400 MHz, CDCl3) 7.38-7.44 (4H, 
m, C(3)Ar(3,5)H, C(3)Ar(4)H and C(2)H), 7.59-7.61 (2H, m, C(3)Ar(2,6)H), 7.89 (1H, 
d, J 15.7, C(3)H), 8.07-8.10 (2H, m, C(1)Ar(2,6)H), 8.28-8.31 (2H, m, C(1)Ar(3,5)H). 
Spectroscopic data are in accordance with the literature.
177
 
  
cinnamoyl cyanide 
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To a solution of cinnamoyl chloride (1.00 g, 6.00 mmol) and n-Bu4NBr (194 mg, 0.60 
mmol) in CH2Cl2 (30 mL) was added a solution of NaCN (293 mg, 6.00 mmol) in H2O 
(2 mL) at 0 °C. The reaction mixture was stirred for 1 h after which time the solids were 
filtered off and washed with CH2Cl2. The organic layer was separated, dried (MgSO4), 
filtered and concentrated in vacuo. Chromatographic purification (eluent Et O:petrol 
4:96) gave enone 219 as a light yellow solid (0.33 g, 35%); mp 110-112 °C; {lit.
178
 mp 
115 °C}; H (500 MHz, CDCl3) 6.80 (1H, dd, J 16.2, 0.8, C(2)H), 7.41-7.44 (2H, m, 
Ar(3,5)H), 7.47-7.50 (1H, m, Ar(4)H), 7.58 (2H, d, J 7.8, Ar(2,6)H), 7.95 (1H, d, J 16.2, 
C(3)H). Spectroscopic data are in accordance with the literature.
178
 
 
(3R,4R)-2-oxo-3,4-diphenyl-3,4-dihydro-2H-pyran-6-carbonitrile 
 
Following general procedure D, phenylacetic acid (27.2 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH2Cl2 (1 mL), HBTM-
2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 10 mol%), enone 219 (31.4 mg, 0.20 mmol) and 
i-Pr2NEt (87 L, 0.50 mmol) for 15 minutes at rt gave crude lactone (3R,4R)-223 (79:21 
dr). Chromatographic purification (eluent EtOAc:petrol 10:90) gave lactone (3R,4R)-223 
(>98:2 dr) as a white solid (36.9 mg, 67%); mp 90-92 °C; 

 
D
20
-204.4 (c 0.25, CH2Cl2); 
Chiral HPLC Chiralpak AD-H (20% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) 
tR(3R,4R): 15.2 min, tR(3S,4S): 17.0 min, 96% ee; max (KBr)/cm
-1 
3079, 3030, 2962 (C-
H), 2238 (CN), 1781 (C=O), 1666; Data for major diastereoisomer: δ (400 MHz, 
CDCl ) 3.90 (1H, d, J 8.9, C(3)H), 4.00 (1H, dd, J 3.9, 8.9, C(4)H), 6.29 (1H, d, J 3.9, 
C(5)H), 6.93-6.95 (2H, m, ArH), 6.99-7.02 (2H, m, ArH), 7.19-7.25 (6H, m, ArH); δ
(100 MHz, CDCl ) 45.9 (C(4)), 52.5 (C(3)), 112.0 (CN), 123.5 (C(5), 127.3 (C(6)), 
127.4 (ArC), 127.4 (ArC), 128.2 (ArC), 128.4 (ArC), 129.0 (ArC), 129.3 (ArC), 134.5 
(C(3)ArC(1)), 138.0 (C(4)ArC(1)), 165.0 (C(2));m/z (APCI+) 293 ([M+NH4]
+
, 100%); 
HRMS (APCI
+
) C18H17O2N2
+
 ([M+NH4]
+
) requires 293.1285; found 293.1292 (+2.5 
ppm). 
 
(E)-1,1,1-trifluoro-4-phenylbut-3-en-2-one 
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To a solution of benzaldehyde (0.51 mL, 5.00 mmol), glacial acetic acid (0.5 mL, 8.73 
mmol) and piperidine (0.50 mL, 5.06 mmol) in THF (40 mL) at rt was added 
trifluoroacetone (0.45 mL, 5.00 mmol). A further three portions of trifluoroacetone (0.45 
mL, 5.00 mmol) were added every 30 minutes. After stirring for 2 h the reaction was 
quenched with sat. aq. NH4Cl and extracted with Et2O (x 3). The combined organic 
fractions were combined, dried (MgSO4), filtered and concentrated in vacuo. 
Chromatographic purification (eluent CH2Cl2:petrol 10:90) gave enone 220 as a 
colourless oil (0.21 g, 21 %); H (500 MHz, CDCl3) 6.96 (1H, d, J 16.0, C(3)H), 7.37-
7.45 (3H, m, Ar(3,5)H and Ar(4)H), 7.57-7.59 (2H, m, Ar(2,6)H), 7.91 (1H, d, J 16.0, 
C(4)H); F (470 MHz, CDCl3) -77.6 (CF ). Spectroscopic data are in accordance with 
the literature.
179
 
 
(Z)-2,2,2-trifluoro-N-phenylacetimidoyl chloride 
 
To a solution of triphenylphosphine (34.6 g, 0.13 mol), Et3N (7.39 mL, 53.0 mmol), 
trifluoroacetic acid (3.37 mL, 44.0 mmol) and CCl4 (21 mL) was stirred for 10 minutes 
before aniline (4.83 mL, 53.0 mmol) was added and the reaction mixture was stirred at 
reflux for 3 h. The reaction mixture was then concentrated in vacuo and the residue 
taken up in hexane. The precipitate was filtered and washed several times with hexane. 
The filtrate was concentrated in vacuo and the residual oil was purified by distillation to 
give imine 245 as a yellow oil (3.08 g, 34%); bp 50-52 °C (5 mmHg); {lit.
83
 bp 55-56 °C 
(11 mmHg)}; δ (300 MHz, CDCl ) 6.98-7.02 (2H, m, Ar(2,6)H), 7.18-7.24 (1H, m, 
Ar(4)H), 7.31-7.38 (2H, m, Ar(3,5)H);F (282 MHz, CDCl3) -72.1 (CF ). Spectroscopic 
data are in accordance with the literature.
83
 
 
General procedure E: Formation of trifluoromethyl enones. 
To a solution of i-Pr2NH (2 eq) in THF was added n-BuLi (2.5M in hexanes, 2 eq) at 
78 °C and the solution was allowed to stir for 20 minutes. Diethyl methylphosphonate 
(1 eq) was added at 78 °C followed by a further 30 minutes of stirring. (Z)-2,2,2-
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trifluoro-N-phenylacetimidoyl chloride (1 eq) was then added slowly followed by 
stirring at 78 °C for 1 h. A solution of the requisite aldehyde (1 eq) in THF was then 
added dropwise at 78 °C. The reaction mixture was then warmed to rt over 2 h and 
stirred for 16 h. HCl (2 M in H2O, 4 eq) was added and the reaction mixture was stirred 
for a further 4 h before being extracted with Et2O (x 3). The combined organic extracts 
were washed with sat. aq. NaHCO3, brine, dried (MgSO4), filtered and concentrated in 
vacuo to give the crude reaction mixture. 
 
(E)-1,1,1-trifluoro-4-phenylbut-3-en-2-one 
 
Following general procedure E, i-Pr2NH (5.44 mL, 40.0 mmol) and n-BuLi (2.5M in 
hexanes, 16.0 mL, 40.0 mmol) in THF (80 mL), diethyl methylphosphonate (2.96 mL, 
20.0 mmol), imine 245 (4.16 g, 20.0 mmol) and benzaldehyde (2.04 mL, 20.0 mmol) in 
THF (20 mL) followed by HCl (2 M in H2O, 40 mL, 80 mmol) gave crude reaction 
mixture. Chromatographic purification (eluent CH2Cl2:petrol 5:95) gave enone 220 as a 
light yellow oil (3.63 g, 91%); H (500 MHz, CDCl3) 6.96 (1H, d, J 16.0, C(3)H), 7.37-
7.45 (3H, m, Ar(3,5)H and Ar(4)H), 7.57-7.59 (2H, m, Ar(2,6)H), 7.91 (1H, d, J 16.0, 
C(4)H); F (470 MHz, CDCl3) -77.6 (CF ). Spectroscopic data are in accordance with 
the literature.
179
 
 
(E)-1,1,1-trifluoronon-3-en-2-one 
 
Following general procedure E, diisopropylamine (1.36 mL, 10.0 mmol) and n-BuLi 
(2.5M in hexanes, 4 mL, 10.0 mmol) in THF (20 mL), diethyl methylphosphonate (0.74 
mL, 5.00 mmol), imine 245 (1.04 g, 5.00 mmol) and hexanal (0.61 mL, 5.00 mmol) in 
THF (10 mL) followed by HCl (2 M in H2O, 10 mL, 20 mmol) gave crude reaction 
mixture. Chromatographic purification (eluent CH2Cl2:petrol 10:90) gave enone 247 as a 
light yellow oil (0.74 g, 76%); max (ATR)/cm
-1
 2959 (C-H), 2932, 1728 (C=O), 1628; 
H (500 MHz, CDCl3) 0.93 (3H, t, J 7.1, CH3), 1.33-1.37 (4H, m, 2 CH2), 1.53-1.58 (2H, 
m, CH2), 2.36 (2H, qd, J 7.4, 1.2, CH2C=), 6.44 (1H, dd, J 15.8, 0.9, C(3)H), 7.36 (1H, 
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dt, J 15.3, 7.4, C(4)H); δ (125 MHz, CDCl ) 14.1 (CH ), 22.5 (CH CH ), 27.4 (CH Et), 
31.5 (=CH ), 116.5 (q, J 290, CF ), 121.5 (C(3)), 157.1 (C(4)), 180.0 (q, J 35.1, C(2)); F 
(376 MHz, CDCl3) -77.5 (CF ); m/z (APCI
+
) 195 ([M+H]
+
, 70%); HRMS (APCI
+
) 
C9H14F3O
+
 ([M+H]
+
) requires 195.0991; found 195.0989 (-1.2 ppm). 
 
(E)-4-(4-bromophenyl)-1,1,1-trifluorobut-3-en-2-one 
 
Following general procedure E, i-Pr2NH (0.68 mL, 5.00 mmol) and n-BuLi (2.5M in 
hexanes, 2.00 mL, 5.00 mmol) in THF (10 mL), diethyl methylphosphonate (0.37 mL, 
2.50 mmol), imine 245 (0.52 g, 2.50 mmol) and 4-bromobenzaldehyde (0.46 g, 2.50 
mmol) in THF (2.5 mL) followed by HCl (2 M in H2O, 5 mL, 10 mmol) gave crude 
reaction mixture. Chromatographic purification (eluent CH2Cl2:petrol 3:97) gave enone 
552 as a light yellow solid (0.52 g, 75%); mp 40-42 °C; {lit.
180
 mp 55-57 °C}; H (300 
MHz, CDCl3) 6.94 (1H, dd, J 16.0, 0.8, C(3)H), 7.41-7.45 (2H, m, ArH), 7.51-7.55 (2H, 
m, ArH), 7.83 (1H, d, J 16.0, C(4)H); F (470 MHz, CDCl3) -78.1 (CF ). Spectroscopic 
data are in accordance with the literature.
180
 
 
(E)-4-(3-bromophenyl)-1,1,1-trifluorobut-3-en-2-one 
 
Following general procedure E, i-Pr2NH (0.68 mL, 5.00 mmol) and n-BuLi (2.5M in 
hexanes, 2.00 mL, 5.00 mmol) in THF (10 mL), diethyl methylphosphonate (0.37 mL, 
2.50 mmol), imine 245 (0.52 g, 2.50 mmol) and 3-bromobenzaldehyde (0.46 g, 2.50 
mmol) in THF (2.5 mL) followed by HCl (2 M in H2O, 5 mL, 10 mmol) gave crude 
reaction mixture. Chromatographic purification (eluent CH2Cl2:petrol 3:97) gave enone 
553 as a light yellow oil (0.43 g, 62%); max (film)/cm
-1
 3067, 2921 (C-H), 1722 (C=O), 
1611, 1561; H (400 MHz, CDCl3) 6.93 (1H, dd, J 16.0, 0.8, C(3)H), 7.26 (1H, t, J 7.9, 
Ar(5)H), 7.48 (1H, d, J 7.8, ArH), 7.55 (1H, ddd, J 8.0, 1.9, 1.0, ArH), 7.71 (1H, t, J 1.8, 
Ar(2)H), 7.80 (1H, d, J 16.0, C(4)H); δ (100 MHz, CDCl ) 116.3 (q, J 289, CF ), 117.9 
(C(3)), 123.4 (ArC(3)), 127.9 (ArC), 130.7 (ArC), 131.7 (ArC), 135.0 (ArC), 135.3 
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(ArC(1)), 148.2 (C(4)), 179.8 (q, J 35.0, C(2)); F (376 MHz, CDCl3) -78.2 (CF ); m/z 
(NSI
+
) 279 ([M+H]
+
, 100%); HRMS (NSI
+
) C10H7
79
BrF3O
+
 ([M+H]
+
) requires 
278.9627; found 278.9626 (-0.3 ppm). 
 
(E)-4-(2-bromophenyl)-1,1,1-trifluorobut-3-en-2-one 
 
Following general procedure E, i-Pr2NH (0.68 mL, 5.00 mmol) and n-BuLi (2.5M in 
hexanes, 2.00 mL, 5.00 mmol) in THF (10 mL), diethyl methylphosphonate (0.37 mL, 
2.50 mmol), imine 245 (0.52 g, 2.50 mmol) and 2-bromobenzaldehyde (0.29 mL, 2.50 
mmol) in THF (2.5 mL) followed by HCl (2 M in H2O, 5 mL, 10 mmol) gave crude 
reaction mixture. Chromatographic purification (eluent CH2Cl2:petrol 5:95) gave enone 
554 as a light yellow oil (0.45 g, 65%); max (film)/cm
-1
 3070, 2923 (C-H), 1724 (C=O), 
1603, 1564; H (300 MHz, CDCl3) 6.89 (1H, dd, J 16.0, 0.7, C(3)H), 7.18-7.34 (2H, m, 
ArH), 7.62 (2H, ddd, J 15.9, 7.7, 1.7, ArH), 8.29 (1H, d, J 16.0, C(4)H); δ (125 MHz, 
CDCl ) 116.3 (q, J 289, CF ), 119.1 (C(3)), 127.0 (ArC(2)), 128.0 (ArC), 128.2 (ArC), 
133.0 (ArC), 133.3 (ArC(1)), 133.9 (ArC), 148.3 (C(4)), 179.8 (q, J 36.0, C(2)); F (282 
MHz, CDCl3) -78.0 (CF ); m/z (NSI
+
) 279 ([M+H]
+
, 100%); HRMS (NSI
+
) 
C10H7
79
BrF3O
+
 ([M+H]
+
) requires 278.9627; found 278.9626 (-0.3 ppm). 
 
(E)-4-(4-chlorophenyl)-1,1,1-trifluorobut-3-en-2-one 
 
Following general procedure E, i-Pr2NH (0.68 mL, 5.00 mmol) and n-BuLi (2.5M in 
hexanes, 2.00 mL, 5.00 mmol) in THF (10 mL), diethyl methylphosphonate (0.37 mL, 
2.50 mmol), imine 245 (0.52 g, 2.50 mmol) and 4-chlorobenzaldehyde (0.35 mg, 2.50 
mmol) in THF (2.5 mL) followed by HCl (2 M in H2O, 5 mL, 10 mmol) gave crude 
reaction mixture. Chromatographic purification (eluent CH2Cl2:petrol 5:95) gave enone 
555 as a white solid (0.44 g, 76%); mp 42-44 °C; {lit.
181
 mp 42-45 °C}; H (300 MHz, 
CDCl3) 6.92 (1H, dd, J 16.0, 0.8, C(3)H), 7.34-7.39 (2H, m, Ar(3,5)H), 7.49-7.54 (2H, 
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m, Ar(2,6)H), 7.85 (1H, d, J 16.0, C(4)H); F (282 MHz, CDCl3) -78.1 (CF ). 
Spectroscopic data are in accordance with the literature.
181
 
 
(E)-1,1,1-trifluoro-4-(4-methoxyphenyl)but-3-en-2-one 
 
Following general procedure E, i-Pr2NH (0.68 mL, 5.00 mmol) and n-BuLi (2.5M in 
hexanes, 2.00 mL, 5.00 mmol) in THF (10 mL), diethyl methylphosphonate (0.37 mL, 
2.50 mmol), imine 245 (0.52 g, 2.50 mmol) and 4-methoxybenzaldehyde (0.31 mL, 2.50 
mmol) in THF (2.5 mL) followed by HCl (2 M in H2O, 5 mL, 10 mmol) gave crude 
reaction mixture. Chromatographic purification (eluent CH2Cl2:petrol 30:70) gave enone 
556 as a yellow solid (0.46 mg, 79%); mp 30-32 °C; {lit.
182
 mp 35-37 °C}; H (400 
MHz, CDCl3) 3.81 (3H, s, OCH3), 6.82 (1H, dd, J 15.8, 0.8, C(3)H), 6.87-6.90 (2H, m, 
Ar(3,5)H), 7.52-7.56 (2H, m, Ar(2,6)H), 7.87 (1H, d, J 15.8, C(4)H); F (376 MHz, 
CDCl3) -78.0 (CF ). Spectroscopic data are in accordance with the literature.
180
 
 
(E)-1,1,1-trifluoro-4-(4-nitrophenyl)but-3-en-2-one 
 
Following general procedure E, i-Pr2NH (0.68 mL, 5.00 mmol) and n-BuLi (2.5M in 
hexanes, 2.00 mL, 5.00 mmol) in THF (10 mL), diethyl methylphosphonate (0.37 mL, 
2.50 mmol), imine 245 (0.52 g, 2.50 mmol) and 4-nitrobenzaldehyde (378 mg, 2.50 
mmol) in THF (2.5 mL) followed by HCl (2 M in H2O, 5 mL, 10 mmol) gave crude 
reaction mixture. Chromatographic purification (eluent CH2Cl2:petrol 30:70) gave enone 
557 as a yellow solid (0.43 g, 70%); mp 80-82 °C; {lit.
84
 mp 98-99 °C}; H (400 MHz, 
CDCl3) 7.05 (1H, dd, J 16.1, 0.7, C(3)H), 7.72-7.76 (2H, m, Ar(2,6)H), 7.91 (1H, d, J 
16.1, C(4)H), 8.23-8.26 (2H, m, Ar(3,5)H); F (376 MHz, CDCl3) -78.2 (CF ). 
Spectroscopic data are in accordance with the literature.
84
 
 
(E)-1,1,1-trifluoro-4-(p-tolyl)but-3-en-2-one 
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Following general procedure E, i-Pr2NH (0.68 mL, 5.00 mmol) and n-BuLi (2.5M in 
hexanes, 2.00 mL, 5.00 mmol) in THF (10 mL), diethyl methylphosphonate (0.37 mL, 
2.50 mmol), imine 245 (0.52 g, 2.50 mmol) and 4-methylbenzaldehyde (0.30 mL, 2.50 
mmol) in THF (2.5 mL) followed by HCl (2 M in H2O, 5 mL, 10 mmol) gave crude 
reaction mixture. Chromatographic purification (eluent CH2Cl2:petrol 5:95) gave enone 
558 as a light yellow solid (0.48 mg, 89%); mp 30-32 °C; {lit.
183
 mp 35 °C}; H (400 
MHz, CDCl3) 2.44 (3H, s, CH3), 7.00 (1H, dd, J 15.9, 0.7, C(3)H), 7.28-7.30 (2H, m, 
Ar(3,5)H), 7.57 (2H, d, J 8.2, Ar(2,6)H), 7.98 (1H, d, J 15.9, C(4)H); F (376 MHz, 
CDCl3) -78.0 (CF ). Spectroscopic data are in accordance with the literature.
183
 
 
(E)-1,1,1-trifluoro-4-(naphthalen-2-yl)but-3-en-2-one 
 
Following general procedure E, i-Pr2NH (0.68 mL, 5.00 mmol) and n-BuLi (2.5M in 
hexanes, 2.00 mL, 5.00 mmol) in THF (10 mL), diethyl methylphosphonate (0.37 mL, 
2.50 mmol), imine 245 (0.52 g, 2.50 mmol) and 2-naphthaldehyde (0.39 g, 2.50 mmol) 
in THF (2.5 mL) followed by HCl (2 M in H2O, 5 mL, 10 mmol) gave crude reaction 
mixture. Chromatographic purification (eluent CH2Cl2:petrol 5:95) gave enone 559 as a 
light yellow solid (0.48 g, 76%); mp 65-67 °C; {lit.
180
 mp 62-64 °C}; H (400 MHz, 
CDCl3) 7.06 (1H, dd, J 15.9, 0.7, C(3)H), 7.47-7.54 (2H, m, ArH), 7.68 (1H, dd, J 8.6, 
1.7, ArH), 7.79-7.85 (3H, m, ArH), 8.01 (1H, s, Ar(1)H), 8.07 (1H, d, J 15.9, C(4)H); F 
(376 MHz, CDCl3) -78.0 (CF ). Spectroscopic data are in accordance with the 
literature.
180
 
 
(E)-1,1,1-trifluoro-4-(naphthalen-1-yl)but-3-en-2-one 
 
Following general procedure E, i-Pr2NH (0.68 mL, 5.00 mmol) and n-BuLi (2.5M in 
hexanes, 2.00 mL, 5.00 mmol) in THF (10 mL), diethyl methylphosphonate (0.37 mL, 
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2.50 mmol), imine 245 (0.52 g, 2.50 mmol) and 1-naphthaldehyde (0.34 mL, 2.50 
mmol) in THF (2.5 mL) followed by HCl (2 M in H2O, 5 mL, 10 mmol) gave crude 
reaction mixture. Chromatographic purification (eluent CH2Cl2:petrol 5:95) gave enone 
560 as a yellow oil (0.56 g, 82%); H (400 MHz, CDCl3) 7.08 (1H, d, J 15.7, C(3)H), 
7.45-7.60 (3H, m, ArH), 7.84-7.88 (2H, m, ArH), 7.94 (1H, d, J 8.2, ArH), 8.15 (1H, d, J 
8.5, ArH), 8.80 (1H, d, J 15.7, C(4)H); F (376 MHz, CDCl3) -78.0 (CF ). Spectroscopic 
data are in accordance with the literature.
179
 
 
(E)-1,1,1-trifluoro-4-(thiophen-2-yl)but-3-en-2-one 
 
Following general procedure E, i-Pr2NH (0.68 mL, 5.00 mmol) and n-BuLi (2.5M in 
hexanes, 2.00 mL, 5.00 mmol) in THF (10 mL), diethyl methylphosphonate (0.37 mL, 
2.50 mmol), imine 245 (0.52 g, 2.50 mmol) and thiophene-2-carbaldehyde (0.23 mL, 
2.50 mmol) in THF (2.5 mL) followed by HCl (2 M in H2O, 5 mL, 10 mmol) gave crude 
reaction mixture. Chromatographic purification (eluent CH2Cl2:petrol 10:90) gave enone 
561 as a light yellow oil (0.46 g, 89%); H (500 MHz, CDCl3) 6.71 (1H, d, J 15.6, 
C(3)H), 7.08 (1H, dd, J 5.0, 3.8, Ar(4)H), 7.41 (1H, d, J 3.6, Ar(3)H), 7.51 (1H, d, J 5.0, 
Ar(5)H), 8.00 (1H, d, J 15.6, C(4)H); F (282 MHz, CDCl3) -78.0 (CF ). Spectroscopic 
data are in accordance with the literature.
184
 
 
(E)-1,1,1-trifluoro-4-(furan-2-yl)but-3-en-2-one 
 
Following general procedure E, i-Pr2NH (0.68 mL, 5.00 mmol) and n-BuLi (2.5M in 
hexanes, 2.00 mL, 5.00 mmol) in THF (10 mL), diethyl methylphosphonate (0.37 mL, 
2.50 mmol), imine 245 (0.52 g, 2.50 mmol) and furfuraldehyde (0.21 mL, 2.50 mmol) in 
THF (2.5 mL) followed by HCl (2 M in H2O, 5 mL, 10 mmol) gave crude reaction 
mixture. Chromatographic purification (eluent CH2Cl2:petrol 10:90) gave enone 562 as a 
yellow oil (0.27 g, 57%); H (300 MHz, CDCl3) 6.51 (1H, dd, J 3.5, 1.8, Ar(4)H), 6.80-
6.85 (2H, m, C(3)H and Ar(3)H), 7.54-7.55 (1H, m, Ar(5)H), 7.62 (1H, d, J 15.6, 
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C(4)H); F (282 MHz, CDCl3) -78.1 (CF ). Spectroscopic data are in accordance with 
the literature.
179
 
 
(E)-1,1,1-trifluoro-4-(4-fluorophenyl)but-3-en-2-one 
 
Following general procedure E, i-Pr2NH (0.68 mL, 5.00 mmol) and n-BuLi (2.5M in 
hexanes, 2.00 mL, 5.00 mmol) in THF (10 mL), diethyl methylphosphonate (0.37 mL, 
2.50 mmol), imine 245 (0.52 g, 2.50 mmol) and 4-fluorobenzaldehyde (0.27 mL, 2.50 
mmol) in THF (2.5 mL) followed by HCl (2 M in H2O, 5 mL, 10 mmol) gave crude 
reaction mixture. Chromatographic purification (eluent CH2Cl2:petrol 5:95) gave enone 
563 as a white solid (0.41 g, 76%); mp 26-28 °C; {lit.
185
 mp 39-41 °C}; H (400 MHz, 
CDCl3) 6.97 (1H, d, J 16.0, C(3)H), 7.16-7.20 (2H, m, Ar(3,5)H), 7.67-7.70 (2H, m, 
Ar(2,6)H), 7.96 (1H, d, J 16.0, C(4)H); F (376 MHz, CDCl3) -78.1 (CF ), -106.0 (ArF). 
Spectroscopic data are in accordance with the literature.
185
 
1,1,1-trifluoro-4-phenylbut-3-yn-2-one 
 
To a solution of phenylacetylene (1.00 mL, 9.12 mmol) in THF (25 mL) at 78 °C was 
added n-BuLi (3.65 mL, 9.12 mmol) and the reaction mixture was stirred at 78 °C for 
20 minutes. A solution of ethyl trifluoroacetate (1.09 mL, 9.12 mmol) in THF (15 mL) 
was added followed by boron trifluoride diethyl etherate (1.37 mL, 10.9 mmol) and the 
reaction mixture was stirred at 78 °C for 2 h. The reaction mixture was quenched by 
dropwise addition of sat. aq. NaCl and extracted with Et2O (x 3). The combined organic 
extracts were dried (MgSO4), filtered and concentrated in vacuo to give the crude 
reaction mixture. Chromatographic purification (eluent Et2O:petrol 20:80) gave alkyne 
298 as a yellow oil (1.80 g, quant.); H (300 MHz, CDCl3) 7.36-7.41 (2H, m, Ar(3,5)H), 
7.48-7.54 (1H, m, Ar(4)H), 7.60-7.64 (2H, m, Ar(2,6)H); F (282 MHz, CDCl3) -78.3 
(CF ). Spectroscopic data are in accordance with the literature.
186
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(Z)-1,1,1-trifluoro-4-phenylbut-3-en-2-one 
 
To a solution of alkyne 298 (1.80 g, 9.10 mmol) in THF (50 mL) at rt was added 5% 
Palladium on calcium carbonate (0.97 g, 0.46 mmol) and hydrogen gas was bubbled 
through the solution using an appended balloon for 4 h at rt. The reaction mixture was 
filtered through celite and the filtrate was concentrated in vacuo to give the crude 
reaction mixture. Chromatographic purification (eluent 100% petrol) gave enone 295 as 
a light yellow oil (0.73 g, 40%); max (film) /cm
-1
 3067, 2965 (C-H), 1719 (C=O), 1593, 
1568; H (300 MHz, CDCl3) 6.52 (1H, dd, J 12.9, 0.7, C(3)H), 7.29 (1H, d, J 12.9, 
C(4)H), 7.42-7.50 (3H, m, ArH), 7.87-7.91 (2H, m, Ar(2,6)H); δ (100 MHz, CDCl ) 
116.3 (q, J 290, CF ), 116.7 (C(3)), 128.4 (ArC), 131.2 (ArC), 131.6 (ArC(4)), 133.7 
(ArC(1)), 151.9 (C(4)), 179.1 (q, J 34.3, C(2)); F (282 MHz, CDCl3) -79.0 (CF ); m/z 
(APCI
+
) 201 ([M+H]
+
, 100%); HRMS (APCI
+
) C10H8F3O
+
 ([M+H]
+
) requires 201.0522; 
found 201.0520 (-0.9 ppm). 
Optimisation studies on compound 224 
3,4-diphenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-one 
 
Following general procedure D, phenylacetic acid (27.2 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 mL), DHPB 
108 (7.60 mg, 0.04 mmol), enone 220 (40.0 mg, 0.20 mmol) and i-Pr2NEt (87 L, 0.50 
mmol) for 30 minutes at rt gave crude lactone (±)-224 (86:14 dr). Chromatographic 
purification (eluent Et O:petrol 3.5:96.5) gave lactone (±)-224 (96:4 dr) as a white solid 
(41.9 mg, 66%); mp 90-92 °C; Chiral HPLC Chiralpak AD-H (5% IPA:hexane, flow 
rate 1 mL min
-1
, 211 nm, 20 °C) tR(3R,4R): 10.9 min, tR(3S,4S): 12.2 min; max 
(KBr)/cm
-1
 3084, 3032, 2962 (C-H), 1774 (C=O), 1702, 1606; Data for major 
diastereoisomer: δ (300 MHz, CDCl ) 3.89 (1H, d, J 8.8, C(3)H), 3.92-3.98 (1H, m, 
C(4)H), 6.06 (1H, d, J 3.5, C(5)H), 6.94-6.96 (2H, m, ArH), 6.99-7.03 (2H, m, ArH), 
7.17-7.24 (6H, m, ArH); δ (100 MHz, CDCl ) 44.8 (C(4)), 52.8 (C(3)), 110.7 (q, J 3.5, 
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C(5)), 118.5 (q, J 270, CF ), 127.4 (ArC), 128.1 (ArC), 128.2 (ArC), 128.3 (ArC), 128.9 
(ArC), 129.2 (ArC), 135.1 (C(3)ArC(1)), 138.8 (C(4)ArC(1)), 140.9 (q, J 38.0, C(6)), 
165.8 (C(2));F (282 MHz, CDCl3) -72.6 (CF ); m/z (NSI
+
) 336 ([M+NH4]
+
, 100%); 
HRMS (NSI
+
) C18H17F3NO2
+
 ([M+NH4]
+
) requires 336.1206; found 336.1205 (-0.3 
ppm). 

Asymmetric Catalyst Screen:  
All reactions for 15 minutes at rt. 
 
Tetramisole hydrochloride (2S)-106 (4.82 mg, 0.02 mmol, 10 mol%) gave crude lactone 
(3S,4S)-224 (87:13 dr). Chromatographic purification (eluent Et O:petrol 3.5:96.5) gave 
lactone (3S,4S)-224 (97:3 dr) as a white solid (38.6 mg, 61%); 89% ee. 
 
Benzotetramisole (2R)-107 (5.04 mg, 0.02 mmol, 10 mol%) gave crude lactone (3R,4R)-
224 (82:18 dr). Chromatographic purification (eluent Et O:petrol 3.5:96.5) gave lactone 
(3R,4R)-224 (94:6 dr) as a white solid (48.5 mg, 76%); 77% ee. 
 
HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 10 mol%) gave crude lactone (3R,4R)-
224 (85:15 dr). Chromatographic purification (eluent Et O:petrol 3.5:96.5) gave lactone 
(3R,4R)-224 (>98:2 dr) as a white solid (46.3 mg, 73%); 95% ee. 
 
Temperature Screen:  
All reactions with HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 10 mol%) 
 
Reaction for 3 h at 30 °C gave crude lactone (3R,4R)-224 (86:14 dr). Chromatographic 
purification (eluent Et O:petrol 3.5:96.5) gave lactone (3R,4R)-224 (97:3 dr) as a white 
solid (50.1 mg, 79%); 96% ee. 
 
Reaction for 4 h at 78 °C gave crude lactone (3R,4R)-224 (90:10 dr). Chromatographic 
purification (eluent Et O:petrol 3.5:96.5) gave lactone (3R,4R)-224 (98:2 dr) as a white 
solid (52.5 mg, 83%); 99% ee. 
 
Catalyst Loading Screen:  
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All reactions at 78 °C for 16 h. 
 
HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%) gave crude lactone (3R,4R)-224 
(90:10 dr). Chromatographic purification (eluent Et O:petrol 3.5:96.5) gave lactone 
(3R,4R)-224 (98:2 dr) as a white solid (50.8 mg, 80%); 

 
D
20
-227.2 (c 0.25, CH2Cl2); 
99% ee. 
 
HBTM-2.1 (2S,3R)-112 (1.23 mg, 0.004 mmol, 2 mol%) gave crude lactone (3R,4R)-
224 (90:10 dr). Chromatographic purification (eluent Et O:petrol 3.5:96.5) gave lactone 
(3R,4R)-224 (98:2 dr) as a white solid (50.5 mg, 79%); 99% ee. 
 
HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%) gave crude lactone (3R,4R)-
224 (90:10 dr). Chromatographic purification (eluent Et O:petrol 3.5:96.5) gave lactone 
(3R,4R)-224 (98:2 dr) as a white solid (50.2 mg, 79%); 99% ee. 
 
(3R,4R)-4-phenyl-3-(p-tolyl)-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-one 
 
Following general procedure D, p-tolylacetic acid (30.0 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 mL), HBTM-
2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 220 (40.0 mg, 0.20 mmol) and i-
Pr2NEt (87 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone (3R,4R)-225 (93:7 dr). 
Chromatographic purification (eluent Et O:petrol 3:97) gave lactone (3R,4R)-225 (98:2 
dr) as a white solid (49.8 mg, 75%); mp 88-90 °C; 

 
D
20
-219.0 (c 0.2, CH2Cl2); Chiral 
HPLC Chiralpak AD-H (2% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) 
tR(3S,4S): 14.0 min, tR(3R,4R): 16.4 min, 98% ee; max (KBr)/cm
-1
 3083, 3030 (C-H), 
1773 (C=O), 1700, 1519; Data for major diastereoisomer: δ (300 MHz, CDCl ) 2.23 
(3H, s, CH ), 3.87 (1H, d, J 8.6, C(3)H), 3.92-3.95 (1H, m, C(4)H), 6.04 (1H, d, J 3.7, 
C(5)H), 6.90-6.92 (2H, m, C(3)Ar(3,5)H), 6.95-6.98 (2H, m, C(3)Ar(2,6)H), 7.02-7.04 
(2H, m, ArH), 7.15-7.23 (3H, m, ArH); δ (100 MHz, CDCl ) 21.1 (CH ), 44.7 (C(4)), 
52.4 (C(3)), 110.7 (q, J 3.5, C(5)), 118.5 (q, J 270, CF ), 127.4 (ArC), 128.0 (ArC), 
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128.0 (C(4)ArC(4)), 129.2 (ArC), 129.7 (ArC), 132.0 (C(3)ArC(1)), 138.0 (ArC), 138.9 
(ArC), 140.8 (q, J 38.0, C(6)), 166.0 (C(2));F (282 MHz, CDCl3) -72.6 (CF ); m/z 
(NSI
+
) 350 ([M+NH4]
+
, 100%); HRMS (NSI
+
) C19H19F3NO2
+
 ([M+NH4]
+
) requires 
350.1362; found 350.1366 (+1.0 ppm). 
 
(3R,4R)-4-phenyl-3-(m-tolyl)-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-one 
 
Following general procedure D, m-tolylacetic acid (30.0 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 mL), HBTM-
2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 220 (40.0 mg, 0.20 mmol) and i-
Pr2NEt (87 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone (3R,4R)-226 (94:6 dr). 
Chromatographic purification (eluent Et O:petrol 3:97) gave lactone (3R,4R)-226 (99:1 
dr) as a white solid (60.1 mg, 91%); mp 52-54 °C; 

 
D
20
-219.5 (c 0.2, CH2Cl2); Chiral 
HPLC Chiralcel OD-H (2% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) 
tR(3R,4R): 18.4 min, tR(3S,4S): 27.7 min, >99% ee; max (KBr)/cm
-1
 3079, 3031 (C-H), 
2921, 1779 (C=O), 1698, 1611; Data for major diastereoisomer: δ (300 MHz, CDCl ) 
2.23 (3H, s, CH ), 3.87 (1H, d, J 8.1, C(3)H), 3.92-3.96 (1H, m, C(4)H), 6.05 (1H, d, J 
3.8, C(5)H), 6.81-6.84 (2H, m, ArH), 6.97-7.02 (3H, m, ArH), 7.11 (1H, t, J 7.6, 
C(3)Ar(5)H), 7.16-7.24 (3H, m, ArH); δ (100 MHz, CDCl ) 21.4 (CH ), 44.8 (C(4)), 
52.7 (C(3)), 110.5 (q, J 3.5, C(5)), 118.5 (q, J 270, CF ), 125.1 (ArC), 127.4 (ArC), 
128.1 (ArC), 128.8 (ArC), 128.9 (ArC), 129.2 (ArC), 135.1 (C(3)ArC(1)), 138.7 (ArC), 
138.9 (ArC), 140.8 (q, J 38.0, C(6)), 165.8 (C(2)); F (376 MHz, CDCl3) -72.7 (CF ); 
m/z (NSI
+
) 350 ([M+NH4]
+
, 100%); HRMS (NSI
+
) C19H19F3NO2
+
 ([M+NH4]
+
) requires 
350.1362; found 350.1367 (+1.3 ppm). 
 
Scale-up: 
Following general procedure D, m-tolylacetic acid (1.13 g, 7.50 mmol), i-Pr2NEt (1.96 
mL, 11.3 mmol) and pivaloyl chloride (1.39 mL, 11.3 mmol) in CH Cl  (75 mL), 
HBTM-2.1 (2S,3R)-112 (23.1 mg, 0.075 mmol, 1 mol%), enone 220 (1.50 g, 7.50 mmol) 
and i-Pr2NEt (3.27 mL, 18.8 mmol) for 40 h at 78 °C gave crude lactone (3R,4R)-226 
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(94:6 dr). Chromatographic purification (eluent Et O:petrol 2:98) gave lactone (3R,4R)-
226 (96:4 dr) as a white solid (2.12 g, 85%); 98% ee. 
 
(3R,4R)-3-(4-bromophenyl)-4-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-
one 
 
Following general procedure D, 4-bromophenylacetic acid (43.0 mg, 0.20 mmol), i-
Pr2NEt (51.9 L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 
mL), HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 220 (40.0 mg, 0.20 
mmol) and i-Pr2NEt (87 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone (3R,4R)-
227 (90:10 dr). Chromatographic purification (eluent Et O:petrol 3.5:96.5) gave lactone 
(3R,4R)-227 (>99:1 dr) as a white solid (56.9 mg, 72%); mp 66-68 °C; 

 
D
20
-198.5 (c 
0.2, CH2Cl2); Chiral HPLC Chiralpak AD-H (2% IPA:hexane, flow rate 1 mL min
-1
, 211 
nm, 20 °C) tR(3S,4S): 23.5 min, tR(3R,4R): 25.5 min, 95% ee; max (KBr)/cm
-1
 3089, 
3030, 2961 (C-H), 1784 (C=O), 1700; Data for major diastereoisomer: δ (300 MHz, 
CDCl ) 3.83 (1H, d, J 10.2, C(3)H), 3.88-3.95 (1H, m, C(4)H), 6.06 (1H, d, J 2.6, 
C(5)H), 6.83-6.87 (2H, m, C(3)Ar(2,6)H), 6.90-6.94 (2H, m, ArH), 7.17-7.24 (3H, m, 
ArH), 7.32-7.36 (2H, m, C(3)Ar(3,5)H); δ (100 MHz, CDCl ) 44.7 (C(4)), 52.3 (C(3)), 
111.0 (q, J 3.3, C(5)), 118.4 (q, J 270, CF ), 122.3 (C(3)ArC(4)), 127.4 (ArC), 128.2 
(C(4)ArC(4)), 129.3 (ArC), 130.2 (ArC), 132.0 (ArC), 133.9 (C(3)ArC(1)), 138.4 
(C(4)ArC(1)), 140.7 (q, J 37.9, C(6)), 165.4 (C(2));F (282 MHz, CDCl3) -72.6 (CF ); 
m/z (NSI
+
) 414 ([M+NH4]
+
, 61%); HRMS (NSI
+
) C18H16
79
BrF3NO2
+
 ([M+NH4]
+
) 
requires 414.0311; found 414.0310 (-0.2 ppm). 
 
(3R,4R)-3-(4-chlorophenyl)-4-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-
one 
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Following general procedure D, 4-chlorophenylacetic acid (34.1 mg, 0.20 mmol), i-
Pr2NEt (51.9 L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 
mL), HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 220 (40.0 mg, 0.20 
mmol) and i-Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone 
(3R,4R)-228 (91:9 dr). Chromatographic purification (eluent Et O:petrol 5:95) gave 
lactone (3R,4R)-228 (>99:1 dr) as a white solid (58.2 mg, 83%); mp 91-93 °C; 

 
D
20
-
226.0 (c 0.25, CH2Cl2); Chiral HPLC Chiralcel OD-H (5% IPA:hexane, flow rate 1 mL 
min
-1
, 211 nm, 20 °C) tR(3R,4R): 25.4 min, tR(3S,4S): 40.3 min, 96% ee; max (KBr)/cm
-1
 
3086, 3031 (C-H), 1771 (C=O), 1701, 1602; Data for major diastereoisomer: δ (400 
MHz, CDCl ) 3.84 (1H, d, J 10.2, C(3)H), 3.89-3.93 (1H, m, C(4)H), 6.06 (1H, d, J 2.8, 
C(5)H), 6.89-6.93 (4H, m, ArH), 7.17-7.23 (5H, m, ArH); δ (100 MHz, CDCl ) 44.7 
(C(4)), 52.3 (C(3)), 111.1 (q, J 3.4, C(5)), 118.4 (q, J 270, CF ), 127.4 (ArC), 128.2 
(C(4)ArC(4)), 129.1 (ArC), 129.2 (ArC), 129.9 (ArC), 133.3 (C(3)ArC(1)), 134.1 
(C(3)ArC(4)), 138.4 (C(4)ArC(1)), 140.9 (q, J 38.0, C(6)), 165.5 (C(2));F (376 MHz, 
CDCl3) -72.6 (CF ); m/z (NSI
+
) 353 ([M+H]
+
, 100%); HRMS (NSI
+
) C18H13
35
ClF3O2
+
 
([M+H]
+
) requires 353.0551; found 353.0551 (+0.1 ppm). 
 
(3R,4R)-3-(4-fluorophenyl)-4-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-
one 
 
Following general procedure D, 4-fluorophenylacetic acid (30.8 mg, 0.20 mmol), i-
Pr2NEt (51.9 L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 
mL), HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 220 (40.0 mg, 0.20 
mmol) and i-Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone 
(3R,4R)-229 (90:10 dr). Chromatographic purification (eluent Et O:petrol 5:95) gave 
lactone (3R,4R)-229 (>99:1 dr) as a white solid (54.3 mg, 81%); mp 79-81 °C; 

 
D
20
-
256.0 (c 0.1, CH2Cl2); Chiral HPLC Chiralcel OD-H (10% IPA:hexane, flow rate 1 mL 
min
-1
, 211 nm, 20 °C) tR(3R,4R): 19.2 min, tR(3S,4S): 39.4 min, 99% ee; max (KBr)/cm
-1
 
3088, 2928 (C-H), 1772 (C=O), 1702, 1611, 1518; Data for major diastereoisomer: δ
(300 MHz, CDCl ) 3.83-3.94 (2H, m, C(3)H and C(4)H), 6.07 (1H, d, J 2.9, C(5)H), 
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6.87-6.97 (6H, m, ArH), 7.17-7.24 (3H, m, ArH); δ (100 MHz, CDCl ) 44.9 (C(4)), 52.1 
(C(3)), 111.0 (q, J 3.5, C(5)), 115.9 (d, J 21.5, C(3)ArC(3,5)), 118.4 (q, J 270, CF ), 
127.4 (ArC), 128.2 (C(4)ArC(4)), 129.2 (ArC), 130.2 (d, J 8.2, C(3)ArC(2,6)), 130.7 (d, 
J 3.4, C(3)ArC(1)), 138.5 (C(4)ArC(1)), 140.9 (q, J 38.0, C(6)), 162.3 (d, J 246, 
C(3)ArC(4)), 165.7 (C(2));F (282 MHz, CDCl3) -72.6 (CF ), -114.2 (ArF); m/z (NSI
+
) 
354 ([M+NH4]
+
, 100%); HRMS (NSI
+
) C18H16F4NO2
+
 ([M+NH4]
+
) requires 354.1112; 
found 354.1115 (+0.9 ppm). 
 
(3R,4R)-3-(4-methoxyphenyl)-4-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-
2-one 
 
Following general procedure D, p-methoxyphenylacetic acid (33.2 mg, 0.20 mmol), i-
Pr2NEt (51.9 L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 
mL), HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 220 (40.0 mg, 0.20 
mmol) and i-Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone 
(3R,4R)-230 (92:8 dr). Chromatographic purification (eluent Et O:petrol 10:90) gave 
lactone (3R,4R)-230 (97:3 dr) as a white solid (58.9 mg, 85%); mp 90-92 °C; 

 
D
20
-
199.5 (c 0.2, CH2Cl2); Chiral HPLC Chiralpak AD-H (2% IPA:hexane, flow rate 1 mL 
min
-1
, 211 nm, 20 °C) tR(3R,4R): 28.7 min, tR(3S,4S): 31.2 min, 98% ee; max (KBr)/cm
-1
 
3033, 2961 (C-H), 2840, 1784 (C=O), 1700, 1614, 1586, 1516; Data for major 
diastereoisomer: δ (400 MHz, CDCl ) 3.69 (3H, s, CH ), 3.84 (1H, d, J 9.0, C(3)H), 
3.89-3.93 (1H, m, C(4)H), 6.05 (1H, d, J 3.5, C(5)H), 6.73-6.76 (2H, m, C(3)Ar(3,5)H), 
6.91-6.96 (4H, m, ArH), 7.17-7.23 (3H, m, ArH); δ (100 MHz, CDCl ) 44.8 (C(4)), 52.0 
(C(3)), 55.3 (CH ), 110.8 (q, J 3.5, C(5)), 114.3 (ArC(3)), 118.5 (q, J 270, CF ), 127.0 
(C(3)ArC(1)), 127.4 (ArC), 128.0 (C(4)ArC(4)), 129.2 (ArC), 129.4 (ArC), 138.9 
(C(4)ArC(1)), 140.8 (q, J 37.9, C(6)), 159.3 (C(3)ArC(4)), 166.1 (C(2));F (376 MHz, 
CDCl3) -72.6 (CF ); m/z (NSI
+
) 366 ([M+NH4]
+
, 100%); HRMS (NSI
+
) C19H19F3NO3
+
 
([M+NH4]
+
) requires 366.1312; found 366.1318 (+1.8 ppm). 
 
(3R,4R)-3-(3,4-dimethoxyphenyl)-4-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-
pyran-2-one 
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Following general procedure D, 3,4-dimethoxyphenylacetic acid (39.4 mg, 0.20 mmol), 
i-Pr2NEt (51.9 L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 
mL), HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 220 (40.0 mg, 0.20 
mmol) and i-Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone 
(3R,4R)-231 (90:10 dr). Chromatographic purification (eluent Et O:petrol 30:70) gave 
lactone (3R,4R)-231 (92:8 dr) as a colourless oil (66.1 mg, 87%); 

 
D
20
-268.0 (c 0.1, 
CH2Cl2); Chiral HPLC Chiralpak AD-H (5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 
20 °C) tR(3S,4S): 19.6 min, tR(3R,4R): 21.1 min, 98% ee; max (thin film)/cm
-1
 3088, 
3006, 2934 (C-H), 1790 (C=O), 1698, 1594, 1516; Data for major diastereoisomer: δ
(300 MHz, CDCl ) 3.71 (3H, s, OCH ), 3.78 (3H, s, OCH ), 3.84 (1H, d, J 8.8, C(3)H), 
3.89-3.94 (1H, m, C(4)H), 6.07 (1H, d, J 3.5, C(5)H), 6.48 (1H, d, J 2.1, C(3)Ar(2)H), 
6.57 (1H, dd, J 8.3, 2.1, C(3)Ar(6)H), 6.70 (1H, d, J 8.3, C(3)Ar(5)H), 6.94-6.98 (2H, m, 
ArH), 7.17-7.25 (3H, m, ArH); δ (75 MHz, CDCl ) 45.0 (C(4)), 52.4 (C(3)), 55.9 
(OCH ), 55.9 (OCH ), 110.7 (q, J 3.5, C(5)), 111.2 (ArC), 111.3 (ArC), 118.5 (q, J 270, 
CF ), 120.6 (C(3)ArC(6)), 127.4 (ArC) 127.4 (C(3)ArC(1)), 128.1 (C(4)ArC(4)), 129.2 
(ArC), 138.9 (C(4)ArC(1)), 140.9 (q, J 38.0, C(6)), 148.8 (ArC), 149.1 (ArC), 165.9 
(C(2));F (282 MHz, CDCl3) -72.6 (CF ); m/z (NSI
+
) 379 ([M+H]
+
, 100%); HRMS 
(NSI
+
) C20H18F3O4
+
 ([M+H]
+
) requires 379.1152; found 379.1149 (-0.7 ppm). 
 
(3R,4R)-3-(4-(dimethylamino)phenyl)-4-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-
pyran-2-one 
 
Following general procedure D, 2-(4-(dimethylamino)phenyl)acetic acid (35.8 mg, 0.20 
mmol), i-Pr2NEt (51.9 L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in 
CH Cl  (1 mL), HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 220 (40.0 
mg, 0.20 mmol) and i-Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude 
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lactone (3R,4R)-232 (95:5 dr). Chromatographic purification (eluent Et O:petrol 15:85) 
gave lactone (3R,4R)-232 (95:5 dr) as a colourless oil (57.5 mg, 80%); 

 
D
20
-286.5 (c 
0.2, CH2Cl2); Chiral HPLC Chiralpak AD-H (2% IPA:hexane, flow rate 2 mL min
-1
, 211 
nm, 20 °C) tR(3R,4R): 14.9 min, tR(3S,4S): 16.8 min, 99% ee; max (thin film)/cm
-1
 3088, 
3031, 2922 (C-H), 1790 (C=O), 1698, 1615, 1525; Data for major diastereoisomer: δ
(300 MHz, CDCl ) 2.85 (6H, s, 2 NCH ), 3.83 (1H, d, J 7.6, C(3)H), 3.88-3.93 (1H, m, 
C(4)H), 6.04 (1H, d, J 4.1, C(5)H), 6.53-6.58 (2H, m, C(3)Ar(3,5)H), 6.87-6.91 (2H, m, 
C(3)Ar(2,6)H), 6.98-7.01 (2H, m, ArH), 7.15-7.25 (3H, m, ArH); δ (100 MHz, CDCl ) 
40.4 (2 NCH ), 44.8 (C(4)), 51.8 (C(3)), 110.4 (q, J 3.4, C(5)), 112.6 (C(3)ArC(3,5)), 
118.6 (q, J 270, CF ), 122.4 (C(3)ArC(1)), 127.4 (ArC), 127.9 (C(4)ArC(4)), 128.7 
(ArC), 129.2 (ArC), 139.3 (C(4)ArC(1)), 140.8 (q, J 37.8, C(6)), 150.2 (C(3)ArC(4)), 
166.3 (C(2));F (282 MHz, CDCl3) -72.6 (CF ); m/z (NSI
+
) 362 ([M+H]
+
, 100%); 
HRMS (NSI
+
) C20H19F3NO2
+
 ([M+H]
+
) requires 362.1362; found 362.1362 (-0.1 ppm). 
 
(3R,4R)-4-phenyl-6-(trifluoromethyl)-3-(4-(trifluoromethyl)phenyl)-3,4-dihydro-
2H-pyran-2-one 
 
Following general procedure D, 2-(4-(trifluoromethyl)phenyl)acetic acid (40.8 mg, 0.20 
mmol), i-Pr2NEt (51.9 L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in 
CH Cl  (1 mL), HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 220 (40.0 
mg, 0.20 mmol) and i-Pr2NEt (87.0 L, 0.50 mmol) for 72 h at 30 °C gave crude 
lactone (3R,4R)-233 (86:14 dr). Chromatographic purification (eluent Et O:petrol 5:95) 
gave lactone (3R,4R)-233 (99:1 dr) as a white solid (46.2 mg, 60%); mp 80-82 °C; 

 
D
20
-153.6 (c 0.125, CH2Cl2); Chiral HPLC Chiralpak AD-H (2% IPA:hexane, flow 
rate 1 mL min
-1
, 211 nm, 20 °C) tR(3S,4S): 16.2 min, tR(3R,4R): 18.8 min, 64% ee; max 
(KBr)/cm
-1
 3030, 2926 (C-H), 1780 (C=O), 1621; Data for major diastereoisomer: δ
(400 MHz, CDCl ) 3.94-3.96 (2H, m, C(3)H and C(4)H), 6.09 (1H, d, J 2.3, C(5)H), 
6.91-6.93 (2H, m, ArH), 7.10 (2H, d, J 8.1, C(3)Ar(2,6)H), 7.19-7.22 (3H, m, ArH), 7.48 
(2H, d, J 8.1, C(3)Ar(3,5)H); δ (100 MHz, CDCl ) 44.7 (C(4)), 52.6 (C(3)), 111.1 (q, J 
3.3, C(5)), 118.4 (q, J 270, CF ), 123.8 (q, J 271, CF ), 125.8 (q, J 3.6, C(3)ArC(3,5)), 
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127.4 (ArC), 128.3 (C(4)ArC(4)), 129.0 (ArC), 129.3 (ArC), 130.4 (q, J 32.4, 
C(3)ArC(4)), 138.1 (ArC), 138.8 (ArC), 141.0 (q, J 38.2, C(6)), 165.2 (C(2));F (376 
MHz, CDCl3) -63.2 (C6H4CF3), -72.6 (CF ); m/z (NSI
+
) 404 ([M+NH4]
+
, 82%); HRMS 
(NSI
+
) C19H16F6NO2
+
 ([M+NH4]
+
) requires 404.1080; found 404.1080 (+0.1 ppm). 
 
(3R,4R)-3-(naphthalen-1-yl)-4-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-
one 
 
Following general procedure D, 1-naphthylacetic acid (37.2 mg, 0.20 mmol), i-Pr2NEt 
(51.9 L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 mL), 
HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 220 (40.0 mg, 0.20 
mmol) and i-Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone 
(3R,4R)-234 (67:33 dr). Chromatographic purification (eluent Et O:petrol 4:96) gave 
lactone (3R,4R)-234 (71:29 dr) as a colourless oil (65.0 mg, 88%); 

 
D
20
-303.0 (c 0.1, 
CH2Cl2); Chiral HPLC Chiralcel OD-H (5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 
20 °C) tR(3S,4S): 18.5 min, tR(3R,4R): 26.0 min, 97% ee; max (thin film)/cm
-1
 3087, 
2962 (C-H), 1780 (C=O), 1702, 1600, 1512; Data for major diastereoisomer: δ (300 
MHz, CDCl ) 4.09-4.13 (1H, m, C(4)H), 4.64 (1H, d, J 6.7, C(3)H), 6.03 (1H, d, J 4.5, 
C(5)H), 6.98-7.01 (2H, m, ArH), 7.12 (1H, d, J 6.8, ArH), 7.16-7.23 (3H, m, ArH), 7.29 
(1H, t, J 7.7, ArH), 7.40-7.49 (2H, m, ArH), 7.72-7.82 (3H, m, ArH); δ (75 MHz, 
CDCl ) 44.3 (C(4)), 49.6 (C(3)), 110.4 (q, J 3.5, C(5)), 118.6 (q, J 270, CF ), 122.8 
(ArC), 125.3 (ArC), 125.8 (ArC), 126.0 (ArC), 126.9 (ArC), 127.2 (ArC), 128.2 (ArC), 
129.2 (ArC), 129.4 (ArC), 129.6 (ArC), 130.5 (ArC), 131.5 (ArC), 134.3 (ArC), 139.2 
(C(4)ArC(1)), 140.8 (q, J 38.0, C(6)), 165.6 (C(2));F (282 MHz, CDCl3) -72.6 (CF ); 
m/z (NSI
+
) 369 ([M+H]
+
, 100%); HRMS (NSI
+
) C22H16F3O2
+
 ([M+H]
+
) requires 
369.1097; found 369.1087 (-2.7 ppm). 
 
(3R,4R)-3-(naphthalen-2-yl)-4-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-
one 
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Following general procedure D, 2-naphthylacetic acid (37.2 mg, 0.20 mmol), i-Pr2NEt 
(51.9 L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 mL), 
HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 220 (40.0 mg, 0.20 
mmol) and i-Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone 
(3R,4R)-235 (94:6 dr). Chromatographic purification (eluent Et O:petrol 5:95) gave 
lactone (3R,4R)-235 (98:2 dr) as a colourless oil (64.5 mg, 88%); 

 
D
20
-289.0 (c 0.1, 
CH2Cl2); Chiral HPLC Chiralcel OD-H (20% IPA:hexane, flow rate 1 mL min
-1
, 211 
nm, 20 °C) tR(3R,4R): 18.0 min, tR(3S,4S): 27.6 min, 97% ee; max (thin film)/cm
-1
 3088, 
2962 (C-H), 1791 (C=O), 1701, 1602, 1509; Data for major diastereoisomer: δ (400 
MHz, CDCl ) 4.05 (2H, s, C(3)H and C(4)H), 6.07 (1H, s, C(5)H), 6.96-6.98 (2H, m, 
ArH), 7.13-7.19 (4H, m, ArH), 7.36-7.40 (3H, m, ArH), 7.61-7.64 (1H, m, ArH), 7.71-
7.74 (2H, m, ArH); δ (75 MHz, CDCl ) 44.7 (C(4)), 52.9 (C(3)), 110.8 (q, J 3.5, C(5)), 
118.5 (q, J 270, CF ), 125.5 (ArC), 126.5 (ArC), 126.5 (ArC), 127.4 (ArC), 127.7 (ArC), 
127.9 (ArC), 128.1 (ArC), 128.9 (ArC), 129.2 (ArC), 132.3 (ArC), 132.8 (ArC), 133.2 
(ArC), 138.7 (C(4)ArC(1)), 140.9 (q, J 38.0, C(6)), 165.8 (C(2));F (282 MHz, CDCl3) -
72.6 (CF ); m/z (NSI
+
) 386 ([M+NH4]
+
, 56%); HRMS (NSI
+
) C22H19F3NO2
+
 
([M+NH4]
+
) requires 386.1362; found 386.1364 (+0.4 ppm). 
 
(3R,4R)-3-([1,1'-biphenyl]-4-yl)-4-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-
pyran-2-one 
 
Following general procedure D, biphenylacetic acid (42.4 mg, 0.20 mmol), i-Pr2NEt 
(51.9 L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 mL), 
HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 220 (40.0 mg, 0.20 
mmol) and i-Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone 
(3R,4R)-236 (90:10 dr). Chromatographic purification (eluent Et O:petrol 5:95) gave 
lactone (3R,4R)-236 (98:2 dr) as a white solid (70.4 mg, 89%); mp 81-83 °C; 

 
D
20
-
 Chapter 9: Experimental 
 
 220 
297.0 (c 0.1, CH2Cl2); Chiral HPLC Chiralpak AD-H (2% IPA:hexane, flow rate 2 mL 
min
-1
, 211 nm, 20 °C) tR(3S,4S): 14.0 min, tR(3R,4R): 16.8 min, 98% ee; max (KBr)/cm
-1
 
3085, 3031 (C-H), 1771 (C=O), 1705, 1600; Data for major diastereoisomer: δ (300 
MHz, CDCl ) 3.92-4.01 (2H, s, C(3)H and C(4)H), 6.08 (1H, d, J 3.4, C(5)H), 6.96-6.99 
(2H, m, ArH), 7.06-7.09 (2H, m, ArH), 7.15-7.37 (6H, m, ArH), 7.42-7.49 (4H, m, 
ArH); δ (100 MHz, CDCl ) 44.8 (C(4)), 52.5 (C(3)), 110.8 (q, J 3.4, C(5)), 118.5 (q, J 
270, CF ), 127.1 (ArC), 127.4 (ArC), 127.6 (ArC), 127.6 (ArC), 128.1 (ArC), 128.7 
(ArC), 128.8 (ArC), 129.2 (ArC), 134.0 (C(3)ArC(1)), 138.8 (ArC), 140.3 (ArC), 140.9 
(q, J 38.0, C(6)), 141.0 (ArC), 165.8 (C(2));F (282 MHz, CDCl3) -72.6 (CF ); m/z 
(NSI
+
) 395 ([M+H]
+
, 100%); HRMS (NSI
+
) C24H18F3O2
+
 ([M+H]
+
) requires 395.1253; 
found 395.1246 (-1.9 ppm). 
 
(3R,4R)-3-(1-methyl-1H-indol-3-yl)-4-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-
pyran-2-one 
 
Following general procedure D, 2-(1-methyl-1H-indol-3-yl)acetic acid (37.8 mg, 0.20 
mmol), i-Pr2NEt (51.9 L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in 
CH Cl  (1 mL), HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 220 (40.0 
mg, 0.20 mmol) and i-Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 30 °C gave crude 
lactones (3R,4R)-237 and (3S,4R)-564 (74:26 dr).  
 
Major (anti) Diasteroisomer: Chromatographic purification (eluent Et O:petrol 10:90) 
gave lactone (3R,4R)-237 (97:3 dr) as a yellow solid (50.2 mg, 68%); mp 126-128 °C;
 

 
D
20
-164.0 (c 0.225, CH2Cl2); Chiral HPLC Chiralpak AD-H (5% IPA:hexane, flow 
rate 1 mL min
-1
, 211 nm, 20 °C) tR(3R,4R): 21.1 min, tR(3S,4S): 34.9 min, 96% ee; max 
(KBr)/cm
-1
 3033, 2939 (C-H), 1780 (C=O), 1699, 1616, 1544; Data for major 
diastereoisomer: δ (400 MHz, CDCl ) 3.66 (3H, s, CH ), 4.06-4.08 (1H, m, C(4)H), 4.26 
(1H, d, J 4.8, C(3)H), 6.05 (1H, d, J 5.1, C(5)H), 6.78 (1H, s, C(3)Ar(2)H), 7.07-7.12 
(3H, m, ArH), 7.18-7.28 (5H, m, ArH), 7.52 (1H, d, J 7.9, C(3)Ar(4)H); δ (100 MHz, 
CDCl ) 32.9 (CH ), 44.0 (C(4)), 44.7 (C(3)), 108.4 (C(3)ArC(3)), 109.6 (q, J 3.4, C(5)), 
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109.8 (ArC), 118.6 (ArC), 118.6 (q, J 270, CF ), 119.9 (ArC), 122.4 (ArC), 126.1 
(C(3)ArC(3a)), 126.6 (ArC), 127.1 (ArC), 128.1 (ArC), 129.4 (ArC), 137.0 
(C(3)ArC(7a)), 139.1 (C(4)ArC(1)), 141.1 (q, J 37.7, C(6)), 165.2 (C(2));F (376 MHz, 
CDCl3) -72.6 (CF ); m/z (NSI
+
) 389 ([M+NH4]
+
, 100%); HRMS (NSI
+
) C21H20F3N2O2
+
 
([M+NH4]
+
) requires 389.1471; found 389.1474 (+0.7 ppm). 
 
Minor (syn) Diasteroisomer: Chromatographic purification (eluent Et O:petrol 10:90) 
gave lactone (3S,4R)-564 (>99:1 dr) as a yellow oil (19.1 mg, 26%);

 
D
20
+47.5 (c 0.2, 
CH2Cl2); Chiral HPLC Chiralpak AD-H (2% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 
20 °C) tR(3R,4S): 16.0 min, tR(3S,4R): 20.0 min, 28% ee; max (KBr)/cm
-1
 3032, 2934 
(C-H), 1791 (C=O), 1700, 1616, 1550; Data for major diastereoisomer: δ (400 MHz, 
CDCl ) 3.55 (3H, s, CH ), 4.00 (1H, td, J 6.4, 1.4, C(4)H), 4.64 (1H, d, J 6.7, C(3)H), 
6.23 (1H, d, J 6.0, C(5)H), 6.40 (1H, s, C(3)Ar(2)H), 6.86-6.71 (2H, m, ArH), 7.00 (1H, 
ddd, J 7.9, 6.9, 1.1, ArH), 7.05-7.09 (2H, m, ArH), 7.12-7.16 (2H, m, ArH), 7.19-7.23 
(2H, m, ArH); δ (100 MHz, CDCl ) 32.8 (CH ), 42.7 (C(4)), 42.9 (C(3)), 104.8 
(C(3)ArC(3)), 109.5 (ArC), 111.5 (q, J 3.4, C(5)), 117.7 (ArC), 118.7 (q, J 270, CF ), 
119.4 (ArC), 121.8 (ArC), 127.2 (C(3)ArC(3a)), 128.2 (ArC), 128.2 (ArC), 128.6 (ArC), 
128.8 (ArC), 135.6 (C(3)ArC(7a)), 136.2 (C(4)ArC(1)), 141.8 (q, J 37.7, C(6)), 166.0 
(C(2));F (376 MHz, CDCl3) -72.4 (CF ); m/z (NSI
+
) 372 ([M+H]
+
, 18%); HRMS 
(NSI
+
) C21H17F3NO2
+
 ([M+H]
+
) requires 372.1206; found 372.1211 (+1.4 ppm). 
 
(3S,4R)-4-phenyl-3-(thiophen-2-yl)-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-one 
 
Following general procedure D, 2-(thiophen-2-yl)acetic acid (28.4 mg, 0.20 mmol), i-
Pr2NEt (51.9 L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 
mL), HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 220 (40.0 mg, 0.20 
mmol) and i-Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone 
(3R,4R)-238 (87:13 dr). Chromatographic purification (eluent Et O:petrol 5:95) gave 
lactone (3R,4R)-238 (96:4 dr) as a white solid (48.4 mg, 75%); mp 51-53 °C; 

 
D
20
-
248.0 (c 0.25, CH2Cl2); Chiral HPLC Chiralpak AD-H (2% IPA:hexane, flow rate 2 mL 
min
-1
, 211 nm, 20 °C) tR(3S,4R): 5.8 min, tR(3R,4S): 8.4 min, 89% ee; max (KBr)/cm
-1
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3084, 2921 (C-H), 1775 (C=O), 1702; Data for major diastereoisomer: δ (400 MHz, 
CDCl ) 3.98-4.01 (1H, m, C(4)H), 4.24 (1H, d, J 6.8, C(3)H), 6.09 (1H, d, J 4.5, C(5)H), 
6.78 (1H, dt, J 3.5, 0.9, C(3)Ar(3)H), 6.85 (1H, dd, J 5.1, 3.6, C(3)Ar(4)H), 7.03-7.06 
(2H, m, ArH), 7.18-7.29 (4H, m, ArH); δ (100 MHz, CDCl ) 45.3 (C(4)), 48.1 (C(3)), 
109.9 (q, J 3.5, C(5)), 118.4 (q, J 270, CF ), 125.9 (ArC), 127.0 (ArC), 127.1 (ArC), 
127.2 (ArC), 128.4 (ArC), 129.4 (ArC), 136.5 (ArC), 138.2 (ArC), 141.1 (q, J 38.2, 
C(6)), 164.4 (C(2));F (282 MHz, CDCl3) -72.7 (CF ); m/z (NSI
+
) 342 ([M+NH4]
+
, 
100%); HRMS (NSI
+
) C16H15F3NO2S
+
 ([M+NH4]
+
) requires 342.0770; found 342.0775 
(+1.4 ppm). 
 
4-phenyl-6-(trifluoromethyl)-2H-pyran-2-one 
 
Following general procedure D, 2-(phenylthio)acetic acid (67.3 mg, 0.40 mmol), i-
Pr2NEt (104 L, 0.60 mmol) and pivaloyl chloride (74 mg, 0.60 mmol) in CH Cl  (2 
mL), acceptor 220 (40.0 mg, 0.20 mmol), DHPB 108 (7.60 mg, 0.04 mmol) and i-
Pr2NEt (87.0 L, 0.50 mmol) for 16 h at rt gave, after chromatographic purification 
(eluent Et O:petrol 15:85) 242 as a light yellow solid (23.0 mg, 48%); mp 48-50 °C; max 
(ATR)/cm
-1
 3113, 3078 (C-H), 1738 (C=O), 1667, 1560; δ (400 MHz, CDCl ) 6.59 (1H, 
d, J 0.8, C(3)H), 6.90 (1H, d, J 0.7, C(5)H), 7.44-7.49 (3H, m, Ar(3,5)H and Ar(4)H), 
7.52-7.54 (2H, m, Ar(2,6)H); δ (75 MHz, CDCl ) 104.8 (q, J 3.7, C(5)), 113.8 (C(3)), 
118.1 (q, J 271, CF ), 126.7 (ArC), 129.6 (ArC), 131.6 (ArC(4)), 134.2 (ArC(1)), 148.5 
(q, J 38.9, C(6)), 153.3 (C(4)), 159.4 (C=O); m/z (NSI
+
) 241 ([M+H]
+
, 100%); HRMS 
(NSI
+
) C12H8F3O2
+
 ([M+H]
+
) requires 241.0471; found 241.0474 (+1.3 ppm). 
 
(3R,4R)-4-(4-bromophenyl)-3-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-
one 
 
Following general procedure D, phenylacetic acid (27.2 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 mL), HBTM-
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2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 552 (55.8 mg, 0.20 mmol) and i-
Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone (3R,4R)-249 (88:12 
dr). Chromatographic purification (eluent Et O:petrol 4.5:95.5) gave lactone (3R,4R)-
249 (99:1 dr) as a white solid (54.0 mg, 68%); mp 58-60 °C;
 

 
D
20
-252.0 (c 0.1, 
CH2Cl2); Chiral HPLC Chiralcel OD-H (5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 
20 °C) tR(3R,4R): 26.9 min, tR(3S,4S): 30.8 min, 98% ee; max (KBr)/cm
-1
 3088, 3033, 
2926 (C-H), 1780 (C=O), 1703; Data for major diastereoisomer: δ (400 MHz, CDCl ) 
3.82 (1H, d, J 9.6, C(3)H), 3.91-3.96 (1H, m, C(4)H), 6.02 (1H, dd, J 3.4, 0.5, C(5)H), 
6.80-6.83 (2H, m, C(4)Ar(2,6)H), 6.97-7.00 (2H, m, ArH), 7.21-7.26 (3H, m, ArH), 
7.30-7.34 (2H, m, C(4)Ar(3,5)H); δ (100 MHz, CDCl ) 44.3 (C(4)), 52.6 (C(3)), 110.2 
(q, J 3.4, C(5)), 118.4 (q, J 270, CF ), 122.1 (C(4)ArC(4)), 128.3 (C(3)ArC(4)), 128.3 
(ArC), 129.0 (ArC), 129.1 (ArC), 132.3 (ArC), 134.6 (C(3)ArC(1)), 137.8 (C(4)ArC(1)), 
141.2 (q, J 38.1, C(6)), 165.4 (C(2));F (376 MHz, CDCl3) -72.7 (CF ); m/z (NSI
+
) 414 
([M+NH4]
+
, 62%); HRMS (NSI
+
) C18H16
79
BrF3NO2
+
 ([M+NH4]
+
) requires 414.0311; 
found 414.0311 (+0.0 ppm). 
 
(3R,4R)-4-(3-bromophenyl)-3-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-
one 
 
Following general procedure D, phenylacetic acid (27.2 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 mL), HBTM-
2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 553 (55.8 mg, 0.20 mmol) and i-
Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone (3R,4R)-250 (80:20 
dr). Chromatographic purification (eluent Et O:petrol 4.5:95.5) gave lactone (3R,4R)-
250 (99:1 dr) as a white solid (51.0 mg, 64%); mp 70-72 °C; 

 
D
20
-227.0 (c 0.1, 
CH2Cl2); Chiral HPLC Chiralcel OD-H (5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 
20 °C) tR(3R,4R): 24.3 min, tR(3S,4S): 47.5 min, 97% ee; max (KBr)/cm
-1
 3083, 2960 
(C-H), 1774 (C=O), 1702, 1592, 1570; Data for major diastereoisomer: δ (300 MHz, 
CDCl ) 3.85 (1H, d, J 9.3, C(3)H), 3.89-3.96 (1H, m, C(4)H), 6.02 (1H, dd, J 3.2, 
C(5)H), 6.84 (1H, dd, J 6.6, 1.2, C(4)Ar(6)H), 6.98-7.01 (2H, m, ArH), 7.06 (1H, t, J 
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7.8, C(4)Ar(5)H), 7.11 (1H, t, J 1.8, C(4)Ar(2)H), 7.21-7.26 (3H, m, ArH), 7.31 (1H, 
ddd, J 8.0, 1.9, 1.0, C(4)Ar(4)H); δ (100 MHz, CDCl ) 44.4 (C(4)), 52.6 (C(3)), 109.9 
(q, J 3.5, C(5)), 118.4 (q, J 270, CF ), 123.1 (C(4)ArC(3)), 126.1 (ArC), 128.3 (ArC), 
128.4 (ArC), 129.1 (ArC), 130.5 (ArC), 130.7 (ArC), 131.3 (ArC), 134.5 (C(3)ArC(1)), 
141.0 (C(4)ArC(1), 141.3 (q, J 38.2, C(6)), 165.3 (C(2));F (282 MHz, CDCl3) -72.7 
(CF ); m/z (NSI
+
) 414 ([M+NH4]
+
, 68%); HRMS (NSI
+
) C19H16
79
BrF3NO2
+
 ([M+NH4]
+
) 
requires 414.0311; found 414.0313 (+0.5 ppm). 
 
(3R,4R)-4-(2-bromophenyl)-3-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-
one 
 
Following general procedure D, phenylacetic acid (27.2 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 mL), HBTM-
2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 554 (55.8 mg, 0.20 mmol) and i-
Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone (3R,4R)-251 (87:13 
dr). Chromatographic purification (eluent Et O:petrol 3:97) gave lactone (3R,4R)-251 
(95:5 dr) as a white solid (68.0 mg, 86%); mp 78-80 °C; 

 
D
20
-214.0 (c 0.25, CH2Cl2); 
Chiral HPLC Chiralcel OD-H (5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) 
tR(3R,4R): 8.8 min, tR(3S,4S): 18.5 min, 97% ee; max (KBr)/cm
-1
 3083, 3037, 2926 (C-
H), 1778 (C=O), 1709, 1567; Data for major diastereoisomer: δ (400 MHz, CDCl ) 4.12 
(1H, d, J 5.6, C(3)H), 4.49-4.52 (1H, m, C(4)H), 5.99 (1H, d, J 5.1, C(5)H), 7.07-7.11 
(2H, m, ArH), 7.20-7.29 (6H, m, ArH), 7.51 (1H, dd, J 8.1, 1.1, C(4)Ar(3)H); δ (125 
MHz, CDCl ) 43.6 (C(4)), 50.9 (C(3)), 109.0 (q, J 3.4, C(5)), 118.4 (q, J 270, CF ), 
124.1 (C(4)ArC(2)), 127.7 (ArC), 128.3 (ArC), 128.4 (ArC), 128.5 (ArC), 129.1 (ArC), 
129.9 (ArC), 133.9 (C(4)ArC(3)), 134.8 (C(3)ArC(1)), 136.9 (C(4)ArC(1), 141.8 (q, J 
38.0, C(6)), 165.2 (C(2));F (376 MHz, CDCl3) -72.6 (CF ); m/z (NSI
+
) 414 ([M+NH4]
+
, 
85%); HRMS (NSI
+
) C19H16
79
BrF3NO2
+
 ([M+NH4]
+
) requires 414.0311; found 414.0314 
(+0.7 ppm). 
 
(3R,4R)-4-(4-fluorophenyl)-3-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-
one 
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Following general procedure D, phenylacetic acid (27.2 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 mL), HBTM-
2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 563 (43.6 mg, 0.20 mmol) and i-
Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone (3R,4R)-252 (86:14 
dr). Chromatographic purification (eluent Et O:petrol 5:95) gave lactone (3R,4R)-252 
(>99:1 dr) as a white solid (57.2 mg, 85%); mp 80-82 °C; 

 
D
20
-302.0 (c 0.1, CH2Cl2); 
Chiral HPLC Chiralpak AD-H (2% IPA:hexane, flow rate 2 mL min
-1
, 211 nm, 20 °C) 
tR(3R,4R): 10.9 min, tR(3S,4S): 22.3 min, 98% ee; max (KBr)/cm
-1
 3086, 3037, 2926 (C-
H), 1774 (C=O), 1703, 1605, 1512; Data for major diastereoisomer: δ (400 MHz, 
CDCl ) 3.82 (1H, d, J 9.5, C(3)H), 3.93-3.97 (1H, m, C(4)H), 6.04 (1H, dd, J 3.5, 0.5, 
C(5)H), 6.86-6.93 (4H, m, ArH), 6.97-7.00 (2H, m, ArH), 7.20-7.25 (3H, m, ArH); δ
(125 MHz, CDCl ) 44.1 (C(4)), 53.0 (C(3)), 110.6 (q, J 3.3, C(5)), 116.1 (d, J 21.4, 
C(4)ArC(3,5)), 118.4 (q, J 270, CF ), 128.2 (C(3)ArC(4)), 128.3 (ArC), 129.0 (ArC), 
129.1 (d, J 8.3, C(4)ArC(2,6)), 134.5 (d, J 3.0, C(4)ArC(1)), 134.7 (C(3)ArC(1)), 141.1 
(q, J 38.0, C(6)), 162.3 (d, J 246, C(4)ArC(4)), 165.6 (C(2));F (470 MHz, CDCl3) -72.2 
(CF ), -113.7 (ArF); m/z (NSI
+
) 354 ([M+NH4]
+
, 100%); HRMS (NSI
+
) C18H16F4NO2
+
 
([M+NH4]
+
) requires 354.1112; found 354.1115 (+0.9 ppm). 
 
(3R,4R)-4-(4-chlorophenyl)-3-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-
one 
 
Following general procedure D, phenylacetic acid (27.2 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 mL), HBTM-
2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 555 (46.9 mg, 0.20 mmol) and i-
Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone (3R,4R)-253 (88:12 
dr). Chromatographic purification (eluent Et O:petrol 5:95) gave lactone (3R,4R)-253 
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(>99:1 dr) as a white solid (52.4 mg, 74%); mp 64-66 °C; 

 
D
20
-353.0 (c 0.1, CH2Cl2); 
Chiral HPLC Chiralpak AD-H (2% IPA:hexane, flow rate 2 mL min
-1
, 211 nm, 20 °C) 
tR(3R,4R): 10.2 min, tR(3S,4S): 30.3 min, >99% ee; max (KBr)/cm
-1
 3086, 3034 (C-H), 
1774 (C=O), 1702, 1597; Data for major diastereoisomer: δ (400 MHz, CDCl ) 3.82 
(1H, d, J 9.6, C(3)H), 3.93-3.96 (1H, m, C(4)H), 6.02 (1H, d, J 3.3, C(5)H), 6.86-6.88 
(2H, m, ArH), 6.97-7.00 (2H, m, ArH), 7.15-7.26 (5H, m, ArH); δ (100 MHz, CDCl ) 
44.2 (C(4)), 52.7 (C(3)), 110.3 (q, J 3.3, C(5)), 118.4 (q, J 270, CF ), 128.3 (ArC(4)), 
128.3 (ArC), 128.8 (ArC), 129.0 (ArC), 129.3 (ArC), 134.0 (C(4)ArC(4)), 134.6 
(C(3)ArC(1)), 137.2 (C(4)ArC(1)), 141.2 (q, J 38.2, C(6)), 165.5 (C(2));F (376 MHz, 
CDCl3) -72.7 (CF ); m/z (NSI
+
) 370 ([M+NH4]
+
, 95%); HRMS (NSI
+
) 
C18H16
35
ClF3NO2
+
 ([M+NH4]
+
) requires 370.0816; found 370.0818 (+0.5 ppm). 
 
(3R,4R)-3-phenyl-4-(p-tolyl)-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-one 
 
Following general procedure D, phenylacetic acid (27.2 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 mL), HBTM-
2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 558 (42.8 mg, 0.20 mmol) and i-
Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone (3R,4R)-254 (95:5 
dr). Chromatographic purification (eluent Et O:petrol 3:97) gave lactone (3R,4R)-254 
(98:2 dr) as a white solid (61.8 mg, 93%); mp 60-62 °C; 

 
D
20
-256.0 (c 0.1, CH2Cl2); 
Chiral HPLC Chiralpak AD-H (2% IPA:hexane, flow rate 2 mL min
-1
, 211 nm, 20 °C) 
tR(3R,4R): 7.2 min, tR(3S,4S): 11.5 min, 97% ee; max (KBr)/cm
-1
 3098, 3033, 2940 (C-
H), 1778 (C=O), 1701, 1635, 1516; Data for major diastereoisomer: δ (400 MHz, 
CDCl ) 2.22 (3H, s, CH ), 3.86-3.93 (2H, m, C(3)H and C(4)H), 6.03 (1H, d, J 3.3, 
C(5)H), 6.84 (2H, d, J 8.1, Ar(3)H), 6.99-7.04 (4H, m, ArH), 7.18-7.25 (3H, m, ArH); δ
(125 MHz, CDCl ) 21.1 (CH ), 44.4 (C(4)), 52.8 (C(3)), 110.9 (q, J 3.3, C(5)), 118.5 (q, 
J 270, CF ), 127.2 (ArC), 128.1 (C(3)ArC(4)), 128.2 (ArC), 128.9 (ArC), 129.8 (ArC), 
135.2 (ArC), 135.7 (ArC), 137.9 (ArC), 140.7 (q, J 38.0, C(6)), 165.9 (C(2));F (376 
MHz, CDCl3) -72.6 (CF ); m/z (NSI
+
) 350 ([M+NH4]
+
, 95%); HRMS (NSI
+
) 
C19H19F3NO2
+
 ([M+NH4]
+
) requires 350.1362; found 350.1368 (+1.6 ppm). 
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(3R,4R)-4-(4-methoxyphenyl)-3-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-
2-one 
 
Following general procedure D, phenylacetic acid (27.2 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 mL), HBTM-
2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 556 (46.0 mg, 0.20 mmol) and i-
Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone (3R,4R)-255 (94:6 
dr). Chromatographic purification (eluent Et O:petrol 7.5:92.5) gave lactone (3R,4R)-
255 (96:4 dr) as a colourless oil (65.0 mg, 93%); 

 
D
20
-345.0 (c 0.1, CH2Cl2); Chiral 
HPLC Chiralpak AD-H (5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) 
tR(3R,4R): 19.4 min, tR(3S,4S): 24.4 min, 98% ee; max (thin film)/cm
-1
 3090, 3033, 2938 
(C-H), 1780 (C=O), 1700, 1612, 1585, 1514; Data for major diastereoisomer: δ (400 
MHz, CDCl ) 3.68 (3H, s, OCH ), 3.85 (1H, d, J 8.8, C(3)H), 3.88-3.91 (1H, m, C(4)H), 
6.03 (1H, d, J 3.4, C(5)H), 6.71-6.73 (2H, m, C(4)Ar(3,5)H), 6.85-6.87 (2H, m, 
C(4)Ar(2,6)H), 7.00-7.02 (2H, m, ArH), 7.18-7.24 (3H, m, ArH); δ (100 MHz, CDCl ) 
44.0 (C(4)), 53.0 (C(3)), 55.3 (OCH ), 111.1 (q, J 3.4, C(5)), 114.5 (C(4)ArC(3,5)), 
118.5 (q, J 270, CF ), 128.1 (C(3)ArC(4)), 128.3 (ArC), 128.5 (ArC), 128.9 (ArC), 130.7 
(C(4)ArC(1), 135.2 (C(3)ArC(1)), 140.7 (q, J 38.0, C(6)), 159.2 (C(4)ArC(4)), 165.9 
(C(2));F (376 MHz, CDCl3) -72.6 (CF ); m/z (NSI
+
) 366 ([M+NH4]
+
, 100%); HRMS 
(NSI
+
) C19H19F3NO3
+
 ([M+NH4]
+
) requires 366.1312; found 366.1316 (+1.2 ppm). 
 
(3R,4R)-4-(4-nitrophenyl)-3-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-
one 
 
Following general procedure D, phenylacetic acid (27.2 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 mL), HBTM-
2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 557 (49.0 mg, 0.20 mmol) and i-
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Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone (3R,4R)-256 (73:27 
dr). Chromatographic purification (eluent Et O:petrol 25:75) gave lactone (3R,4R)-256 
(>99:1 dr) as a white solid (47.4 mg, 65%); mp 102-104 °C; 

 
D
20
-216.2 (c 0.5, 
CH2Cl2); Chiral HPLC Chiralpak AD-H (20% IPA:hexane, flow rate 1 mL min
-1
, 211 
nm, 20 °C) tR(3R,4R): 15.0 min, tR(3S,4S): 29.9 min, 86% ee; max (KBr)/cm
-1
 3089, 
2925, 2854 (C-H), 1778 (C=O), 1707, 1608, 1518 (N=O), 1342 (N=O); Data for major 
diastereoisomer: δ (400 MHz, CDCl ) 3.84 (1H, d, J 10.4, C(3)H), 4.09-4.14 (1H, m, 
C(4)H), 6.05 (1H, d, J 3.0, C(5)H), 6.96-6.98 (2H, m, ArH), 7.10-7.13 (2H, m, 
C(4)Ar(2,6)H), 7.21-7.25 (3H, m, ArH), 8.03-8.07 (2H, m, C(4)Ar(3,5)H); δ (100 MHz, 
CDCl ) 44.6 (C(4)), 52.4 (C(3)), 109.4 (q, J 3.4, C(5)), 118.3 (q, J 270, CF ), 124.3 
(C(4)ArC(3,5), 128.4 (ArC), 128.6 (C(3)ArC(4)), 128.6 (ArC), 129.2 (ArC), 133.9 
(C(3)ArC(1)), 141.9 (q, J 38.3, C(6)), 145.9 (C(4)ArC(1)), 147.6 (C(4)ArC(4)), 164.9 
(C(2));F (376 MHz, CDCl3) -72.7 (CF ); m/z (NSI
+
) 381 ([M+NH4]
+
, 74%); HRMS 
(NSI
+
) C18H16F3N2O4
+
 ([M+NH4]
+
) requires 381.1057; found 381.1059 (+0.6 ppm). 
 
(3R,4R)-4-(naphthalen-2-yl)-3-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-
one 
 
Following general procedure D, phenylacetic acid (27.2 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 mL), HBTM-
2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 559 (50.0 mg, 0.20 mmol) and i-
Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone (3R,4R)-257 (90:10 
dr). Chromatographic purification (eluent Et O:petrol 5:95) gave lactone (3R,4R)-257 
(98:2 dr) as a white solid (59.8 mg, 81%); mp 60-62 °C; 

 
D
20
-294.4 (c 0.25, CH2Cl2); 
Chiral HPLC Chiralpak AD-H (2% IPA:hexane, flow rate 2 mL min
-1
, 211 nm, 20 °C) 
tR(3R,4R): 11.1 min, tR(3S,4S): 26.8 min, >99% ee; max (KBr)/cm
-1
 3062, 2927 (C-H), 
1771 (C=O), 1700, 1634, 1601, 1509; Data for major diastereoisomer: δ (300 MHz, 
CDCl ) 4.00 (1H, d, J 8.9, C(3)H), 4.08-4.14 (1H, m, C(4)H), 6.12 (1H, d, J 3.3, C(5)H), 
7.01-7.07 (3H, m, ArH), 7.17-7.22 (3H, m, ArH), 7.37-7.43 (3H, m, ArH), 7.64-7.73 
(3H, m, ArH); δ (125 MHz, CDCl ) 44.9 (C(4)), 52.6 (C(3)), 110.7 (q, J 3.4, C(5)), 
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118.5 (q, J 270, CF ), 124.9 (ArC), 126.5 (ArC), 126.5 (ArC), 126.7 (ArC), 127.7 (ArC), 
127.8 (ArC), 128.2 (ArC), 128.3 (ArC), 129.0 (ArC), 129.2 (ArC), 132.8 (ArC), 133.3 
(ArC), 135.0 (ArC), 136.0 (ArC), 140.8 (q, J 37.9, C(6)), 165.8 (C(2));F (282 MHz, 
CDCl3) -72.5 (CF ); m/z (NSI
+
) 386 ([M+NH4]
+
, 75%); HRMS (NSI
+
) C22H19F3NO2
+
 
([M+NH4]
+
) requires 386.1362; found 386.1365 (+0.7 ppm).  
 
(3R,4R)-4-(naphthalen-1-yl)-3-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-
one 
 
Following general procedure D, phenylacetic acid (27.2 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 mL), HBTM-
2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 560 (50.0 mg, 0.20 mmol) and i-
Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone (3R,4R)-258 (94:6 
dr). Chromatographic purification (eluent Et O:petrol 4:96) gave lactone (3R,4R)-258 
(99:1 dr) as a white solid (66.7 mg, 91%); mp 118-120 °C; 

 
D
20
-284.0 (c 0.1, CH2Cl2); 
Chiral HPLC Chiralpak AD-H (2% IPA:hexane, flow rate 2 mL min
-1
, 211 nm, 20 °C) 
tR(3R,4R): 8.5 min, tR(3S,4S): 10.3 min, 98% ee; max (KBr)/cm
-1
 3094, 3038, 2875 (C-
H), 1774 (C=O), 1708, 1596, 1513; Data for major diastereoisomer: δ (400 MHz, 
CDCl ) 4.20 (1H, d, J 5.3, C(3)H), 4.75-4.77 (1H, m, C(4)H), 6.15 (1H, d, J 5.0, C(5)H), 
7.16-7.28 (6H, m, ArH), 7.35 (1H, t, J 7.7, ArH), 7.42-7.48 (2H, m, ArH), 7.73 (1H, d, J 
8.2, ArH), 7.77-7.83 (2H, m, ArH); δ (100 MHz, CDCl ) 40.0 (C(4)), 51.5 (C(3)), 109.8 
(q, J 3.3, C(5)), 118.5 (q, J 270, CF ), 122.1 (ArC), 124.7 (ArC), 125.6 (ArC), 126.1 
(ArC), 127.0 (ArC), 127.6 (ArC), 128.4 (ArC), 129.0 (ArC), 129.3 (ArC), 129.6 (ArC), 
130.4 (ArC), 133.7 (ArC), 134.4 (ArC), 135.6 (ArC), 141.5 (q, J 37.9, C(6)), 165.4 
(C(2));F (376 MHz, CDCl3) -72.5 (CF ); m/z (NSI
+
) 386 ([M+NH4]
+
, 57%); HRMS 
(NSI
+
) C22H19F3NO2
+
 ([M+NH4]
+
) requires 386.1362; found 386.1366 (+0.9 ppm). 
 
(3R,4R)-4-(furan-2-yl)-3-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-one 
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Following general procedure D, phenylacetic acid (27.2 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 mL), HBTM-
2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 562 (38.0 mg, 0.20 mmol) and i-
Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone (3R,4R)-259 (89:11 
dr). Chromatographic purification (eluent Et O:petrol 5:95) gave lactone (3R,4R)-259 
(>99:1 dr) as a white solid (47.3 mg, 77%); mp 61-63 °C; 

 
D
20
-267.0 (c 0.1, CH2Cl2); 
Chiral HPLC Chiralpak AD-H (2% IPA:hexane, flow rate 2 mL min
-1
, 211 nm, 20 °C) 
tR(3S,4S): 6.3 min, tR(3R,4R): 7.4 min, 98% ee; max (KBr)/cm
-1
 3033, 2940, 2879 (C-H), 
1780 (C=O), 1703, 1635, 1510; Data for major diastereoisomer: δ (300 MHz, CDCl ) 
4.04-4.09 (1H, m, C(4)H), 4.16 (1H, d, J 7.1, C(3)H), 5.94 (1H, d, J 3.3, C(5)H), 6.03 
(1H, d, J 4.4, C(4)Ar(3)H), 6.18 (1H, dd, J 3.3, 1.9, C(4)Ar(4)H), 7.09-7.12 (2H, m, 
ArH), 7.24-7.31 (4H, m, ArH); δ (100 MHz, CDCl ) 38.3 (C(4)), 49.5 (C(3)), 107.6 
(C(4)ArC(3)), 107.8 (q, J 3.5, C(5)), 110.5 (C(4)ArC(4)), 118.4 (q, J 270, CF ), 127.8 
(ArC), 128.4 (C(3)ArC(4)), 129.1 (ArC), 134.7 (C(3)ArC(1)), 141.2 (q, J 38.1, C(6)), 
143.0 (C(4)ArC(5)), 150.4 (C(4)ArC(2)), 165.4 (C(2));F (282 MHz, CDCl3) -72.9 
(CF ); m/z (NSI
+
) 326 ([M+NH4]
+
, 100%); HRMS (NSI
+
) C16H15F3NO3
+
 ([M+NH4]
+
) 
requires 326.0999; found 326.1003 (+1.4 ppm). 
 
(3R,4R)-3-phenyl-4-(thiophen-2-yl)-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-
one 
 
Following general procedure D, phenylacetic acid (27.2 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 mL), HBTM-
2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 561 (41.2 mg, 0.20 mmol) and i-
Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone (3R,4R)-260 (88:12 
dr). Chromatographic purification (eluent Et O:petrol 5:95) gave lactone (3R,4R)-260 
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(98:2 dr) as a white solid (55.6 mg, 86%); mp 58-60 °C; 

 
D
20
-258.0 (c 0.1, CH2Cl2); 
Chiral HPLC Chiralpak AD-H (2% IPA:hexane, flow rate 2 mL min
-1
, 211 nm, 20 °C) 
tR(3S,4S): 6.8 min, tR(3R,4R): 9.1 min, 95% ee; max (KBr)/cm
-1
 3088, 3034, 2923, 2865 
(C-H), 1774 (C=O), 1703; Data for major diastereoisomer: δ (400 MHz, CDCl ) 4.00 
(1H, d, J 8.1, C(3)H), 4.24-4.27 (1H, m, C(4)H), 6.11 (1H, d, J 4.1, C(5)H), 6.65-6.66 
(1H, m, C(4)Ar(3)H), 6.81 (1H, dd, J 5.1, 3.5, C(4)Ar(4)H), 7.06-7.09 (2H, m, ArH), 
7.13 (1H, dd, J 5.1, 1.1, C(4)Ar(5)H), 7.23-7.29 (3H, m, ArH); δ (100 MHz, CDCl ) 
39.8 (C(4)), 53.3 (C(3)), 110.2 (q, J 3.5, C(5)), 118.4 (q, J 270, CF ), 125.4 (ArC), 125.7 
(ArC), 127.3 (ArC), 128.1 (ArC), 128.4 (C(3)ArC(4)), 129.1 (ArC), 134.7 (C(3)ArC(1)), 
140.8 (q, J 38.2, C(6)), 141.1 (C(4)ArC(2)), 165.3 (C(2));F (376 MHz, CDCl3) -72.8 
(CF ); m/z (NSI
+
) 342 ([M+NH4]
+
, 97%); HRMS (NSI
+
) C16H15F3NO2S
+
 ([M+NH4]
+
) 
requires 342.0770; found 342.0775 (+1.4 ppm). 
 
(3R,4R)-4-pentyl-3-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-one 
 
Following general procedure D, phenylacetic acid (27.2 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (2 mL), HBTM-
2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 247 (38.8 mg, 0.20 mmol) and i-
Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone (3R,4R)-261 (78:22 
dr). Chromatographic purification (eluent Et O:petrol 2:98) gave lactone (3R,4R)-261 
(86:14 dr) as a colourless oil (45.7 mg, 73%); 

 
D
20
-73.0 (c 0.2, CH2Cl2); Chiral HPLC 
Chiralpak IB (2% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(3R,4R): 7.0 min, 
tR(3S,4S): 7.7 min, 98% ee; max (ATR)/cm
-1 
2957, 2932 (C-H), 1786 (C=O), 1713; Data 
for major diastereoisomer: δ (500 MHz, CDCl ) 0.89 (3H, J 7.0, CH ), 1.21-1.50 (8H, m, 
4CH ), 2.85-2.87 (1H, m, C(4)H), 3.72 (1H, d, J 8.6, C(3)H), 6.03 (1H, d, J 3.8, C(5)H), 
7.21-7.22 (2H, m, ArH), 7.35-7.43 (3H, m, ArH); Selected data for minor 
diastereoisomer δ (500 MHz, CDCl ) 4.08 (1H, d, J 6.5, C(3)H), 6.12 (1H, d, J 5.0, 
C(5)H); Data for major diastereoisomer: δ (100 MHz, CDCl ) 13.9 (CH ), 22.4 (CH ), 
25.6 (CH ), 31.4 (CH ), 32.6 (CH ), 37.6 (C(4)), 50.1 (C(3)), 111.2 (q, J 3.3, C(5)), 118.5 
(q, J 270, CF ), 128.1 (ArC), 128.2 (C(3)ArC(4)), 129.1 (ArC), 135.4 (C(3)ArC(1)), 
140.1 (q, J 37.9, C(6)), 166.9 (C(2)); Selected data for minor diastereoisomer: δ (100 
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MHz, CDCl ) 26.4 (CH ), 29.5 (CH ), 31.6 (CH ), 36.9 (C(4)), 48.9 (C(3)), 112.4 (q, J 
3.3, C(5)), 128.7 (ArC), 129.4 (ArC), 166.4 (C(2)); m/z (APCI
+
) 313 ([M+H]
+
, 100%); 
HRMS (APCI
+
) C17H20F3O2
+
 ([M+H]
+
) requires 313.1410; found 313.1408 (-0.6 ppm). 
 
(2R,3R)-methyl 6,6,6-trifluoro-5-oxo-3-phenyl-2-(m-tolyl)hexanoate 
 
Following general procedure D, m-tolylacetic acid (30.0 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 mL), HBTM-
2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 220 (40.0 mg, 0.20 mmol) and i-
Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C, followed by addition of MeOH (2 mL) 
and stirring at rt for 1 h gave crude ester (2R,3R)-263 (92:8 dr). Chromatographic 
purification (eluent Et O:petrol 10:90) gave ester (2R,3R)-263 (92:8 dr) as a white solid 
(52.6 mg, 72%); mp 58-60 °C; 

 
D
20
-130.4 (c 0.25, CH2Cl2); Chiral HPLC Chiralpak 
AD-H (5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(2S,3S): 4.4 min, 
tR(2R,3R): 5.1 min, 97% ee; max (KBr)/cm
-1
 3031, 2958, 1761 (C=O ketone), 1732 
(C=O ester), 1605; Data for major diastereoisomer: δ (300 MHz, CDCl ) 2.15 (3H, s, 
CH ), 3.08 (1H, dd, J 18.3, 3.8, C(4)H), 3.29 (1H, dd, J 18.4, 9.4, C(4)H), 3.60 (3H, s, 
CO CH ), 3.76 (1H, d, J 10.3, C(2)H), 3.82-3.90 (1H, m, C(3)H), 6.80-6.84 (3H, m, 
ArH), 6.93-7.09 (6H, m, ArH); δ (100 MHz, CDCl ) 21.3 (CH ), 40.6 (C(4)), 43.4 
(C(3)), 52.3 (CO CH ), 56.9 (C(2), 115.3 (q, J 290,CF ), 125.5 (ArC), 127.1 (ArC), 128.0 
(ArC), 128.0 (ArC), 128.3 (ArC), 128.4 (ArC), 129.1 (ArC), 136.0 (ArC), 138.1 (ArC), 
139.6 (ArC), 173.2 (C(1)), 189.2 (q, J 35.2, C(5)); F (282 MHz, CDCl3) -80.0 (CF ); 
m/z (NSI
+
) 382 ([M+NH4]
+
, 50%); HRMS (NSI
+
) C20H23F3NO3
+
 ([M+NH4]
+
) requires 
382.1625; found 382.1627 (+0.6 ppm). 
 
(3R,4R,6R)-4-phenyl-3-(m-tolyl)-6-(trifluoromethyl)tetrahydro-2H-pyran-2-one and 
(3R,4R,6S)-4-phenyl-3-(m-tolyl)-6-(trifluoromethyl)tetrahydro-2H-pyran-2-one 
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To a solution of lactone (3R,4R)-226 (96:4 dr) (100 mg, 0.30 mmol) in EtOAc (5 mL) 
was added 10% Pd/C (31.9 mg, 0.03 mmol). Hydrogen gas (1 balloon) was bubbled 
through the solution and the reaction mixture was stirred at rt for 16 h. The reaction 
mixture was filtered through Celite and washed several times with CH Cl . 
Concentration in vacuo gave crude lactones (3R,4R,6R)-264 and (3R,4R,6S)-265 (53:47 
dr). Chromatographic purification (eluent Et O:petrol 20:80) gave: 
 
Lactone (3R,4R,6R)-264 (>99:1 dr) as a white solid (51.6 mg, 51%); mp 96-98 °C; 

 
D
20
-252.7 (c 0.15, CH2Cl2); Chiral HPLC Chiralpak AD-H (5% IPA:hexane, flow rate 
1 mL min
-1
, 211 nm, 20 °C) tR(3R,4R,6R): 14.6 min, tR(3S,4S,6S): 41.8 min, 98% ee; 
max (KBr)/cm
-1
 3071, 3031, 2921 (C-H), 1743 (C=O), 1612; Data for major 
diastereoisomer: δ (300 MHz, CDCl ) 2.16 (3H, s, CH ), 2.23-2.37 (2H, m, C(5)HH and 
C(5)HH), 3.26 (1H, td, J 11.8, 3.9, C(4)H), 3.72 (1H, d, J 11.5, C(3)H), 4.88 (1H, ddq, J 
12.2, 6.8, 3.2, C(6)H), 6.65-6.70 (2H, m, ArH), 6.91-6.94 (3H, m, ArH), 7.01 (1H, t, J 
7.5, C(3)Ar(5)H), 7.10-7.20 (3H, m, ArH); δ (125 MHz, CDCl ) 21.4 (CH ), 29.4 (C(5), 
45.1 (C(4)), 55.5 (C(3)), 76.0 (q, J 33.8, C(6)), 122.6 (q, J 278, CF ), 125.7 (ArC), 127.1 
(ArC), 127.6 (ArC), 128.5 (ArC), 128.5 (ArC), 128.9 (ArC), 129.3 (ArC), 136.7 (ArC), 
138.4 (ArC), 140.0 (ArC), 169.4 (C(2)); F (282 MHz, CDCl3) -79.8 (CF ); m/z (ES
+
) 
357 ([M+Na]
+
, 100%); HRMS (ES
+
) C19H17F3NaO2
+
 ([M+Na]
+
) requires 357.1078; 
found 357.1087 (+2.5 ppm). 
 
Lactone (3R,4R,6S)-265 (>99:1 dr) as a colourless oil (45.6 mg, 45%); 

 
D
20
-100.0 (c 
0.1, CH2Cl2); Chiral HPLC Chiralpak AD-H (5% IPA:hexane, flow rate 1 mL min
-1
, 211 
nm, 20 °C) tR(3R,4R,6S): 17.8 min, tR(3S,4S,6R): 36.4 min, 97% ee; max (thin film)/cm
-1
 
3031, 2923 (C-H), 1756 (C=O), 1606; Data for major diastereoisomer: δ (300 MHz, 
CDCl ) 2.16-2.26 (4H, s, CH  and C(5)H), 2.37-2.46 (1H, m, C(5)H), 3.46 (1H, q, J 6.6, 
C(4)H), 3.93 (1H, d, J 8.0, C(3)H), 4.70-4.76 (1H, ddq, 6.8, 5.6, 4.6, C(6)H), 6.77-6.80 
(2H, m, ArH), 6.91-7.25 (7H, m, ArH); δ (125 MHz, CDCl ) 21.4 (CH ), 27.3 (C(5), 
42.5 (C(4)), 52.5 (C(3)), 74.1 (q, J 33.0, C(6)), 123.3 (q, J 279, CF ), 125.5 (ArC), 126.9 
(ArC), 127.6 (ArC), 128.4 (ArC), 128.6 (ArC), 129.1 (ArC), 129.2 (ArC), 137.0 (ArC), 
138.4 (ArC), 140.6 (ArC), 169.6 (C(2)); F (282 MHz, CDCl3) -77.7 (CF ); m/z (ES
+
) 
357 ([M+Na]
+
, 100%); HRMS (ES
+
) C19H17F3NaO2
+
 ([M+Na]
+
) requires 357.1078; 
found 357.1076 (-0.6 ppm). 
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(3R,4R,6R)-4-phenyl-3-(m-tolyl)-6-(trifluoromethyl)tetrahydro-2H-pyran-2-one 
 
To a solution of lactone (3R,4R)-226 (96:4 dr) (100 mg, 0.30 mmol) in EtOAc (3 mL) 
was added 5% Rh(PPh ) Cl (14.0 mg, 0.015 mmol). The reaction mixture was heated at 
80 °C under a 50 bar pressure of Hydrogen gas for 16 h. The reaction mixture was 
filtered through Celite and washed several times with CH Cl . Concentration in vacuo 
gave crude lactone (3R,4R,6R)-264 (96:4 dr). Chromatographic purification (eluent 
Et O:petrol 20:80) gave lactone (3R,4R,6R)-264 (>99:1 dr) as a white solid (96.3 mg, 
96%); Chiral HPLC Chiralpak AD-H (5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 
20 °C) tR(3R,4R,6R): 14.6 min, tR(3S,4S,6S): 41.8 min, 98% ee. 
 
(2R,3R,5R)-methyl 6,6,6-trifluoro-5-hydroxy-3-phenyl-2-(m-tolyl)hexanoate 
 
To a solution of lactone (3R,4R,6R)-264 (50.0 mg, 0.15 mmol) (>99:1 dr) in methanol (5 
mL) was added DMAP (3.66 mg, 0.03 mmol). The reaction mixture was stirred at 40 °C 
for 5 h before being concentrated in vacuo to give crude alcohol (2R,3R,5R)-268 (>99:1 
dr). Chromatographic purification (eluent Et O:petrol 20:80) gave alcohol (2R,3R,5R)-
268 (>99:1 dr) as a white solid (49.3 mg, 90%); mp 78-80 °C; 

 
D
20
-169.0 (c 0.1, 
CH2Cl2); Chiral HPLC Chiralpak AD-H (5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 
20 °C) tR(2S,3S,5S): 7.4 min, tR(2R,3R,5R): 12.8 min, 98% ee; max (KBr)/cm
-1
 3431 (O-
H), 3030, 2958 (C-H), 1728 (C=O), 1700, 1608; Data for major diastereoisomer: δ (400 
MHz, CDCl ) 1.91-2.03 (2H, m, C(4)H), 2.12 (3H, s, CH ), 2.53 (1H, d, J 7.0, OH), 
3.43-3.48 (1H, m, C(5)H), 3.56-3.63 (4H, m, C(3)H and CH ), 3.70 (1H, d, J 7.9 C(2)H), 
6.80-6.84 (3H, m, ArH), 6.89-6.94 (3H, m, ArH), 6.98-7.02 (1H, m, ArH), 7.05-7.09 
(2H, m, ArH); δ (100 MHz, CDCl ) 21.3 (CH ), 34.4 (C(4)), 44.6 (C(3)), 52.4 (CH ), 
57.8 (C(2)), 68.3 (q, J 31.0, C(5)), 125.1 (q, J 280,CF ), 125.5 (ArC), 126.9 (ArC), 128.0 
(ArC), 128.1 (ArC), 128.4 (ArC), 128.5 (ArC), 129.1 (ArC), 136.6 (ArC), 137.9 (ArC), 
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139.5 (ArC), 174.0 (C(1); F (376 MHz, CDCl3) -80.5 (CF ); m/z (EI
+
) 366 ([M]
+
, 12%); 
HRMS (EI
+
) C20H21F3O3
+
 ([M]
+
) requires 366.1443; found 366.1451 (+2.2 ppm). 
 
(2R,3R,5R)-6,6,6-trifluoro-3-phenyl-2-(m-tolyl)hexane-1,5-diol 
 
To a solution of lactone (3R,4R,6R)-264 (50.0 mg, 0.15 mmol) (>99:1 dr) in THF (1 
mL) at 0 °C was added LiAlH4 (2 M in THF, 0.23 mL, 0.45 mmol) and the reaction 
mixture was allowed to stir for 10 minutes at rt. The reaction mixture was quenched by 
addition of sat. aq. NaHCO3 and extracted with Et2O (x 3). The combined organic 
extracted were dried (MgSO4), filtered and concentrated in vacuo to give crude diol 
(2R,3R,5R)-269 (>99:1 dr). Chromatographic purification (eluent Et O) gave diol 
(2R,3R,5R)-269 (>99:1 dr) as a colourless oil (41.5 mg, 82%); 

 
D
20
-17.0 (c 0.1, 
CH2Cl2); Chiral HPLC Chiralcel OD-H (10% IPA:hexane, flow rate 1 mL min
-1
, 211 
nm, 20 °C) tR(2R,3R,5R): 6.1 min, tR(2S,3S,5S): 7.5 min, 98% ee; max (thin film)/cm
-1
 
3334 (O-H), 3030, 2925 (C-H), 1606, 1589; Data for major diastereoisomer: δ (300 
MHz, CDCl ) 1.67 (1H, br s, OH), 1.84-1.93 (1H, m, C(4)H), 2.06 (1H, ddd, J 14.2, 
10.9, 3.5, C(4)H), 2.15 (3H, s, CH ), 2.83 (1H, br s, OH), 2.93-3.00 (1H, m, C(2)H), 
3.32-3.43 (2H, m, C(3)H and C(5)H), 3.83 (2H, d, J 6.3, C(1)HH and C(1)HH), 
6.64-6.67 (2H, m, ArH), 6.83-6.87 (3H, m, ArH), 6.98 (1H, t, J 7.7, C(3)Ar(5)H), 7.01-
7.12 (3H, m, ArH); δ (125 MHz, CDCl ) 21.4 (CH ), 33.1 (C(4)), 42.2 (C(3)), 53.4 
(C(2), 64.6 (C(1), 68.3 (q, J 31.0, C(5)), 125.3 (q, J 280,CF ), 126.1 (ArC), 126.7 (ArC), 
127.6 (ArC), 128.0 (ArC), 128.2 (ArC), 128.9 (ArC), 129.8 (ArC), 137.7 (ArC), 139.5 
(ArC), 140.1 (ArC); F (282 MHz, CDCl3) -80.5 (CF ); m/z (ES
+
) 361 ([M+Na]
+
, 100%); 
HRMS (ES
+
) C19H21F3NaO2
+
 ([M+Na]
+
) requires 361.1391; found 361.1398 (+1.9 
ppm). 
 
(2R,3R,5S)-6,6,6-trifluoro-3-phenyl-2-(m-tolyl)hexane-1,5-diol 
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To a solution of lactone (3R,4R,6S)-265 (50.0 mg, 0.15 mmol) (>99:1 dr) in THF (1 mL) 
at 0 °C was added LiAlH4 (2 M in THF, 0.23 mL, 0.45 mmol) and the reaction mixture 
was allowed to stir for 10 minutes at rt. The reaction mixture was quenched by addition 
of sat. aq. NaHCO3 and extracted with Et2O (x 3). The combined organic extracted were 
dried (MgSO4), filtered and concentrated in vacuo to give crude diol (2R,3R,5S)-270 
(>99:1 dr). Chromatographic purification (eluent Et O:petrol 60:40) gave diol 
(2R,3R,5R)-270 (>99:1 dr) as a white solid (42.3 mg, 83%); mp 102-104 °C; 

 
D
20
-19.0 
(c 0.1, CH2Cl2); Chiral HPLC Chiralpak IB (5% IPA:hexane, flow rate 1 mL min
-1
, 211 
nm, 20 °C) tR(2S,3S,5R): 8.2 min, tR(2R,3R,5S): 9.3 min, 96% ee; max (KBr)/cm
-1
 3412 
(O-H), 2924 (C-H), 2854; Data for major diastereoisomer: δ (400 MHz, CDCl ) 1.92-
2.00 (1H, m, C(4)H), 2.13-2.20 (4H, m, C(4)H and CH ), 3.11 (1H, q, J 6.9, C(3)H), 
3.29 (1H, q, J 7.1, C(2)H), 3.78 (1H, dd, J 10.7, 6.7, C(1)H), 3.84-3.94 (2H, m, C(1)H 
and C(5)H), 6.57-6.59 (2H, m, ArH), 6.86-6.90 (3H, m, ArH), 6.97-7.00 (1H, m, 
C(3)Ar(5)H), 7.05-7.13 (3H, m, ArH); δ (125 MHz, CDCl ) 21.4 (CH ), 33.8 (C(4)), 
43.5 (C(3)), 51.7 (C(2), 64.9 (C(1), 69.1 (q, J 30.5, C(5)), 125.3 (q, J 281,CF ), 126.1 
(ArC), 126.8 (ArC), 127.7 (ArC), 128.0 (ArC), 128.1 (ArC), 129.0 (ArC), 129.9 (ArC), 
137.7 (ArC), 138.8 (ArC), 140.7 (ArC); F (376 MHz, CDCl3) -80.0 (CF ); m/z (ES
+
) 
361 ([M+Na]
+
, 100%); HRMS (ES
+
) C19H21F3NaO2
+
 ([M+Na]
+
) requires 361.1391; 
found 361.1380 (-3.2 ppm). 
 
General procedure F: LiAlH4 Mediated Rearrangements. 
To a solution of lactone (1 eq) in THF at rt was added LiAlH4 (2 M in THF, 4 eq) and 
the reaction mixture was allowed to stir for 10 minutes at rt. The reaction mixture was 
quenched by addition of sat. aq. NaHCO3 and extracted with Et2O (x 3). The combined 
organic extracts were dried (MgSO4), filtered and concentrated in vacuo to give crude 
the crude reaction mixture. Note: Racemic samples for HPLC analysis were obtained via 
the same general procedure using racemic dihydropyranones as starting materials.  
 
(2R,4R,5R)-4-phenyl-5-(m-tolyl)-2-(trifluoromethyl)tetrahydro-2H-pyran-2-ol 
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Following general procedure F, lactone (3R,4R)-226 (100 mg, 0.30 mmol) (96:4 dr) and 
LiAlH4 (2 M in THF, 0.60 mL, 1.2 mmol) in THF (1 mL) for 10 minutes at rt gave crude 
pyran (2R,4R,5R)-271 (96:4 dr). Chromatographic purification (eluent Et O:petrol 10:90) 
gave pyran (2R,4R,5R)-271 (>99:1 dr) as a colourless oil (77.1 mg, 80%); 

 
D
20
-38.3 (c 
1.0, CH2Cl2); Chiral HPLC Chiralpak IB (5% IPA:hexane, flow rate 1 mL min
-1
, 211 
nm, 20 °C) tR(2R,4R,5R): 5.8 min, tR(2S,4S,5S): 7.3 min, 97% ee; max (thin film)/cm
-1
 
3418 (O-H), 3030, 2941 (C-H), 1705, 1608. 1591; Data for major diastereoisomer: δ
(500 MHz, CDCl ) 1.94 (1H, t, J 13.1, C(3)H), 2.12-2.15 (4H, m, C(3)H and CH ), 2.74 
(1H, br s, OH), 3.08 (1H, td, J 11.7, 4.6, C(5)H), 3.43 (1H, td, 12.2, 3.8, C(4)H), 3.86 
(1H, dd, J 11.4, 4.7, C(6)H), 4.00 (1H, t, J 11.5, C(6)H), 6.81-6.83 (3H, m, ArH), 6.96-
7.03 (4H, m, ArH), 7.07-7.10 (2H, m, ArH); δ (125 MHz, CDCl ) 21.4 (CH ), 35.3 
(C(3)), 40.7 (C(4)), 47.2 (C(5), 67.2 (C(6), 94.5 (q, J 32.0, C(2)), 122.7 (q, J 284,CF ), 
125.2 (ArC), 126.6 (ArC), 127.6 (ArC), 127.8 (ArC), 128.3 (ArC), 128.5 (ArC), 128.9 
(ArC), 138.0 (ArC), 138.5 (ArC), 142.0 (C(4)ArC(1)); F (470 MHz, CDCl3) -87.1 
(CF ); m/z (ES
+
) 359 ([M+Na]
+
, 100%); HRMS (ES
-
) C19H18F3O2
+
 ([M-H]
+
) requires 
335.1259; found 335.1258 (-0.4 ppm). 
 
(2R,4R,5R)-5-(naphthalen-2-yl)-4-phenyl-2-(trifluoromethyl)tetrahydro-2H-pyran-
2-ol 
 
Following general procedure F, lactone (3R,4R)-235 (39.8 mg, 0.11 mmol) (98:2 dr) and 
LiAlH4 (2 M in THF, 0.22 mL, 0.44 mmol) in THF (1 mL) for 10 minutes at rt gave 
crude pyran (2R,4R,5R)-272 (98:2 dr). Chromatographic purification (eluent Et O:petrol 
15:85) gave pyran (2R,4R,5R)-272 (>99:1 dr) as a white solid (36.7 mg, 90%); mp 111-
113 °C; 

 
D
20
-98.7 (c 0.15, CH2Cl2); Chiral HPLC Chiralpak AD-H (5% IPA:hexane, 
flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(2R,4R,5R): 11.9 min, tR(2S,4S,5S): 17.6 min, 
97% ee; max (KBr)/cm
-1
 3490 (O-H), 3031, 2941 (C-H); Data for major diastereoisomer: 
δ (400 MHz, CDCl ) 2.00 (1H, td, J 13.0, 2.6, C(3)H), 2.20 (1H, dd, J 13.6, 4.0, C(3)H), 
2.75 (1H, d, J 2.7, OH), 3.30 (1H, td, J 11.7, 4.7, C(5)H), 3.58 (1H, td, 12.1, 4.0, C(4)H), 
3.94 (1H, dd, J 11.4, 4.7, C(6)H), 4.12 (1H, t, J 11.5, C(6)H), 6.94-6.98 (1H, m, ArH), 
7.03-7.08 (4H, m, ArH), 7.17-7.19 (1H, m, ArH), 7.29-7.35 (2H, m, ArH), 7.49 (1H, s, 
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C(5)Ar(1)H), 7.58-7.65 (3H, m, ArH); δ (100 MHz, CDCl ) 35.4 (C(3)), 40.8 (C(4)), 
47.4 (C(5), 67.1 (C(6), 94.5 (q, J 32.0, C(2)), 122.7 (q, J 284, CF ), 125.7 (ArC), 126.0 
(ArC), 126.2 (ArC), 126.7 (ArC), 127.2 (ArC), 127.5 (ArC), 127.6 (ArC), 127.6 (ArC), 
128.2 (ArC), 128.6 (ArC), 132.5 (ArC), 133.4 (ArC), 136.1 (ArC), 141.8 (ArC); F (376 
MHz, CDCl3) -87.6 (CF ); m/z (ES
-
) 371 ([M-H]
+
, 100%); HRMS (ES
-
) C22H18F3O2
+
 
([M-H]
+
) requires 371.1259; found 371.1272 (+3.6 ppm). 
 
(2R,4R,5R)-5-(4-chlorophenyl)-4-phenyl-2-(trifluoromethyl)tetrahydro-2H-pyran-
2-ol 
 
Following general procedure F, lactone (3R,4R)-228 (42.2 mg, 0.12 mmol) (>99:1 dr) 
and LiAlH4 (2 M in THF, 0.22 mL, 0.44 mmol) in THF (1 mL) for 10 minutes at rt gave 
crude pyran (2R,4R,5R)-273 (>99:1 dr). Chromatographic purification (eluent 
Et O:petrol 15:85) gave pyran (2R,4R,5R)-273 (>99:1 dr) as a colourless oil (40.3 mg, 
94%); 

 
D
20
-67.0 (c 0.1, CH2Cl2); Chiral HPLC Chiralpak AD-H (5% IPA:hexane, flow 
rate 1 mL min
-1
, 211 nm, 20 °C) tR(2R,4R,5R): 10.7 min, tR(2S,4S,5S): 18.5 min, 92% 
ee; max (thin film)/cm
-1
 3399 (O-H), 3031, 2940 (C-H) 1600; Data for major 
diastereoisomer: δ (400 MHz, CDCl ) 1.95 (1H, td, J 13.0, 2.1, C(3)H), 2.15 (1H, dd, J 
13.5, 3.8, C(3)H), 2.72 (1H, d, J 2.2, OH), 3.09 (1H, td, J 11.7, 4.7, C(5)H), 3.38 (1H, td, 
12.1, 3.9, C(4)H), 3.85 (1H, dd, J 11.4, 4.6, C(6)H), 4.00 (1H, t, J 11.5, C(6)H), 
6.95-7.13 (9H, m, ArH); δ (100 MHz, CDCl ) 35.2 (C(3)), 41.0 (C(4)), 46.9 (C(5), 66.8 
(C(6), 94.4 (q, J 31.9, C(2)), 122.6 (q, J 283,CF ), 126.9 (C(4)ArC(4)), 127.5 (ArC), 
128.6 (ArC), 128.7 (ArC), 129.4 (ArC), 132.7 (C(5)ArC(4)), 137.1 (C(5)ArC(1)), 141.4 
(C(4)ArC(1)); F (376 MHz, CDCl3) -87.6 (CF ); m/z (ES
-
) 355 ([M-H]
+
, 100%); HRMS 
(ES
-
) C18H15
35
ClF3O2
+
 ([M-H]
+
) requires 355.0713; found 355.0716 (+0.8 ppm). 
 
(2R,4R,5R)-4-(naphthalen-1-yl)-5-phenyl-2-(trifluoromethyl)tetrahydro-2H-pyran-
2-ol 
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Following general procedure F, lactone (3R,4R)-258 (52.8 mg, 0.14 mmol) (99:1 dr) and 
LiAlH4 (2 M in THF, 0.29 mL, 0.57 mmol) in THF (1 mL) for 10 minutes at rt gave 
crude pyran (2R,4R,5R)-274 (99:1 dr). Chromatographic purification (eluent Et O:petrol 
15:85) gave pyran (2R,4R,5R)-274 (>99:1 dr) as a white solid (50.7 mg, 95%); mp 132-
134 °C; 

 
D
20
+159.6 (c 0.25, CH2Cl2); Chiral HPLC Chiralpak IB (5% IPA:hexane, 
flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(2S,4S,5S): 9.7 min, tR(2R,4R,5R): 13.0 min, 
98% ee; max (KBr)/cm
-1
 3517 (O-H), 3065, 2948 (C-H), 1599; Data for major 
diastereoisomer: δ (500 MHz, CDCl ) 1.85 (1H, t, J 12.9, C(3)H), 2.36 (1H, dd, J 13.7, 
3.3, C(3)H), 2.81 (1H, s, OH), 3.54 (1H, td, J 11.4, 4.5, C(5)H), 4.00 (1H, dd, J 11.5, 
4.6, C(6)H), 4.10 (1H, t, J 11.4, C(6)H), 4.48 (1H, td, 12.0, 3.3, C(4)H), 6.96 (1H, t, J 
7.3, ArH), 7.03 (2H, t, J 7.5, ArH) 7.11 (2H, d, J 7.3, ArH), 7.22 (1H, t, J 7.6, ArH), 
7.27 (1H, d, J 6.9 ArH), 7.38 (1H, t, J 7.5, ArH), 7.47-7.50 (1H, m, ArH), 7.54 (1H, d, J 
7.9, C(3)Ar(4)H), 7.72 (1H, d, J 8.1, C(4)Ar(5)H), 8.17 (1H, d, J 8.6, C(4)Ar(8)H); δ
(100 MHz, CDCl ) 33.9 (C(4)), 36.0 (C(3)), 45.9 (C(5), 68.1 (C(6), 94.6 (q, J 32.1, 
C(2)), 122.3 (ArH), 122.6 (q, J 283,CF ), 123.8 (ArC), 125.5 (ArC), 125.5 (ArC), 126.4 
(ArC), 127.0 (ArC), 127.1 (ArC), 128.0 (ArC), 128.6 (ArC), 129.1 (ArC), 131.4 (ArC), 
134.0 (ArC), 137.7 (ArC) 138.4 (ArC); F (470 MHz, CDCl3) -87.0 (CF ), -116.6 (ArF); 
m/z (ES
-
) 371 ([M-H]
+
, 100%); HRMS (ES
-
) C22H18F3O2
+
 ([M-H]
+
) requires 371.1259; 
found 371.1258 (-0.3 ppm). 
 
(2R,4R,5R)-4-(4-methoxyphenyl)-5-phenyl-2-(trifluoromethyl)tetrahydro-2H-
pyran-2-ol 
 
Following general procedure F, lactone (3R,4R)-255 (49.7 mg, 0.14 mmol) (96:4 dr) and 
LiAlH4 (2 M in THF, 0.29 mL, 0.57 mmol) in THF (1 mL) for 10 minutes at rt gave 
crude pyran (2R,4R,5R)-275 (96:4 dr). Chromatographic purification (eluent Et O:petrol 
15:85) gave pyran (2R,4R,5R)-275 (>99:1 dr) as a colourless oil (46.8 mg, 93%); 

 
D
20
-
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39.0 (c 0.1, CH2Cl2); Chiral HPLC Chiralpak AD-H (5% IPA:hexane, flow rate 1 mL 
min
-1
, 211 nm, 20 °C) tR(2R,4R,5R): 12.7 min, tR(2S,4S,5S): 44.4 min, 98% ee; max (thin 
film)/cm
-1
 3391 (O-H), 3031, 2939 (C-H), 1612, 1515; Data for major diastereoisomer: 
δ (300 MHz, CDCl ) 1.92 (1H, td, J 13.0, 2.5, C(3)H), 2.12 (1H, dd, J 13.5, 4.0, C(3)H), 
2.77 (1H, d, J 2.6, OH), 3.06 (1H, td, J 11.7, 4.7, C(5)H), 3.34-3.43 (1H, m, C(4)H), 
3.62 (3H, s, OCH ), 3.87 (1H, dd, J 11.4, 4.8, C(6)H), 4.02 (1H, t, J 11.5, C(6)H), 6.60-
6.65 (2H, m, C(4)Ar(3,5)H), 6.91-6.96 (2H, m, C(4)Ar(2,6)H), 7.01-7.14 (5H, m, ArH); 
δ (125 MHz, CDCl ) 35.4 (C(3)), 40.0 (C(4)), 47.7 (C(5), 55.1 (OCH ), 67.1 (C(6), 94.4 
(q, J 32.0, C(2)), 113.8 (C(4)ArC(3,5)), 122.7 (q, J 284, CF ), 126.9 (C(5)ArC(4)), 128.2 
(ArC), 128.4 (ArC), 128.5 (ArC), 134.0 (C(4)ArC(1)), 138.7 (C(5)ArC(1)), 158.1 
(C(4)ArC(4)); F (282 MHz, CDCl3) -87.6 (CF ), -116.6 (ArF); m/z (ES
-
) 351 ([M-H]
+
, 
100%); HRMS (ES
-
) C19H18F3O3
+
 ([M-H]
+
) requires 351.1208; found 351.1204 (-1.1 
ppm). 
 
(2R,4R,5R)-4-(4-fluorophenyl)-5-phenyl-2-(trifluoromethyl)tetrahydro-2H-pyran-2-
ol 
 
Following general procedure F, lactone (3R,4R)-252 (40.3 mg, 0.12 mmol) (>99:1 dr) 
and LiAlH4 (2 M in THF, 0.22 mL, 0.44 mmol) in THF (1 mL) for 10 minutes at rt gave 
crude pyran (2R,4R,5R)-276 (>99:1 dr). Chromatographic purification (eluent 
Et O:petrol 15:85) gave pyran (2R,4R,5R)-276 (>99:1 dr) as a colourless oil (37.9 mg, 
93%); 

 
D
20
-52.0 (c 0.1, CH2Cl2); Chiral HPLC Chiralpak AD-H (5% IPA:hexane, flow 
rate 1 mL min
-1
, 211 nm, 20 °C) tR(2R,4R,5R): 8.4 min, tR(2S,4S,5S): 26.0 min, 98% ee; 
max (thin film)/cm
-1
 3419 (O-H), 3032, 2941 (C-H), 1704, 1606; Data for major 
diastereoisomer: δ (400 MHz, CDCl ) 1.93 (1H, td, J 13.0, 2.4, C(3)H), 2.13 (1H, dd, J 
13.4, 3.9, C(3)H), 2.72 (1H, d, J 2.5, OH), 3.04 (1H, td, J 11.7, 4.7, C(5)H), 3.42 (1H, 
ddd, 14.5, 9.8, 4.4, C(4)H), 3.88 (1H, dd, J 11.4, 4.7, C(6)H), 4.04 (1H, t, J 11.5, 
C(6)H), 6.77-6.79 (2H, m, C(4)Ar(3,5)H), 6.96-7.13 (7H, m, ArH); δ (100 MHz, CDCl ) 
35.2 (C(3)), 40.3 (C(4)), 47.8 (C(5), 66.9 (C(6), 94.4 (q, J 32.1, C(2)), 115.3 (d, J 21.1, 
C(4)ArC(3,5)), 122.6 (q, J 283,CF ), 127.1 (C(5)ArC(4)), 128.1 (ArC), 128.6 (ArC), 
128.9 (d, J 7.8, C(4)ArC(2,6)), 137.5 (d, J, 3.0, C(4)ArC(1)), 138.3 (C(5)ArC(1)), 161.5 
 Chapter 9: Experimental 
 
 241 
(d, J 243, C(4)ArC(4)); F (376 MHz, CDCl3) -87.6 (CF ), -116.6 (ArF); m/z (ES
-
) 339 
([M-H]
+
, 100%); HRMS (ES
-
) C18H15F4O2
+
 ([M-H]
+
) requires 339.1008; found 
339.1014 (+1.8 ppm). 
 
4-pentyl-5-phenyl-2-(trifluoromethyl)tetrahydro-2H-pyran-2-ol 
 
Following general procedure F, lactone (±)-261 (50.0 mg, 0.27 mmol) (90:10 dr) and 
LiAlH4 (2 M in THF, 0.54 mL, 1.1 mmol) in THF (1 mL) for 10 minutes at rt gave crude 
pyran (±)-277 (90:10 dr). Chromatographic purification (eluent Et O:petrol 10:90) gave 
pyran (±)-277 (>99:1 dr) as a colourless oil (41.0 mg, 80%); max (ATR)/cm
-1
 3408 (O-
H), 2957, 2932 (C-H), 1602; δ (500 MHz, CDCl ) 0.84 (3H, t, J 7.11, CH ), 0.96-1.31 
(8H, m, 4CH ), 1.51 (1H, app t, J 12.7, C(3)HH), 2.18 (1H, dd, J 13.3, 3.9, C(3)HH), 
2.22-2.29 (1H, m, C(4)H), 2.61 (1H, td, J 11.6, 4.7, C(5)H), 2.68 (1H, br s, OH), 3.80 
(1H, dd, J 11.3, 4.7, C(6)HH), 3.95 (1H, t, J 11.6, C(6)HH), 7.22 (2H, d, J 7.2, 
C(5)Ar(2,6)H), 7.29 (1H, t, J 7.3, C(5)Ar(4)H), 7.36 (2H, t, J 7.5, C(5)Ar(3,5)H); δ (125 
MHz, CDCl ) 14.0 (CH ), 22.5 (CH ), 25.5 (CH ), 31.8 (CH ), 32.0 (CH ), 33.0 (CH ), 
33.5 (C(4)), 48.1 (C(5)), 66.9 (C(6), 94.5 (q, J 31.8, C(2)), 122.8 (q, J 284,CF ), 127.1 
(C(5)ArC(4)), 128.2 (ArC), 128.7 (ArC), 139.5 (C(5)ArC(1)); m/z (APCI
+
) 316 ([M]
+
, 
100%); HRMS (APCI
+
) C17H27F3NO2
+
 ([M+NH4]
+
) requires 334.1988; found 334.1986 
(-0.7 ppm). 
 
2-(4-fluorophenyl)acetic pivalic anhydride 
 
To a solution of 4-fluorophenylacetic acid (0.10 g, 0.65 mmol) in CH2Cl2 (3 mL) at rt 
was added i-Pr2NEt (0.17 mL, 0.98 mmol) and pivaloyl chloride (0.12 mL, 0.98 mmol). 
The reaction mixture was allowed to stir for 15 minutes before being concentrated in 
vacuo. The crude reaction mixture was treated with petrol (10 mL) and then filtered to 
remove inorganic salts. The filtrate was concentrated in vacuo to give mixed anhydride 
282 as a yellow oil (0.15 g, 97%) which was characterised crude without further 
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purification: δ (400 MHz, CD Cl ) 1.09 (9H, s, C(CH ) ), 3.66 (2H, s, CH ), 6.93-6.99 
(2H, m, Ar(3,5)H), 7.15-7.20 (2H, m, Ar(2,6)H);F (376 MHz, CD Cl ) -116.2 (ArF). 
 
(2S,3R)-1-(2-(4-fluorophenyl)acetyl)-3-isopropyl-2-phenyl-1,2,3,4-
tetrahydrobenzo[4,5]thiazolo[3,2-a]pyrimidin-5-ium chloride 
 
To a solution of 4-fluorophenylacetyl chloride (0.10 g, 0.58 mmol) in CH2Cl2 (2 mL) 
was added isothiourea (2S,3R)-112 (0.18 g, 0.58 mmol) and the reaction mixture was 
allowed to stir at rt for 10 minutes before being filtered to give salt (2S,3R)-293 as a light 
yellow solid (0.26 g, 92%); mp 102-104 °C (Decomp); max (KBr)/cm
-1
 2925 (C-H), 
1712 (C=O), 1603, 1535, 1511; δ (400 MHz, CD Cl ) 0.95 (3H, d, J 6.7, CH3), 1.42 (3H, 
d, J 6.6, CH3), 1.65-1.74 (1H, m, CH(CH3)2), 3.13-3.21 (1H, m, C(3)H), 3.66 (1H, d, J 
17.7, CHH), 3.95 (1H, app. t, J 13.0, C(4)HH), 4.79 (1H, dd, J 13.3, 4.4, C(4)HH), 5.51 
(1H, d, J 17.8, CHH), 6.60 (1H, d, J 4.2, C(2)H), 6.95-6.99 (2H, m, 4-FAr(3,5)H), 7.15-
7.18 (2H, m, ArH), 7.19-7.23 (2H, m, 4-FAr(2,6)H), 7.42-7.48 (3H, m, ArH), 7.66-7.70 
(1H, m, ArH), 7.81 (1H, td, J 7.9, 1.0), 8.02 (1H, d, J 8.4, ArH), 8.10 (1H, d, J 7.6, 
ArH); δ (125 MHz, CD Cl ) 19.6 (CH ), 21.9 (CH ), 26.8 (CH(CH3)2), 39.8 (C(3)), 40.6 
(CH ), 44.8 (C(4)), 61.5 (C(2)), 114.2 (ArC), 115.4 (d, J 21.3, 4-FArC(3,5)), 123.4 
(ArC), 126.2 (ArC), 127.1 (ArC), 127.7 (d, J 3.0, 4-FArC(1)), 127.9 (ArC), 129.6 (ArC), 
129.9 (ArC), 129.9 (ArC), 131.9 (d, J 8.0, 4-FArC(2,6)), 134.6 (ArC), 136.1 (ArC), 160.7 
(C=N), 162.2 (d, J 245, 4-FArC(4)), 173.7 (C=O); F (376 MHz, CD Cl ) -116.3 (ArF); 
m/z (ES
+
) 445 ([M]
+
, 100%); HRMS (ES
+
) C27H26FN2OS
+
 ([M]
+
) requires 445.1750; 
found 445.1743 (-1.4 ppm). 
 
(3R,4R)-3-(4-fluorophenyl)-4-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-
one 
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Following general procedure D, 4-fluorophenylacetic acid (30.8 mg, 0.20 mmol), i-
Pr2NEt (51.9 L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (2 
mL), acyl ammonium (2S,3R)-293 (4.81 mg, 0.01 mmol, 5 mol%), enone 220 (40.0 mg, 
0.20 mmol) and i-Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone 
(3R,4R)-229 (90:10 dr). Chromatographic purification (eluent Et O:petrol 5:95) gave 
lactone (3R,4R)-229 (>99:1 dr) as a white solid (59.3 mg, 88%) with identical 
spectroscopic properties to those given previously; 

 
D
20
-256.0 (c 0.1, CH2Cl2); Chiral 
HPLC Chiralcel OD-H (10% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) 
tR(3R,4R): 19.2 min, tR(3S,4S): 39.4 min, 99% ee. 
 
2-d
2
-(4-fluorophenyl)acetic acid 
 
To a solution of 4-fluorophenylacetic acid (1.00 g, 6.49 mmol) in D2O (6 mL) was added 
K2CO3 (3.59 g, 26.0 mmol) and the reaction mixture was heated at reflux for 16 h. The 
crude reaction mixture was acidified by careful addition of HCl (8 M in H2O) and 
extracted with CH2Cl2 (x 3). The organic layer was separated, dried (MgSO4), filtered 
and concentrated in vacuo. The whole process was repeated a further 3 times to give acid 
285 as a white solid (0.57 g, 56%) which was 99% deuterated according to 
1
H NMR; mp 
83-84 °C; max (ATR)/cm
-1
 3200-2520 (CO2H), 2922 (C-H), 1692 (C=O), 1608, 1512; δ
(300 MHz, CDCl ) 7.02-7.10 (2H, m, Ar(3,5)H), 7.25-7.32 (2H, m, Ar(2,6)H), 11.9 (1H, 
s, OH); δ (75 MHz, CDCl ) 116.0 (d, J 21.4, ArC(3,5)), 129.3 (ArC(1)), 131.4 (d, J 8.0, 
ArC(2,6)), 163.0 (d, J 244, ArC(4)), 178.7 (C=O); m/z (ES
+
) 155 ([M-H]
+
, 100%); 
HRMS (NSI
+
) C8H4D2FO2
+
 ([M-H]
+
) requires 155.0483; found 155.0484 (+0.7 ppm). 
 
(3R,4R)-3-(4-fluorophenyl)-4-phenyl-6-(trifluoromethyl)-3-deutero-4-hydro-2H-
pyran-2-one 
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Following general procedure D, acetic acid 285 (31.2 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (2 mL), HBTM-
2.1 (2S,3R)-112 (3.08 mg, 0.01 mmol, 5 mol%), enone 220 (40.0 mg, 0.20 mmol) and i-
Pr2NEt (87.0 L, 0.50 mmol) for 16 h at 78 °C gave crude lactone (3R,4R)-294 (90:10 
dr) with 30% proton incorporation observed at C(3). Chromatographic purification 
(eluent Et O:petrol 5:95) gave lactone (3R,4R)-294 (>99:1 dr) as a white solid (49.0 mg, 
73%). 
 
(3R,4S)-3,4-diphenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-one 
 
Following general procedure D, phenylacetic acid (27.2 mg, 0.20 mmol), i-Pr2NEt (51.9 
L, 0.30 mmol) and pivaloyl chloride (37.0 L, 0.30 mmol) in CH Cl  (1 mL), HBTM-
2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 295 (40.0 mg, 0.20 mmol) and i-
Pr2NEt (87.0 L, 0.50 mmol) for 1 h at 78 °C gave crude lactone (3R,4S)-299 (85:15 
dr). Chromatographic purification (eluent Et O:petrol 3:97) gave lactone (3R,4S)-299 
(91:9 dr) as a white solid (47.3 mg, 74%); mp 100-102 °C; 

 
D
20
+370.0 (c 0.2, CH2Cl2); 
Chiral HPLC Chiralpak IB (5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) 
tR(3S,4R): 6.5 min, tR(3R,4S): 9.2 min, 99% ee; max (KBr)/cm
-1
 3094, 2922 (C-H), 1790 
(C=O), 1705; Data for major diastereoisomer: δ (300 MHz, CDCl ) 3.86-3.91 (1H, m, 
C(4)H), 4.23 (1H, d, J 7.1, C(3)H), 6.23 (1H, dd, J 5.9, 0.6, C(5)H), 6.63-6.66 (2H, m, 
ArH), 6.69-6.72 (2H, m, ArH), 7.05-7.23 (6H, m, ArH); δ (100 MHz, CDCl ) 44.4 
(C(4)), 51.0 (C(3)), 111.3 (q, J 3.4, C(5)), 118.6 (q, J 270, CF ), 128.0 (ArC), 128.1 
(ArC), 128.4 (ArC), 128.5 (ArC), 128.8 (ArC), 129.6 (ArC), 132.6 (4ry ArC), 134.7 (4ry 
ArC), 141.6 (q, J 38, C(6)), 165.5 (C(2));F (282 MHz, CDCl3) -72.5 (CF ); m/z 
(APCI
+
) 319 ([M+H]
+
, 100%); HRMS (APCI
+
) C18H14F3O2
+
 ([M+H]
+
) requires 
319.0940; found 319.0944 (+1.1 ppm). 
 
(2R,4S,5R)-4,5-diphenyl-2-(trifluoromethyl)tetrahydro-2H-pyran-2-ol 
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Following general procedure F, lactone (3R,4S)-299 (84 mg, 0.26 mmol) (92:8 dr) and 
LiAlH4 (2 M in THF, 0.53 mL, 1.06 mmol) in THF (1 mL) for 10 minutes at rt gave 
crude pyran (2R,4S,5R)-300 (92:8 dr). Chromatographic purification (eluent Et O:petrol 
15:85) gave pyran (2R,4S,5R)-300 (94:6 dr) as a white solid (65.0 mg, 76%); mp 130-
132 °C; 

 
D
20
-232 (c 0.2, CH2Cl2); Chiral HPLC Chiralcel OJ-H (5% IPA:hexane, flow 
rate 1 mL min
-1
, 211 nm, 30 °C) tR(2S,4R,5S): 13.2 min, tR(2R,4S,5R): 15.5 min, 99% 
ee; max (ATR)/cm
-1
 3526 (O-H), 3029, 2944 (C-H), 1700, 1618; Data for major 
diastereoisomer: δ (400 MHz, CDCl ) 1.82 (1H, dd, J 13.2, 3.3, C(3)HH), 2.21 (1H, t, J 
13.5, C(3)HH), 2.73 (1H, br s, OH), 2.94 (1H, t, J 4.0, C(5)H), 3.73 (1H, dt, 14.0, 4.0, 
C(4)H), 4.21 (1H, d, J 11.5, C(6)HH), 4.53 (1H, dd, J 11.5, 3.5, C(6)HH), 6.68-6.71 
(2H, m, ArH), 6.87-6.89 (2H, m, ArH), 7.00-7.10 (6H, m, ArH); δ (125 MHz, CDCl ) 
26.4 (C(3)), 38.6 (C(4)), 45.2 (C(5), 66.8 (C(6), 94.7 (q, J 32.1, C(2)), 122.9 (q, J 
284,CF ), 126.6 (ArC), 126.7 (ArC), 127.6 (ArC), 127.9 (ArC), 128.1 (ArC), 129.7 
(ArC), 138.8 (4ry ArC), 141.3 (4ry ArC); F (376 MHz, CDCl3) -87.8 (CF ); m/z 
(APCI
+
) 340 ([M+NH4]
+
, 100%); HRMS (APCI
+
) C18H21F3NO2
+
 ([M+NH4]
+
) requires 
340.1519; found 340.1517 (-0.6 ppm). 
  
9.3.2 Kinetic Studies 
General Experimental Procedure For Kinetic Studies 
To an NMR tube was added the required amount of 4-fluorophenylacetic acid, 1-fluoro-
4-nitrobenzene, i-Pr2NEt, pivaloyl chloride and CD2Cl2. Subsequently, at 78 °C was 
added the required amount of HBTM-2.1 (2S,3R)-112, enone 220 and i-Pr2NEt. The 
reaction was followed dynamically by 
19
F NMR at 78 °C.  
 
Data from NMR experiments  
Concentrations are calculated based on 20 mM internal standard of 4-
fluoronitrobenzene. See Table 10 in Section 3.6.1 for initial conditions. Plots of 
ln([mixed anhydride 282]/mM) and ln([trifluoromethyl enone 220]/mM) vs. time are 
included for each run. 
 
Run 1 
Time/minutes [mixed anhydride 282]/mM [trifluoromethyl enone 220]/mM 
14.40 75.9 72.33 
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24.02 71.3 68.67 
40.52 64.6 61.67 
57.03 58.5 55.33 
73.55 53.2 49.67 
90.07 48.2 45.67 
106.58 43.9 40.33 
123.00 40.0 36.67 
139.60 35.7 32.93 
156.10 32.9 29.77 
172.65 29.9 27.13 
189.17 27.1 24.47 
205.67 24.9 20.67 
222.20 22.6 18.47 
238.70 20.4 16.6 
255.22 18.7 14.93 
271.73 17.1 13.5 
288.23 15.8 12.5 
304.75 14.3 11.17 
321.27 13.1 9.97 
337.80 12.1 8.93 
354.32 11.1 7.9 
370.82 10.3 7.13 
 
  
 
Run 2 
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Time/minutes [mixed anhydride 282]/mM [trifluoromethyl enone 220]/mM 
5.52 73.30 35.33 
11.53 71.60 32.93 
26.77 66.50 26.53 
42.00 60.30 20.90 
57.25 57.00 15.90 
72.48 53.10 11.23 
87.72 49.70 7.67 
102.97 46.60 4.53 
118.20 43.80 1.97 
133.45 41.60 0.40 
 
  
 
Run 3 
Time/minutes [mixed anhydride 282]/mM [trifluoromethyl enone 220]/mM 
5.07 74.10 65.00 
11.52 72.20 62.00 
26.75 67.50 55.33 
41.98 62.60 48.67 
57.22 58.40 43.67 
72.45 55.20 37.67 
87.70 51.70 32.97 
102.92 48.70 29.37 
118.17 45.90 26.37 
133.40 43.10 23.37 
 Chapter 9: Experimental 
 
 248 
148.65 40.60 20.67 
163.88 37.90 18.23 
179.12 35.50 15.87 
194.37 33.20 13.77 
209.58 31.40 11.57 
224.82 29.50 9.67 
240.07 27.60 8.10 
255.30 26.40 6.53 
270.55 25.00 5.10 
285.78 23.40 3.70 
301.03 22.20 2.88 
316.27 20.70 1.73 
331.50 20.00 1.07 
346.75 19.20 0.50 
361.98 18.50 0.29 
377.22 18.20 0.00 
 
  
 
Run 4 
Time/minutes [mixed anhydride 282]/mM [trifluoromethyl enone 220]/mM 
3.4 67.7 153.30 
8.4 66.6 150.00 
23.6 61.6 143.70 
38.9 58.0 138.00 
54.1 53.7 132.67 
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69.4 50.7 128.67 
84.6 47.4 126.00 
99.8 44.8 122.00 
115.1 42.0 120.67 
130.3 39.3 117.00 
145.6 36.1 114.67 
160.8 33.7 112.67 
176.0 31.7 110.33 
191.3 29.8 108.00 
206.5 27.5 106.67 
221.8 25.8 104.67 
236.0 23.5 103.00 
252.2 22.2 101.67 
267.5 20.7 100.00 
282.7 18.8 98.00 
298.0 17.8 96.00 
313.2 16.5 94.67 
328.4 15.2 93.67 
  
  
 
Run 5 
Time/minutes [mixed anhydride 282]/mM [trifluoromethyl enone 220]/mM 
4.0 66.6 247.00 
9.9 64.7 244.00 
25.2 60.8 238.00 
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40.4 56.9 231.67 
55.7 52.8 225.33 
70.9 50.3 222.67 
86.2 46.6 219.33 
101.4 43.5 216.00 
116.6 40.4 214.00 
131.9 37.7 210.00 
147.1 35.3 207.67 
162.4 32.4 205.33 
177.6 30.4 204.00 
192.8 28.3 202.00 
208.1 26.3 200.00 
223.3 24.2 198.23 
238.5 22.4 195.67 
253.8 20.9 194.00 
269.0 19.7 192.33 
284.3 18.3 191.33 
299.5 16.9 190.00 
314.7 15.3 189.00 
330.0 14.3 188.00 
 
  
 
Run 6 
Time (minutes) [mixed anhydride 282]/mM [trifluoromethyl enone 220]/mM 
3.70 65.80 81.00 
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8.52 65.00 79.33 
23.75 61.90 75.66 
39.00 58.80 72.00 
54.23 56.30 69.00 
69.48 54.20 66.00 
84.72 51.10 63.33 
99.97 48.90 61.00 
115.20 46.70 58.66 
130.43 44.70 56.66 
145.68 42.80 54.33 
160.92 40.70 52.00 
176.15 38.33 50.00 
191.40 36.70 48.00 
206.63 35.10 46.00 
221.88 33.50 44.67 
237.13 31.70 43.00 
252.37 30.60 41.67 
267.62 28.90 40.33 
282.85 27.90 39.00 
298.13 26.30 37.66 
313.33 25.30 36.33 
 
  
 
Run 7 
Time/minutes [mixed anhydride 282]/mM [trifluoromethyl enone 220]/mM 
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5.18 60.3 70.67 
10.13 57.4 68.33 
25.38 48 59.00 
40.62 40 50.33 
55.87 33.4 43.67 
71.12 27.8 38.33 
86.35 23.3 33.33 
101.60 19.2 29.00 
116.85 16 25.97 
132.08 13.3 23.33 
147.30 11 21.00 
162.53 9.09 18.87 
177.78 7.61 16.67 
193.02 5.8 15.00 
208.28 5.33 14.20 
223.53 4.19 13.33 
238.77 3.6 12.60 
254.02 3.05 11.90 
 
  
 
Run 8 
Time/minutes [mixed anhydride 282]/mM [trifluoromethyl enone 220]/mM 
8.1 71.3 77.7 
23.3 69.6 75.7 
38.6 68.0 73.7 
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53.8 66.5 72.0 
69.1 65.0 70.3 
84.3 63.5 68.3 
99.6 62.0 66.0 
114.8 60.6 64.0 
130.0 59.3 62.3 
145.3 58.1 61.0 
160.5 56.9 59.7 
175.7 55.8 58.3 
191.0 54.6 57.0 
206.3 53.2 55.7 
221.5 51.8 54.0 
236.7 50.6 52.7 
 
  
 
9.3.3 Computational Studies 
Diastereoisomeric transition states TS C1 – TS C9 
TS C1 towards (3R,4R)-224 
 
TS C2 towards (3R,4R)-224 
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TS C3 towards (3R,4R)-224 
 
TS C4 towards (3R,4R)-224 
 
TS C5 towards (3R,4S)-299 
 
TS C6 towards (3R,4S)-299 
 
TS C7 towards (3S,4S)-224 
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TS C8 towards (3S,4R)-299 
 
TS C9 towards (3S,4R)-299 
 
 
tert-butyl ((3,5-bis(trifluoromethyl)phenyl)(phenylsulfonyl)methyl)carbamate 
 
To a stirred solution of tert-butyl carbamate (4.22 g, 36.0 mmol) in THF (20 mL) under 
argon was added H2O (40 mL), sodium benzenesulfinate (5.91 g, 36.0 mmol) and 3,5-
bis(trifluoromethyl)benzaldehyde (6.05 mL, 36.7 mmol) sequentially followed by formic 
acid (7.90 mL, 0.21 mol). The reaction mixture was stirred under nitrogen for 18 h at rt. 
The resulting precipitate was filtered and washed with H2O. Trituration with 
hexane/CH2Cl2 (91/9) gave sulfone 304 as a white solid (11.5 g, 66%); mp 172-174 °C; 
max (ATR)/cm
-1
 3345 (N-H), 3078 (C-H), 1699 (C=O), 1583, 1508, 1315 (S=O), 1146 
(S=O); δ (300 MHz, (CD ) C=O) 1.09 (9H, s, C(CH ) ), 6.32 (1H, d, J 11.0, CH), 7.54 
(2H, t, J 7.5, SO Ar(3,5)H), 7.63 (1H, t, J 7.4, SO Ar(4)H), 7.82-7.90 (3H, m, 
SO Ar(2,6)H and NH), 8.01 (1H, s, (CF ) Ar(4)H), 8.32 (2H, s, (CF ) Ar(2,6)H); δ (75 
MHz, (CD ) C=O) 28.2 (C(CH ) ), 74.1 (CH), 81.0 (C(CH ) ), 124.0 (heptet, J 3.7, 
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(CF ) ArC(4)), 124.3 (q, J 270, CF ), 130.1 (ArC), 130.5 (ArC), 131.3 ((CF ) ArC(2,6)), 
132.1 (q, J 33.3, (CF ) ArC(3,5)), 135.2 (ArC), 135.2 (SO ArC(4)), 137.8 (ArC), 154.8 
(C=O); m/z (ES
+
) 506 ([M+Na]
+
, 75%); HRMS (ES
+
) C20H19F6NNaO4S
+
 ([M+Na]
+
) 
requires 506.0837; found 506.0841 (+0.9 ppm). 
 
tert-butyl 3,5-bis(trifluoromethyl)benzylidenecarbamate 
 
To a stirred solution of sulfone 304 (13.9 g, 28.8 mmol) in CH2Cl2 (460 mL) was added 
a solution of K2CO3 (88.8 g, 0.65 mol) in H2O (460 mL). The reaction mixture was 
stirred at rt for 1 h. The layers were separated and the aqueous layer was extracted 
CH2Cl2 (x 3). The combined organics were dried (MgSO4), filtered and concentrated in 
vacuo to give imine 302 as a colourless oil (9.80 g, 99%) which was used immediately 
without purification; max (ATR)/cm
-1
 2984 (C-H), 1717 (C=O), 1647, 1618; δ (400 
MHz, (CD ) C=O) 1.58 (9H, s, C(CH ) ), 8.32 (1H, s, Ar(4)H), 8.58 (2H, s, Ar(2,6)H), 
9.02 (1H, s, CH); δ (100 MHz, (CD ) C=O) 28.0 (C(CH ) ), 83.0 (C(CH ) ), 124.1 (q, J 
270, CF ), 126.9 (heptet, J 3.5, ArC(4)), 130.4 (ArC(2,6)), 132.9 (q, J 33.6, ArC(3,5)), 
137.9 (ArC(1)), 162.5 (C=O), 165.7 (=CH); m/z (NSI
+
) 342 ([M+H]
+
, 63%); HRMS 
(NSI
+
) C14H14F6NO2
+
 ([M+H]
+
) requires 342.0923; found 342.0927 (+1.1 ppm). 
 
tert-butyl ((1S,2S)-1-(3,5-bis(trifluoromethyl)phenyl)-2-(hydroxymethyl)-3-
methylbutyl)carbamate 
 
To a stirred solution of imine 302 (8.32 g, 24.4 mmol) in anhydrous CH3CN (240 mL) 
under argon was added isovaleraldehyde (5.23 mL, 48.8 mmol). The resulting solution 
was cooled to 0 °C. (S)-proline (0.56 g, 4.87 mmol) was added and the reaction mixture 
was stirred for 18 h at 0 °C. Distilled H2O (80 mL) was added and the reaction mixture 
was allowed to warm to rt whilst maintaining vigorous stirring. Et2O (100 mL) was 
added and the organic layer was separated. The aqueous layer was extracted with Et2O 
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(x 3). The organic extracts were combined, washed with brine, dried (MgSO4), filtered 
and concentrated in vacuo. The resulting solid was triturated with hexane and filtered. 
The filtrate was concentrated in vacuo to give crude aldehyde (1S,2S)-305 as a white 
solid (2.84 g, 27%) which was used directly without purification. To a stirred solution of 
aldehyde (1S,2S)-305 (2.84 g, 6.65 mmol) in methanol (50 mL) under argon was added 
NaBH4 (0.38 g, 10.0 mmol) and the reaction mixture was left to stir for 2 h at rt. 
Saturated aqueous NaHCO3 was added and the methanol was removed in vacuo. The 
aqueous layer was extracted with CH2Cl2 (x 3). The organic extracts were combined, 
dried (MgSO4), filtered and concentrated in vacuo. The resulting solid was recrystallised 
(Et2O:petrol) to give alcohol (1S,2S)-306 as a white solid (1.65 g, 16% over 2 steps); mp 
110-112 °C (Et2O:petrol); 

 
D
20
–8.4 (c 0.25 in CHCl3); max (ATR)/cm
-1
 3348 (O-H and 
N-H), 2970 (C-H) 1682 (C=O), 1508; δ (500 MHz, CDCl ) 0.77 (3H, d, J 6.8, CH ), 
1.00 (3H, d, J 6.8, CH ), 1.35 (9H, s, C(CH ) ), 1.50-1.85 (3H, m, C(2)H, C(3)H and 
OH), 3.28-3.31 (1H, m, CHH), 3.67-3.70 (1H, m, CHH), 5.11 (1H, br s, NH), 6.01 (1H, 
d, J 8.6, C(1)H), 7.71 (1H, s, Ar(4)H), 7.74 (2H, s, Ar(2,6)H); δ (125 MHz, CDCl ) 22.6 
(CH ), 26.7 (CH ), 28.2 (C(3)), 28.4 (C(CH ) ), 50.7 (C(2)), 54.9 (C(1)), 61.2 (CH ), 80.1 
(C(CH ) ), 121.5 (ArC(4)), 123.4 (q, J 271, CF ), 127.5 (ArC(2,6)), 131.4 (q, J 33.0, 
ArC(3,5)), 144.1 (ArC(1)), 155.4 (C=O); m/z (NSI
+
) 452 ([M+Na]
+
, 45%); HRMS 
(NSI
+
) C19H25F6NNaO3
+
 ([M+Na]
+
) requires 452.1631; found 452.1628 (-0.6 ppm). 
 
(S)-2-((S)-amino(3,5-bis(trifluoromethyl)phenyl)methyl)-3-methylbutan-1-ol 
hydrochloride 
 
To a flask containing alcohol (1S,2S)-306 (1.57 g, 3.65 mmol) under argon was added 
HCl (4 M in dioxane, 11.5 mL, 45.9 mmol) and the reaction mixture was left to stir for 4 
h at rt. The reaction mixture was concentrated in vacuo to give amino alcohol (1S,2S)-
307 as a white solid (1.22 g, 91%); mp 218-220 °C; 

 
D
20
–9.2 (c 0.25 in CH3OH); max 
(ATR)/cm
-1
 3277 (O-H and N-H), 2967 (C-H), 1588; δ (500 MHz, CDCl ) 0.89 (3H, d, 
J 6.8, CH ), 1.18 (3H, d, J 6.8, CH ), 1.58 (1H, dq, J 13.5, 6.8, C(3)H), 2.10-2.15 (1H, 
m, C(2)H), 3.38 (1H, t, J 10.1, C(1)HH), 3.78 (1H, dd, J 11.0, 4.4, C(1)HH), 4.85 (1H, 
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d, J 4.8, CHN), 8.11 (1H, s, Ar(4)H), 8.21 (2H, s, Ar(2,6)H); δ (125 MHz, CDCl ) 19.5 
(CH ), 22.2 (CH ), 28.1 (C(3)), 49.8 (C(2)), 57.4 (CHN), 60.8 (C(1)), 124.0 (heptet, J 
3.6, ArC(4)), 124.6 (q, J 271, CF ), 130.4 (ArC(2,6)), 133.3 (q, J 33.5, ArC(3,5)), 139.4 
(ArC(1)); m/z (NSI
+
) 330 ([M-Cl]
+
, 100%); HRMS (NSI
+
) C14H18F6NO
+
 ([M-Cl]
+
) 
requires 330.1287; found 330.1292 (+1.5 ppm). 
 
(S)-2-((S)-(benzo[d]thiazol-2-ylamino)(3,5-bis(trifluoromethyl)phenyl)methyl)-3-
methylbutan-1-ol 
 
To a sealed pressure tube containing amino alcohol (1S,2S)-307 (1.12 g, 3.05 mmol) and 
i-Pr2NEt (2.12 mL, 12.2 mmol) under argon at 135 °C was added 2-chlorobenzothiazole 
(0.41 mL, 3.23 mmol) and the reaction mixture was left to stir for 2 days at 135 °C. The 
reaction mixture was allowed to cool to rt. Chromatographic purification (eluent 
EtOH:CH2Cl2 2:98) gave alcohol (1S,2S)-308 as a brown oil (1.12 g, 66%); 

 
D
20
–20.2 
(c 0.5 in CHCl3); max (ATR)/cm
-1
 3281 (O-H and N-H), 2967 (C-H), 1541; δ (300 
MHz, CDCl ) 0.77 (3H, d, J 6.8, CH ), 1.08 (3H, d, J 6.8, CH ), 1.47 (1H, dq, J 13.7, 6.9, 
C(3)H), 2.10-2.16 (1H, m, C(2)H), 3.46 (1H, t, J 10.5, C(1)HH), 3.87 (1H, dd, J 10.8, 
4.2, C(1)HH), 5.12 (1H, d, J 3.6, CHN), 6.96-7.01 (1H, m, ArH), 7.15-7.21 (1H, m, 
ArH), 7.34 (1H, dd, J 8.1, 0.6, ArH), 7.46 (1H, dd, J 7.9, 0.8, ArH), 7.71 (1H, s, 
(CF ) Ar(4)H), 7.90 (2H, s, (CF ) Ar(2,6)H); δ (100 MHz, CDCl ) 19.9 (CH ), 22.6 
(CH ), 26.9 (C(3)), 50.7 (C(2)), 60.6 (C(1)), 60.8 (CHN), 118.6 (ArC), 121.0 (ArC), 
121.7 (heptet, J 3.4, (CF ) ArC(4)), 121.9 (ArC), 123.3 (q, J 271, CF ), 126.2 (ArC), 
128.2 ((CF ) ArC(2,6)), 129.7 (ArC(7a)), 131.7 (q, J 33.1, (CF ) ArC(3,5)), 142.3 
((CF ) ArC(1)), 151.3 (ArC(3a)), 167.0 (C=N); m/z (NSI
+
) 463 ([M+H]
+
, 100%); HRMS 
(NSI
+
) C21H21F6N2OS
+
 ([M+H]
+
) requires 463.1273; found 463.1269 (-0.9 ppm). 
 
(2S,3R)-2-(3,5-bis(trifluoromethyl)phenyl)-3-isopropyl-3,4-dihydro-2H-
benzo[4,5]thiazolo[3,2-a]pyrimidine hydrochloride 
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To a stirred solution of alcohol (1S,2S)-308 (1.08 g, 2.35 mmol) in toluene (20 mL) 
under argon was added SOCl2 (0.38 mL, 5.17 mmol) and the reaction mixture was 
heated at reflux for 3 h with no condenser fitted. The reaction mixture was allowed to 
cool to rt and was quenched by addition of a few drops of methanol before being 
concentrated in vacuo. 10% aqueous NaOH solution (20 mL) was added and the aqueous 
layer was extracted with CH2Cl2 (x 3). The combined extracts were washed with brine, 
dried (MgSO4), filtered and concentrated in vacuo. Column chromatography (eluent 
MeOH:petrol 2:98) gave isothiourea (2S,3R)-301 free base. To a flask containing the 
free base was added HCl (4 M in dioxane, 10 mL, 40.0 mmol). After stirring at rt for 1 h 
the reaction mixture was concentrated in vacuo and the resulting solid recrystallised 
(EtOAc:Et2O) to give the hydrochloride salt of isothiourea (2S,3R)-301 as a white solid 
(0.32 g, 31%); mp 148-150 °C; 

 
D
20
+150.0 (c 0.75 in EtOAc:Et2O); Chiral HPLC 
Chiralpak AD-H (2% IPA:hexane, flow rate 1 mL min
-1
, 254 nm, 30 °C) tR(2R,3S): 22.3 
min, tR(2S,3R): 40.5 min, 97% ee; max (ATR)/cm
-1
 2937 (C-H), 1607, 1557; δ (300 
MHz, CD OD) 0.92 (3H, d, J 6.7, CH ), 1.17 (3H, d, J 6.7, CH ), 1.43 (1H, dq, J 13.7, 
6.9, CH(CH ) ), 2.55-2.61 (1H, m, C(3)H), 4.00 (1H, dd, J 13.4, 10.6, C(4)HH), 4.64 
(1H, dd, J 13.5, 4.6, C(4)HH), 5.56 (1H, d, J 4.7, C(2)H), 7.55 (1H, t, J 7.7, ArH), 7.70 
(1H, t, J 7.8, ArH), 7.82 (1H, d, J 8.2, ArH), 7.96-8.00 (3H, m, (CF ) Ar(2,6)H and 
ArH), 8.10 (1H, s, (CF ) Ar(4)H); δ (100 MHz, CD OD) 19.5 (CH ), 22.2 (CH ), 27.8 
(CH(CH ) ), 41.2 (C(3)), 44.0 (C(4)), 57.5 (C(2)), 114.3 (ArC), 123.8 (ArC), 124.0 
(heptet, J 3.5, (CF ) ArC(4)), 124.5 (ArC), 124.5 (q, J 271, CF ), 127.3 (ArC), 129.6 
((CF ) ArC(2,6)), 129.6 (ArC), 133.6 (q, J 33.4, (CF ) ArC(3,5)), 139.8 (ArC), 141.8 
((CF ) ArC(1)), 166.3 (C=N); m/z (APCI
+
) 445 ([M-Cl]
+
, 100%); HRMS (APCI
+
) 
C21H19F6N2S
+
 ([M-Cl]
+
) requires 445.1168; found 445.1168 (+0.1 ppm). Note: Racemic 
sample for HPLC analysis made via same route using (DL)-proline for Mannich reaction 
to form 305. 
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9.4 Experimental for Chapter 4  
9.4.1 Experimental Procedures and Characterisation Data 
General procedure G: Cu(I) mediated N-arylation. 
To a flask under inert atmosphere was charged the requisite aryl iodide (1 eq), copper 
iodide (10 mol%), 1,10-phenanthroline (20 mol%), cesium carbonate (1.4 eq), benzyl 
carbazate (1.2 eq) and anhydrous DMF and the reaction mixture was heated at 80 °C for 
1 h. Once cool the reaction mixture was filtered and concentrated in vacuo to give the 
crude reaction mixture. 
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benzyl 1-(4-methoxyphenyl)hydrazinecarboxylate 
 
Following general procedure G, 4-iodoanisole (10.0 g, 42.7 mmol), copper iodide (0.81 
g, 4.27 mmol), 1,10-phenanthroline (1.54 g, 8.55 mmol), cesium carbonate (19.5 g, 59.8 
mmol), benzyl carbazate (8.51 g, 51.3 mmol) and anhydrous DMF (45 mL) gave, after 
chromatographic purification (eluent Et O:petrol 50:50), amine 327 as a yellow solid 
(11.2 g, 96%); mp 69-71 °C; {lit.
187
 mp 74-75 °C}; δ (300 MHz, CDCl ) 3.73 (3H, s, 
OCH ), 4.30 (2H, br s, NH ), 5.13 (2H, s, CH ), 6.77-6.80 (2H, m, NAr(3,5)H), 7.23-7.29 
(7H, m, ArH). Spectroscopic data are in accordance with the literature.
187
 
  
benzyl 1-(4-(trifluoromethyl)phenyl)hydrazinecarboxylate 
 
Following general procedure G, 4-iodobenzotrifluoride (1.08 mL, 7.35 mmol), copper 
iodide (0.14 g, 0.74 mmol), 1,10-phenanthroline (0.27 g, 1.47 mmol), cesium carbonate 
(3.35 g, 10.3 mmol), benzyl carbazate (1.46 g, 8.82 mmol) and anhydrous DMF (10 mL) 
gave, after chromatographic purification (eluent Et O:petrol 25:75), amine 565 as a 
white solid (1.02 g, 45%); mp 62-64 °C; max (KBr)/cm
-1
 3367 (N-H), 2956 (C-H), 1684 
(C=O), 1616, 1512; δ (500 MHz, CDCl ) 4.52 (2H, s, NH ), 5.29 (2H, s, CH ), 7.38-7.41 
(5H, m, ArH), 7.58 (2H, d, J 8.7, Ph(2,6)H), 7.74 (2H, d, J 7.8, NAr(3,5)H); δ (125 
MHz, CDCl ) 68.7 (CH ), 122.4 (ArC), 124.2 (q, J 270, CF ), 125.5 (q, J 3.5, 
NArC(3,5)), 126.3 (q, J 32.1, NArC(4)), 128.4 (ArC), 128.6 (ArC), 128.7 (ArC), 135.5 
(PhC(1)), 145.6 (NArC(1)), 155.5 (C=O); m/z (CI
+
) 311 ([M+H]
+
, 100%); HRMS (CI
+
) 
C15H14F3N2O2
+
 ([M+H]
+
) requires 311.1002; found 311.1005 (+1.0 ppm). 
 
General procedure H: Hydrazine acylation. 
To a solution of requisite hydrazine (1.2 eq) and Et3N (1.2 eq) in Et2O at 0 °C was added 
the requisite acid chloride (1 eq) dropwise. The reaction mixture was stirred at 0 °C for 
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30 minutes before being filtered. The residue was washed with H2O and recrystallised 
(EtOH) to give the corresponding hydrazide. 
 
N'-phenylbenzohydrazide 
 
Following general procedure H, phenylhydrazine (1.82 mL, 18.5 mmol), Et3N (2.58 mL, 
18.5 mmol) and benzoyl chloride (2.18 mL, 15.6 mmol) in Et2O (35 mL) gave, after 
recrystallisation (EtOH), hydazide 319 as a white solid (1.60 g, 45%); mp 163-165 °C; 
{lit.
107
 mp 171-172 °C}; δ (400 MHz, CDCl ) 6.30 (1H, br s, ArNH), 6.84-6.86 (3H, m, 
NAr(2,6)H and NAr(4)H), 7.15-7.19 (2H, m, NAr(3,5)H), 7.40 (2H, t, J 7.6, 
C(O)Ar(3,5)H), 7.49 (1H, t, J 7.4, C(O)Ar(4)H), 7.77 (2H, d, J 7.4, C(O)Ar(2,6)H), 7.94 
(1H, br s, C=ONH). Spectroscopic data are in accordance with the literature.
189
 
 
N'-(4-methoxyphenyl)-4-(trifluoromethyl)benzohydrazide 
 
To a solution of 327 (11.1 g, 40.8 mmol) and Et3N (6.25 mL, 44.9 mmol) in EtOAc (100 
mL) at 0 °C was added 4-trifluoromethylbenzoyl chloride (6.06 mL, 40.8 mmol). The 
reaction mixture was stirred at rt for 1 h. The reaction mixture was washed with HCl (1 
M in H2O) and sat. aq. NaHCO3. The organic layer was dried (MgSO4), filtered and 
concentrated in vacuo to give the crude acylated product 329 which was used without 
purification. To a solution of crude acylated product 329 (17.7 g, 40.8 mmol assuming 
100% conversion) and 10% palladium on charcoal (4.27 g, 4.08 mmol, 10 mol%) in 
EtOAc (100 mL) was appended a balloon of hydrogen gas. The hydrogen gas was 
allowed to bubble through the reaction mixture at rt for 4 h. The reaction mixture was 
filtered through celite and concentrated in vacuo. Recrystallisation (EtOH) gave 
hydrazide 330 as a white solid (7.95 g, 63% over 2 steps); mp 158-160 °C; max 
(KBr)/cm
-1
 3270 (N-H), 3068 (C-H), 1649 (C=O), 1551, 1510; δ (300 MHz, (CH ) S=O) 
3.67 (3H, s, OCH ), 6.79 (4H, s, NAr(2,6)H and NAr(3,5)H), 7.69 (1H, d, J 2.5, ArNH), 
7.89 (2H, d, J 8.2, ArH), 8.11 (2H, d, J 8.1, ArH), 10.6 (1H, d, J 2.2, C=ONH); δ (75 
 Chapter 9: Experimental 
 
 263 
MHz, (CH ) S=O) 55.2 (OCH ), 113.9 (ArC), 114.3 (ArC), 123.9 (q, J 271, CF ), 125.5 
(q, J 3.7, C(O)ArC(3,5)), 128.2 (C(O)ArC(2,6)), 131.4 (q, J 31.7, C(O)ArC(4)), 136.9 
(C(O)ArC(1)), 143.0 (NArC(1)), 152.8 (NArC(4)), 165.1 (C=O); m/z (NSI
+
) 311 
([M+H]
+
, 100%); HRMS (NSI
+
) C15H14F3N2O2
+
 ([M+H]
+
) requires 311.1002; found 
311.1005 (+1.0 ppm). 
 
4-fluoro-N'-phenylbenzohydrazide 
 
Following general procedure H, phenylhydrazine (0.55 mL, 5.59 mmol), Et3N (0.78 mL, 
5.59 mmol) and 4-fluorobenzoyl chloride (0.60 mL, 5.08 mmol) in Et2O (20 mL) gave, 
after recrystallisation (EtOH), hydazide 566 as a white solid (0.38 g, 32%); mp 171-173 
°C; {lit.
190
 mp 177-179 °C}; max (ATR)/cm
-1
 3271 (N-H), 3026 (C-H), 1641 (C=O), 
1599, 1530; δ (500 MHz, (CD )S=O) 6.72-6.80 (3H, m, NAr(2,6)H and NAr(4)H), 7.10-
7.20 (2H, m, NAr(3,5)H), 7.31-7.39 (2H, m, C(O)Ar(2,6)H), 7.95-8.01 (3H, m, 
C(O)Ar(3,5)H and ArNH), 10.42 (1H, s, C(O)NH); δ (125 MHz, (CD )S=O) 112.4 
(NArC(2,6)), 115.5 (d, J 21.6, C(O)ArC(3,5)), 118.7 (NArC(4)), 128.8 (NArC(3,5)), 
129.5 (d, J 2.6, C(O)ArC(1)), 130.0 (d, J 8.9, C(O)ArC(2,6)), 149.5 (NArC(1)), 164.1 (d, 
J 248, C(O)ArC(4)), 165.3 (C=O); m/z (NSI
+
) 231 ([M+H]
+
, 73%); HRMS (NSI
+
) 
C13H12FN2O
+
 ([M+H]
+
) requires 231.0928; found 231.099 (+0.4 ppm). 
 
3-fluoro-N'-phenylbenzohydrazide 
 
Following general procedure H, phenylhydrazine (0.91 mL, 9.25 mmol), Et3N (1.29 mL, 
9.25 mmol) and 3-fluorobenzoyl chloride (1.01 mL, 8.41 mmol) in Et2O (20 mL) gave, 
after recrystallisation (EtOH), hydazide 567 as a white solid (0.65 g, 34%); mp 120-122 
°C; max (KBr)/cm
-1
 3251 (N-H), 3026 (C-H), 1646 (C=O), 1588, 1551; δ (300 MHz, 
CD OD) 6.79-6.88 (3H, m, NAr(2,6)H and NAr(4)H), 7.16-7.22 (2H, m, NAr(3,5)H), 
7.29-7.35 (1H, m, ArH), 7.51 (1H, td, J 8.0, 5.7, ArH), 7.62 (1H, dt, J 9.6, 2.0, ArH), 
7.71-7.74 (1H, m, ArH); δ (75 MHz, CD OD) 114.3 (NArC(2,6)), 115.5 (d, J 30.9, ArC), 
119.9 (d, J 28.5, ArC), 121.3 (NArC(4)), 124.3 (d, J 3.9, C(O)ArC(6)), 130.0 
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(NArC(3,5)), 131.8 (d, J 10.6, C(O)ArC(5)), 136.5 (d, J 9.2, C(O)ArC(1)), 150.0 
(NArC(1)), 164.2 (d, J 326, C(O)ArC(3)), 168.8 (C=O); m/z (NSI
+
) 231 ([M+H]
+
, 
100%); HRMS (NSI
+
) C13H12FN2O
+
 ([M+H]
+
) requires 231.0928; found 231.0930 (+0.8 
ppm). 
 
2-fluoro-N'-phenylbenzohydrazide 
 
Following general procedure H, phenylhydrazine (0.91 mL, 9.25 mmol), Et3N (1.29 mL, 
9.25 mmol) and 2-fluorobenzoyl chloride (1.01 mL, 8.41 mmol) in Et2O (20 mL) gave, 
after recrystallisation (EtOH), hydazide 568 as a white solid (1.07 g, 55%); mp 107-109 
°C; max (KBr)/cm
-1
 3272 (N-H), 3024 (C-H), 1639 (C=O), 1546, 1499; δ (400 MHz, 
CD OD) 6.80-6.84 (1H, m, NAr(4)H), 6.91 (2H, m, NAr(2,6)H), 7.18-7.31 (4H, m, 
ArH), 7.53-7.58 (1H, m, ArH), 7.72-7.76 (1H, m, ArH); δ (75 MHz, CD OD) 114.3 
(NArC(2,6)), 117.3 (d, J 29.9, C(O)ArC(3)), 121.3 (NArC(4)), 123.1 (d, J 19.7, 
C(O)ArC(1)), 125.8 (d, J 4.6, C(O)ArC(6)), 130.1 (NArC(3,5)), 131.5 (d, J 3.3, 
C(O)ArC(5)), 134.5 (d, J 11.4, C(O)ArC(4)), 149.9 (NArC(1)), 161.4 (d, J 331, 
C(O)ArC(2)), 167.2 (C=O); m/z (NSI
+
) 231 ([M+H]
+
, 100%); HRMS (NSI
+
) 
C13H12FN2O
+
 ([M+H]
+
) requires 231.0928; found 231.0930 (+0.8 ppm). 
 
4-bromo-N'-phenylbenzohydrazide 
 
Following general procedure H, phenylhydrazine (0.91 mL, 9.25 mmol), Et3N (1.29 mL, 
9.25 mmol) and 4-bromobenzoyl chloride (1.85 g, 8.41 mmol) in Et2O (20 mL) gave, 
after recrystallisation (EtOH), hydazide 569 as a white solid (0.83 mg, 34%); mp 196-
198 °C; {lit.
190
 mp 198-199 °C}; max (ATR)/cm
-1
 3229 (N-H), 3048 (C-H), 1647 (C=O), 
1589, 1530; δ (500 MHz, CD )S=O) 6.72 (1H, t, J 7.3, NAr(4)H), 6.79 (2H, d, J 8.0, 
NAr(2,6)H), 7.15 (2H, t, J 7.8, NAr(3,5)H), 7.23 (2H, d, J 8.4, C(O)ArH), 7.87 (2H, d, J 
8.4, C(O)ArH), 7.96 (1H, s, ArNH), 10.5 (1H, s, C(O)NH); δ (125 MHz, (CD )S=O) 
112.3 (NArC(2,6)), 118.7 (NArC(4)), 125.5 (C(O)ArC(4)), 128.8 (NArC(3,5)), 129.4 
(C(O)ArC), 131.6 (C(O)ArC), 132.1 (C(O)ArC(1)), 149.4 (NArC(1)), 165.5 (C=O); m/z 
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(NSI
+
) 291 ([M+H]
+
, 100%); HRMS (NSI
+
) C13H12
79
BrN2O
+
 ([M+H]
+
) requires 
291.0128; found 291.0128 (+0.2 ppm). 
 
4-chloro-N'-phenylbenzohydrazide 
 
Following general procedure H, phenylhydrazine (0.91 mL, 9.25 mmol), Et3N (1.29 mL, 
9.25 mmol) and 4-chlorobenzoyl chloride (1.08 mL, 8.41 mmol) in Et2O (20 mL) gave, 
after recrystallisation (EtOH), hydazide 570 as a white solid (1.17 g, 56%); mp 166-168 
°C; {lit.
190
 mp 193-195 °C}; δ (400 MHz, CDCl ) 6.35 (1H, d, J 3.5, ArNH), 6.94-6.99 
(3H, m, ArH), 7.27-7.31 (2H, m, ArH), 7.49 (2H, d, J 8.5 C(O)Ar(3,5)H), 7.82 (2H, d, J 
8.5, C(O)Ar(2,6)H), 7.93 (1H, br s, C=ONH). Spectroscopic data are in accordance with 
the literature.
191
 
 
N'-phenyl-1-naphthohydrazide 
 
Following general procedure H, phenylhydrazine (0.91 mL, 9.25 mmol), Et3N (1.29 mL, 
9.25 mmol) and 1-naphthoyl chloride (1.27 mL, 8.41 mmol) in Et2O (20 mL) gave, after 
recrystallisation (EtOH), hydazide 571 as a white solid (740 mg, 34%); mp 194-196 °C; 
{lit.
192
 mp 240 °C}; δ (300 MHz, CDCl ) 6.52 (1H, d, J 4.3, ArNH), 6.99-7.05 (3H, m, 
NAr(2,6)H and NAr(4)H), 7.32-7.37 (2H, m, NAr(3,5)H), 7.52-7.64 (3H, m, ArH), 7.77-
7.79 (2H, m, ArH), 7.92-7.96 (1H, m, ArH), 8.03 (1H, d, J 8.3, ArH), 8.36-8.39 (1H, m, 
NH). Spectroscopic data are in accordance with the literature.
191
 
 
4-nitro-N'-phenylbenzohydrazide 
 
Following general procedure H, phenylhydrazine (1.82 mL, 18.5 mmol), Et3N (2.58 mL, 
16.8 mmol) and 4-nitrobenzoyl chloride (3.12 g, 16.8 mmol) in Et2O (35 mL) gave, after 
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recrystallisation (EtOH), hydazide 572 as an orange solid (2.06 g, 48%); mp 198-200 
°C; {lit.
193
 mp 206 °C}; δ (400 MHz, CDCl ) 6.37 (1H, d, J 3.0, ArNH), 6.96-7.00 (3H, 
m, NAr(2,6)H and NAr(4)H), 7.31-7.33 (2H, m, NAr(3,5)H), 8.01-8.06 (3H, m, 
C(O)Ar(2,6)H and C=ONH), 8.38 (2H, d, J 8.8, C(O)Ar(3,5)H). Spectroscopic data are 
in accordance with the literature.
191
 
 
4-methyl-N'-phenylbenzohydrazide 
 
Following general procedure H, phenylhydrazine (0.91 mL, 9.25 mmol), Et3N (1.29 mL, 
9.25 mmol) and p-toluoyl chloride (1.11 mL, 8.41 mmol) in Et2O (20 mL) gave, after 
recrystallisation (EtOH), hydazide 573 as a white solid (0.83 g, 44%); mp 166-167 °C; 
{lit.
193
 mp 172 °C}; δ (300 MHz, CDCl ) 2.36 (3H, s, CH ), 6.26 (1H, d, J 3.5, ArNH), 
6.87 (2H, d, J 8.2, C(O)Ar(3,5)H), 7.15-7.22 (5H, m, ArH), 7.68 (2H, d, J 8.2, 
C(O)Ar(2,6)H), 7.76 (1H, br s, C=ONH). Spectroscopic data are in accordance with the 
literature.
191
 
 
N'-phenylfuran-2-carbohydrazide 
 
Following general procedure H, phenylhydrazine (0.91 mL, 9.25 mmol), Et3N (1.29 mL, 
9.25 mmol) and 2-furoyl chloride (0.83 mL, 8.41 mmol) in Et2O (20 mL) gave, after 
recrystallisation (EtOH), hydazide 574 as a white solid (0.80 g, 47%); mp 141-142 °C; 
{lit.
194
 mp 144-145 °C}; δ (300 MHz, CDCl ) 6.24 (1H, br s, ArNH), 6.60 (1H, dd, J 
3.5, 1.7, C(O)Ar(4)H), 6.94-6.98 (3H, m, ArH), 7.24-7.35 (3H, m, ArH), 7.56 (1H, d, J 
1.0, C(O)Ar(5)H), 8.10 (1H, br s, C=ONH). Spectroscopic data are in accordance with 
the literature.
194
 
 
N'-mesityl-4-nitrobenzohydrazide 
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Following general procedure H, mesitylhydrazine hydrochloride (1.00 g, 5.73 mmol), 
Et3N (1.60 mL, 11.5 mmol) and 4-nitrobenzoyl chloride (0.97 g, 5.21 mmol) in Et2O (20 
mL) gave, after recrystallisation (EtOH), hydazide 575 as a yellow solid (0.32 g, 21%); 
mp 214-216 °C; max (KBr)/cm
-1
 3235 (N-H), 3072 (C-H), 1675 (C=O), 1602, 1521 
(N=O), 1349 (N=O); δ (400 MHz, CDCl ) 2.27 (3H, s, CH ), 2.49 (6H, s, 2 CH ), 6.35 
(1H, br s, ArNH), 6.89 (2H, s, NAr(3,5)H), 7.82 (1H, br s, C=ONH), 7.91-7.94 (2H, m, 
C(O)Ar(2,6)H), 8.31-8.34 (2H, m, C(O)Ar(3,5)H); δ (75 MHz, CD OD) 18.6 (2 CH ), 
20.1 (CH ), 123.6 (C(O)ArC(3,5)), 128.0 (C(O)ArC(1)), 128.8 (ArC), 129.1 (ArC), 130.5 
(NArC(2,6)), 138.8 (NArC(4)), 141.9 (NArC(1)), 149.1 (C(O)ArC(4)), 164.5 (C=O); m/z 
(APCI
+
) 300 ([M+H]
+
, 100%); HRMS (APCI
+
) C16H18N3O3
+
 ([M+H]
+
) requires 
300.1343; found 300.1342 (-0.2 ppm). 
 
4-methoxy-N'-phenylbenzohydrazide 
 
Following general procedure H, phenylhydrazine (0.91 mL, 9.25 mmol), Et3N (1.29 mL, 
9.25 mmol) and 4-methoxybenzoyl chloride (1.44 g, 8.41 mmol) in Et2O (20 mL) gave, 
after recrystallisation (EtOH), hydazide 576 as a white solid (0.78 g, 38%); mp 171-173 
°C; {lit.
193
 mp 170 °C}; δ (400 MHz, CDCl ) 3.90 (3H, s, OCH ), 6.34 (1H, br s, ArNH), 
6.39-7.01 (5H, m, ArH), 7.26-7.30 (2H, m, ArH), 7.81 (1H, br s, C=ONH), 7.83-7.87 
(2H, m, C(O)Ar(2,6)H). Spectroscopic data are in accordance with the literature.
191
 
 
General procedure I: Diazene formation. 
To a solution of requisite hydrazide (1 eq) and pyridine (1.1 eq) in CH2Cl2 at 78 °C was 
added N-bromosuccinimide (1 eq) portion wise. The reaction mixture was warmed to rt 
and stirred for 30 minutes before being filtered. The filtrate was concentrated in vacuo 
and the resulting solid was triturated with Et2O. The mixture was filtered and the filtrate 
was washed with HCl (1 M in H2O) followed by sat. aq. NaHCO3. The organic layer 
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was dried (MgSO4), filtered and concentrated in vacuo to give the crude reaction 
mixture. 
 
(E)-phenyl(phenyldiazenyl)methanone 
 
Following general procedure I, hydrazide 319 (1.50 g, 7.08 mmol), pyridine (0.63 mL, 
7.79 mmol) and N-bromosuccinimide (1.26 g, 7.08 mmol) in CH2Cl2 (7 mL) gave, after 
chromatographic purification (eluent Et O:petrol 20:80), diazene 313 as a red oil (1.17 g, 
79%); δ (400 MHz, CDCl ) 7.43-7.63 (6H, m, ArH), 7.91-8.02 (4H, m, ArH). 
Spectroscopic data are in accordance with the literature.
107
 
 
(E)-1-(phenyldiazenyl)ethanone 
 
Following general procedure I, 1-acetyl-2-phenylhydrazine (0.22 g, 1.47 mmol), 
pyridine (0.13 mL, 1.61 mmol) and N-bromosuccinimide (0.26 g, 1.47 mmol) in CH2Cl2 
(5 mL) gave, after chromatographic purification (eluent Et O:petrol 10:90), diazene 322 
as a red oil (37.2 mg, 17%); δ (300 MHz, CDCl ) 2.36 (3H, s, CH ), 7.42-7.50 (3H, m, 
ArH), 7.80-7.83 (2H, m, ArH). Spectroscopic data are in accordance with the 
literature.
198
 
 
(E)-(4-nitrophenyl)(phenyldiazenyl)methanone 
 
Following general procedure I, hydrazide 572 (2.00 g, 7.78 mmol), pyridine (0.69 mL, 
8.56 mmol) and N-bromosuccinimide (1.39 g, 7.78 mmol) in CH2Cl2 (10 mL) gave, after 
chromatographic purification (eluent Et O:petrol 50:50), diazene 367 as a red solid (0.91 
g, 46%); mp 127-129 °C; max (KBr)/cm
-1
 3080 (C-H), 1711 (C=O), 1605, 1529 (N=O), 
1499, 1352 (N=O); δ (300 MHz, CDCl ) 7.50-7.62 (3H, m, NAr(3,5)H and NAr(4)H), 
7.94-7.97 (2H, m, NAr(2,6)H), 8.19-8.23 (2H, m, C(O)Ar(2,6)H), 8.29-8.33 (2H, m, 
C(O)Ar(3,5)H); δ (100 MHz, CDCl ) 124.0 (ArC), 124.0 (ArC), 129.6 (ArC), 131.7 
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(ArC), 134.3 (NArC(4)), 136.1 (C(O)ArC(1)), 151.1 (ArC), 152.1 (ArC), 179.7 (C=O); 
m/z (APCI
+
) 256 ([M+H]
+
, 100%); HRMS (APCI
+
) C13H10N3O
+
 ([M+H]
+
) requires 
256.0717; found 256.0714 (-1.0 ppm). 
 
(E)-((4-fluorophenyl)diazenyl)(phenyl)methanone 
 
To a solution of 4-fluorophenylhydrazine hydrochloride 577 (2.00 g, 12.3 mmol) and 
Et3N (3.43 mL, 24.6 mmol) in Et2O (30 mL) at 0 °C was slowly added benzoyl chloride 
(1.29 mL, 11.2 mmol). After stirring at rt for 30 minutes the reaction mixture was 
concentration in vacuo. The solid was dissolved in CH2Cl2 and washed with HCl (1 M in 
H2O). The organic layer was dried (MgSO4), filtered and concentrated in vacuo to give a 
crude hydrazide 578 which was used without purification. Following general procedure 
I, hydrazide 578 (2.57 g, 11.2 mmol assuming 100% conversion), pyridine (1.07 mL, 
12.3 mmol) and N-bromosuccinimide (1.98 g, 11.2 mmol) in CH2Cl2 (15 mL) gave, after 
chromatographic purification (eluent Et O:petrol 20:80), diazene 579 as a red solid (0.55 
mg, 21% over 2 steps); mp 48-50 °C; max (KBr)/cm
-1
 3067 (C-H), 1702 (C=O), 1591, 
1503; δ (300 MHz, CDCl ) 7.26-7.32 (2H, m, NAr(3,5)H), 7.54-7.60 (2H, m, 
C(O)Ar(3,5)H), 7.68-7.74 (1H, m, C(O)Ar(4)H), 8.06-8.12 (4H, m, NAr(2,6)H and 
C(O)Ar(2,6)H); δ (75 MHz, CDCl ) 116.5 (d, J 23.0, NArC(3,5)), 126.0 (d, J 9.5, 
NArC(2,6)), 128.9 (ArC), 130.6 (ArC), 130.9 (C(O)ArC(1)), 134.6 (C(O)ArC(4)), 148.7 
(d, 2.9, NArC(1)), 165.9 (d, J 254, NArC(4)), 181.7 (C=O); m/z (ES
+
) 251 ([M+Na]
+
, 
100%); HRMS (ES
+
) C13H9FN2NaO
+
 ([M+Na]
+
) requires 251.0597; found 251.0590 (-
2.5 ppm). 
 
(E)-(4-fluorophenyl)(phenyldiazenyl)methanone 
 
Following general procedure I, hydrazide 566 (0.37 g, 1.61 mmol), pyridine (0.14 mL, 
1.77 mmol) and N-bromosuccinimide (0.29 g, 1.61 mmol) in CH2Cl2 (5 mL) gave, after 
chromatographic purification (eluent Et O:petrol 20:80), diazene 580 as a red oil (0.28 g, 
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76%); max (thin film)/cm
-1
 3068 (C-H), 1707 (C=O), 1597, 1507; δ (400 MHz, CDCl ) 
7.20-7.26 (2H, m, C(O)Ar(3,5)H), 7.58-7.67 (3H, m, ArH), 8.02-8.05 (2H, m, ArH), 
8.12-8.17 (2H, m, C(O)Ar(2,6)H); δ (100 MHz, CDCl ) 116.3 (d, J 21.9, C(O)ArC(3,5)), 
123.7 (NArC(2,6)), 127.4 (d, J 2.7, C(O)ArC(1)), 129.4 (NArC(3,5)), 133.4 (d, J 9.7, 
C(O)ArC(2,6)), 133.7 (NArC(4)), 152.1 (NArC(1)), 166.6 (d, J 256, C(O)ArC(4)), 180.5 
(C=O); m/z (ES
+
) 251 ([M+Na]
+
, 100%); HRMS (ES
+
) C13H9FN2NaO
+
 ([M+Na]
+
) 
requires 251.0597; found 251.0602 (+2.1 ppm). 
 
(E)-(3-fluorophenyl)(phenyldiazenyl)methanone 
 
Following general procedure I, hydrazide 567 (488 mg, 2.13 mmol), pyridine (0.19 mL, 
2.34 mmol) and N-bromosuccinimide (0.38 g, 2.13 mmol) in CH2Cl2 (5 mL) gave, after 
chromatographic purification (eluent Et O:petrol 20:80), diazene 581 as a red oil (0.36 g, 
75%); max (thin film)/cm
-1
 3073 (C-H), 1716 (C=O), 1589, 1499; δ (400 MHz, CDCl ) 
7.37-7.42 (1H, m, ArH), 7.54 (1H, td, J 8.0, 5.4, ArH), 7.58-7.68 (3H, m, NAr(3,5)H 
and NAr(4)H), 7.81 (1H, ddd, J 9.0, 2.6, 1.5, ArH), 7.88-7.90 (1H, m, ArH), 8.02-8.05 
(2H, m, NAr(2,6)H); δ (100 MHz, CDCl ) 117.2 (d, J 22.8, ArC), 121.7 (d, J 21.3, ArC), 
123.8 (NArC(2,6)), 126.4 (d, J 3.0, C(O)ArC(6)), 129.5 (NArC(3,5)), 130.7 (d, J 7.4, 
C(O)ArC(5)), 133.0 (d, J 6.7, C(O)ArC(1)), 133.8 (NArC(4)), 152.1 (NArC(1)), 162.7 
(d, J 247, C(O)ArC(3)), 180.6 (C=O); m/z (ES
+
) 251 ([M+Na]
+
, 100%); HRMS (ES
+
) 
C13H9FN2NaO
+
 ([M+Na]
+
) requires 251.0597; found 251.0602 (+2.1 ppm). 
 
(E)-(2-fluorophenyl)(phenyldiazenyl)methanone 
 
Following general procedure I, hydrazide 568 (0.80 g, 3.49 mmol), pyridine (0.31 mL, 
3.84 mmol) and N-bromosuccinimide (0.62 g, 3.49 mmol) in CH2Cl2 (5 mL) gave, after 
chromatographic purification (eluent Et O:petrol 20:80), diazene 582 as a red oil (0.54 g, 
68%); max (thin film)/cm
-1
 3066 (C-H), 1695 (C=O), 1609, 1586, 1505; δ (300 MHz, 
CDCl ) 7.20 (1H, ddd, J 10.6, 8.4, 1.0, ArH), 7.36 (1H, td, J 7.6, 0.9, ArH), 7.56-7.71 
(4H, m, ArH), 7.98-8.02 (2H, m, ArH), 8.13 (1H, ddd, J 7.8, 7.1, 1.8, ArH); δ (75 MHz, 
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CDCl ) 117.2 (d, J 29.3, C(O)ArC(3)), 119.3 (d, J 15.0, C(O)ArC(1)), 123.6 
(NArC(2,6)), 124.6 (d, J 4.8, C(O)ArC(5)), 129.4 (NArC(3,5)), 132.5 (ArC), 133.4 
(ArC), 136.4 (d, J 12.0, C(O)ArC(4)), 152.1 (NArC(1)), 162.5 (d, J 346, C(O)ArC(2)), 
180.9 (d, J 7.8, C=O); m/z (ES
+
) 251 ([M+Na]
+
, 100%); HRMS (ES
+
) C13H9FN2NaO
+
 
([M+Na]
+
) requires 251.0597; found 251.0593 (-1.4 ppm). 
 
(E)-(4-bromophenyl)(phenyldiazenyl)methanone 
 
Following general procedure I, hydrazide 569 (0.82 g, 2.82 mmol), pyridine (0.26 mL, 
3.10 mmol) and N-bromosuccinimide (0.50 g, 2.82 mmol) in CH2Cl2 (5 mL) gave, after 
chromatographic purification (eluent Et O:petrol 20:80), diazene 583 as a red solid (0.67 
g, 82%); mp 39-40 °C; {lit.
195
 mp 38-39.5 °C}; δ (300 MHz, CDCl ) 7.57-7.66 (3H, m, 
NAr(3,5)H and NAr(4)H), 7.68-7.72 (2H, m, ArH), 7.95-7.99 (2H, m, ArH), 8.01-8.04 
(2H, m, NAr(2,6)H). Spectroscopic data are in accordance with the literature.
195
 
 
(E)-(4-chlorophenyl)(phenyldiazenyl)methanone 
 
Following general procedure I, hydrazide 570 (1.16 g, 4.71 mmol), pyridine (0.42 mL, 
5.18 mmol) and N-bromosuccinimide (0.84 g, 4.71 mmol) in CH2Cl2 (5 mL) gave, after 
chromatographic purification (eluent Et O:petrol 20:80), diazene 584 as a red oil (0.91 g, 
76%); max (thin film)/cm
-1
 3064 (C-H), 1701 (C=O), 1591, 1500; δ (300 MHz, CDCl ) 
7.50-7.55 (2H, m, ArH), 7.57-7.67 (3H, m, ArH), 8.01-8.07 (4H, m, ArH); δ (75 MHz, 
CDCl ) 123.8 (NArC(2,6)), 129.4 (ArC), 129.5 (ArC), 131.9 (NArC(4)), 131.9 
(C(O)ArC(1)), 133.7 (ArC), 141.2 (C(O)ArC(4)), 152.1 (NArC(1)), 180.8 (C=O); m/z 
(ES
+
) 267 ([M+Na]
+
, 100%); HRMS (ES
+
) C9H13
35
ClN2NaO3
+
 ([M+Na]
+
) requires 
267.0303; found 267.0302 (-0.3 ppm). 
 
(E)-naphthalen-1-yl(phenyldiazenyl)methanone 
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Following general procedure I, hydrazide 571 (0.74 g, 2.81 mmol), pyridine (0.26 mL, 
3.10 mmol) and N-bromosuccinimide (0.50 g, 2.81 mmol) in CH2Cl2 (5 mL) gave, after 
chromatographic purification (eluent Et O:petrol 20:80), diazene 585 as a red solid (0.58 
g, 79%); mp 76-78 °C; max (KBr)/cm
-1
 3061 (C-H), 1697 (C=O), 1591, 1500; δ (400 
MHz, CDCl ) 7.54-7.66 (5H, m, ArH), 7.76 (1H, ddd, J 8.6, 7.0, 1.4, ArH), 7.96 (1H, dd, 
J 8.2, 0.4, ArH), 8.05-8.07 (2H, m, ArH), 8.15 (1H, d, J 8.2, ArH), 8.31 (1H, dd, J 7.3, 
1.2, ArH), 9.25 (1H, d, J 8.7, C(O)Ar(8)H); δ (100 MHz, CDCl ) 123.7 (NArC(2,6)), 
124.4 (ArC), 126.2 (ArC), 126.9 (ArC), 127.1 (ArC), 128.8 (ArC), 129.0 (ArC), 129.4 
(ArC), 131.6 (ArC), 133.3 (ArC), 133.4 (ArC), 134.1 (C(O)ArC(1)), 135.6 (ArC), 152.1 
(NArC(1)), 183.1 (C=O); m/z (ES
+
) 283 ([M+Na]
+
, 100%); HRMS (ES
+
) C17H12N2NaO
+
 
([M+Na]
+
) requires 283.0847; found 283.0848 (+0.2 ppm). 
 
(E)-(phenyldiazenyl)(p-tolyl)methanone 
 
Following general procedure I, hydrazide 573 (0.82 g, 3.63 mmol), pyridine (0.32 mL, 
4.00 mmol) and N-bromosuccinimide (0.65 g, 3.63 mmol) in CH2Cl2 (5 mL) gave, after 
chromatographic purification (eluent Et O:petrol 15:85), diazene 587 as a red oil (0.63 g, 
77%); δ (400 MHz, CDCl ) 2.38 (3H, s, CH ), 7.25 (2H, d, J 8.0, C(O)Ar(3,5)H), 7.47-
7.55 (3H, m, ArH), 7.87-7.89 (2H, d, J 8.0, C(O)Ar(2,6)H), 7.91-7.93 (2H, m, ArH). 
Spectroscopic data are in accordance with the literature.
196
 
 
(E)-furan-2-yl(phenyldiazenyl)methanone 
 
Following general procedure I, hydrazide 574 (0.79 g, 3.91 mmol), pyridine (0.35 mL, 
4.30 mmol) and N-bromosuccinimide (0.69 g, 3.91 mmol) in CH2Cl2 (5 mL) gave, after 
chromatographic purification (eluent Et O:petrol 20:80), diazene 588 as a red oil (0.41 g, 
52%); δ (300 MHz, CDCl ) 6.70 (1H, dd, J 3.6, 1.7, C(O)Ar(4)H), 7.45 (1H, dd, J 3.6, 
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0.7, C(O)Ar(3)H), 7.58-7.69 (3H, m, NAr(3,5)H and NAr(4)H), 7.84 (1H, dd, J 1.7, 0.7, 
C(O)Ar(5)H), 8.03-8.07 (2H, m, NAr(2,6)H). Spectroscopic data are in accordance with 
the literature.
197
 
 
(E)-4-(benzoyldiazenyl)benzonitrile 
 
To a solution of 4-cyanophenylhydrazine hydrochloride 589 (2.00 g, 11.8 mmol) and 
Et3N (3.29 mL, 23.6 mmol) in Et2O (30 mL) at 0 °C was slowly added benzoyl chloride 
(1.24 mL, 10.7 mmol). After stirring at rt for 30 minutes the reaction mixture was 
concentration in vacuo. The solid was dissolved in CH2Cl2 and washed with HCl (1M in 
H2O). The organic layer was dried (MgSO4), filtered and concentrated in vacuo to give a 
crude hydrazide 590 which was used without purification. Following general procedure 
I, hydrazide 590 (2.54 g, 10.7 mmol assuming 100% conversion), pyridine (0.97 mL, 
11.8 mmol) and N-bromosuccinimide (1.90 g, 10.7 mmol) in CH2Cl2 (15 mL) gave, after 
chromatographic purification (eluent Et O:petrol 20:80), diazene 591 as a purple solid 
(0.26 g, 10% over 2 steps); mp 110-112 °C; max (KBr)/cm
-1
 3043 (C-H), 2229 (CN), 
1706 (C=O), 1598, 1506; δ (400 MHz, CDCl ) 7.57 (2H, t, J 7.7, C(O)Ar(3,5)H), 7.73 
(1H, t, J 7.4, C(O)Ar(4)H), 7.91 (2H, d, J 8.4, ArH), 8.05 (2H, d, J 7.3, C(O)Ar(2,6)H), 
8.09 (2H, d, J 8.4, ArH); δ (75 MHz, CDCl ) 116.5 (CN), 117.9 (NArC(4)), 123.9 
(ArC), 129.1 (ArC), 130.2 (C(O)ArC(1)), 130.6 (ArC), 133.5 (ArC), 135.0 
(C(O)ArC(4)), 153.5 (NArC(1)), 181.5 (C=O); m/z (ES
+
) 236 ([M+H]
+
, 100%); HRMS 
(ES
+
) C14H10N3O
+
 ([M+H]
+
) requires 236.0824; found 236.0824 (+0.2 ppm). 
 
(E)-phenyl((4-(trifluoromethyl)phenyl)diazenyl)methanone 
 
To a solution of 565 (1.00 g, 3.23 mmol) and Et3N (0.49 mL, 3.55 mmol) in EtOAc (10 
mL) at 0 °C was added benzoyl chloride (0.37 mL, 3.23 mmol). The reaction mixture 
was stirred at rt for 1 h. The reaction mixture was washed with HCl (1 M in H2O) and 
sat. aq. NaHCO3. The organic layer was dried (MgSO4), filtered and concentrated in 
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vacuo to give the crude acylated product 592 which was used without purification. To a 
solution of crude acylated product 592 (1.34 g, 3.23 mmol assuming 100% conversion) 
and 10% palladium on charcoal (0.34 g, 0.32 mmol, 10 mol%) in EtOAc (10 mL) was 
appended a balloon of hydrogen gas. The hydrogen gas was allowed to bubble through 
the reaction mixture at rt for 4 h. The reaction mixture was filtered through celite and 
concentrated in vacuo to give the hydrazide 593 which was used without purification. 
Following general procedure I, hydrazide 593 (903 mg, 3.23 mmol assuming 100% 
conversion), pyridine (0.29 mL, 3.55 mmol) and N-bromosuccinimide (0.57 g, 3.23 
mmol) in CH2Cl2 (10 mL) gave, after chromatographic purification (eluent Et O:petrol 
10:90), diazene 594 as a red oil (0.60 g, 66% over 3 steps); max (thin film)/cm
-1
 3070 
(C-H), 1716 (C=O), 1599; δ (500 MHz, CDCl ) 7.46 (2H, t, J 7.8, C(O)Ar(3,5)H), 7.61 
(1H, t, J 7.5, C(O)Ar(4)H), 7.76 (2H, d, J 8.3, C(O)Ar(2,6)H), 7.94-7.96 (2H, m, ArH), 
8.00 (2H, d, J 8.2, ArH); δ (125 MHz, CDCl ) 123.6 (q, J 271, CF ), 123.7 (ArC), 126.7 
(q, J 3.5, NArC(3,5)), 129.0 (ArC), 130.3 (C(O)ArC(1)), 130.6 (ArC), 134.4 (q, J 32.5, 
NArC(4)), 134.9 (C(O)ArC(4)), 153.6 (NArC(1)), 181.7 (C=O); m/z (ES
+
) 301 
([M+Na]
+
, 100%); HRMS (ES
+
) C14H9F3N2NaO
+
 ([M+Na]
+
) requires 301.0565; found 
301.0566 (+0.4 ppm). 
 
(E)-((4-methoxyphenyl)diazenyl)(4-(trifluoromethyl)phenyl)methanone 
 
Following general procedure I, hydrazide 330 (3.50 g, 11.3 mmol), pyridine (1.02 mL, 
12.4 mmol) and N-bromosuccinimide (2.00 g, 11.3 mmol) in CH2Cl2 (50 mL) gave, after 
chromatographic purification (eluent Et O:petrol 20:80), diazene 595 as a red solid (2.57 
g, 74%) mp 56-58 °C; max (KBr)/cm
-1
 2936 (C-H), 1696 (C=O), 1597, 1504; δ (300 
MHz, CDCl ) 3.97 (3H, s, OCH ), 7.07-7.11 (2H, m, NAr(3,5)H), 7.82 (2H, d, J 8.2, 
ArH), 8.04-8.10 (2H, m, NAr(2,6)H), 8.29 (2H, d, J 8.1, ArH); δ (100 MHz, CDCl ) 
55.8 (OCH ), 114.7 (NArC(3,5)), 123.5 (q, J 271, CF ), 125.8 (q, J 3.6, C(O)ArC(3,5)), 
126.6 (C(O)ArC(2,6)), 131.0 (NArC(2,6)), 134.9 (NArC(1)), 135.3 (q, J 32.7, 
C(O)ArC(4)), 146.8 (C(O)ArC(1)), 164.8 (NArC(4)), 179.9 (C=O); m/z (ES
+
) 331 
([M+Na]
+
, 100%); HRMS (ES
+
) C15H11N2NaO2F3
+
 ([M+Na]
+
) requires 331.0670; found 
331.0675 (+1.4 ppm). 
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(E)-(mesityldiazenyl)(4-nitrophenyl)methanone 
 
Following general procedure I, hydrazide 575 (0.28 g, 0.94 mmol), pyridine (0.09 mL, 
1.03 mmol) and N-bromosuccinimide (0.17 g, 0.94 mmol) in CH2Cl2 (5 mL) gave, after 
chromatographic purification (eluent CH Cl :petrol 80:20), diazene 596 as a red solid 
(0.15 g, 53%); mp 104-106 °C; max (KBr)/cm
-1
 3109 (C-H), 2921, 1694 (C=O), 1606, 
1535 (N=O), 1353 (N=O); δ (400 MHz, CDCl ) 2.30 (3H, s, CH ), 2.46 (6H, s, 2 CH ), 
6.95 (2H, s, NAr(3,5)H), 8.21 (2H, d, J 8.8, ArH), 8.29 (2H, d, J 8.8, ArH); δ (75 MHz, 
CDCl ) 20.6 (2 CH ), 21.5 (CH ), 124.0 (ArC), 130.9 (ArC), 131.7 (ArC), 135.7 
(NArC(2,6)), 136.9 (NArC(1)), 143.8 (NArC(4)), 147.3 (C(O)ArC(1)), 150.9 
(C(O)ArC(4)), 179.2 (C=O); m/z (ES
+
) 298 ([M+H]
+
, 100%); HRMS (ES
+
) C16H16N3O3
+
 
([M+H]
+
) requires 298.1192; found 298.1186 (-1.8 ppm). 
 
(E)-((4-methoxyphenyl)diazenyl)(phenyl)methanone 
 
To a solution of 4-methoxyphenylhydrazine hydrochloride 597 (0.38 g, 2.18 mmol) and 
Et3N (0.61 mL, 4.36 mmol) in Et2O (10 mL) at 0 °C was slowly added benzoyl chloride 
(0.23 mL, 1.98 mmol). After stirring at rt for 30 minutes the reaction mixture was 
concentration in vacuo. The solid was dissolved in CH2Cl2 and washed with HCl (1 M 
H2O). The organic layer was dried (MgSO4), filtered and concentrated in vacuo to give 
crude hydrazide 598 which was used without purification. Following general procedure 
I, crude hydrazide 598 (0.37 g, 1.53 mmol), pyridine (0.14 mL, 1.68 mmol) and N-
bromosuccinimide (0.27 g, 1.53 mmol) in CH2Cl2 (10 mL) gave, after chromatographic 
purification (eluent Et O:petrol 20:80), diazene 599 as a red solid (0.10 g, 21% over 2 
steps); mp 50-52 °C; max (KBr)/cm
-1
 3098 (C-H), 1700 (C=O), 1599, 1503; δ (400 
MHz, CDCl ) 3.86 (3H, s, OCH ), 6.95-6.99 (2H, m, NAr(3,5)H), 7.43-7.47 (2H, m, 
C(O)Ar(3,5)H), 7.56-7.60 (1H, m, C(O)Ar(4)H), 7.93-7.97 (2H, m, NAr(2,6)H), 8.05 
(2H, d, J 8.3, C(O)Ar(2,6)H); δ (75 MHz, CDCl ) 55.8 (OC), 114.5 (NArC(3,5)), 
126.2 (ArC), 128.8 (ArC), 130.7 (ArC), 131.7 (C(O)ArC(1)), 134.3 (C(O)ArC(4)), 146.8 
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(NArC(1)), 164.2 (NArC(4)), 181.6 (C=O); m/z (ES
+
) 263 ([M+Na]
+
, 100%); HRMS 
(ES
+
) C14H12N2NaO
+
 ([M+Na]
+
) requires 263.0796; found 263.0796 (+0.1 ppm). 
 
(E)-(4-methoxyphenyl)(phenyldiazenyl)methanone 
 
Following general procedure I, hydrazide 576 (0.78 g, 3.21 mmol), pyridine (0.29 mL, 
3.53 mmol) and N-bromosuccinimide (0.57 g, 3.21 mmol) in CH2Cl2 (5 mL) gave, after 
chromatographic purification (eluent Et O:petrol 20:80), diazene 600 as a red oil (0.59 g, 
77%); max (ATR)/cm
-1
 2933 (C-H), 1694 (C=O), 1595, 1501; δ (300 MHz, CDCl ) 3.91 
(3H, s, OCH ), 6.99-7.04 (2H, m, C(O)Ar(3,5)H), 7.55-7.62 (3H, m, ArH), 8.00-8.09 
(4H, m, ArH); δ (125 MHz, CDCl ) 55.7 (OC), 114.3 (C(O)ArC(3,5)), 123.6 
(C(O)ArC(1)), 123.6 (NArC(2,6)), 129.4 (NArC(3,5)), 133.1 (C(O)ArC(2,6)), 133.4 
(NArC(4)), 152.2 (NArC(1)), 164.7 (C(O)ArC(4)), 181.1 (C=O); m/z (ESI
+
) 241 
([M+H]
+
, 100%); HRMS (ESI
+
) C14H13N2O2
+
 ([M+H]
+
) requires 241.0977; found 
241.0967 (-0.5 ppm). 
 
General procedure J: Intermolecular Michael addition-lactonisation. 
To a solution of acid (1.5 eq) in CH2Cl2 (~1 mL per 0.2 mmol of acid) were added i-
Pr2NEt (1.5 eq based on acid) and p-methoxybenzoyl chloride (1.5 eq based on acid) at 
rt. The reaction mixture was allowed to stir at rt for 10 minutes. The requisite Lewis base 
(0.1-20 mol%), Michael acceptor (1 eq) and i-Pr2NEt (1.5 eq) were then added at the 
required temperature in that order. The reaction mixture was stirred at the required 
temperature until complete by TLC and was subsequently quenched by addition of HCl 
(1 M in H2O). The reaction mixture was poured into H2O and extracted with CH2Cl2 (x 
3). The combined organics were dried (MgSO4), filtered and concentrated in vacuo to 
give the crude reaction mixture. Note: All racemic samples were obtained via this 
general procedure using DHPB 108 as catalyst. 
 
Optimisation studies on compound 320 
triphenyl-4H-1,3,4-oxadiazin-6(5H)-one 
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Following general procedure J, phenylacetic acid (40.9 mg, 0.30 mmol), i-Pr2NEt (78.0 
L, 0.45 mmol) and p-methoxybenzoyl chloride (77.0 mg, 0.45 mmol) in CH Cl  (2 
mL), diazene 313 (42.0 mg, 0.20 mmol), DHPB 108 (7.60 mg, 0.04 mmol) and i-Pr2NEt 
(52.0 L, 0.30 mmol) for 1 h at rt gave, after chromatographic purification (eluent 
Et O:petrol 2:98) (±)-302 as a colourless oil (41.0 mg, 63%); Chiral HPLC Chiralpak 
AD-H (5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(5S): 9.0 min, tR(5R): 
14.9 min; max (thin film)/cm
-1
 3063, 2977 (C-H), 1791 (C=O), 1596, 1495; δ (400 MHz, 
CDCl ) 5.96 (1H, s, C(5)H), 6.89-6.92 (1H, m, N(4)Ar(4)H), 7.15-7.28 (9H, m, ArH), 
7.31-7.34 (3H, m, C(2)Ar(3,5)H and C(2)Ar(4)H), 7.86-7.89 (2H, m, C(2)Ar(2,6)H); δ
(100 MHz, CDCl ) 59.5 (C(5)), 114.5 (N(4)ArC(2,6)), 121.9 (N(4)ArC(4)), 125.6 (ArC), 
126.7 (ArC), 128.6 (ArC), 128.9 (C(2)ArC(1)), 129.1 (ArC), 129.4 (ArC), 129.4 (ArC), 
130.3 (ArC), 131.2 (C(5)ArC(1)), 141.0 (N(4)ArC(1)), 144.3 (C(2)), 160.4 (C(6));m/z 
(APCI
+
) 328 ([M]
+
, 12%); HRMS (APCI
+
) C21H16N2O2
+
 ([M]
+
) requires 328.1206; 
found 328.1201 (-1.6 ppm). 

Asymmetric Catalyst Screen:  
Tetramisole hydrochloride (2S)-106 (4.82 mg, 0.02 mmol, 10 mol%) gave 
approximately 65% conversion to the desired product after 16 h at rt. 
 
Benzotetramisole (2R)-107 (5.04 mg, 0.02 mmol, 10 mol%) gave approximately 20% 
conversion to the desired product after 16 h at rt. 
 
HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 10 mol%) gave full conversion to the 
desired product after 1 h at rt. Chromatographic purification (eluent Et O:petrol 2:98) 
gave (5R)-320 as a colourless oil (43.0 mg, 66%); 95% ee. 
 
Temperature Screen:  
All reactions with HBTM-2.1 (2S,3R)-112 (6.17 mg, 0.02 mmol, 10 mol%) 
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Reaction for 2 h at 0 °C gave, after chromatographic purification (eluent Et O:petrol 
2:98) (5R)-320 as a colourless oil (42.3 mg, 65%); 98% ee. 
 
Reaction for 16 h at 30 °C gave, after chromatographic purification (eluent Et O:petrol 
2:98) (5R)-320 as a colourless oil (39.7 mg, 61%); 99% ee. 
 
Reaction for 16 h at 78 °C gave, after chromatographic purification (eluent Et O:petrol 
2:98) (5R)-320 as a colourless oil (53.2 mg, 81%); 99% ee. 
 
Catalyst Loading Screen:  
All reactions at 78 °C for 16 h. 
 
HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%) gave, after chromatographic 
purification (eluent Et O:petrol 2:98) (5R)-320 as a colourless oil (54.3 mg, 83%); >99% 
ee. 
 
HBTM-2.1 (2S,3R)-112 (1.23 mg, 0.004 mmol, 1 mol%) gave, after chromatographic 
purification (eluent Et O:petrol 2:98) (5R)-320 as a colourless oil (58.6 mg, 89%); 

 
D
20
-
621.7 (c 1.075, CH2Cl2); >99% ee. 
 
(5R)-2,4-diphenyl-5-(p-tolyl)-4H-1,3,4-oxadiazin-6(5H)-one 
 
Following general procedure J, p-tolylacetic acid (45.1 mg, 0.30 mmol), i-Pr2NEt (78.0 
L, 0.45 mmol) and p-methoxybenzoyl chloride (77.0 mg, 0.45 mmol) in CH Cl  (2 
mL), HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 313 (42.0 mg, 
0.20 mmol) and i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C gave, after 
chromatographic purification (eluent Et O:petrol 1:99) (5R)-331 as a white solid (53.3 
mg, 78%); mp 120-122 °C; 

 
D
20
-603.3 (c 0.75, CH2Cl2); Chiral HPLC Chiralpak AD-H 
(5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(5S): 8.7 min, tR(5R): 20.2 
min, >99% ee; max (KBr)/cm
-1
 3059, 2931 (C-H), 1789 (C=O), 1597, 1494; δ (400 
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MHz, CDCl ) 2.18 (3H, s, CH ), 5.92 (1H, s, C(5)H), 6.89-6.93 (1H, m, N(4)Ar(4)H), 
7.01 (2H, d, J 8.1, ArH), 7.13-7.18 (4H, m, ArH), 7.21-7.25 (2H, m, ArH), 7.31-7.35 
(3H, m, C(2)Ar(3,5)H, C(2)Ar(4)H), 7.85-7.90 (2H, m, C(2)Ar(2,6)H); δ (100 MHz, 
CDCl ) 21.1 (CH ), 59.3 (C(5)), 114.5 (N(4)ArC(2,6)), 121.8 (N(4)ArC(4)), 125.6 (ArC), 
126.6 (ArC), 128.1 (ArC), 128.6 (ArC), 128.9 (ArC), 129.4 (ArC), 130.0 (ArC), 130.2 
(C(2)ArC(4)), 139.0 (C(5)ArC(4)), 140.9 (N(4)ArC(1)), 144.4 (C(2)), 160.6 (C(6)); m/z 
(APCI
+
) 343 ([M+H]
+
, 23%); HRMS (APCI
+
) C22H19N2O2
+
 ([M+H]
+
) requires 
343.1441; found 343.1438 (-0.9 ppm). 
 
(5R)-5-(4-bromophenyl)-2,4-diphenyl-4H-1,3,4-oxadiazin-6(5H)-one 
 
Following general procedure J, p-bromophenylacetic acid (64.5 mg, 0.30 mmol), i-
Pr2NEt (78.0 L, 0.45 mmol) and p-methoxybenzoyl chloride (77.0 mg, 0.45 mmol) in 
CH Cl  (2 mL), HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 313 
(42.0 mg, 0.20 mmol) and i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C gave, after 
chromatographic purification (eluent Et O:petrol 1:99) (5R)-332 as a white solid (64.9 
mg, 80%); mp 38-40 °C; 

 
D
20
-572.0 (c 0.50, CH2Cl2); Chiral HPLC Chiralpak AD-H 
(5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(5S): 10.1 min, tR(5R): 19.0 
min, 99% ee; max (KBr)/cm
-1
 3060, 2934 (C-H), 1789 (C=O), 1597, 1486; δ (300 MHz, 
CDCl ) 5.92 (1H, s, C(5)H), 6.92-6.97 (1H, m, N(4)Ar(4)H), 7.13-7.18 (4H, m, ArH), 
7.22-7.28 (2H, m, ArH), 7.33-7.37 (5H, m, ArH), 7.86-7.89 (2H, m, C(2)Ar(2,6)H); δ
(100 MHz, CDCl ) 59.1 (C(5)), 114.5 (N(4)ArC(2,6)), 122.1 (N(4)ArC(4)), 123.4 
(C(5)ArC(4)), 125.6 (ArC), 128.4 (ArC), 128.6 (C(2)ArC(1)), 128.6 (ArC), 129.5 (ArC), 
130.2 (C(5)ArC(1)), 130.5 (C(2)ArC(4)), 132.5 (ArC), 141.2 (N(4)ArC(1)), 144.0 (C(2)), 
160.0 (C(6));m/z (NSI+) 439 ([M+CH5O]
+
, 95%); HRMS (NSI
+
) C22H20
79
BrN2O3
+
 ([M+ 
CH5O]
+
) requires 439.0652; found 439.0655 (+0.7 ppm). 
 
(5R)-5-(4-chlorophenyl)-2,4-diphenyl-4H-1,3,4-oxadiazin-6(5H)-one 
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Following general procedure J, p-chlorophenylacetic acid (51.2 mg, 0.30 mmol), i-
Pr2NEt (78.0 L, 0.45 mmol) and p-methoxybenzoyl chloride (77.0 mg, 0.45 mmol) in 
CH Cl  (2 mL), HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 313 
(42.0 mg, 0.20 mmol) and i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C gave, after 
chromatographic purification (eluent Et O:petrol 1:99) (5R)-333 as a white solid (47.8 
mg, 66%); mp 40-42 °C; 

 
D
20
-613.5 (c 0.2, CH2Cl2); Chiral HPLC Chiralpak AD-H 
(5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(5S): 9.2 min, tR(5R): 16.9 
min, >99% ee; max (KBr)/cm
-1
 2933 (C-H), 1790 (C=O), 1598, 1490; δ (300 MHz, 
CDCl ) 5.93 (1H, s, C(5)H), 6.93 (1H, t, J 7.2, N(4)Ar(4)H), 7.13-7.28 (8H, m, ArH), 
7.30-7.38 (3H, m, C(2)Ar(3,5)H and C(2)Ar(4)H), 7.84-7.90 (2H, m, C(2)Ar(2,6)H); δ
(100 MHz, CDCl ) 59.0 (C(5)), 114.5 (N(4)ArC(2,6)), 122.1 (N(4)ArC(4)), 125.6 (ArC), 
128.1 (ArC), 128.6 (ArC), 128.6 (ArC), 129.5 (ArC), 129.6 (ArC), 129.6 (ArC), 130.5 
(C(2)ArC(4)), 135.2 (ArC), 141.2 (N(4)ArC(1)), 144.1 (C(2)), 160.1 (C(6)); m/z (NSI+) 
395 ([M+CH5O]
+
, 100%); HRMS (NSI
+
) C22H20
35
ClN2O3
+
 ([M+ CH5O]
+
) requires 
395.1157; found 395.1157 (+0.0 ppm). 
 
(5R)-5-(4-fluorophenyl)-2,4-diphenyl-4H-1,3,4-oxadiazin-6(5H)-one 
 
Following general procedure J, p-fluorophenylacetic acid (46.2 mg, 0.30 mmol), i-
Pr2NEt (78.0 L, 0.45 mmol) and p-methoxybenzoyl chloride (77.0 mg, 0.45 mmol) in 
CH Cl  (2 mL), HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 313 
(42.0 mg, 0.20 mmol) and i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C gave, after 
chromatographic purification (eluent Et O:petrol 1.5:98.5) (5R)-334 as a colourless oil 
(53.6 mg, 77%); 

 
D
20
-634.2 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak AD-H (5% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(5S): 8.5 min, tR(5R): 12.7 min, 
>99% ee; max (thin film)/cm
-1
 3063, 2928 (C-H), 1791 (C=O), 1597, 1506; δ (400 MHz, 
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CDCl ) 5.94 (1H, s, C(5)H), 6.89-6.96 (3H, m, ArH), 7.15-7.28 (2H, m, ArH), 7.23-7.27 
(4H, m, ArH), 7.33-7.37 (3H, m, C(2)Ar(3,5)H and C(2)Ar(4)H), 7.87-7.90 (2H, m, 
C(2)Ar(2,6)H); δ (100 MHz, CDCl ) 58.9 (C(5)), 114.5 (N(4)ArC(2,6)), 116.4 (d, J 21.8, 
C(5)ArC(3,5)), 122.0 (N(4)ArC(4)), 125.6 (ArC), 126.9 (d, J 3.0, C(5)ArC(1)), 128.5 
(ArC), 128.6 (ArC), 128.7 (C(2)ArC(1)), 129.4 (ArC), 130.4 (C(2)ArC(4)), 141.1 
(N(4)ArC(1)), 144.1 (C(2)), 160.3 (C(6)), 163.1 (d, J 247, C(5)ArC(4)); m/z (NSI+) 379 
([M+CH5O]
+
, 100%); HRMS (NSI
+
) C22H20FN2O3
+
 ([M+ CH5O]
+
) requires 379.1452; 
found 379.1454 (+0.4 ppm). 
 
(5R)-5-([1,1'-biphenyl]-4-yl)-2,4-diphenyl-4H-1,3,4-oxadiazin-6(5H)-one 
 
Following general procedure J, biphenylacetic acid (63.6 mg, 0.30 mmol), i-Pr2NEt 
(78.0 L, 0.45 mmol) and p-methoxybenzoyl chloride (77.0 mg, 0.45 mmol) in CH Cl  
(2 mL), HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 313 (42.0 mg, 
0.20 mmol) and i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C gave, after 
chromatographic purification (eluent Et O:petrol 1:99) (5R)-335 as a white solid (70.8 
mg, 88%); mp 39-41 °C; 

 
D
20
-532.2 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak AD-H 
(5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(5S): 13.5 min, tR(5R): 16.7 
min, 98% ee; max (KBr)/cm
-1
 3059, 2925 (C-H), 1790 (C=O), 1597, 1494; δ (400 MHz, 
CDCl ) 6.01 (1H, s, C(5)H), 6.92-6.96 (1H, m, N(4)Ar(4)H), 7.20-7.37 (12H, m, ArH), 
7.40-7.44 (4H, m, ArH), 7.90-7.92 (2H, m, C(2)Ar(2,6)H); δ (100 MHz, CDCl ) 59.3 
(C(5)), 114.5 (N(4)ArC(2,6)), 121.9 (N(4)ArC(4)), 125.6 (ArC), 127.1 (ArC), 127.1 
(ArC), 127.7 (ArC), 128.1 (ArC), 128.6 (ArC), 128.6 (C(2)ArC(1)), 128.8 (ArC), 129.4 
(ArC), 130.1 (ArC), 130.3 (ArC), 140.1 (ArC), 141.1 (C(2)), 142.0 (ArC), 144.3 (ArC), 
160.4 (C(6));m/z (APCI+) 405 ([M+H]+, 100%); HRMS (APCI+) C27H21N2O2
+
 
([M+H]
+
) requires 405.1598; found 405.1591 (-1.6 ppm). 
 
(5R)-2,4-diphenyl-5-(m-tolyl)-4H-1,3,4-oxadiazin-6(5H)-one 
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Following general procedure J, m-tolylacetic acid (45.1 mg, 0.30 mmol), i-Pr2NEt (78.0 
L, 0.45 mmol) and p-methoxybenzoyl chloride (77.0 mg, 0.45 mmol) in CH Cl  (2 
mL), HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 313 (42.0 mg, 
0.20 mmol) and i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C gave, after 
chromatographic purification (eluent Et O:petrol 1:99) (5R)-336 as a white solid (53.8 
mg, 79%); mp 130-132 °C; 

 
D
20
-651.6 (c 0.25, CH2Cl2); Chiral HPLC Chiralpak AD-H 
(5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(5S): 7.7 min, tR(5R): 8.9 min, 
>99% ee; max (KBr)/cm
-1
 3030, 2926 (C-H), 1789 (C=O), 1597, 1494; δ (400 MHz, 
CDCl ) 2.19 (3H, s, CH ), 5.91 (1H, s, C(5)H), 6.91 (1H, tt, J 7.2, 1.1, N(4)Ar(4)H), 
7.00-7.03 (2H, m, ArH), 7.06-7.11 (2H, m, ArH), 7.14-7.17 (2H, m, ArH), 7.21-7.26 
(2H, m, ArH), 7.31-7.35 (3H, m, C(2)Ar(3,5)H and C(2)Ar(4)H), 7.86-7.90 (2H, m, 
C(2)Ar(2,6)H); δ (100 MHz, CDCl ) 21.5 (CH ), 59.5 (C(5)), 114.5 (N(4)ArC(2,6)), 
121.8 (N(4)ArC(4)), 123.6 (ArC), 125.6 (ArC), 127.2 (ArC), 128.6 (ArC), 128.9 
(C(2)ArC(1)), 129.2 (ArC), 129.4 (ArC), 129.9 (ArC), 130.2 (ArC), 131.2 (C(5)ArC(3)), 
139.3 (C(5)ArC(1)), 140.9 (N(4)ArC(1)), 144.3 (C(2)), 160.5 (C(6)); m/z (APCI+) 343 
([M+H]
+
, 92%); HRMS (APCI
+
) C22H19N2O2
+
 ([M+H]
+
) requires 343.1441; found 
343.1438 (-0.9 ppm). 
 
(5R)-5-(naphthalen-2-yl)-2,4-diphenyl-4H-1,3,4-oxadiazin-6(5H)-one 
 
Following general procedure J, 2-naphthylacetic acid (55.9 mg, 0.30 mmol), i-Pr2NEt 
(78.0 L, 0.45 mmol) and p-methoxybenzoyl chloride (77.0 mg, 0.45 mmol) in CH Cl  
(2 mL), HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 313 (42.0 mg, 
0.20 mmol) and i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C gave, after 
chromatographic purification (eluent Et O:petrol 1:99) (5R)-337 as a white solid (57.6 
mg, 76%); mp 40-42 °C; 

 
D
20
-540.4 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak AD-H 
(5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(5S): 13.0 min, tR(5R): 22.5 
 Chapter 9: Experimental 
 
 283 
min, 99% ee; max (KBr)/cm
-1
 3058, 2935 (C-H), 1788 (C=O), 1596, 1494; δ (400 MHz, 
CDCl ) 6.12 (1H, s, C(5)H), 6.90-6.94 (1H, m, N(4)Ar(4)H), 7.20-7.27 (4H, m, ArH), 
7.32-7.42 (6H, m, ArH), 7.64-7.74 (4H, m, ArH), 7.88-7.91 (2H, m, C(2)Ar(2,6)H); δ
(100 MHz, CDCl ) 59.8 (C(5)), 114.6 (N(4)ArC(2,6)), 121.9 (N(4)ArC(4)), 123.7 (ArC), 
125.6 (ArC), 126.2 (ArC), 126.7 (ArC), 126.8 (ArC), 127.7 (ArC), 128.2 (ArC), 128.6 
(ArC), 128.6 (ArC), 128.8 (ArC), 129.4 (ArC), 129.5 (ArC), 130.3 (ArC), 133.2 (ArC), 
133.4 (ArC), 141.1 (N(4)ArC(1)), 144.3 (C(2)), 160.4 (C(6));m/z (APCI+) 379 ([M+H]+, 
100%); HRMS (APCI
+
) C25H19N2O2
+
 ([M+H]
+
) requires 379.1441; found 379.1433 (-
2.1 ppm). 
 
(5R)-4-(4-fluorophenyl)-2,5-diphenyl-4H-1,3,4-oxadiazin-6(5H)-one 
 
Following general procedure J, phenylacetic acid (40.9 mg, 0.30 mmol), i-Pr2NEt (78.0 
L, 0.45 mmol) and p-methoxybenzoyl chloride (77.0 mg, 0.45 mmol) in CH Cl  (2 
mL), HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 579 (45.4 mg, 
0.20 mmol) and i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C gave, after 
chromatographic purification (eluent Et O:petrol 1:99) (5R)-338 as a white solid (56.7 
mg, 82%); mp 48-50 °C; 

 
D
20
-604.2 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak AD-H 
(5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(5S): 11.9 min, tR(5R): 16.5 
min, >99% ee; max (thin film)/cm
-1
 3062, 2924 (C-H), 1791 (C=O), 1600, 1506; δ (400 
MHz, CDCl ) 5.88 (1H, s, C(5)H), 6.90-6.95 (2H, m, N(4)Ar(2,6)H), 7.08-7.12 (2H, m, 
ArH), 7.20-7.26 (5H, m, ArH), 7.31-7.35 (3H, m, C(2)Ar(3,5)H and C(2)Ar(4)H), 7.85-
7.87 (2H, m, C(2)Ar(2,6)H); δ (75 MHz, CDCl ) 59.9 (C(5)), 116.0 (d, J 22.6, 
N(4)ArC(3,5)), 116.0 (d, J 7.7, N(4)ArC(2,6)), 125.6 (ArC), 126.7 (ArC), 128.6 (ArC), 
128.7 (C(2)ArC(1)), 129.2 (ArC), 129.4 (ArC), 130.4 (ArC), 131.0 (C(5)ArC(1)), 140.7 
(d, J 2.1, N(4)ArC(1)), 141.1 (C(2)), 158.4 (d, J 240, N(4)ArC(4)), 160.3 (C(6)); m/z 
(NSI
+
) 379 ([M+CH5O]
+
, 100%); HRMS (NSI
+
) C22H20FN2O3
+
 ([M+CH5O]
+
) requires 
379.1452; found 379.1450 (-0.7 ppm). 
 
(5R)-2-(4-fluorophenyl)-4,5-diphenyl-4H-1,3,4-oxadiazin-6(5H)-one 
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Following general procedure J, phenylacetic acid (40.9 mg, 0.30 mmol), i-Pr2NEt (78.0 
L, 0.45 mmol) and p-methoxybenzoyl chloride (77.0 mg, 0.45 mmol) in CH Cl  (2 
mL), HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 580 (45.4 mg, 
0.20 mmol) and i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C gave, after 
chromatographic purification (eluent Et O:petrol 1:99) (5R)-339 as a colourless oil (60.9 
mg, 88%); 

 
D
20
-609.2 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak AD-H (5% IPA:hexane, 
flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(5S): 9.9 min, tR(5R): 18.6 min, 99% ee; max 
(thin film)/cm
-1
 3064, 2920 (C-H), 1790 (C=O), 1597, 1496; δ (300 MHz, CDCl ) 5.96 
(1H, s, C(5)H), 6.89-6.94 (1H, m, N(4)Ar(4)H), 6.98-7.04 (2H, m, C(2)Ar(3,5)H), 7.13-
7.17 (2H, m, ArH), 7.20-7.28 (7H, m, ArH), 7.83-7.89 (2H, m, C(2)Ar(2,6)H); δ (100 
MHz, CDCl ) 59.5 (C(5)), 114.4 (N(4)ArC(2,6)), 115.8 (d, J 21.9, C(2)ArC(3,5)), 121.9 
(N(4)ArC(4)), 125.0 (d, J 3.2, C(2)ArC(1)), 126.6 (ArC), 127.7 (d, J 8.4, C(2)ArC(2,6)), 
129.1 (C(5)ArC(4)), 129.4 (ArC), 129.4 (ArC), 131.1 (C(5)ArC(1)), 140.4 (N(4)ArC(1)), 
144.2 (C(2)), 160.2 (C(6)), 164.0 (d, J 250, C(2)ArC(4)); m/z (NSI+) 379 ([M+CH5O]
+
, 
100%); HRMS (NSI
+
) C22H20FN2O3
+
 ([M+CH5O]
+
) requires 379.1452; found 379.1456 
(+0.9 ppm). 
 
(5R)-2-(3-fluorophenyl)-4,5-diphenyl-4H-1,3,4-oxadiazin-6(5H)-one 
 
Following general procedure J, phenylacetic acid (40.9 mg, 0.30 mmol), i-Pr2NEt (78.0 
L, 0.45 mmol) and p-methoxybenzoyl chloride (77.0 mg, 0.45 mmol) in CH Cl  (2 
mL), HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 581 (45.4 mg, 
0.20 mmol) and i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C gave, after 
chromatographic purification (eluent Et O:petrol 1:99) (5R)-340 as a colourless oil (52.5 
mg, 76%); 

 
D
20
-608.0 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak AD-H (5% IPA:hexane, 
flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(5S): 8.1 min, tR(5R): 10.5 min, 99% ee; max 
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(thin film)/cm
-1
 3062 (C-H), 1792 (C=O), 1597, 1498; δ (400 MHz, CDCl ) 5.96 (1H, s, 
C(5)H), 6.91-6.95 (1H, m, N(4)Ar(4)H), 7.02 (1H, tdd, J 8.3, 2.6, 0.9, C(2)Ar(4)H), 
7.14-7.17 (2H, m, ArH), 7.20-7.31 (8H, m, ArH), 7.56-7.59 (1H, m, ArH), 7.63-7.65 
(1H, m, ArH); δ (100 MHz, CDCl ) 59.5 (C(5)), 112.6 (d, J 24.4, C(2)ArC(2)), 114.6 
(N(4)ArC(2,6)), 117.2 (d, J 21.4, C(2)ArC(4)), 121.2 (d, J 2.7, C(2)ArC(6)), 122.2 
(ArC), 126.6 (ArC), 129.2 (ArC), 129.4 (ArC), 129.4 (ArC), 130.2 (d, J 8.1, 
C(2)ArC(5)), 131.0 (d, J 5.6, C(2)ArC(1)), 131.0 (C(5)ArC(1)), 139.9 (N(4)ArC(1)), 
144.1 (C(2)), 160.0 (C(6)), 162.9 (d, J 245, C(2)ArC(3)); m/z (NSI+) 379 ([M+CH5O]
+
, 
100%); HRMS (NSI
+
) C22H20FN2O3
+
 ([M+CH5O]
+
) requires 379.1452; found 379.1456 
(+0.9 ppm). 
 
(5R)-2-(2-fluorophenyl)-4,5-diphenyl-4H-1,3,4-oxadiazin-6(5H)-one 
 
Following general procedure J, phenylacetic acid (40.9 mg, 0.30 mmol), i-Pr2NEt (78.0 
L, 0.45 mmol) and p-methoxybenzoyl chloride (77.0 mg, 0.45 mmol) in CH Cl  (2 
mL), HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 582 (45.4 mg, 
0.20 mmol) and i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C gave, after 
chromatographic purification (eluent Et O:petrol 1:99) (5R)-341 as a colourless oil (48.5 
mg, 70%); 

 
D
20
-599.4 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak AD-H (5% IPA:hexane, 
flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(5S): 10.4 min, tR(5R): 13.0 min, 99% ee; max 
(thin film)/cm
-1
 3064 (C-H), 2925, 1791 (C=O), 1597, 1495; δ (300 MHz, CDCl ) 5.99 
(1H, s, C(5)H), 6.92 (1H, tt, J 6.9, 1.4, N(4)Ar(4)H), 7.04-7.12 (2H, m, ArH), 7.16-7.34 
(10H, m, ArH), 7.69 (1H, td, J 7.7, 1.7, C(2)Ar(6)H); δ (75 MHz, CDCl ) 59.6 (C(5)), 
114.5 (N(4)ArC(2,6)), 117.0 (d, J 28.8, C(2)ArC(3)), 117.3 (d, J 12.8, C(2)ArC(1)), 
122.1 (N(4)ArC(4)), 124.1 (d, J 5.1, C(2)ArC(5)), 126.7 (N(4)ArC(3,5)), 128.7 (ArC), 
129.1 (ArC), 129.4 (ArC), 129.4 (ArC), 131.1 (C(5)ArC(1)), 131.7 (d, J 11.2, 
C(2)ArC(4)), 137.7 (d, J 9.1, C(2)), 144.2 (N(4)ArC(1)), 160.2 (C(6)), 160.3 (d, J 342, 
C(2)ArC(2)); m/z (NSI+) 379 ([M+CH5O]
+
, 100%); HRMS (NSI
+
) C22H20FN2O3
+
 
([M+CH5O]
+
) requires 379.1452; found 379.1456 (+0.9 ppm). 
 
(5R)-2-(4-bromophenyl)-4,5-diphenyl-4H-1,3,4-oxadiazin-6(5H)-one 
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Following general procedure J, phenylacetic acid (40.9 mg, 0.30 mmol), i-Pr2NEt (78.0 
L, 0.45 mmol) and p-methoxybenzoyl chloride (77.0 mg, 0.45 mmol) in CH Cl  (2 
mL), HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 583 (57.8 mg, 
0.20 mmol) and i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C gave, after 
chromatographic purification (eluent Et O:petrol 1:99) (5R)-342 as an off-white solid 
(63.3 mg, 78%); mp 44-46 °C; 

 
D
20
-609.0 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak 
AD-H (5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(5S): 12.8 min, tR(5R): 
24.1 min, >99% ee; max (KBr)/cm
-1
 3062 (C-H), 1789 (C=O), 1597, 1497; δ (300 MHz, 
CDCl ) 5.95 (1H, s, C(5)H), 6.89-6.95 (1H, m, N(4)Ar(4)H), 7.13-7.27 (9H, m, ArH), 
7.42-7.47 (2H, m, C(2)Ar(3,5)H), 7.70-7.75 (2H, m, C(2)Ar(2,6)H); δ (100 MHz, 
CDCl ) 59.5 (C(5)), 114.5 (N(4)ArC(2,6)), 122.1 (N(4)ArC(4)), 124.7 (ArC), 126.6 
(ArC), 127.0 (ArC), 127.8 (ArC), 129.2 (C(5)ArC(4)), 129.4 (ArC), 129.4 (ArC), 131.0 
(C(5)ArC(1)), 131.8 (ArC), 140.3 (N(4)ArC(1)), 144.1 (C(2)), 160.1 (C(6)); m/z (NSI
+
) 
439 ([M+CH5O]
+
, 100%); HRMS (NSI
+
) C22H20
79
BrN2O3
+
 ([M+CH5O]
+
) requires 
439.0652; found 439.0655 (+0.7 ppm). 
 
(5R)-2-(4-chlorophenyl)-4,5-diphenyl-4H-1,3,4-oxadiazin-6(5H)-one 
 
Following general procedure J, phenylacetic acid (40.9 mg, 0.30 mmol), i-Pr2NEt (78.0 
L, 0.45 mmol) and p-methoxybenzoyl chloride (77.0 mg, 0.45 mmol) in CH Cl  (2 
mL), HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 584 (48.9 mg, 
0.20 mmol) and i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C gave, after 
chromatographic purification (eluent Et O:petrol 1:99) (5R)-343 as an off-white solid 
(56.3 mg, 78%); mp 80-82 °C; 

 
D
20
-614.4 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak 
AD-H (5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(5S): 11.5 min, tR(5R): 
22.8 min, >99% ee; max (KBr)/cm
-1
 2966 (C-H), 1777 (C=O), 1595, 1497; δ (300 MHz, 
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CDCl ) 5.95 (1H, s, C(5)H), 6.89-6.95 (1H, m, N(4)Ar(4)H), 7.13-7.32 (11H, m, ArH), 
7.77-7.82 (2H, m, C(2)Ar(2,6)H); δ (75 MHz, CDCl ) 59.5 (C(5)), 114.5 
(N(4)ArC(2,6)), 122.1 (N(4)ArC(4)), 126.6 (ArC), 126.8 (ArC), 127.3 (C(2)ArC(1)), 
128.9 (ArC), 129.2 (C(5)ArC(4)), 129.4 (ArC), 129.4 (ArC), 131.1 (C(5)ArC(1)), 136.4 
(C(2)ArC(4)), 140.2 (N(4)ArC(1)), 144.1 (C(2)), 160.1 (C(6)); m/z (NSI+) 395 
([M+CH5O]
+
, 100%); HRMS (NSI
+
) C22H20ClN2O3
+
 ([M+CH5O]
+
) requires 395.1157; 
found 395.1158 (+0.3 ppm). 
 
(5R)-2-(naphthalen-1-yl)-4,5-diphenyl-4H-1,3,4-oxadiazin-6(5H)-one 
 
Following general procedure J, phenylacetic acid (40.9 mg, 0.30 mmol), i-Pr2NEt (78.0 
L, 0.45 mmol) and p-methoxybenzoyl chloride (77.0 mg, 0.45 mmol) in CH Cl  (2 
mL), HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 585 (52.0 mg, 
0.20 mmol) and i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C gave, after 
chromatographic purification (eluent Et O:petrol 1:99) (5R)-344 as an off-white solid 
(53.5 mg, 71%); mp 138-140 °C; 

 
D
20
-611.5 (c 1.0, CH2Cl2); Chiral HPLC Chiralpak 
AD-H (2% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(5S): 15.7 min, tR(5R): 
16.9 min, >99% ee; max (KBr)/cm
-1
 3063 (C-H), 1791 (C=O), 1599, 1506; δ (400 MHz, 
CDCl ) 6.05 (1H, s, C(5)H), 6.93 (1H, tt, J 6.9, 1.4, N(4)Ar(4)H), 7.20-7.28 (7H, m, 
ArH), 7.33-7.40 (3H, m, ArH), 7.44 (1H, ddd, J 8.0, 6.9, 1.2, ArH), 7.51 (1H, ddd, J 8.5, 
6.9, 1.6, ArH), 7.78-7.83 (2H, m, ArH), 7.86 (1H, dd, J 7.4, 1.2, ArH), 8.80-8.82 (1H, m, 
C(2)Ar(2)H); δ (75 MHz, CDCl ) 59.5 (C(5)), 114.6 (N(4)ArC(2,6)), 122.1 
(N(4)ArC(4)), 124.9 (ArC), 125.4 (ArC), 125.8 (ArC), 126.3 (ArC), 126.8 (ArC), 127.4 
(ArC), 127.5 (ArC), 128.9 (ArC), 129.2 (ArC), 129.4 (ArC), 129.5 (ArC), 130.3 (ArC), 
131.2 (ArC), 131.4 (ArC), 134.1 (ArC), 141.5 (N(4)ArC(1)), 144.5 (C(2)), 160.6 (C(6)); 
m/z (NSI
+
) 397 ([M+H3O]
+
, 100%); HRMS (NSI
+
) C25H21N2O3
+
 ([M+H3O]
+
) requires 
397.1547; found 397.1548 (+0.3 ppm). 
 
General procedure K: One-pot intermolecular Michael addition-lactonisation ring 
opening. 
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To a solution of acid (1.5 eq) in CH2Cl2 (~1 mL per 0.2 mmol of acid) were added i-
Pr2NEt (1.5 eq based on acid) and benzoyl chloride (1.5 eq based on acid) at rt. The 
reaction mixture was allowed to stir at rt for 10 minutes. The requisite Lewis base (0.1-
20 mol%), Michael acceptor (1 eq) and i-Pr2NEt (1.5 eq) were then added at the required 
temperature in that order. The reaction mixture was stirred at the required temperature 
until complete by TLC. The required nucleophile was added and the reaction mixture 
was stirred at rt until ring-opening was complete by TLC. The reaction mixture was 
subsequently quenched by addition of HCl (1 M in H2O). The reaction mixture was 
poured into H2O and extracted with CH2Cl2 (x 3). The combined organics were dried 
(MgSO4), filtered and concentrated in vacuo to give the crude reaction mixture. Note: 
All racemic samples were obtained via this general procedure using DHPB 108 as 
catalyst. 
 
(2R)-methyl 2-(2-benzoyl-1-phenylhydrazinyl)-2-phenylacetate 
 
Following general procedure K, phenylacetic acid (40.9 mg, 0.30 mmol), i-Pr2NEt (78.0 
L, 0.45 mmol) and benzoyl chloride (52.2 L, 0.45 mmol) in CH Cl  (2 mL), HBTM-
2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 313 (42.0 mg, 0.20 mmol) and 
i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C followed by addition of MeOH (2 mL) 
and stirring for 1 h at rt gave, after chromatographic purification (eluent EtOAc:petrol 
25:75) a rotameric mixture (ratio 91:9) of (2R)-321 as a white solid (67.8 mg, 94%); mp 
148-150 °C; 

 
D
20
-37.6 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IB (10% IPA:hexane, 
flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(2S): 12.7 min, tR(2R): 15.0 min, 99% ee; max 
(KBr)/cm
-1
 3355 (N-H), 3075, 2950 (C-H), 1729 (C=O), 1687 (C=O), 1599; Data for 
major rotamer δ (300 MHz, CDCl ) 3.74 (3H, s, CH ), 5.82 (1H, s, C(2)H), 6.90-6.96 
(3H, m, ArH), 7.18-7.31 (7H, m, ArH), 7.36-7.42 (3H, m, ArH), 7.44-7.48 (2H, m, 
C(O)Ar(2,6)H), 8.43 (1H, s, NH); δ (100 MHz, CDCl ) 52.5 (CH ), 66.7 (C(2)), 114.8 
(NArC(2,6)), 121.7 (NArC(4)), 127.0 (ArC), 128.6 (ArC), 128.6 (ArC), 128.9 (ArC), 
129.1 (ArC), 129.5 (ArC), 131.8 (ArC), 133.0 (ArC), 133.3 (ArC), 148.4 (NArC(1)), 
166.6 (NHC=O), 173.1 (MeOC=O);Selected data for minor rotamer: δ (300 MHz, 
CDCl ) 3.62 (3H, s, CH ), 5.50 (1H, s, C(2)H), 7.90 (1H, s, NH); δ (100 MHz, CDCl ) 
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52.4 (CH ), 68.0 (C(2)), 115.4 (NArC(2,6)), 122.3 (NArC(4)), 127.8 (ArC), 129.9 (ArC), 
130.2 (ArC), 130.4 (ArC); m/z (NSI
+
) 361 ([M+H]
+
, 100%); HRMS (NSI
+
) C22H21N2O3
+
 
([M+H]
+
) requires 361.1547; found 361.1546 (-0.2 ppm). 
 
The same procedure using HBTM-2.1 (2S,3R)-112 (0.31 mg, 0.001 mmol, 0.5 mol%) 
for 16 h at 78 °C gave (2R)-321 as a white solid (61.0 mg, 85%), >99% ee. 
 
The same procedure using HBTM-2.1 (2S,3R)-112 (0.16 mg, 0.0005 mmol, 0.25 mol%) 
for 40 h at 78 °C gave (2R)-321 as a white solid (60.0 mg, 83%), >99% ee. 
 
The same procedure using HBTM-2.1 (2S,3R)-112 (0.062 mg, 0.0002 mmol, 0.1 mol%) 
for 40 h at 78 °C gave (2R)-321 as a white solid (43.0 mg, 60%), 99% ee. The 
conversion was determined to be 65% by analysis of the crude 
1
H NMR. 
 
 
 
(2R)-allyl 2-(2-benzoyl-1-phenylhydrazinyl)-2-phenylacetate 
 
Following general procedure K, phenylacetic acid (40.9 mg, 0.30 mmol), i-Pr2NEt (78.0 
L, 0.45 mmol) and benzoyl chloride (52.2 L, 0.45 mmol) in CH Cl  (2 mL), HBTM-
2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 313 (42.0 mg, 0.20 mmol) and 
i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C followed by addition of allyl alcohol 
(2 mL) and stirring for 1 h at rt gave, after chromatographic purification (eluent 
Et O:petrol 40:60) a rotameric mixture (ratio 91:9) of (2R)-349 as a colourless oil (63.8 
mg, 83%); 

 
D
20
-30.0 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IB (10% IPA:hexane, 
flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(2R): 18.1 min, tR(2S): 21.8 min, 98% ee; max 
(thin film)/cm
-1
 3287 (N-H), 3064, 2948 (C-H), 1733 (C=O ester), 1683 (C=O amide), 
1599; Data for major rotamer δ (500 MHz, CDCl ) 4.75 (2H, d, J 5.1, CH ), 5.26-5.32 
(2H, m, CH =CH), 5.87-5.93 (2H, m, C(2)H and CH =CH), 6.98-7.06 (3H, m, 
NAr(2,6)H and NAr(4)H), 7.31-7.43 (7H, m, ArH), 7.48-7.59 (5H, m, ArH), 8.51 (1H, s, 
NH); δ (100 MHz, CDCl ) 66.2 (CH ), 66.8 (C(2)), 114.9 (NArC(2,6)), 119.6 
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(CH =CH), 121.7 (NArC(4)), 127.0 (ArC), 128.6 (ArC), 128.6 (ArC), 128.9 (ArC), 129.1 
(ArC), 129.4 (ArC), 131.2 (CH =CH), 131.7 (ArC), 133.0 (ArC), 133.2 (ArC), 148.3 
(NArC(1)), 166.5 (NHC=O), 172.3 (CH =CHCH C=O); Selected data for minor rotamer: 
δ (500 MHz, CDCl ) 5.61 (1H, s, C(2)H), 7.98 (1H, s, NH); δ (100 MHz, CDCl ) 65.8 
(CH ), 68.1 (C(2)), 115.4 (NArC(2,6)), 122.3 (NArC(4)), 127.8 (ArC), 129.8 (ArC), 
130.2 (ArC); m/z (NSI
+
) 387 ([M+H]
+
, 100%); HRMS (NSI
+
) C24H23N2O3
+
 ([M+H]
+
) 
requires 387.1703; found 387.1711 (+2.0 ppm). 
 
(2R)-2-(2-benzoyl-1-phenylhydrazinyl)-N-isopropyl-2-phenylacetamide 
 
Following general procedure K, phenylacetic acid (40.9 mg, 0.30 mmol), i-Pr2NEt (78.0 
L, 0.45 mmol) and benzoyl chloride (52.2 L, 0.45 mmol) in CH Cl  (2 mL), HBTM-
2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 313 (42.0 mg, 0.20 mmol) and 
i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C followed by addition of 
isopropylamine (2 mL) and stirring for 1 h at rt gave, after chromatographic purification 
(eluent Et O:petrol 75:25) a rotameric mixture (ratio 93:7) of (2R)-350 as a white solid 
(71.0 mg, 92%); mp 64-66 °C;
 

 
D
20
-132 (c 0.125, CH2Cl2); Chiral HPLC Chiralpak IB 
(20% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(2S): 6.6 min, tR(2R): 7.6 
min, 99% ee; max (KBr)/cm
-1
 3235 (N-H), 3064, 2971 (C-H), 1730 (C=O ester), 1653 
(C=O amide), 1598; Data for major rotamer δ (500 MHz, CDCl ) 1.15 (3H, d, J 6.6, 
CH ), 1.21-1.26 (3H, m, CH ), 4.13 (1H, s, J 6.5, CH), 5.29 (1H, s, C(2)H), 6.85 (2H, d, 
J 6.8, NAr(2,6)H), 7.00 (1H, t, J 7.3, NAr(4)H), 7.20-7.35 (11H, m, ArH), 7.50 (1H, t, J 
7.3, ArH), 7.59 (1H, s, NH), 9.38 (1H, s, NH); δ (100 MHz, CDCl ) 22.4 (CH ), 22.5 
(CH ), 41.6 (CH), 72.0 (C(2)), 112.5 (NArC(2,6)), 120.7 (NArC(4)), 127.0 (ArC), 128.7 
(ArC), 128.9 (ArC), 129.0 (ArC), 129.5 (ArC), 129.7 (ArC), 132.0 (ArC), 132.3 (ArC), 
134.2 (ArC), 147.3 (NArC(1)), 168.9 (C=O), 169.5 (C=O); Selected data for minor 
rotamer: δ (500 MHz, CDCl ) 1.04 (6H, d, J 6.6, CH ), 3.96-4.03 (1H, m, CH); δ (100 
MHz, CDCl ) 22.6 (CH ), 41.5 (CH); m/z (NSI
+
) 388 ([M+H]
+
, 100%); HRMS (NSI
+
) 
C24H26N3O2
+
 ([M+H]
+
) requires 388.2020; found 388.2027 (+1.9 ppm). 
 
(2R)-N'-(2-oxo-1-phenyl-2-(pyrrolidin-1-yl)ethyl)-N'-phenylbenzohydrazide 
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Following general procedure K, phenylacetic acid (40.9 mg, 0.30 mmol), i-Pr2NEt (78.0 
L, 0.45 mmol) and benzoyl chloride (52.2 L, 0.45 mmol) in CH Cl  (2 mL), HBTM-
2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 313 (42.0 mg, 0.20 mmol) and 
i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C followed by addition of pyrrolidine (2 
mL) and stirring for 1 h at rt gave, after chromatographic purification (eluent Et O) a 
rotameric mixture (ratio 96:4) of (2R)-351 as a colourless oil (69.7 mg, 87%); 

 
D
20
-96.6 
(c 0.5, CH2Cl2); Chiral HPLC Chiralpak IB (40% IPA:hexane, flow rate 1 mL min
-1
, 211 
nm, 20 °C) tR(2S): 6.3 min, tR(2R): 11.1 min, 99% ee; max (thin film)/cm
-1
 3344 (N-H), 
3063 (C-H), 1687 (C=O), 1582; Data for major rotamer δ (500 MHz, CDCl ) 1.74-1.92 
(4H, m, 2 CH ), 3.07-3.10 (1H, m, CHH), 3.42-3.54 (3H, m, CH  and CHH), 5.77 (1H, s, 
C(2)H), 6.85-6.93 (3H, m, NAr(2,6)H and NAr(4)H), 7.19-7.27 (7H, m, ArH), 7.36 (1H, 
t, J 7.1, ArH), 7.45 (2H, d, J 7.1, ArH), 7.50 (2H, d, J 7.4, ArH), 9.41 (1H, s, NH); δ
(100 MHz, CDCl ) 24.1 (CH ), 26.1 (CH ), 45.8 (NCH ), 46.3 (NCH ), 65.7 (C(2)), 
114.9 (NArC(2,6)), 121.4 (NArC(4)), 127.1 (ArC), 128.4 (ArC), 128.7 (ArC), 128.8 
(ArC), 129.4 (ArC), 129.5 (ArC), 131.5 (ArC), 133.2 (ArC), 133.4 (ArC), 149.2 
(NArC(1)), 166.4 (NHC=O), 170.7 (NC=O);Selected data for minor rotamer: δ (500 
MHz, CDCl ) 5.44 (1H, s, C(2)H), 8.65 (1H, s, NH); δ (100 MHz, CDCl ) 23.9 (CH ), 
26.0 (CH ), 67.7 (C(2)), 115.7 (NArC(2,6)), 121.8 (NArC(4)), 126.9 (ArC), 127.8 (ArC), 
129.7 (ArC), 130.5 (ArC); m/z (NSI
+
) 400 ([M+H]
+
, 100%); HRMS (NSI
+
) C25H26N3O2
+
 
([M+H]
+
) requires 400.2020; found 400.2026 (+1.6 ppm).   
 
(2R)-methyl 2-(2-benzoyl-1-phenylhydrazinyl)-2-(thiophen-3-yl)acetate 
 
Following general procedure K, thiophene-3-acetic acid (42.7 mg, 0.30 mmol), i-Pr2NEt 
(78.0 L, 0.45 mmol) and benzoyl chloride (52.2 L, 0.45 mmol) in CH Cl  (2 mL), 
HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 313 (42.0 mg, 0.20 
mmol) and i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C followed by addition of 
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MeOH (2 mL) and stirring for 1 h at rt gave, after chromatographic purification (eluent 
EtOAc:petrol 25:75) a rotameric mixture (ratio 91:9) of (2R)-352 as a light yellow solid 
(63.1 mg, 86%); mp 128-130 °C; 

 
D
20
-26.2 (c 0.5, CH2Cl2); Chiral HPLC Chiralcel 
OD-H (10% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(2S): 28.0 min, tR(2R): 
31.5 min, >99% ee; max (KBr)/cm
-1
 3355 (N-H), 3078, 2952 (C-H), 1727 (C=O ester), 
1685 (C=O amide), 1600, 1514; Data for major rotamer δ (400 MHz, CDCl ) 3.72 (3H, 
s, CH ), 5.83 (1H, s, C(2)H), 6.87-6.95 (3H, m, ArH), 7.16-7.23 (4H, m, ArH), 7.28-7.33 
(3H, m, ArH), 7.38-7.42 (1H, m, ArH), 7.49-7.51 (2H, m, C(O)Ar(2,6)H), 8.47 (1H, s, 
NH); δ (75 MHz, CDCl ) 52.6 (CH ), 62.7 (C(2)), 114.8 (NArC(2,6)), 121.8 (NArC(4)), 
125.0 (ArC), 126.3 (ArC), 127.1 (ArC), 128.2 (ArC), 128.7 (ArC), 129.5 (ArC), 131.9 
(ArC), 133.0 (ArC), 133.8 (ArC), 148.1 (NArC(1)), 166.8 (NHC=O), 173.0 (MeOC=O); 
Selected data for minor rotamer: δ (400 MHz, CDCl ) 3.59 (3H, s, CH ), 5.56 (1H, s, 
C(2)H), 6.57 (1H, dd, J 5.0, 1.3, ArH), 7.89 (1H, s, NH); δ (100 MHz, CDCl ) 52.5 
(CH ), 62.8 (C(2)), 115.4 (NArC(2,6)), 122.3 (NArC(4)), 126.1 (ArC), 127.8 (ArC), 
129.9 (ArC), 130.6 (ArC); m/z (NSI
+
) 367 ([M+H]
+
, 100%); HRMS (NSI
+
) 
C20H19N2O3S
+
 ([M+H]
+
) requires 367.1111; found 367.1114 (+0.8 ppm).   
 
(2R)-methyl 2-(2-benzoyl-1-phenylhydrazinyl)-2-(4-methoxyphenyl)acetate 
 
Following general procedure K, 4-methoxyphenylacetic acid (49.9 mg, 0.30 mmol), i-
Pr2NEt (78.0 L, 0.45 mmol) and benzoyl chloride (52.2 L, 0.45 mmol) in CH Cl  (2 
mL), HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 313 (42.0 mg, 
0.20 mmol) and i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C followed by addition 
of MeOH (2 mL) and stirring for 1 h at rt gave, after chromatographic purification 
(eluent EtOAc:petrol 30:70) a rotameric mixture (ratio 89:11) of (2R)-353 as a light 
yellow solid (59.3 mg, 76%); mp 36-38 °C; 

 
D
20
-30.8 (c 0.5, CH2Cl2); Chiral HPLC 
Chiralpak IB (10% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(2S): 19.3 min, 
tR(2R): 26.2 min, 98% ee; max (KBr)/cm
-1
 3368 (N-H), 3060, 2952 (C-H), 1734 (C=O 
ester), 1675 (C=O amide), 1612, 1514; Data for major rotamer δ (300 MHz, CDCl ) 
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3.66 (3H, s, CH ), 3.71 (3H, s, CH ), 5.75 (1H, s, C(2)H), 6.75-6.79 (2H, m, 
C(2)Ar(3,5)H), 6.85-6.95 (3H, m, ArH), 7.18-7.24 (2H, m, ArH), 7.26-7.34 (4H, m, 
ArH), 7.36-7.42 (1H, m, ArH), 7.48-7.52 (2H, m, C(O)Ar(2,6)H), 8.43 (1H, s, NH); δ
(75 MHz, CDCl ) 52.5 (CH ), 55.2 (CH ), 66.1 (C(2)), 114.0 (ArC), 114.8 (ArC), 121.6 
(NArC(4)), 125.2 (C(2)ArC(1)), 127.1 (ArC), 128.6 (ArC), 129.5 (ArC), 130.4 (ArC), 
131.8 (C(O)ArC(4)), 133.0 (C(O)ArC(1)), 148.4 (NArC(1)), 159.9 (C(2)ArC(4)), 166.6 
(NHC=O), 173.3 (MeOC=O); Selected data for minor rotamer: δ (300 MHz, CDCl ) 
3.60 (3H, s, CH ), 3.71 (3H, s, CH ), 5.45 (1H, s, C(2)H), 6.56-6.59 (2H, m, 
C(2)Ar(3,5)H), 7.85 (1H, s, NH); δ (75 MHz, CDCl ) 52.4 (CH ), 55.4 (CH ), 67.2 
(C(2)), 115.3 (ArC), 122.2 (NArC(4)), 127.8 (ArC), 129.9 (ArC), 131.4 (C(O)ArC(4)); 
m/z (NSI
+
) 391 ([M+H]
+
, 100%); HRMS (NSI
+
) C23H23N2O4
+
 ([M+H]
+
) requires 
391.1652; found 391.1655 (+0.7 ppm). 
 
(2R)-methyl 2-(2-(4-methylbenzoyl)-1-phenylhydrazinyl)-2-phenylacetate 
 
Following general procedure K, phenylacetic acid (81.7 mg, 0.60 mmol), i-Pr2NEt (156 
L, 0.90 mmol) and benzoyl chloride (104 L, 0.90 mmol) in CH Cl  (2 mL), HBTM-
2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 587 (44.8 mg, 0.20 mmol) and 
i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C followed by addition of MeOH (2 mL) 
and stirring for 1 h at rt gave, after chromatographic purification (eluent Et O:petrol 
40:60) a rotameric mixture (ratio 92:8) of (2R)-354 as a white solid (49.2 mg, 66%); mp 
36-38 °C; 

 
D
20
-24.3 (c 1.0, CH2Cl2); Chiral HPLC Chiralcel OD-H (10% IPA:hexane, 
flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(2S): 11.9 min, tR(2R): 14.3 min, >99% ee; max 
(KBr)/cm
-1
 3374 (N-H), 3030, 2924 (C-H), 1750 (C=O ester), 1708 (C=O amide), 1599; 
Data for major rotamer δ (400 MHz, CDCl ) 2.28 (3H, s, CH ), 3.73 (3H, s, OCH ), 5.80 
(1H, s, C(2)H), 6.86-6.95 (3H, m, ArH), 7.08 (2H, d, J 7.9, ArH), 7.19-7.27 (5H, m, 
ArH), 7.34-7.39 (4H, m, ArH), 8.40 (1H, s, NH); δ (75 MHz, CDCl ) 21.5 (CH ), 52.5 
(OCH ), 66.7 (C(2)), 114.8 (NArC(2,6)), 121.6 (NArC(4)), 127.1 (ArC), 128.6 (ArC), 
128.9 (C(2)ArC(4)), 129.1 (ArC), 129.2 (ArC), 129.5 (ArC), 130.0 (C(O)ArC(1)), 133.3 
(C(2)ArC(1)), 142.3 (C(O)ArC(4)), 148.5 (NArC(1)), 166.5 (NHC=O), 173.1 
(MeOC=O); Selected data for minor rotamer: δ (400 MHz, CDCl ) 2.18 (3H, s, CH ), 
 Chapter 9: Experimental 
 
 294 
3.61 (3H, s, OCH ), 5.51 (1H, s, C(2)H), 6.70-6.80 (2H, m, ArH), 7.84 (1H, s, NH); δ
(100 MHz, CDCl ) 22.7 (CH ), 52.4 (OCH ), 68.0 (C(2)), 115.4 (NArC(2,6)), 122.2 
(NArC(4)), 127.8 (ArC), 128.0 (ArC), 129.8 (ArC), 130.2 (ArC); m/z (NSI
+
) 375 
([M+H]
+
, 100%); HRMS (NSI
+
) C23H23N2O3
+
 ([M+H]
+
) requires 375.1703; found 
375.1706 (+0.7 ppm).  
 
(2R)-methyl 2-(2-(furan-2-carbonyl)-1-phenylhydrazinyl)-2-phenylacetate 
 
Following general procedure K, phenylacetic acid (40.9 mg, 0.30 mmol), i-Pr2NEt (78.0 
L, 0.45 mmol) and benzoyl chloride (52.2 L, 0.45 mmol) in CH Cl  (2 mL), HBTM-
2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 588 (40.0 mg, 0.20 mmol) and 
i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C followed by addition of MeOH (2 mL) 
and stirring for 1 h at rt gave, after chromatographic purification (eluent Et O:petrol 
50:50) a rotameric mixture (ratio 93:7) of (2R)-355 as a white solid (59.5 mg, 85%); mp 
148-150 °C; 

 
D
20
-38.8 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IB (10% IPA:hexane, 
flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(2S): 16.2 min, tR(2R): 21.5 min, 99% ee; max 
(KBr)/cm
-1
 3345 (N-H), 3097, 2950 (C-H), 1729 (C=O ester), 1695 (C=O amide), 1598; 
Data for major rotamer δ (300 MHz, CDCl ) 3.72 (3H, s, OCH ), 5.77 (1H, s, C(2)H), 
6.36 (1H, dd, J 3.5, 1.8, C(O)Ar(4)H), 6.86-6.96 (4H, m, ArH), 7.18-7.24 (5H, m, ArH), 
7.34-7.38 (3H, m, ArH), 8.67 (1H, s, NH); δ (75 MHz, CDCl ) 52.5 (OCH ), 66.7 (C(2)), 
112.0 (C(O)ArC(4)), 115.0 (NArC(2,6)), 115.5 (C(O)ArC(3)), 121.8 (NArC(4)), 128.6 
(ArC), 128.9 (ArC), 129.2 (ArC), 129.4 (ArC), 133.1 (C(2)ArC(1)), 144.4 (C(O)ArC(5)), 
146.6 (ArC), 148.4 (ArC), 157.2 (NHC=O), 172.7 (MeOC=O); Selected data for minor 
rotamer: δ (300 MHz, CDCl ) 3.65 (3H, s, OCH ), 5.65 (1H, s, C(2)H), 6.14 (1H, dd, J 
3.5, 1.7, C(O)Ar(4)H), 7.82 (1H, s, NH); δ (75 MHz, CDCl ) 52.5 (CH ), 67.6 (C(2)), 
112.0 (ArC), 115.2 (ArC), 117.2 (ArC), 122.4 (ArC), 128.5 (ArC), 129.8 (ArC), 130.0 
(ArC), 144.9 (ArC); m/z (NSI
+
) 351 ([M+H]
+
, 100%); HRMS (NSI
+
) C20H19N2O4
+
 
([M+H]
+
) requires 351.1339; found 351.1339 (-0.1 ppm).  
 
(2R)-methyl 2-(2-(4-nitrobenzoyl)-1-phenylhydrazinyl)-2-phenylacetate 
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Following general procedure K, phenylacetic acid (40.9 mg, 0.30 mmol), i-Pr2NEt (78.0 
L, 0.45 mmol) and benzoyl chloride (52.2 L, 0.45 mmol) in CH Cl  (2 mL), HBTM-
2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 367 (51.0 mg, 0.20 mmol) and 
i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C followed by addition of MeOH (2 mL) 
and stirring for 1 h at rt gave, after chromatographic purification (eluent Et O:petrol 
50:50) a rotameric mixture (ratio 69:31) of (2R)-356 as a light yellow solid (67.8 mg, 
84%); mp 58-56 °C; 

 
D
20
-47.0 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IA (40% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(2S): 20.9 min, tR(2R): 30.6 min, 
99% ee; max (KBr)/cm
-1
 3412 (N-H), 3075, 2953 (C-H), 1735 (C=O ester), 1678 (C=O 
amide), 1599, 1525 (N=O), 1346 (N=O); Data for major rotamer δ (300 MHz, CDCl ) 
3.74 (3H, s, OCH ), 5.81 (1H, s, C(2)H), 6.91-6.95 (3H, m, ArH), 7.21-7.28 (5H, m, 
ArH), 7.35-7.39 (2H, m, ArH), 7.55-7.58 (2H, m, C(O)Ar(2,6)H), 8.10-8.13 (2H, m, 
C(O)Ar(3,5)H), 8.62 (1H, s, NH); δ (75 MHz, CDCl ) 52.6 (OCH ), 66.8 (C(2)), 114.9 
(NArC(2,6)), 122.1 (NArC(4)), 123.8 (ArC), 128.3 (ArC), 128.7 (ArC), 129.1 (ArC), 
129.1 (ArC), 129.6 (ArC), 133.1 (ArC), 138.5 (ArC), 148.0 (ArC), 148.6 (ArC), 164.8 
(NHC=O), 173.1 (MeOC=O);Selected data for minor rotamer: δ (300 MHz, CDCl ) 
3.61 (3H, s, OCH ), 5.46 (1H, s, C(2)H), 7.77-7.80 (2H, m, C(O)Ar(3,5)H), 8.12 (1H, s, 
NH); δ (75 MHz, CDCl ) 52.6 (OCH ), 68.4 (C(2)), 115.8 (NArC(2,6)), 122.3 
(NArC(4)), 123.0 (ArC), 128.6 (ArC), 128.9 (ArC), 130.1 (ArC), 130.3 (ArC), 132.4 
(ArC), 138.6 (ArC), 149.7 (ArC), 171.4 (NHC=O), 171.5 (MeOC=O); m/z (NSI
+
) 406 
([M+H]
+
, 100%); HRMS (NSI
+
) C22H20N3O5
+
 ([M+H]
+
) requires 406.1397; found 
406.1399 (+0.4 ppm). 
 
(2R)-methyl 2-(2-(4-nitrobenzoyl)-1-phenylhydrazinyl)-2-(o-tolyl)acetate 
 
Following general procedure K, o-tolylacetic acid (45.1 mg, 0.30 mmol), i-Pr2NEt (78.0 
L, 0.45 mmol) and benzoyl chloride (52.2 L, 0.45 mmol) in CH Cl  (2 mL), HBTM-
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2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 367 (51.0 mg, 0.20 mmol) and 
i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C followed by addition of MeOH (2 mL) 
and stirring for 1 h at rt gave, after chromatographic purification (eluent Et O:petrol 
50:50) a rotameric mixture (ratio 55:45) of (2R)-357 as a light yellow solid (67.7 mg, 
81%); mp 56-58 °C; 

 
D
20
-30.0 (c 0.25, CH2Cl2); Chiral HPLC Chiralpak IA (40% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(2S): 11.7 min, tR(2R): 16.1 min, 
99% ee; max (KBr)/cm
-1
 3333 (N-H), 3085, 2962 (C-H), 1721 (C=O ester), 1679 (C=O 
amide), 1598, 1529 (N=O), 1348 (N=O); Data for both rotamers δ (400 MHz, CDCl ) 
1.69 (3H, s, CH ), 2.53 (3H, s, CH ), 3.60 (3H, s, OCH ), 3.73 (3H, s, OCH ), 5.64 (1H, 
s, C(2)H), 5.91 (1H, s, C(2)H), 6.74-6.76 (1H, m, ArH), 6.82-6.85 (2H, m, NAr(2,6)H), 
6.90-7.07 (7H, m, ArH), 7.12-7.21 (6H, m, ArH), 7.23-7.27 (2H, m, ArH), 7.36-7.40 
(2H, m, ArH), 7.55-7.58 (2H, m, C(O)Ar(2,6)H), 7.79-7.82 (2H, m, C(O)Ar(3,5)H), 
8.10-8.13 (2H, m, C(O)Ar(3,5)H), 8.18 (1H, s, NH), 8.50 (1H, s, NH); Data for both 
rotamers δ (100 MHz, CDCl ) 18.5 (CH ), 19.2 (CH ), 52.5 (OCH ), 52.6 (OCH ), 63.8 
(C(2)), 65.2 (C(2)), 114.3 (NArC(2,6)), 115.5 (NArC(2,6)), 121.7 (ArC), 122.3 (ArC), 
123.0 (ArC), 123.8 (ArC), 125.5 (ArC), 126.7 (ArC), 127.7 (ArC), 128.2 (ArC), 128.4 
(ArC), 129.3 (ArC), 129.6 (ArC), 129.7 (ArC), 129.9 (ArC), 130.2 (ArC), 130.8 (ArC), 
130.8 (ArC), 131.2 (ArC), 131.3 (ArC), 138.2 (ArC), 138.6 (ArC), 138.7 (ArC), 139.8 
(ArC), 148.0 (ArC), 148.6 (ArC), 14.8.8 (ArC), 149.7 (ArC), 164.7 (C=O), 171.7 (C=O), 
171.9 (C=O), 173.6 (C=O); m/z (NSI+) 442 ([M+Na]+, 42%); HRMS (NSI+) 
C23H21N3NaO5
+
 ([M+Na]
+
) requires 442.1373; found 442.1375 (+0.4 ppm). 
 
(2R)-methyl 2-(naphthalen-1-yl)-2-(2-(4-nitrobenzoyl)-1-phenylhydrazinyl)acetate 
 
Following general procedure K, 1-naphthylacetic acid (55.9 mg, 0.30 mmol), i-Pr2NEt 
(78.0 L, 0.45 mmol) and benzoyl chloride (52.2 L, 0.45 mmol) in CH Cl  (2 mL), 
HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 367 (51.0 mg, 0.20 
mmol) and i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C followed by addition of 
MeOH (2 mL) and stirring for 1 h at rt gave, after chromatographic purification (eluent 
Et O:petrol 50:50) a rotameric mixture (ratio 78:22) of (2R)-358 as a light yellow solid 
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(72.0 mg, 79%); mp 74-76 °C; 

 
D
20
+20.0 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IA 
(40% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(2S): 13.2 min, tR(2R): 29.0 
min, 99% ee; max (KBr)/cm
-1
 3415 (N-H), 3062, 2953 (C-H), 1735 (C=O ester), 1670 
(C=O amide), 1599, 1522 (N=O), 1344 (N=O); Data for major rotamer δ (400 MHz, 
CDCl ) 3.66 (3H, s, OCH ), 6.30 (1H, s, C(2)H), 6.53-6.56 (2H, m, ArH), 6.96-7.00 (1H, 
m, ArH), 7.10 (1H, t, J 7.3, ArH), 7.16-7.19 (1H, m, ArH), 7.23-7.32 (6H, m, ArH), 
7.41-7.47 (3H, m, ArH), 7.59 (1H, d, J 8.1, ArH), 7.75-7.79 (1H, m, ArH), 8.16 (1H, s, 
NH); Data for both rotamers δ (100 MHz, CDCl ) 52.7 (OCH ), 52.7 (OCH ), 63.5 
(C(2)), 63.9 (C(2)), 114.5 (ArC), 115.0 (ArC), 122.0 (ArC), 122.1 (NArC(2,6)), 122.1 
(NArC(2,6)), 122.9 (ArC), 123.7 (ArC), 123.7 (ArC), 124.3 (ArC), 125.3 (ArC), 125.8 
(ArC), 126.2 (ArC), 126.6 (ArC), 126.8 (ArC), 127.3 (ArC), 127.4 (ArC), 127.4 (ArC), 
128.2 (ArC), 128.5 (ArC), 128.7 (ArC), 128.7 (ArC), 129.3 (ArC), 129.8 (ArC), 130.4 
(ArC), 130.4 (ArC), 130.5 (ArC), 131.7 (ArC), 132.3 (ArC), 133.6 (ArC), 133.8 (ArC), 
137.5 (ArC), 138.5 (ArC), 148.0 (ArC), 148.0 (ArC), 148.5 (ArC), 149.6 (ArC), 164.3 
(C=O), 171.6 (C=O), 172.0 (C=O), 173.5 (C=O); Selected data for minor rotamer δ (400 
MHz, CDCl ) 3.76 (3H, s, OCH ), 6,52 (1H, s, C(2)H), 7.03-7.05 (2H, m, ArH), 8.04-
8.07 (2H, m, ArH), 8.18 (1H, d, J 8.7, ArH), 8.57 (1H, s, NH); m/z (NSI
+
) 478 
([M+Na]
+
, 97%); HRMS (NSI
+
) C26H21N3NaO5
+
 ([M+Na]
+
) requires 478.1373; found 
478.1377 (+0.7 ppm). 
 
(2R)-methyl 2-(2-(4-nitrobenzoyl)-1-phenylhydrazinyl)-2-(4-
(trifluoromethyl)phenyl)acetate 
 
Following general procedure K, 4-trifluoromethylphenylacetic acid (61.3 mg, 0.30 
mmol), i-Pr2NEt (78.0 L, 0.45 mmol) and benzoyl chloride (52.2 L, 0.45 mmol) in 
CH Cl  (2 mL), HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 367 
(51.0 mg, 0.20 mmol) and i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C followed by 
addition of MeOH (2 mL) and stirring for 1 h at 78 °C gave, after chromatographic 
purification (eluent Et O:petrol 50:50) a rotameric mixture (ratio 74:26) of (2R)-359 as a 
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light yellow solid (78.5 mg, 83%); mp 150-152 °C; 

 
D
20
-26.6 (c 0.5, CH2Cl2); Chiral 
HPLC Chiralpak IA (80% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 40 °C) tR(2S): 7.5 
min, tR(2R): 17.8 min, 97% ee; max (KBr)/cm
-1
 3412 (N-H), 3085, 2956 (C-H), 1735 
(C=O ester), 1680 (C=O amide), 1600, 1524 (N=O), 1323 (N=O); Data for major 
rotamer δ (400 MHz, CDCl ) 3.77 (3H, s, OCH ), 5.83 (1H, s, C(2)H), 6.93-6.97 (2H, m, 
ArH), 7.23-7.28 (2H, m, ArH), 7.34-7.41 (1H, m, ArH), 7.52 (4H, s, ArH), 7.58-7.61 
(2H, m, C(O)Ar(2,6)H), 8.11-8.15 (2H, m, C(O)Ar(3,5)H), 8.71 (1H, s, NH); Data for 
both rotamers δ (100 MHz, CDCl ) 52.8 (OCH ), 52.9 (OCH ), 66.4 (C(2)), 67.9 (C(2)), 
115.1 (NArC(2,6)), 115.8 (NArC(2,6)), 122.4 (ArC), 122.6 (ArC), 123.4 (ArC), 123.9 
(ArC), 125.1 (ArC), 125.6 (q, J 3.6, ArC), 125.7 (q, J 3.6, ArC), 128.2 (ArC), 128.6 
(ArC), 129.4 (ArC), 129.7 (ArC), 130.2 (ArC), 130.6 (ArC), 131.0 (ArC), 131.3 (ArC), 
136.4 (ArC), 137.3 (ArC), 138.1 (ArC), 147.7 (ArC), 148.2 (ArC), 148.8 (ArC), 149.9 
(ArC), 164.6 (C=O), 170.7 (C=O), 171.1 (C=O), 172.5 (C=O); Selected data for minor 
rotamer: δ (400 MHz, CDCl ) 3.65 (3H, s, OCH ), 5.12 (1H, s, C(2)H), 6.90-6.92 (2H, 
m, ArH), 7.03-7.10 (3H, m, ArH), 7.15-7.18 (2H, m, ArH), 7.78-7.81 (2H, m, 
C(O)Ar(3,5)H), 8.17 (1H, s, NH); m/z (NSI
+
) 396 ([M+Na]
+
, 65%); HRMS (NSI
+
) 
C23H18F3N3NaO5
+
 ([M+Na]
+
) requires 496.1091; found 496.1094 (+0.7 ppm). Note: 
Enantiomeric excess was 92% when methanolysis carried out at rt. When the product is 
re-subjected to the reaction conditions at rt the ee drops with time.  
 
(2R)-methyl 2-(2-benzoyl-1-(4-(cyano)phenyl)hydrazinyl)-2-phenylacetate 
 
Following general procedure K, phenylacetic acid (40.9 mg, 0.30 mmol), i-Pr2NEt (78.0 
L, 0.45 mmol) and benzoyl chloride (52.2 L, 0.45 mmol) in CH Cl  (2 mL), HBTM-
2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 591 (47.0 mg, 0.20 mmol) and 
i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C followed by addition of MeOH (2 mL) 
and stirring for 1 h at 78 °C gave, after chromatographic purification (eluent 
Et O:petrol 60:40) a rotameric mixture (ratio 94:6) of (2R)-360 as a white solid (71.5 
mg, 93%); mp 72-74 °C

 
D
20
-46.8 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IA (80% 
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IPA:hexane, flow rate 1 mL min
-1
, 254 nm, 40 °C) tR(2R): 5.8 min, tR(2S): 12.9 min, 
98% ee; max (KBr)/cm
-1
 3412 (N-H), 2954 (C-H), 2220 (CN), 1748 (C=O amide), 
1684 (C=O ester), 1604, 1508; Data for major rotamer δ (300 MHz, CDCl ) 3.76 (3H, s, 
OCH ), 5.83 (1H, s, C(2)H), 6.89-6.94 (2H, m, NAr(2,6)H), 7.21-7.49 (12H, m, ArH), 
8.37 (1H, s, NH); δ (75 MHz, CDCl ) 52.9 (OCH ), 66.4 (C(2)), 103.7 (NArC(4)), 114.1 
(NArC(2,6)), 119.4 (CN), 127.0 (ArC), 128.7 (ArC), 128.8 (ArC), 129.3 (ArC), 129.4 
(ArC), 132.0 (ArC), 132.1 (ArC), 132.2 (ArC), 133.8 (ArC), 151.5 (NArC(1)), 166.4 
(NHC=O), 172.2 (MeOC=O); Selected data for minor rotamer: δ (300 MHz, CDCl ) 
3.65 (3H, s, OCH ), 5.56 (1H, s, C(2)H), 6.78 (2H, dd, J 8.2, 1.0, NAr(2,6)H), 7.81 (1H, 
s, NH); δ (75 MHz, CDCl ) 52.9 (CH ), 67.5 (C(2)), 115.2 (ArC), 127.3 (ArC), 127.5 
(ArC), 130.4 (ArC), 134.2 (ArC); m/z (NSI
+
) 386 ([M+H]
+
, 100%); HRMS (NSI
+
) 
C23H20N3O3
+
 ([M+H]
+
) requires 386.1499; found 386.1502 (+0.7 ppm).Note: 
Enantiomeric excess was 91% when methanolysis carried out at rt. When the product is 
re-treated with i-Pr2NEt at rt the ee drops with time. 
 
(2R)-methyl 2-(2-benzoyl-1-(4-(trifluoromethyl)phenyl)hydrazinyl)-2-phenylacetate 
 
Following general procedure K, phenylacetic acid (0.20 g, 1.50 mmol), i-Pr2NEt (0.39 
mL, 2.25 mmol) and benzoyl chloride (0.26 mL, 2.25 mmol) in CH Cl  (10 mL), 
HBTM-2.1 (2S,3R)-112 (3.08 mg, 0.01 mmol, 1 mol%), diazene 594 (0.28 g, 1.00 
mmol) and i-Pr2NEt (0.26 mL, 1.50 mmol) for 16 h at 78 °C followed by addition of 
MeOH (10 mL) and stirring for 1 h at rt gave, after chromatographic purification (eluent 
Et O:petrol 30:70) a rotameric mixture (ratio 94:6) of (2R)-361 as a white solid (0.34 g, 
86%); mp 120-122 °C

 
D
20
-48.6 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IA (30% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(2R): 9.0 min, tR(2S): 15.5 min, 
99% ee; max (KBr)/cm
-1
 3392 (N-H), 2952 (C-H), 1738 (C=O etser), 1682 (C=O 
amide), 1616; Data for major rotamer δ (300 MHz, CDCl ) 3.82 (3H, s, OCH ), 5.97 
(1H, s, C(2)H), 7.07 (2H, d, J 8.6, NAr(2,6)H), 7.32-7.38 (5H, m, ArH), 7.47-7.58 (7H, 
m, ArH), 8.67 (1H, s, NH); δ (75 MHz, CDCl ) 52.7 (OCH ), 66.8 (C(2)), 114.0 
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(NArC(2,6)), 122.8 (q, J 32.9, NArC(4)), 124.5 (q, J 269, CF ), 126.8 (q, J 3.5, 
NArC(3,5)), 127.1 (ArC), 128.7 (ArC), 128.7 (ArC), 129.2 (ArC), 129.3 (ArC), 132.1 
(ArC), 132.4 (ArC), 132.7 (ArC), 151.0 (NArC(1)), 166.6 (NHC=O), 172.4 (MeOC=O); 
Selected data for minor rotamer: δ (300 MHz, CDCl ) 3.72 (3H, s, OCH ), 5.70 (1H, s, 
C(2)H), 8.04 (1H, s, NH); δ (75 MHz, CDCl ) 52.7 (OCH ), 67.8 (C(2)), 114.9 
(NArC(2,6)), 127.3 (ArC), 127.7 (ArC), 130.3 (ArC), 130.8 (ArC); m/z (NSI
+
) 429 
([M+H]
+
, 100%); HRMS (NSI
+
) C23H20F3N2O3
+
 ([M+H]
+
) requires 429.1421; found 
429.1422 (+0.3 ppm). 
 
(2R)-methyl 2-(1-(4-methoxyphenyl)-2-(4-(trifluoromethyl)benzoyl)hydrazinyl)-2-
phenylacetate 
 
Following general procedure K, phenylacetic acid (40.9 mg, 0.30 mmol), i-Pr2NEt (78.0 
L, 0.45 mmol) and benzoyl chloride (52.2 L, 0.45 mmol) in CH Cl  (2 mL), HBTM-
2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 595 (61.6 mg, 0.20 mmol) and 
i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C followed by addition of MeOH (2 mL) 
and stirring for 1 h at rt gave, after chromatographic purification (eluent Et O:petrol 
50:50) a rotameric mixture (ratio 76:24) of (2R)-362 as a light yellow oil (68.8 mg, 
75%); 

 
D
20
-34.6 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IA (50% IPA:hexane, flow 
rate 1 mL min
-1
, 211 nm, 20 °C) tR(2R): 19.0 min, tR(2S): 34.7 min, 99% ee; max (thin 
film)/cm
-1
 3283 (N-H), 2955 (C-H), 1737 (C=O ester), 1674 (C=O amide), 1511; Data 
for major rotamer δ (400 MHz, CDCl ) 3.69 (3H, s, OCH ), 3.72 (3H, s, OCH ), 5.69 
(1H, s, C(2)H), 6.77-6.79 (2H, m, NAr(2,6)H), 6.93-6.95 (2H, m, NAr(3,5)H), 7.07-7.11 
(1H, m, ArH), 7.21-7.28 (3H, m, ArH), 7.37-7.39 (1H, m, ArH), 7.54 (4H, m, ArH), 
8.63 (1H, s, NH); Data for both rotamers δ (100 MHz, CDCl ) 52.4 (OCH ), 52.5 
(OCH ) 55.6 (OCH ), 55.6 (OCH ), 67.7 (C(2)), 69.3 (C(2)), 114.7 (NArC(2,6)), 115.1 
(NArC(2,6)), 117.3 (NArC(3,5)), 117.7 (NArC(3,5)), 124.0 (q, J 3.8, C(O)ArC(3,5)), 
125.6 (q, J 3.5, C(O)ArC(3,5)), 127.5 (ArC), 128.1 (ArC), 128.7 (ArC), 128.8 (ArC), 
128.9 (ArC), 129.0 (ArC), 129.0 (ArC), 130.0 (ArC), 131.7 (ArC), 132.6 (ArC), 133.2 
(ArC), 133.5 (ArC), 136.2 (ArC), 136.4 (ArC), 142.0 (NArC(1)), 142.4 (NArC(1)), 155.2 
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(NArC(4)), 158.9 (NArC(4)), 165.3 (C=O), 171.6 (C=O), 172.3 (C=O), 173.3 (C=O); 
Selected data for minor rotamer: δ (400 MHz, CDCl ) 3.60 (3H, s, OCH ), 3.75 (3H, s, 
OCH ), 5.32 (1H, s, C(2)H), 6.87-6.92 (2H, m, ArH), 8.15 (1H, s, NH); m/z (NSI
+
) 459 
([M+H]
+
, 100%); HRMS (NSI
+
) C24H22F3N2O4
+
 ([M+H]
+
) requires 459.1526; found 
459.1520 (-1.3 ppm). 
 
Scale-up: 
Following general procedure K, phenylacetic acid (1.33 g, 9.74 mmol), i-Pr2NEt (2.53 
mL, 14.6 mmol) and benzoyl chloride (1.70 mL, 14.6 mmol) in CH Cl  (40 mL), 
HBTM-2.1 (2S,3R)-112 (20.0 mg, 0.065 mmol, 1 mol%), diazene 595 (2.00 g, 6.49 
mmol) and i-Pr2NEt (1.69 mL, 9.74 mmol) for 16 h at 78 °C rt followed by addition of 
MeOH (10 mL) and stirring for 1 h at rt gave, after chromatographic purification (eluent 
Et O:petrol 50:50) a rotameric mixture (ratio 76:24) of (2R)-362 as a light yellow oil 
(2.83 g, 95%); 99% ee. 
 
(2R)-methyl 2-(4-fluorophenyl)-2-(1-(4-methoxyphenyl)-2-(4-
(trifluoromethyl)benzoyl)hydrazinyl)acetate 
 
Following general procedure K, 4-fluorophenylacetic acid (0.23 g, 1.50 mmol), i-Pr2NEt 
(0.39 mL, 2.25 mmol) and benzoyl chloride (0.26 mL, 2.25 mmol) in CH Cl  (10 mL), 
HBTM-2.1 (2S,3R)-112 (3.08 mg, 0.01 mmol, 1 mol%), diazene 595 (0.31 g, 1.00 
mmol) and i-Pr2NEt (0.26 mL, 1.50 mmol) for 16 h at 78 °C followed by addition of 
MeOH (10 mL) and stirring for 1 h at rt gave, after chromatographic purification (eluent 
Et O:petrol 40:60) a rotameric mixture (ratio 79:21) of (2R)-363 as a white solid (0.38 g, 
79%); mp 68-70 °C; 

 
D
20
-43.8 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IA (50% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(2S): 17.0 min, tR(2R): 26.4 min, 
99% ee; max (KBr)/cm
-1
 3363 (N-H), 2956 (C-H), 1741 (C=O ester), 1674 (C=O 
amide), 1513; Data for major rotamer δ (400 MHz, CDCl ) 3.75 (3H, s, OCH ), 3.78 
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(3H, s, OCH ), 5.77 (1H, s, C(2)H), 6.86 (2H, d, J 9.0, ArH), 6.98-7.05 (4H, m, ArH), 
7.47 (2H, dd, J 8.4, 5.3, ArH), 7.59 (2H, d, J 8.2, ArH), 7.66 (2H, d, J 8.2, ArH), 8.96 
(1H, s, NH); Data for both rotamers δ (75 MHz, CDCl ) 52.4 (OCH ), 52.5 (OCH ), 55.4 
(OCH ), 55.5 (OCH ), 67.1 (C(2)), 68.5 (C(2)), 114.7 (ArC), 115.1 (ArC), 115.7 (d, J 
21.7, C(2)ArC(3,5)), 115.7 (d, J 21.7, C(2)ArC(3,5)), 117.6 (ArC), 117.7 (ArC), 123.6 
(q, J 271, CF ), 123.6 (q, J 271, CF ), 124.0 (q, J 3.5, C(O)ArC(3,5)), 125.6 (q, J 3.6, 
C(O)ArC(3,5)), 127.6 (ArC), 128.2 (ArC), 128.7 (d, J 3.2, C(2)ArC(1)), 129.6 (d, J 3.2, 
C(2)ArC(1)), 130.8 (d, J 8.3, C(2)ArC(2,6)), 131.9 (d, J 8.5, C(2)ArC(2,6)), 133.4 (q, J 
32.5, C(O)ArC(4)), 133.4 (q, J 32.5, C(O)ArC(4)), 136.2 (ArC), 136.2 (ArC), 141.9 
(ArC), 142.1 (ArC), 155.3 (ArC), 155.7 (ArC), 162.8 (d, J 247, C(2)ArC(4)), 162.8 (d, J 
248 C(2)ArC(4)), 165.4 (C=O), 171.7 (C=O), 172.0 (C=O), 172.9 (C=O);Selected data 
for minor rotamer: δ (400 MHz, CDCl ) 3.68 (3H, s, OCH ), 3.81 (3H, s, OCH ), 5.43 
(1H, s, C(2)H), 7.19 (2H, d, J 9.0 ArH), 7.36 (2H, d, J 8.1, ArH), 8.29 (1H, s, NH); m/z 
(NSI
+
) 477 ([M+H]
+
, 100%); HRMS (NSI
+
) C24H21F4N2O4
+
 ([M+H]
+
) requires 
477.1432; found 477.1420 (-2.5 ppm). 
 
(2R)-methyl 2-(1-(4-methoxyphenyl)-2-(4-(trifluoromethyl)benzoyl)hydrazinyl)-2-
(naphthalen-2-yl)acetate 
 
Following general procedure K, 2-naphthylacetic acid (0.28 g, 1.50 mmol), i-Pr2NEt 
(0.39 mL, 2.25 mmol) and benzoyl chloride (0.26 mL, 2.25 mmol) in CH Cl  (10 mL), 
HBTM-2.1 (2S,3R)-112 (3.08 mg, 0.01 mmol, 1 mol%), diazene 595 (0.31 mg, 1.00 
mmol) and i-Pr2NEt (0.26 mL, 1.50 mmol) for 16 h at 78 °C followed by addition of 
MeOH (10 mL) and stirring for 1 h at rt gave, after chromatographic purification (eluent 
Et O:petrol 45:55) a rotameric mixture (ratio 70:30) of (2R)-364 as a light yellow solid 
(0.41 g, 80%); mp 74-76 °C; 

 
D
20
-75.8 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IB 
(20% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(2S): 12.5 min, tR(2R): 14.5 
min, 98% ee; max (KBr)/cm
-1
 3414 (N-H), 2954 (C-H), 1735 (C=O ester), 1670 (C=O 
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amide), 1510; Data for major rotamer δ (300 MHz, CDCl ) 3.79 (3H, s, OCH ), 3.85 
(3H, s, OCH ), 6.03 (1H, s, C(2)H), 6.92 (2H, d, J 9.0, ArH), 7.16 (2H, d, J 9.1, ArH), 
7.48-7.59 (6H, m, ArH), 7.73-7.93 (5H, m, ArH), 9.07 (1H, s, NH); Data for both 
rotamers δ (75 MHz, CDCl ) 52.5 (OCH ), 52.6 (OCH ), 55.5 (OCH ), 55.6 (OCH ), 
68.1 (C(2)), 69.2 (C(2)), 114.7 (ArC), 115.2 (ArC), 117.6 (ArC), 117.8 (ArC), 123.8 (q, J 
3.5, C(O)ArC(3,5)), 125.5 (q, J 3.6, C(O)ArC(3,5)), 126.5 (ArC), 126.6 (ArC), 126.7 
(ArC), 126.7 (ArC), 126.7 (ArC), 126.8 (ArC), 127.2 (ArC), 127.5 (ArC), 127.8 (ArC), 
127.9 (ArC), 128.1 (ArC), 128.2 (ArC), 128.2 (ArC), 128.4 (ArC), 128.6 (ArC), 129.9 
(ArC), 130.1 (ArC), 131.3 (ArC), 133.0 (ArC), 133.1 (ArC), 133.3 (ArC), 133.4 (ArC), 
136.0 (ArC), 136.4 (ArC), 142.2 (ArC), 142.4 (ArC), 155.3 (ArC), 155.6 (ArC), 165.5 
(C=O), 171.7 (C=O), 172.1 (C=O), 173.1 (C=O); Selected data for minor rotamer: δ
(300 MHz, CDCl ) 3.76 (3H, s, OCH ), 3.85 (3H, s, OCH ), 5.68 (1H, s, C(2)H), 6.77 
(2H, d, J 8.1 ArH), 7.04 (2H, d, J 9.0, ArH), 7.29 (2H, d, J 9.0, ArH), 7.66 (2H, d, J 8.3, 
ArH), 8.42 (1H, s, NH); m/z (NSI
+
) 509 ([M+H]
+
, 100%); HRMS (NSI
+
) C28H24F3N2O4
+
 
([M+H]
+
) requires 509.1683; found 509.1680 (-0.5 ppm). 
 
(2S)-methyl 2-(2-benzoyl-1-phenylhydrazinyl)-2-(thiophen-2-yl)acetate 
 
Following general procedure K, thiophene-2-acetic acid (42.7 mg, 0.30 mmol), i-Pr2NEt 
(78.0 L, 0.45 mmol) and benzoyl chloride (52.2 L, 0.45 mmol) in CH Cl  (2 mL), 
HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 313 (42.0 mg, 0.20 
mmol) and i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C followed by addition of 
MeOH (2 mL) and stirring for 1 h at rt gave, after chromatographic purification (eluent 
EtOAc:petrol 25:75) a rotameric mixture (ratio 92:8) of (2S)-366 as a light yellow solid 
(59.8 mg, 82%); mp 116-118 °C; 

 
D
20
-12.0 (c 0.25, CH2Cl2); Chiral HPLC Chiralpak 
IB (10% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(2R): 16.5 min, tR(2S): 
19.7 min, 54% ee; max (KBr)/cm
-1
 3346 (N-H), 3066, 2952 (C-H), 1729 (C=O ester), 
1685 (C=O amide), 1599; Data for major rotamer δ (300 MHz, CDCl ) 3.72 (3H, s, 
CH ), 5.98 (1H, s, C(2)H), 6.85-6.96 (4H, m, ArH), 7.09 (1H, d, J 3.5, ArH), 7.18-7.24 
(3H, m, ArH), 7.31-7.36 (2H, m, ArH), 7.40-7.45 (1H, m, ArH), 7.60-7.63 (2H, m, 
C(O)Ar(2,6)H), 8.54 (1H, s, NH); δ (100 MHz, CDCl ) 52.8 (CH ), 62.3 (C(2)), 115.1 
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(NArC(2,6)), 122.0 (NArC(4)), 126.7 (ArC), 127.3 (ArC), 127.3 (ArC), 127.4 (ArC), 
128.7 (ArC), 129.5 (ArC), 132.0 (ArC), 132.8 (C(O)ArC(1)), 135.0 (C(2)ArC(2)), 147.8 
(NArC(1)), 166.7 (NHC=O), 172.2 (MeOC=O); Selected data for minor rotamer δ (300 
MHz, CDCl ) 3.60 (3H, s, CH ), 5.65 (1H, s, C(2)H), 7.94 (1H, s, NH); δ (100 MHz, 
CDCl ) 52.7 (CH ), 62.5 (C(2)), 115.6 (NArC(2,6)), 122.5 (NArC(4)), 127.1 (ArC), 
127.8 (ArC), 128.0 (ArC), 129.9 (ArC), 130.1 (ArC), 130.6 (ArC); m/z (NSI
+
) 367 
([M+H]
+
, 100%); HRMS (NSI
+
) C20H19N2O3S
+
 ([M+H]
+
) requires 367.1111; found 
367.1115 (+1.1 ppm). 
 
(2R)-methyl 2-(2-(4-nitrobenzoyl)-1-phenylhydrazinyl)-2-(phenylthio)acetate 
 
Following general procedure K, (phenylthio)acetic acid (50.5 mg, 0.30 mmol), i-Pr2NEt 
(78.0 L, 0.45 mmol) and benzoyl chloride (52.2 L, 0.45 mmol) in CH Cl  (2 mL), 
HBTM-2.1 (2S,3R)-112 (0.62 mg, 0.002 mmol, 1 mol%), diazene 367 (51.0 mg, 0.20 
mmol) and i-Pr2NEt (52.0 L, 0.30 mmol) for 16 h at 78 °C followed by addition of 
MeOH (2 mL) and stirring for 1 h at 78 °C gave, after chromatographic purification 
(eluent Et O:petrol 50:50) a rotameric mixture (ratio 87:13) of (2R)-368 as an orange oil 
(72.7 mg, 83%); 

 
D
20
+5.0 (c 0.2, CH2Cl2); Chiral HPLC Chiralpak IA (40% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(2R): 13.1 min, tR(2S): 20.2 min, 
98% ee; max (ATR)/cm
-1
 3269 (N-H), 3061, 2953 (C-H), 1736 (C=O ester), 1682 (C=O 
amide), 1597, 1523 (N=O), 1348 (N=O); Data for major rotamer δ (300 MHz, CDCl ) 
3.70 (3H, s, OCH ), 5.69 (1H, s, C(2)H), 6.82-6.91 (3H, m, NAr(2,6)H and NAr(4)H), 
7.13-7.25 (5H, m, ArH), 7.60-7.64 (2H, m, ArH), 7.95-8.00 (2H, m, C(O)Ar(2,6)H), 
8.22-8.25 (2H, m, C(O)Ar(3,5)H), 8.81 (1H, s, NH); δ (100 MHz, CDCl ) 53.1 (OCH ), 
72.1 (C(2)), 115.7 (NArC(2,6)), 122.7 (NArC(4)), 124.0 (C(O)ArC(3,5)), 128.8 (ArC), 
129.1 (ArC), 129.4 (ArC), 129.5 (ArC), 132.6 (C(2)ArC(1)), 133.7 (C(2)ArC(4)), 138.6 
(C(O)ArC(1)), 146.8 (ArC), 150.0 (ArC), 165.2 (NHC=O), 169.7 (MeOC=O);Selected 
data for minor rotamer: δ (300 MHz, CDCl ) 3.57 (3H, s, OCH ), 5.60 (1H, s, C(2)H), 
7.50 (2H, d, J 8.8, ArH), 7.83 (2H, d, J 8.8, ArH), 8.17 (1H, s, NH); δ (100 MHz, 
CDCl ) 53.1 (OCH ), 72.3 (C(2)), 116.4 (NArC(2,6)), 122.8 (NArC(4)), 123.8 
(C(O)ArC(3,5)), 127.3 (ArC), 127.8 (ArC), 130.2 (ArC), 139.4 (C(O)ArC(1)), 147.5 
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(ArC), 168.6 (NHC=O), 172.4 (MeOC=O); m/z (ES
+
) 460 ([M+Na]
+
, 100%); HRMS 
(ES
+
) C22H19N3NaO5S
+
 ([M+Na]
+
) requires 460.0943; found 460.0932 (-2.4 ppm). 
 
(2R)-methyl 2-methoxy-2-(2-(4-nitrobenzoyl)-1-phenylhydrazinyl)acetate 
 
Following general procedure K, methoxyacetic acid (23.0 L, 0.30 mmol), i-Pr2NEt 
(78.0 L, 0.45 mmol) and benzoyl chloride (52.2 L, 0.45 mmol) in CH Cl  (2 mL), 
HBTM-2.1 (2S,3R)-112 (6.16 mg, 0.02 mmol, 10 mol%), diazene 367 (51.0 mg, 0.20 
mmol) and PS-BEMP (2.2 mmol/g, 0.23 g, 0.5 mmol) for 16 h at rt followed by 
addition of MeOH (2 mL) and stirring for 1 h at rt gave, after chromatographic 
purification (eluent Et O:petrol 70:30) a rotameric mixture (ratio 95:5) of (2R)-370 as an 
orange solid (38.7 mg, 54%); mp 122-124 °C; 

 
D
20
+15.5 (c 0.2, CH2Cl2); Chiral HPLC 
Chiralpak AD-H (20% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(2S): 22.4 
min, tR(2R): 24.7 min, 83% ee; max (ATR)/cm
-1
 3278 (N-H), 3071, 2960 (C-H), 1748 
(C=O ester), 1676 (C=O amide), 1597, 1525 (N=O), 1346 (N=O); Data for major 
rotamer δ (400 MHz, CDCl ) 3.56 (3H, s, OCH ), 3.73 (3H, s, OCH ), 5.28 (1H, s, 
C(2)H), 6.93-7.00 (3H, m, NAr(2,6)H and NAr(4)H), 7.22-7.26 (2H, m, NAr(3,5)H), 
7.93-7.96 (2H, m, C(O)Ar(2,6)H), 8.21-8.24 (2H, m, C(O)Ar(3,5)H), 8.41 (1H, s, NH); 
δ (100 MHz, CDCl ) 53.0 (OCH ), 57.5 (OCH ), 89.3 (C(2)), 115.8 (NArC(2,6)), 122.8 
(NArC(3,5)), 124.0 (C(O)ArC(3,5)), 128.7 (ArC), 129.5 (ArC), 138.4 (C(O)ArC(1)), 
146.2 (ArC), 150.0 (ArC), 165.2 (NHC=O), 168.3 (MeOC=O);Selected data for minor 
rotamer δ (400 MHz, CDCl ) 3.45 (3H, s, OCH ), 3.67 (3H, s, OCH ), 4.93 (1H, s, 
C(2)H); δ (100 MHz, CDCl ) 53.4 (OCH ), 90.7 (C(2)), 114.0 (ArC(2)), 121.9 (ArC(4)), 
127.3 (ArC); m/z (ES
+
) 382 ([M+Na]
+
, 100%); HRMS (ES
+
) C17H17N3NaO6
+
 ([M+Na]
+
) 
requires 382.1015; found 382.1023 (+2.0 ppm).  
 
(2R)-methyl 2-(2-(4-benzoyl)-1-phenylhydrazinyl)-3-phenylpropanoate 
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Following general procedure K, 3-phenylpropionic acid (45.1 mg, 0.30 mmol), i-Pr2NEt 
(78.0 L, 0.45 mmol) and benzoyl chloride (52.2 L, 0.45 mmol) in CH Cl  (2 mL), 
HBTM-2.1 (2S,3R)-112 (6.16 mg, 0.02 mmol, 10 mol%), diazene 367 (51.0 mg, 0.20 
mmol) and PS-BEMP (2.2 mmol/g, 227 mg, 0.5 mmol) for 16 h at rt followed by 
addition of MeOH (2 mL) and stirring for 1 h at rt gave, after chromatographic 
purification (eluent Et O:petrol 40:60) a rotameric mixture (ratio 90:10) of (2R)-371 as a 
light yellow solid (51.8 mg, 62%); mp 42-44 °C; 

 
D
20
-28.4 (c 0.5, CH2Cl2); Chiral 
HPLC Chiralpak IA (40% IPA:hexane, flow rate 1 mLmin
-1
, 211 nm, 30 °C) tR(2R): 9.8 
min, tR(2S): 18.1 min, 99% ee; max (ATR)/cm
-1
 3279 (N-H), 3065, 2943 (C-H), 1728 
(C=O ester), 1686 (C=O amide), 1597, 1522 (N=O), 1344 (N=O); Data for major 
rotamer δ (400 MHz, CDCl ) 3.10 (1H, dd, J 13.6, 8.2, CHH), 3.39 (1H, dd, J 13.6, 6.1, 
CHH), 3.52 (3H, s, OCH ), 4.71 (1H, dd, J 8.2, 6.1, C(2)H), 6.83-6.92 (3H, m, 
NAr(2,6)H and NAr(4)H), 7.16-7.26 (7H, m, ArH), 7.99-8.02 (2H, m, C(O)Ar(2,6)H), 
8.26-8.29 (2H, m, C(O)Ar(3,5)H), 8.86 (1H, s, NH); δ (100 MHz, CDCl ) 37.1 (CH ), 
52.1 (OCH ), 65.2 (C(2)), 115.3 (NArC(2,6)), 122.3 (NArC(4)), 124.1 (C(O)ArC(3,5)), 
127.2 (C(2)ArC(4)), 128.6 (ArC), 128.7 (ArC), 129.2 (ArC), 129.5 (ArC), 136.5 (ArC), 
138.2 (ArC), 147.9 (ArC), 150.1 (ArC), 164.8 (NHC=O), 174.2 (MeOC=O); Selected 
data for minor rotamer: δ (400 MHz, CDCl ) 3.47 (3H, s, OCH ), 7.42 (2H, d, J 8.9, 
ArH), 8.20 (1H, s, NH); δ (100 MHz, CDCl ) 35.6 (CH ), 52.1 (OCH ), 66.3 (C(2)), 
116.4 (NArC(2,6)), 122.8 (NArC(4)), 128.2 (ArC), 128.5 (ArC), 130.0 (ArC); m/z (ES
+
) 
442 ([M+Na]
+
, 100%); HRMS (ES
+
) C23H21N3NaO5
+
 ([M+Na]
+
) requires 442.1379; 
found 442.1363 (-3.6 ppm). 
 
General procedure L: Samarium iodide N-N bond cleavage. 
To a solution of hydrazide (1 eq) in MeOH was added SmI2 (0.1 M in THF, 3 eq) and 
the reaction mixture was allowed to stir at 78 °C for 10 minutes. The reaction mixture 
was poured into sat. aq. NaHCO3 and extracted with ethyl acetate (x 3). The combined 
organics were dried (MgSO4), filtered and concentrated in vacuo to give the crude 
reaction mixture. Note: All racemic samples for HPLC analysis were obtained via the 
same general procedure using racemic hydrazide products. 
 
(2R)-methyl 2-((4-methoxyphenyl)amino)-2-phenylacetate 
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Following general procedure L, ester (2R)-362 (0.23 g, 0.50 mmol) and SmI2 (0.1 M in 
THF, 15.0 mL, 1.50 mmol) in MeOH (5 mL) gave, after chromatographic purification 
(eluent Et O:petrol 20:80) (2R)-383 as a white solid (112 mg, 83%); mp 104-106 °C; 
{lit.
199
 mp 107-108 °C}; 

 
D
20
-99.2 (c 0.125, CHCl3); {lit.
119
 

 
D
20
+97.6 (c 1.29 in 
CHCl3) for a 98% ee sample (2S)-configuration}; Chiral HPLC Chiralcel OJ-H (30% 
IPA:hexane, flow rate 1 mL min
-1
, 220 nm, 30 °C) tR(2R): 28.1 min, tR(2S): 30.9 min, 
99% ee; δ (300 MHz, CDCl ) 3.73 (3H, s, OCH ), 3.75 (3H, s, OCH ), 4.69 (1H, br s, 
NH), 5.05 (1H, s, C(2)H), 6.54-6.59 (2H, m, ArH), 6.72-6.76 (2H, m, ArH), 7.33-7.41 
(3H, m, ArH), 7.50-7.53 (2H, m, ArH). Spectroscopic data are in accordance with the 
literature.
200
 Note: Enantiomeric excess was 91% when reaction carried out at rt. 
 
(2R)-methyl 2-(4-fluorophenyl)-2-((4-methoxyphenyl)amino)acetate 
 
Following general procedure L, ester (2R)-363 (0.24 g, 0.50 mmol) and SmI2 (0.1 M in 
THF, 15.0 mL, 1.50 mmol) in MeOH (5 mL) gave, after chromatographic purification 
(eluent Et O:petrol 25:75) (2R)-384 as a light yellow solid (110 mg, 76%); mp 102-104 
°C; {lit.
199
 mp 99-100 °C}; 

 
D
20
-86.8 (c 0.25, CH2Cl2); {lit.
119
 

 
D
20
+70.4 (c 1.40 in 
CHCl3) for a 93% ee sample (2S)-configuration}; Chiral HPLC Chiralpak AD-H (10% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(2S): 13.7 min, tR(2R): 15.9 min, 
98% ee; δ (300 MHz, CDCl ) 3.64 (3H, s, OCH ), 3.66 (3H, s, OCH ), 4.60 (1H, br s, 
NH), 4.92 (1H, s, C(2)H), 6.42-6.45 (2H, m, ArH), 6.64-6.67 (2H, m, ArH), 6.94-7.00 
(2H, m, C(2)Ar(3,5)H), 7.37-7.42 (2H, m, C(2)Ar(2,6)H). Spectroscopic data are in 
accordance with the literature.
119
 
 
(2R)-methyl 2-((4-methoxyphenyl)amino)-2-(naphthalen-2-yl)acetate 
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Following general procedure L, ester (2R)-364 (0.25 g, 0.50 mmol) and SmI2 (0.1 M in 
THF, 15.0 mL, 1.50 mmol) in MeOH (5 mL) gave, after chromatographic purification 
(eluent Et O:petrol 25:75) (2R)-385 as a colourless oil (131 mg, 82%); 

 
D
20
-180.4 (c 
0.25, CH2Cl2); {lit.
119
 

 
D
20
+130.6 (c 1.60 in CHCl3) for a 97% ee sample (2S)-
configuration}; Chiral HPLC Chiralcel OJ-H (30% IPA:hexane, flow rate 1 mL min
-1
, 
220 nm, 30 °C) tR(2R): 30.4 min, tR(2S): 33.0 min, 98% ee; δ (300 MHz, CDCl ) 3.59 
(3H, s, OCH ), 3.62 (3H, s, OCH ), 4.73 (1H, br s, NH), 5.09 (1H, s, C(2)H), 6.47-6.51 
(2H, m, ArH), 6.59-6.65 (2H, m, ArH), 7.36-7.41 (2H, m, ArH), 7.51 (1H, dd, J 8.6, 1.8, 
ArH), 7.71-7.76 (3H, m, ArH), 7.87 (1H, s, C(2)Ar(1)H). Spectroscopic data are in 
accordance with the literature.
119
 
 
(2R)-methyl 2-phenyl-2-(phenylamino)acetate 
 
Following general procedure L, ester (2R)-321 (0.18 g, 0.50 mmol) and SmI2 (0.1 M in 
THF, 15.0 mL, 1.50 mmol) in MeOH (5 mL) gave, after chromatographic purification 
(eluent Et O:petrol 25:75) (2R)-386 as a white solid (110 mg, 91%); mp 73-74 °C; 
{lit.
201
 mp 79-80 °C}; 

 
D
20
-51.5 (c 0.2, CH2Cl2); {lit.
119
 

 
D
20
+49.9 (c 0.9 in CHCl3) for 
a 97% ee sample (2S)-configuration}; Chiral HPLC Chiralcel OD-H (1% IPA:hexane, 
flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(2S): 23.7 min, tR(2R): 26.1 min, 99% ee; δ (300 
MHz, CDCl ) 3.63 (3H, s, OCH ), 4.87 (1H, d, J 5.7, NH), 5.00 (1H, d, J 5.9, C(2)H), 
6.47 (2H, dd, J 8.6, 0.9, NAr(2,6)H), 6.58-6.64 (1H, m, NAr(4)H), 7.00-7.06 (2H, m, 
NAr(3,5)H), 7.21-7.29 (3H, m, C(2)Ar(3,5)H and C(2)Ar(4), 7.39-7.43 (2H, m, 
C(2)Ar(2,6)H). Spectroscopic data are in accordance with the literature.
119
 
 
(2R)-methyl 2-phenyl-2-((4-(trifluoromethyl)phenyl)amino)acetate 
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Following general procedure L, ester (2R)-361 (0.21 g, 0.50 mmol) and SmI2 (0.1 M in 
THF, 15.0 mL, 1.50 mmol) in MeOH (5 mL) gave, after chromatographic purification 
(eluent Et O:petrol 25:75) (2R)-387 as a colourless oil (117 mg, 76%); 

 
D
20
-98.0 (c 
0.25, CH2Cl2); Chiral HPLC Chiralcel OD-H (1% IPA:hexane, flow rate 1 mL min
-1
, 
211 nm, 30 °C) tR(2R): 13.6 min, tR(2S): 14.7 min, 98% ee; δ (300 MHz, CDCl ) 3.66 
(3H, s, OCH ), 5.01 (1H, d, J 5.7, C(2)H), 5.28 (1H, d, J 5.5, NH), 6.47 (2H, d, J 8.5, 
NAr(2,6)H), 7.23-7.31 (5H, m, ArH), 7.37-7.40 (2H, m, C(2)Ar(2,6)H). Spectroscopic 
data are in accordance with the literature.
202
 
 
(2R)-methyl 2-amino-2-phenylacetate 
 
To a solution of PMP protected amine (2R)-383 (34.5 mg, 0.13 mmol) in MeCN:H2O 
(1:1, 10 mL) was added periodic acid (28.9 mg, 0.13 mmol) and H2SO4 (1 M in H2O, 
0.13 mL, 0.13 mmol) and the reaction mixture was allowed to stir for 16 h at rt. The 
reaction mixture was washed with CH2Cl2. The aqueous layer was retained, basified 
with sat. aq. NaHCO3 and extracted with ethyl acetate (x 3). The combined organics 
were dried (MgSO4), filtered and concentrated in vacuo to give (2R)-388 as a yellow oil 
(9.8 mg, 47%); 

 
D
20
-192 (c 0.025, CH2Cl2); {lit.
102(c)
 

 
D
20
+202.3 (c 0.49 in CH2Cl2) 
for a 91% ee sample (2S)-configuration}; δ (300 MHz, CDCl ) 1.97 (2H, br s, NH ), 
3.63 (3H, s, OCH ), 4.55 (1H, s, C(2)H), 7.23-7.30 (5H, m, ArH). Spectroscopic data are 
in accordance with the literature.
102(c)
 
 
(2R)-methyl 2-acetamido-2-phenylacetate 
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To a solution of amine (2R)-388 (6.0 mg, 0.036 mmol) and Et3N (5.58 L, 0.04 mmol) 
in CH2Cl2 (1 mL) at 0 °C was added acetic anhydride (3.78 L, 0.04 mmol) and the 
reaction mixture was stirred at rt for 30 minutes. The reaction mixture was washed 
several times with H O and the organic layer was dried (MgSO ), filtered and 
concentrated in vacuo to give acylated amine (2R)-389 as a yellow oil (6.8 mg, 90%); 

 
D
20
-188 (c 0.05, CH2Cl2); {lit.
203
 

 
D
20
-36 (c 1.00 in CHCl3) for a 24% ee sample 
(2R)-configuration}; Chiral HPLC Chiralcel OJ-H (10% IPA:hexane, flow rate 1 mL 
min
-1
, 211 nm, 30 °C) tR(2S): 16.1 min, tR(2R): 17.9 min, 90% ee; δ (300 MHz, CDCl ) 
1.97 (3H, s, CH ), 3.66 (3H, s, OCH ), 5.52 (1H, d, J 7.3, C(2)H), 6.42 (1H, br s, NH), 
7.27-7.29 (5H, m, ArH). Spectroscopic data are in accordance with the literature.
120(c)
 
 
(1R)-N'-(2-hydroxy-1-(p-tolyl)ethyl)-N'-phenylbenzohydrazide 
 
To a solution of (2R)-331 (33.9 mg, 0.10 mmol) in THF (1 mL) was added LiAlH  (2M 
in THF, 0.5 mL, 1.0 mmol) and the reaction mixture was allowed to stir at rt for 10 
minutes. The reaction mixture was quenched by addition of sat. aq. NH Cl and extracted 
with Et O (x 3). The organic layer was dried (MgSO ), filtered and concentrated in 
vacuo. Chromatographic purification (eluent Et O:petrol 60:40) gave (1R)-390 as a white 
solid (33.6 mg, 97%); mp 148-150 °C; 

 
D
20
-73.2 (c 0.25, CH2Cl2); Chiral HPLC 
Chiralpak AD-H (30% IPA:hexane, flow rate 1 mL min
-1
, 254 nm, 30 °C) tR(1R): 7.4 
min, tR(1S): 10.7 min, >99% ee; max (KBr)/cm
-1
 3551 (O-H), 3412 (N-H), 2933 (C-H), 
1662 (C=O), 1597, 1497; δ (500 MHz, CDCl ) 2.23 (3H, s, CH ), 3.78 (1H, td, J 11.7, 
3.6, C(2)HH), 3.94 (1H, t, J 10.5, C(2)HH), 4.61 (1H, br s, OH), 5.18 (1H, d, J 7.2, 
C(1)H)), 6.82 (1H, t, J 7.3, NAr(4)H), 6.94 (2H, d, J 8.1, NAr(2,6)H), 7.02-7.05 (4H, m, 
ArH), 7.17-7.20 (2H, m, ArH), 7.41 (2H, t, J 7.6, C(O)Ar(3,5)H), 7.51 (1H, t, J 7.4, 
C(O)Ar(4)H), 7.74 (2H, d, J 7.6, C(O)Ar(2,6)H); δ (125 MHz, CDCl ) 21.1 (CH ), 61.2 
(C(2)), 65.2 (C(1)), 114.2 (NArC(2,6)), 120.6 (NArC(4)), 127.3 (ArC), 127.5 (ArC), 
129.0 (ArC), 129.5 (ArC), 129.7 (ArC), 131.8 (ArC), 132.4 (ArC), 132.7 (C(O)ArC(4)), 
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138.3 (C(1)ArC(1)), 148.6 (NArC(1)), 168.7 (C=O); m/z (NSI+) 347 ([M+H]+, 35%); 
HRMS (NSI
+
) C22H23N2O2
+
 ([M+H]
+
) requires 347.1754; found 347.1760 (+1.7 ppm). 
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9.5 Experimental for Chapter 5  
9.5.1 Experimental Procedures and Characterisation Data 
ethyl 2-cyclopentylideneacetate 
 
To a suspension of 60% NaH in mineral oil (1.23 g, 51.4 mmol) in Et2O (120 mL) at 0 
°C was added ethyl 2-(diethoxyphosphoryl)acetate (10.2 mL, 51.4 mmol) and the 
reaction mixture was stirred for 5 minutes at 0 °C. A solution of cyclopentanone (4.42 
mL, 50.0 mmol) in Et2O (10 mL) was added and the reaction mixture was allowed to stir 
at rt for 4 h. The reaction mixture was diluted with water and extracted with Et2O (x 3). 
The combined organic extracts were dried (MgSO4), filtered and concentrated in vacuo. 
Chromatographic purification (eluent Et O:petrol 10:90) gave ester 419 as a colourless 
oil (7.00 g, 91%); δ (500 MHz, CDCl ) 1.30 (3H, t, J 7.1, CH ), 1.68 (2H, quintet, J 6.8, 
CH ), 1.77 (2H, quintet, J 7.0, CH ), 2.44-2.47 (2H, m, CH C=), 2.78-2.81 (2H, m, 
CH C=), 4.17 (2H, q, J 7.1, CH CH ), 5.82 (1H, quintet, J 2.2, =CH). Spectroscopic data 
are in accordance with the literature.
  
ethyl 2-(cyclopent-1-en-1-yl)acetate 
 
To a solution of i-Pr2NH (5.82 mL, 41.2 mmol) in THF (80 mL) at 0 °C was added 2.5 
M n-BuLi (16.5 mL, 41.2 mmol) and the reaction mixture was stirred at that temperature 
for 30 minutes. The reaction mixture was cooled to 78 °C and a solution of ester 419 
(5.88 g, 38.2 mmol) in THF (25 mL) was added dropwise over 15 minutes before 
stirring for a further 20 minutes. The reaction mixture was quenched by addition of sat. 
aq. NH4Cl and the reaction mixture was warmed to rt before being poured into water and 
extracted with Et2O (x 3). The combined organic extracts were dried (MgSO4), filtered 
and concentrated in vacuo to give ester 601 as a light yellow oil (5.68 g, 97%); δ (500 
MHz, CDCl ) 1.29 (3H, t, J 7.1, CH ), 1.93 (2H, quintet, J 7.5, CH ), 2.33-2.38 (4H, m, 
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CH  and CH ), 3.14 (2H, s, CH CO Et), 4.17 (2H, q, J 7.1, CH CH ), 5.55-5.57 (1H, m, 
=CH). Spectroscopic data are in accordance with the literature.
 
2-(cyclopent-1-en-1-yl)acetic acid 
 
A solution of ester 601 (4.15 g, 27.0 mmol) in 0.5 M KOH (80.8 mL, 40.4 mmol) was 
heated at reflux for 16 h. Once cooled to rt the reaction mixture was extracted with Et2O 
(x 3). The combined organic extracts were dried (MgSO4), filtered and concentrated in 
vacuo. Recrystallisation from petrol gave acid 416 as a white solid (2.74 g, 59%); mp 
44-46 °C; {lit
206
 mp 50-51 °C}; δ (300 MHz, CDCl ) 1.90-2.00 (2H, m, CH ), 2.37-2.42 
(4H, m, CH  and CH ), 3.21 (2H, s, CH CO H), 5.63 (1H, m, =CH). Spectroscopic data 
are in accordance with the literature.
 
(E)-ethyl 3-phenylbut-2-enoate 
 
To a suspension of 60% NaH in mineral oil (1.00 g, 41.6 mmol) in THF (35 mL) at 0 °C 
was added ethyl 2-(diethoxyphosphoryl)acetate (8.26 mL, 41.6 mmol) dropwise over 30 
minutes and the reaction mixture was stirred for 30 minutes at rt. A solution of 
acetophenone (4.85 mL, 41.6 mmol) in THF (15 mL) was added dropwise and the 
reaction mixture was allowed to stir at rt for 4 h. The reaction mixture was diluted with 
water and extracted with Et2O (x 3). The combined organic extracts were dried 
(MgSO4), filtered and concentrated in vacuo. Chromatographic purification (eluent 
Et O:petrol 5:95) gave ester 602 as a colourless oil (2.35 g, 30%); δ (500 MHz, CDCl ) 
1.35 (3H, t, J 7.1, CH CH ), 2.61 (3H, d, J 1.3, CH ), 4.25 (2H, q, J 7.1, CH CH ), 6.16 
(1H, q, J 1.2, =CH), 7.38-7.42 (3H, m, ArH), 7.50-7.52 (2H, m, ArH). Spectroscopic 
data are in accordance with the literature.  
 
(E)-3-phenylbut-2-enoic acid 
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A solution of ester 602 (2.35 g, 12.4 mmol) in 0.5 M KOH (37.1 mL, 18.6 mmol) was 
heated at reflux for 16 h. Once cooled to rt the reaction mixture was extracted with Et2O 
(x 3). The reaction mixture was treated with 1M H2SO4 until acidic and extracted with 
Et2O (x 3). The combined organic extracts were dried (MgSO4), filtered and 
concentrated in vacuo. Recrystallisation from Et2O gave acid 420 as a white solid (1.39 
g, 70%); mp 94-96 °C; {lit.
207
 mp 95-97 °C}; δ (500 MHz, CDCl ) 2.64 (3H, d, J 1.2, 
CH ), 6.21 (1H, q, J 1.2, =CH), 7.41-7.44 (3H, m, ArH), 7.51-7.54 (2H, m, ArH). 
Spectroscopic data are in accordance with the literature.
 
(E)-ethyl 3,4-diphenylbut-2-enoate 
 
To a suspension of 60% NaH in mineral oil (2.04 g, 51.0 mmol) in THF (50 mL) at 0 °C 
was added ethyl 2-(diethoxyphosphoryl)acetate (10.1 mL, 51.0 mmol) dropwise over 30 
minutes and the reaction mixture was stirred for 30 minutes at rt. A solution of 1,2-
diphenylethanone (10 g, 51.0 mmol) in THF (20 mL) was added dropwise and the 
reaction mixture was allowed to stir at rt for 4 h. The reaction mixture was diluted with 
water and extracted with Et2O (x 3). The combined organic extracts were dried 
(MgSO4), filtered and concentrated in vacuo. Chromatographic purification (eluent 
Et O:petrol 5:95) gave ester 603 as a colourless oil (2.35 g, 17%); δ (300 MHz, CDCl ) 
1.35 (3H, t, J 7.1, CH CH ), 4.27 (2H, q, J 7.1, CH CH ), 4.55 (2H, s, CH Ph), 6.29 (1H, 
d, =CH), 7.14-7.27 (5H, m, ArH), 7.33-7.36 (3H, m, ArH), 7.42-7.48 (2H, m, ArH). 
Spectroscopic data are in accordance with the literature.  
 
(E)-3,4-diphenylbut-2-enoic acid 
 
A solution of ester 603 (2.35 g, 8.84 mmol) in 0.5 M KOH (26.8 mL, 13.3 mmol) was 
heated at reflux for 16 h. Once cooled to rt the reaction mixture was extracted with Et2O 
(x 3). The reaction mixture was treated with 1M H2SO4 until acidic and extracted with 
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Et2O (x 3). The combined organic extracts were dried (MgSO4), filtered and 
concentrated in vacuo. Chromatographic purification (eluent Et O:petrol 25:75) gave 
acid 421 as a white solid (210 mg, 10%); mp 122-124 °C; {lit.
210
 mp 138-139 °C}; δ
(300 MHz, CDCl ) 4.59 (2H, s, CH Ph), 6.34 (1H, s, =CH), 7.18-7.29 (5H, m, ArH), 
7.34-7.39 (3H, m, ArH), 7.46-7.49 (2H, m, ArH). Spectroscopic data are in accordance 
with the literature.  
 
3-methylbut-3-enoic acid 
 
To a solution of 3-methylbut-3-en-1-ol (2.00 mL, 19.8 mmol) in acetone (100 mL) at 0 
°C was added 2.68 M Jones’ reagent (10.4 mL, 27.7 mmol) and the reaction mixture was 
stirred at 0 °C for 1 h. The reaction mixture was washed with 2M NaOH and then the 
aqueous layer acidified with conc HCl and extracted with Et2O (x 3). The combined 
organic extracts were dried (MgSO4), filtered and concentrated in vacuo. The residual oil 
was purified by distillation to give acid 422 as a colourless oil (1.50 g, 76%); bp 88-90 
°C (20 mmHg); {lit.
211
 bp 90-95 °C (53 mmHg)}; δ (500 MHz, CDCl ) 1.87 (3H, s, 
CH ), 3.11 (2H, s, CH ), 4.92 (1H, s, =CHH), 4.99 (1H, s, =CHH). Spectroscopic data 
are in accordance with the literature.  
 
(E)-3-phenylbut-2-enoyl chloride 
 
A solution of acid 420 (5.00 g, 30.9 mmol) in toluene (40 mL) at 0 °C was added oxalyl 
chloride (8.87 mL, 101 mmol) and DMF (1 drop) and the reaction mixture was stirred at 
rt for 5 h before being concentrated in vacuo. The residual oil was purified by distillation 
to give acid chloride 403 as a colourless oil (4.91 g, 88%); bp 140-142 °C (22 mmHg); 
{lit.
212
 bp 78-80 °C (0.08 mmHg)}; δ (500 MHz, CDCl ) 2.59 (3H, s, CH ), 6.50 (1H, s, 
=CH), 7.44-7.48 (3H, m, ArH), 7.54-7.56 (2H, m, ArH). Spectroscopic data are in 
accordance with the literature.  
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(E)-1-(3-phenylbut-2-enoyl)-3,4-dihydro-2H-benzo[4,5]thiazolo[3,2-a]pyrimidin-1-
ium chloride 
 
To a solution of acid chloride 403 (250 mg, 1.39 mmol) in DCM (10 mL) was added 
DHPB 108 (263 mg, 1.39 mmol) and the reaction mixture was stirred at rt for 5 minutes 
before being filtered to give salt 427 as a white solid (270 mg, 73%); mp 164-166 °C 
(dec); max (ATR)/cm
-1
 3443, 3381, 3036 (C-H), 1666 (C=O), 1606, 1533; δ (300 MHz, 
DMSO) 2.46-2.50 (2H, m, CH2CH2CH2), 2.56 (3H, d, J 1.0, CH3), 4.44 (2H, t, J 5.6, 
CH2), 4.53 (2H, t, J 5.7, CH2), 6.93 (1H, q, J 1.2, =CH), 7.50-7.52 (3H, m, ArH), 7.66-
7.83 (4H, m, ArH), 8.07 (1H, d, J 8.3, ArH), 8.32 (1H, dd, J 7.9, 0.6, ArH); δ (75 MHz, 
DMSO) 18.5 (CH2CH2CH2), 18.7 (CH ), 44.8 (CH2), 45.8 (CH ), 114.5 (=CH or ArC), 
114.6 (=CH or ArC), 123.7 (ArC), 125.7 (4ry ArC), 126.8 (ArC), 126.9 (ArC), 128.6 
(ArC), 128.7 (ArC), 130.1 (ArC), 136.7 (4ry ArC), 140.6 (4ry ArC), 158.6 (C=CH), 
160.8 (C=N), 166.8 (C=O); m/z (NSI
+
) 335 ([M-Cl]
+
, 58%); HRMS (NSI
+
) 
C20H19N2OS
+
 ([M-Cl]
+
) requires 335.1213; found 335.1219 (+1.9 ppm). 
 
(E)-5-methylhex-3-enoic acid
 
 
A solution of piperidine (39.5 L, 0.40 mmol) and acetic acid (22.9 L, 0.40 mmol) in 
DMSO (1 mL) was stirred at rt for 5 minutes after which time a solution of malonic acid 
(4.16 g, 40.0 mmol) and isovaleraldehyde (4.29 mL, 40.0 mmol) in DMSO (20 mL) was 
added. The reaction mixture was stirred at rt for 20 minutes and then at 100 °C for 16 h. 
Once cooled to rt, the reaction mixture was diluted with H2O and extracted with Et2O (x 
3). The combined organic fractions were washed with H2O, dried (MgSO4), filtered and 
concentrated in vacuo. Chromatographic purification (eluent Et O:petrol 30:70) gave 
acid 436 as a colourless oil (2.93 g, 57%); δ (400 MHz, CDCl ) 0.99 (6H, d, J 6.8, 
CH(CH ) ), 2.26-2.34 (1H, m, C(5)H), 3.07 (2H, dt, J 6.6, 0.9, C(2)H ), 5.47 (1H, dtd, J 
15.4, 6.7, 1.1, C(3)H), 5.54-5.60 (1H, m, C(4)H). Spectroscopic data are in accordance 
with the literature.
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(E)-5-phenylpent-3-enoic acid
 
 
A solution of piperidine (39.5 L, 0.40 mmol) and acetic acid (22.9 L, 0.40 mmol) in 
DMSO (1 mL) was stirred at rt for 5 minutes after which time a solution of malonic acid 
(4.16 g, 40.0 mmol) and 3-phenylpropionaldehyde (5.28 mL, 40.0 mmol) in DMSO (20 
mL) was added. The reaction mixture was stirred at rt for 20 minutes and then at 100 °C 
for 16 h. Once cooled to rt, the reaction mixture was diluted with H2O and extracted with 
Et2O (x 3). The combined organic fractions were washed with H2O, dried (MgSO4), 
filtered and concentrated in vacuo. Chromatographic purification (eluent Et O:petrol 
25:75) gave acid 437 as a colourless oil (4.15 g, 59%); δ (400 MHz, CDCl ) 3.13 (2H, 
dq, J 6.8, 1.1, C(5)H ), 3.40 (2H, d, J 6.7, C(2)H ), 5.63 (1H, dtt, J 15.3, 6.9, 1.4, C(3)H), 
5.77 (1H, dtt, J 15.3, 6.7, 1.3, C(4)H), 7.18-7.23 (3H, m, Ar(2,6)H and Ar(4)H), 7.28-
7.32 (2H, m, Ar(3,5)H). Spectroscopic data are in accordance with the literature.  
 
(Z)-pent-3-en-1-ol
 
 
Lindlar’s catalyst (5% on CaCO , Pb poisoned, 900 mg (45 mg Pd), 0.43 mmol) was 
degassed in a RB flask. Quinoline (0.72 mL, 6.04 mmol), Et O (150 mL) and pent-3-yn-
1-ol (2.74 mL, 29.7 mmol) were added and a balloon of H  gas was appended to the 
reaction flask. H  gas was bubbled through the reaction mixture at rt for 20 h. The 
reaction mixture was filtered through Celite concentrated in vacuo and the residual oil 
was purified by distillation to give alcohol 440 (94:6 (Z):(E)) as a colourless oil (1.64 g, 
64%); bp 140-141 °C (760 mmHg); {lit.
135
 bp 140 °C (760 mmHg)}; Data for (Z)-
isomer: δ (500 MHz, CDCl ) 1.65-1.68 (3H, m, CH ), 2.32-2.37 (2H, m, C(2)H ), 3.66 
(2H, q, J 6.2, C(1)H ), 5.37-5.43 (1H, m, C(4)H), 5.62-5.68 (1H, m, C(3)H); Selected 
data for (E)-isomer: δ (500 MHz, CDCl ) 1.68-1.70 (3H, m, CH ), 2.23-2.28 (2H, m, 
C(2)H ). Spectroscopic data are in accordance with the literature.  
 
(Z)-pent-3-enoic acid 
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To K Cr O  (56.1 mg, 0.19 mmol), HNO  (343 mg, 3.81 mmol) and NaIO  (8.97 g, 42.0 
mmol) in H O (25 mL) was added a solution of alcohol 440 (1.64 g, 19.1 mmol) in 
MeCN (50 mL) at 0 °C. The reaction mixture was stirred at 0 °C for 8 h followed by rt 
for 16 h. The inorganic salts were filtered and washed with Et2O. H2O was added and the 
reaction mixture was extracted with Et2O (x 3). The combined organic fractions were 
dried (MgSO4), filtered and concentrated in vacuo. The residual oil was purified by 
distillation to give acid 438 (94:6 (Z):(E)) as a colourless oil (0.69 g, 36%); bp 100-102 
°C (22 mmHg); {lit.
135
 bp 100 °C (20 mmHg)}; Data for (Z)-isomer: δ (500 MHz, 
CDCl ) 1.64 (3H, dt, J 6.8, 0.8, CH ), 3.14 (2H, dd, J 7.2, 0.4, C(2)H ), 3.66 (2H, q, J 
6.2, C(1)H ), 5.56 (1H, dtq, J 10.7, 7.1, 1.8, C(3)H), 5.66-5.73 (1H, m, C(4)H); Selected 
data for (E)-isomer: δ (500 MHz, CDCl ) 1.70 (3H, dt, J 6.3, 1.3, CH ), 3.06 (2H, dt, J 
6.7, 1.2, C(2)H ). Spectroscopic data are in accordance with the literature.
 
But-3-ynoic acid 
 
To a solution of CrO3 (1.39 g, 13.9 mmol) in water (36 mL) at 0 °C was added 18.4 M 
H2SO4 (9.6 mL, 177 mmol). A solution of but-3-yn-1-ol (0.54 mL, 7.10 mmol) in 
acetone (7 mL) was added over 1 h before the reaction mixture was allowed to stir for a 
further 3.5 h at 0 °C. The reaction mixture was extracted with Et2O (x 3) and the 
combined organic extracts were washed with water, dried (MgSO4), filtered and 
concentrated in vacuo. Recrystallisation (Et2O/petrol) gave acid 450 as an off-white 
solid (124 mg, 21%); mp 80-82 °C; {lit.
215
 mp 84 °C}; δ (400 MHz, CDCl ) 2.28 (1H, t, 
J 2.6, CH), 3.42 (2H, d, J 2.6, CH ), 8.91 (1H, s, CO H). Spectroscopic data are in 
accordance with the literature.  
General procedure M: Intermolecular formal [2+2] and [4+2] cycloadditions. 
To a solution of acid (1-2 eq) in CH2Cl2 (~1 mL per 0.2 mmol of acid) were added i-
Pr2NEt (1.5 eq based on acid) and pivaloyl chloride (1.5 eq based on acid) at rt. The 
reaction mixture was allowed to stir at rt for 10 minutes. The requisite Lewis base (0.1-
20 mol%), 2 or 4 electrophile (1 eq) and i-Pr2NEt (2.5 eq) were then added at the 
required temperature in that order. The reaction mixture was stirred at the required 
temperature until complete by TLC and was subsequently quenched by addition of HCl 
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(1 M in H2O). The reaction mixture was poured into H2O and extracted with CH2Cl2 (x 
3). The combined organics were dried (MgSO4), filtered and concentrated in vacuo to 
give the crude reaction mixture. Note: All racemic samples were obtained via this 
general procedure using HBTM-2.1 (±)-112 as catalyst. 
 
(3S,4S)-4-phenyl-3-[(E)-2-phenylethynyl]-4-(trifluoromethyl)oxetan-2-one and 
(3S,4R)-4-phenyl-3-[(E)-2-phenylethynyl]-4-(trifluoromethyl)oxetan-2-one 
 
Following general procedure M, (E)-4-phenylbut-3-enoic acid 423 (259 mg, 1.60 mmol), 
iPr2NEt (0.42 mL, 2.40 mmol) and pivaloyl chloride (296 L, 2.40 mmol) in CH Cl  (10 
mL), DHPB 108 (15.2 mg, 0.08 mmol, 10 mol%), 2,2,2-trifluoro-1-phenylethan-1-one 
404 (109 L, 0.80 mmol) and iPr2NEt (0.35 ml, 2.00 mmol) for 1.5 h at rt gave crude 
lactones 424 and 426 (60:40 dr). Chromatographic purification (eluent Et O:petrol 
2.5:97.5) gave lactone 424 (>98:2 dr) as a white solid (110 mg, 43%) and lactone 426 
(>98:2 dr) as a white solid (73.4 mg, 29%). 
Following general procedure M, (E)-4-phenylbut-3-enoic acid 423 (259 mg, 1.60 mmol), 
i-Pr2NEt (0.42 mL, 2.40 mmol) and pivaloyl chloride (296 L, 2.40 mmol) in CH Cl  
(10 mL), HBTM-2.1 (2S,3R)-112 (24.6 mg, 0.08 mmol, 10 mol%), 2,2,2-trifluoro-1-
phenylethan-1-one 404 (109 L, 0.80 mmol) and i-Pr2NEt (0.35 ml, 2.00 mmol) for 1.5 
h at 78 °C gave crude lactones (3S,4S)-424 and (3S,4R)-426 (65:35 dr). 
Chromatographic purification (eluent Et O:petrol 2.5:97.5) gave lactone (3S,4S)-424 
(>98:2 dr) as a white solid (98.3 mg, 39%) and lactone (3S,4R)-426 (>98:2 dr) as a white 
solid (52.6 mg, 21 %):  
Data for lactone (3S,4S)-424: mp 66 °C; 

 
D
20
-14.8 (c 0.5, CH2Cl2); Chiral HPLC 
Chiralcel OD-H (0.5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(3R,4R): 9.6 
min, tR(3S,4S): 12.6 min, 79% ee; max (ATR)/cm
-1
 3080, 3030 (C-H), 1847 (C=O), 
1698; δ (400 MHz, CDCl ) 4.95-4.98 (1H, m, C(3)H), 5.64 (1H, dd, J 15.7, 9.4, 
PhCH=CH), 6.71 (1H, d, J 15.7, PhCH=CH), 7.20-7.23 (2H, m, ArH), 7.27-7.31 (3H, m, 
ArH), 7.46-7.49 (5H, m, ArH); δ (100 MHz, CDCl ) 60.9 (C(3)), 79.5 (q, J 32.8, C(4)), 
116.1 (PhCH=CH), 123.6 (q, J 280, CF ), 126.9 (ArC), 127.3 (ArC), 128.8 (ArC), 128.8 
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(ArC), 128.9 (4ry ArC), 129.0 (ArC), 130.1 (ArC), 135.3 (C(4)ArC(1), 138.4 
(PhCH=CH), 165.9 (C(2)=O); F (376 MHz, CDCl3) -78.7 (CF ); m/z (APCI
+
) 319 
([M+H]
+
, 100%); HRMS (APCI
+
) C18H14F3O2
+
 ([M+H]
+
) requires 319.0940; found 
319.0940 (-0.1 ppm). 
Data for lactone (3S,4R)-426: mp 110-112 °C; 

 
D
20
-93.0 (c 0.5, CH2Cl2); Chiral HPLC 
Chiralcel OD-H (2% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(3S,4S): 13.1 
min, tR(3R,4R): 14.9 min, 77% ee; max (ATR)/cm
-1
 3080, 2944 (C-H), 1834 (C=O), 
1692; δ (400 MHz, CDCl ) 4.77 (1H, d, J 8.7, C(3)H), 6.38-6.47 (1H, m, PhCH=CH), 
6.83-6.88 (1H, m, PhCH=CH), 7.34-7.50 (9H, m, ArH); δ (100 MHz, CDCl ) 64.9 
(C(3)), 79.6 (q, J 30.1, C(4)), 115.1 (PhCH=CH), 123.3 (q, J 281, CF ), 126.3 (ArC), 
127.1 (ArC), 128.9 (ArC), 128.9 (ArC), 129.1 (ArC), 130.2 (ArC), 132.9 (4ry ArC), 
135.4 (C(4)ArC(1)), 139.0 (PhCH=CH), 165.9 (C(2)=O); F (376 MHz, CDCl3) -74.2 
(CF ); m/z (APCI
+
) 319 ([M+H]
+
, 100%); HRMS (APCI
+
) C18H14F3O2
+
 ([M+H]
+
) 
requires 319.0940; found 319.0941 (+0.2 ppm). 
 
(3S,4R)-4-phenyl-3-((E)-prop-1-en-1-yl)-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-
2-one 
 
Following general procedure M, (E)-pent-3-enoic acid (40.6 L, 0.40 mmol), i-Pr2NEt 
(104 L, 0.60 mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH Cl  (2 mL), 
HBTM-2.1 (2S,3R)-112 (6.16 mg, 0.02 mmol, 5 mol%), enone 220 (80.0 mg, 0.40 
mmol) and i-Pr2NEt (174 L, 1.0 mmol) for 5 minutes at rt gave crude lactone (3S,4R)-
431 (88:12 dr). Chromatographic purification (eluent Et O:petrol 4:96) gave lactone 
(3S,4R)-431 (88:12 dr) as a colourless oil (89.8 mg, 80%); 

 
D
20
-212.4 (c 0.5, CH2Cl2); 
Chiral HPLC Chiralcel OD-H (1% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) 
major diastereoisomer: tR(3S,4R): 9.7 min, tR(3R,4S): 13.2 min, 96% ee; minor 
diastereoisomer tR: 10.7 min, tR: 14.8 min, 15% ee; max (ATR)/cm
-1
 3060, 3027 (C-H), 
1784 (C=O), 1699; Data for major diastereoisomer: δ (500 MHz, CDCl ) 1.68 (3H, t, J, 
5.9, CH ), 3.43 (1H, t, J 6.9, C(3)H), 3.70-3.75 (1H, m, C(4)H), 5.44-5.56 (2H, m, 
C(3)CH=CHCH  and C(3)CH=CHCH ), 6.09 (1H, d, J 4.5, C(5)H), 7.11 (2H, d, J 7.8, 
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C(4)Ar(2,6)H), 7.31-7.40 (3H, m, C(4)Ar(3,5)H and C(4)Ar(4)H); δ (75 MHz, CDCl ) 
18.0 (CH ), 43.2 (C(4)), 49.8 (C(3)), 109.7 (q, J 3.5, C(5)), 118.5 (q, J 270, CF ), 123.8 
(C(3)CH=CHCH ), 127.4 (ArC), 128.1 (ArC), 129.2 (ArC), 132.1 (C(3)CH=CHCH ), 
138.7 (C(4)ArC(1)), 140.8 (q, J 37.9, C(6)), 166.0 (C(2)); m/z (NSI
+
) 300 ([M+NH4]
+
, 
100%); HRMS (NSI
+
) C15H17F3NO2
+
 ([M+NH4]
+
) requires 300.1206; found 300.1206 
(+0.0 ppm). Selected data for minor diastereoisomer: δ (500 MHz, CDCl ) 3.63 (1H, t, J 
7.8, C(3)H), 3.86-3.88 (1H, m, C(4)H), 5.13 (1H, dd, J 15.4, 8.6, C(3)CH=CHCH ), 5.69 
(1H, dq, J 14.7, 7.1, C(3)CH=CHCH ), 6.23 (1H, d, J 5.7, C(5)H), 7.11 (2H, d, J 7.7, 
Ar(2,6)H); δ (75 MHz, CDCl ) 18.0 (CH ), 43.0 (C(4)), 47.7 (C(3)), 110.8 (q, J 3.5, 
C(5)), 122.6 (C(3)CH=CHCH ), 128.2 (ArC), 128.3 (ArC), 129.1 (ArC), 132.2 
(C(3)CH=CHCH ), 166.6 (C(2)).  
 
(3S,4R)-3-((E)-but-1-en-1-yl)-4-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-
one 
 
Following general procedure M, (E)-hex-3-enoic acid (47.4 L, 0.40 mmol), i-Pr2NEt 
(104 L, 0.60 mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH Cl  (2 mL), 
HBTM-2.1 (2S,3R)-112 (6.16 mg, 0.02 mmol, 5 mol%), enone 220 (80.0 mg, 0.40 
mmol) and i-Pr2NEt (174 L, 1.0 mmol) for 5 minutes at rt gave crude lactone (3S,4R)-
432 (90:10 dr). Chromatographic purification (eluent Et O:petrol 3:97) gave lactone 
(3S,4R)-432 (93:7 dr) as a colourless oil (98.7 mg, 83%); 

 
D
20
-191.0 (c 0.5, CH2Cl2); 
Chiral HPLC Chiralcel OD-H (1% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) 
major diastereoisomer: tR(3S,4R): 8.9 min, tR(3R,4S): 12.4 min, 96% ee; minor 
diastereoisomer tR: 9.9 min, tR: 14.4 min, 12% ee; max (ATR)/cm
-1
 3065, 2968 (C-H), 
1786 (C=O), 1699; Data for major diastereoisomer: δ (500 MHz, CDCl ) 0.92 (3H, t, J 
7.5, CH ), 2.00-2.06 (2H, m, CH CH ), 3.42 (1H, t, J 7.1, C(3)H), 3.71-3.74 (1H, m, 
C(4)H), 5.41-5.45 (1H, m, C(3)CH=CHCH CH  or C(3)CH=CHCH CH ), 5.49-5.54 
(1H, m, C(3)CH=CHCH CH  or C(3)CH=CHCH CH ), 6.10 (1H, d, J 4.6, C(5)H), 7.14-
7.16 (2H, m, C(4)Ar(2,6)H), 7.31-7.40 (3H, m, C(4)Ar(3,5)H and C(4)Ar(4)H); δ (125 
MHz, CDCl ) 13.1 (CH ), 25.5 (CH CH ), 43.2 (C(4)), 49.8 (C(3)), 109.7 (q, J 3.5, C(5)), 
118.5 (q, J 270, CF ), 121.6 (C(3)CH=CHCH CH ), 127.5 (ArC), 128.1 (ArC), 129.2 
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(ArC), 138.7 (C(4)ArC(1)), 138.8 (C(3)CH=CHCH CH ), 140.8 (q, J 37.9, C(6)), 166.1 
(C(2)); m/z (NSI
+
) 297 ([M+H]
+
, 20%); HRMS (NSI
+
) C16H16F3O2
+
 ([M+H]
+
) requires 
297.1097; found 297.1101 (+1.4 ppm). Selected data for minor diastereoisomer: δ (500 
MHz, CDCl ) 3.63 (1H, t, J 7.7, C(3)H), 3.87-3.90 (1H, m, C(4)H), 5.10 (1H, ddt, J 
15.5, 8.5, 1.6, C(3)CH=CHCH CH ), 5.70 (1H, dt, J 15.4, 6.4, C(3)CH=CHCH CH ), 
6.23 (1H, d, J 5.7, C(5)H), 7.11 (2H, d, J 8.0, Ar(2,6)H); δ (125 MHz, CDCl ) 43.0 
(C(4)), 47.6 (C(3)), 110.7 (q, J 3.5, C(5)), 120.5 (C(3)CH=CHCH CH ), 128.2 (ArC), 
128.2 (ArC), 129.0 (ArC), 138.9 (C(3)CH=CHCH CH ), 166.6 (C(2)). 
 
(3S,4R)-4-phenyl-3-((E)-styryl)-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-one 
 
Following general procedure M, (E)-4-phenylbut-3-enoic acid (64.9 mg, 0.40 mmol), i-
Pr2NEt (104 L, 0.60 mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH Cl  (2 
mL), HBTM-2.1 (2S,3R)-112 (6.16 mg, 0.02 mmol, 5 mol%), enone 220 (80.0 mg, 0.40 
mmol) and i-Pr2NEt (174 L, 1.0 mmol) for 5 minutes at 78 °C gave crude lactone 
(3S,4R)-433 (95:5 dr). Chromatographic purification (eluent Et O:petrol 7.5:92.5) gave 
lactone (3S,4R)-433 (95:5 dr) as a colourless oil (113 mg, 82%); 

 
D
20
-159.6 (c 0.5, 
CH2Cl2); Chiral HPLC Chiralpak IB (5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 
°C) major diastereoisomer: tR(3R,4S): 12.3 min, tR(3S,4R): 13.9 min, 60% ee; minor 
diastereoisomer tR: 8.00 min, tR: 10.6 min, 52% ee; max (ATR)/cm
-1
 3063, 3030 (C-H), 
1782 (C=O), 1699, 1601; Data for major diastereoisomer: δ (500 MHz, CDCl ) 3.65 
(1H, t, J 7.6, C(3)H), 3.85-3.90 (1H, m, C(4)H), 6.15-6.20 (2H, m, C(5)H and 
C(3)CH=CHPh), 6.36 (1H, d, J 15.9, C(3)CH=CHPh), 7.21 (2H, d, J 7.5, ArH), 7.28-
7.42 (8H, m, ArH); δ (125 MHz, CDCl ) 43.3 (C(4)), 50.0 (C(3)), 109.9 (q, J 3.3, C(5)), 
118.5 (q, J 270, CF ), 122.0 (C(3)CH=CHPh), 126.6 (ArC), 127.5 (ArC), 128.3 (ArC), 
128.4 (ArC), 128.7 (ArC), 129.4 (ArC), 135.7 (C(3)CH=CHPh), 135.8 (4ry ArC), 138.5 
(4ry ArC), 141.0 (q, J 38.0, C(6)), 165.6 (C(2)); m/z (NSI
+
) 345 ([M+H]
+
, 15%); HRMS 
(NSI
+
) C20H16F3O2
+
 ([M+H]
+
) requires 345.1097; found 345.1098 (+0.3 ppm). Selected 
data for minor diastereoisomer: δ (500 MHz, CDCl ) 3.99 (1H, t, J 6.2, C(4)H), 5.84 
(1H, dd, J 16.0, 8.6, C(3)CH=CHPh), 6.30 (1H, d, J 5.9, C(5)H), 6.59 (1H, d, J 16.0, 
C(3)CH=CHPh), 7.16 (2H, d, J 7.6, ArH); δ (125 MHz, CDCl ) 47.9 (C(3)), 110.7 (q, J 
 Chapter 9: Experimental 
 
 323 
3.4, C(5)), 121.4 (C(3)CH=CHPh), 128.2 (ArC), 128.5 (ArC), 129.3 (ArC), 135.4 
(C(3)CH=CHPh), 166.2 (C(2)). 
 
(3S,4R)-4-(4-bromophenyl)-3-((E)-prop-1-en-1-yl)-6-(trifluoromethyl)-3,4-dihydro-
2H-pyran-2-one 
 
Following general procedure M, (E)-pent-3-enoic acid (40.6 L, 0.40 mmol), i-Pr2NEt 
(104 L, 0.60 mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH Cl  (2 mL), 
HBTM-2.1 (2S,3R)-112 (6.16 mg, 0.02 mmol, 5 mol%), enone 552 (112 mg, 0.40 mmol) 
and i-Pr2NEt (174 L, 1.0 mmol) for 5 minutes at rt gave crude lactone (3S,4R)-434 
(80:20 dr). Chromatographic purification (eluent Et O:petrol 3:97) gave lactone (3S,4R)-
434 (95:5 dr) as a colourless oil (105 mg, 73%); 

 
D
20
-201.0 (c 0.5, CH2Cl2); Chiral 
HPLC Chiralcel OD-H (1% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) major 
diastereoisomer: tR(3R,4S): 10.1 min, tR(3S,4R): 11.8 min, 92% ee; minor 
diastereoisomer tR: 9.3 min, tR: 12.8 min, 90% ee; max (ATR)/cm
-1
 2987 (C-H), 1786 
(C=O), 1753, 1660; Data for major diastereoisomer: δ (500 MHz, CDCl ) 1.69 (3H, t, J, 
6.4, CH ), 3.37 (1H, t, J 7.4, C(3)H), 3.68-3.71 (1H, m, C(4)H), 5.43 (1H, ddd, J 15.3, 
7.5, 1.3, C(3)CH=CHCH ), 5.52 (1H, dq, J 15.4, 6.3, C(3)CH=CHCH ), 6.03 (1H, d, J 
4.4, C(5)H), 7.02-7.04 (2H, m, C(4)Ar(3,5)H), 7.50-7.52 (2H, m, C(4)Ar(2,6)H); δ (125 
MHz, CDCl ) 18.0 (CH ), 42.6 (C(4)), 49.6 (C(3)), 109.1 (q, J 3.5, C(5)), 118.4 (q, J 
270, CF ), 122.1 (C(4)ArC(4)), 123.4 (C(3)CH=CHCH ), 129.1 (C(4)ArC(3,5)), 132.3 
(C(4)ArC(2,6)), 132.6 (C(3)CH=CHCH ), 137.7 (C(4)ArC(1)), 141.1 (q, J 38, C(6)), 
165.7 (C(2)); m/z (NSI
+
) 378 ([M+NH4]
+
, 56%); HRMS (NSI
+
) C15H16
78
BrF3NO2
+
 ([M+ 
NH4]
+
) requires 378.0311; found 378.0311 (+0.0 ppm). Selected data for minor 
diastereoisomer: δ (500 MHz, CDCl ) 3.62 (1H, t, J 7.8, C(3)H), 3.82-3.85 (1H, m, 
C(4)H), 5.09-5.14 (1H, m, C(3)CH=CHCH ), 5.65-5.72 (1H, m, C(3)CH=CHCH ), 6.18 
(1H, d, J 5.7, C(5)H); δ (75 MHz, CDCl ) 18.0 (CH ), 44.4 (C(4)), 47.4 (C(3)). 
 
(3S,4R)-3-((E)-prop-1-en-1-yl)-4-(thiophen-2-yl)-6-(trifluoromethyl)-3,4-dihydro-2H-
pyran-2-one 
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Following general procedure M, (E)-pent-3-enoic acid (40.6 L, 0.40 mmol), i-Pr2NEt 
(104 L, 0.60 mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH Cl  (2 mL), 
HBTM-2.1 (2S,3R)-112 (6.16 mg, 0.02 mmol, 5 mol%), enone 561 (82.4 mg, 0.40 
mmol) and i-Pr2NEt (174 L, 1.0 mmol) for 5 minutes at rt gave crude lactone (3S,4R)-
435 (84:16 dr). Chromatographic purification (eluent Et O:petrol 4:96) gave lactone 
(3S,4R)-435 (84:16 dr) as a colourless oil (95.8 mg, 83%); 

 
D
20
-187.0 (c 0.5, CH2Cl2); 
Chiral HPLC Chiralpak AS-H (0.5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) 
major diastereoisomer: tR(3S,4R): 14.1 min, tR(3R,4S): 16.1 min, 93% ee; max 
(ATR)/cm
-1
 2998 (C-H), 1784 (C=O), 1699, 1674; Data for major diastereoisomer: δ
(300 MHz, CDCl ) 1.72-1.74 (3H, m, CH ), 3.55 (1H, td, J 6.7, 0.7, C(3)H), 4.00-4.04 
(1H, m, C(4)H), 5.47 (1H, ddq, J 15.4, 8.4, 1.7, C(3)CH=CHCH ), 5.63-5.75 (1H, m, 
C(3)CH=CHCH ), 6.16 (1H, d, J 5.0, C(5)H), 6.89-6.90 (1H, m, ArH), 6.98-7.03 (1H, 
m, ArH), 7.27-7.30 (1H, m, ArH); δ (125 MHz, CDCl ) 18.0 (CH ), 38.1 (C(4)), 50.5 
(C(3)), 109.1 (q, J 3.5, C(5)), 118.4 (q, J 270, CF ), 123.2 (C(3)CH=CHCH ), 125.4 
(ArC), 125.4 (ArC), 127.4 (ArC), 132.4 (C(3)CH=CHCH ), 140.7 (q, J 37.9, C(6)), 
141.2 (C(4)ArC(1)), 165.4 (C(2)); m/z (APCI
+
) 289 ([M+H]
+
, 100%); HRMS (APCI
+
) 
C13H12F3O2S
+
 ([M+H]
+
) requires 289.0505; found 289.0507 (+0.8 ppm). Selected data 
for minor diastereoisomer: δ (500 MHz, CDCl ) 3.64 (1H, t, J 7.5, C(3)H), 4.13-4.18 
(1H, m, C(4)H), 5.35 (1H, ddq, J 15.4, 8.4, 1.7, C(3)CH=CHCH ), 6.28 (1H, d, J 5.8, 
C(5)H); δ (75 MHz, CDCl ) 18.1 (CH ), 38.0 (C(4)), 48.0 (C(3)), 110.7 (q, J 3.5, C(5)), 
122.5 (C(3)CH=CHCH ), 125.7 (ArC), 126.3 (ArC), 127.4 (ArC), 132.7 
(C(3)CH=CHCH ), 166.2 (C(2)). 
 
General procedure N: One-pot intermolecular Michael addition-lactonisation ring 
opening. 
To a solution of acid (1 eq) in CH2Cl2 (~1 mL per 0.2 mmol of acid) were added i-
Pr2NEt (1.5 eq based on acid) and pivaloyl chloride (1.5 eq based on acid) at rt. The 
reaction mixture was allowed to stir at rt for 10 minutes. The requisite Lewis base (0.1-
20 mol%), Michael acceptor (1 eq) and i-Pr2NEt (2.5 eq) were then added at the required 
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temperature in that order. The reaction mixture was stirred at the required temperature 
until complete by TLC. Methanol was added and the reaction mixture was stirred at rt 
until ring-opening was complete by TLC. The reaction mixture was subsequently 
quenched by addition of HCl (1 M in H2O). The reaction mixture was poured into H2O 
and extracted with CH2Cl2 (x 3). The combined organics were dried (MgSO4), filtered 
and concentrated in vacuo to give the crude reaction mixture. Note: All racemic samples 
were obtained via this general procedure using DHPB 108 as catalyst. 
 
(2R,E)-methyl 2-(2-benzoyl-1-phenylhydrazinyl)pent-3-enoate 
 
Following general procedure N, (E)-pent-3-enoic acid (40.6 L, 0.40 mmol), i-Pr2NEt 
(104 L, 0.60 mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 mL), 
HBTM-2.1 (2S,3R)-112 (1.23 mg, 0.004 mmol, 1 mol%), diazene 313 (84.0 mg, 0.40 
mmol) and i-Pr2NEt (174 L, 1.00 mmol) for 15 min at rt, followed by addition of 
MeOH (2 mL) and stirring for 1 h at rt gave, after chromatographic purification (eluent 
Et O:petrol 40:60) a rotameric mixture (ratio 95:5) of (2R)-441 as a white solid (105 mg, 
80%); mp 108-110 °C; 

 
D
20
-67.0 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IB (5% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(2S): 13.2 min, tR(2R): 17.3 min, 
99% ee; max (ATR)/cm
-1
 3350 (N-H), 2949 (C-H), 1721 (C=O ester), 1698 (C=O 
amide), 1597; Data for major rotamer δ (500 MHz, CDCl ) 1.72 (3H, d, J 4.7, CH CH=), 
3.78 (3H, s, OCH ), 5.25-5.26 (1H, m, C(2)H), 5.79-5.89 (2H, m, CH=CHCH  and 
CH=CHCH ), 6.94-6.97 (3H, m, NAr(2,6)H and NAr(4)H), 7.27-7.30 (2H, m, 
NAr(3,5)H), 7.50 (2H, t, J 7.6, C(O)Ar(3,5)H), 7.58 (1H, t, J 7.4, C(O)Ar(4)H), 7.86-
7.88 (2H, m, C(O)Ar(2,6)H), 8.64 (1H, s, NH); δ (125 MHz, CDCl ) 18.1 (CH CH=), 
52.3 (OCH ), 64.5 (C(2)), 114.7 (NArC(2,6)), 121.5 (NArC(4)), 123.6 (CH=CHCH ), 
127.2 (ArC), 128.8 (ArC), 129.4 (ArC), 132.0 (ArC or CH=CHCH ), 132.3 (ArC or 
CH=CHCH ), 133.0 (C(O)ArC(1)), 148.1 (NArC(1)), 167.4 (NHC=O), 173.3 
(MeOC=O); Selected data for minor rotamer δ (500 MHz, CDCl ) 1.65 (3H, d, J 5.9, 
CH CH=), 3.67 (3H, s, OCH ), 4.97 (1H, d, J 7.1, C(2)H); δ (125 MHz, CDCl ) 18.1 
(CH CH=), 52.3 (OCH ), 65.8 (C(2)), 115.0 (NArC(2,6)); m/z (NSI
+
) 325 ([M+H]
+
, 
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100%); HRMS (NSI
+
) C19H21N2O3
+
 ([M+H]
+
) requires 325.1547; found 325.1548 (+0.4 
ppm). 
 
(2R,E)-methyl 2-(2-benzoyl-1-phenylhydrazinyl)hex-3-enoate 
 
Following general procedure N, (E)-hex-3-enoic acid (47.4 L, 0.40 mmol), i-Pr2NEt 
(104 L, 0.60 mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 mL), 
HBTM-2.1 (2S,3R)-112 (1.23 mg, 0.004 mmol, 1 mol%), diazene 313 (84.0 mg, 0.40 
mmol) and i-Pr2NEt (174 L, 1.00 mmol) for 15 min at rt, followed by addition of 
MeOH (2 mL) and stirring for 1 h at rt gave, after chromatographic purification (eluent 
Et O:petrol 40:60) a rotameric mixture (ratio 95:5) of (2R)-442 as a white solid (115 mg, 
85%); mp 98-100 °C; 

 
D
20
-54.8 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IB (5% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(2S): 11.3 min, tR(2R): 15.6 min, 
99% ee; max (ATR)/cm
-1
 3352 (N-H), 2990 (C-H), 1721 (C=O ester), 1688 (C=O 
amide), 1597, 1508; Data for major rotamer δ (500 MHz, CDCl ) 0.92 (3H, t, J 7.5, 
CH CH ), 2.03-2.13 (2H, m, CH CH ) 3.68 (3H, s, OCH ), 5.29 (1H, d, J 4.5, C(2)H), 
5.77-5.90 (2H, m, CH=CHCH CH  and CH=CHCH CH ), 6.97-6.99 (3H, m, NAr(2,6)H 
and NAr(4)H), 7.27-7.32 (2H, m, NAr(3,5)H), 7.47-7.56 (2H, m, C(O)Ar(3,5)H), 7.56-
7.62 (1H, m, C(O)Ar(4)H), 7.86-7.90 (2H, m, C(O)Ar(2,6)H), 8.65 (1H, s, NH); δ (125 
MHz, CDCl ) 13.0 (CH CH ), 25.5 (CH CH ), 52.3 (OCH ), 64.5 (C(2)), 114.6 
(NArC(2,6)), 121.5 (NArC(4) or CH=CHCH CH ), 121.7 (NArC(4) or CH=CHCH CH ), 
127.2 (ArC), 128.8 (ArC), 129.4 (ArC), 129.7 (ArC), 132.1 (CH=CHCH CH ), 133.0 
(C(O)ArC(1)), 148.1 (NArC(1)), 167.4 (NHC=O), 173.4 (MeOC=O);Selected data for 
minor rotamer: δ (500 MHz, CDCl ) 3.68 (3H, s, OCH ); δ (125 MHz, CDCl ) 52.2 
(OCH ), 66.1 (C(2)), 115.0 (NArC(2,6)); m/z (NSI
+
) 325 ([M+H]
+
, 100%); HRMS 
(NSI
+
) C19H21N2O3
+
 ([M+H]
+
) requires 325.1547; found 325.1548 (+0.4 ppm). 
 
(2R,E)-methyl 2-(2-benzoyl-1-phenylhydrazinyl)-5-methylhex-3-enoate 
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Following general procedure N, acid 436 (51.2 mg, 0.40 mmol), i-Pr2NEt (104 L, 0.60 
mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 mL), HBTM-2.1 
(2S,3R)-112 (1.23 mg, 0.004 mmol, 1 mol%), diazene 313 (84.0 mg, 0.40 mmol) and i-
Pr2NEt (174 L, 1.00 mmol) for 15 min at rt, followed by addition of MeOH (2 mL) and 
stirring for 1 h at rt gave, after chromatographic purification (eluent Et O:petrol 40:60) a 
rotameric mixture (ratio 95:5) of (2R)-443 as a white solid (104 mg, 74%); mp 128-130 
°C; 

 
D
20
-66.6 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IB (5% IPA:hexane, flow rate 1 
mL min
-1
, 211 nm, 30 °C) tR(2S): 14.5 min, tR(2R): 19.0 min, 99% ee; max (ATR)/cm
-1
 
3326 (N-H), 2988 (C-H), 1719 (C=O Ester), 1678 (C=O Amide), 1597, 1506; Data for 
major rotamer: δ (500 MHz, CDCl ) 0.89 (3H, t, J 6.8, CH(CH )CH ), 0.92 (3H, t, J 6.8, 
CH(CH )CH ), 2.27-2.34 (1H, m, CH(CH )CH ), 3.78 (3H, s, OCH ), 5.27-5.28 (1H, m, 
C(2)H), 5.72-5.80 (2H, m, CH=CHCH(CH )CH  and CH=CHCH(CH )CH ), 6.93-6.97 
(3H, m, NAr(2,6)H and NAr(4)H), 7.26-7.30 (2H, m, NAr(3,5)H), 7.46-7.49 (2H, m, 
C(O)Ar(3,5)H), 7.54-7.58 (1H, m, C(O)Ar(4)H), 7.85-7.88 (2H, m, C(O)Ar(2,6)H), 8.64 
(1H, s, NH); δ (100 MHz, CDCl ) 21.8 (CH(CH )CH ), 22.0 (CH(CH )CH ), 31.1 
(CH(CH )CH ), 52.3 (OCH ), 64.4 (C(2)), 114.8 (NArC(2,6)), 120.0 
(CH=CHCH(CH )CH ), 121.5 (NArC(4)), 127.3 (C(O)ArC(2,6)), 128.8 (C(O)ArC(3,5)), 
129.4 (NArC(3,5)), 132.1 (C(O)ArC(4)), 133.0 (C(O)ArC(1)), 143.9 
(CH=CHCH(CH )CH ), 148.2 (NArC(1)), 167.3 (NHC=O), 173.4 (MeOC=O); Selected 
data for minor rotamer: δ (500 MHz, CDCl ) 3.66 (3H, s, OCH ), 5.01 (1H, d, J 7.0, 
C(2)H); δ (100 MHz, CDCl )  21.4 (CH(CH )CH ), 21.5 (CH(CH )CH ), 31.1 
(CH(CH )CH ), 52.2 (OCH ), 66.3 (C(2)), 115.2 (NArC(2,6)), 146.1 (CH=CHCH CH ), 
148.8 (NArC(1)), 172.0 (MeOC=O); m/z (NSI
+
) 353 ([M+H]
+
, 100%); HRMS (NSI
+
) 
C21H25N2O3
+
 ([M+H]
+
) requires 353.1860; found 353.1862 (+0.7 ppm). 
 
(2R,E)-methyl 2-(2-benzoyl-1-phenylhydrazinyl)-5-phenylpent-3-enoate 
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Following general procedure N, acid 437 (70.4 mg, 0.40 mmol), i-Pr2NEt (104 L, 0.60 
mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 mL), HBTM-2.1 
(2S,3R)-112 (1.23 mg, 0.004 mmol, 1 mol%), diazene 313 (84.0 mg, 0.40 mmol) and i-
Pr2NEt (174 L, 1.00 mmol) for 15 min at rt, followed by addition of MeOH (2 mL) and 
stirring for 1 h at rt gave, after chromatographic purification (eluent Et O:petrol 50:50) a 
rotameric mixture (ratio 96:4) of (2R)-444 as a white solid (123 mg, 77%); mp 136-138 
°C; 

 
D
20
-70.8 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IB (5% IPA:hexane, flow rate 1 
mL min
-1
, 220 nm, 30 °C) tR(2S): 28.5 min, tR(2R): 41.2 min, 99% ee; max (ATR)/cm
-1
 
3323 (N-H), 2890 (C-H), 1730 (C=O Ester), 1686 (C=O Amide), 1599, 1514; Data for 
major rotamer: δ (500 MHz, CDCl ) 3.41 (2H, d, J 6.1, CHHPh and CHHPh), 3.78 (3H, 
s, OCH ), 5.34-5.35 (1H, m, C(2)H), 5.89-6.00 (2H, m, CH=CHBn and CH=CHBn), 
6.96-6.99 (3H, m, NAr(2,6)H and NAr(4)H), 7.05-7.03 (CH Ar(2,6)H), 7.12-7.15 
(CH Ar(3,5)H and CH Ar(4)H), 7.28-7.32 (2H, m, NAr(3,5)H), 7.48-7.51 (2H, m, 
C(O)Ar(3,5)H), 7.58-7.62 (1H, m, C(O)Ar(4)H), 7.85-7.86 (2H, m, C(O)Ar(2,6)H), 8.68 
(1H, s, NH); δ (100 MHz, CDCl ) 38.9 (CH Ph), 52.4 (OCH ), 64.5 (C(2)), 114.7 
(NArC(2,6)), 121.6 (NArC(4)), 124.1 (CH=CHBn), 126.2 (CH ArC(4)), 127.3 
(C(O)ArC(2,6)), 128.4 (ArC), 128.6 (ArC), 128.8 (C(O)ArC(3,5)), 129.4 (NArC(3,5)), 
132.1 (C(O)ArC(4)), 132.8 (C(O)ArC(1)), 135.7 (CH=CHBn), 138.9 (CH ArC(1)), 
148.1 (NArC(1)), 167.1 (NHC=O), 173.1 (MeOC=O); Selected data for minor rotamer δ
(500 MHz, CDCl ) 3.67 (3H, s, OCH ), 5.06-5.08 (1H, m, C(2)H); δ (100 MHz, CDCl )  
38.8 (CH Ph), 52.3 (OCH ), 66.2 (C(2)), 115.2 (NArC(2,6)), 148.7 (NArC(1)); m/z 
(NSI
+
) 401 ([M+H]
+
, 100%); HRMS (NSI
+
) C25H25N2O3
+
 ([M+H]
+
) requires 401.1860; 
found 401.1859 (-0.2 ppm). 
 
(2R,E)-methyl 2-(2-benzoyl-1-phenylhydrazinyl)-4-phenylbut-3-enoate 
 
Following general procedure N, (E)-4-phenylbut-3-enoic acid (64.9 mg, 0.40 mmol), i-
Pr2NEt (104 L, 0.60 mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 
mL), HBTM-2.1 (2S,3R)-112 (1.23 mg, 0.004 mmol, 1 mol%), diazene 313 (84.0 mg, 
0.40 mmol) and i-Pr2NEt (174 L, 1.00 mmol) for 15 min at rt, followed by addition of 
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MeOH (2 mL) and stirring for 1 h at rt gave, after chromatographic purification (eluent 
Et O:petrol 40:60) a rotameric mixture (ratio 95:5) of (2R)-445 as an off-white solid 
(109 mg, 71%); mp 116-118 °C; 

 
D
20
-19.6 (c 0.25, CH2Cl2); Chiral HPLC Chiralpak IB 
(5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(2S): 22.0 min, tR(2R): 27.9 
min, 91% ee; max (ATR)/cm
-1
 3325 (N-H), 3057, 2959 (C-H), 1728 (C=O ester), 1693 
(C=O amide), 1599; Data for major rotamer δ (500 MHz, CDCl ) 3.84 (3H, s, CH ), 5.50 
(1H, d, J 5.1, C(2)H), 6.54 (1H, dd, J 16.3, 5.7, CH=CHPh), 6.76 (1H, d, J 16.3, 
CH=CHPh), 6.99-7.04 (3H, m, ArH), 7.24-7.41 (7H, m, ArH), 7.44 (2H, t, J 8.7, 
C(O)Ar(3,5)H), 7.54 (1H, t, J 7.4, C(O)Ar(4)H), 7.83 (2H, d, J 7.4, C(O)Ar(2,6)H), 8.72 
(1H, s, NH); δ (125 MHz, CDCl ) 52.6 (CH ), 64.9 (C(2)), 114.8 (NArC(2,6)), 121.7 
(NArC(4) or CH=CHPh), 122.1 (NArC(4) or CH=CHPh), 126.8 (ArC), 127.2 (ArC), 
128.3 (ArC), 128.7 (ArC), 128.8 (ArC), 129.5 (ArC), 132.1 (ArC), 133.0 (4ry ArC), 
135.0 (CH=CHPh), 135.9 (4ry ArC), 148.0 (NArC(1)), 167.6 (NHC=O), 172.8 
(MeOC=O); Selected data for minor rotamer: δ (500 MHz, CDCl ) 3.73 (3H, s, CH ), 
5.21 (1H, d, J 7.2, C(2)H), 6.02 (1H, dd, J 16.1, 7.2, CH=CHPh), 7.98 (1H, s, NH); δ
(125 MHz, CDCl ) 52.5 (CH ), 66.1 (C(2)), 115.1 (NArC(2,6)), 137.5 (CH=CHPh); m/z 
(NSI
+
) 387 ([M+H]
+
, 100%); HRMS (NSI
+
) C24H23N2O3
+
 ([M+H]
+
) requires 387.1703; 
found 387.1704 (-0.2 ppm). 
 
(2R,Z)-methyl 2-(2-benzoyl-1-phenylhydrazinyl)pent-3-enoate 
 
Following general procedure A, acid 438 (40.0 mg, 0.40 mmol), i-Pr2NEt (104 L, 0.60 
mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 mL), HBTM-2.1 
(2S,3R)-112 (1.23 mg, 0.004 mmol, 1 mol%), diazene 313 (84.0 mg, 0.40 mmol) and i-
Pr2NEt (174 L, 1.00 mmol) for 15 min at rt, followed by addition of MeOH (2 mL) and 
stirring for 1 h at rt gave, after chromatographic purification (eluent Et O:petrol 50:50) a 
rotameric mixture (ratio 95:5) of (2R)-446 (94:6 (Z):(E)) as a colourless oil (93.7 mg, 
72%); 

 
D
20
-76.8 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak AD-H (20% IPA:hexane, 
flow rate 1 mL min
-1
, 220 nm, 30 °C) tR(2S): 19.1 min, tR(2R): 23.6 min, 99% ee; max 
(ATR)/cm
-1
 3291 (N-H), 2953 (C-H), 1732 (C=O Ester), 1674 (C=O Amide), 1599; 
Data for major isomer (Z) and major rotamer: δ (400 MHz, CDCl ) 1.88 (3H, dd, J 7.0, 
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1.8, CH CH=), 3.75 (3H, s, OCH ), 5.48 (1H, d, J 8.2, C(2)H), 5.61-5.67 (1H, m, 
CH=CHCH ), 5.91 (1H, dqd, J 10.7, 7.0, 1.0, CH=CHCH ), 6.93-6.99 (3H, m, 
NAr(2,6)H and NAr(4)H), 7.26-7.30 (2H, m, NAr(3,5)H), 7.46-7.51 (2H, m, 
C(O)Ar(3,5)H), 7.54-7.59 (1H, m, C(O)Ar(4)H), 7.88-7.91 (2H, m, C(O)Ar(2,6)H), 8.67 
(1H, s, NH); δ (100 MHz, CDCl ) 14.1 (CH CH=), 52.6 (OCH ), 59.8 (C(2)), 114.7 
(NArC(2,6)), 121.6 (NArC(4)), 121.7 (CH=CHCH ), 127.4 (C(O)ArC(2,6)), 128.9 
(C(O)ArC(3,5)), 129.5 (NArC(3,5)), 132.2 (C(O)ArC(4), 132.7 (CH=CHCH ), 132.8 
(C(O)ArC(1)), 148.3 (NArC(1)), 167.0 (NHC=O), 173.6 (MeOC=O); m/z (NSI
+
) 325 
([M+H]
+
, 100%); HRMS (NSI
+
) C19H21N2O3
+
 ([M+H]
+
) requires 325.1547; found 
325.1548 (+0.4 ppm). 
 
(2R,E)-methyl 2-(2-(4-fluorobenzoyl)-1-phenylhydrazinyl)pent-3-enoate 
 
Following general procedure N, (E)-pent-3-enoic acid (40.6 L, 0.40 mmol), i-Pr2NEt 
(104 L, 0.60 mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 mL), 
HBTM-2.1 (2S,3R)-112 (1.23 mg, 0.004 mmol, 1 mol%), diazene 580 (91.2 mg, 0.40 
mmol) and i-Pr2NEt (174 L, 1.00 mmol) for 15 min at rt, followed by addition of 
MeOH (2 mL) and stirring for 1 h at rt gave, after chromatographic purification (eluent 
Et O:petrol 40:60) a rotameric mixture (ratio 92:8) of (2R)-447 as a white solid (109 mg, 
79%); mp 102-104 °C; 

 
D
20
-57.8 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IB (5% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(2S): 13.2 min, tR(2R): 17.1 min, 
99% ee; max (ATR)/cm
-1
 3522 (N-H), 2951 (C-H), 1751 (C=O ester), 1661 (C=O 
amide), 1599; Data for major rotamer δ (500 MHz, CDCl ) 1.71 (3H, d, J 5.1, CH CH=), 
3.78 (3H, s, OCH ), 5.24 (1H, d, J 4.2, C(2)H), 5.77-5.87 (2H, m, CH=CHCH  and 
CH=CHCH ), 6.94-6.97 (3H, m, NAr(2,6)H and NAr(4)H), 7.17 (2H, t, J 8.4, 
NAr(3,5)H), 7.28 (2H, t, J 7.8, C(O)Ar(3,5)H), 7.87-7.90 (2H, m, C(O)Ar(2,6)H), 8.63 
(1H, s, NH); δ (125 MHz, CDCl ) 18.0 (CH CH=), 52.3 (OCH ), 64.6 (C(2)), 114.7 
(NArC(2,6)), 115.9 (d, J 21.8, C(O)ArC(3,5)), 121.6 (NArC(4)), 123.6 (CH=CHCH ), 
129.1 (d, J 3.0, C(O)ArC(1)), 129.4 (NArC(3,5)), 129.6 (d, J 8.9, C(O)ArC(2,6)), 132.2 
(CH=CHCH ), 148.1 (NArC(1)), 165.1 (d, J 251, C(O)ArC(4)), 166.3 (NHC=O), 173.3 
(MeOC=O); Selected data for minor rotamer δ (500 MHz, CDCl ) 1.64 (3H, d, J 6.1, 
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CH CH=), 3.67 (3H, s, OCH ), 4.98 (1H, d, J 7.0, C(2)H); δ (125 MHz, CDCl ) 18.0 
(CH CH=), 52.2 (OCH ), 65.9 (C(2)), 115.0 (NArC(2,6)); m/z (NSI
+
) 343 ([M+H]
+
, 
100%); HRMS (NSI
+
) C19H20FN2O3
+
 ([M+H]
+
) requires 343.1452; found 343.1458 
(+1.6 ppm). 
 
(2R,E)-methyl 2-(2-(furan-2-carbonyl)-1-phenylhydrazinyl)pent-3-enoate 
 
Following general procedure N, (E)-pent-3-enoic acid (40.6 L, 0.40 mmol), i-Pr2NEt 
(104 L, 0.60 mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 mL), 
HBTM-2.1 (2S,3R)-112 (1.23 mg, 0.004 mmol, 1 mol%), diazene 588 (80.0 mg, 0.40 
mmol) and i-Pr2NEt (174 L, 1.00 mmol) for 15 min at rt, followed by addition of 
MeOH (2 mL) and stirring for 1 h at rt gave, after chromatographic purification (eluent 
Et O:petrol 50:50) a rotameric mixture (ratio 94:6) of (2R)-448 as a colourless oil (109 
mg, 87%); 

 
D
20
-82.4 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IB (5% IPA:hexane, flow 
rate 1 mL min
-1
, 211 nm, 30 °C) tR(2S): 16.0 min, tR(2R): 22.2 min, 99% ee; max 
(ATR)/cm
-1
 3335 (N-H), 2953 (C-H), 1730 (C=O ester), 1688 (C=O amide), 1589; Data 
for major rotamer δ (500 MHz, CDCl ) 1.70 (3H, d, J 6.1, CH CH=), 3.70 (3H, s, 
OCH ), 5.21 (1H, d, J 5.5, C(2)H), 5.75 (1H, dd, J 15.7, 5.6, CH=CHCH ), 5.85 (1H, dt, 
J 14.5, 7.0, CH=CHCH ), 6.56 (1H, s, C(O)Ar(4)H), 6.93-6.94 (3H, m, NAr(2,6)H and 
NAr(4)H), 7.25-7.28 (3H, m, NAr(3,5)H and C(O)Ar(3)H), 7.52 (1H, s, C(O)Ar(5)H), 
8.75 (1H, s, NH); δ (125 MHz, CDCl ) 18.1 (CH CH=), 52.3 (OCH ), 64.6 (C(2)), 112.2 
(C(O)ArC(4)), 114.7 (NArC(2,6)), 115.8 (C(O)ArC(3)), 121.6 (NArC(4)), 123.3 
(CH=CHCH ), 129.3 (NArC(3,5)), 132.7 (CH=CHCH ), 144.6 (C(O)ArC(5)), 146.5 
(C(O)ArC(2)), 148.0 (NArC(1)), 158.2 (NHC=O), 173.0 (MeOC=O); Selected data for 
minor rotamer: δ (500 MHz, CDCl ) 3.69 (3H, s, OCH ), 5.10 (1H, d, J 6.9, C(2)H); δ
(125 MHz, CDCl ) 52.4 (OCH ), 65.5 (C(2)), 114.9 (NArC(2,6)), 129.7 (NArC(3,5)) m/z 
(NSI
+
) 315 ([M+H]
+
, 100%); HRMS (NSI
+
) C17H19N2O4
+
 ([M+H]
+
) requires 315.1339; 
found 315.1335 (-1.4 ppm). 
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N'-((3R,4R,5R)-4-hydroxy-5-methyl-2-oxotetrahydrofuran-3-yl)-N'-
phenylbenzohydrazide and N'-((3R,4S,5S)-4-hydroxy-5-methyl-2-
oxotetrahydrofuran-3-yl)-N'-phenylbenzohydrazide 
 
To a solution of hydrazide (2R)-441 (1.12 g, 3.44 mmol) in acetone:water (9:1, 40 mL) 
was added 2,6-lutidine (0.80 mL, 6.88 mmol), N-methylmorpholine-N-oxide (0.60 g, 
5.16 mmol) and OsO  (4% wt in H O, 0.44 mL, 0.07 mmol) and the reaction mixture 
was stirred at rt for 5 h after which time if was quenched by addition of sat. aq. Na S O . 
The reaction mixture as extracted with EtOAc (x 3) and the combined organic fractions 
were washed with HCl (2M in H O), dried (MgSO ), filtered and concentrated in vacuo 
to give a mixture of crude diols (2R,3R,4R)-604 and (2R,3S,4S)-605 which were used 
directly in the next reaction without purification. The crude reaction mixture was 
dissolved in CH Cl (50 mL) and treated with p-toluenesulfonic acid (0.65 g, 3.44 
mmol). The reaction mixture was stirred at rt for 2 h before being quenched by addition 
of H O. The reaction mixture was extracted with CH Cl (x 3) and the combined organic 
fractions were dried (MgSO ), filtered and concentrated in vacuo to give crude lactones 
(3R,4R,5R)-451 and (3R,4S,5S)-452 (70:30 dr).  
 
Major diastereoisomer: Chromatographic purification (eluent Et O:petrol 60:40 to 100% 
Et O) gave a rotameric mixture (ratio 84:16) of lactone (3R,4R,5R)-451 (>99:1 dr) as a 
white solid (0.59 g, 53%); mp 58-60 °C; 

 
D
20
+37.0 (c 0.5, CH2Cl2); Chiral HPLC 
Chiralcel OJ-H (10% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(3S,4S,5S): 
13.5 min, tR(3R,4R,5R): 19.3 min, 99% ee; max (ATR)/cm
-1
 3306 (N-H and O-H), 2980 
(C-H), 1767 (C=O lactone), 1661 (C=O amide), 1597; Data for major rotamer δ (300 
MHz, CDCl ) 1.38 (3H, d, J 6.4, CH ), 4.58-4.74 (3H, m, C(3)H C(4)H and C(5)H), 
6.83-6.86 (3H, m, NAr(2,6)H and NAr(4)H), 7.16 (2H, t, J 8.0, NAr(3,5)H), 7.38 (2H, t, 
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J 7.6, C(O)Ar(3,5)H), 7.49-7.55 (1H, m, C(O)Ar(4)H), 7.73-7.75 (2H, m, 
C(O)Ar(2,6)H), 8.47 (1H, s, NH); δ (125 MHz, CDCl ) 14.8 (CH ), 66.5 (C(3)), 69.1 
(C(4)), 77.2 (C(5)), 114.5 (NArC(2,6)), 121.6 (NArC(4)), 127.5 (ArC), 129.0 (ArC), 
129.5 (ArC), 131.3 (C=OArC(1)), 133.0 (C=OArC(4)), 147.8 (NArC(1)), 168.9 
(NHC=O), 171.9 (MeOC=O); Selected data for minor rotamer δ (300 MHz, CDCl ) 8.12 
(1H, s, NH); δ (125 MHz, CDCl ) 15.3 (CH ), 114.2 (NArC(2,6)), 121.7 (NArC(4)), 
127.2 (ArC), 128.8 (ArC), 129.2 (ArC), 132.3 (C=OArC(4)); m/z (NSI
+
) 327 ([M+H]
+
, 
86%); HRMS (NSI
+
) C18H19N2O4
+
 ([M+H]
+
) requires 327.1339; found 327.1345 (+1.7 
ppm).   
 
Minor diastereoisomer: Chromatographic purification (eluent Et O:petrol 60:40 to 100% 
Et O) gave lactone (3R,4S,5S)-452 (>99:1 dr) as a white solid (0.28 g, 25%); mp 110-
112 °C; 

 
D
20
-266.4 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IA (40% IPA:hexane, flow 
rate 1 mL min
-1
, 211 nm, 30 °C) tR(3S,4R,5R): 8.9 min, tR(3R,4S,5S): 14.8 min, 99% ee; 
max (ATR)/cm
-1
 3238 (N-H and O-H), 2938 (C-H), 1776 (C=O lactone), 1668 (C=O 
amide), 1597, 1510; δ (500 MHz, CDCl ) 1.53 (3H, d, J 6.3, CH ), 4.64-4.69 (2H, m, 
C(4)H and C(5)H), 4.79 (1H, d, J 8.1, C(3)H), 4.97 (1H, s, OH), 6.91 (2H, d, J 7.4, 
NAr(2,6)H), 6.99 (1H, t, J 7.4, NAr(4)H), 7.33 (2H, dd, J 8.7. 7.5, NAr(3,5)H), 7.52 
(2H, t, J 7.7, C(O)Ar(3,5)H), 7.63 (1H, t, J 7.5, C(O)Ar(4)H), 7.92-7.93 (2H, m, 
C(O)Ar(2,6)H), 8.93 (1H, s, NH); δ (75 MHz, CDCl ) 13.8 (CH ), 67.7 (C(3)), 70.2 
(C(4)), 79.3 (C(5)), 113.0 (NArC(2,6)), 121.4 (NArC(4)), 127.5 (ArC), 129.0 (ArC), 
129.7 (ArC), 131.3 (C=OArC(1)), 133.0 (C=OArC(4)), 147.2 (NArC(1)), 168.8 
(NHC=O), 171.9 (MeOC=O); m/z (NSI
+
) 327 ([M+H]
+
, 100%); HRMS (NSI
+
) 
C18H19N2O4
+
 ([M+H]
+
) requires 327.1339; found 327.1346 (+2.0 ppm). 
 
(3R,4R,5R)-4-hydroxy-5-methyl-2-(phenylamino)dihydrofuran-2(3H)-one 
 
To a solution of lactone (3R,4R,5R)-451 (65.2 g, 0.20 mmol) in MeOH (2 mL) at 78 °C 
was added SmI2 (0.1 M in THF, 6.00 mL, 0.60 mmol) and the reaction mixture was 
stirred at 78 °C for 10 minutes after which time if was quenched by addition of sat. aq. 
NaHCO . The reaction mixture was extracted with EtOAc (x 3) and the combined 
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organic fractions were dried (MgSO ), filtered and concentrated in vacuo. 
Chromatographic purification (eluent Et O:petrol 60:40) gave lactone (3R,4R,5R)-453 as 
a colourless oil (29.0 mg, 70%); 

 
D
20
+18.0 (c 0.1, CH2Cl2); max (ATR)/cm
-1
 3381 (N-H 
or O-H), 2986 (C-H), 1761 (C=O), 1603, 1499; δ (500 MHz, CDCl ) 1.45 (3H, d, J 6.8, 
CH ), 2.74 (1H, d, J 4.9, OH or NH), 4.13 (1H, s, OH or NH), 4.18-4.19 (1H, m, C(3)H), 
4.41 (1H, td, J 7.0, 4.8, C(4)H), 4.73 (1H, app. quintet, J 6.7, C(5)H), 6.80-6.85 (3H, m, 
NAr(2,6)H and NAr(4)H), 7.19-7.23 (2H, m, NAr(3,5)H); δ (125 MHz, CDCl ) 14.7 
(CH ), 59.6 (C(3)), 74.9 (C(4)), 77.4 (C(5)), 114.1 (NArC(2,6)), 119.6 (NArC(4)), 129.6 
(NArC(3,5)), 146.8 (NArC(1)), 174.2 (C=O);m/z (NSI+) 208 ([M+H]+, 100%); HRMS 
(NSI
+
) C11H14NO3
+
 ([M+H]
+
) requires 208.0968; found 208.0968 (-0.1 ppm).  
 
(3R,4S,5S)-4-hydroxy-5-methyl-2-(phenylamino)dihydrofuran-2(3H)-one 
 
To a solution of lactone (3R,4S,5S)-452 (65.2 g, 0.20 mmol) in MeOH (2 mL) at 78 °C 
was added SmI2 (0.1 M in THF, 6.00 mL, 0.60 mmol) and the reaction mixture was 
stirred at 78 °C for 10 minutes after which time if was quenched by addition of sat. aq. 
NaHCO . The reaction mixture was extracted with EtOAc (x 3) and the combined 
organic fractions were dried (MgSO ), filtered and concentrated in vacuo. 
Chromatographic purification (eluent Et O:petrol 60:40) gave lactone (3R,4S,5S)-454 as 
a colourless oil (31.4 mg, 76%); 

 
D
20
-98.0 (c 0.1, CH2Cl2); max (ATR)/cm
-1
 3389 (N-H 
or O-H), 2982 (C-H), 1761 (C=O), 1603, 1506; δ (400 MHz, CDCl ) 1.47 (3H, d, J 6.5, 
CH ), 2.76 (1H, br s, OH or NH), 4.08 (1H, d, J 4.4, C(3)H), 4.40 (1H, dd, J 4.4, 2.9, 
C(4)H), 4.58 (1H, qd, J 6.5, 2.9, C(5)H), 6.67-6.70 (2H, m, NAr(2,6)H), 6.84 (1H, tt, J 
7.4, 1.0, NAr(4)H), 7.16-7.21 (2H, m, NAr(3,5)H); δ (100 MHz, CDCl ) 13.8 (CH ), 
60.4 (C(3)), 69.8 (C(4)), 78.6 (C(5)), 114.2 (NArC(2,6)), 120.5 (NArC(4)), 129.6 
(NArC(3,5)), 146.0 (NArC(1)), 174.6 (C=O); m/z (NSI+) 208 ([M+H]+, 100%); HRMS 
(NSI
+
) C11H14NO3
+
 ([M+H]
+
) requires 208.0968; found 208.0968 (-0.1 ppm). 
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9.6 Experimental for Chapter 6  
9.6.1 Experimental Procedures and Characterisation Data 
General procedure O: Formation of anhydrides. 
To a solution of carboxylic acid (1 eq) in toluene was added DCC (0.50-0.55 eq) and the 
solution was allowed to stir at rt for 15 minutes. The reaction mixture was filtered and 
the filtrate was concentrated in vacuo to give the crude reaction mixture. 
  
2-phenylacetic anhydride 
 
Following general procedure O, phenylacetic acid (1.00 g, 7.34 mmol) and DCC (0.83 g, 
4.04 mmol) in toluene (20 mL) gave anhydride 462 as a white solid (1.68 g, 90%); mp 
68-70 °C; {lit.
217
 mp 72-72.5 °C}; δ (400 MHz, CDCl ) 3.76 (4H, s, 2 CH2), 7.23-7.25 
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(4H, m, ArH), 7.32-7.38 (6H, m, ArH). Spectroscopic data are in accordance with the 
literature.
217
 
 
2-(p-tolyl)acetic anhydride 
 
Following general procedure O, p-tolylacetic acid (1.00 g, 6.66 mmol) and DCC (0.70 g, 
3.40 mmol) in toluene (20 mL) gave anhydride 463 as a white solid (1.00 g, 53%); mp 
47-49 °C; {lit.
218
 mp 56-57 °C}; δ (300 MHz, CDCl ) 2.39 (6H, s, 2 CH3), 3.72 (4H, s, 2 
CH2), 7.12-7.19 (8H, m, ArH). Spectroscopic data are in accordance with the 
literature.
218
 
 
2-(4-fluorophenyl)acetic anhydride 
 
Following general procedure O, 4-fluorophenylacetic acid (1.00 g, 6.49 mmol) and DCC 
(0.74 g, 3.57 mmol) in toluene (20 mL) gave anhydride 464 as a white solid (1.48 g, 
79%); mp 36-38 °C; max (KBr)/cm
-1
 3073, 2919 (C-H), 1821, 1750 (C=O), 1612, 1511; 
δ (400 MHz, CDCl ) 3.63 (4H, s, 2 CH2), 6.91-6.96 (4H, m, 2 Ar(3,5)H), 7.08-7.11 (4H, 
m, 2 Ar(2,6)H); δ (100 MHz, CDCl ) 41.2 (2 CH ), 115.7 (d, J 21.5, 2 ArC(3,5)), 127.6 
(d, J 3.1, 2 ArC(1)), 131.0 (d, J 8.1, 2 ArC(2,6)), 162.3 (d, J 245, 2 ArC(4)), 166.7 (2 
C=O); F (376 MHz, CDCl ) -115.1 (ArF); m/z (ES
+
) 313 ([M+Na]
+
, 100%); HRMS 
(ES
+
) C16H12F2NaO3
+
 ([M+Na]
+
) requires 313.0652; found 313.0655 (+1.0 ppm). 
 
General procedure P: Intermolecular Michael addition-lactonisations. 
To a solution of anhydride (1.25 eq) in CH Cl  (~2 mL per 0.2 mmol of anhydride) was 
added HBTM-2.1 112 (5 mol%), Michael acceptor (1 eq) and i-Pr2NEt (1.25 eq) at 78 
°C in that order. The reaction mixture was stirred at 78 °C until complete by TLC and 
was subsequently quenched by addition of HCl (1 M in H2O). Once warmed to rt, the 
reaction mixture was poured into H2O and extracted with CH2Cl2 (x 3). The combined 
organics were dried (MgSO4), filtered and concentrated in vacuo to give the crude 
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reaction mixture. Note: Racemic samples for HPLC analysis were obtained via the same 
general procedure using HBTM-2.1 (±)-112 as catalyst. 
 
(3R,4R)-methyl 2-oxo-3,4-diphenyl-3,4-dihydro-2H-pyran-6-carboxylate 
 
Following general procedure P, anhydride 462 (63.5 mg, 0.25 mmol) in CH Cl  (2 mL), 
HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), keto ester 143 (38.0 mg, 0.20 
mmol) and i-Pr2NEt (43.5 L, 0.25 mmol) for 16 h at 78 °C gave crude lactone 
(3R,4R)-147 (98:2 dr). Chromatographic purification (eluent Et O:petrol 30:70) gave 
lactone (3R,4R)-147 (>99:1 dr) as a white solid (47.8 mg, 78%) with identical physical 
and spectroscopic data as previously reported; Chiral HPLC Chiralpak AD-H (40% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(3R,4R): 11.1 min, tR(3S,4S): 17.8 
min, >99% ee. 
 
(3R,4R)-methyl 3-(4-chlorophenyl)-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-
carboxylate 
 
Following general procedure P, 2-(4-chlorophenyl)acetic anhydride  (80.8 mg, 0.25 
mmol) in CH Cl  (2 mL), HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), keto 
ester 143 (38.0 mg, 0.20 mmol) and i-Pr2NEt (43.5 L, 0.25 mmol) for 16 h at 78 °C 
gave crude lactone (3R,4R)-465 (90:10 dr). Chromatographic purification (eluent 
Et O:petrol 30:70) gave lactone (3R,4R)-465 (>99:1 dr) as a white solid (53.3 mg, 79%); 
mp 138-140 °C; 

 
D
20
-193.0 (c 0.1, CH2Cl2); Chiral HPLC Chiralpak AD-H (40% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(3R,4R): 13.2 min, tR(3S,4S): 19.1 
min, >99% ee; max (ATR)/cm
-1
 3059, 3030, 2957 (C-H), 1778 (C=O lactone), 1746 
(C=O ester), 1663; δ (300 MHz, CDCl ) 3.78-3.82 (4H, m, C(3)H and CH ), 3.94 (1H, 
dd, J 10.1, 3.4, C(4)H), 6.60 (1H, d, J 3.5, C(5)H), 6.91-6.95 (4H, m, ArH), 7.15-7.21 
(5H, m, ArH); δ (75 MHz, CDCl ) 45.4 (C(4)), 52.0 (C(3)), 52.9 (CH ), 118.2 (C(5)), 
 Chapter 9: Experimental 
 
 338 
127.6 (ArC), 128.1 (ArC), 129.0 (ArC), 129.2 (ArC), 129.9 (ArC), 133.7 (4ry ArC), 
133.9 (4ry ArC), 138.8 (4ry ArC), 142.0 (C(6)), 160.6 (CO CH ), 166.6 (C(2)); m/z 
(NSI
+
) 365 ([M+Na]
+
, 70%); HRMS (NSI
+
) C19H15
35
ClO4
+
 ([M+Na]
+
) requires 
365.0551; found 365.0547 (-1.1 ppm). 
 
(3R,4R)-methyl 2-oxo-4-phenyl-3-(thiophen-3-yl)-3,4-dihydro-2H-pyran-6-
carboxylate 
 
Following general procedure P, 2-(thiophen-3-yl)acetic anhydride
219
 (66.6 mg, 0.25 
mmol) in CH Cl  (2 mL), HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), keto 
ester 143 (38.0 mg, 0.20 mmol) and i-Pr2NEt (43.5 L, 0.25 mmol) for 16 h at 78 °C 
gave crude lactone (3R,4R)-466 (93:7 dr). Chromatographic purification (eluent 
Et O:petrol 30:70) gave lactone (3R,4R)-466 (>99:1 dr) as a white solid (52.3 mg, 83%); 
mp 128-130 °C; 

 
D
20
-209.5 (c 0.2, CH Cl ); Chiral HPLC Chiralpak AD-H (40% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(3R,4R): 11.1 min, tR(3S,4S): 19.4 
min, >99% ee; max (ATR)/cm
-1
 3105, 2951, 2924 (C-H), 1767 (C=O lactone), 1736 
(C=O ester), 1661; δ (500 MHz, CDCl ) 3.81 (3H, s, CH ), 3.97 (1H, dd, J 7.1, 4.5, 
C(4)H), 4.01 (1H, d, J 7.1, C(3)H), 6.62 (1H, d, J 4.4, C(5)H), 6.90-6.91 (2H, m, ArH), 
7.01 (2H, d, J 6.8, ArH), 7.19-7.25 (4H, m, ArH); δ (75 MHz, CDCl ) 44.9 (C(4)), 48.0 
(C(3)), 52.9 (CH ), 117.2 (C(5)), 123.4 (ArC), 126.6 (ArC), 126.8 (ArC), 127.4 (ArC), 
128.1 (ArC), 129.2 (ArC), 135.1 (4ry ArC), 139.0 (4ry ArC), 142.1 (C(6)), 160.7 
(CO CH ), 166.2 (C(2)); m/z (NSI
+
) 332 ([M+NH4]
+
, 61%); HRMS (NSI
+
) C17H18NO4S
+
 
([M+NH4]
+
) requires 332.0951; found 332.0955 (+1.2 ppm). 
 
(3R,4R)-methyl 4-(4-methoxyphenyl)-2-oxo-3-phenyl-3,4-dihydro-2H-pyran-6-
carboxylate 
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Following general procedure P, anhydride 462 (63.5 mg, 0.25 mmol) in CH Cl  (2 mL), 
HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), keto ester 549 (44.0 mg, 0.20 
mmol) and i-Pr2NEt (43.5 L, 0.25 mmol) for 16 h at 78 °C gave crude lactone 
(3R,4R)-194 (93:7 dr). Chromatographic purification (eluent Et O:petrol 30:70) gave 
lactone (3R,4R)-194 (>99:1 dr) as a white solid (57.9 mg, 86%) with identical physical 
and spectroscopic data as previously reported; Chiral HPLC Chiralpak AD-H (40% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(3R,4R): 14.9 min, tR(3S,4S): 35.5 
min, >99% ee. 
 
(3R,4R)-methyl 4-(4-nitrophenyl)-2-oxo-3-phenyl-3,4-dihydro-2H-pyran-6-
carboxylate 
 
Following general procedure P, anhydride 462 (63.5 mg, 0.25 mmol) in CH Cl  (2 mL), 
HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), (E)-methyl 4-(4-nitrophenyl)-2-
oxobut-3-enoate  (49.8 mg, 0.20 mmol) and i-Pr2NEt (43.5 L, 0.25 mmol) for 16 h at 
78 °C gave crude lactone (3R,4R)-195 (91:9 dr). Chromatographic purification (eluent 
Et O:petrol 40:60) gave lactone (3R,4R)-195 (93:7 dr) as an off-white solid (60.6 mg, 
86%) with identical physical and spectroscopic data as previously reported; Chiral 
HPLC Chiralcel OD-H (50% IPA:hexane, flow rate 1 mL min
-1
, 254 nm, 30 °C) 
tR(3S,4S): 18.5 min, tR(3R,4R): 23.2 min, >99% ee. 
 
(3R,4R)-methyl 4-(furan-2-yl)-2-oxo-3-phenyl-3,4-dihydro-2H-pyran-6-carboxylate 
 
Following general procedure P, anhydride 462 (63.5 mg, 0.25 mmol) in CH Cl  (2 mL), 
HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), keto ester 174 (36.0 mg, 0.20 
mmol) and i-Pr2NEt (43.5 L, 0.25 mmol) for 16 h at 78 °C gave crude lactone 
(3R,4R)-196 (95:5 dr). Chromatographic purification (eluent Et O:petrol 30:70) gave 
lactone (3R,4R)-196 (>99:1 dr) as a white solid (47.6 mg, 80%) with identical physical 
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and spectroscopic data as previously reported; Chiral HPLC Chiralcel OJ-H (20% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(3R,4R): 25.9 min, tR(3S,4S): 29.1 
min, >99% ee. 
 
(3R,4R)-3,4-diphenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-one 
 
Following general procedure P, anhydride 462 (63.5 mg, 0.25 mmol) in CH Cl  (2 mL), 
HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 220 (40.0 mg, 0.20 
mmol) and i-Pr2NEt (43.5 L, 0.25 mmol) for 16 h at 78 °C gave crude lactone 
(3R,4R)-224 (94:6 dr). Chromatographic purification (eluent Et O:petrol 3.5:96.5) gave 
lactone (3R,4R)-224 (>99:1 dr) as a white solid (51.8 mg, 81%) with identical physical 
and spectroscopic data as previously reported; Chiral HPLC Chiralpak AD-H (5% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(3R,4R): 10.9 min, tR(3S,4S): 12.2 
min, 98% ee. 
 
(3R,4R)-4-phenyl-3-(p-tolyl)-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-one 
 
Following general procedure P, anhydride 463 (70.5 mg, 0.25 mmol) in CH Cl  (2 mL), 
HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 220 (40.0 mg, 0.20 
mmol) and i-Pr2NEt (43.5 L, 0.25 mmol) for 16 h at 78 °C gave crude lactone 
(3R,4R)-225 (95:5 dr). Chromatographic purification (eluent Et O:petrol 3:97) gave 
lactone (3R,4R)-225 (>99:1 dr) as a white solid (51.8 mg, 81%) with identical physical 
and spectroscopic data as previously reported; Chiral HPLC Chiralpak AD-H (2% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(3S,4S): 14.0 min, tR(3R,4R): 16.4 
min, 99% ee. 
 
(3R,4R)-3-(4-fluorophenyl)-4-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-
one 
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Following general procedure P, anhydride 464 (72.5 mg, 0.25 mmol) in CH Cl  (2 mL), 
HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 220 (40.0 mg, 0.20 
mmol) and i-Pr2NEt (43.5 L, 0.25 mmol) for 16 h at 78 °C gave crude lactone 
(3R,4R)-229 (87:13 dr). Chromatographic purification (eluent Et O:petrol 5:95) gave 
lactone (3R,4R)-229 (>99:1 dr) as a white solid (54.0 mg, 80%) with identical physical 
and spectroscopic data as previously reported; Chiral HPLC Chiralcel OD-H (10% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 20 °C) tR(3R,4R): 19.2 min, tR(3S,4S): 39.4 
min, >99% ee. 
 
(3R,4R)-4-(4-chlorophenyl)-3-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-
one 
 
Following general procedure P, anhydride 462 (63.5 mg, 0.25 mmol) in CH Cl  (2 mL), 
HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 555 (46.9 mg, 0.20 
mmol) and i-Pr2NEt (43.5 L, 0.25 mmol) for 16 h at 78 °C gave crude lactone 
(3R,4R)-253 (85:15 dr). Chromatographic purification (eluent Et O:petrol 5:95) gave 
lactone (3R,4R)-253 (>99:1 dr) as a white solid (59.8 mg, 85%) with identical physical 
and spectroscopic data as previously reported; Chiral HPLC Chiralpak AD-H (2% 
IPA:hexane, flow rate 2 mL min
-1
, 211 nm, 20 °C) tR(3R,4R): 10.2 min, tR(3S,4S): 30.3 
min, >99% ee. 
 
(3R,4R)-4-(naphthalen-2-yl)-3-phenyl-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-
one 
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Following general procedure P, anhydride 462 (63.5 mg, 0.25 mmol) in CH Cl  (2 mL), 
HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), enone 559 (50.0 mg, 0.20 
mmol) and i-Pr2NEt (43.5 L, 0.25 mmol) for 16 h at 78 °C gave crude lactone 
(3R,4R)-257 (89:11 dr). Chromatographic purification (eluent Et O:petrol 5:95) gave 
lactone (3R,4R)-257 (>99:1 dr) as a white solid (63.0 mg, 86%) with identical physical 
and spectroscopic data as previously reported; Chiral HPLC Chiralpak AD-H (2% 
IPA:hexane, flow rate 2 mL min
-1
, 211 nm, 20 °C) tR(3R,4R): 11.1 min, tR(3S,4S): 26.8 
min, 99% ee. 
 
(2R)-methyl 2-(2-benzoyl-1-phenylhydrazinyl)-2-phenylacetate 
 
Following general procedure P, anhydride 462 (63.5 mg, 0.25 mmol) in CH Cl  (2 mL), 
HBTM-2.1 (2S,3R)-112 (3.09 mg, 0.01 mmol, 5 mol%), diazene 313 (42.0 mg, 0.20 
mmol) and i-Pr2NEt (43.5 L, 0.25 mmol) for 30 minutes at 78 °C, followed by 
addition of MeOH (2 mL) and stirring for 1 h at rt gave, after chromatographic 
purification (eluent Et O:petrol 50:50) a rotameric mixture (ratio 90:10) of hydrazide 
(2R)-321 as a pale yellow solid (43.9 mg, 61%) with identical physical and 
spectroscopic data as previously reported; Chiral HPLC Chiralpak IB (10% IPA:hexane, 
flow rate 1 mL min
-1
, 220 nm, 30 °C) tR(2S): 10.5 min, tR(2R): 12.2 min, 98% ee. 
 
9.6.2 References and Notes 
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9.7 Experimental for Chapter 7 
9.7.1 Experimental Procedures and Characterisation Data  
(E)-4,4,4-trichloro-1-phenylbut-2-en-1-one 
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To a solution of 1,3-diphenylpropan-1,3-dione (4.49 g, 20.0 mmol) in THF (15 mL) was 
added K2CO3 (4.15 g, 30.0 mmol) and chloral (2.53 mL, 24.0 mmol) and the reaction 
mixture was stirred at rt for 48 h before being diluted with H2O and extracted with Et2O 
(x 3). The combined organic fractions were dried (MgSO4), filtered and concentrated in 
vacuo. Chromatographic purification (eluent Et O:petrol 3:97), gave enone 501 as a 
white solid (3.34 g, 67%); mp 98-100 °C; {lit.
220
 mp 98-99 °C}; δ (500 MHz, CDCl ) 
7.30 (1H, d, J 14.7, C(2)H), 7.44 (1H, d, J 14.6, C(3)H), 7.54-7.57 (2H, m, Ar(3,5)H), 
7.65-7.68 (1H, m, Ar(4)H), 8.01-8.03 (2H, m, Ar(2,6)H). Spectroscopic data are in 
accordance with the literature.
 
Dimethyl 2-(phenyl(tosylimino)methyl)fumarate 
 
To a solution of N-benzylidene-4-methylbenzenesulfonamide (1.00 g, 3.86 mmol) in 
THF (25 mL) was added dimethyl acetylenedicarboxylate (0.56 mL, 4.63 mmol) and the 
reaction mixture was stirred at rt for 5 minutes. DMAP (94.0 mg, 0.77 mmol) was added 
and the reaction mixture was stirred at 60 °C for 16 h before being concentrated in 
vacuo. Chromatographic purification (eluent Et O:petrol 40:60) gave imine 505 as a 
white solid (0.53 g, 34%); mp 124-126 °C; {lit.
222
 mp 128-130 °C}; δ (300 MHz, 
CDCl ) 2.46 (3H, s, ArCH ), 3.61 (3H, s, CO CH ), 3.87 (3H, s, CO CH ), 7.23 (1H, s, 
CH), 7.35 (2H, d, J 8.0, SO Ar(3,5)H), 7.40-7.46 (2H, m, Ph(3,5)H), 7.54-7.60 (1H, m, 
Ph(4)H), 7.85-7.91 (4H, m, Ph(2,6)H and SO Ar(2,6)H). Spectroscopic data are in 
accordance with the literature.
Methyl 2-(phenyl(tosylimino)methyl)acrylate 
 
To a solution of N-benzylidene-4-methylbenzenesulfonamide (1.00 g, 3.86 mmol) and 
PPh3 (202 mg, 0.77 mmol) in toluene (60 mL) at 80 °C was added a solution of methyl 
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propiolate (0.41 mL, 4.63 mmol) in toluene (20 mL) dropwise over 3 h. After complete 
addition the reaction mixture was cooled and concentrated in vacuo. Chromatographic 
purification (eluent Et O:petrol 25:75) gave imine 506 as a colourless oil (0.35 g, 27%); 
δ (500 MHz, CDCl ) 2.47 (3H, s, ArCH ), 3.81 (3H, s, CO CH ), 5.96 (1H, s, =CHH), 
6.86 (1H, s, =CHH), 7.37 (2H, d, J 8.1, SO Ar(3,5)H), 7.44 (2H, t, J 7.9, Ph(3,5)H), 7.59 
(1H, t, J 7.4, Ph(4)H), 7.88-7.93 (4H, m, Ph(2,6)H and SO Ar(2,6)H). Spectroscopic 
data are in accordance with the literature.
 
(E)-(3,3-dimethoxyprop-1-en-1-yl)benzene 
 
To a solution cinnamaldehyde (3.90 mL, 31.0 mmol) in MeOH (100 mL) was added p-
TSA monohydrate (178 mg, 0.93 mmol) and trimethyl orthoformate (6.80 mL, 62.0 
mmol) and the reaction mixture was heated at 80 °C for 3 h. The reaction mixture was 
quenched with sat. aq. NaHCO3 and concentrated in vacuo. The reaction mixture was 
diluted with Et2O and washed with H2O. The organic fraction was dried (MgSO4), 
filtered and concentrated in vacuo. The residual oil was purified by distillation to give 
acetal 514 as a colourless oil (4.49 g, 81%); bp 126-128 °C (22 mmHg); {lit.
5
 bp 115 °C 
(20 mmHg)}; δ (500 MHz, CDCl ) 3.41 (6H, s, 2 CH ), 5.00 (1H, dd, J 4.9, 1.1, C(3)H), 
6.19 (1H, dd, J 16.2, 4.9, C(2)H), 6.76 (1H, d, J 16.0, C(1)H), 7.28-7.31 (1H, m, 
Ar(4)H), 7.35-7.38 (2H, m, Ar(3,5)H), 7.44-7.45 (2H, m, Ar(2,6)H). Spectroscopic data 
are in accordance with the literature.
 
(E)-4-methoxy-N-((E)-3-phenylallylidene)benzenesulfonamide 
 
A flask was charged with acetal 514 (2.00 g, 11.2 mmol) 4-methoxybenzenesulfonamide 
(2.10 g, 11.2 mmol) and the contents were heated to 180 °C without a stopper for 30 
minutes. Recrystallisation (EtOAc:Et2O) gave imine 513 as a light yellow solid (1.86 g, 
55%); mp 118-120 °C; δ (400 MHz, CDCl ) 3.90 (3H, s, CH ), 6.98-7.05 (3H, m, 
=CHCH=N and SO Ar(3,5)H), 7.44-7.52 (4H, m, Ph(3,5)H, Ph(4)H and PhCH=), 7.56-
7.58 (2H, m, Ph(2,6)H), 7.92-7.94 (2H, m, SO Ar(2,6)H), 8.78 (1H, d, J 9.4, CH=N). 
Spectroscopic data are in accordance with the literature.
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General Procedure Q: Preparation of trifluoromethyl enones. 
To a solution of i-Pr2NH (2.2 eq) in THF at 78 °C was added n-BuLi (2.2 eq) and the 
solution was allowed to stir for 20 minutes. A pre-cooled (78 °C) solution of 2-bromo-
3,3,3-trifluoroprop-1-ene (1 eq) in THF was added dropwise at 78 °C followed by a 
further 5 minutes of stirring. The desired aldehyde (1.2 eq) was added slowly followed 
by stirring at 78 °C for 30 minutes. The reaction mixture was quenched by addition of 
HCl (1 M in H2O) and allowed to warm to rt. The reaction mixture was extracted with 
EtOAc (x 3) and the combined organics were dried (MgSO4), filtered and concentrated 
in vacuo to give the crude intermediate propargyl alcohol. The residual oil was dissolved 
in THF and Et3N (4 eq) was added before the reaction mixture was heated at reflux for 
16 h. Once cool the reaction mixture was quenched by addition of HCl (1 M in H2O) and 
the reaction mixture was extracted with EtOAc (x 3). The combined organics were dried 
(MgSO4), filtered and concentrated in vacuo to give the crude reaction mixture typically 
containing an 80:20 mixture of (E)- and (Z)-enones. 
 
(E)-4,4,4-trifluoro-1-phenylbut-2-en-1-one and (Z)-4,4,4-trifluoro-1-phenylbut-2-
en-1-one 
 
Following general procedure Q, diisopropylamine (15.42 mL, 110 mmol) and n-BuLi 
(2.5M in hexanes, 44.0 mL, 110 mmol) in THF (130 mL), 2-bromo-3,3,3-trifluoroprop-
1-ene (5.30 mL, 50.0 mmol) in THF (90 mL) and benzaldehyde (6.10 mL, 60.0 mmol) 
gave the intermediate alcohol. Subsequent treatment with Et3N (27.9 mL, 200 mmol) in 
THF (280 mL) gave, after chromatographic purification (eluent Et O:petrol 5:95):  
(E)-enone 488 as a light yellow solid (7.22 g, 72% over 2 steps); mp 26-28 °C; {lit.
225
 
mp 28 °C}; δ (500 MHz, CDCl ) 6.85 (1H, dq, J 15.6, 6.6, C(3)H), 7.55-7.59 (3H, m, 
C(2)H and Ar(3,5)H), 7.66-7.69 (1H, m, Ar(4)H), 8.00-8.02 (2H, m, Ar(2,6)H). 
Spectroscopic data are in accordance with the literature.
  
(Z)-enone 489 as a light yellow oil (1.72 g, 17% over 2 steps); δ (500 MHz, CDCl ) 6.12 
(1H, dq, J 12.8, 7.9, C(3)H), 6.90 (1H, d, J 12.8, C(2)H), 7.54 (2H, t, J 7.8, Ar(3,5)H), 
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7.65-7.68 (1H, m, Ar(4)H), 7.95-7.97 (2H, m, Ar(2,6)H). Spectroscopic data are in 
accordance with the literature.  
 
(2E)-1-(4-bromophenyl)-4,4,4-trifluorobut-2-en-1-one 
 
Following general procedure Q, diisopropylamine (7.71 mL, 55.0 mmol) and n-BuLi 
(2.5M in hexanes, 22.0 mL, 55.0 mmol) in THF (65 mL), 2-bromo-3,3,3-trifluoroprop-
1-ene (2.65 mL, 25.0 mmol) in THF (45 mL) and 4-bromobenzaldehyde (5.55 g, 30.0 
mmol) gave the intermediate alcohol. Subsequent treatment with Et3N (13.9 mL, 100 
mmol) in THF (140 mL) gave, after chromatographic purification (eluent Et O:petrol 
3:97), enone 606 as a light yellow solid (3.75 g, 54% over 2 steps); mp 52-54 °C; {lit.
227
 
mp 51-52 °C}; δ (500 MHz, CDCl ) 6.86 (1H, dq, J 15.5, 6.6, C(3)H), 7.51 (1H, dq, J 
15.5, 2.0, C(2)H), 7.69-7.72 (2H, m, ArH), 7.86-7.88 (2H, m, ArH). Spectroscopic data 
are in accordance with the literature.
227
 
 
(E)-4,4,4-trifluoro-1-(furan-2-yl)but-2-en-1-one 
 
Following general procedure Q, diisopropylamine (7.71 mL, 55.0 mmol) and n-BuLi 
(2.5M in hexanes, 22.0 mL, 55.0 mmol) in (65 mL), 2-bromo-3,3,3-trifluoroprop-1-ene 
(2.65 mL, 25.0 mmol) in THF (45 mL) and furfural (2.50 mL, 30.0 mmol) gave the 
intermediate alcohol. Subsequent treatement with Et3N (13.9 mL, 100 mmol) in THF 
(140 mL) gave, after chromatographic purification (eluent Et O:petrol 10:90), enone 607 
as an off-white solid (2.48 g, 52% over 2 steps); mp 66-68 °C; {lit.
228
 mp 64-66 °C}; δ
(500 MHz, CDCl ) 6.67 (1H, dd, J 3.65, 1.7, C(1)Ar(4)H), 6.92 (1H, dq, J 15.6, 6.7, 
C(3)H), 7.41-7.46 (2H, m, C(2)H and ArH), 7.73 (1H, m, ArH). Spectroscopic data are 
in accordance with the literature.
228
 
 
(E)-4,4,4-trifluoro-1-(4-(methylthio)phenyl)but-2-en-1-one 
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Following general procedure Q, diisopropylamine (7.71 mL, 55.0 mmol) and n-BuLi 
(2.5M in hexanes, 22.0 mL, 55.0 mmol) in THF (65 mL), 2-bromo-3,3,3-trifluoroprop-
1-ene (2.65 mL, 25.0 mmol) in THF (45 mL) and 4-(methylthio)benzaldehyde (3.99 mL, 
30.0 mmol) gave the intermediate alcohol. Subsequent treatement with Et3N (13.9 mL, 
100 mmol) in THF (140 mL) gave, after chromatographic purification (eluent 
Et O:petrol 10:90), enone 608 as a light yellow solid (3.48 g, 57% over 2 steps); mp 102-
104 °C; max (ATR) 3123 (C-H), 2967, 1682 (C=O), 1636, 1585; δ (500 MHz, CDCl ) 
2.57 (3H, s, CH ), 6.84 (1H, dq, J 15.5, 6.7, C(3)H), 7.33-7.35 (2H, m, C(1)Ar(3,5)H), 
7.54 (1H, dq, J 15.5, 2.0, C(2)H), 7.91-7.93 (2H, m, C(1)Ar(2,6)H); δ (125 MHz, 
CDCl ) 14.6 (CH ), 122.6 (q, J 268, CF ), 125.1 (C(1)ArC(3,5)), 129.2 (C(1)ArC(2,6)), 
130.0, (q, J 35.0, C(3)), 130.9 (q, J 5.5, C(2)), 132.4 (C(1)ArC(4)), 147.9 (C(1)ArC(1)), 
168.7 (C(1)); m/z (APCI
+
) 247 ([M+H]
+
, 10%); HRMS (APCI
+
) C11H10F3OS
+
 ([M+H]
+
) 
requires 247.0399; found 247.0396 (-1.2 ppm). 
 
General Procedure R: Preparation of imines. 
To a solution of the desired enone (1 eq) and 4-toluenesulfonamide (1 eq) in CH2Cl2 at 0 
°C was added Et3N (2 eq) followed by TiCl4 (1 eq) and the reaction mixture was allowed 
to stir at rt for 16 h. The reaction mixture was quenched by addition of H2O and 
extracted with EtOAc (x 3). The combined organic extracts were dried (MgSO4), filtered 
and concentrated in vacuo to give the crude reaction mixture. 
 
N-((E)-1,3-diphenylallylidene)-4-methylbenzenesulfonamide 
 
Following general procedure R, chalcone (2.08 g, 10.0 mmol) and 4-toluenesulfonamide 
(1.71 g, 10.0 mmol) in CH2Cl2 (20 mL), Et3N (2.79 mL, 20.0 mmol) and TiCl4 (1.10 
mL, 10.0 mmol) gave, after recrystallisation (EtOAc:Petrol), imine 82 as a light yellow 
solid (1.68 g, 46%); mp 146-148 °C; {lit.
229
 mp 147-149 °C}; δ (500 MHz, CDCl ) 2.45 
(3H, s, CH ), 7.09 (1H, d, J 16.2, C(2)H), 7.34 (2H, m, ArH), 7.43-7.47 (5H, m, ArH), 
7.55-7.68 (5H, m, ArH), 7.94-8.10 (3H, m, ArH and C(3)H). Spectroscopic data are in 
accordance with the literature.
229
 
 
4-methyl-N-((E)-4,4,4-trifluoro-1-phenylbut-2-en-1-ylidine)benzenesulfonamide 
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Following general procedure R, trifluoromethyl enone 488 (7.22 g, 36.1 mmol) and 4-
toluenesulfonamide (6.18 g, 36.1 mmol) in CH2Cl2 (200 mL), Et3N (10.1 mL, 72.2 
mmol) and TiCl4 (3.98 mL, 36.1 mmol) gave, after recrystallisation (Et2O:Petrol), imine 
486 as a white solid (10.2 g, 80%); mp 102-104 °C; max (ATR) 3053 (C-H), 1597, 1582, 
1549, 1306 (S=O), 1146 (S=O); δ (500 MHz, CDCl ) 2.47 (3H, s, CH ), 6.15 (1H, dq, J 
16.3, 6.1, C(3)H), 7.38 (2H, d, J 8.0, SO Ar(3,5)H), 7.48 (2H, t, J 7.7, C(1)Ar(3,5)H), 
7.62 (1H, t, J 7.4, C(1)Ar(4)H), 7.67-7.80 (2H, m, SO Ar(2,6)H), 7.82-8.00 (3H, m, 
C(2)H and C(1)Ar(2,6)H); δ (125 MHz, CDCl ) 21.7 (CH ), 121.9 (q, J 270, CF ), 126.5 
(C(3)), 127.5 (C(1)ArC(3,5)), 128.9 (C(1)ArC(4)), 129.7 (C(1)ArC(2,6)), 130.2 
(SO ArC), 131.7 (SO ArC), 133.7 (C(2)), 135.5 (SO ArC(4)), 137.4 (C(1)ArC(1)), 144.3 
(SO ArC(1)), 172.9 (C(1)); m/z (APCI
+
) 354 ([M+H]
+
, 100%); HRMS (APCI
+
) 
C17H15F3NO2S
+
 ([M+H]
+
) requires 354.0770; found 354.0768 (-0.6 ppm). 
 
4-methyl-N-((Z)-4,4,4-trifluoro-1-phenylbut-2-en-1-ylidine)benzenesulfonamide 
 
Following general procedure R, trifluoromethyl enone 489 (1.72 g, 8.60 mmol) and 4-
toluenesulfonamide (1.47 g, 8.60 mmol) in CH2Cl2 (50 mL), Et3N (2.40 mL, 17.2 mmol) 
and TiCl4 (0.95 mL, 8.60 mmol) gave, after recrystallisation (Et2O:Petrol), imine 487 
(90% pure with 10% TsNH2 impurity) as a white solid (0.64 g, 21%); mp 98-100 °C; 
max (ATR) 2968 (C-H), 1587, 1557, 1310 (S=O), 1143 (S=O); δ (500 MHz, CDCl ) 
2.48 (3H, s, CH ), 6.20 (1H, dq, J 12.8, 7.7, C(3)H), 7.18 (1H, d, J 12.8, C(2)H), 7.39 
(2H, d, J 8.0, SO Ar(3,5)H), 7.47 (2H, t, J 7.9, C(1)Ar(3,5)H), 7.62 (1H, t, J 7.4, 
C(1)Ar(4)H), 7.92-7.95 (4H, m, C(1)Ar(2,6)H and SO Ar(2,6)H); δ (100 MHz, CDCl ) 
21.7 (CH ), 121.7 (q, J 270, CF ), 122.1 (q, J 34.8, C(3)), 127.6 (ArC), 128.9 (ArC), 
129.5 (ArC), 129.6 (ArC), 132.7 (q, J 5.4, C(2)), 134.2 (C(1)ArC(4)), 134.5 
(SO ArC(4)), 137.2 (C(1)ArC(1)), 144.2 (SO ArC(1)), 172.8 (C(1)); m/z (NSI
+
) 354 
([M+H]
+
, 12%); HRMS (NSI
+
) C17H15F3NO2S
+
 ([M+H]
+
) requires 354.0770; found 
354.0762 (-2.3 ppm). 
 
4-methyl-N-((E)-1,1,1-trifluoro-4-phenylbut-3-en-2-ylidene)benzenesulfonamide 
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Following general procedure R, trifluoromethyl enone 220 (1.50 g, 7.50 mmol) and 4-
toluenesulfonamide (1.29 g, 7.50 mmol) in CH2Cl2 (20 mL), Et3N (2.10 mL, 15.0 mmol) 
and TiCl4 (0.83 mL, 7.50 mmol) gave, after recrystallisation (EtOAc:Petrol), imine 492 
as a light yellow solid (404 mg, 19%); mp 140-142 °C; max (ATR) 3053 (C-H), 1608, 
1585, 1574, 1306 (S=O), 1146 (S=O); δ (500 MHz, CDCl ) 2.49 (3H, s, CH ), 7.40 (2H, 
d, J 8.1, SO Ar(3,5)H), 7.48-7.55 (3H, m, C(4)Ar(3,4,5)H), 7.66-7.70 (3H, m, 
C(4)Ar(2,6)H and =CH), 7.87 (1H, dd, J 16.7, 1.6, =CH), 7.94 (2H, d, J 8.3, 
SO Ar(2,6)H); δ (100 MHz, CDCl ) 21.7 (CH ), 116.0 (C(4)), 119.1 (q, J 280, CF ), 
127.5 (ArC), 129.3 (ArC), 129.4 (ArC), 129.8 (ArC), 132.5 (C(4)ArC(4)), 133.9 
(C(4)ArC(1)), 137.0 (SO ArC(4)), 144.7 (SO ArC(1)), 149.2 (q, J 2.5, C(3)), 161.2 (q, J 
33.8, C(2)); m/z (APCI
+
) 354 ([M+H]
+
, 100%); HRMS (APCI
+
) C17H14F3NO2S
+
 
([M+H]
+
) requires 354.0770; found 354.0766 (-1.2 ppm). 
 
4-methyl-N-((E)-4,4,4-trichloro-1-phenylbut-2-en-1-ylidine)benzenesulfonamide 
 
Following general procedure R, trichloromethyl enone 501 (2.84 g, 11.4 mmol) and 4-
toluenesulfonamide (1.96 g, 11.4 mmol) in CH2Cl2 (30 mL), Et3N (3.17 mL, 22.8 mmol) 
and TiCl4 (1.25 mL, 11.4 mmol) gave, after recrystallisation (Et2O:Petrol), imine 499 as 
a white solid (3.45 g, 75%); mp 126-128 °C; max (ATR) 3059 (C-H), 1595, 1580, 1543, 
1317 (S=O), 1153 (S=O); δ (500 MHz, CDCl ) 2.47 (3H, s, CH ), 6.60 (1H, d, J 15.3, 
C(3)H), 7.37 (2H, d, J 8.0, SO Ar(3,5)H), 7.49 (2H, t, J 7.7, C(1)Ar(3,5)H), 7.62 (1H, t, 
J 7.4, C(1)Ar(4)H), 7.70-7.80 (2H, m, SO Ar(2,6)H), 7.90-7.95 (3H, m, C(2)H and 
C(1)Ar(2,6)H); δ (125 MHz, CDCl ) 21.7 (CH ), 92.4 (CCl ), 124.5 (C(2)), 127.5 
(C(1)ArC(2,6)), 128.8 (C(1)ArC(3,5)), 129.7 (SO ArC(3,5)), 130.3 (SO ArC(2,6)), 133.5 
(C(1)ArC(4)), 133.7 (C(2)), 137.6 (SO ArC(4)), 137.4 (C(1)ArC(1)), 144.2 (SO ArC(1)), 
145.3 (C(3)), 173.8 (C(1); m/z (APCI
+
) 402 ([M+H]
+
, 75%); HRMS (APCI
+
) 
C17H15Cl3NO2S
+
 ([M+H]
+
) requires 401.9884; found 401.9880 (-0.9 ppm). 
 
(3E)-methyl 4-phenyl-2-(tosylimino)but-3-enoate 
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Following general procedure R, keto ester 143 (1.60 g, 8.42 mmol) and 4-
toluenesulfonamide (1.44 g, 8.42 mmol) in CH2Cl2 (20 mL), Et3N (2.35 mL, 16.8 mmol) 
and TiCl4 (0.93 mL, 8.42 mmol) gave, after chromatographic purification (eluent 
Et O:petrol 50:50), imine 502 as a yellow oil (1.59 g, 55%); max (ATR) 3061 (C-H), 
1736 (C=O), 1612, 1560, 1310 (S=O), 1145 (S=O); δ (500 MHz, CDCl ) 2.46 (3H, s, 
ArCH ), 4.10 (3H, s, CO CH ), 6.86 (1H, d, J 16.4, C(3)H), 7.36-7.54 (8H, m, ArH and 
C(4)H), 7.92 (2H, d, J 8.3, SO Ar(2,6)H); δ (125 MHz, CDCl ) 21.7 (ArCH ), 53.6 
(CO CH ), 123.4 (C(3)), 128.1 (ArC), 128.8 (ArC), 129.2 (ArC), 129.2 (ArC), 129.8 
(ArC), 131.9 (C(4)ArC(4)), 133.9 (C(4)ArC(1)), 135.7 (SO ArC(4)), 149.7 (C(4)), 165.0 
(C(2)), 167.5 (C(1)); m/z (NSI
+
) 344 ([M+H]
+
, 18%); HRMS (NSI
+
) C18H18NO4S
+
 
([M+H]
+
) requires 344.0951; found 344.0955 (+1.1 ppm). 
 
4-methyl-N-((E)-4,4,4-trifluoro-1-(4-(methylsulfonyl)phenyl)but-2-en-1-
ylidine)benzenesulfonamide 
 
To a solution of imine 611 (4.60 g, 11.5 mmol) in CH2Cl2 (200 mL) at 0 °C was added 
m-CPBA (70% w/w, 5.70 g, 23.0 mmol) portionwise and the reaction mixture was 
allowed to stir at rt for 30 minutes. The reaction mixture was quenched by addition of 
sat. aq. NaHCO3. The organic layer was dried (MgSO4), filtered and concentrated in 
vacuo. Recrystallisation (Et2O:Petrol) gave imine 534 as a white solid (2.85 g, 57%); mp 
126-130 °C; max (ATR) 3098 (C-H), 2920, 1584, 1558, 1309 (S=O), 1145 (S=O); δ
(500 MHz, CDCl ) 2.48 (3H, s, ArCH ), 3.09 (3H, s, SO CH ), 6.09-6.17 (1H, m, 
C(3)H), 7.38-7.40 (2H, m, NSO Ar(3,5)H), 7.66-8.05 (7H, m, ArH and C(2)H); δ (125 
MHz, CDCl ) 21.7 (ArCH ), 44.3 (SO CH ), 121.7 (q, J 270, CF ), 124.0 (C(3)), 127.6 
(ArC), 127.9 (ArC), 129.9 (ArC), 130.9, (ArC), 136.6 (4ry C), 138.2 (C(2)), 140.3 (4ry 
C), 144.4 (4ry C), 144.9 (4ry C), 171.0 (C(1)); m/z (NSI
+
) 432 ([M+H]
+
, 5%); HRMS 
(NSI
+
) C18H17F3NO4S2
+
 ([M+H]
+
) requires 432.0546; found 432.0543 (-0.6 ppm). 
 
N-[(1Z,2E)-1-(4-bromophenyl)-4,4,4-trifluorobut-2-en-1-ylidine]-4-methylbenzene-
1-sulfonamide 
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Following general procedure R, trifluoromethyl enone 606 (3.75 g, 13.44 mmol) and 4-
toluenesulfonamide (2.30 g, 13.4 mmol) in CH2Cl2 (60 mL), Et3N Et3N (3.76 mL, 26.9 
mmol) and TiCl4 (1.48 mL, 13.4 mmol) gave, after recrystallisation (Et2O:Petrol) gave 
imine 541 as a white solid (2.96 g, 56%); mp 78-80 °C; max (ATR) 3103 (C-H), 1574, 
1549, 1305 (S=O), 1144 (S=O); δ (500 MHz, CDCl ) 2.47 (3H, s, CH ), 6.15 (1H, dq, J 
16.3, 6.1, C(3)H), 7.38 (2H, d, J 8.0, C(1)Ar(2,6)H), 7.62 (4H, app. s, SO ArH), 7.85-
7.92 (3H, m, C(2)H and C(1)Ar(3,5)H); δ (125 MHz, CDCl ) 21.7 (CH ), 121.8 (q, J 
282, CF ), 127.5 (C(1)ArC(3,5)), 129.2 (C(1)ArC(4)), 129.7 (C(1)ArC(2,6)), 129.7, 
(C(2)), 131.5 (SO ArC), 131.5 (SO ArC), 132.2 (C(3)), 134.3 (SO ArC(4)), 137.1 
(C(1)ArC(1)), 144.5 (SO ArC(1)), 171.7 (C(1)); m/z (APCI
+
) 432 ([M+H]
+
, 95%); 
HRMS (APCI
+
) C17H14
79
BrF3NO2S
+
 ([M+H]
+
) requires 431.9875; found 431.9875 (+0.0 
ppm). 
 
N-((E)-4,4,4-trifluoro-1-phenylbut-2-en-1-ylidine)benzenesulfonamide 
 
Following general procedure R, trifluoromethyl enone 488 (7.22 g, 36.1 mmol) and 
benzenesulfonamide (5.67 g, 36.1 mmol) in CH2Cl2 (200 mL), Et3N (10.1 mL, 72.2 
mmol) and TiCl4 (3.98 mL, 36.1 mmol) gave, after recrystallisation (Et2O:Petrol), imine 
542 as a white solid (6.98 g, 57%); mp 72-74 °C; max (ATR) 3083 (C-H), 1551, 1304 
(S=O), 1151 (S=O); δ (500 MHz, CDCl ) 6.18 (1H, dq, J 16.3, 6.1, C(3)H), 7.48-7.68 
(7H, m, ArH), 7.70-7.80 (2H, m, ArH), 7.85-7.95 (1H, m, C(2)H), 8.05 (2H, d, J 4.1, 
C(1)Ar(2,6)H); δ (125 MHz, CDCl ) 121.9 (q, J 270, CF ), 126.4 (C(3)), 127.4 
(C(1)ArC(3,5)), 128.9 (C(1)ArC(4)), 129.1 (C(1)ArC(2,6)), 130.2 (SO ArC), 131.7 
(SO ArC), 133.4 (C(2)), 133.9 (SO ArC(4)), 135.3 (C(1)ArC(1)), 140.3 (SO ArC(1)), 
173.3 (C(1)); m/z (NSI
+
) 340 ([M+H]
+
, 7%); HRMS (NSI
+
) C16H13F3NO2S
+
 ([M+H]
+
) 
requires 340.0614; found 340.0615 (+0.4 ppm). 
 
N-((E)-1-(4-bromophenyl)-4,4,4-trifluorobut-2-en-1-ylidine)-benzenesulfonamide 
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Following general procedure R, trifluoromethyl enone 606 (4.62 g, 16.6 mmol) and 
benzenesulfonamide (2.61 g, 16.6 mmol) in CH2Cl2 (70 mL), Et3N (4.63 mL, 33.1 
mmol) and TiCl4 (1.82 mL, 16.6 mmol) gave, after chromatographic purification (eluent 
Et O:petrol 15:85), imine 609 as an orange oil (3.46 g, 50%); max (ATR) 3110 (C-H), 
1574, 1549, 1310 (S=O), 1147 (S=O); δ (500 MHz, CDCl ) 6.17 (1H, dq, J 16.3, 6.1, 
C(3)H), 7.57-7.70 (7H, m, ArH), 7.82-7.93 (1H, m, C(2)H), 8.04 (2H, d, J 5.8, 
C(1)Ar(2,6)H); δ (125 MHz, CDCl ) 121.8 (q, J 270, CF ), 127.5 (C(1)ArC(3,5)), 129.2 
(C(1)ArC(2,6)), 129.3 (C(1)ArC(4)), 130.1 (C(3)), 131.5 (SO ArC), 131.5 (SO ArC), 
132.3 (C(2)), 134.5 (SO ArC), 134.3 (SO ArC(1)), 140.1 (C(1)ArC(1)), 172.1 (C(1)); m/z 
(NSI
+
) 419 ([M+H]
+
, 65%); HRMS (NSI
+
) C16H11
81
BrF3NO2S
+
 ([M+H]
+
) requires 
419.9704; found 419.9694 (-1.2 ppm). 
 
N-((E)-1-(furan-2-yl)-4,4,4-trifluorobut-2-en-1-ylidine)-4-
methylbenzenesulfonamide 
 
Following general procedure R, trifluoromethyl enone 607 (2.48 g, 13.1 mmol) and 4-
toluenesulfonamide (2.23 g, 13.1 mmol) in CH2Cl2 (60 mL), Et3N (3.65 mL, 26.1 mmol) 
and TiCl4 (1.44 mL, 13.1 mmol) gave, after recrystallisation (Et2O:Petrol), imine 610 as 
a light brown solid (2.79 g, 62%); mp 80-82 °C; max (ATR) 3110 (C-H), 2989, 1595, 
1566, 1539, 1305 (S=O), 1146 (S=O); δ (300 MHz, (CD ) S=O, 80 °C) 2.32 (3H, s, 
CH ), 6.61-6.73 (2H, m, C(3)H and C(1)Ar(4)H), 7.35 (2H, d, J 8.0, SO Ar(3,5)H), 7.40 
(1H, d, J 3.7, C(1)Ar(3)H), 7.52 (1H, dq, J 16.3, 2.1, C(2)H), 7.73 (2H, d, J 8.3, 
SO Ar(2,6)H), 8.04 (1H, d, J 1.1, C(1)Ar(5)H); δ (75 MHz, (CD ) S=O, 80 °C) 21.4 
(CH ), 114.6 (C(1)ArC(4)), 122.8 (q, J 269, CF ), 125.5 (C(1)ArC(3)), 126.7 (q, J 34.0, 
C(3)), 127.3 (SO ArC(2,6)), 130.2 (SO ArC(3,5)), 132.1 (q, J 7.1, C(2)), 138.3 
(SO ArC(1)), 144.4 (SO ArC(4)), 149.4 (C(1)ArC(2)), 151.6 (C(1)ArC(5)) 159.7 (C(1)); 
m/z (APCI
+
) 344 ([M+H]
+
, 100%); HRMS (NSI
+
) C15H13F3NO3S
+
 ([M+H]
+
) requires 
344.0563; found 344.0561 (-0.5 ppm). 
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4-methyl-N-((E)-4,4,4-trifluoro-1-(4-(methylthio)phenyl)but-2-en-1-
ylidine)benzenesulfonamide 
 
Following general procedure R, trifluoromethyl enone 608 (3.27 g, 13.3 mmol) and 4-
toluenesulfonamide (2.28 g, 13.3 mmol) in CH2Cl2 (60 mL), Et3N (3.73 mL, 26.6 mmol) 
and TiCl4 (1.47 mL, 13.3 mmol) gave, chromatographic purification (eluent Et O:petrol 
40:60), imine 611 as a yellow solid (4.60 g, 87%); mp 80-82 °C; max (ATR) 3106 (C-
H), 2924, 1560, 1535, 1306 (S=O), 1144 (S=O); δ (500 MHz, CDCl ) 2.47 (3H, s, CH ), 
2.54 (3H, s, CH ), 6.13 (1H, dq, J 16.5, 5.8, C(3)H), 7.27 (2H, d, J 8.5, SO Ar(3,5)H), 
7.37 (2H, d, J 8.1, C(1)Ar(3,5)H), 7.67 (2H, d, J 7.2, SO Ar(2,6)H)), 7.81 (1H, br s, 
C(2)H), 7.92 (2H, d, J 8.1, C(1)Ar(2,6)H); δ (125 MHz, CDCl ) 14.7 (SCH ), 21.7 
(ArCH ), 121.9 (q, J 270, CF ), 125.1 (ArC), 127.4 (ArC), 128.9 (C), 129.6 (ArC), 130.5 
(C), 131.2 (C(1)ArC(1)), 131.9 (C), 137.6 (4ry C), 144.2 (4ry C), 148.0 (4ry C), 172.0 
(C(1)); m/z (NSI
+
) 400 ([M+H]
+
, 45%); HRMS (NSI
+
) C18H17F3NO2S2
+
 ([M+H]
+
) 
requires 400.0647; found 400.0646 (-0.3 ppm). 
 
General procedure S: Intermolecular formal [4+2] cycloaddition. 
To a solution of (phenylthio)acetic acid (1 eq) in THF (~1 mL per 0.1 mmol of acid) 
were added i-Pr2NEt (1.5 eq) and pivaloyl chloride (1.5 eq) at rt. The reaction mixture 
was allowed to stir at rt for 10 minutes. The requisite Michael acceptor (1 eq), DHPB 
(20 mol%) and i-Pr2NEt (1 eq) were then added at rt and the reaction mixture was stirred 
at reflux for the required time for complete conversion to the pyridine. The reaction 
mixture was subsequently quenched by addition of H2O and extracted with CH2Cl2 (x 3). 
The combined organics were dried (MgSO4), filtered and concentrated in vacuo to give 
the crude reaction mixture. 
 
6-phenyl-4-(trifluoromethyl)pyridin-2-yl 4-methylbenzene-1-sulfonate 
 
Following general procedure S, (phenylthio)acetic acid (84.1 mg, 0.50 mmol) in THF (5 
mL), i-Pr2NEt (130 L, 0.75 mmol), pivaloyl chloride (92.5 L, 0.75 mmol), imine 486 
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(177 mg, 0.5 mmol), DHPB 108 (19.0 mg, 0.1 mmol, 20 mol%) and i-Pr2NEt (87.5 L, 
0.50 mmol) for 16 h at 80 °C gave, after chromatographic purification (eluent 
Et O:petrol 10:90), pyridine 491 as light yellow solid (113 mg, 58%) which was 
recrystallised (Et O:petrol) for an analytical sample; mp 100-102 °C; max (ATR)/cm
-1
 
3109, 2940 (C-H), 1616, 1595, 1564, 1306 (S=O), 1142 (S=O); δ (500 MHz, CDCl ) 
2.51 (3H, s, CH ), 7.26 (1H, s, C(3)H), 7.40 (2H, d, J 8.1, OSO Ar(3,5)H), 7.45-7.49 
(3H, m, C(6)Ar(3,4,5)H), 7.78-7.79 (2H, m, C(6)Ar(2,6)H), 7.85 (1H, s, C(5)H), 7.99 
(2H, d, J 8.2,  OSO Ar(2,6)H); δ (100 MHz, CDCl ) 21.8 (CH ), 109.8 (q, J 3.4, (C(3)), 
114.3 (q, J 3.3, C(5)),  122.2 (q, J 272, CF ), 127.1 (C(6)ArC(2,6)), 128.9 (ArC), 128.9 
(ArC), 129.8 (ArC), 130.5 (C(6)ArC(4)), 134.0 (OSO ArC(1)), 136.2 (C(6)ArC(1)), 
143.1 (q, J 34.2, C(4)), 145.6 (OSO ArC(4)), 157.5 (C(2) or C(6)), 158.0 (C(2) or C(6)); 
m/z (APCI
+
) 394 ([M+H]
+
, 100%); HRMS (APCI
+
) C19H15F3NO3S
+
 ([M+H]
+
) requires 
394.0719; found 394.0721 (+0.4 ppm). 
 
Scale-up: Following general procedure S, (phenylthio)acetic acid (4.35 g, 25.9 mmol) in 
THF (250 mL), i-Pr2NEt (6.73 mL, 38.9 mmol), pivaloyl chloride (4.80 mL, 38.9 
mmol), imine 486 (9.13 g, 25.9 mmol), DHPB 108 (0.98 g, 5.18 mmol, 20 mol%) and i-
Pr2NEt (4.48 mL, 25.9 mmol) for 16 h at 80 °C gave, after chromatographic purification 
(eluent Et O:petrol 10:90), pyridine 491 as light yellow solid (5.18 g, 51%) with 
identical spectroscopic properties to above. 
 
From (Z)-imine 487: Following general procedure S, (phenylthio)acetic acid (84.1 mg, 
0.50 mmol) in THF (5 mL), i-Pr2NEt (130 L, 0.75 mmol), pivaloyl chloride (92.5 L, 
0.75 mmol), imine 487 (177 mg, 0.5 mmol), DHPB 108 (19.0 mg, 0.1 mmol, 20 mol%) 
and i-Pr2NEt (87.5 L, 0.50 mmol) for 16 h at 80 °C gave, after chromatographic 
purification (eluent Et O:petrol 10:90), pyridine 491 as light yellow solid (107 mg, 54%) 
with identical spectroscopic properties to above. 
 
6-(4-bromophenyl)-4-(trifluoromethyl)pyridin-2-yl 4-methylbenzene-1-sulfonate 
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Following general procedure S, (phenylthio)acetic acid (84.1 mg, 0.50 mmol) in THF (5 
mL), i-Pr2NEt (130 L, 0.75 mmol), pivaloyl chloride (92.5 L, 0.75 mmol), imine 541 
(216 mg, 0.5 mmol), DHPB 108 (19.0 mg, 0.1 mmol, 20 mol%) and i-Pr2NEt (87.5 L, 
0.50 mmol) for 16 h at 80 °C gave, chromatographic purification (eluent Et O:petrol 
10:90), pyridine 493 as white solid (146.8 mg, 62%) which was recrystallised 
(Et O:petrol) for an analytical sample; mp 134-136 °C; max (ATR)/cm
-1
 3110 (C-H), 
1614, 1591, 1564, 1306 (S=O), 1146 (S=O); δ (400 MHz, CDCl ) 2.51 (3H, s, CH ), 
7.26 (1H, s, C(3)H), 7.40 (2H, d, J 8.6, OSO Ar(3,5)H), 7.56-7.60 (2H, m, C(6)ArH), 
7.65-7.68 (2H, m, C(6)ArH), 7.81 (1H, s, C(5)H), 7.95-7.98 (2H, m, OSO Ar(2,6)H); δ
(100 MHz, CDCl ) 21.8 (CH ), 110.2 (q, J 3.5, (C(3)), 114.1 (q, J 3.2, C(5)),  122.0 (q, J 
272, CF ), 125.3 (C(6)ArC(4)), 128.6 (ArC), 128.8 (ArC), 129.8 (ArC), 132.1 (ArC), 
134.0 (SO ArC(1)), 135.1 (C(6)ArC(1)), 143.3 (q, J 34.4, C(4)), 145.7 (SO ArC(4)), 
156.7 (C(6)), 157.5 (C(2)); m/z (APCI
+
) 472 ([M+H]
+
, 100%); HRMS (APCI
+
) 
C19H14
79
BrF3NO3S
+
 ([M+H]
+
) requires 471.9824; found 471.9825 (+0.1 ppm). 
 
6-(4-(methylsulfonyl)phenyl)-4-(trifluoromethyl)pyridin-2-yl 4-
methylbenzenesulfonate 
 
Following general procedure S, (phenylthio)acetic acid (0.39 g, 2.32 mmol) in THF (25 
mL), i-Pr2NEt (0.60 mL, 3.48 mmol), pivaloyl chloride (0.44 mL, 3.48 mmol), imine 
534 (1.00 g, 2.32 mmol), DHPB 108 (88.3 mg, 0.46 mmol, 20 mol%) and i-Pr2NEt (0.41 
mL, 2.32 mmol) for 16 h at 80 °C gave, after chromatographic purification (eluent 
Et O:petrol 65:35), pyridine 494 as white solid (580 mg, 53%) which was recrystallised 
(Et O:petrol) for an analytical sample; mp 146-148 °C; max (ATR)/cm
-1
 3118 (C-H), 
2934, 2912, 1599, 1562, 1306 (S=O), 1144 (S=O); δ (500 MHz, CDCl ) 2.52 (3H, s, 
ArCH ), 3.13 (3H, s, SO CH ), 7.35 (1H, s, C(3)H), 7.42 (2H, d, J 8.0, OSO Ar(3,5)H), 
7.91 (1H, s, C(5)H), 7.96-8.06 (6H, m, ArH); δ (125 MHz, CDCl ) 21.9 (ArCH ), 44.5 
(SO CH ), 111.3 (q, J 3.5, (C(3)), 115.0 (q, J 3.1, C(5)),  121.9 (q, J 272, CF ), 128.1 
(ArC), 128.1 (ArC), 128.7 (ArC), 129.9 (ArC), 133.8 (OSO ArC(1)), 141.2 (4ry ArC), 
142.0 (4ry ArC), 143.7 (q, J 34.5, C(4)), 145.9 (OSO ArC(4)), 155.7 (C(6)), 157.7 
 Chapter 9: Experimental 
 
 356 
(C(2)); m/z (NSI
+
) 472 ([M+H]
+
, 100%); HRMS (NSI
+
) C20H17F3NO5S2
+
 ([M+H]
+
) 
requires 472.0495; found 472.0485 (-2.1 ppm). 
 
6-(furan-2-yl)-4-(trifluoromethyl)pyridin-2-yl 4-methylbenzene-1-sulfonate 
 
Following general procedure S, (phenylthio)acetic acid (84.1 mg, 0.50 mmol) in THF (5 
mL), i-Pr2NEt (130 L, 0.75 mmol), pivaloyl chloride (92.5 L, 0.75 mmol), imine 610 
(172 mg, 0.5 mmol), DHPB 108 (19.0 mg, 0.1 mmol, 20 mol%) and i-Pr2NEt (87.5 L, 
0.50 mmol) for 16 h at 80 °C gave, after chromatographic purification (eluent 
Et O:petrol 10:90), pyridine 495 as white solid (89.9 mg, 47%) which was recrystallised 
(Et O:petrol) for an analytical sample; mp 78-80 °C; max (ATR)/cm
-1
 3090 (C-H), 1624, 
1570, 1305 (S=O), 1146 (S=O); δ (500 MHz, CDCl ) 2.50 (3H, s, CH ), 6.55 (1H, s, 
C(6)ArH), 6.88 (1H, d, J 2.8, C(6)ArH), 7.14 (1H, s, C(3)H), 7.42 (2H, d, J 7.9, 
OSO Ar(3,5)H), 7.56 (1H, s, C(6)Ar(5)H), 7.77 (1H, s, C(5)H), 7.99 (2H, d, J 8.0 
OSO Ar(2,6)H); δ (125 MHz, CDCl ) 21.8 (CH ), 109.2 (q, J 3.6, (C(3)), 111.6 
(C(6)ArC), 112.4 (q, J 3.4, C(5)), 112.6 (C(6)ArC), 122.0 (q, J 272, CF ), 128.9 
(SO ArC), 129.7 (SO ArC), 133.9 (SO ArC(1)), 143.1 (q, J 34.3, C(4)), 144.6 
(C(6)ArC(5), 145.6 (SO ArC(4)), 149.4 (C(6)ArC(2)), 151.4 (C(6)), 157.4 (C(2)); m/z 
(APCI
+
) 384 ([M+H]
+
, 100%); HRMS (APCI
+
) C17H13F3NO4S
+
 ([M+H]
+
) requires 
384.0512; found 384.0509 (-0.8 ppm). 
 
6-phenyl-4-(trifluoromethyl)pyridin-2-yl benzene-1-sulfonate 
 
Following general procedure S, (phenylthio)acetic acid (84.1 mg, 0.50 mmol) in THF (5 
mL), i-Pr2NEt (130 L, 0.75 mmol), pivaloyl chloride (92.5 L, 0.75 mmol), imine 542 
(170 mg, 0.5 mmol), DHPB 108 (19.0 mg, 0.1 mmol, 20 mol%) and i-Pr2NEt (87.5 L, 
0.50 mmol) for 16 h at 80 °C gave, after chromatographic purification (eluent 
Et O:petrol 10:90), pyridine 496 as white solid (103 mg, 54%) which was recrystallised 
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(Et O:petrol) for an analytical sample; mp 88-90 °C; max (ATR)/cm
-1
 3118 (C-H), 1570, 
1371 (S=O), 1177 (S=O); δ (300 MHz, CDCl ) 7.26 (1H, s, C(3)H), 7.43-7.50 (3H, m, 
OSO Ar(3,5)H and OSO Ar(4)H), 7.62 (2H, t, J 7.8, C(6)Ar(3,5)H), 7.72-7.78 (3H, m, 
C(6)Ar(2,6)H and C(6)Ar(4)H), 7.85 (1H, s, C(5)H), 8.11 (2H, d, J 8.3, OSO Ar(2,6)H); 
δ (75 MHz, CDCl ) 109.8 (q, J 3.5, (C(3)), 114.4 (q, J 3.2, C(5)), 122.2 (q, J 272, CF ), 
127.1 (C(6)ArC(2,6)), 128.8 (ArC), 128.9 (ArC), 129.2 (ArC), 130.6 (C(6)ArC(4)), 134.3 
(OSO ArC(4)), 136.2 (C(6)ArC(1)), 137.2 (OSO ArC(1)), 143.2 (q, J 34.1, C(4)), 157.4 
(C(2) or C(6)), 158.0 (C(2) or C(6)); m/z (NSI
+
) 380 ([M+H]
+
, 100%); HRMS (NSI
+
) 
C18H13F3NO3S
+
 ([M+H]
+
) requires 380.0563; found 380.0563 (+0.1 ppm). 
 
6-(4-bromophenyl)-4-(trifluoromethyl)pyridin-2-yl benzene-1-sulfonate 
 
Following general procedure S, (phenylthio)acetic acid (84.1 mg, 0.50 mmol) in THF (5 
mL), i-Pr2NEt (130 L, 0.75 mmol), pivaloyl chloride (92.5 L, 0.75 mmol), imine 609 
(209 mg, 0.5 mmol), DHPB 108 (19.0 mg, 0.1 mmol, 20 mol%) and i-Pr2NEt (87.5 L, 
0.50 mmol) for 16 h at 80 °C gave, chromatographic purification (eluent Et O:petrol 
5:10), pyridine 497 as white solid (151 mg, 66%) which was recrystallised (Et O:petrol) 
for an analytical sample; mp 150-152 °C; max (ATR)/cm
-1
 3115 (C-H), 1616, 1564, 
1373 (S=O), 1172 (S=O); δ (500 MHz, CDCl ) 7.28 (1H, s, C(3)H), 7.54-7.65 (6H, m, 
ArH), 7.75 (1H, t, J 7.2, OSO Ar(4)H), 7.82 (1H, s, C(5)H), 8.09 (2H, d, J 7.6, 
OSO Ar(2,6)H); δ (75 MHz, CDCl ) 110.2 (q, J 3.6, (C(3)), 114.2 (q, J 3.2, C(5)), 122.1 
(q, J 272, CF ), 125.3 (C(6)ArC(4)), 128.6 (ArC), 128.7 (ArC), 129.2 (ArC), 132.1 
(ArC), 134.3 (SO ArC(4)), 135.0 (C(6)ArC(1)), 137.2  
(SO ArC(1)), 143.4 (q, J 34.3, C(4)), 156.8 (C(6)), 157.5 (C(2)); m/z (NSI
+
) 457 
([M+H]
+
, 97%); HRMS (NSI
+
) C18H12
79
BrF3N2O2S
+
 ([M+H]
+
) requires 457.9668; found 
457.9667 (-0.2 ppm). 
 
4-phenyl-6-(trifluoromethyl)pyridin-2-yl 4-methylbenzenesulfonate 
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Following general procedure S, (phenylthio)acetic acid (84.1 mg, 0.50 mmol) in THF (5 
mL), i-Pr2NEt (130 L, 0.75 mmol), pivaloyl chloride (92.5 L, 0.75 mmol), imine 492 
(177 mg, 0.5 mmol), DHPB 108 (19.0 mg, 0.1 mmol, 20 mol%) and i-Pr2NEt (87.5 L, 
0.50 mmol) for 48 h at 80 °C gave, after chromatographic purification (eluent 
Et O:petrol 15:85), pyridine 498 as white solid (79.0 mg, 40%) which was recrystallised 
(Et O:petrol) for an analytical sample; mp 130-132 °C; max (ATR)/cm
-1
 3119 (C-H), 
1614, 1597, 1553, 1303 (S=O), 1147 (S=O); δ (300 MHz, CDCl ) 2.51 (3H, s, CH ), 
7.41 (2H, d, J 8.1, OSO Ar(3,5)H), 7.52-7.68 (6H, m, ArH and C(3)H), 7.80 (1H, s, 
C(5)H), 8.03 (2H, d, J 8.0, OSO Ar(2,6)H); δ (75 MHz, CDCl ) 21.8 (CH ), 115.8 
(C(3)), 117.1 (q, J 2.9, C(5)), 120.8 (q, J 273, CF ), 127.2 (ArC), 129.3 (ArC), 129.5 
(ArC), 129.6 (ArC), 130.5 (C(4)ArC(4)), 133.4 (4ry ArC), 135.9 (4ry ArC), 145.8 
(OSO ArC(4)), 146.8 (q, J 35.7, C(6)), 154.9 (C(4)), 157.9 (C(2)); m/z (NSI
+
) 394 
([M+H]
+
, 100%); HRMS (NSI
+
) C19H15F3NO3S
+
 ([M+H]
+
) requires 394.0719; found 
394.0716 (-0.8 ppm). 
 
Methyl 6-oxo-4-phenyl-1-tosyl-1,6-dihydropyridine-2-carboxylate 
 
Following general procedure S, (phenylthio)acetic acid (84.1 mg, 0.50 mmol) in THF (5 
mL), i-Pr2NEt (130 L, 0.75 mmol), pivaloyl chloride (92.5 L, 0.75 mmol), imine 502 
(172 mg, 0.5 mmol), DHPB 108 (19.0 mg, 0.1 mmol, 20 mol%) and i-Pr2NEt (87.5 L, 
0.50 mmol) for 16 h at 80 °C gave, after chromatographic purification (eluent 
Et O:petrol 40:60), pyridone 504 as an off-white solid (86.0 mg, 45%); mp 150-152 °C; 
max (ATR)/cm
-1
 3071 (C-H), 2951, 1728 (C=O Ester), 1668 (C=O Lactam), 1612, 1595; 
δ (500 MHz, CDCl ) 2.48 (3H, s, ArCH ), 4.03 (3H, s, CO CH ), 6.65 (1H, d, J 1.8, 
C(5)H), 6.81 (1H, d, J 1.8, C(3)H), 7.39 (2H, d, J 8.2, SO Ar(3,5)H), 7.48-7.50 (3H, m, 
ArH), 7.55-7.57 (2H, m, ArH), 8.16 (2H, d, J 8.4, SO Ar(2,6)H); δ (75 MHz, CDCl ) 
21.9 (ArCH ), 53.6 (CO CH ), 110.7 (C(3)), 121.1 (C(5)), 126.7 (ArC), 129.3 (ArC), 
129.4 (ArC), 130.2 (ArC), 130.7 (C(4)ArC(4)), 134.3 (4ry ArC), 135.2 (4ry ArC), 137.3 
(4ry ArC), 146.2 (SO ArC(4)), 151.0 (C(4)), 161.1 (C(6)), 163.4 (CO CH ); m/z (NSI
+
) 
384 ([M+H]
+
, 100%); HRMS (NSI
+
) C20H18NO5S
+
 ([M+H]
+
) requires 384.0900; found 
384.0900 (-0.1 ppm). 
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Methyl 6-oxo-2-phenyl-5-(phenylthio)-1-tosyl-1,4,5,6-tetrahydropyridine-3-
carboxylate 
 
Following general procedure S, (phenylthio)acetic acid (84.1 mg, 0.50 mmol) in THF (5 
mL), i-Pr2NEt (130 L, 0.75 mmol), pivaloyl chloride (92.5 L, 0.75 mmol), imine 506 
(172 mg, 0.5 mmol), DHPB 108 (19.0 mg, 0.1 mmol, 20 mol%) and i-Pr2NEt (87.5 L, 
0.50 mmol) for 16 h at 80 °C gave, after chromatographic purification (eluent 
Et O:petrol 40:60), lactam 510 as a white solid (130 mg, 53%); mp 128-130 °C; max 
(ATR)/cm
-1
 2930 (C-H), 1717 (C=O Ester), 1636 (C=O Lactam), 1597; δ (500 MHz, 
CDCl ) 2.42 (3H, s, ArCH ), 2.99 (1H, dd, J 15.8, 5.6, C(4)HH), 3.14 (1H, dd, J 15.8, 
4.2, C(4)HH), 3.55 (3H, s, CO CH ), 4.00 (1H, dd, J 5.5, 4.3, C(5)H), 7.17 (2H, d, J 8.2, 
SO Ar(3,5)H), 7.25-7.34 (7H, m, ArH), 7.40 (1H, m, ArH), 7.47 (2H, d, J 8.4, 
SO Ar(2,6)H), 7.51-7.53 (2H, m, C(2)Ar(2,6)H); δ (125 MHz, CDCl ) 21.8 (ArCH ), 
29.0 (C(4)), 50.9 (CO CH or C(5)), 52.1 (CO CH or C(5)), 119.2 (C(3)), 127.5 (ArC), 
128.5 (ArC), 128.8 (ArC), 129.0 (ArC), 129.2 (ArC), 129.3 (ArC), 129.4 (ArC), 132.2 
(4ry ArC), 133.1 (C(2)ArC(2,6)), 133.8 (4ry ArC), 136.0 (4ry ArC), 145.2 (4ry ArC), 
145.2 (4ry ArC), 166.4 (CO CH ), 169.6 (C(6)); m/z (NSI
+
) 494 ([M+H]
+
, 100%); 
HRMS (NSI
+
) C26H24NO5S2
+
 ([M+H]
+
) requires 494.1090; found 494.1080 (-2.1 ppm). 
 
2-phenyl-4-(trifluoromethyl)pyridine 
 
To a screw cap glass test tube was charged Pd(OAc)  (3.37 mg, 15.0 mol), 1,3-
Bis(diphenylphosphino)propane (6.19 mg, 15.0 mol), Et N (0.21 mL, 1.50 mmol), 
pyridine 491 (118 mg, 0.30 mmol), DMF (2 mL) and formic acid (34.0 L, 0.90 mmol) 
and the reaction mixture was heated at 60 °C for 1 h. Once cooled, the reaction mixture 
was quenched with brine and extracted with EtOAc (x 3). The combined organic extracts 
were dried (MgSO4), filtered and concentrated in vacuo. Chromatographic purification 
 Chapter 9: Experimental 
 
 360 
(eluent 10% Et O:petrol) gave pyridine 516 as a colourless oil (59.8 mg, 89%); δ (300 
MHz, CDCl ) 7.48-7.59 (4H, m, C(2)Ar(3,5)H, C(2)Ar(4)H and C(5)H), 7.97 (1H, s, 
C(3)H), 8.05-8.09 (2H, m, C(2)Ar(2,6)H), 8.91 (1H, d, J 5.1, C(6)H). Spectroscopic data 
are in accordance with the literature.
 
6-phenyl-4-(trifluoromethyl)pyridin-2(1H)-one 
 
To a solution of pyridine 491 (118 mg, 0.30 mmol) in EtOH (10 mL) was added n-
Bu NOH (1.5 M in H O, 2 mL, 3.00 mmol) and the reaction mixture was stirred at rt for 
15 minutes. The reaction mixture was extracted with CH2Cl2 (x 3) and the combined 
organic extracts were dried (MgSO4), filtered and concentrated in vacuo. 
Chromatographic purification (eluent 100% Et O) gave pyridone 517 as a white solid 
(63.9 mg, 89%); mp 174-176 °C; max (ATR)/cm
-1
 3063 (C-H), 1667 (C=O), 1612, 1506; 
δ (300 MHz, CDCl ) 6.66 (1H, d, J 1.5, C(5)H), 6.84 (1H, s, C(3)H), 7.55-7.60 (3H, m, 
C(6)Ar(3,5)H and C(6)Ar(4)H), 7.78-7.82 (2H, m, C(6)Ar(2,6)H); δ (125 MHz, CDCl ) 
100.4 (q, J 2.4, C(5)), 115.8 (q, J 3.0, C(3)), 122.3 (q, J 273, CF ), 127.0 (C(6)ArC(2,6)), 
129.4 (C(6)ArC(3,5)), 131.0 (C(6)ArC(4)), 132.5 (C(6)ArC(1)), 143.2 (q, J 33.3, C(4)), 
149.1 (C(6)), 164.8 (C(2)=O); m/z (NSI
+
) 240 ([M+H]
+
, 100%); HRMS (NSI
+
) 
C12H9F3NO
+
 ([M+H]
+
) requires 240.0631; found 240.0631 (+0.1 ppm). 
 
4-(6-phenyl-4-(trifluoromethyl)pyridin-2-yl)morpholine 
 
To a solution of pyridine 491 (78.6 mg, 0.20 mmol) in toluene (2 mL) was added Et N 
(55.8 L, 0.40 mmol) and morpholine (172 L, 2.00 mmol) and the reaction mixture 
was heated at 120 °C for 16 h. Once cooled, the reaction mixture was concentrated in 
vacuo. Chromatographic purification (eluent 15% Et O:petrol) gave pyridine 520 as a 
white solid (52.6 mg, 85%); mp 98-100 °C; max (ATR)/cm
-1
 2988 (C-H), 2968, 2860, 
1611, 1568; δ (500 MHz, CDCl ) 3.71 (4H, t, J 4.9, 2 NCH ), 3.90 (4H, t, J 4.9, 2 
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OCH ), 6.78 (1H, s, C(3)H), 7.32 (1H, s, C(5)H), 7.44-7.52 (3H, m, C(6)Ar(3,5)H and 
C(6)Ar(4)H), 8.04-8.06 (2H, m, C(6)Ar(2,6)H); δ (100 MHz, CDCl ) 45.3 (2 NCH ), 
66.7 (2 OCH ), 100.8 (q, J 3.9, C(3)), 105.3 (q, J 3.2, C(5)),  123.4 (q, J 272, CF ), 126.9 
(C(6)ArC(2,6)), 128.7 (C(6)ArC(3,5)), 129.5 (C(6)ArC(4)), 138.6 (C(6)ArC(1)), 140.7 
(q, J 32.7, C(4)), 156.8 (C(6)), 159.2 (C(2)); m/z (NSI
+
) 309 ([M+H]
+
, 100%); HRMS 
(NSI
+
) C16H16F3N2O
+
 ([M+H]
+
) requires 309.1209; found 309.1210 (+0.2 ppm). 
 
N-cyclohexyl-6-phenyl-4-(trifluoromethyl)pyridin-2-amine 
 
To a solution of pyridine 491 (78.6 mg, 0.20 mmol) in toluene (2 mL) was added Et N 
(55.8 L, 0.40 mmol) and cyclohexylamine (115 L, 1.00 mmol) and the reaction 
mixture was heated at 120 °C for 16 h. A further portion of cyclohexylamine (115 L, 
1.00 mmol) was added and the reaction mixture was heated at 120 °C for a further 24 h. 
Once cooled, the reaction mixture was concentrated in vacuo. Chromatographic 
purification (eluent 10% Et O:petrol) gave pyridine 521 as a colourless oil (50.7 mg, 
79%); max (ATR)/cm
-1
 2930 (C-H), 2855, 1616, 1572, 1510; δ (500 MHz, CDCl ) 1.27-
1.33 (3H, m, cyclohexyl CH), 1.43-1.52 (2H, m, cyclohexyl CH), 1.69-1.85 (3H, m, 
cyclohexyl CH), 2.11-2.14 (2H, m, cyclohexyl CH), 3.71-3.72 (1H, m, NHCH), 4.82 
(1H, d, J 7.6, NH), 6.50 (1H, s, C(3)H), 7.19 (1H, s, C(5)H), 7.43-7.51 (3H, m, 
C(6)Ar(3,5)H and C(6)Ar(4)H), 7.99-8.01 (2H, m, C(6)Ar(2,6)H); δ (100 MHz, CDCl ) 
24.9 (cyclohexyl CH ), 25.8 (cyclohexyl CH ), 33.2 (cyclohexyl CH ), 50.4 (NHCH), 
100.8 (C(3)), 104.4 (q, J 3.3, C(5)),  123.4 (q, J 271, CF ), 126.9 (C(6)ArC(2,6)), 128.7 
(C(6)ArC(3,5)), 129.2 (C(6)ArC(4)), 138.9 (C(6)ArC(1)), 140.4 (q, J 32.5, C(4)), 157.5 
(C(2) or C(6)), 158.0 (C(2) or C(6)); m/z (NSI
+
) 321 ([M+H]
+
, 97%); HRMS (NSI
+
) 
C18H20F3N2
+
 ([M+H]
+
) requires 321.1573; found 321.1573 (+0.0 ppm). 
 
N-(1-(6-phenyl-4-(trifluoromethyl)pyridine-2-yl)vinyl)acetamide 
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To a screw cap glass test tube was charged Pd(dba)  (8.60 mg, 15.0 mol), 1,1’-
bis(diphenylphosphino)ferrocene (8.30 mg, 15.0 mol), dicyclohexylamine (0.19 mL, 
0.90 mmol), N-vinylacetamide (102 mg, 1.2 mmol), pyridine 491 (118 mg, 0.30 mmol) 
and 1,4-dioxane (3 mL) and the reaction mixture was heated 100 °C for 16 h. Once 
cooled, the reaction mixture filtered through Celite using CH2Cl2 as eluent and 
concentrated in vacuo. Chromatographic purification (eluent 30% Et O:petrol) gave 
pyridine 522 as a white solid (69.7 mg, 76%); mp 130-132 °C;  max (ATR)/cm
-1
 3310 
(N-H), 3082 (C-H), 1692 (C=O), 1566, 1506; δ (300 MHz, CDCl ) 2.30 (3H, s, CH ), 
5.72 (1H, s, =CHH), 6.70 (1H, s, =CHH), 7.56-7.63 (3H, m, C(6)Ar(3,5)H and 
C(6)Ar(4)H), 7.91 (1H, s, C(3)H or C(5)H), 7.92 (1H, s, C(3)H or C(5)H), 8.02-8.05 
(2H, m, C(6)Ar(2,6)H), 9.30 (1H, s, NH); δ (75 MHz, CDCl ) 25.2 (CH ), 101.1 
(=CHH), 113.2 (q, J 3.5, C(3) or C(5)), 115.5 (q, J 3.3, C(3) or C(5)), 122.8 (q, J 272, 
CF ), 127.0 (C(6)ArC(2,6)), 129.2 (C(6)ArC(3,5)), 130.3 (C(6)ArC(4)), 136.8 
(C(2)C=CHH), 137.5 (C(6)ArC(1)), 140.4 (q, J 33.7, C(4)), 153.3 (C(2)), 157.2 (C(6)), 
169.1 (C=O); m/z (NSI
+
) 307 ([M+H]
+
, 57%); HRMS (NSI
+
) C16H14F3N2O
+
 ([M+H]
+
) 
requires 307.1053; found 307.1052 (-0.2 ppm). 
 
2-(furan-3-yl)-6-phenyl-4-(trifluoromethyl)pyridine 
 
To a screw cap glass test tube was charged Pd(OAc)  (2.25 mg, 0.01 mmol), 2-
(Dicyclohexylphospino)-3,6-dimethoxy-2’,4’,6’-triisopropyl-1,1’-biphenyl (10.7 mg, 
0.02 mmol), pyridine 491 (197 mg, 0.50 mmol), 3-furanylboronic acid (112 mg, 1.00 
mmol), K PO .H O (345 mg, 1.50 mmol) and toluene (1 mL) and the reaction mixture 
was heated at 110 °C for 2 h. Once cooled, the reaction mixture was quenched with H2O 
and extracted with EtOAc (x 3). The combined organic extracts were dried (MgSO4), 
filtered and concentrated in vacuo. Chromatographic purification (eluent 5% 
Et O:petrol) gave pyridine 525 as a colourless oil (101 mg, 70%); max (ATR)/cm
-1
 3012, 
2988 (C-H), 2959, 1616, 1572, 1508; δ (500 MHz, CDCl ) 7.05 (1H, s, C(2)Ar(4)H), 
7.50-7.59 (5H, m, ArH), 7.82 (1H, s, C(3)H), 8.15 (2H, d, J 7.3, C(6)Ar(2,6)H), 8.22 
(1H, s, C(5)H); δ (125 MHz, CDCl ) 108.7 (C(2)ArC(4)), 113.6 (q, J 3.4, C(3), 113.6 (q, 
J 3.4, C(5)), 123.1 (q, J 272, CF ), 126.6 (C(2)ArC(3)), 127.1 (C(6)ArC(2,6)), 128.9 
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(C(6)ArC(3,5)), 129.9 (C(6)ArC(4)), 138.1 (C(6)ArC(1)), 139.7 (q, J 33.3, C(4)), 142.3 
(C(2)ArC(2)), 144.2 (C(2)ArC(5)), 152.9 (C(2)), 158.3 (C(6)); m/z (NSI
+
) 290 ([M+H]
+
, 
100%); HRMS (NSI
+
) C16H11F3NO
+
 ([M+H]
+
) requires 290.0787; found 290.0789 (+0.6 
ppm). 
 
tert-butyl 5-methoxy-2-(6-phenyl-4-(trifluoromethyl)pyridine-2-yl)-1H-indole-1-
carboxylate 
 
To a screw cap glass test tube was charged Pd(OAc)  (2.25 mg, 0.01 mmol), 2-
(Dicyclohexylphospino)-3,6-dimethoxy-2’,4’,6’-triisopropyl-1,1’-biphenyl (10.7 mg, 
0.02 mmol), pyridine 491 (197 mg, 0.50 mmol), (1-(tert-butoxycarbonyl)5-methoxy-1H-
indol-2-yl)boronic acid (291 mg, 1.00 mmol), K PO .H O (345 mg, 1.50 mmol) and 
toluene (1 mL) and the reaction mixture was heated at 110 °C for 2 h. Once cooled, the 
reaction mixture was quenched with H2O and extracted with EtOAc (x 3). The combined 
organic extracts were dried (MgSO4), filtered and concentrated in vacuo. 
Chromatographic purification (eluent 5% Et O:petrol) gave pyridine 526 as a colourless 
oil (190 mg, 81%); max (ATR)/cm
-1
 2978 (C-H), 2936, 1732 (C=O), 1612, 1572; δ (300 
MHz, CDCl ) 1.37 (9H, s, C(CH ) ), 3.92 (3H, s, OCH ), 6.91 (1H, s, C(2)Ar(3)H), 7.06-
7.12 (2H, m, C(2)Ar(4)H and C(2)Ar(6)H), 7.47-7.60 (3H, m, C(6)Ar(3,5)H and 
C(6)Ar(4)H), 7.70 (1H, s, C(3)H), 7.96 (1H, s, C(5)H), 8.16-8.19 (3H, m, C(6)Ar(2,6)H 
and C(2)Ar(7)H); δ (75 MHz, CDCl ) 27.6 (C(CH ) ), 55.7 (OCH ), 83.7 (C(CH ) ), 
103.4 (C(2)ArC(4)), 112.2 (C(2)ArC(3)), 114.0 (q, J 3.2, C(5)), 114.6 (C(2)ArC(6)), 
116.1 (C(2)ArC(7)), 117.1 (q, J 3.3, C(3)), 123.1 (q, J 271, CF ), 127.2 (C(6)ArC(2,6)), 
129.0 (C(6)ArC(3,5)), 129.5 (C(2)ArC(7a)), 130.0 (C(6)ArC(4)), 132.8 (C(2)ArC(3a)), 
137.7 (C(6)ArC(1)), 138.9 (C(2)ArC(2)), 139.3 (q, J 33.5, C(4)), 149.9 (C=O), 154.3 
(C(2)), 156.2 (C(2)ArC(5)), 157.8 (C(6)); m/z (NSI
+
) 469 ([M+H]
+
, 70%); HRMS (NSI
+
) 
C26H24F3N2O3
+
 ([M+H]
+
) requires 469.1734; found 469.1727 (-1.4 ppm). 
 
2-(4-methoxyphenyl)-6-phenyl-4-(trifluoromethyl)pyridine 
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To a screw cap glass test tube was charged Pd(dba)  (7.20 mg, 12.5 mol), 4,4,5,5-
tetramethyl-1,3,2-dioxaphospholane 2-oxide (4.10 mg, 25.0 mol) and 1,4-dioxane (2 
mL) and the reaction mixture was stirred at rt for 5 minutes. 4-
Methoxylphenylmagnesium bromide solution (0.5 M in THF, 1.5 mL, 0.75 mmol) was 
added and the reaction mixture was stirred at rt for 5 minutes. Pyridine 491 (197 mg, 
0.50 mmol) was added and the reaction was heated at 80 °C for 16 h. Once cooled, the 
reaction mixture was quenched with HCl (1M in H2O) and extracted with Et2O (x 3). 
The combined organic extracts were dried (MgSO4), filtered and concentrated in vacuo. 
Chromatographic purification (eluent 3% Et O:petrol) gave pyridine 528 as a colourless 
oil (109 mg, 66%); max (ATR)/cm
-1
 3042, 2961 (C-H), 1609, 1566, 1516; δ (300 MHz, 
CDCl ) 3.78 (3H, s, OCH ), 6.91-6.96 (2H, m, C(2)Ar(3,5)H), 7.34-7.46 (3H, m, 
C(6)Ar(3,5)H and C(6)Ar(4)H), 7.70 (2H, app. s, C(3)H and C(5)H), 8.01-8.08 (4H, m, 
C(2)Ar(2,6)H and C(6)Ar(2,6)H); δ (75 MHz, CDCl ) 55.4 (OCH ), 113.3 (app. t, J 3.6, 
C(3) and C(5)), 114.3 (C(2)ArC(3,5)), 123.3 (q, J 272, CF ), 127.1 (C(6)ArC(2,6)), 
128.5 (C(2)ArC(2,6)), 128.9 (C(6)ArC(3,5)), 129.8 (C(6)ArC(4)), 132.8 (C(2)ArC(1)), 
138.4 (C(6)ArC(1)), 139.9 (q, J 33.1, C(4)), 157.8 (C(2) or C(6)), 158.0 (C(2) or C(6)), 
161.2 (C(2)ArC(4)); m/z (NSI
+
) 330 ([M+H]
+
, 100%); HRMS (NSI
+
) C19H15F3NO
+
 
([M+H]
+
) requires 330.1100; found 330.1102 (+0.5 ppm). 
 
2-hexyl-6-phenyl-4-(trifluoromethyl)pyridine 
 
To a flask containing Mg turnings (486 mg, 20.0 mmol) in Et O (10 ml) under an argon 
atmosphere was added 2 drops of bromohexane and the reaction mixture was heated to 
intiate grigard formation. Bromohexane (2.81 mL, 20.0 mmol) was added dropwise to 
maintain autoreflux. Once all bromide was added the reaction mixture was stirred at rt 
for 30 minutes until all Mg was consumed. 
To a screw cap glass test tube was charged pyridine 491 (197 mg, 0.50 mmol), FeCl  
(4.06 mg, 0.025 mmol) and THF (2 mL). N-Methyl-2-pyrrolidone (0.43 mL, 4.50 mmol) 
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was added and the reaction mixture was cooled to –10 °C before the freshly prepared 
hexylmagnesium bromide (2.0 M in Et2O, 0.38 mL, 0.75 mmol) was added dropwise. 
The reaction mixture was stirred at –10 °C for 15 minutes before being quenched with 
MeOH and diluted with H2O. The reaction mixture was extracted with Et2O (x 3). The 
combined organic extracts were dried (MgSO4), filtered and concentrated in vacuo. 
Chromatographic purification (eluent 3% Et O:petrol) gave pyridine 529 as a colourless 
oil (114 mg, 74%); max (ATR)/cm
-1
 2957 (C-H), 2928, 1574; δ (400 MHz, CDCl ) 0.82 
(3H, t, J 7.0, CH ), 1.22-1.35 (6H, m, 3 CH ), 1.70-1.78 (2H, m, C(2)CH CH C H ), 2.84 
(2H, t, J 7.8, C(2)CH C H ), 7.20 (1H, s, C(3)), 7.34-7.43 (3H, m, C(6)Ar(3,5)H and 
C(6)Ar(4)H), 7.64 (1H, s, C(5)H), 7.94-7.97 (2H, m, C(6)Ar(2,6)H); δ (100 MHz, 
CDCl ) 14.1 (CH ) 22.6 (CH CH ), 29.1 (CH ), 29.6 (CH ), 31.7 (CH ), 38.6 
(C(2)CH C H ), 113.3 (q, J 3.5, C(5)), 116.4 (q, J 3.4, C(3)), 123.2 (q, J 272, CF ), 
127.1 (C(6)ArC(2,6)), 128.9 (C(6)ArC(3,5)), 129.6 (C(6)ArC(4)), 138.5 (C(6)ArC(1)), 
139.1 (q, J 33.2, C(4)), 158.1 (C(6)), 164.0 (C(2)); m/z (NSI
+
) 308 ([M+H]
+
, 100%); 
HRMS (NSI
+
) C18H21F3N
+
 ([M+H]
+
) requires 308.1621; found 308.1621 (+0.1 ppm). 
 
6-(4’-ethoxy-[1,1’-biphenyl-4-yl)-4-(trifluoromethyl)pyridine-2-yl 4-
methylbenzenesulfonate 
 
To a screw cap glass test tube was charged Pd(OAc)  (4.49 mg, 0.02 mmol), tris(2,4-di-
tertbutylphenyl)phoshite (25.9 mg, 0.04 mmol), pyridine 493 (944 mg, 2.00 mmol), 4-
ethoxyphenylboronic acid (0.50 g, 3.00 mmol), KF (349 mg, 6.00 mmol) and THF (2 
mL) and the reaction mixture was stirred at rt for 2 h. The reaction mixture was filtered 
through Celite using CH2Cl2 as eluent and concentrated in vacuo. Chromatographic 
purification (eluent 20% Et O:petrol) gave pyridine 531 as a white solid (890 mg, 87%); 
mp 150-152 °C; max (ATR)/cm
-1
 3042, 2976 (C-H), 2936, 1605, 1574, 1503, 1306 
(S=O), 1146 (S=O); δ (500 MHz, CDCl ) 1.49 (3H, t, J 7.0, CH CH ), 2.51 (3H, s, CH ), 
4.13 (2H, m, CH CH ), 7.03 (2H, d, J 8.7, C(6)Ar(3’,5’)H), 7.24 (1H, s, C(3)H), 7.41 
(2H, d, J 8.1, OSO Ar(3,5)H), 7.60 (2H, d, J 8.7, C(6)Ar(2’,6’)H), 7.64 (2H, d, J 8.5, 
C(6)Ar(3,5)H), 7.84 (2H, d, J 8.5, C(6)Ar(2,6)H), 7.87 (1H, s, C(5)H), 8.00 (2H, d, J 
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8.3, OSO Ar(2,6)H); δ (100 MHz, CDCl ) 14.9 (CH CH O), 21.8 (CH Ar), 63.6 
(CH CH O), 109.6 (q, J 3.4, C(3)), 114.0 (q, J 3.0, C(5)), 114.9 (C(6)ArC(3’,5’), 122.2 
(q, J 272, CF ), 127.0 (C(6)ArC(3,5)), 127.5 (C(6)ArC(2,6)), 128.2 (C(6)ArC(2’,6’)), 
128.9 (OSO ArC(2,6)), 129.8 (OSO ArC(3,5)), 132.3 (C(6)ArC(1’)), 134.0 
(OSO ArC(1)), 134.4 (C(6)ArC(4)), 143.0 (C(6)ArC(1)), 143.1 (q, J 34.1, C(4)), 145.5 
(OSO ArC(4)), 157.5 (C(2) or C(6)), 157.7 (C(2) or C(6)), 159.1 (C(6)ArC(4’)); m/z 
(NSI
+
) 514 ([M+H]
+
, 100%); HRMS (NSI
+
) C27H23F3NO4S
+
 ([M+H]
+
) requires 
514.1294; found 514.1287 (-1.4 ppm). 
 
6-(4’-ethoxy-[1,1’-biphenyl-4-yl)-4-(trifluoromethyl)pyridine-2-yl 2-morpholine 
 
To a solution of pyridine 531 (240 mg, 0.47 mmol) in toluene (4 mL) was added Et N 
(131 L, 0.94 mmol) and morpholine (0.40 mL, 4.68 mmol) and the reaction mixture 
was heated at 120 °C for 16 h. Once cooled, the reaction mixture was concentrated in 
vacuo. Chromatographic purification (eluent 30% Et O:petrol) gave pyridine 532 as a 
white solid (163 mg, 82%); mp 178-180 °C; max (ATR)/cm
-1
 2982 (C-H), 2853, 1603, 
1574; δ (300 MHz, CDCl ) 1.36 (3H, t, J 7.0, CH CH ), 3.60 (4H, t, J 4.9, 2 NCH ), 3.79 
(4H, t, J 4.9, 2 OCH ), 4.00 (2H, q, J 7.0, CH CH ), 6.66 (1H, s, C(3)H), 6.88-6.93 (2H, 
m, C(6)Ar(3’,5’)H), 7.24 (1H, s, C(5)H), 7.47-7.52 (2H, m, C(6)Ar(2’,6’)H), 7.54-7.58 
(2H, m, C(6)Ar(3,5)H), 7.96-8.00 (2H, m, C(6)Ar(2,6)H); δ (75 MHz, CDCl ) 14.9 
(CH CH O), 45.4 (NCH ), 63.6 (CH CH O), 66.7 (OCH ), 100.7 (q, J 3.8, C(3)), 105.1 
(q, J 3.2, C(5)), 114.9 (C(6)ArC(3’,5’), 123.4 (q, J 272, CF ), 126.9 (C(6)ArC(3,5)), 
127.3 (C(6)ArC(2,6)), 128.1 (C(6)ArC(2’,6’)), 132.8 (C(6)ArC(1’)), 136.9 (C(6)ArC(4)), 
140.7 (q, J 32.3, C(4)), 141.9 (C(6)ArC(1)), 157.5 (C(6)), 158.9 (C(6)ArC(4’)), 159.3 
(C(2)); m/z (NSI
+
) 429 ([M+H]
+
, 100%); HRMS (NSI
+
) C24H24F3N2O2
+
 ([M+H]
+
) 
requires 429.1784; found 429.1782 (-0.6 ppm). 
 
N-cyclohexyl-6-(4-(methylsulfonyl)phenyl)-4-(trifluoromethyl)pyridin-2-amine 
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To a solution of pyridine 494 (335 mg, 0.71 mmol) in toluene (5 mL) was added Et N 
(0.20 mL, 1.42 mmol) and cyclohexylamine (0.40 mL, 3.56 mmol) and the reaction 
mixture was heated at 120 °C for 16 h. A further portion of cyclohexylamine (0.40 mL, 
3.56 mmol) was added and the reaction mixture was heated at 120 °C for a further 24 h. 
Once cooled, the reaction mixture was concentrated in vacuo. Chromatographic 
purification (eluent 100% Et O) gave pyridine 533 as white solid (260 mg, 92%); mp 
130-132 °C;
3
 δ (400 MHz, CDCl ) 1.27-1.55 (5H, m, cyclohexyl CH), 1.69-1.74 (1H, m, 
cyclohexyl CH), 1.80-1.86 (2H, m, cyclohexyl CH), 2.10-2.14 (2H, m, cyclohexyl CH), 
3.11 (3H, s, SO CH ), 3.72-3.76 (1H, m, NHCH), 4.86 (1H, d, J 7.1, NH), 6.58 (1H, s, 
C(3)H), 7.21 (1H, s, C(5)H), 8.03-8.06 (2H, m, ArH), 8.17-8.20 (2H, m, ArH). 
 
Crossover Experiment 
Following general procedure S, (phenylthio)acetic acid (84.1 mg, 0.50 mmol) in THF (5 
mL), i-Pr2NEt (130 L, 0.75 mmol), pivaloyl chloride (92.5 L, 0.75 mmol), imine 542 
(85.0 mg, 0.25 mmol), imine 541 (108 mg, 0.25 mmol), DHPB 108 (19.0 mg, 0.1 mmol, 
20 mol%) and i-Pr2NEt (87.5 L, 0.50 mmol) for 30 minutes at rt followed by heating at 
reflux for 16 h gave, by analysis of the crude 
1
H NMR, a crude reaction mixture 
containing 50% of both pyridines 493 and 496. 
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